Citrus Sinensis ID: 047038
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 708 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.944 | 0.894 | 0.430 | 1e-144 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.939 | 0.923 | 0.440 | 1e-143 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.887 | 0.792 | 0.429 | 1e-141 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.884 | 0.822 | 0.437 | 1e-140 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.864 | 0.795 | 0.429 | 1e-137 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.891 | 0.864 | 0.416 | 1e-134 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.881 | 0.830 | 0.431 | 1e-132 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.867 | 0.841 | 0.438 | 1e-132 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.867 | 0.839 | 0.419 | 1e-127 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.841 | 0.758 | 0.426 | 1e-126 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 512 bits (1319), Expect = e-144, Method: Compositional matrix adjust.
Identities = 314/730 (43%), Positives = 433/730 (59%), Gaps = 61/730 (8%)
Query: 21 KAKERCPNQCGGVNIRYPFGIG-EGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMS 79
+ +RC CG ++I +PFGIG + CY + +EVVC NST S L IN EL
Sbjct: 30 QPPDRCNRVCGEISIPFPFGIGGKDCYLNPWYEVVC--NSTNS-VPFLSRINRELVNISL 86
Query: 80 NGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQTD-NRFIAIGCNSYA-- 136
NG + + V TS + +N++G + TD N +A+GC A
Sbjct: 87 NG----VVHIKAPVTSSGCSTGTSQPLTPPPLNVAGQGSPYFLTDKNLLVAVGCKFKAVM 142
Query: 137 ----QQIDSSWCRPICTCNPTQNSDCCNMLCN--------IPQSSIIIKVLDAYSSYVYS 184
QI S C C + + + N +CN IP+ + +D +
Sbjct: 143 AGITSQITS--CESSCNERNSSSQEGRNKICNGYKCCQTRIPEGQPQVISVDIEIPQGNN 200
Query: 185 QNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEW-------GKTGGSTC---- 233
C V+ + D + S + P Y + +L W T +C
Sbjct: 201 TTGEGGC-RVAFLTSDKYSSLNVTEPEKFHGHGYAAVELGWFFDTSDSRDTQPISCKNAS 259
Query: 234 -SEEYNLDTSCNQDGYCLVQLGSGYF---CLCNDRRLSGTYPDLCEGYYDFNQ------E 283
+ Y DT C+ C SG+ C CN G P L G D ++
Sbjct: 260 DTTPYTSDTRCS----CSYGYFSGFSYRDCYCNSPGYKGN-PFLPGGCVDVDECKLDIGR 314
Query: 284 LQCQSRTSHSL------RFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIK 337
QC+ ++ +L + +K + K +I G IG +L G LYKF ++R ++
Sbjct: 315 NQCKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGS-ALLLFAFGIFGLYKFVQKRRKLI 373
Query: 338 LKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKG 397
KFF+RNGG+LL+Q+L+ EG ++ +++F+S+ELEKATDNFN NR+LGQGGQGTVYKG
Sbjct: 374 RMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKG 433
Query: 398 MLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457
ML DG+IVAVK+SK +DE +VEEFINEVV+L+QINHRN+VKLLGCCLETEVP+LVYEF+
Sbjct: 434 MLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVP 493
Query: 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517
NG L + + D++ D+ ++WE+RL IAI+++GA+SYLHSAAS PIYHRDIK+TNILLD++
Sbjct: 494 NGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERN 553
Query: 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG 577
AKVSDFG SRS+ +DQTHLTTQV GTFGY+DPEYFQSS FTEKSDVYSFGVVLVELLTG
Sbjct: 554 RAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTG 613
Query: 578 ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNG 637
E+P SEE++ LAA+F+ A++E+R+ +I+D +I E D+ VA LA+RCLN G
Sbjct: 614 EKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKG 673
Query: 638 KKRPTMREVGIELTGIRGCNGASNI-VHQGCFEEIHCVDGGIAETSEIYGSVAQSI-SES 695
KKRP MREV IEL IR + S I + E+ ++ +T E+ + S+ + +
Sbjct: 674 KKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNFNDTWEVGATAPASMFNNA 733
Query: 696 TISKDADPLI 705
+ + DA+PL+
Sbjct: 734 SPTSDAEPLV 743
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-143, Method: Compositional matrix adjust.
Identities = 313/710 (44%), Positives = 419/710 (59%), Gaps = 45/710 (6%)
Query: 22 AKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMSNG 81
A C + CG V++ YPFGIG+GCY +K FE+VC ++S + P LL I ++ + + G
Sbjct: 29 ALRNCSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRRAVTSF-NLG 87
Query: 82 SGLAYISVNISVIRLNRRKSTSHN---INAKGVNLSGTPFSFSQTDNRFIAIGCNSYA-- 136
+ N I+ + S N ++ +NL G+PF S+ +N+F A+GCN+ A
Sbjct: 88 DPFSISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLKGSPFFISE-NNKFTAVGCNNKAFM 146
Query: 137 --QQIDSSWCRPIC----TCNPTQNSDCCNMLC---NIPQSSIIIKVLDAYSSYVYSQNI 187
+ C C N+ C C IP + ++V DA +
Sbjct: 147 NVTGLQIVGCETTCGNEIRSYKGANTSCVGYKCCQMTIP-PLLQLQVFDATVEKLEPNK- 204
Query: 188 SQVCTSVSVVYLDWFFSNYLRF--PNVLENKEYVSAKLEWGKTGGSTCSEEYNLDTSCNQ 245
Q C V +L F + F P ++E EY + +LEW LD S
Sbjct: 205 -QGC---QVAFLTQFTLSGSLFTPPELMEYSEYTTIELEW------------RLDLSYMT 248
Query: 246 DGYCLVQLGSGYF-----CLCNDRRLSGTY-PDLCEGYYDFNQEL--QCQSRTSHSLRFR 297
L + G+ +F C C++ Y P C+ + +C R ++
Sbjct: 249 SKRVLCK-GNTFFEDSYQCSCHNGYEGNPYIPGGCQDIDECRDPHLNKCGKRKCVNVLGS 307
Query: 298 KKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELSS 357
+ + I G+L L+ G L K R+R K K KFF+RNGGLLLQQ+ S
Sbjct: 308 YRCEKTWPAILSGTLSSGLLLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSF 367
Query: 358 NEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESK 417
G +++TK+F+SN+LE ATD FN +RILGQGGQGTVYKGMLEDG IVAVKKSK + E
Sbjct: 368 LHGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEEN 427
Query: 418 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWE 477
+EEFINE+++LSQINHRNVVK+LGCCLETEVP+LVYEFI N L ++ + ++DF +SWE
Sbjct: 428 LEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWE 487
Query: 478 MRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537
+RLCIA +V+ A+SYLHSA SIPIYHRD+KSTNILLD+K+ AKVSDFG SRS+A+D THL
Sbjct: 488 VRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHL 547
Query: 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597
TT VQGT GY+DPEY QS+HFT KSDVYSFGV+L+ELLTGE+P+ L +E + L AYFL
Sbjct: 548 TTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFL 607
Query: 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657
AMR DRL EILDA+I +E ++E VAKLA+RCL+LN + RPTMR+V IEL ++
Sbjct: 608 EAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKR 667
Query: 658 GASNIVHQGCFEEIHCVDGGIAETSEIYGSVAQSISESTISKDADPLISN 707
+ Q E H S Y S + S+ S D PL+ +
Sbjct: 668 KGTQSQAQNGEEHAHIQIAMPESMSLSYSSPNIVVENSSFSLDTKPLMPH 717
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 310/721 (42%), Positives = 423/721 (58%), Gaps = 93/721 (12%)
Query: 14 LLLCPIIKAKER----CPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKS 69
L LC I+ + +R C CGG+ I YPFG+G+GCY +K +E+ C+ +++ L
Sbjct: 15 LQLCFILDSADRTVSLCQPDCGGIKIPYPFGMGKGCYLEKWYEITCNTSTSGKLVPYLSV 74
Query: 70 INLELS----PYMSNGSGL--AYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQT 123
IN E+ P GS Y SVNI ++ S++ +NL+GTPF SQ
Sbjct: 75 INKEVVGISLPTEGRGSRYNNPYQSVNIKNPIASKECSSNGEELGSLLNLTGTPFYVSQ- 133
Query: 124 DNRFIAIGCNSYAQQIDSS----WCRPICTCNP------------TQNSDCCNMLCNIPQ 167
N +A+GCN+ A + C C+ P QN + CN
Sbjct: 134 HNELVAVGCNNTASLTNVKPSIVQCTSSCSTKPHTHIKDYLAVLNCQNYNGYEKNCN-ED 192
Query: 168 SSIIIKVLDAYS--------SYVYSQNISQVC-----TSVSVVYLDWFFSNYLRF----- 209
SS+ ++D S +Y+ +I Q+ +++ F +N +
Sbjct: 193 SSMDESIMDETSCNGIGCCNAYMRGGSIQQIVGVTIENTITRGCKVAFLTNKAEYLSNKS 252
Query: 210 -PNVLENKEYVSAKLEWG---------KTGGSTCSEEYNLD-----------TSCNQDGY 248
P L + Y + +L W K+ G +EYN + TSC D
Sbjct: 253 DPQKLHARGYSTVELGWFIHTTNHSFIKSLGCYSVKEYNNERYTSTQRRINITSCICDDN 312
Query: 249 CLVQLGSGYFCLC------NDRRLSGTYPDLCEGYYDFNQEL--------QCQSRTSHSL 294
+ C C N RL G C+ + +E +C + H
Sbjct: 313 AYLSYAR---CSCTRGFQGNPYRLGG-----CKDINECKEEEGMTYCGTNKCVNLQGHFK 364
Query: 295 RFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQE 354
R I +G + G L + G LYKF +++ ++ K KFFKRNGGLLLQQ+
Sbjct: 365 CVYNNHRPLAIGLGASFGS---LIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQ 421
Query: 355 LSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID 414
L S G ++KT +F+S ELEKAT+NF++NRILGQGGQGTVYKGML DG+IVAVKKSK++D
Sbjct: 422 LISTVGMVEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVD 481
Query: 415 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQ-NKDFR 473
E K+EEFINEVVILSQINHRN+VKLLGCCLET+VP+LVYEFI NG L +++ D+ +++
Sbjct: 482 EDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIM 541
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533
+W +RL IAID++GA+SYLHS+AS PIYHRD+KSTNI+LD+KY AKVSDFG SR++ VD
Sbjct: 542 ATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVD 601
Query: 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA 593
THLTT V GT GY+DPEYFQSS FT+KSDVYSFGVVLVEL+TGE+ I S+E+++LA
Sbjct: 602 HTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLA 661
Query: 594 AYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
YF+ AM+E++LF+I+DA+I + AK+A++CLNL G+KRP+MREV +EL I
Sbjct: 662 TYFILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSI 721
Query: 654 R 654
R
Sbjct: 722 R 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 499 bits (1285), Expect = e-140, Method: Compositional matrix adjust.
Identities = 300/685 (43%), Positives = 406/685 (59%), Gaps = 59/685 (8%)
Query: 26 CPNQCGGVNIRYPFGIG-EGCYFDKSFEVVCDNNSTRSPKALLKSINLEL--------SP 76
C CGG++I +PFGIG + CY + +EVVC N +T P L IN EL +
Sbjct: 33 CNRVCGGISIPFPFGIGGKECYLNPWYEVVC-NTTTSVP--FLSRINRELVNIYLPDPTE 89
Query: 77 YMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQTD-NRFIAIGCNSY 135
Y SNG + + V TS + + +N++G + TD N +A+GCN
Sbjct: 90 YYSNG----VVHIKGPVTSSGCSTGTSQPLTPQPLNVAGQGSPYFLTDKNLLMAVGCNVK 145
Query: 136 AQQIDSS----WCRPICTCNPTQNSDCCNMLCN--------IPQSSIIIKVLDAYSSYVY 183
A +D C C + + N +C+ IP+ +V+
Sbjct: 146 AVMMDVKSQIIGCESSCDERNSSSQVVRNKICSGNKCCQTRIPEGQP--QVIGVNIEIPE 203
Query: 184 SQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEW-GKTGGSTCSEE---YNL 239
++N ++ V+ + + + S + P + Y +L W T S N+
Sbjct: 204 NKNTTEGGCKVAFLTSNKYSSLNVTEPEEFHSDGYAVVELGWYFDTSDSRVLSPIGCMNV 263
Query: 240 DTSCNQDGY---CLVQLGSGYF-------CLCNDRRLSGTYPDLCEGYYDFNQ------E 283
+ GY + GYF C CN +G P L G D ++
Sbjct: 264 SDASQDGGYGSETICVCSYGYFSGFSYRSCYCNSMGYAGN-PFLPGGCVDIDECKLEIGR 322
Query: 284 LQCQSRTS------HSLRFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIK 337
+C+ ++ + +K + K + G IG +L G LYKF +++
Sbjct: 323 KRCKDQSCVNKPGWFTCEPKKPGQIKPVFQGVLIGS-ALLLFAFGIFGLYKFIKKQRRSS 381
Query: 338 LKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKG 397
FF+RNGG+LL+Q+L+ EG ++ +K+F+SNELEKATDNFNTNR+LGQGGQGTVYKG
Sbjct: 382 RMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKG 441
Query: 398 MLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457
ML DG+IVAVK+SK +DE KVEEFINEVV+L+QINHRN+VKLLGCCLETEVP+LVYEF+
Sbjct: 442 MLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVP 501
Query: 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517
NG L + + D+ D+ ++WE+RL IAI+++GA+SYLHSAAS PIYHRDIK+TNILLD+KY
Sbjct: 502 NGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKY 561
Query: 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG 577
KVSDFG SRS+ +DQTHLTTQV GTFGY+DPEYFQSS FT+KSDVYSFGVVLVEL+TG
Sbjct: 562 QVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITG 621
Query: 578 ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNG 637
+ P SEE++ AA+F+ A++E+R +I+D +I E D+ VAKLAKRCLN G
Sbjct: 622 KNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKG 681
Query: 638 KKRPTMREVGIELTGIRGCNGASNI 662
KKRP MREV +EL IR + S I
Sbjct: 682 KKRPNMREVSVELERIRSSSYKSEI 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 300/699 (42%), Positives = 403/699 (57%), Gaps = 87/699 (12%)
Query: 26 CPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMSNGSGLA 85
CP CGG++I YPFGIG GCY +K +E++C NNS L IN E+ +
Sbjct: 27 CPKTCGGIDIPYPFGIGTGCYLEKWYEIICVNNSV----PFLSIINREVVSISFSDMYRR 82
Query: 86 YISVNISVIRLNRRKSTSHNINAKG------VNLSGTPFSFSQTDNRFIAIGCNSYA--- 136
+ +V IR+ R S ++ G +N++G PF +N IA+GCN+ A
Sbjct: 83 FFNVGYGSIRI-RNPIASKGCSSGGQEFGSLLNMTGYPFYLGD-NNMLIAVGCNNTASLT 140
Query: 137 ----------------QQI----------------DSSWCRPICTCNPT--QNSDCCNML 162
Q I DS +C+ I N T CC
Sbjct: 141 NVEPSIVGCESTCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKAS 200
Query: 163 CNIPQSSIIIKVLDAYSSYVYSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAK 222
II +D S S+ C + ++F SN P L Y +
Sbjct: 201 LPARYQQIIGVEIDD------SNTESKGCKVAFITDEEYFLSNGSD-PERLHANGYDTVD 253
Query: 223 LEW----------GKTGGSTCSE---------EYNLDTSCNQD----GYCLVQLGSGYFC 259
L W G G + E EY + C+ + GY SG+
Sbjct: 254 LRWFIHTANHSFIGSLGCKSIDEYTILRRDNREYGIGCLCDYNSTTTGYATCSCASGFE- 312
Query: 260 LCNDRRLSGTYPDLCEGYYDFNQELQCQSRTSHSLRFR---KKSRDKFIIIGCTIGGLGM 316
+ + G D+ E + C + +L + + + ++IG +
Sbjct: 313 --GNPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNHRPLVIGLSTS-FST 369
Query: 317 LSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKA 376
L + G WLYKF RR+ + K KFFKRNGGLLLQQ+L++ EG +D T++F S ELEKA
Sbjct: 370 LVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKA 429
Query: 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
T+NF+ RILG+GGQGTVYKGML DG+IVAVKKSK++DE K+EEFINEVVILSQINHRN+
Sbjct: 430 TENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNI 489
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRIS-WEMRLCIAIDVSGAISYLHS 495
VKLLGCCLET+VP+LVYEFI NG L +++ D + D+ ++ WE+RL IA+D++GA+SYLHS
Sbjct: 490 VKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHS 549
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
AAS PIYHRDIKSTNI+LD+K+ AKVSDFG SR++ VD THLTT V GT GY+DPEYFQS
Sbjct: 550 AASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQS 609
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615
S FT+KSDVYSFGVVL EL+TGE+ + S+E ++LA YF AM+E+RL +I+DA+I
Sbjct: 610 SQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRD 669
Query: 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
++ AK+A++CLN+ G+KRP+MR+V +EL IR
Sbjct: 670 GCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 480 bits (1236), Expect = e-134, Method: Compositional matrix adjust.
Identities = 283/679 (41%), Positives = 402/679 (59%), Gaps = 48/679 (7%)
Query: 18 PIIKAKERCPNQCGGVNIRYPFGIG-EGCYFDKSFEVVCDNNSTRSPK--ALLKSINLEL 74
PI + C CGG++I +PFGIG + CY + +EV+C+ ++ S LL IN E+
Sbjct: 31 PISNSSTSCNKTCGGISIPFPFGIGGKDCYLNGWYEVICNTTTSDSNTTVPLLSMINREV 90
Query: 75 S----PYMSNGSGLAYISVNISVI--RLNRRKSTSHNINAKGVNLSGTPFSFSQTDNRFI 128
P + GL I ++ + N + +++ V G+P+ F +NR +
Sbjct: 91 VNISLPDSNEPYGLVQIKGPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPY-FLTDENRLV 149
Query: 129 AIGCNSYAQQIDSS----WCRPICTCNPTQNSDCCNMLCN---IPQSSIIIKVLDAYSSY 181
A+GC A D+ C C + + N++C Q+ + + A +
Sbjct: 150 AVGCGIKALMTDTESEILGCESSCE-HRKSGEEVTNLICTGYRCCQARLPVGRPQAITVN 208
Query: 182 VYSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEW-------------GKT 228
+ + + + V+ + + + + P N YV +L W G T
Sbjct: 209 IENSSGGEETCKVAFLTDKRYSPSNVTEPEQFHNNGYVVLELGWYFATSNSRFKSLLGCT 268
Query: 229 GGSTCSEEYNLDT-SCNQDGYCLVQLGSGYF-CLCNDRRLSGTY-------PDLCEGYYD 279
S ++ D SC D + G Y C C+ Y D CEG ++
Sbjct: 269 NMSRKGSGFSDDNCSCEYDYFS----GMSYRNCYCDYGYTGNPYLRGGCVDTDSCEGNHN 324
Query: 280 FNQELQCQSRTSHSLRFRKKSR----DKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGE 335
++ C + R + K ++ + GL L G WL+K ++R
Sbjct: 325 CGEDAHCVNMPGPMSMCRPNPKITKPTKPPVLQGILIGLSGLVFFVGLFWLFKLIKKRRN 384
Query: 336 IKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVY 395
I KFFKRNGGLLL+Q+L++ +G ++ +K+F+S EL KATDNF+ +R+LGQGGQGTVY
Sbjct: 385 INRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVY 444
Query: 396 KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455
KGML DG IVAVK+SK++DE K+EEFINE+V+LSQINHRN+VKLLGCCLETEVP+LVYE+
Sbjct: 445 KGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEY 504
Query: 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD 515
I NG L + + D++ D+ ++WE+RL IAI+++GA++Y+HSAAS PI+HRDIK+TNILLD+
Sbjct: 505 IPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDE 564
Query: 516 KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575
KY AKVSDFG SRS+ +DQTHLTT V GTFGY+DPEYF SS +T KSDVYSFGVVLVEL+
Sbjct: 565 KYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELI 624
Query: 576 TGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNL 635
TGE+P+ SEE + LA +FL AM+E+R+ +I+D +I E ++ VAKLA++CLN
Sbjct: 625 TGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNR 684
Query: 636 NGKKRPTMREVGIELTGIR 654
GK RP M+EV EL IR
Sbjct: 685 KGKNRPNMKEVSNELERIR 703
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1220), Expect = e-132, Method: Compositional matrix adjust.
Identities = 306/709 (43%), Positives = 416/709 (58%), Gaps = 85/709 (11%)
Query: 8 VLLHIILLLC--PIIKAKERCPNQ-------CGGVNIRYPFGIGE-GCYFDKSFEVVCDN 57
VLL I+ L P+I + P+ CGG+ I +PFGIG C+ + +EVVC
Sbjct: 10 VLLSILTLFINGPLITTAQSPPSSSTSCNRICGGIEIPFPFGIGRRDCFLNDWYEVVC-- 67
Query: 58 NSTRSPKAL---LKSINLELSPYMSNGS-----GLAYISVNISVIRLNRRKSTSHNINAK 109
NST S K+L L IN EL S G+ +I ++ ++R +N
Sbjct: 68 NSTTSGKSLAPFLYKINRELVSITLRSSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLT 127
Query: 110 GVNLSGTPFSFSQTDNRFIAIGCNSYAQQIDS----SWCRPICTCNPTQ-NSDCCNMLC- 163
G G+PF F NR +++GC++ A D + C C + ++ + C C
Sbjct: 128 G---KGSPF-FITDSNRLVSVGCDNRALITDIESQITGCESSCDGDKSRLDKICGGYTCC 183
Query: 164 --NIPQSSIIIKVLDAYSS-----------------YVYSQ-NISQ----VCTSVSVVYL 199
IP + +D SS YS N+++ +V+ L
Sbjct: 184 QAKIPADRPQVIGVDLESSGGNTTQGGNCKVAFLTNETYSPANVTEPEQFYTNGFTVIEL 243
Query: 200 DWFF-------SNYLRFPNVLENKEYVSAK---LEWGKTGGSTCSEEYNLDTSCNQDGYC 249
W+F +N + N+ E Y SA E+G G S Y CNQ GY
Sbjct: 244 GWYFDTSDSRLTNPVGCVNLTETGIYTSAPSCVCEYGNFSGFGYSNCY-----CNQIGY- 297
Query: 250 LVQLGSGYF---CLCNDRRLSGTYPDLCEGYYDFNQELQCQSRT-SHSLRFRKKSRDKFI 305
G+ Y C+ D G C EL C + S + K +
Sbjct: 298 ---RGNPYLPGGCIDIDECEEGKGLSSC-------GELTCVNVPGSWRCELNGVGKIKPL 347
Query: 306 IIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKT 365
G +G +L L+ G L KF ++R +I K FFKRNGGLLL+Q+L++ G + +
Sbjct: 348 FPGLVLG-FPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSS 406
Query: 366 KLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEV 425
K+F+S ELEKATDNFN NR+LGQGGQGTVYKGML DG+IVAVK+SK++DE KVEEFINEV
Sbjct: 407 KIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEV 466
Query: 426 VILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAID 485
+LSQINHRN+VKL+GCCLETEVP+LVYE I NG L + + + D+ ++W++RL I+++
Sbjct: 467 GVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVE 526
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
++GA++YLHSAAS P+YHRD+K+TNILLD+KY AKVSDFG SRSI VDQTHLTT V GTF
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTF 586
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
GYLDPEYFQ+S FT+KSDVYSFGVVLVEL+TGE+P + EE++ L ++F AM+++R+
Sbjct: 587 GYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRV 646
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
+I+D++I + ++ VAKLA+RCL+L GKKRP MREV +EL IR
Sbjct: 647 LDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIR 695
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 298/679 (43%), Positives = 414/679 (60%), Gaps = 65/679 (9%)
Query: 26 CPNQCGGVNIRYPFGIG-EGCYFDKSFEVVCDNNSTRSPKAL--LKSINLEL-------- 74
C GG++I +PFGIG + CY + +EVVC++ ++ S K + L IN E+
Sbjct: 37 CNRTFGGISIPFPFGIGGKDCYLNSWYEVVCNSTTSGSCKTVPFLTRINREVVNISLPKS 96
Query: 75 ---SPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSG--TPFSFSQTDNRFIA 129
SPY G+ +I ++ + + S +N++G +P+ F +NR +A
Sbjct: 97 DFFSPY-----GVVHIKGPVTSLGCSSNISQGLQKTLPDLNITGRGSPY-FLTDENRLVA 150
Query: 130 IGCNSYA--QQIDSSWCRPICTCNPTQNSDCCNMLCN---IPQSSIIIKVLDAYSSYVYS 184
+GC + A I+S +C T++++ N LCN Q+ + ++ A + S
Sbjct: 151 VGCGTKALMTDIESEILGCESSCKDTKSNEVGNSLCNGYKCCQARLPVERPQAVGVNIES 210
Query: 185 QNIS--QVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEW-------------GKTG 229
N + + C + + + +F SN + P + Y +L W G T
Sbjct: 211 NNDTRGEGCKAAFLTSMKYFPSNITK-PEWFQADGYAVVELGWYFDTSDSRFRNPLGCTN 269
Query: 230 GSTCSEEYNLDTSC-------NQDGYCLVQLGSGYFCLCNDRRLSGTYPDL--CEGYYDF 280
+ S Y L C ++ Y GSGY + + G D+ CE
Sbjct: 270 LTRSSGSYFLTDICLCRYGYFSRMSYRSCYCGSGYR---GNPYIRGGCIDIDECEVPNKC 326
Query: 281 NQE--LQCQSRTSHSLRFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKL 338
++ + R S + K ++ ++ G IG LG+L + G LYKF R+R I
Sbjct: 327 GEDTCVNMAGRYSCVPKITKPAKLAHVLRGVLIGLLGLLFFVIGIFGLYKFIRKRRRIIR 386
Query: 339 KHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM 398
KFFKRNGGLLL+Q+L++ +G ++ +K+F+S ELEKATDNF+ +R+LGQGGQGTVYK M
Sbjct: 387 SMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRM 446
Query: 399 LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458
L DG IVAVK+SK++DE K+EEFINE+V+LSQINHRN+VKLLGCCLETEVP+LVYE+I N
Sbjct: 447 LVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPN 506
Query: 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518
G L + + D+ D+ ++WE+RL IA++++GA+SY+HSAAS PI+HRDIK+TNILLD+KY
Sbjct: 507 GDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYR 566
Query: 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
AK+SDFG SRS+A DQTHLTT V GTFGY+DPEYF SS +T KSDVYSFGVVLVEL+TGE
Sbjct: 567 AKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGE 626
Query: 579 RPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKM---VAKLAKRCLNL 635
+P+ SEE LA YFL AM+E+R +I+D +I KDE K VAKLA+RCLN
Sbjct: 627 KPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRI-----KDESKQVMAVAKLARRCLNR 681
Query: 636 NGKKRPTMREVGIELTGIR 654
G KRP MREV I+L IR
Sbjct: 682 KGNKRPNMREVSIKLERIR 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 285/680 (41%), Positives = 413/680 (60%), Gaps = 66/680 (9%)
Query: 26 CPNQCGGVNIRYPFGIG-EGCYFDKSFEVVCD---NNSTRSPKALLKSINLE---LSPYM 78
C CGG++I +PFGIG + CY + +EVVC+ + S+ + L IN E +S
Sbjct: 42 CNRTCGGISIPFPFGIGGKDCYLNGWYEVVCNATTSGSSGTTVPFLSRINREVVNISLPE 101
Query: 79 SNGSGLAYISVNISVIRLNRRKSTSH-------NINAKGVNLSGTPFSFSQTDNRFIAIG 131
N + + V L +TS ++N G G+P+ F +NR +A+G
Sbjct: 102 GNNEQYGVVHIKGPVTSLGCSSNTSQVPQKSLPDLNVTG---KGSPY-FITDENRLVAVG 157
Query: 132 CNSYA--QQIDSSWCRPICTCNPTQNS-DCCNMLCN---IPQSSIIIKVLDAYS------ 179
C + A I+S +C +++S + N+LC+ Q+ I ++ A
Sbjct: 158 CGTKALMTDIESEILGCESSCKDSKSSQEVTNLLCDGYKCCQARIPVERPQAVGVNIESS 217
Query: 180 -------SYVYSQNISQVCTSVS---------VVYLDWFFSNY-LRFPNVLE--NKEYVS 220
+++ S+ S ++ VV L W+F+ RF N L N Y
Sbjct: 218 GGDGCKVAFLSSKRYSPSNVTIPEQFHAGGYVVVELGWYFATTDSRFRNPLGCINLTYSG 277
Query: 221 AKLEWGKTGGSTCSEEYNLDTSCN-QDGYCLVQL-GSGYF---CLCNDRRLSGTYPDLCE 275
+ L G +C EY + + ++ YC + G+ Y C+ ND P++CE
Sbjct: 278 SYLS-----GDSCLCEYGYFSEMSYRNCYCSLGFTGNPYLRGGCIDND---DCKGPNICE 329
Query: 276 GYYDFNQELQCQSRTSHSLRFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGE 335
N + R + K ++ + + ++ GTL L F ++R
Sbjct: 330 EGTCVN--VPGGYRCDPKPKIIKPAKPLVLQGVLLGLMGLLFLVV-GTLGLIIFIKKRRR 386
Query: 336 IKLKHKFFKRNGGLLLQQELSS-NEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTV 394
I KFFKRNGGLLL+Q+L++ N+G +D ++LF+S EL+KATDNF+ R+LG+G QGTV
Sbjct: 387 IISSRKFFKRNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATDNFSVKRVLGKGSQGTV 446
Query: 395 YKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454
YKGM+ DGKI+AVK+SK++DE K+E+FINE+++LSQINHRN+VKL+GCCLETEVP+LVYE
Sbjct: 447 YKGMMVDGKIIAVKRSKVVDEDKLEKFINEIILLSQINHRNIVKLIGCCLETEVPILVYE 506
Query: 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD 514
+I NG + + + D++ D+ ++WE+RL IAI+++GA++Y+HSAAS PIYHRDIK+TNILLD
Sbjct: 507 YIPNGDMFKRLHDESDDYAMTWEVRLRIAIEIAGALTYMHSAASFPIYHRDIKTTNILLD 566
Query: 515 DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVEL 574
+KY AKVSDFG SRS+ +DQTHLTT V GTFGY+DPEYF SS +T+KSDVYSFGVVLVEL
Sbjct: 567 EKYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEYFLSSQYTDKSDVYSFGVVLVEL 626
Query: 575 LTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLN 634
+TGE+P+ SEE + LA +FL AM+E+R+ +I+D +I +E D+ VAKLA++CL+
Sbjct: 627 ITGEKPLSRIRSEEGRGLATHFLEAMKENRVIDIIDIRIKEESKLDQLMAVAKLARKCLS 686
Query: 635 LNGKKRPTMREVGIELTGIR 654
G KRP MRE +EL IR
Sbjct: 687 RKGIKRPNMREASLELERIR 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 302/708 (42%), Positives = 404/708 (57%), Gaps = 112/708 (15%)
Query: 29 QCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMSNGSGLAYIS 88
+CGG+ I YPFGIG+GCY +KS+E+ C N S + L P++S IS
Sbjct: 41 KCGGIAIPYPFGIGKGCYLEKSYEIECLNTSGK------------LVPFLS------VIS 82
Query: 89 VNISVIRLNRRKS----------TSHNINAKG------VNLSGTPFSFSQTDNRFIAIGC 132
+ I L R+S TS ++ G +NL+ +PF S +N + +GC
Sbjct: 83 KEVVSIHLPGRQSFGSVRVRSPITSAGCSSDGKDSAPVMNLTDSPFFVSDINN-LVGVGC 141
Query: 133 NS-----YAQQ----------------------IDSSWCR------PICTCNPTQNSDCC 159
+S + +Q D + C +CT N ++ C
Sbjct: 142 SSKVSLEHIKQNMVGCELNCSTTNASDSNSIPFFDKTGCSFSYTFAQVCTGNKPEDMGCD 201
Query: 160 NMLC------NIPQSSIIIKVLDAYSSYVYSQNISQVCTS--VSVVYL-DWFFS-NYLRF 209
C PQ I I++ N + TS V +L D FFS + L
Sbjct: 202 GRGCCQASLPREPQQVIGIRI---------ESNDGKSTTSGDCRVAFLTDEFFSLSKLTK 252
Query: 210 PNVLENKEYVSAKLEWGKTGGST-------CSEEYNLDTSCNQD-------GYCLVQLGS 255
P L K Y + L W +T C + DT+ + D Y + +
Sbjct: 253 PEQLHAKRYATLSLGWIMQTRNTSFVNSLACKIRKDTDTAYSNDQSIKCICDYTMSIISD 312
Query: 256 GYF--CLCNDRRLSGTY-PDLCEGYYDFNQELQCQSRTSHSLRFRKKSR-----DKFIII 307
+ C CN Y D C + + + T + F R K I+I
Sbjct: 313 IRYANCECNLGYKGNPYDSDGCRDIDECKENPKYCKETDTCVNFEGGYRCVGDKTKAIMI 372
Query: 308 GCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKL 367
G G G+L L+ G WL KF +R K K KFFKRNGGLLLQQEL++ +G ++K ++
Sbjct: 373 GAGTG-FGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARI 431
Query: 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVI 427
FTS ELEKAT+NF+ NR+LG GGQGTVYKGML DG+ VAVKKSK+IDE K++EFINEVVI
Sbjct: 432 FTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVI 491
Query: 428 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDV 486
LSQINHR+VVKLLGCCLETEVP+LVYEFI NG L ++I +++ D+ + W MRL IA+D+
Sbjct: 492 LSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDI 551
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
+GA+SYLHSAAS PIYHRDIKSTNILLD+KY AKV+DFG SRS+ +DQTH TT + GT G
Sbjct: 552 AGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVG 611
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRL 605
Y+DPEY++SS +TEKSDVYSFGV+L EL+TG++P I + N++E +LA +F AM+E RL
Sbjct: 612 YVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRL 671
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+I+DA+I + ++ VA LA +CL+ G+ RP MREV EL I
Sbjct: 672 SDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 708 | ||||||
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.902 | 0.920 | 0.517 | 1e-173 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.967 | 0.942 | 0.492 | 1e-171 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.851 | 0.695 | 0.526 | 1e-171 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.847 | 0.883 | 0.514 | 1e-170 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.861 | 0.742 | 0.514 | 1e-166 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.903 | 0.861 | 0.503 | 1e-164 | |
| 224075946 | 729 | predicted protein [Populus trichocarpa] | 0.867 | 0.842 | 0.490 | 1e-156 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.964 | 0.945 | 0.466 | 1e-155 | |
| 224143699 | 635 | predicted protein [Populus trichocarpa] | 0.867 | 0.966 | 0.493 | 1e-155 | |
| 224075944 | 702 | predicted protein [Populus trichocarpa] | 0.901 | 0.908 | 0.474 | 1e-154 |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 356/688 (51%), Positives = 451/688 (65%), Gaps = 49/688 (7%)
Query: 3 VHYGLVLLHIILLL-CPIIKAKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTR 61
V + L+ L + L+L ++ E C + CG V I +PFGIG+GCY D+SFEV C N+S+
Sbjct: 8 VIFVLIKLQLFLILWLAQARSVEPCESYCGNVPIEFPFGIGKGCYMDESFEVTC-NSSSE 66
Query: 62 SPKALLKSINLELSPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFS 121
PK L SIN+EL +S + VN VI N TS A V+LSGTPF+FS
Sbjct: 67 PPKPFLTSINMELLEVLSPNQ----VQVNNPVIYSNCSHKTS---TASRVSLSGTPFTFS 119
Query: 122 QTDNRFIAIGCNSYA---QQIDSSWCRPICTCNPTQNSDCCNMLCNIPQSSI--IIKVLD 176
NRF A GCN+YA Q I + + C NS C + N Q++I +K +
Sbjct: 120 NASNRFTAKGCNNYAILMQDIGDTVGGCLSICRDEANSSGCYGI-NCWQTTIPPYMKSFE 178
Query: 177 AYSSYVYSQNISQVCTSVSVVYLDWFFSNYLRFPNV--LENKEYVSAKLEWGKTGG-STC 233
A + +S N + C S +V WF ++ L K++V A L+W G
Sbjct: 179 ANMTNPFSDNTNN-CKSAFMVDQSWFAFQSSSSRSLDDLNYKDHVPAVLDWANYQGYCDI 237
Query: 234 SEEYNLDTSCNQDG-YCLVQLGSGYFCLCNDRRLSGTYPDLC-EGYYDFNQELQCQSRT- 290
SE YN+ +C D YC +L C+C P+ C + ++N L C R
Sbjct: 238 SEYYNI--TCTTDSSYCWKELNRSQVCICQCED-----PNKCPDQSSNYNCRLFCMYRPG 290
Query: 291 -------------SHSLR------FRKKSRDKFIIIGCTIGGLGMLSLLTGTLW-LYKFF 330
+S R F KSR K I G LL +W LYK
Sbjct: 291 GYNCPCPRGHGKYENSNRCYPNSVFWGKSRTKTKSIIIGCGSGIGFLLLLIGIWSLYKII 350
Query: 331 RRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGG 390
+RR +KLK FFKRNGGLLL+Q+LSS E +++TK+FTS ELEKATD+++TNRILGQGG
Sbjct: 351 KRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEKATDDYHTNRILGQGG 410
Query: 391 QGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450
QGTVYKGML DG++VA+KKSK++DE K+++FINEVVILSQINHRNVVKL+GCCLETEVPL
Sbjct: 411 QGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVKLIGCCLETEVPL 470
Query: 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510
LVYEFI NGTL QYI + N++F ++WEMRL IA +V+GA++YLH+AAS+PIYHRDIKS+N
Sbjct: 471 LVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAASMPIYHRDIKSSN 530
Query: 511 ILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVV 570
ILLD+KY AKV+DFG S+SI++DQTH+TT+VQGTFGYLDPEYFQSS FTEKSDVYSFGVV
Sbjct: 531 ILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVV 590
Query: 571 LVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAK 630
LVELLTG++PI S E++SLA YFL M E RLFEILDA++LKEGG++E +AKLA+
Sbjct: 591 LVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGREEIIAMAKLAE 650
Query: 631 RCLNLNGKKRPTMREVGIELTGIRGCNG 658
+CLNLNGKKRP M+ V IEL GIR G
Sbjct: 651 KCLNLNGKKRPKMKTVAIELEGIRSSQG 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1569), Expect = e-171, Method: Compositional matrix adjust.
Identities = 359/729 (49%), Positives = 458/729 (62%), Gaps = 44/729 (6%)
Query: 10 LHIILLLCPI------IKAKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSP 63
LHIIL+ + A C CG + +PFGIG+GCY + FE+VC N+S P
Sbjct: 10 LHIILIQLWLNQALLATAAGPVCQESCGDITFPFPFGIGKGCYMSEMFEIVC-NDSFTPP 68
Query: 64 KALLKSINLELSPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQT 123
K L SIN+EL S GS I+VN VI N +S + V+L GT F FS
Sbjct: 69 KPFLTSINMELLHDPSIGS--ERITVNSPVISSNCSNKSS---TSTEVSLLGTSFLFSNE 123
Query: 124 DNRFIAIGCNSYAQQIDSS----WCRPICTCNPTQNS---DCCNMLCNIPQSSIIIKVLD 176
NRF IGC+SYA S C IC N + +CC S + + +
Sbjct: 124 SNRFTTIGCDSYAMLTQSGNTVGGCLSICRDNSSSGCYGLNCCQTTIPPYVQSFEVNITN 183
Query: 177 AYSSYVYSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWGKTGGSTCSEE 236
++S + C S +V +W S V + ++V A L+W G C
Sbjct: 184 PFNS---DGDGRDRCKSAFMVSQNWLASKSTNLDEVRQ-MDHVPAVLDWANDQG-YCDIS 238
Query: 237 YNLDTSCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYY----------DFNQELQC 286
N + +C YC QL FC+C G + YY +N
Sbjct: 239 KNPNITCTSR-YCWAQLTENQFCICRQCEDVGKCTNPKNYYYCQLKCMYNRGGYNCPCPV 297
Query: 287 QSRTSHSL-----RFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHK 341
+ +S+ F KSR K I+ GLG+L L+ G YK +RR KLK K
Sbjct: 298 EHHKEYSICYPDSAFAGKSRIK-TILIGCGSGLGLLLLIIGIWLSYKIIKRRRATKLKQK 356
Query: 342 FFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLED 401
FFKRNGGLLL+Q+LSS E +++TK+FTS ELEKATDN++T+RILGQGGQGTVYKGML D
Sbjct: 357 FFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRILGQGGQGTVYKGMLTD 416
Query: 402 GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461
G++VA+KKSK++DE K+++FINEVVILSQINHRNVVKL GCCLETEVPLLVYEFI NGTL
Sbjct: 417 GRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETEVPLLVYEFIPNGTL 476
Query: 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521
QYI + NK+F I+WEMRL IA +V+GA++YLHSAAS+PIYHRDIKS+NILLD+KY AKV
Sbjct: 477 FQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIKSSNILLDEKYRAKV 536
Query: 522 SDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
+DFG S+SIA++QTH+TT VQGTFGYLDPEYFQSS FTEKSDVYSFGVVLVELLTG++PI
Sbjct: 537 ADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 596
Query: 582 RLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP 641
S E++SLA YFL M E+RLFEILDA++LKEGG++E +AK+A++CLNLNGKKRP
Sbjct: 597 SSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAKMAEKCLNLNGKKRP 656
Query: 642 TMREVGIELTGIRGCNGASNIVHQGCFEEIHCVDGGIAETSEIYGSVAQSISESTISK-- 699
M+ V IEL GIR G S+ + Q +EE+ V G + ++ S S++ +TI
Sbjct: 657 KMKTVAIELEGIRSSQGVSSTIQQD-YEEVDYVVGDYTASWDVASSSTGSLNSTTIRARF 715
Query: 700 DADPLISND 708
D PL+ ++
Sbjct: 716 DVKPLLPSN 724
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1566), Expect = e-171, Method: Compositional matrix adjust.
Identities = 345/655 (52%), Positives = 431/655 (65%), Gaps = 52/655 (7%)
Query: 21 KAKERCPNQCGGVNIRYPFGIGE-GCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMS 79
+AK C +CG V+I YPFGIG GCYFD+ FEV C NNST PK LK +NLE+
Sbjct: 32 QAKPGCQERCGDVDIPYPFGIGSAGCYFDEWFEVTC-NNSTDPPKPFLKGVNLEVLNVSL 90
Query: 80 NGSGLAYISVNISVIRLNRRKSTSHNINAKGVN----LSGTPFSFSQTDNRFIAIGCNS- 134
+G+ IR+N S N + K N G PFSFS T RF A+GC++
Sbjct: 91 DGT-----------IRVNNPVLLSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSAL 139
Query: 135 -YAQQIDS--SWCRPICTCNPTQNS-------DCCNMLCNIPQSSIIIKV-LDAYSSYVY 183
Y Q D+ C C + T +CC +P + L +S
Sbjct: 140 VYIMQDDTVIGGCMTFCKKDATAAKKASCYGLECCQT--QVPPGLLSFTANLGTFSDG-- 195
Query: 184 SQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWGKTGGSTCSEEYNLDTSC 243
S + + C +V +WF SN + P+ +++ EYV A L+W + + NL+TS
Sbjct: 196 SADEQEQCKFAFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCAASTSNLNTST 254
Query: 244 NQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFNQELQCQSRTSHSLRFRKKSRDK 303
+ +C G LC+ + + C Y+ N L + + S+ D
Sbjct: 255 S---FC------GENTLCSTDTQTSSLICSCFPVYEGNPYLPQGCQGTQSIE------DC 299
Query: 304 FIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGID 363
+I TIG LG L L+ WLY +RR +IK K K F RNGGLLL+Q+LSS EG ID
Sbjct: 300 AVI---TIGALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNID 356
Query: 364 KTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFIN 423
KTKLFTS ELEKATD +N NR++GQGG+GTVYKGML DG+IVAVKK KI+ +SK+E+FIN
Sbjct: 357 KTKLFTSKELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFIN 416
Query: 424 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIA 483
EVVIL QINHRNVVKLLGCCLETEVPLLVYEFI NGTLS++I QN++F I+WE+RL IA
Sbjct: 417 EVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIA 476
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG 543
+V+GA+SYLHSAAS+PIYHRDIKSTNILLDDKY AKV+DFG S+ +A+DQTHLTTQVQG
Sbjct: 477 TEVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQG 536
Query: 544 TFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603
TFGYLDPEYFQSS FTEKSDVYSFG+VL+ELLTG++PI T SEE KSLA+YF+ +M ED
Sbjct: 537 TFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNED 596
Query: 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658
RL ++LDAQ++KE K+E +A LA+RC+NLNGKKRPTM EV +EL IR C G
Sbjct: 597 RLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQG 651
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 348/676 (51%), Positives = 435/676 (64%), Gaps = 76/676 (11%)
Query: 21 KAKERCPNQCGGVNIRYPFGIGE-GCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMS 79
+AK C CG V+I YPFGIG GCYFD+ FEV C NNST PK LK +NLE+
Sbjct: 25 QAKPGCQEWCGDVDIPYPFGIGSSGCYFDEWFEVTC-NNSTDPPKPFLKGVNLEV----- 78
Query: 80 NGSGLAYISVNISV---IRLNRRKSTSHNINAKGVN----LSGTPFSFSQTDNRFIAIGC 132
+N+S+ +R+N S N + K N G PFSFS T RF A+GC
Sbjct: 79 ---------LNVSLHGTVRVNNPVLLSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGC 129
Query: 133 NS--YAQQIDS--SWCRPIC---TCNPTQNSDCCNMLC---NIPQSSIIIKV-LDAYSSY 181
++ Y Q D+ C +C +N+ C + C +P + LD +
Sbjct: 130 SAMAYFMQDDTVIGGCMTLCKKDVATAAKNASCYGLECCQTQVPPGLLSFTANLDTFPEG 189
Query: 182 VYSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWGKTGGSTCSEEYNLDT 241
S + + C +V +WF SN + P+ +++ EYV A L+W + + NL+T
Sbjct: 190 --SADEQEPCKYAFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCDASTSNLNT 246
Query: 242 SCNQDGYCLVQLGSGYFCLCNDR--RLSGTYPDLCEGYYDFNQELQCQSRTSHSLRFRKK 299
S + +C G FC + + L+ + P L EG
Sbjct: 247 STS---FC----GENTFCSTDTQTSSLTCSCPLLYEG----------------------- 276
Query: 300 SRDKFIIIGC---TIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELS 356
+ ++ GC TIG LG L L+ WLY +RR +IK K K F RNGGLLL+Q+LS
Sbjct: 277 --NPYLPQGCQVITIGSLGTLLLVLCAWWLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLS 334
Query: 357 SNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES 416
S+EG IDKTKLFTS ELEKATD +N NR++GQG QGT YKGML DG+IVAVKK KI+ +S
Sbjct: 335 SSEGNIDKTKLFTSKELEKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDS 394
Query: 417 KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISW 476
K+E+FINEVVIL QINHRNVVKLLGCCLETEVPLLVYEFI NGTLS++I QN++F I+W
Sbjct: 395 KLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITW 454
Query: 477 EMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536
EMRL IA +V GA+SYLHS ASIPIYHRDIKSTNILLBDKY AKV+DFG S+ +A+DQTH
Sbjct: 455 EMRLRIATEVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTH 514
Query: 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596
LTTQVQGTFGYLDPEYFQSS FTEKSDVYSFG+VL+ELLTG++PI SEE KSLA+YF
Sbjct: 515 LTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIASEEGKSLASYF 574
Query: 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656
+ +M EDRL ++LDAQ++KE K+E +A LA+RC+NLNGKKRPTM EV +EL IR C
Sbjct: 575 ILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKC 634
Query: 657 NGASNIVHQGCFEEIH 672
G + Q FEEI
Sbjct: 635 QG--DFRAQENFEEIE 648
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1526), Expect = e-166, Method: Compositional matrix adjust.
Identities = 346/672 (51%), Positives = 433/672 (64%), Gaps = 62/672 (9%)
Query: 21 KAKERCPNQCGGVNIRYPFGIGE-GCYFDKSFEVVCDNN-STRSPKALLKSINLELSPYM 78
+ K C CG V+I YPFGIG GCYFD+ FEV C+N+ PK LK +NLE+
Sbjct: 148 QGKSGCLETCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSIHPHIPKPFLKILNLEV---- 203
Query: 79 SNGSGLAYISVNISVIRLNRRKSTSHNINAKGVN----LSGTPFSFSQTDNRFIAIGCNS 134
+S+N S IR+N N + K N G PFSFS T RF A+GC++
Sbjct: 204 ------LNVSLNRSTIRVNNPVLGYMNCSGKPSNDAQSWEGGPFSFSDTYTRFTAVGCST 257
Query: 135 --YAQQIDS------SWCRPICTCNPTQNSDCCNMLC----NIPQSSIIIKVLDAYSSYV 182
Y Q DS S+C+ T +N C + C P +L + S
Sbjct: 258 LAYITQNDSVIGGCMSYCKQGTTA--AKNGSCYGLKCCQTQFPPGLQYFTTMLGDFPSNS 315
Query: 183 YSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWGKTGGSTCSE------- 235
Q+ C +V +WF S + P+ +++ + A L+W + +TC
Sbjct: 316 DDQD---ECKYAFMVDQEWFIS-MEQDPDKVKDVGHAPAVLDW-RIYNATCKSVGWNNTS 370
Query: 236 -EYNLDTSCNQDGYCLVQLGSGYF-CLCNDRRLSGTYPDLCEGYYDFNQELQ-----CQS 288
+ C + C + C C R G P L EG N +L C +
Sbjct: 371 TSNTSTSFCGANAICSADTQTPSLTCRC-PRGYEGN-PYLTEGCEGTNYKLYENGTVCIN 428
Query: 289 RTSH-------SLRFRKKSRDKFIIIGCTIG---GLGMLSLLTGTLWLYKFFRRRGEIKL 338
R ++ L + R + ++ G +G G+G L L+ WLYK +RR +IK
Sbjct: 429 RNANFSCYPVDKLIVDPRPR-RMVLPGICVGILAGVGTLLLVICAWWLYKVLKRRQKIKY 487
Query: 339 KHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM 398
K K FKRNGGLLL+Q+LSS+EG +DKTKLFTS ELEKATD +N NR++GQGGQGTVYKGM
Sbjct: 488 KEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGM 547
Query: 399 LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458
L DG+IVAVKK KI+ + KVE+FINEVVILSQINHRNVVKLLGCCLET VPLLVYEFI N
Sbjct: 548 LMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPN 607
Query: 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518
GTLS++I DQN++F I+WEMRL IAI+V+GA+SYLHSAASIPIYHRDIKSTNILLDDKY
Sbjct: 608 GTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYR 667
Query: 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
AKV+DFG S+S+A+DQTHLTTQVQGTFGYLDPEYFQSS FTEKSDVYSFG+VL+ELLTG+
Sbjct: 668 AKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGK 727
Query: 579 RPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGK 638
+PI T SEE KSLA+YF+ +M EDRL ++LDAQ++KEG K+E +A LA+RC+NLNGK
Sbjct: 728 KPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGK 787
Query: 639 KRPTMREVGIEL 650
KRPTM EV +EL
Sbjct: 788 KRPTMMEVAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 365/725 (50%), Positives = 453/725 (62%), Gaps = 85/725 (11%)
Query: 1 MAVHYGLVLLHIILLLCPIIK--------AKERCPNQCGGVNIRYPFGIGEGCYFDKSFE 52
MAV LVLL I++ +I AK C ++CG V I YPFGIGEGCY D F
Sbjct: 1 MAVQ--LVLLFRIIIFPWLINSSMAAASVAKPGCSDRCGNVTIPYPFGIGEGCYMDSGFA 58
Query: 53 VVCDNNSTRSPKALLKSINLELSPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGV- 111
V C N ++ + L SINLEL +S+ +++R+N S+ + V
Sbjct: 59 VTC-NKTSLPYRPYLTSINLEL----------LRVSLESTLVRVNNPVLNSNCQDRPPVS 107
Query: 112 NLSGTPFSFSQTDN-RFIAIGCNS----YAQQIDSSWCRPICTCNPTQNS----DCCNML 162
+LS + FS +DN RF A+GCN+ Y Q + C IC T++S +CC
Sbjct: 108 DLSFSGSPFSFSDNNRFTALGCNNLALIYRQDMVIGGCLSICNVTVTESSCYGINCCQT- 166
Query: 163 CNIPQSSIIIKVLDAYSSYVYSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAK 222
+IP +K ++A + Q C +V +WF SN + L + V A
Sbjct: 167 -SIPP---YLKFINASLRSIDPVPDEQ-CRVAFMVDREWFSSNASDNISALLGAKQVPAV 221
Query: 223 LEWGKTGGSTCSEEYNLDTS---CNQDGYCLVQLGSGYFCLCNDR--------------- 264
LEWG + G TC++ + S C + C V++G Y C CN
Sbjct: 222 LEWGISNG-TCADSPGAENSTDICGSNASCSVKVGINYQCSCNQGYEGNPYLSCQDINEC 280
Query: 265 -------------RLSGTYPDLC-EGYYDFNQELQCQSRTSHSLRFRKKSRDKFIIIGCT 310
G+Y C +GY C ++ RFR +I
Sbjct: 281 EDSQKNKCSMICVNTPGSYKCSCPDGYISMGN--NCYLTDGYTERFRP------VIAIVL 332
Query: 311 IGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTS 370
GLG+ LL GT WLYK +RR + KL+ +FFKRNGGLLLQQ+LSS+E I+KT +FT+
Sbjct: 333 SAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFTA 392
Query: 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQ 430
ELEKATD++N NRILGQGGQGTVYKGML DGK+VA+KKSKI DESK E+FINEVVILSQ
Sbjct: 393 KELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFINEVVILSQ 452
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
INHRNVVKLLGCCLETEVPLLVYEFI NGTL Q++ D +++F I+WEMRL IAI+ A+
Sbjct: 453 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSAL 512
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
SYLHSAAS+PIYHRDIKSTNILLDDKY AKVSDFG S+SIAVDQTH+TT+VQGTFGYLDP
Sbjct: 513 SYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDP 572
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
EYFQSS FTEKSDVYSFGVVLVELLTG++PI + E++SLA YFL +M ++RLFEILD
Sbjct: 573 EYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEILD 632
Query: 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG-------CNGASNIV 663
A++LKEGGK+E VAKLA+RCLNLNGKKRPTMR V E+ IR NG ++
Sbjct: 633 ARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRASQQGTCFTNGENDYQ 692
Query: 664 HQGCF 668
CF
Sbjct: 693 ELDCF 697
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1439), Expect = e-156, Method: Compositional matrix adjust.
Identities = 335/683 (49%), Positives = 432/683 (63%), Gaps = 69/683 (10%)
Query: 22 AKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRS-PKALLKSINLELSPYMSN 80
K C N+CG ++I YPFG + CY ++ F++VC + S P+A + IN+E+ ++
Sbjct: 28 TKPGCQNRCGNISIPYPFGTAQDCYANEMFKIVCRETTNESAPRAFISMINMEV---LNI 84
Query: 81 GSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQTDNRFIAIGCNSYA---- 136
G A ++ I + R+S N +NL+G+PF FS N F A+GCN A
Sbjct: 85 TDGAAIVNGPIMSSNCSDRQS-----NLPALNLTGSPFFFS-FGNVFTAVGCNVRALLTG 138
Query: 137 --QQIDSSWCRPICTCNPTQ---------NSDCCNMLCNIPQSSIIIKVLDAYSSYVYSQ 185
+Q+ C C+ + Q NS C + C + ++ ++V + + ++
Sbjct: 139 IGRQVVG--CDSTCSADSNQKTLLYGQEINSLCADGNCCVARAPYRMQV---FQPSLDTK 193
Query: 186 NISQVCTSVSVVYL----DWFFSNYLRFPNVLENKEYVSAKLEW------GKTGGSTCSE 235
N S+ + + +L ++ F N + P L+ V L W + ST
Sbjct: 194 NGSEDSSGCKLAFLTDETNFSFLN-ITNPQALQGWRSVPLVLAWMMDYSIWRYDKSTMDC 252
Query: 236 EYNLDTSCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFNQELQCQSRTSHS-- 293
+Y L S V SGY C C++ Y G D N+ C+ HS
Sbjct: 253 KYFLYESS-------VSNVSGYECSCSNGYEGNPYL----GCTDINE---CKDPNRHSCL 298
Query: 294 --------LRFRKKSRDKFIIIGCTIGGL-GMLSLLTGTLWLYKFFRRRGEIKLKHKFFK 344
L K +K+ I+ + + G+LSLL G WLYK ++R I+LK KFFK
Sbjct: 299 GITKCVNTLGSYKCEVNKYWIVPILVVVIAGILSLLAGISWLYKLAKKRKNIELKRKFFK 358
Query: 345 RNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKI 404
RNGGLLLQQ+LSSN G + KTK+FTS ELE ATD FN NRILGQGGQGTVYKGMLEDG+I
Sbjct: 359 RNGGLLLQQQLSSNHGSVQKTKIFTSKELETATDRFNENRILGQGGQGTVYKGMLEDGRI 418
Query: 405 VAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQY 464
VAVK+S I+ E K+EEFINEVVILSQINHRNVVKL GCCLETEVPLLVYEFISNG L QY
Sbjct: 419 VAVKRSTIVGEEKLEEFINEVVILSQINHRNVVKLFGCCLETEVPLLVYEFISNGNLFQY 478
Query: 465 IDD--QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522
+ + QN+DF +SWEMRL IAI+V+GA+SYLHSAASIPIYHRDIKS NILLDDKY AKVS
Sbjct: 479 LHNFYQNEDFILSWEMRLQIAIEVAGALSYLHSAASIPIYHRDIKSANILLDDKYRAKVS 538
Query: 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
DFG+SRS+A+DQTHLTT VQGTFGYLDPEYFQSS FT+KSDVYSFGVVLVELL+G++PI
Sbjct: 539 DFGSSRSMAIDQTHLTTNVQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLVELLSGKKPII 598
Query: 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642
+ S+E +SLA +F+ M E+RLF+ILD Q+ ++ ++E VA LAKRCLN++ K RPT
Sbjct: 599 SSTSQETRSLATHFIVLMEENRLFDILDVQVKEDCLEEEIMAVANLAKRCLNVSRKHRPT 658
Query: 643 MREVGIELTGIRGCNGASNIVHQ 665
M+EV EL I G +IV Q
Sbjct: 659 MKEVSAELERI-GLLHRKSIVQQ 680
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1433), Expect = e-155, Method: Compositional matrix adjust.
Identities = 343/735 (46%), Positives = 446/735 (60%), Gaps = 52/735 (7%)
Query: 3 VHYGLVLLHIILLLCPIIKAKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRS 62
+ + L L+ I + +I A+ C CG + I +PFGIG GCY + F V C+ + S
Sbjct: 9 IFFLLFLVPEIATVSALIMARPNCTETCGNITIPFPFGIGTGCYMNDWFSVHCNETTADS 68
Query: 63 P-KALLKSINLELSPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKG----VNLSGTP 117
P +A L IN+E + IS+ SV+R+N S + +G +N++G+P
Sbjct: 69 PSRAFLSRINME----------VFKISLESSVVRVN-SPIISSGCSGRGANLAINMTGSP 117
Query: 118 FSFSQTDNRFIAIGCNSYA--QQIDSSWCRPICTCNPT----QNSDCCNMLC---NIPQS 168
FSFS + N F A+GCN+ A I+ TC + +NS C C IP S
Sbjct: 118 FSFS-SSNIFTAMGCNNRALLNGIEPEIVGCTSTCGASTEGKENSYCSGNNCCQTTIPSS 176
Query: 169 SIIIKVLDAYSSYVYSQNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWGKT 228
++ + + C +V WF +N + P V+++ +YV L+W +
Sbjct: 177 LQVVNASLGTPEHPINDQGRNQCKVAFIVQEKWFRNN-ISSPEVVQDMQYVPVILDW-NS 234
Query: 229 GGSTCSEEYNLDTSCNQDGYCLVQLGS-GYFCLCNDRRLSGTYPDLCEGYYDFNQELQCQ 287
C NL + + G V L S C CN Y L +G D + +C+
Sbjct: 235 DAMYCDPPMNLTSG--RSGLRTVTLYSNSTICSCNWGYDGNPY--LPDGCTDID---ECK 287
Query: 288 SRTSHSLRFRKKSRDKFIIIGCTI---------GGLGMLSLLTGTLWLYKFFRRRGEIKL 338
+S K + C + G+L LL G LYK ++R I+L
Sbjct: 288 IPRGNSCSGMTKCVNVPGGFKCELDKAKITFLSAATGLLLLLVGIWRLYKLVKKRKNIEL 347
Query: 339 KHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM 398
K KFFKRNGGLLLQQ+LSS++G I KTK+FTS ELEKATD FN NRILGQGGQGTVYKGM
Sbjct: 348 KKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGM 407
Query: 399 LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458
DG IVAVKKS ++DE K+EEFINEVVILSQ+NHRNVVKLLGCCLETEVPLLVYEFI N
Sbjct: 408 QADGMIVAVKKSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPN 467
Query: 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518
G L +YI DQ ++F SWEMRL IA +V+ A+SYLHSAASIP+YHRDIKSTNI+LD+K+
Sbjct: 468 GNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFR 527
Query: 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
AKVSDFG SRSIA+DQTHLTT VQGTFGYLDPEYFQSS FT KSDVYSFGVVL ELL+G+
Sbjct: 528 AKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQ 587
Query: 579 RPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGK 638
+PI SEE SLA +F+ + E+++F+ILD +++ + ++E VA LA+RCLNL G+
Sbjct: 588 KPISYERSEERGSLATHFILLVEENKIFDILDERLMGQDREEEVIAVANLARRCLNLIGR 647
Query: 639 KRPTMREVGIELTGIRGCNGASNIVHQGCFEEIHCVDGGIAETSEIYG-----SVAQSIS 693
KRPTMREV IEL IR GA + Q C +E+ + + EI G ++ +
Sbjct: 648 KRPTMREVAIELEQIRLSKGA--LHPQQCSKELENIWDEVPNVWEIAGPPTSVTIGDFRN 705
Query: 694 ESTISKDADPLISND 708
+ S D PLIS++
Sbjct: 706 GTAPSLDVQPLISHE 720
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143699|ref|XP_002336072.1| predicted protein [Populus trichocarpa] gi|222869913|gb|EEF07044.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 325/659 (49%), Positives = 420/659 (63%), Gaps = 45/659 (6%)
Query: 7 LVLLHIILLLCPIIKAKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKAL 66
+++ + PI A+ CP++CG ++I YPFGI + CY ++ F + C N S +A
Sbjct: 10 MLMFQVAAAAAPI--ARSGCPDRCGDISIPYPFGIRKDCYMNEWFAIEC-NASVNPARAF 66
Query: 67 LKSINLELSPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQTDNR 126
+ IN+E+ ++ + A +V +I N + + +NL+GTPF FS+ DN
Sbjct: 67 ISRINMEV---LNISAERATATVKSPIISSN----CTGREDGVPLNLTGTPFVFSRYDNV 119
Query: 127 FIAIGCNSYAQQ--IDSSWCRPICTCNPTQNSDCCNMLCNIPQSSIIIKVLDAYSSYVYS 184
FIA+GCN+ A I + + TC+ ++ + C L +P S ++V +
Sbjct: 120 FIAVGCNTQALMTGITPNLIGCVSTCSDVKSKNFCEAL--LPSS---LQVFNPRIEATDD 174
Query: 185 QNISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWGKTGGST----CSEEYN-- 238
+ C +V WF SN + P L++++YV A+L W + C YN
Sbjct: 175 NQDREGCKLAFLVNHTWFESN-VSDPFSLQSRDYVPAELGWAMSVNDDDPVYCRGYYNRS 233
Query: 239 LDTSCNQDGYCLVQLGSGY----FCLCNDRRLSGTYPDLCEGYYDFNQELQCQSRTSHSL 294
+ C DG GY + C D C G L+C + +
Sbjct: 234 FGSECECDG--------GYEGIPYLGCIDVDECKESKHSCRGL------LKCVNTRGYFN 279
Query: 295 RFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFFKRNGGLLLQQE 354
K I+IG + L SLL G WLYK ++ +I+LK KFFKRNGGLLLQQE
Sbjct: 280 CEINKLYIALIVIGAVVLAL---SLLMGIWWLYKLVKKWKKIELKKKFFKRNGGLLLQQE 336
Query: 355 LSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID 414
L + EG + KTK+++S ELE ATD FN NRILGQGGQGTVYKGML DG+IVAVKKS ++D
Sbjct: 337 LRAAEGWVQKTKIYSSKELEVATDRFNVNRILGQGGQGTVYKGMLADGRIVAVKKSMVVD 396
Query: 415 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRI 474
E K+EEFINEVV+LSQINHRNVVKLLGCCLETEVPLLVYEFI NG L +YI D N+DF +
Sbjct: 397 EGKLEEFINEVVVLSQINHRNVVKLLGCCLETEVPLLVYEFIPNGNLYKYIHDPNEDFLL 456
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534
SWEMRL IAI+V+GA+SYLHSA SIPIYHRDIKSTNILLD+KY AKVSDFG+SRSI++DQ
Sbjct: 457 SWEMRLRIAIEVAGALSYLHSATSIPIYHRDIKSTNILLDEKYRAKVSDFGSSRSISIDQ 516
Query: 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594
THLTT VQGTFGYLDPEYFQSS FTEKSDVYSFGVVLVEL++G++PI + E +SLA
Sbjct: 517 THLTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELISGQKPIFSVSQTETRSLAT 576
Query: 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+F+ M ++RL ++LDA++ + +E VA LAKRCLNLNGK RPTMREV EL I
Sbjct: 577 HFIMLMEDNRLSDVLDARVKEGCQNEEVISVANLAKRCLNLNGKNRPTMREVTSELERI 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075944|ref|XP_002304840.1| predicted protein [Populus trichocarpa] gi|222842272|gb|EEE79819.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1419), Expect = e-154, Method: Compositional matrix adjust.
Identities = 327/689 (47%), Positives = 426/689 (61%), Gaps = 51/689 (7%)
Query: 7 LVLLHIILLLCPIIKAKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKAL 66
L++L L AK CP++CG ++I YPFG + CY D+ F + C N + P+A
Sbjct: 3 LLMLMFQLAKAAAPVAKFGCPDRCGAISIPYPFGTRKECYMDERFAIEC-NETANPPRAF 61
Query: 67 LKSINLELSPYMSNGSGLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQTDNR 126
+ I +E+ ++ A +V VI N ++ +NL+GTPF FS N
Sbjct: 62 ISRIKMEV---LNISVKTATATVKSPVISFN----CIGRVDGAPLNLTGTPFVFSSKRNL 114
Query: 127 FIAIGCNSYAQQI---------DSSWCRPICTCNPTQNSDCCNMLCNIPQSSIIIKVLDA 177
F+A+GC++ A +S+W +N C C++ + I +L
Sbjct: 115 FVAVGCDTRAFMTGTEPDLVVWESTWGNLESNVRLQENKMCSGQNCSLAR---IPSLLQV 171
Query: 178 YSSYVYSQNISQV---CTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEW-----GKTG 229
++ + S N +QV C +V WF SN + P ++ ++YV L W
Sbjct: 172 FNPRLVSTNANQVGEGCKLAFLVNPTWFESN-ISDPFAMQYRDYVPMDLGWMMNLNDNDI 230
Query: 230 GSTCSEEYNLDTSCN---QDGYCLVQLGSGYFCL-CNDRRLSGT-YPDLCEGYYD----- 279
+ C E YN + +DG+ G+ Y L C D T + C G
Sbjct: 231 STHCEESYNQSSKSECVCEDGF----EGNPYLELGCTDVDECKTPEKNTCRGMLKCMNTR 286
Query: 280 --FNQELQCQSRTSHSLRFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIK 337
+ + + + D F IG +G+L LL G W+Y I+
Sbjct: 287 GGYRCAINKIYIIIIGTQQTENLSDAFFAPNTVIGLVGVLFLLIGARWIYNC------IR 340
Query: 338 LKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKG 397
LK KFFKRNGGLLLQQ+LSS++G + KTK+F+SNELEKATD FN +RILG GGQGTVYKG
Sbjct: 341 LKKKFFKRNGGLLLQQQLSSSDGSVQKTKIFSSNELEKATDYFNESRILGHGGQGTVYKG 400
Query: 398 MLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457
ML DG IVAVKKSKI+DE K+EEFINEVVILSQI+HRNVV+LLGCCLET+VPLLVYEFI
Sbjct: 401 MLADGTIVAVKKSKIVDEDKLEEFINEVVILSQISHRNVVRLLGCCLETDVPLLVYEFIP 460
Query: 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517
NGTL QY+ +QN+DF +SWE+RL IA + +GAISYLHS ASIPIYHRDIKSTNILLD+KY
Sbjct: 461 NGTLFQYLHEQNEDFTLSWELRLRIASEAAGAISYLHSTASIPIYHRDIKSTNILLDEKY 520
Query: 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG 577
AKVSDFG SRS+++DQTHLTT+VQGTFGYLDPEYF++S TEKSDVYSFGVVLVELL+G
Sbjct: 521 RAKVSDFGTSRSVSIDQTHLTTKVQGTFGYLDPEYFRTSQLTEKSDVYSFGVVLVELLSG 580
Query: 578 ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNG 637
++PI LT+S E SLA +F+ M + RLF+I+DAQ+ + ++E ++A LAKRCLNLNG
Sbjct: 581 KKPIFLTHSLETMSLAEHFIELMEDSRLFDIIDAQVKGDCTEEEAIVIANLAKRCLNLNG 640
Query: 638 KKRPTMREVGIELTGIRGCNGASNIVHQG 666
+ RPTMREV +EL GI NI G
Sbjct: 641 RNRPTMREVAMELEGILLSRNGINIQQIG 669
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 708 | ||||||
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.481 | 0.430 | 0.635 | 5e-136 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.940 | 0.925 | 0.438 | 1.2e-134 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.655 | 0.620 | 0.519 | 2e-134 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.723 | 0.665 | 0.474 | 3.2e-134 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.531 | 0.477 | 0.614 | 1.3e-128 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.463 | 0.449 | 0.628 | 1.9e-127 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.460 | 0.426 | 0.654 | 3e-127 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.481 | 0.430 | 0.621 | 5.7e-127 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.460 | 0.434 | 0.643 | 1.3e-126 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.532 | 0.479 | 0.571 | 1.2e-123 |
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 5.0e-136, Sum P(3) = 5.0e-136
Identities = 220/346 (63%), Positives = 283/346 (81%)
Query: 327 YKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRIL 386
YKF +++ ++ K KFFKRNGGLLLQQ+L S G ++KT +F+S ELEKAT+NF++NRIL
Sbjct: 394 YKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRIL 453
Query: 387 GQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET 446
GQGGQGTVYKGML DG+IVAVKKSK++DE K+EEFINEVVILSQINHRN+VKLLGCCLET
Sbjct: 454 GQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLET 513
Query: 447 EVPLLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRD 505
+VP+LVYEFI NG L +++ D+ +++ +W +RL IAID++GA+SYLHS+AS PIYHRD
Sbjct: 514 KVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRD 573
Query: 506 IKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVY 565
+KSTNI+LD+KY AKVSDFG SR++ VD THLTT V GT GY+DPEYFQSS FT+KSDVY
Sbjct: 574 VKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVY 633
Query: 566 SFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK-DEFKM 624
SFGVVLVEL+TGE+ I S+E+++LA YF+ AM+E++LF+I+DA+I ++G +
Sbjct: 634 SFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARI-RDGCMLSQVTA 692
Query: 625 VAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVHQGCFEE 670
AK+A++CLNL G+KRP+MREV +EL IR G + Q C E
Sbjct: 693 TAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQL--QECVSE 736
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1319 (469.4 bits), Expect = 1.2e-134, P = 1.2e-134
Identities = 309/705 (43%), Positives = 419/705 (59%)
Query: 22 AKERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMSNG 81
A C + CG V++ YPFGIG+GCY +K FE+VC ++S + P LL I ++ + + G
Sbjct: 29 ALRNCSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRRAVTSF-NLG 87
Query: 82 SGLAYISVNISVIRLNRRKSTSHN---INAKGVNLSGTPFSFSQTDNRFIAIGCNSYAQQ 138
+ N I+ + S N ++ +NL G+PF S+ +N+F A+GCN+ A
Sbjct: 88 DPFSISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLKGSPFFISE-NNKFTAVGCNNKAFM 146
Query: 139 ----IDSSWCRPICTCNPTQ-----NSDCCNMLC---NIPQSSIIIKVLDAYSSYVYSQN 186
+ C C N + N+ C C IP + ++V DA + N
Sbjct: 147 NVTGLQIVGCETTCG-NEIRSYKGANTSCVGYKCCQMTIPPL-LQLQVFDATVEKL-EPN 203
Query: 187 ISQVCTSVSVVYLDWFFSNYLRF--PNVLENKEYVSAKLEWGKTGGSTCSEEYNLDTSCN 244
Q C V +L F + F P ++E EY + +LEW + S + + L C
Sbjct: 204 -KQGC---QVAFLTQFTLSGSLFTPPELMEYSEYTTIELEW-RLDLSYMTSKRVL---CK 255
Query: 245 QDGYCLVQLGSGYFCLCNDRRLSGTY-PDLCEGYYDFNQ-EL-QCQSRTSHSLRFRKKSR 301
+ + Y C C++ Y P C+ + L +C R ++ +
Sbjct: 256 GNTF----FEDSYQCSCHNGYEGNPYIPGGCQDIDECRDPHLNKCGKRKCVNVLGSYRCE 311
Query: 302 DKFIIIGCXXXXXXXXXXXXXXXXXYKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGG 361
+ I K R+R K K KFF+RNGGLLLQQ+ S G
Sbjct: 312 KTWPAILSGTLSSGLLLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGS 371
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEF 421
+++TK+F+SN+LE ATD FN +RILGQGGQGTVYKGMLEDG IVAVKKSK + E +EEF
Sbjct: 372 VNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEF 431
Query: 422 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
INE+++LSQINHRNVVK+LGCCLETEVP+LVYEFI N L ++ + ++DF +SWE+RLC
Sbjct: 432 INEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLC 491
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
IA +V+ A+SYLHSA SIPIYHRD+KSTNILLD+K+ AKVSDFG SRS+A+D THLTT V
Sbjct: 492 IACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIV 551
Query: 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
QGT GY+DPEY QS+HFT KSDVYSFGV+L+ELLTGE+P+ L +E + L AYFL AMR
Sbjct: 552 QGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMR 611
Query: 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASN 661
DRL EILDA+I +E ++E VAKLA+RCL+LN + RPTMR+V IEL ++ +
Sbjct: 612 NDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQ 671
Query: 662 IVHQGCFEEIHCVDGGIAETSEI-YGSVAQSISESTISKDADPLI 705
Q E H + + E+ + Y S + S+ S D PL+
Sbjct: 672 SQAQNGEEHAH-IQIAMPESMSLSYSSPNIVVENSSFSLDTKPLM 715
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 2.0e-134, Sum P(2) = 2.0e-134
Identities = 252/485 (51%), Positives = 336/485 (69%)
Query: 237 YNLDTSCNQD-GYCLVQLGSGYF-CLCNDRRLSGTYPDLCEGYYDFNQ-EL-----QCQS 288
Y DT C+ GY G Y C CN G P L G D ++ +L QC+
Sbjct: 264 YTSDTRCSCSYGYFS---GFSYRDCYCNSPGYKGN-PFLPGGCVDVDECKLDIGRNQCKD 319
Query: 289 RTSHSLR--F----RKKSRDKFIIIGCXXXXXXXXXXXXXXXXXYKFFRRRGEIKLKHKF 342
++ +L F +K + K +I G YKF ++R ++ KF
Sbjct: 320 QSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSALLLFAFGIFGL-YKFVQKRRKLIRMRKF 378
Query: 343 FKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDG 402
F+RNGG+LL+Q+L+ EG ++ +++F+S+ELEKATDNFN NR+LGQGGQGTVYKGML DG
Sbjct: 379 FRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDG 438
Query: 403 KIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462
+IVAVK+SK +DE +VEEFINEVV+L+QINHRN+VKLLGCCLETEVP+LVYEF+ NG L
Sbjct: 439 RIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLC 498
Query: 463 QYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522
+ + D++ D+ ++WE+RL IAI+++GA+SYLHSAAS PIYHRDIK+TNILLD++ AKVS
Sbjct: 499 KRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVS 558
Query: 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
DFG SRS+ +DQTHLTTQV GTFGY+DPEYFQSS FTEKSDVYSFGVVLVELLTGE+P
Sbjct: 559 DFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSS 618
Query: 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642
SEE++ LAA+F+ A++E+R+ +I+D +I E D+ VA LA+RCLN GKKRP
Sbjct: 619 RVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPN 678
Query: 643 MREVGIELTGIRGCNGASNI-VHQGCFEEIHCVDGGIAETSEIYGSVAQSI-SESTISKD 700
MREV IEL IR + S I + E+ ++ +T E+ + S+ + ++ + D
Sbjct: 679 MREVSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNFNDTWEVGATAPASMFNNASPTSD 738
Query: 701 ADPLI 705
A+PL+
Sbjct: 739 AEPLV 743
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 3.2e-134, Sum P(2) = 3.2e-134
Identities = 261/550 (47%), Positives = 345/550 (62%)
Query: 132 CNSYAQQIDSSWCRPICTCNPTQ-NS-DCCNMLCNIPQSSIIIKVLDAYSSYVYSQNISQ 189
CN A+ DS +C+ I N T N CC II +D S S+
Sbjct: 170 CN--ARYGDSEYCKNISIMNDTSCNGIGCCKASLPARYQQIIGVEIDD------SNTESK 221
Query: 190 VCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEW-------GKTGGSTCS--EEYNLD 240
C + ++F SN P L Y + L W G C +EY +
Sbjct: 222 GCKVAFITDEEYFLSNGSD-PERLHANGYDTVDLRWFIHTANHSFIGSLGCKSIDEYTIL 280
Query: 241 TSCNQD-GY-CLVQLGS---GYF-CLC-----NDRRLSGTYPDLCEGYYDFNQELQCQSR 289
N++ G CL S GY C C + + G D+ E + C +
Sbjct: 281 RRDNREYGIGCLCDYNSTTTGYATCSCASGFEGNPYIPGECKDINECVRGIDGNPVCTAG 340
Query: 290 TSHSLRFR---KKSRDKFIIIGCXXXXXXXXXXXXXXXXXYKFFRRRGEIKLKHKFFKRN 346
+L + + + ++IG YKF RR+ + K KFFKRN
Sbjct: 341 KCVNLLGGYTCEYTNHRPLVIGLSTSFSTLVFIGGIYWL-YKFIRRQRRLNQKKKFFKRN 399
Query: 347 GGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVA 406
GGLLLQQ+L++ EG +D T++F S ELEKAT+NF+ RILG+GGQGTVYKGML DG+IVA
Sbjct: 400 GGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVA 459
Query: 407 VKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYID 466
VKKSK++DE K+EEFINEVVILSQINHRN+VKLLGCCLET+VP+LVYEFI NG L +++
Sbjct: 460 VKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLH 519
Query: 467 DQNKDFRIS-WEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525
D + D+ ++ WE+RL IA+D++GA+SYLHSAAS PIYHRDIKSTNI+LD+K+ AKVSDFG
Sbjct: 520 DDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFG 579
Query: 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTN 585
SR++ VD THLTT V GT GY+DPEYFQSS FT+KSDVYSFGVVL EL+TGE+ +
Sbjct: 580 TSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLR 639
Query: 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK-DEFKMVAKLAKRCLNLNGKKRPTMR 644
S+E ++LA YF AM+E+RL +I+DA+I ++G K ++ AK+A++CLN+ G+KRP+MR
Sbjct: 640 SQEYRTLATYFTLAMKENRLSDIIDARI-RDGCKLNQVTAAAKIARKCLNMKGRKRPSMR 698
Query: 645 EVGIELTGIR 654
+V +EL IR
Sbjct: 699 QVSMELEKIR 708
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 1.3e-128, Sum P(2) = 1.3e-128
Identities = 236/384 (61%), Positives = 295/384 (76%)
Query: 328 KFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILG 387
KF ++R K K KFFKRNGGLLLQQ+L++N+G ++KT++F+S ELEKATDNF+ +RILG
Sbjct: 399 KFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILG 458
Query: 388 QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447
QGGQGTVYKGML DG+ VAVKKSK++DE K+EEFINEVVILSQINHR+VVKLLGCCLETE
Sbjct: 459 QGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETE 518
Query: 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507
VP LVYEFI NG L Q+I +++ D+ +W MRL IA+D++GA+SYLHSAAS PIYHRDIK
Sbjct: 519 VPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIK 578
Query: 508 STNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSF 567
STNILLD+KY KVSDFG SRS+ +D TH TT + GT GY+DPEY+ SS +T+KSDVYSF
Sbjct: 579 STNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSF 638
Query: 568 GVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKM-V 625
GVVLVEL+TGE+P I ++NS+E + LA +F AM+E+R FEI+DA+I ++G K E M V
Sbjct: 639 GVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARI-RDGCKPEQVMAV 697
Query: 626 AKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGAS--NIVHQ-GCFEEIHCVDG-GIAET 681
A LA+RCLN GKKRP MR+V +L I S NI + G +E + I ++
Sbjct: 698 ANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIENDDGADDEEEGMTMINIDDS 757
Query: 682 SEIYGSV-AQSISESTISKDADPL 704
IY + A SI S+ S D PL
Sbjct: 758 QTIYVTAPAPSIVASSSSSDVQPL 781
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 1.9e-127, Sum P(2) = 1.9e-127
Identities = 206/328 (62%), Positives = 268/328 (81%)
Query: 327 YKFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRIL 386
+K ++R I KFFKRNGGLLL+Q+L++ +G ++ +K+F+S EL KATDNF+ +R+L
Sbjct: 376 FKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVL 435
Query: 387 GQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET 446
GQGGQGTVYKGML DG IVAVK+SK++DE K+EEFINE+V+LSQINHRN+VKLLGCCLET
Sbjct: 436 GQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLET 495
Query: 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI 506
EVP+LVYE+I NG L + + D++ D+ ++WE+RL IAI+++GA++Y+HSAAS PI+HRDI
Sbjct: 496 EVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDI 555
Query: 507 KSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYS 566
K+TNILLD+KY AKVSDFG SRS+ +DQTHLTT V GTFGY+DPEYF SS +T KSDVYS
Sbjct: 556 KTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYS 615
Query: 567 FGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVA 626
FGVVLVEL+TGE+P+ SEE + LA +FL AM+E+R+ +I+D +I E ++ VA
Sbjct: 616 FGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVA 675
Query: 627 KLAKRCLNLNGKKRPTMREVGIELTGIR 654
KLA++CLN GK RP M+EV EL IR
Sbjct: 676 KLARKCLNRKGKNRPNMKEVSNELERIR 703
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 3.0e-127, Sum P(2) = 3.0e-127
Identities = 214/327 (65%), Positives = 260/327 (79%)
Query: 328 KFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILG 387
K R+R K KFFKRNGGLLLQQ+L++ +G ++KTKLF+S ELEKATDNFN NR++G
Sbjct: 402 KLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIG 461
Query: 388 QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447
QGGQGTVYKGML DG+ VAVKKS ++DE K++EFINEV+ILSQINHR+VVKLLGCCLETE
Sbjct: 462 QGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETE 521
Query: 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507
VP+LVYEFI NG L Q++ ++ D+ W +R+ IA+D+SGA SYLH+AA PIYHRDIK
Sbjct: 522 VPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIK 581
Query: 508 STNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSF 567
STNILLD+KY AKVSDFG SRS+++D TH TT + GT GY+DPEY+ SSHFTEKSDVYSF
Sbjct: 582 STNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSF 641
Query: 568 GVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVA 626
GVVLVEL+TGE+P I L+ ++E LA YF AMRE+RLFEI+DA+I + ++ VA
Sbjct: 642 GVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAVA 701
Query: 627 KLAKRCLNLNGKKRPTMREVGIELTGI 653
LA RCL GK RP MREV L I
Sbjct: 702 NLALRCLKKTGKTRPDMREVSTALERI 728
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 5.7e-127, Sum P(3) = 5.7e-127
Identities = 215/346 (62%), Positives = 272/346 (78%)
Query: 328 KFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILG 387
KF +R K K KFFKRNGGLLL QEL++ EG ++KT++F S ELEKAT+NF+ NR+LG
Sbjct: 401 KFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRVLG 460
Query: 388 QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447
GGQGTVYKGML DG+ VAVKKSK+IDE K++EFINEVVILSQINHR+VVKLLGCCLETE
Sbjct: 461 HGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETE 520
Query: 448 VPLLVYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI 506
VP+LVYEFI NG L ++I ++++ D+ + W MRL IA+D++GA+SYLHS+AS PIYHRDI
Sbjct: 521 VPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRDI 580
Query: 507 KSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYS 566
KSTNILLD+KY AKV+DFG SRS+ +DQTH TT + GT GY+DPEY+QSS +TEKSDVYS
Sbjct: 581 KSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVYS 640
Query: 567 FGVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMV 625
FGV+L EL+TG++P I + N++E +LA +F AM+E RL +I+DA+I + ++ V
Sbjct: 641 FGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQVMAV 700
Query: 626 AKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNI-VHQGCFEE 670
AK+A +CL+ GKKRP MREV EL I C + VH EE
Sbjct: 701 AKVAMKCLSSKGKKRPNMREVFTELERI--CTSPEDSQVHNRIDEE 744
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 1.3e-126, Sum P(2) = 1.3e-126
Identities = 211/328 (64%), Positives = 272/328 (82%)
Query: 328 KFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILG 387
KF ++R +I K FFKRNGGLLL+Q+L++ G + +K+F+S ELEKATDNFN NR+LG
Sbjct: 369 KFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLG 428
Query: 388 QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447
QGGQGTVYKGML DG+IVAVK+SK++DE KVEEFINEV +LSQINHRN+VKL+GCCLETE
Sbjct: 429 QGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETE 488
Query: 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507
VP+LVYE I NG L + + + D+ ++W++RL I+++++GA++YLHSAAS P+YHRD+K
Sbjct: 489 VPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVK 548
Query: 508 STNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSF 567
+TNILLD+KY AKVSDFG SRSI VDQTHLTT V GTFGYLDPEYFQ+S FT+KSDVYSF
Sbjct: 549 TTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSF 608
Query: 568 GVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK-DEFKMVA 626
GVVLVEL+TGE+P + EE++ L ++F AM+++R+ +I+D++I KEG ++ VA
Sbjct: 609 GVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRI-KEGCTLEQVLAVA 667
Query: 627 KLAKRCLNLNGKKRPTMREVGIELTGIR 654
KLA+RCL+L GKKRP MREV +EL IR
Sbjct: 668 KLARRCLSLKGKKRPNMREVSVELERIR 695
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 1.2e-123, Sum P(2) = 1.2e-123
Identities = 219/383 (57%), Positives = 286/383 (74%)
Query: 328 KFFRRRGEIKLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILG 387
KF +R K K KFFKRNGGLLLQQEL++ +G ++K ++FTS ELEKAT+NF+ NR+LG
Sbjct: 392 KFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLG 451
Query: 388 QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447
GGQGTVYKGML DG+ VAVKKSK+IDE K++EFINEVVILSQINHR+VVKLLGCCLETE
Sbjct: 452 HGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETE 511
Query: 448 VPLLVYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI 506
VP+LVYEFI NG L ++I +++ D+ + W MRL IA+D++GA+SYLHSAAS PIYHRDI
Sbjct: 512 VPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDI 571
Query: 507 KSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYS 566
KSTNILLD+KY AKV+DFG SRS+ +DQTH TT + GT GY+DPEY++SS +TEKSDVYS
Sbjct: 572 KSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYS 631
Query: 567 FGVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMV 625
FGV+L EL+TG++P I + N++E +LA +F AM+E RL +I+DA+I + ++ V
Sbjct: 632 FGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAV 691
Query: 626 AKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVHQGCFEEIHCVDGGIAETSEIY 685
A LA +CL+ G+ RP MREV EL I C + Q +E DG + E E+
Sbjct: 692 ANLAMKCLSSRGRNRPNMREVFTELERI--CTSPEDSQVQNRIDEEEEEDG-VEEEEEVV 748
Query: 686 GSVAQSISEST-ISKDADPLISN 707
V + S S ++ A ++++
Sbjct: 749 TIVHRGDSWSIGVTAPASSIVAS 771
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q7X8C5 | WAKLB_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4301 | 0.9449 | 0.8943 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 708 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-26 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 6e-54
Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 39/277 (14%)
Query: 383 NRILGQGGQGTVYKGMLEDGKI-----VAVKKSK-IIDESKVEEFINEVVILSQINHRNV 436
+ LG+G G VYKG L+ VAVK K E ++EEF+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
VKLLG C E E ++V E++ G L Y+ N+ +S L A+ ++ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
FT KSDV+SFGV+L E+ T GE P ++N+E + E L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE------------VLEY----------L 217
Query: 615 KEGGKDEF-----KMVAKLAKRCLNLNGKKRPTMREV 646
K+G + + KL +C + + RPT E+
Sbjct: 218 KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-53
Identities = 83/272 (30%), Positives = 128/272 (47%), Gaps = 30/272 (11%)
Query: 383 NRILGQGGQGTVYKGMLEDGKI-----VAVKKSK-IIDESKVEEFINEVVILSQINHRNV 436
+ LG+G G VYKG L+ VAVK K E ++EEF+ E I+ +++H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
VKLLG C E E +V E++ G L Y+ + ++S L A+ ++ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
FT KSDV+SFGV+L E+ T GE+P ++N E + Y R +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----VLEYLKNGYRLPQPPNCPPE--- 231
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ L +C + + RPT E+
Sbjct: 232 ----------LYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 5e-52
Identities = 75/193 (38%), Positives = 110/193 (56%), Gaps = 10/193 (5%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK-VEEFINEVVILSQINHRNVVKLLGCC 443
LG+GG GTVY + GK VA+K K D S +EE + E+ IL ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ LV E+ G+L + + + ++S + L I + + + YLH S I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 504 RDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEK 561
RD+K NILLD D K++DFG S+ + D++ L T V GT Y+ PE +++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174
Query: 562 SDVYSFGVVLVEL 574
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 8e-52
Identities = 91/271 (33%), Positives = 129/271 (47%), Gaps = 21/271 (7%)
Query: 380 FNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNV 436
+ R LG G GTVYK GKIVAVK K K + E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
V+L+ + + LV E+ G L Y+ +S + IA+ + + YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQS 555
I HRD+K NILLD+ K++DFG ++ + + LTT V GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615
+ + K DV+S GV+L ELLTG+ P N + L R + F+
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL---IRRILGPPLEFDEPKWSSGS 230
Query: 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E KD L K+CLN + KRPT E+
Sbjct: 231 EEAKD-------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 5e-50
Identities = 80/265 (30%), Positives = 120/265 (45%), Gaps = 23/265 (8%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
LG+G G VY + GK+VA+K K + E + E+ IL ++ H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ + LV E+ G L + + R+S + + A+ YLHS I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSK---GI 118
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
HRD+K NILLD+ K++DFG +R + LTT V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKGYGKA 176
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621
D++S GV+L ELLTG+ P D L F + + F + I E
Sbjct: 177 VDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPPFPPPEWDI-----SPE 226
Query: 622 FKMVAKLAKRCLNLNGKKRPTMREV 646
K L ++ L + +KR T E
Sbjct: 227 AKD---LIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 5e-49
Identities = 87/278 (31%), Positives = 129/278 (46%), Gaps = 36/278 (12%)
Query: 384 RILGQGGQGTVYKGMLEDGK----IVAVKKSKII-DESKVEEFINEVVILSQINHRNVVK 438
+ LG+G G VYKG L+ VAVK K E + ++F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF------RISWEMRLCIAIDVSGAISY 492
LLG C E E LV E++ G L Y+ F +S + L AI ++ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDP 550
L S HRD+ + N L+ + K+SDFG SR + D + + G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIRWMAP 176
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSEEDKSLAAYFLRAMREDRLFEI 608
E + FT KSDV+SFGV+L E+ T G P L+N E L +R+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------VLEYLRKGYRLPK 228
Query: 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E DE + +L C L+ + RPT E+
Sbjct: 229 ------PEYCPDE---LYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 169 bits (432), Expect = 4e-48
Identities = 83/283 (29%), Positives = 135/283 (47%), Gaps = 51/283 (18%)
Query: 383 NRILGQGGQGTVYKGML-----EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNV 436
+ LG+G G VYKG L VAVK K E + EEF+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
V+LLG C + E +V E++ G L ++ + +++ + L +A+ ++ + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG---YLDPEYF 553
S HRD+ + N L+ + K+SDFG SR I D + G ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 554 QSSHFTEKSDVYSFGVVLVELLT-GERPI-RLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+ FT KSDV+SFGV+L E+ T GE+P ++N E+L+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--------------------EVLEL 216
Query: 612 QILKEGGK--------DEFKMVAKLAKRCLNLNGKKRPTMREV 646
L++G + DE + +L +C + + RPT E+
Sbjct: 217 --LEDGYRLPRPENCPDE---LYELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 384 RILGQGGQGTVYKGMLED-GKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLL 440
+LG+G G+VY + +D G+++AVK ++ E ++E E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 441 GCCL-ETEVPLLVY-EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
G E + L ++ E++S G+LS + + +R + ++YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEP-VIRKY-TRQILEGLAYLHSNG- 121
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA-VDQTHLTTQVQGTFGYLDPEYFQSSH 557
I HRDIK NIL+D K++DFG ++ + ++ T V+GT ++ PE +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
+ +D++S G ++E+ TG+ P SE +AA + + EI + L E
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPW----SELGNPMAALY-KIGSSGEPPEIPEH--LSEE 232
Query: 618 GKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
KD F ++CL + KKRPT E
Sbjct: 233 AKD-F------LRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 7e-40
Identities = 84/264 (31%), Positives = 124/264 (46%), Gaps = 34/264 (12%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G+GG G VYK GK VA+K K+ + K E+ INE+ IL + H N+VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ + +V EF S G+L + N+ +I+ + ++ + YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKGLEYLHSNG---I 119
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
HRDIK+ NILL K+ DFG S ++ T + GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK-- 619
+D++S G+ +EL G+ P E + A F A L+ K
Sbjct: 178 ADIWSLGITAIELAEGKPPYS-----ELPPMKALFKIA--------TNGPPGLRNPEKWS 224
Query: 620 DEFK-MVAKLAKRCLNLNGKKRPT 642
DEFK + K+CL N +KRPT
Sbjct: 225 DEFKDFL----KKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLL 440
+ +G+G G VY DGK+ +K+ + + E + E+ +NEV IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR-------ISWEMRLCIAIDVSGAISYL 493
E +V E+ G LSQ I Q K+ + + W ++LC+A+ YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK------YL 119
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS I HRDIK NI L K+ DFG S+ ++ T V GT YL PE
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
Q+ + KSD++S G VL EL T + P E ++L L+ ++ + + +Q
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPF------EGENLLELALKILKGQ--YPPIPSQY 227
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E + L L + ++RP++ ++
Sbjct: 228 SSE--------LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 2e-32
Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 22/280 (7%)
Query: 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH-R 434
++ R LG+G G VY D K+VA+K K +VE F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+VKL + LV E++ G+L + + +S L I + A+ YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 495 SAASIPIYHRDIKSTNILLDDKYC-AKVSDFGASRSIAVDQTHLTTQVQ-----GTFGYL 548
S I HRDIK NILLD K+ DFG ++ + + + GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 549 DPEYFQSS---HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
PE + + SD++S G+ L ELLTG P + S + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELP 231
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
L + + + K + L K+ L + K R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRN 435
N+ ++G+G G VYKG+ LE G VA+K+ + I E ++ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI-DVSGAISYLH 494
+VK +G ++ ++ E+ NG+L Q I K F E + + + V ++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
I HRDIK+ NIL K++DFG + + D + V GT ++ PE +
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERP 580
S + SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 44/269 (16%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G+G G VYK GK VA+KK ++ ++K E INE++I+ H N+V L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ +V E++ G+L+ I +I++ R + + YLHS I
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ-----GLEYLHSQNVI-- 138
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
HRDIKS NILL K++DFG + + +++ + V GT ++ PE + + K
Sbjct: 139 -HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPK 196
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF----LRAMREDRLFEILDAQI--LK 615
D++S G++ +E+ GE P Y LRA+ F I I LK
Sbjct: 197 VDIWSLGIMCIEMAEGEPP--------------YLREPPLRAL-----FLITTKGIPPLK 237
Query: 616 EGGK--DEFKMVAKLAKRCLNLNGKKRPT 642
K EFK +CL + +KRP+
Sbjct: 238 NPEKWSPEFK---DFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 79/271 (29%), Positives = 132/271 (48%), Gaps = 31/271 (11%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESK-VEEFINEVVILSQINHRNVVKLLGCCL 444
+G+G G V G G+ VAVK K D+S + F+ E +++ + H N+V+LLG L
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504
+ +V E+++ G+L Y+ + + I+ +L A+DV + YL HR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDV 564
D+ + N+L+ + AKVSDFG ++ + Q V+ T PE + F+ KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182
Query: 565 YSFGVVLVELLT-GERPI-RLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEF 622
+SFG++L E+ + G P R+ + + + + R + EG E
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD----VVPHVEKGYRMEA----------PEGCPPE- 227
Query: 623 KMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
V K+ K C L+ KRPT +++ +L I
Sbjct: 228 --VYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 71/271 (26%), Positives = 112/271 (41%), Gaps = 22/271 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFI-NEVVILSQINHRN 435
+ ++LGQG G VYK GKI A+KK + + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
VVK G + +V E++ G+L+ + K I + IA + + YLH+
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHT 117
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRDIK +N+L++ K K++DFG S+ + T V GT Y+ PE Q
Sbjct: 118 KRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQG 174
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615
++ +D++S G+ L+E G+ P S L
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQAICDGPPPS-------LP 224
Query: 616 EGGK-DEFKMVAKLAKRCLNLNGKKRPTMRE 645
EF+ CL + KKRP+ E
Sbjct: 225 AEEFSPEFR---DFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 82/248 (33%), Positives = 128/248 (51%), Gaps = 35/248 (14%)
Query: 384 RILGQGGQGTVYKGML--EDGKIV--AVKK-SKIIDESKVEEFINEVVILSQINHRNVVK 438
R++G+G G VY G L DG+ + AVK ++I D +VE+F+ E +I+ +H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 439 LLGCCLETE-VPLLVYEFISNGTLSQYIDDQN-----KDFRISWEMRLCIAIDVSGAISY 492
LLG CL +E PL+V ++ +G L +I + KD + + V+ + Y
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-------IGFGLQVAKGMEY 113
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI---AVDQTHLTTQVQGTFGYLD 549
L AS HRD+ + N +LD+ + KV+DFG +R I H T + ++
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMR------- 601
E Q+ FT KSDV+SFGV+L EL+T G P +S + + Y L+ R
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQGRRLLQPEYC 227
Query: 602 EDRLFEIL 609
D L+E++
Sbjct: 228 PDPLYEVM 235
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 70/231 (30%), Positives = 108/231 (46%), Gaps = 36/231 (15%)
Query: 384 RILGQGGQGTVYKGMLEDGK------IVAVKKSK-IIDESKVEEFINEVVILSQINHRNV 436
R LG+G G V+ G + +VAVK K ++F E +L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMR-----------LCIAID 485
VK G C E + P++V+E++ +G L++++ D L IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT---QVQ 542
++ + YL AS HRD+ + N L+ K+ DFG SR + TT +V
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVG 181
Query: 543 GT----FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
G ++ PE FT +SDV+SFGVVL E+ T G++P L+N E
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 18/209 (8%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHRNVVKLLGCC 443
LG G G V+ G VA+K +I E + ++FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E+++NG L Y+ ++ W + +C DV A+ YL S I H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC--SDVCEAMEYLESNGFI---H 123
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT---FGYLDPEYFQSSHFTE 560
RD+ + N L+ + KVSDFG +R + DQ T QGT + PE F S F+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 561 KSDVYSFGVVLVELLT-GERPI-RLTNSE 587
KSDV+SFGV++ E+ + G+ P R +NSE
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 75/209 (35%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
LG+G G V +D GK+ A+K K KII +VE + E ILS+INH +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 442 CCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRIS-WEMRLCIAIDVSGAISYLHSAASI 499
+TE L LV E+ G L ++ +K+ R S R A ++ A+ YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAA-EIVLALEYLHSLG-- 113
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFT 559
I +RD+K NILLD K++DFG ++ ++ + + T GT YL PE +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 560 EKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ D +S GV+L E+LTG+ P + +E
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 69/259 (26%), Positives = 127/259 (49%), Gaps = 24/259 (9%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGC 442
+G+G G V+K + + D ++ A+K+ + ++ + EE I+E +L++++ +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
L+ +V E+ NG L + + Q + + I + +++LHS I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK---IL 123
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
HRDIKS N+ LD K+ D G ++ ++ D T+ + GT YL PE + + EKS
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 563 DVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEF 622
DV++ GVVL E TG+ P N A L+ +R +F + ++
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQ------GALILKIIRG--VFPPVSQMYSQQ------ 228
Query: 623 KMVAKLAKRCLNLNGKKRP 641
+A+L +CL + ++RP
Sbjct: 229 --LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 73/213 (34%), Positives = 118/213 (55%), Gaps = 8/213 (3%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445
+G G G V+ G + + VA+K + S+ E+FI E ++ +++H +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRD 505
LV+EF+ +G LS Y+ Q F S E L + +DV ++YL S+ I HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---HRD 125
Query: 506 IKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVY 565
+ + N L+ + KVSDFG +R + DQ +T + + PE F S ++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 566 SFGVVLVELLT-GERPI-RLTNSEEDKSLAAYF 596
SFGV++ E+ + G+ P +NSE +++ A F
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEVVETINAGF 218
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 39/272 (14%)
Query: 380 FNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVK 438
F+ LG+G G+VYK + E G++VA+K + E ++E I E+ IL Q + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDVSGAISYLHS 495
G + +V E+ G++S + NK I+ I + YLHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA-----AILYQTLKGLEYLHS 117
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRDIK+ NILL+++ AK++DFG S D V GT ++ PE Q
Sbjct: 118 NKKI---HRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-LRAMREDRLFEILD--AQ 612
+ K+D++S G+ +E+ G+ P Y + MR +F I +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP--------------YSDIHPMRA--IFMIPNKPPP 217
Query: 613 ILKEGGK--DEFKMVAKLAKRCLNLNGKKRPT 642
L + K EF K+CL + ++RP+
Sbjct: 218 TLSDPEKWSPEFN---DFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 83/292 (28%), Positives = 139/292 (47%), Gaps = 38/292 (13%)
Query: 384 RILGQGGQGTVYKGMLE-----DGKIVAVKKSKIIDESKV-EEFINEVVILSQINHRNVV 437
+ LG+G G V + G+ VAVK E + +F E+ IL ++H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 438 KLLGCCLET--EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
K G C + L+ E++ +G+L Y+ +++D +I+ + L + + + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRD-QINLKRLLLFSSQICKGMDYLGS 127
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG---TFGYLDPEY 552
I HRD+ + NIL++ + K+SDFG ++ + D+ + + G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD-- 610
++S F+ SDV+SFGV L EL T P +S A FLR + + I+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDP--------SQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 611 AQILKEGGK--------DEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
++LKEG + DE V L K C + RP+ ++ + + +R
Sbjct: 236 LELLKEGERLPRPPSCPDE---VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 40/275 (14%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLGC 442
+G G G VY + L+ G+++AVK+ +I D ++E +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 443 CLETEVPLLVYEFISNGTLSQ-----YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+ E + E+ S GTL + I D++ + + + ++YLHS
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEH--------VIRVYTLQLLEGLAYLHSHG 119
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG---YLDPEYFQ 554
I HRDIK NI LD K+ DFG + + + T + +VQ G Y+ PE
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 555 SSHFTEK---SDVYSFGVVLVELLTGERPIRLTNSEEDKSLA-AYFLRAMREDRLFEILD 610
+D++S G V++E+ TG+RP SE D + + A + + + L
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW----SELDNEFQIMFHVGAGHKPPIPDSLQ 232
Query: 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
GKD RCL + KKRPT E
Sbjct: 233 LSPE---GKDFL-------DRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQINHRNVVKL 439
LG+G G VYK + G+IVA+KK ++ +E E + E+ +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
L LV+E+ L +Y+D + + + I + ++Y HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN--LIKSIMYQLLRGLAYCHSHR-- 118
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHF 558
I HRD+K NIL++ K++DFG +R+ + T +V T Y PE S H+
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
+ D++S G + E++TG +P+ +SE D
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPLFPGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 10/206 (4%)
Query: 384 RILGQG--GQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKL 439
R+LG+G G+ T+Y+ ED +V K+ + + E + + +NE+VILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
++ L+ E+ + GTL I Q K EM L + A+SY+H A
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFT 559
I HRDIK+ NI L K+ DFG S+ + + + T V GT Y+ PE Q +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 560 EKSDVYSFGVVLVELLTGERPIRLTN 585
KSD+++ G VL ELLT +R TN
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 58/206 (28%), Positives = 110/206 (53%), Gaps = 14/206 (6%)
Query: 383 NRILGQGGQGTVYKGML----EDGKIVAVK--KSKIIDESKVEEFINEVVILSQINHRNV 436
+++G G G V +G L + VA+K K+ D+ +++ F+ E I+ Q +H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
++L G ++ +++ E++ NG+L +++ + D + + + + ++ + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQGTFGYLDPEYFQS 555
+ HRD+ + NIL++ KVSDFG SR + + T+ T + + PE
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 556 SHFTEKSDVYSFGVVLVELLT-GERP 580
FT SDV+SFG+V+ E+++ GERP
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 68/231 (29%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN- 432
D+F +I+G+G TV E K A+K K ++I E KV+ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAIS 491
H ++KL + E V E+ NG L QYI + D + + R A + A+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT---RFYAAEILL-ALE 116
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR--------------------SIA 531
YLHS I HRD+K NILLD K++DFG ++ I
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
++ + V GT Y+ PE + SD+++ G ++ ++LTG+ P R
Sbjct: 174 KNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 75/208 (36%), Positives = 113/208 (54%), Gaps = 16/208 (7%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHRNVVKLLGCC 443
LG G G V G VA+K +I E + +EFI E ++ +++H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E++SNG L Y+ + K F+ S + +C DV ++YL S I H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC--KDVCEGMAYLESKQFI---H 123
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHFTEK 561
RD+ + N L+DD+ C KVSDFG SR + D+ T+ V F + PE S F+ K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 562 SDVYSFGVVLVELLT-GERPI-RLTNSE 587
SDV++FGV++ E+ + G+ P R NSE
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 80/294 (27%), Positives = 123/294 (41%), Gaps = 57/294 (19%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN-----EVVILSQINHRNVVKL 439
LG+G VYK E G+IVA+KK K+ + + ++ IN E+ +L ++ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRI----SWEMRLCIAIDVSGAISYLHS 495
L LV+EF+ L + I D++ S+ + + YLHS
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL------RGLEYLHS 120
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQ 554
I HRD+K N+L+ K++DFG +RS +T QV T Y PE F
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFG 176
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL----- 609
+ H+ D++S G + ELL P +S+ D+ ++FE L
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQL-----------GKIFEALGTPTE 224
Query: 610 ----DAQILKEG----------GKDEFKMVAK----LAKRCLNLNGKKRPTMRE 645
L + K F + L +R L LN KR T R+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVK--KSKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
+G+G G VYKG+L+ VAVK +S + + K +F+ E IL Q +H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
C++ + +V E + G+L ++ + + +++ +D + + YL S I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMS--LDAAAGMEYLESKNCI-- 115
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV-QGTFGYLDPEYFQSSHFTE 560
HRD+ + N L+ + K+SDFG SR ++ + Q + PE +T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 561 KSDVYSFGVVLVELLT-GERPIR-LTNSE 587
+SDV+S+G++L E + G+ P ++N +
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 383 NRILGQGGQGTVYKGM---LEDGKI-VAVKKSKI-IDESKVEEFINEVVILSQINHRNVV 437
R +G+G G VY+G+ E+ KI VAVK K S E+F+ E I+ Q +H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 438 KLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
KL+G TE P+ +V E G L Y+ NK + + + +S A++YL S
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYLQ-VNKY-SLDLASLILYSYQLSTALAYLES- 125
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
HRDI + N+L+ C K+ DFG SR + + + ++ + ++ PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 557 HFTEKSDVYSFGVVLVELLT-GERPIR-LTNSE 587
FT SDV+ FGV + E+L G +P + + N++
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSK--IIDESKVEEFINEVVILSQINHRNVVKLLG 441
+G+G GTV K DGKI+ K+ + E + ++ ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 442 CCL--ETEVPLLVYEFISNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGAISYLH--SA 496
+ + +V E+ G L+Q I K+ I E I + A+ H S
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
+ HRD+K NI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616
+ EKSD++S G ++ EL P N + L + ++ F + + E
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGKFRRIPYRYSSE 237
Query: 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
+ ++ K LN++ KRP+ E
Sbjct: 238 --------LNEVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 35/273 (12%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
LG G G VY+G+ + VAVK K D +VEEF+ E ++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 445 ETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
E P ++ EF++ G L Y+ + N+ ++ + L +A +S A+ YL I H
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHFTEK 561
RD+ + N L+ + + KV+DFG SR + D T F + PE + F+ K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 562 SDVYSFGVVLVELLT-GERP---IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
SDV++FGV+L E+ T G P I L+ ++E+L+ E
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VYELLEKGYRMER 226
Query: 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
+ V +L + C N RP+ E+
Sbjct: 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 40/279 (14%)
Query: 379 NFNTNRILGQGGQGTVYK-GMLEDGKIVAVKKSKIIDESKVE--EFINEVVILSQINHRN 435
+F + LG+G G+VYK L D + A+K+ + S+ E + +NE+ IL+ +NH N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 436 VVK-----LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR-ISWEMRLCIAIDVSGA 489
++ L G L +V E+ G LS+ I + K + I + I I +
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ LH I HRD+KS NILL K+ D G S+ + + TQ+ GT Y+
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMA 169
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE--DRLFE 607
PE ++ ++ KSD++S G +L E+ T P E +S+ + R +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF------EARSMQDLRYKVQRGKYPPIPP 223
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
I + + L + K RP ++
Sbjct: 224 IYSQDL------------QNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 20/213 (9%)
Query: 386 LGQGGQGTVYKG--MLEDGKIVAV-----KKSKIIDESKVEEFINEVVILSQINHRNVVK 438
LG G G+V KG +++ GK V V K+ I K EF+ E +++Q++H +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCIVR 60
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L+G C E +LV E G L +Y+ ++ +S +++ +A V+ ++YL S
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKK-RREIPVS-DLKE-LAHQVAMGMAYLESKHF 116
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSS 556
+ HRD+ + N+LL +++ AK+SDFG SR++ + G + + PE
Sbjct: 117 V---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 557 HFTEKSDVYSFGVVLVELLT-GERPIR-LTNSE 587
F+ KSDV+S+GV L E + G +P + +E
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 48/293 (16%)
Query: 384 RILGQGGQGTVYKGML--EDGKI--VAVK--KSKIIDESKVEEFINEVVILSQINHRNVV 437
+ILG+G G+V +G L +DG VAVK K I S++EEF++E + +H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 438 KLLGCCLETE------VPLLVYEFISNGTLSQY-----IDDQNKDFRISWEMRLCIAIDV 486
KL+G C E P+++ F+ +G L + + + + + L +D+
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDI 122
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD----QTHLTTQVQ 542
+ + YL + I HRD+ + N +L + V+DFG S+ I Q +
Sbjct: 123 ALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-- 177
Query: 543 GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSEEDKSLAAYFLRAM 600
++ E +T KSDV++FGV + E+ T G+ P + N E + Y
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLRHGN 232
Query: 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
R + + LD + L C + K RPT ++ L I
Sbjct: 233 RLKQPEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 43/112 (38%), Positives = 63/112 (56%), Gaps = 6/112 (5%)
Query: 23 KERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMSNGS 82
CP++CG V+I YPFGIG GC D FE+ C NN+T P+ LL + N E+ +S +
Sbjct: 1 LPGCPDRCGNVSIPYPFGIGPGCARDPGFELTC-NNTTSPPRLLLGNGNYEVL-SISLAN 58
Query: 83 GLAYISVNISVIRLNRRKSTSHNINAKGVNLSGTPFSFSQTDNRFIAIGCNS 134
G + IS N S+ + ++L G PF FS + N+F+ +GCN+
Sbjct: 59 GTVRVLDPISSNCYN---SSGKRTDNGSLSL-GGPFFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 385 ILGQGGQGTVYKGMLEDGKIVAVKK------SKIIDESKVEEFINEVVILSQINHRNVVK 438
+LG+G GTVY G+ G+++AVK+ + + E + E+ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAISYLHSAA 497
LG CL+ + EF+ G++S + F E C + ++YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA-----VDQTHLTTQVQGTFGYLDPEY 552
+ HRDIK N++L K+ DFG +R +A +++ + GT ++ PE
Sbjct: 123 VV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
S + KSD++S G + E+ TG+ P+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 85/292 (29%), Positives = 138/292 (47%), Gaps = 42/292 (14%)
Query: 386 LGQGGQGTVYK---GMLED--GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLL 440
LG+G G+V L+D G++VAVKK + + +F E+ IL + H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 441 GCCLETEVP--LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
G C LV E++ G+L Y+ Q R+ L A + + YL S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYLGSKRY 129
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG---TFGYLDPEYFQS 555
+ HRD+ + NIL++ + K+ DFG ++ + D+ + + G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR-----LFEILD 610
S F+ SDV+SFGVVL EL T S++ S A F+R M D+ ++ +++
Sbjct: 186 SKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 611 AQILKEGGK--------DEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
+LK G+ E + + K C N + +RP+ E+ +++ IR
Sbjct: 238 --LLKNNGRLPAPPGCPAE---IYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
R LG G G V+ G VAVK K S E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 443 CLETEVPLLVYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
C E E +V E++S G+L ++ + K R+ + +A ++ ++YL S I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESRNYI-- 125
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHFT 559
HRD+ + NIL+ + K++DFG +R I D T + F + PE FT
Sbjct: 126 -HRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 560 EKSDVYSFGVVLVELLT 576
KSDV+SFG++L E++T
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 66/218 (30%), Positives = 121/218 (55%), Gaps = 14/218 (6%)
Query: 384 RILGQGGQGTVYKGMLE-DGK---IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVK 438
+++G G G V++G+L+ G+ VA+K K E + ++F++E I+ Q +H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L G + + +++ E++ NG L +Y+ D + +F + + I + + YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI--AAGMKYL---SD 125
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD--QTHLTTQVQGTFGYLDPEYFQSS 556
+ HRD+ + NIL++ KVSDFG SR + D T+ T+ + + PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 557 HFTEKSDVYSFGVVLVELLT-GERPI-RLTNSEEDKSL 592
FT SDV+SFG+V+ E+++ GERP ++N E K++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 70/225 (31%), Positives = 105/225 (46%), Gaps = 12/225 (5%)
Query: 379 NFNTNRILGQGGQGTVYKGMLEDGKIV-AVK---KSKIIDESKVEEFINEVVILSQINHR 434
+F R++G+G G V D K + A+K K K +++ V +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+V L + E LV + + G L ++ Q F +++ I V A+ YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS-QKVKFSEE-QVKFWICEIVL-ALEYLH 117
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
S I HRDIK NILLD++ ++DF + + D LTT GT GY+ PE
Sbjct: 118 SKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLC 172
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599
++ D +S GV E L G+RP R + + A A
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 7/204 (3%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH 433
E+ + F R LG G G V++G+ ++ VA+K K D K ++F EV L ++ H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAISY 492
++++ L C E ++ E + G+L ++ + + ++ + +A V+ ++Y
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVA--SLIDMACQVAEGMAY 119
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
L SI HRD+ + NIL+ + KV+DFG +R I + +L++ + + + PE
Sbjct: 120 LEEQNSI---HRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEA 175
Query: 553 FQSSHFTEKSDVYSFGVVLVELLT 576
F+ KSDV+SFG++L E+ T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 77/270 (28%), Positives = 132/270 (48%), Gaps = 39/270 (14%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+GQG GTVY + + G+ VA+K+ + + K E INE++++ + H N+V L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 445 ETEVPLLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E+++ G+L+ + + + +I+ R C+ A+ +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-----ALEFLHSNQVI---H 138
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSD 563
RDIKS NILL K++DFG I +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 564 VYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFK 623
++S G++ +E++ GE P N LRA+ ++ G E +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENP----------LRAL-----------YLIATNGTPELQ 236
Query: 624 MVAKLA-------KRCLNLNGKKRPTMREV 646
KL+ RCL ++ +KR + +E+
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 70/209 (33%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK----VEEFINEVVILSQINHRNVVKLL 440
+G G VY + L + + VA+K+ ID K V+E EV +SQ NH NVVK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 441 GCCLETEVPLLVYEFISNGTL-----SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+ + LV ++S G+L S Y + I+ + +V + YLHS
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLHS 120
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA--VDQTHLT-TQVQGTFGYLDPEY 552
I HRDIK+ NILL + K++DFG S S+A D+T GT ++ PE
Sbjct: 121 NGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 553 FQSSH-FTEKSDVYSFGVVLVELLTGERP 580
+ H + K+D++SFG+ +EL TG P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 80/287 (27%), Positives = 133/287 (46%), Gaps = 46/287 (16%)
Query: 385 ILGQGGQGTVY----KGMLEDGK--IVAVKK-SKIIDESKVEEFINEVVILSQINHRNVV 437
LG+G G V+ KG+ E+G +V VK K DE+ EF E+ + +++H+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYI------DDQNKDFRISWEMRLCIAIDVSGAIS 491
+LLG C E E ++ E+ G L Q++ D++ K +S + ++ + ++ +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
+L +A + HRD+ + N L+ + KVS S+ + + + +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
Q F+ KSDV+SFGV++ E+ T GE P + EE L ++
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQA-------- 233
Query: 611 AQILKEGGKDEFKM-------VAKLAKRCLNLNGKKRPTMREVGIEL 650
GK E + + KL RC +N K RP+ E+ L
Sbjct: 234 -------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 9/207 (4%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
R LG G G V++G+ + VAVK K ++F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFR-ISWEMRLCIAIDVSGAISYLHSAASIPIY 502
E +V E + G+L +Y+ Q R + + +A V+ ++YL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI--- 125
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
HRD+ + N+L+ + KV+DFG +R I D + + PE + F+ KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 563 DVYSFGVVLVELLT-GERPIR-LTNSE 587
DV+SFG++L E++T G P +TN+E
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 53/276 (19%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIID----ESKVEEFINEVVILSQINHRNVVKLL 440
+G+G G VYK + ++VA+K +ID E ++E+ E+ LSQ + K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 441 GCCLETEVPLLVYEFISNGTLSQ----YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
G L+ ++ E+ G+ D+ I++ +R +V + YLH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY---IAFILR-----EVLLGLEYLHEE 117
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
I HRDIK+ NILL ++ K++DFG S + + T V GT ++ PE + S
Sbjct: 118 GKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI-------L 609
+ EK+D++S G+ +EL GE P S+ L MR LF I L
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPP----LSD---------LHPMRV--LFLIPKNNPPSL 218
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
+ + KD V+ CLN + K+RP+ +E
Sbjct: 219 EGNKFSKPFKD---FVSL----CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 24/223 (10%)
Query: 386 LGQGGQGTVYKGML------EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
LG+G G V+ +D +VAVK K ES ++F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMR------------LCIAIDVS 487
G C E L+V+E++ +G L++++ D +I L IA ++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQGTFG 546
+ YL AS+ HRD+ + N L+ K+ DFG SR I + D + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
++ PE FT +SD++SFGVVL E+ T G++P +L+N+E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHRNVVKLLG 441
+ LG G G V+ G VA+K I+E + E+FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
C + + +V EF+ NG L Y+ + + ++S +M L + DV + YL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
HRD+ + N L+ KVSDFG +R + D+ ++ + + PE F S ++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 562 SDVYSFGVVLVELLT-GERP 580
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN--EVVILSQINHRNVVKLLGC 442
+G+G G VYK G+IVA+KK K+ ES+ E+ +L ++NH N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDF---RISWEM-RLCIAIDVSGAISYLHSAAS 498
LV+EF+ L + I D+ + I + +L + + HS
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLA------FCHSHG- 118
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSH 557
I HRD+K N+L++ + K++DFG +RS T V T Y PE
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKG 175
Query: 558 FTEKSDVYSFGVVLVELLTGERPI 581
++ D++S G + ELL+ RP+
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 27/271 (9%)
Query: 385 ILGQGGQGTVYKGMLEDGKIVAVK--KSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
+LG+G G V+KG L+D VAVK K + E K++ F++E IL Q +H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
C + + +V E + G ++ + + + ++ A+D + ++YL S I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKNCI--- 115
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
HRD+ + N L+ + K+SDFG SR + Q + PE ++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 563 DVYSFGVVLVELLT-GERPIR-LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620
DV+S+G++L E + G P +TN + + + ++ + + Q +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV----------EKGYRMSCPQKCPDD--- 222
Query: 621 EFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651
V K+ +RC + + RP E+ EL
Sbjct: 223 ----VYKVMQRCWDYKPENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
DNF +G+G G V G+ VAVKK + + + E NEVVI+ H N+
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
V++ L + +V EF+ G L+ + R++ E + + V A+S+LH+
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ 134
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
I HRDIKS +ILL K+SDFG ++ + + V GT ++ PE
Sbjct: 135 GVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRL 190
Query: 557 HFTEKSDVYSFGVVLVELLTGERP 580
+ + D++S G++++E++ GE P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 78/282 (27%), Positives = 136/282 (48%), Gaps = 42/282 (14%)
Query: 384 RILGQGGQGTVYKGM----LEDGKI-VAVKKSKIIDES---KVEEFINEVVILSQINHRN 435
++LG G GTVYKG+ E KI VA+K + +E+ +E ++E +++ ++H +
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPH 70
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
VV+LLG CL + L+ + + G L Y+ +KD I + L + ++ +SYL
Sbjct: 71 VVRLLGICL-SSQVQLITQLMPLGCLLDYVR-NHKD-NIGSQYLLNWCVQIAKGMSYLEE 127
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG---TFGYLDPEY 552
+ HRD+ + N+L+ K++DFG ++ + VD+ +G ++ E
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALES 182
Query: 553 FQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLF--EIL 609
+T KSDV+S+GV + EL+T G +P + E L + +RL I
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE------KGERLPQPPIC 236
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651
+ MV L K C ++ + RPT +E+ E +
Sbjct: 237 TIDVY---------MV--LVK-CWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQINHRNVVK 438
+G+G G VYK + G++VA+KK I E++ E F I E+ +L ++ H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 439 LLGCCLETEVP--LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
L +V+E++ + L+ +D + + + + C + + YLHS
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLD--SPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQS 555
I HRDIK +NIL+++ K++DFG +R + T T Y PE +
Sbjct: 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPI 581
+ + + D++S G +L EL G +PI
Sbjct: 177 TRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 62/213 (29%), Positives = 113/213 (53%), Gaps = 25/213 (11%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVK---------KSKIIDESKVEEFINEVVILSQINHR 434
++G G G+VY GM G+++AVK SK S ++ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC--IAIDVSGAISY 492
N+V+ LG L+ + + E++ G+++ +++ ++E L + ++Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNY 121
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ-----VQGTFGY 547
LH+ I HRDIK NIL+D+K K+SDFG S+ + + T +QG+ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
+ PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 386 LGQGGQGTVYKGML------EDGKIVAVKKSKIIDESKV-EEFINEVVILSQINHRNVVK 438
LG+G G VYKG L VA+K K E KV +EF E ++S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYI--------------DDQNKDFRISWEMRLCIAI 484
LLG C + + +++E++++G L +++ D+ K + L IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF-LHIAI 131
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQG 543
++ + YL +S HRD+ + N L+ + K+SDFG SR I + D + ++
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 544 TFGYLDPEYFQSSHFTEKSDVYSFGVVLVEL 574
++ PE FT +SD++SFGVVL E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 65/199 (32%), Positives = 110/199 (55%), Gaps = 17/199 (8%)
Query: 385 ILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
I+G+G G V +G G+ VAVK K + + F+ E ++++++H+N+V+LLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504
+ +V E +S G L ++ + + +S L ++DV+ + YL S + HR
Sbjct: 70 HNGL-YIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 505 DIKSTNILLDDKYCAKVSDFGASR--SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
D+ + NIL+ + AKVSDFG +R S+ VD + L + + PE + F+ KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 563 DVYSFGVVLVELLT-GERP 580
DV+S+GV+L E+ + G P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 386 LGQGGQGTVYKGMLED--GKI--VAVKKSKIIDESK-VEEFINEVVILSQINHRNVVKLL 440
LG G G V +G GK+ VAVK K S +++F+ E I+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLC-IAIDVSGAISYLHSAAS 498
G L T ++V E G+L + F IS LC A+ ++ + YL S
Sbjct: 63 GVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS---TLCDYAVQIANGMRYLESKRF 118
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT--FGYLDPEYFQSS 556
I HRD+ + NILL K+ DFG R++ ++ H + F + PE ++
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP 580
F+ SDV+ FGV L E+ T GE P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 73/308 (23%), Positives = 131/308 (42%), Gaps = 47/308 (15%)
Query: 379 NFNTNRILGQGGQGTVYKGMLEDGK------IVAVKKSKI-IDESKVEEFINEVVILSQI 431
N + LG+G G V K K VAVK K S++ + ++E +L Q+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI---------------------DDQNK 470
NH +V+KL G C + LL+ E+ G+L ++ D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 471 DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530
+ ++ + A +S + YL A + + HRD+ + N+L+ + K+SDFG SR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 531 AVDQTHLT-TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
+ +++ ++ + ++ E +T +SDV+SFGV+L E++T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------- 224
Query: 590 KSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649
L + +RLF +L E ++ + + L C KRPT ++ E
Sbjct: 225 --LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
Query: 650 LTGIRGCN 657
L + +
Sbjct: 283 LEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 38/266 (14%)
Query: 405 VAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQ 463
VAVK + ++ E+F+ EV ILS+++ N+ +LLG C ++ E++ NG L+Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 464 YI--------DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD 515
++ +S+ L +A ++ + YL S+ HRD+ + N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 516 KYCAKVSDFGASRSI-AVDQTHLTTQVQGT----FGYLDPEYFQSSHFTEKSDVYSFGVV 570
Y K++DFG SR++ + D +VQG ++ E FT KSDV++FGV
Sbjct: 166 NYTIKIADFGMSRNLYSSDY----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 571 LVELLT--GERPI-RLTNSEEDKSLAAYFLRAMREDRLFEILD--AQILKEGGKDEFKMV 625
L E+LT E+P LT+ + ++ +F R+D L K+ +
Sbjct: 222 LWEILTLCREQPYEHLTDQQVIENAGHFF----RDDGRQIYLPRPPNCPKD--------I 269
Query: 626 AKLAKRCLNLNGKKRPTMREVGIELT 651
+L C + + RPT RE+ + L
Sbjct: 270 YELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 74/270 (27%), Positives = 133/270 (49%), Gaps = 39/270 (14%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+GQG GTV+ + + G+ VA+K+ + + K E INE++++ ++ + N+V L L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E+++ G+L+ + + D +I+ R C+ A+ +LH+ I H
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ-----ALEFLHANQVI---H 138
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSD 563
RDIKS N+LL K++DFG I +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 564 VYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFK 623
++S G++ +E++ GE P N LRA+ ++ G E +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENP----------LRAL-----------YLIATNGTPELQ 236
Query: 624 MVAKLA-------KRCLNLNGKKRPTMREV 646
KL+ RCL ++ +KR + +E+
Sbjct: 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 77/272 (28%), Positives = 134/272 (49%), Gaps = 36/272 (13%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK-----VEEFINEVVILSQINHRNVV 437
+LG G G+VY+G+ L+DG AVK+ + D+ + V++ E+ +LS++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 438 KLLGCCLETEVPLLVY-EFISNGTLSQYIDDQNKDFRISWE--MRLCIAIDVSGAISYLH 494
+ LG E + L ++ E + G+L++ + K + E +RL + G + YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLG-LEYLH 119
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
++ HRDIK NIL+D K++DFG ++ V + +G+ ++ PE
Sbjct: 120 DRNTV---HRDIKGANILVDTNGVVKLADFGMAKQ--VVEFSFAKSFKGSPYWMAPEVIA 174
Query: 555 SSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
+ +D++S G ++E+ TG+ P + + +AA F + R L I D
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW-----SQLEGVAAVF-KIGRSKELPPIPDH-- 226
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
L + KD F + +CL + RPT E
Sbjct: 227 LSDEAKD-FIL------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 63/199 (31%), Positives = 110/199 (55%), Gaps = 16/199 (8%)
Query: 384 RILGQGGQGTVYKGMLED--GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
+ +G+G G V ML D G VAVK K +++ + F+ E +++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 442 CCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
+E + L +V E+++ G+L Y+ + + + + L ++DV A+ YL + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV- 124
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTE 560
HRD+ + N+L+ + AKVSDFG ++ + Q V+ T PE + F+
Sbjct: 125 --HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 561 KSDVYSFGVVLVELLTGER 579
KSDV+SFG++L E+ + R
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 2e-22
Identities = 77/270 (28%), Positives = 133/270 (49%), Gaps = 39/270 (14%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+GQG GTVY M + G+ VA+++ + + K E INE++++ + + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E+++ G+L+ + + D +I+ R C+ A+ +LHS I H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-----ALEFLHSNQVI---H 139
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSD 563
RDIKS NILL K++DFG I +Q+ +T V GT ++ PE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 564 VYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFK 623
++S G++ +E++ GE P N LRA+ ++ G E +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENP----------LRAL-----------YLIATNGTPELQ 237
Query: 624 MVAKLA-------KRCLNLNGKKRPTMREV 646
KL+ RCL+++ +KR + +E+
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 386 LGQGGQGTVYKG---MLEDGKIVAVK--KSKIIDESKVEEFINEVVILSQINHRNVVKLL 440
LG G GTV KG M + K VAVK K+ D + +E + E ++ Q+++ +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
G C E E +LV E G L++++ +NK L VS + YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ-KNKHVTEKNITEL--VHQVSMGMKYLEETNFV- 117
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHF 558
HRD+ + N+LL ++ AK+SDFG S+++ D+ + + G + + PE F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 559 TEKSDVYSFGVVLVELLT-GERPIR 582
+ KSDV+SFGV++ E + G++P +
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 81/282 (28%), Positives = 131/282 (46%), Gaps = 36/282 (12%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI---IDESKVEEFINEVVILSQIN 432
NF + +G+G VYK + L DG++VA+KK +I +D ++ + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWE-------MRLCIAID 485
H NV+K L +E +V E G LS+ I K R+ E ++LC A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
++HS I HRDIK N+ + K+ D G R + T + V GT
Sbjct: 121 ------HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK-SLAAYFLRAMREDR 604
Y+ PE + + KSD++S G +L E+ + P DK +L + + + D
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEKCD- 224
Query: 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ L A E +D L RC+N + +KRP + V
Sbjct: 225 -YPPLPADHYSEELRD-------LVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 63/197 (31%), Positives = 107/197 (54%), Gaps = 11/197 (5%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+GQG GTVY + + G+ VA+K+ + + K E INE++++ + + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E+++ G+L+ + + D +I+ R C+ A+ +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-----ALDFLHSNQVI---H 138
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSD 563
RDIKS NILL K++DFG I +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 564 VYSFGVVLVELLTGERP 580
++S G++ +E++ GE P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 41/273 (15%)
Query: 386 LGQGGQGTVYKGMLE--DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGC 442
LG G G V K +L GKI+AVK ++ I+E+ ++ + E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 443 CL-ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
++ + + E++ G+L + + + RI + IA+ V ++YLH I
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQG--RIPERILGKIAVAVLKGLTYLHEKHKI-- 122
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASR----SIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
HRD+K +NIL++ + K+ DFG S S+A GT Y+ PE Q +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-------GTSSYMAPERIQGND 175
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
++ KSD++S G+ L+EL TG P E D +FE+L I+ E
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPY---PPENDPPDG-----------IFELLQ-YIVNEP 220
Query: 618 G----KDEF-KMVAKLAKRCLNLNGKKRPTMRE 645
+F CL + ++RP+ +E
Sbjct: 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 45/284 (15%)
Query: 384 RILGQGGQGTVYKGML-------EDGKIVAVKKSKIIDESKVE--EFINEVVILSQINHR 434
R LGQG G VY+G+ + + VA+K + + S E EF+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETR-VAIK-TVNENASMRERIEFLNEASVMKEFNCH 69
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYI-----DDQNKDFR--ISWEMRLCIAIDVS 487
+VV+LLG + L+V E ++ G L Y+ + +N + + + +A +++
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQGTFG 546
++YL A+ HRD+ + N ++ + K+ DFG +R I D +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSEEDKSLAAYFLRAMREDR 604
++ PE + FT KSDV+SFGVVL E+ T E+P L+N E ++
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-----------VLK--- 232
Query: 605 LFEILDAQILK--EGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
++D L E D + +L + C N K RPT E+
Sbjct: 233 --FVIDGGHLDLPENCPD---KLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 18/218 (8%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGML--EDGKI----VAVKK-SKIIDESKVEEFINEVV 426
E D+ R LG G G VY+G+ DG VAVK + E +F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 427 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD----QNKDFRISWEMRLCI 482
I+S+ NH+N+V+L+G E ++ E ++ G L ++ + + ++ + L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSI-AVDQTHLT 538
A DV+ YL I HRDI + N LL K AK++DFG +R I
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
+ ++ PE F FT K+DV+SFGV+L E+ +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 26/272 (9%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF--INEVVILSQINHRN 435
+ R++G+G G V+ D K+V +K+ + +K E NE +L ++H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+++ LE + ++V E+ GTL++YI + + + L + + A+ ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHT 119
Query: 496 AASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
I HRD+K+ NILLD K K+ DFG S+ ++ T V GT Y+ PE +
Sbjct: 120 KL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCE 174
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
+ +KSD+++ G VL EL + +R N L A L+ M F + +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAAN------LPALVLKIMSGT--FAPISDRYS 226
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + +L LNL+ KRP + ++
Sbjct: 227 PD--------LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 383 NRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDE------SKVEEFINEVVILSQINHRN 435
NRI G+G G VY+ G+IVA+KK ++ +E S + E + +L + H N
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPN 67
Query: 436 VVKLL----GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+V+L G L++ LV E+ L+ +D+ F S +++ C+ + + +
Sbjct: 68 IVELKEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES-QVK-CLMLQLLRGLQ 122
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLH I HRD+K +N+LL DK C K++DFG +R+ + +T +V T Y PE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 552 -YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587
+ +T D+++ G +L ELL + P+ SE
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK-PLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 34/279 (12%)
Query: 384 RILGQGGQGTV----YKGMLED-GKIVAVKKSKIIDESKVEE-FINEVVILSQINHRNVV 437
R+LG+G G V Y + G++VAVK K + + E+ IL + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 438 KLLGCCLET--EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
K GCC E + L+ E++ G+L Y+ ++ L A + ++YLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS 125
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG---TFGYLDPEY 552
I HRD+ + N+LLD+ K+ DFG ++++ + + G F Y E
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR-------AMREDRL 605
+ + F+ SDV+SFGV L EL LT+ + +S F M RL
Sbjct: 182 LKENKFSYASDVWSFGVTLYEL--------LTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644
E+L+ + K+ + V L K C K RPT R
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 77/229 (33%), Positives = 112/229 (48%), Gaps = 32/229 (13%)
Query: 384 RILGQGGQGTVYKGMLED------GKI-VAVK---KSKIIDESKVEEFINEVVILSQINH 433
LG G G VY+G D G I VAVK K E K EF+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR----ISWEMRLCIAIDVSGA 489
N+VKLLG CL E ++ E + G L Y+ D + ++ + L I +DV+
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDK-YCA----KVSDFGASRSIAVDQTHLTTQVQG- 543
YL I HRD+ + N L+ +K Y A K+ DFG +R I + + +G
Sbjct: 119 CVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 544 ---TFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588
++ PE FT +SDV+SFGV++ E+LT G++P N++E
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 65/228 (28%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 379 NFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKIIDESKVEEFINEVVILSQIN 432
N R LG+G G V+ +D +VAVK K ++ ++F E +L+ +
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKD----------FRISWEMRLCI 482
H ++VK G C+E + ++V+E++ +G L++++ D ++ L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQV 541
A ++ + YL AS HRD+ + N L+ + K+ DFG SR + + D +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
++ PE FT +SDV+S GVVL E+ T G++P +L+N+E
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-21
Identities = 76/307 (24%), Positives = 134/307 (43%), Gaps = 43/307 (14%)
Query: 283 ELQCQSRTSHSL---RFRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLK 339
C T+ L + +K+ + I CT+G +L+L+ + + F R R ++LK
Sbjct: 605 IDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA---FGFVFIRGRNNLELK 661
Query: 340 HKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDN-----FNTNRILGQGGQGTV 394
NE G + + F S + T N ++ +G +G
Sbjct: 662 R---------------VENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706
Query: 395 YKGMLEDGKI-VAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453
YKG + VK+ ++ S I + + ++ H N+VKL+G C + L++
Sbjct: 707 YKGKSIKNGMQFVVKEINDVN-SIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIH 762
Query: 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL 513
E+I LS+ + + +SWE R IAI ++ A+ +LH S + ++ I++
Sbjct: 763 EYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816
Query: 514 DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVE 573
D K + + D + Y+ PE ++ TEKSD+Y FG++L+E
Sbjct: 817 DGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIE 870
Query: 574 LLTGERP 580
LLTG+ P
Sbjct: 871 LLTGKSP 877
|
Length = 968 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G+G G V ++ GK+VAVKK + + + E NEVVI+ H NVV++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504
+ +V EF+ G L+ + R++ E + + V A+S LH+ I HR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQGVI---HR 140
Query: 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDV 564
DIKS +ILL K+SDFG ++ + + V GT ++ PE + + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 565 YSFGVVLVELLTGERP 580
+S G++++E++ GE P
Sbjct: 200 WSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 32/266 (12%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIID----ESKVEEFINEVVILSQINHRNVVKLLG 441
+G+G G V+KG+ D + V KIID E ++E+ E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLCIAIDVSGAISYLHSAASIP 500
L+ ++ E++ G+ + D F+I+ ++ ++ + YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSEKKI- 123
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTE 560
HRDIK+ N+LL ++ K++DFG + + Q T V GT ++ PE Q S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 561 KSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620
K+D++S G+ +EL GE P NS+ + MR L + L
Sbjct: 181 KADIWSLGITAIELAKGEPP----NSD---------MHPMRVLFLIPKNNPPTLTGEFSK 227
Query: 621 EFKMVAKLAKRCLNLNGKKRPTMREV 646
FK + CLN + RPT +E+
Sbjct: 228 PFK---EFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 80/272 (29%), Positives = 129/272 (47%), Gaps = 35/272 (12%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G+G G V + GK VAVKK + + + E NEVVI+ +H NVV + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504
+ +V EF+ G L+ + R++ E + + V A+SYLH+ I HR
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQGVI---HR 142
Query: 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDV 564
DIKS +ILL K+SDFG ++ + + V GT ++ PE + + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDI 201
Query: 565 YSFGVVLVELLTGERPIRLTNSEEDKSLAAYF----LRAMREDRLFEILDAQILKEGGKD 620
+S G++++E++ GE P YF L+AMR R+ + L ++ KD
Sbjct: 202 WSLGIMVIEMIDGEPP--------------YFNEPPLQAMR--RIRDNLPPRV-----KD 240
Query: 621 EFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652
K V+ + + L+L + P+ R EL
Sbjct: 241 SHK-VSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 76/289 (26%), Positives = 138/289 (47%), Gaps = 35/289 (12%)
Query: 374 EKATDNFNTNRILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEE---FINEVV 426
E A + +R LGQG G VY KG+++D V + + + + E F+NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 427 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-----DDQNKDFRISWEMRLC 481
++ + N +VV+LLG + + L++ E ++ G L Y+ + +N + ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 482 I--AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLT 538
I A +++ ++YL++ + HRD+ + N ++ + + K+ DFG +R I D
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFL 597
+ ++ PE + FT SDV+SFGVVL E+ T E+P + ++E+ L
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VL 231
Query: 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
R + E L + D + M+ +L + C N K RP+ E+
Sbjct: 232 RFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 71/281 (25%), Positives = 131/281 (46%), Gaps = 41/281 (14%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKI----------IDESKVEEFINEVVILSQINH 433
++G+G G VY + + G+++AVK+ ++ + V+ +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 434 RNVVKLLGCCLETEVPLLVY-EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
N+V+ LG TE L ++ E++ G++ + R ++ V ++Y
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFGYLDPE 551
LHS I HRD+K+ N+L+D K+SDFG S+ S + +QG+ ++ PE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 552 YFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
S ++ K D++S G V++E+ G RP +++++AA F +L
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW-----SDEEAIAAMF-------KLGNKR 228
Query: 610 DAQILKEGGKDEFKMVAKLA----KRCLNLNGKKRPTMREV 646
A + D ++ +A C +N RPT RE+
Sbjct: 229 SAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 61/204 (29%), Positives = 112/204 (54%), Gaps = 13/204 (6%)
Query: 386 LGQGGQGTVYKGM--LEDGKI-VAVKKSKIIDESKV-EEFINEVVILSQINHRNVVKLLG 441
LG G G V KG+ + +I VA+K K +E V +E + E I+ Q+++ +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
C E E +LV E S G L++++ + + +S + L VS + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKNFV-- 117
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHFT 559
HRD+ + N+LL +++ AK+SDFG S+++ D ++ + G + + PE F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 560 EKSDVYSFGVVLVELLT-GERPIR 582
+SDV+S+G+ + E + G++P +
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 384 RILGQGGQGTVYKGMLE-DGK---IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVK 438
+++G G G V G L+ GK VA+K K E + +F++E I+ Q +H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L G +++ ++V E++ NG+L ++ + F + + + I + + YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI--ASGMKYLSDMGY 127
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG--YLDPEYFQSS 556
+ HRD+ + NIL++ KVSDFG SR + D T G + PE
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 557 HFTEKSDVYSFGVVLVELLT-GERPI-RLTNSEEDKSL 592
FT SDV+S+G+V+ E+++ GERP ++N + K++
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 61/205 (29%), Positives = 114/205 (55%), Gaps = 14/205 (6%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKS-KIIDESKVE----EFINEVVILSQINHRNVV 437
++LG G GTVYKG+ + +G+ V + + KI++E+ EF++E +I++ ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+LLG CL + LV + + +G L Y+ ++KD I ++ L + ++ + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYV-HEHKD-NIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ-VQGTFGYLDPEYFQSS 556
+ HRD+ + N+L+ K++DFG +R + D+ + ++ E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP 580
FT +SDV+S+GV + EL+T G +P
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 386 LGQGGQGTVYK-GMLEDGKIVAVKK--SKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
+G+G G V+K E G+ VA+KK + ++ + + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+LV E++ LS+ + D+ + + +++ + ++Y+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEA-QVK-SYMRMLLKGVAYMHANG---IM 121
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEK 561
HRD+K N+L+ K++DFG +R + ++ L + T Y PE + + +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 562 SDVYSFGVVLVELLTG 577
D+++ G + ELL G
Sbjct: 182 VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G+G G V + G+ VAVK + + + E NEVVI+ H+NVV++ L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504
E ++ EF+ G L+ + R++ E + V A+ YLHS I HR
Sbjct: 89 VGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQGVI---HR 141
Query: 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDV 564
DIKS +ILL K+SDFG I+ D + V GT ++ PE + + + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200
Query: 565 YSFGVVLVELLTGERP 580
+S G++++E++ GE P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 29/289 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHR 434
+ + ++G+G G V K G+IVA+KK K ++ + + + EV +L Q+ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+V L LV+E++ TL + ++ +R I + AI+Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYIWQLLQ-AIAYCH 117
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD-QTHLTTQVQGTFGYLDPEYF 553
S I HRDIK NIL+ + K+ DFG +R++ + LT V T Y PE
Sbjct: 118 SHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELL 173
Query: 554 QSSHFTEKS-DVYSFGVVLVELLTGERP-------------IRLTNSEEDKSLAAYFLRA 599
K DV++ G ++ ELL G P I+ S F
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 600 MR--EDRLFEILDAQILKEGGKDEFKMVA-KLAKRCLNLNGKKRPTMRE 645
R E + L+ + A K CL ++ K+R T E
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 64/233 (27%), Positives = 115/233 (49%), Gaps = 36/233 (15%)
Query: 374 EKATDNFNTNRILGQGGQGTVYK----GML--EDGKIVAVKKSKIIDESKVE---EFINE 424
E +N R +GQG G V++ G+L E +VAVK K +E+ + +F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQRE 58
Query: 425 VVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI------------------- 465
++++ +H N+VKLLG C + L++E+++ G L++++
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 466 -DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524
N +S +LCIA V+ ++YL + HRD+ + N L+ + K++DF
Sbjct: 119 KCGLNP-LPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADF 174
Query: 525 GASRSI-AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
G SR+I + D + ++ PE + +T +SDV+++GVVL E+ +
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 38/294 (12%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLED---GKIVAVKKSKIIDES----KVEEFINEVV 426
E + + R LGQG G VY+G D G+ K ++ES + EF+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 427 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-----DDQNKDFRISWEMRLC 481
++ +VV+LLG + + L+V E +++G L Y+ + +N R ++
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 482 I--AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLT 538
I A +++ ++YL++ + HRD+ + N ++ + K+ DFG +R I D
Sbjct: 122 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSEEDKSLAAYF 596
+ ++ PE + FT SD++SFGVVL E+ + E+P + L+N
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------- 227
Query: 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
E L ++D L + ++ L + C N K RPT E+ + L
Sbjct: 228 -----EQVLKFVMDGGYLDQPDNCPERV-TDLMRMCWQFNPKMRPTFLEI-VNL 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 10/215 (4%)
Query: 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKI-VAVKKSKIIDESKVEEFINEVVILS 429
E E D +LG+G G VY ++ +A+K+ D V+ E+ + S
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 430 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ HRN+V+ LG E + E + G+LS + + + + + + +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTFGY 547
+ YLH I HRDIK N+L+ + Y K+SDFG S+ +A T GT Y
Sbjct: 121 LKYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQY 175
Query: 548 LDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERP 580
+ PE + +D++S G +VE+ TG+ P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 9e-20
Identities = 83/292 (28%), Positives = 129/292 (44%), Gaps = 52/292 (17%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN--EVVILSQIN-HRNVVKLLG 441
LG G G+VY E G++VA+KK K S EE +N EV L ++N H N+VKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 442 CCLETEVPLLVYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
E + V+E++ G L Q + D + K F S +R I + G ++++H
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES-VIRSIIYQILQG-LAHIHKHG--- 119
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF-QSSHFT 559
+HRD+K N+L+ K++DFG +R I + T V T Y PE +S+ ++
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-STRWYRAPEILLRSTSYS 177
Query: 560 EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL---DAQILKE 616
D+++ G ++ EL T RP+ +SE D+ ++ +L Q E
Sbjct: 178 SPVDIWALGCIMAELYTL-RPLFPGSSEIDQL-----------YKICSVLGTPTKQDWPE 225
Query: 617 G----GKDEFKM------------------VAKLAKRCLNLNGKKRPTMREV 646
G K F+ L K L + KKRPT +
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 14/211 (6%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQINHRNVVKLL 440
+G+G G VYKG + G+IVA+KK ++ ES+ E I E+ +L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL--ESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
++ L++EF+S L +Y+D K + E+ + I + HS
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--- 121
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFT 559
+ HRD+K N+L+D+K K++DFG +R+ + T +V T Y PE S ++
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYS 180
Query: 560 EKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
D++S G + E+ T ++P+ +SE D+
Sbjct: 181 TPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKII----DESKVEEFINEVVILSQINH---RNV 436
++G+G G VY+G + G++VA+K II + V + EV +LSQ+ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALK---IINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR-ISWEMRLCIAIDVSGAISYLHS 495
K G L+ ++ E+ G++ + + IS +R +V A+ Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHK 119
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
+ HRDIK+ NIL+ + K+ DFG + + + + +T V GT ++ PE
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 556 -SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
++ K+D++S G+ + E+ TG P S+ D A + + RL
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPY----SDVDAFRAMMLIPKSKPPRL 222
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
D+F + LG G G V ML GK A+K K+KI+ +VE +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
I H +V L G + LV E++ G L ++ K R + A V A+
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLAL 114
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
YLHS I +RD+K N+LLD K++DFG ++ + +T+ GT YL P
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAP 167
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
E S + + D ++ G+++ E+L G P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 385 ILGQGGQGTVYKGMLE-DGK---IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKL 439
++G G G V +G L+ GK VA+K K E + +F++E I+ Q +H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
G ++ +++ EF+ NG L ++ + F + + + I + + YL + +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI--AAGMKYL---SEM 125
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT-TQVQG---TFGYLDPEYFQS 555
HRD+ + NIL++ KVSDFG SR + D + T T G + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 556 SHFTEKSDVYSFGVVLVELLT-GERP 580
FT SDV+S+G+V+ E+++ GERP
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 64/226 (28%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 384 RILGQGGQGTVYKGM------LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
R LG+G G V+ +D +VAVK K + ++F E +L+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRI-------------SWEMRLCIAI 484
K G C + + ++V+E++ +G L++++ D I L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQG 543
++ + YL AS HRD+ + N L+ K+ DFG SR + + D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 544 TFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
++ PE FT +SDV+SFGV+L E+ T G++P +L+N+E
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 32/266 (12%)
Query: 386 LGQGGQGTVYKGMLEDGK-IVAVKKSKIID----ESKVEEFINEVVILSQINHRNVVKLL 440
+G+G G VYKG+ K +VA+K IID E ++E+ E+ +LSQ + + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIK---IIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
G L+ ++ E++ G+ D K + I ++ + YLHS I
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSERKI- 123
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTE 560
HRDIK+ N+LL ++ K++DFG + + Q T V GT ++ PE + S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 561 KSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620
K+D++S G+ +EL GE P NS+ L MR L L+
Sbjct: 181 KADIWSLGITAIELAKGEPP----NSD---------LHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 621 EFKMVAKLAKRCLNLNGKKRPTMREV 646
FK + + CLN + + RPT +E+
Sbjct: 228 PFK---EFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 81/279 (29%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID-ESKVEEFI-NEVVILSQINHRN 435
++ T LG G G+V K V KK I +S V + I E+ I+ +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGAISYLH 494
+V G L + EF+ G+L D K I E+ IA+ V ++YL+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFGYLDP 550
+ I HRDIK +NIL++ + K+ DFG S SIA T + GT Y+ P
Sbjct: 121 NVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFV-----GTSTYMSP 171
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
E Q +T KSDV+S G+ ++EL G+ P +N ++D ILD
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP-----------MGILD 220
Query: 611 --AQILKEGG----KDEFKMVAK-LAKRCLNLNGKKRPT 642
QI++E +F + CL + +RPT
Sbjct: 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 69/286 (24%), Positives = 128/286 (44%), Gaps = 43/286 (15%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK------SKIIDESKVEEFINEVVILSQI 431
+ + LG G + Y+ ++ G ++AVK+ + E VE E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
NH +++++LG E L E+++ G++S + F+ + + + + G +S
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA-FKEAVIINYTEQL-LRG-LS 117
Query: 492 YLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGASRSIAVDQT---HLTTQVQGTFGY 547
YLH I HRD+K N+L+D +++DFGA+ +A T Q+ GT +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
+ PE + + DV+S G V++E+ T + P +L +F+
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------------IFK 222
Query: 608 ILDA-------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
I A + L G +D + RCL L + RP RE+
Sbjct: 223 IASATTAPSIPEHLSPGLRD-------VTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 44/289 (15%)
Query: 363 DKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID----ESKV 418
D +LFT +LEK +G+G G V+KG+ D + V KIID E ++
Sbjct: 1 DPEELFT--KLEK----------IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEI 46
Query: 419 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM 478
E+ E+ +LSQ + V K G L+ ++ E++ G+ ++ D E
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ET 101
Query: 479 RLC-IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537
++ I ++ + YLHS I HRDIK+ N+LL + K++DFG + + Q
Sbjct: 102 QIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158
Query: 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597
T V GT ++ PE + S + K+D++S G+ +EL GE P E + FL
Sbjct: 159 NTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-----HSELHPMKVLFL 212
Query: 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E ++ LKE + CLN RPT +E+
Sbjct: 213 IPKNNPPTLEGNYSKPLKE-----------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 65/234 (27%), Positives = 121/234 (51%), Gaps = 37/234 (15%)
Query: 386 LGQGGQGTVY----KGMLE---------DGK--IVAVKKSKI-IDESKVEEFINEVVILS 429
LG+G G V+ +G+ E DG+ +VAVK + + ++ +F+ E+ I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 430 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQ---------NKDFRISWEMRL 480
++ + N+++LLG C+ + ++ E++ NG L+Q++ + N +S L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+A+ ++ + YL AS+ HRD+ + N L+ + Y K++DFG SR++ + +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY---R 186
Query: 541 VQG----TFGYLDPEYFQSSHFTEKSDVYSFGVVLVEL--LTGERPIRLTNSEE 588
+QG ++ E FT SDV++FGV L E+ L E+P L + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 386 LGQGGQGTVYKG-MLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G G G VYK + G++VA+K K+ E E+ +L + H N+V G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 445 ETEVPLLVYEFISNGTLS---QYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ +V E+ G+L Q + +I++ R + ++YLH I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHETGKI-- 123
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFGYLDPEYFQ--- 554
HRDIK NILL + K++DFG S +IA ++ + GT ++ PE
Sbjct: 124 -HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVER 177
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI----LD 610
+ K D+++ G+ +EL + P+ + L MR LF I
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPM-------------FDLHPMRA--LFLISKSNFP 222
Query: 611 AQILKEGGK--DEFKMVAKLAKRCLNLNGKKRPTMRE 645
LK+ K F K+CL + KKRPT +
Sbjct: 223 PPKLKDKEKWSPVFHD---FIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 79/293 (26%), Positives = 139/293 (47%), Gaps = 38/293 (12%)
Query: 380 FNTNRILGQGGQGTVYKGML--EDGKI--VAVK--KSKIIDESKVEEFINEVVILSQINH 433
F R+LG+G G+V + L EDG VAVK K+ I S +EEF+ E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 434 RNVVKLLGCCLETE------VPLLVYEFISNGTLSQYIDDQ---NKDFRISWEMRLCIAI 484
NV+KL+G L + +P+++ F+ +G L ++ + F + + + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQG 543
D++ + YL S I HRD+ + N +L++ V+DFG S+ I + D +
Sbjct: 121 DIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 544 TFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSEEDKSLAAYFLRAMR 601
+L E + +T SDV++FGV + E++T G+ P + NSE + Y ++ R
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNYLIKGNR 233
Query: 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
+ + L+ V +L +C + K RP+ + + +L I
Sbjct: 234 LKQPPDCLED-------------VYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 80/286 (27%), Positives = 137/286 (47%), Gaps = 41/286 (14%)
Query: 384 RILGQGGQGTVYKGML-EDGKI--VAVKKSKI--IDESKVEEFINEVVILSQINHRNVVK 438
+ LG+G G+V +G L +D I VAVK KI S++E+F++E V + + +H NV++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 439 LLGCCLETE------VPLLVYEFISNGTLSQY-----IDDQNKDFRISWEMRLCIAIDVS 487
L+G CL+T P+++ F+ +G L + + D + +M + D++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC--PQYLPTQMLVKFMTDIA 122
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV-QGTFG 546
+ YL S + I HRD+ + N +L++ V+DFG S+ I + ++ +
Sbjct: 123 SGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSEEDKSLAAYFLRAMREDR 604
++ E +T KSDV+SFGV + E+ T G+ P + NSE + Y + R +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGNRLKQ 235
Query: 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
+ LD + L C LN K RP+ + EL
Sbjct: 236 PPDCLDG-------------LYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK-----VEEFINEVVILSQIN 432
N+ ++LGQG G VY ++ G+ +AVK+ +S V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG---- 488
H +V+ GC + E + E++ G+ + DQ K + + V+
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYG-------ALTETVTRKYTR 111
Query: 489 ----AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR---SIAVDQTHLTTQV 541
+ YLHS I HRDIK NIL D K+ DFGAS+ +I T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
GT ++ PE + K+DV+S G +VE+LT + P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 18/211 (8%)
Query: 380 FNTNRILGQGGQGTVYKGML----EDGKI-VAVKKSKIIDESKV-EEFINEVVILSQINH 433
F ++LG G GTVYKG+ E KI VA+K+ + K +E ++E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+V +LLG CL + V L+ + + G L Y+ ++KD I + L + ++ ++YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKD-NIGSQYLLNWCVQIAKGMNYL 125
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG---TFGYLDP 550
+ HRD+ + N+L+ K++DFG ++ + D+ +G ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY--HAEGGKVPIKWMAL 180
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
E +T +SDV+S+GV + EL+T G +P
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 25/269 (9%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSK-IIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+G+G G V+ G L D VAVK + + +F+ E IL Q +H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ + +V E + G ++ + + R+ + + + + + + YL S I H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT--QVQGTFGYLDPEYFQSSHFTEK 561
RD+ + N L+ +K K+SDFG SR D + +T Q + PE ++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621
SDV+SFG++L E SL A + + E ++ + +
Sbjct: 177 SDVWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLPCPELC 221
Query: 622 FKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
V +L +RC + +RP+ V EL
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 72/304 (23%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKI-IDESKVEEF-INEVVILSQI---NHRNVVK 438
+G+G GTVYK L G+ VA+KK ++ + E + + E+ +L Q+ H N+V+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 439 LLGCC----LETEVPL-LVYEFISNGTLSQYID---------DQNKDFRISWEMRLCIAI 484
LL C + E+ L LV+E + L+ Y+ + KD + ++
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD--LMRQL------ 116
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
+ G + +LHS I HRD+K NIL+ K++DFG +R I + LT+ V T
Sbjct: 117 -LRG-VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-T 169
Query: 545 FGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603
Y PE QSS+ T D++S G + EL RP+ SE D+ D
Sbjct: 170 LWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFR-RRPLFRGTSEADQL-----------D 216
Query: 604 RLFEIL----------DAQILKE-----GGKDEFKMV-------AKLAKRCLNLNGKKRP 641
++F+++ + + + + V L K+ L N KR
Sbjct: 217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276
Query: 642 TMRE 645
+ E
Sbjct: 277 SAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 386 LGQGGQGTVYKGML-----EDGKIVAVKKSKIIDESKV-EEFINEVVILSQINHRNVVKL 439
LG+ G +YKG L + ++VA+K K I+ + EF E ++++++H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYI------------DDQNKDFRISWEMR--LCIAID 485
LG + + +++E+++ G L +++ D++ + S + L IAI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQGT 544
++ + YL S + H+D+ + NIL+ ++ K+SD G SR I + D + +
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
++ PE F+ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 386 LGQGGQGTVYKGMLEDG--KIVAVK----------KSKIIDESKVEEFINEVVIL-SQIN 432
LG G G VYK ++ ++A+K K K + + + ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAIS 491
H N+V+ LE + +V + I L ++ + + K R + E I + + A+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLH I HRD+ NI+L + ++DFG ++ ++ LT+ V GT Y PE
Sbjct: 128 YLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV-GTILYSCPE 183
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
++ + EK+DV++FG +L ++ T + P TN SLA + A+ E
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP-------- 232
Query: 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L EG E V + CL + + RP + +V
Sbjct: 233 --LPEGMYSE--DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI---IDESKVEEFINEVVILSQINHR 434
NF + +G+G VY+ L D K VA+KK +I +D ++ + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAISYL 493
NV+K L +E +V E G LSQ I K R+ E + + + A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERP 580
+ + KSD++S G +L E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 7/216 (3%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH 433
E ++ + LG G G V+ G VAVK K S E F+ E I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRH 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+V+L E + +V E++S G+L ++ D + + +A V+ ++Y+
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYI 118
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
I HRD++S NIL+ D K++DFG +R I ++ + + PE
Sbjct: 119 ERMNYI---HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 554 QSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588
FT KSDV+SFG++L EL+T G P N+ E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445
LG G G V+ G VA+K K S E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 446 TEVPL-LVYEFISNGTLSQYID-DQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
T+ P+ ++ E++ NG+L ++ + I+ + +A ++ ++++ I H
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIERKNYI---H 125
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHFTEK 561
RD+++ NIL+ + C K++DFG +R I + T + F + PE FT K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 562 SDVYSFGVVLVELLT-GERPIR-LTNSE 587
SDV+SFG++L E++T G P +TN E
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445
LGQG G V+ G VA+K K S E F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI-SYLHSAASIPIYHR 504
+ +V E++S G+L ++ + + +RL +D++ I S + + HR
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDV 564
D+++ NIL+ + KV+DFG +R I ++ + + PE FT KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 565 YSFGVVLVELLTGER 579
+SFG++L EL T R
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 14/205 (6%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKS-KIIDESKV----EEFINEVVILSQINHRNVV 437
++LG G GTVYKG+ + DG+ V + + K++ E+ +E ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+LLG CL + V L V + + G L Y+ +NKD RI + L + ++ +SYL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVR-ENKD-RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ-VQGTFGYLDPEYFQSS 556
+ + HRD+ + N+L+ K++DFG +R + +D+T + ++ E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP 580
FT +SDV+S+GV + EL+T G +P
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 19/227 (8%)
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGML-----EDGKI-VAVKKSK-IID 414
ID T+L + E +N + + LG G G V + D + VAVK K
Sbjct: 19 IDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78
Query: 415 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR 473
S+ E ++E+ I+S + NH N+V LLG C L++ E+ G L ++ + + F
Sbjct: 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL 138
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533
++ L + V+ +++L S I HRD+ + N+LL K+ DFG +R I D
Sbjct: 139 TLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMND 194
Query: 534 QTHLTTQVQGT----FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
++ V+G ++ PE + +T +SDV+S+G++L E+ +
Sbjct: 195 SNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 379 NFNTNRILGQGGQGTVY--KGMLEDGKIV--AVKKSKIIDESKVEEFINEVVILSQINHR 434
+ + +G+G G +Y K + V + +K+ + K E EV++L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHP 59
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+V E +V E+ G L + I+ Q + S + L + +S + ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH 118
Query: 495 SAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
I HRDIKS NI L + AK+ DFG +R + D L GT YL PE
Sbjct: 119 DRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEIC 174
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTN 585
Q+ + K+D++S G VL EL T + P N
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID--ESKV-EEFINEVVILSQINHR 434
NF + +G+G VY+ L DG VA+KK +I D ++K + I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAISYL 493
NV+K +E +V E G LS+ I K R+ E + + + A+ ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERP 580
+ + KSD++S G +L E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 384 RILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
R+LG+G G V + E G++ AVK K I+ + VE + E ILS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 440 LGCCLET-EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAA 497
L CC +T + V EF++ G L +I K R E R A +++ A+ +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFD-EARARFYAAEITSALMFLHDKG 116
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
I +RD+K N+LLD + K++DFG + + T+ GT Y+ PE Q
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE-ILDAQILKE 616
+ D ++ GV+L E+L G P N ED LFE IL+ +++
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAEN----------------EDDLFEAILNDEVVYP 216
Query: 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652
+++ A L K PTMR + L G
Sbjct: 217 T------WLSQDAVDILKAFMTKNPTMRLGSLTLGG 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 65/245 (26%), Positives = 117/245 (47%), Gaps = 18/245 (7%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH 433
E ++ + LG G G V+ G + VAVK K S V+ F+ E ++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQH 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS-- 491
+V+L + E ++ E+++ G+L ++ ++ L ID S I+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG-----KVLLPKLIDFSAQIAEG 115
Query: 492 --YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
Y+ I HRD+++ N+L+ + K++DFG +R I ++ + +
Sbjct: 116 MAYIERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSEEDKSLA-AYFLRAMRE--DR 604
PE FT KSDV+SFG++L E++T G+ P ++NS+ +L Y + M D
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232
Query: 605 LFEIL 609
L++I+
Sbjct: 233 LYDIM 237
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 66/248 (26%), Positives = 120/248 (48%), Gaps = 31/248 (12%)
Query: 385 ILGQGGQGTVYKGMLEDGKI-----VAVKKSKIID---ESKVEEFINEVVILSQINHRNV 436
+L +G G ++ G+L D K V VK + D E +V + E +L ++H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 437 VKLLGCCLE-TEVPLLVYEFISNGTLSQYID-----DQNKDFRISWEMRLCIAIDVSGAI 490
+ +L C+E E P ++Y +++ G L ++ + N +S + + +AI ++ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLD 549
SYLH + H+DI + N ++D++ K++D SR + H L ++
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMR------- 601
E + ++ SDV+SFGV+L EL+T G+ P + E +AAY R
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDGYRLAQPINC 244
Query: 602 EDRLFEIL 609
D LF ++
Sbjct: 245 PDELFAVM 252
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 73/262 (27%), Positives = 127/262 (48%), Gaps = 35/262 (13%)
Query: 402 GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYEFISN 458
G+ VAVK K + + + E+ IL + H N+VK G C E L+ EF+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518
G+L +Y+ +NK+ +I+ + +L A+ + + YL S + HRD+ + N+L++ ++
Sbjct: 93 GSLKEYLP-RNKN-KINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 147
Query: 519 AKVSDFGASRSIAVDQTHLTTQ--VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
K+ DFG +++I D+ + T + + + PE S F SDV+SFGV L EL
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL-- 205
Query: 577 GERPIRLTNSEEDKSLAAYFLR-------AMREDRLFEILDAQILKEGGK-----DEFKM 624
LT + + S FL+ M RL ++L+EG + + +
Sbjct: 206 ------LTYCDSESSPMTLFLKMIGPTHGQMTVTRL-----VRVLEEGKRLPRPPNCPEE 254
Query: 625 VAKLAKRCLNLNGKKRPTMREV 646
V +L ++C KR T + +
Sbjct: 255 VYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 77/308 (25%), Positives = 123/308 (39%), Gaps = 65/308 (21%)
Query: 386 LGQGGQGTVY---KGMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
+ +G G V+ K G I A+K K+ +I +++V++ + E ILSQ VVKL
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQ------YIDDQNKDFRISWEMRLCIAIDVSGAISY 492
+ + L LV E++ G L+ +D+ R+ IA ++ A+ Y
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV--------ARIYIA-EIVLALEY 108
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ-------THLTTQVQGTF 545
LHS I HRD+K NIL+D K++DFG S+ V + ++ GT
Sbjct: 109 LHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
Y+ PE ++ D +S G +L E L G P EE +
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----------------I 209
Query: 606 FE-ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVH 664
F+ IL+ +I + L + L + +KR G I +
Sbjct: 210 FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRL-------------GAKSIEEIKN 256
Query: 665 QGCFEEIH 672
F+ I
Sbjct: 257 HPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 383 NRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQINHRNVV 437
NRI +G G VY+ + G+IVA+KK K+ E + E F + E+ IL ++ H N+V
Sbjct: 11 NRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQHPNIV 67
Query: 438 KLLGCCLETEVPL--------LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ EV + +V E++ + L ++ + F S E++ C+ + +
Sbjct: 68 TV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-EVK-CLMLQLLSG 118
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+++LH I HRD+K++N+LL+++ K+ DFG +R T V T Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174
Query: 550 PE-YFQSSHFTEKSDVYSFGVVLVELLTGE 578
PE + ++ D++S G + ELLT +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGML-----EDGKI-VAVKKSKI-IDESKVEEFINE 424
EL + D + LG+G G V K + VAVK K E + + ++E
Sbjct: 8 ELPR--DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65
Query: 425 VVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-------DDQNKDFRISW 476
+ ++ I H+N++ LLG C + +V E+ ++G L ++ + + D
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 477 EMRLC------IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530
E L A V+ + +L S I HRD+ + N+L+ + + K++DFG +R I
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 531 -AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
+D TT + ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 76/280 (27%), Positives = 119/280 (42%), Gaps = 36/280 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHRN 435
+ LG+G G+V K L++ ++ K+ D + ++ + E+ I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 436 VVKLLGCCL---ETEVPLLVYEFISNGTL-SQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+VK G L + + + + E+ G+L S Y + + RI ++ IA V +S
Sbjct: 61 IVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG----Y 547
YLHS I HRDIK +NILL K K+ DFG S L + GTF Y
Sbjct: 120 YLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFY 169
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA-----AYFLRAMRE 602
+ PE Q ++ SDV+S G+ L+E+ P E + L +Y +
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPIELLSYIVNM--- 223
Query: 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642
E+ D +EFK K+CL + +RPT
Sbjct: 224 -PNPELKDEPGNGIKWSEEFK---DFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK--VEEFINEVVILSQINHRN 435
NF +G+G G VYK G++VA+KK ++ E++ I E+ +L ++NH N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 436 VVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+VKLL + TE L LV+EF+ + L +++D I + + +++ H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCH 117
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
S + HRD+K N+L++ + K++DFG +R+ V T +V T Y PE
Sbjct: 118 SHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173
Query: 555 SSHF-TEKSDVYSFGVVLVELLT 576
+ + D++S G + E++T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 384 RILGQGGQGTV----YKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
++LG+G G V KG E + +KK I+ + VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +T+ L V E+++ G L +I + R A ++ + +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLHERG- 116
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
I +RD+K N+LLD + K++DFG + I T T+ GT Y+ PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQP 172
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ D ++ GV+L E+L G+ P + +E
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEF----INEVVIL 428
++ D F+ +G+G G VYK +D G++VA+KK ++ +E E F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 429 SQINHRNVVKLLGCCLETEVPL----------LVYEFISN---GTLSQYIDDQNKDFRIS 475
Q+NHRN+V L + + L LV+E++ + G L + ++D S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 476 WEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535
+ +L ++Y H + HRDIK +NILL++K K++DFG +R +++
Sbjct: 121 FMKQLL------EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 536 HLTTQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587
T T Y PE + DV+S G +L EL T ++PI N E
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF---I 422
LF+ ++ EK F R +G G G VY + ++VA+KK + E++ I
Sbjct: 7 LFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII 63
Query: 423 NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI 482
EV L Q+ H N ++ GC L LV E+ G+ S ++ K + + I
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQ-----EVEI 117
Query: 483 AIDVSGAI---SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539
A GA+ +YLHS I HRDIK+ NILL + K++DFG++ ++ + +
Sbjct: 118 AAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-- 172
Query: 540 QVQGTFGYLDPEY---FQSSHFTEKSDVYSFGVVLVEL 574
GT ++ PE + K DV+S G+ +EL
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 361 GIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYK----GMLED--GKI--VAVKKSKI 412
G+ + +L E D + LG+G G V G+ ++ ++ VAVK K
Sbjct: 1 GVSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS 60
Query: 413 -IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYID---- 466
E + + I+E+ ++ I H+N++ LLG C + ++ E+ S G L +Y+
Sbjct: 61 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 120
Query: 467 ---------DQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517
Q + ++S++ + A V+ + YL S I HRD+ + N+L+ +
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDN 177
Query: 518 CAKVSDFGASRSIA-VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
K++DFG +R I +D TT + ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 379 NFNTNRILGQG--GQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
+N R++G+G G+ + + + D K + S VE+ E V+L+++ H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 437 VKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN-----KDFRISWEMRLCIAIDVSGAI 490
V E + L +V E+ G L Q I Q +D + W +++C+ +
Sbjct: 61 VAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----- 114
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
++H + HRDIKS NI L K+ DFG++R + + T V GT Y+ P
Sbjct: 115 -HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPP 169
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
E +++ + KSD++S G +L EL T + P +
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 383 NRILGQGGQGTVYKGM-LEDGKIVAVKKSKII----DESKVEEFIN----------EVVI 427
LG+G G V K GKIVA+KK KII D +K + + E+ I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 428 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVS 487
+++I H N++ L+ +E + LV + I L + +D + R++ CI + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRK---IRLTESQVKCILLQIL 129
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD-------------- 533
++ LH HRD+ NI ++ K K++DFG +R
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 534 QTHLTTQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTG 577
+ +T++V T Y PE + + D++S G + ELLTG
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
LG G G VYK E G A K +I E ++E+F+ E+ ILS+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDVSGAISYLHSAASIPI 501
++ EF G L + + + +I + R + A+++LHS I
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR-----QMLEALNFLHSHKVI-- 125
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGAS-RSIAVDQTHLTTQVQGTFGYLDPEY-----FQS 555
HRD+K+ NILL K++DFG S ++ + Q T GT ++ PE F+
Sbjct: 126 -HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKD 182
Query: 556 SHFTEKSDVYSFGVVLVELLTGERP 580
+ + K+D++S G+ L+EL E P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 6/194 (3%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445
LGQG G V+ G VA+K K E F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRD 505
+ +V EF+ G+L ++ + + + + + +A ++ ++Y+ I HRD
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 506 IKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVY 565
+++ NIL+ D K++DFG +R I ++ + + PE FT KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 566 SFGVVLVELLTGER 579
SFG++L EL+T R
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 13/227 (5%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKK--SKIIDESKVEEFINEVVILSQI 431
E D+F LG G G V K + ++ +K I + + I E+ +L +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
N +V G + E + G+L Q + + RI E+ ++I V ++
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLA 117
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YL I HRD+K +NIL++ + K+ DFG S + +D + GT Y+ PE
Sbjct: 118 YLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 172
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598
Q +H++ +SD++S G+ LVEL G PI +++E L A F R
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGR 216
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 386 LGQGGQGTVYKGML--EDGKIVAVKK-SKIIDESKVEEFINEV-VILSQINHRNVVKLLG 441
+G+G GTV K ML G I+AVK+ +DE + + + ++ V++ + +VK G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 442 CCLETEVPLLVYEF--ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
+ E IS +Y+ + K I E+ IA+ A++YL +
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKS-VIPEEILGKIAVATVKALNYLKE--EL 127
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRD+K +NILLD K+ DFG S SIA T+ G Y+ PE
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERIDP 181
Query: 556 SH---FTEKSDVYSFGVVLVELLTGERPIRLTNS 586
S + +SDV+S G+ L E+ TG+ P NS
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 373 LEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI 431
L T F ++G+G G VYK + G++VA+K II++ + EE E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 432 -NHRNVVKLLGCCLETEVPL------LVYEFISNGT---LSQYIDDQNKDFRISWEMRLC 481
NH N+ G ++ P LV E G+ L + + + K R+ E
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAY 117
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
I + ++YLH I HRDIK NILL K+ DFG S L + +
Sbjct: 118 ILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSA-------QLDSTL 167
Query: 542 Q------GTFGYLDPE-----YFQSSHFTEKSDVYSFGVVLVELLTGERP 580
GT ++ PE + + +SDV+S G+ +EL G+ P
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 379 NFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDES-----KVEEFINEVVILSQIN 432
N+ ++LGQG G VY D G+ +AVK+ + ES +V E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 433 HRNVVKLLGCCLET-EVPLLVY-EFISNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGA 489
H +V+ GC + E L ++ E + G+ I DQ K + ++ + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEG 118
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR---SIAVDQTHLTTQVQGTFG 546
+SYLHS I HRDIK NIL D K+ DFGAS+ +I + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
++ PE + K+D++S G +VE+LT E+P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 83/309 (26%), Positives = 133/309 (43%), Gaps = 45/309 (14%)
Query: 379 NFNTNRILGQGGQGTVY----KGMLEDGKIVAVK---KSKIIDESKVEEFI-NEVVILSQ 430
NF R+LG G G V+ G + GK+ A+K K+ I+ ++K E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ + L +T+ L L+ ++++ G L ++ Q + F S E+R+ IA ++ A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLA 117
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ +LH + I +RDIK NILLD + ++DFG S+ ++ GT Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 550 PEYFQ--SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE + S + D +S GV+ ELLTG P T E S + R ++ F
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--FTVDGEQNSQSEISRRILKSKPPF- 231
Query: 608 ILDAQILKEGGKDEFKMVAK-LAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVHQG 666
A+ ++ L + KKR G NGA I +
Sbjct: 232 -----------PKTMSAEARDFIQKLLEKDPKKR-------------LGANGADEIKNHP 267
Query: 667 CFEEIHCVD 675
F+ I D
Sbjct: 268 FFQGIDWDD 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 25/216 (11%)
Query: 404 IVAVKKSKIIDESK--VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461
+VAVK + D +K +F+ EV ILS++ N+++LLG C++ + ++ E++ NG L
Sbjct: 48 LVAVKILRP-DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 462 SQYIDDQNKDFR----------------ISWEMRLCIAIDVSGAISYLHSAASIPIYHRD 505
+Q++ + D + IS+ L +A+ ++ + YL +S+ HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 506 IKSTNILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDV 564
+ + N L+ + K++DFG SR++ A D + + ++ E FT SDV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 565 YSFGVVLVELLT--GERPIRLTNSEEDKSLAAYFLR 598
++FGV L E+L E+P E+ A F R
Sbjct: 224 WAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVK--KSKIIDESKVEEFI-NEVVILSQINHRNVVKLLG 441
LG GG G V ++ + A+K K + I E+ +E I +E IL + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIP 500
+ + ++ E+ G L + D+ D + R IA V A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD---EYTARFYIACVVL-AFEYLHN---RG 113
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTE 560
I +RD+K N+LLD K+ DFG ++ + Q T GT Y+ PE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYDF 171
Query: 561 KSDVYSFGVVLVELLTGERPIRLTNSEED 589
D +S G++L ELLTG P +ED
Sbjct: 172 SVDYWSLGILLYELLTGRPP--FGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 400 EDGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLL--GCCLETEVPLL--V 452
G VA+K + +E + F E + +++ H N+V LL G E LL V
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAV 57
Query: 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512
+E++ TL + + + + + V A++ H+ I HRD+K NI+
Sbjct: 58 FEYVPGRTLREVLAADGA---LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 513 L---DDKYCAKVSDFGAS------RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSD 563
+ + AKV DFG R V TT+V GT Y PE + T SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 564 VYSFGVVLVELLTGER 579
+Y++G++ +E LTG+R
Sbjct: 172 LYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDES-----KVEEFINEVVILSQIN 432
N+ ++LGQG G VY ++ G+ +A K+ + ES +V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 433 HRNVVKLLGCCLE-TEVPLLVY-EFISNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGA 489
H +V+ GC + E L ++ E++ G+ + DQ K + ++ + +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTRKYTRQILEG 118
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR---SIAVDQTHLTTQVQGTFG 546
+SYLHS I HRDIK NIL D K+ DFGAS+ +I + T + + V GT
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
++ PE + K+DV+S G +VE+LT + P E +++AA F A +
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW-----AEYEAMAAIFKIATQPTN-- 227
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L + I E +D C+ + + RP+ E+
Sbjct: 228 PQLPSHI-SEHARDFL--------GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 390 GQGTVYKGML----EDGKIVAVKKSKIIDESKVE--EFINEVVILSQINHRNVVKLLGCC 443
G+G+ K +L EDGK +K+ I S E E EV +LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQN-----KDFRISWEMRLCIAIDVSGAISYLHSAAS 498
E +V ++ G L + I+ Q +D + W +++C+A+ ++H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHDRK- 121
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I HRDIKS NI L K+ DFG +R + L GT YL PE ++ +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPY 178
Query: 559 TEKSDVYSFGVVLVELLT 576
KSD+++ G VL E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 376 ATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQ 430
++ LG+G G VYK ++ G++VA+KK I+ ++ + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITALREIKILKK 63
Query: 431 INHRNVVKLLGCCLE-----TEVPLLVYEFISNGTLSQYIDD------QNKDFRISWEMR 479
+ H NVV L+ +E VY ++ Y+D +N +++
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVKLTESQI 117
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT- 538
C + + I+YLH I HRDIK+ NIL+D++ K++DFG +R +
Sbjct: 118 KCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 539 ---------TQVQGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
T + T Y PE +T D++ G V E+ T RPI
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKK--SKIIDESKVEEFINEVVILSQI 431
E D+F LG G G V+K + ++ +K I + + I E+ +L +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
N +V G + E + G+L Q + K RI ++ ++I V ++
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 117
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YL I HRD+K +NIL++ + K+ DFG S + +D + GT Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 172
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
Q +H++ +SD++S G+ LVE+ G PI +++E
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINH 433
D+ + +G G G V+ A+K I I + + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+++L + ++ E++ G L Y+ + R S L A ++ A+ YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYL 117
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS I +RD+K NILLD + K++DFG ++ + D+T + GT YL PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAPEVI 170
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIR 582
QS + D ++ G+++ E+L G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 65/264 (24%), Positives = 126/264 (47%), Gaps = 32/264 (12%)
Query: 404 IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462
+VAVK + +++ +F+ E+ I+S++ N+++LL C+ ++ ++ E++ NG L+
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 463 QYI---------DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL 513
Q++ + + IS+ + +A ++ + YL +S+ HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVT-ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 514 DDKYCAKVSDFGASRSIAVDQTHLTTQVQG----TFGYLDPEYFQSSHFTEKSDVYSFGV 569
Y K++DFG SR++ + ++QG ++ E FT SDV++FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 570 VLVELLT--GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAK 627
L E+LT E+P + E+ F R + R + + + + K
Sbjct: 221 TLWEILTLCKEQPYSQLSDEQVIENTGEFFR--DQGRQVYLPKPALCPD-------SLYK 271
Query: 628 LAKRCLNLNGKKRPTMREVGIELT 651
L C N K+RP+ +E+ L
Sbjct: 272 LMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 29/211 (13%)
Query: 384 RILGQGGQGTVY---KGMLED-GKIVAVK---KS--KIIDESKVEEFINEVVILSQINHR 434
++LGQG G V+ K D G++ A+K K+ K+ D + + E IL+++NH
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHP 58
Query: 435 NVVKLLGCCLETEVPL-LVYEFISNGT----LSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+VKL +TE L L+ +F+ G LS+ + +D + + L +A+D
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALD---- 112
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+LHS + I +RD+K NILLD++ K++DFG S+ ++D GT Y+
Sbjct: 113 --HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMA 166
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
PE T+ +D +SFGV++ E+LTG P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 43/225 (19%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII----DESKVEEFINEVV 426
ELE+ NRI G G GTVYK + G++ A+K +I +++ + E+
Sbjct: 75 ELER------VNRI-GSGAGGTVYKVIHRPTGRLYALK---VIYGNHEDTVRRQICREIE 124
Query: 427 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
IL +NH NVVK C + E+ +L+ EF+ G+L + I+ E L
Sbjct: 125 ILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLA 171
Query: 482 -IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+A + I+YLH I HRDIK +N+L++ K++DFG SR +A +
Sbjct: 172 DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 541 VQGTFGYLDPEYF-----QSSHFTEKSDVYSFGVVLVELLTGERP 580
V GT Y+ PE ++ D++S GV ++E G P
Sbjct: 229 V-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 27/277 (9%)
Query: 385 ILGQGGQGTVYK-GMLEDGKIVAVKKSKIIDESKVEEFI--NEVVILSQINHRNVVKLLG 441
++G+G G V K E G+IVA+KK ++ K+ + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ LV+EF+ + L D + + + I + HS I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD---DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF-QSSHFTE 560
HRDIK NIL+ K+ DFG +R++A T V T Y PE + +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGR 180
Query: 561 KSDVYSFGVVLVELLTGERPIRLTNSEEDK---------SLAAYFLRAMREDRLFEILDA 611
D+++ G ++ E+LTGE P+ +S+ D+ +L +++ LF +
Sbjct: 181 AVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 612 QILKEGGKDEFK------MVAKLAKRCLNLNGKKRPT 642
+KE E + +V LAK+CL ++ RP+
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 384 RILGQGGQGTVYKGMLE-DGK---IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVK 438
RILG G G + +G L+ K VA+ + + + F+ E + L Q +H N+V+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L G ++V E++SNG L ++ M + + + + YL
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL--ASGMKYLSEMGY 128
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
+ H+ + + +L++ K+S F + + + T + + PE Q HF
Sbjct: 129 V---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 559 TEKSDVYSFGVVLVELLT-GERP 580
+ SDV+SFG+V+ E+++ GERP
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEF-INEVV-------ILSQINHRNVV 437
LG+G GTVY +++D K VA ++ K++ E V E NE V +LS+++H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAISYLHSA 496
K LE + ++ E+ L +++ + E ++C I + + Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
I HRD+K+ NI L K+ DFG SR + + L T GT Y+ PE +
Sbjct: 126 R---ILHRDLKAKNIFLK-NNLLKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 557 HFTEKSDVYSFGVVLVEL 574
+ KSD++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGC 442
ILG G GTVYK L +I+AVK + I ++ ++E+ IL + + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+ EF+ G+L Y +I + IA+ V ++YL S + I
Sbjct: 68 FFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASR----SIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
HRD+K +N+L++ + K+ DFG S SIA T V GT Y+ PE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA------KTYV-GTNAYMAPERISGEQY 170
Query: 559 TEKSDVYSFGVVLVELLTGERP 580
SDV+S G+ +EL G P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-15
Identities = 79/241 (32%), Positives = 113/241 (46%), Gaps = 42/241 (17%)
Query: 383 NRILGQGGQGTV-YKGMLEDGKIVAVKKSKIID-ESKVEEFIN----EVVILSQINHRNV 436
+R+LG G GTV + DG+ AVK ++D E E N EV L + ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 437 VKLLGCCLE------------TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRL-CIA 483
VK C E + LV ++ + G L Q I + K R E +
Sbjct: 94 VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA------VDQTHL 537
I V A+ ++HS I HRDIKS NILL K+ DFG S+ A V +T
Sbjct: 150 IQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--DKSLAAY 595
GT Y+ PE ++ +++K+D++S GV+L ELLT +RP N EE K+LA
Sbjct: 207 -----GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261
Query: 596 F 596
+
Sbjct: 262 Y 262
|
Length = 496 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGC 442
+G+G G VYK G+IVA+KK ++ DE I E+ +L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 443 CLETEVPLLVYEFISNGTLSQYID---DQNKDFRI--SWEMRLCIAIDVSGAISYLHSAA 497
LV+EF+ + L +Y+D D + S+ +L I+Y HS
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL------QGIAYCHSHR 119
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSS 556
+ HRD+K N+L+D + K++DFG +R+ V T +V T Y PE S
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
++ D++S G + E++ RP+ +SE D
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNR-RPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 8/212 (3%)
Query: 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
+ LG G G V+ VAVK K S VE F+ E ++ + H +VKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+ E ++ EF++ G+L ++ + + + ++ ++++ I
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
HRD+++ NIL+ K++DFG +R I ++ + + PE FT KS
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 563 DVYSFGVVLVELLT-GERPIR-LTNSEEDKSL 592
DV+SFG++L+E++T G P ++N E ++L
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKK--SKIIDESKVEEF-INEVVILSQINHRN 435
F R+LG+GG G V + GK+ A K+ K I + K E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISYLH 494
VV L + LV ++ G L +I + N F E L A ++ + LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE--EERALFYAAEILCGLEDLH 119
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
++ +RD+K NILLDD ++SD G + + + + GT GY+ PE
Sbjct: 120 RENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIR 582
+ +T D + G ++ E++ G+ P R
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 25/230 (10%)
Query: 379 NFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESK-----VEEFINEVVILSQIN 432
N+ ++LG+G G VY D G+ +AVK+ +S+ V E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 433 HRNVVKLLGCCLE-TEVPLLVY-EFISNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGA 489
H +V+ GC + E L ++ E++ G+ I DQ K + ++ + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQG 118
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR---SIAVDQTHLTTQVQGTFG 546
+SYLHS I HRDIK NIL D K+ DFGAS+ +I + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPY 174
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596
++ PE + K+DV+S +VE+LT + P E +++AA F
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW-----AEYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKK--SKIIDESKVEEF-INEVVILSQINHRN 435
F R+LG+GG G V + GK+ A KK K I + K E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 436 VVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
VV L ET+ L LV ++ G L +I + + A ++ + LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH 119
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
I +RD+K NILLDD ++SD G + + QT + +V GT GY+ PE +
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVK 174
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIR 582
+ +T D ++ G +L E++ G+ P +
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 59/227 (25%), Positives = 108/227 (47%), Gaps = 27/227 (11%)
Query: 374 EKATDNFNTNRILGQGGQGTVY--------KGMLEDGKIVAVKKSKI-IDESKVEEFINE 424
E + D + LG+G G V K ++ VAVK K E + + ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 425 VVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYID-----------DQNK-- 470
+ ++ I H+N++ LLG C + ++ E+ S G L +Y+ D +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 471 DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530
D +++++ + V+ + YL S I HRD+ + N+L+ + K++DFG +R +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 531 -AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
+D TT + ++ PE +T +SDV+SFGV++ E+ T
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 60/217 (27%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGC 442
+G+G G VYK + +A+KK ++ DE I E+ +L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 443 CLETEVPLLVYEFISNGTLSQYID---DQNKDFRIS----WEMRLCIAIDVSGAISYLHS 495
+ LV+E++ + L +++D D K+ R+ +++ + G I+Y HS
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI-------LRG-IAYCHS 120
Query: 496 AASIPIYHRDIKSTNILLDDKYCA-KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YF 553
+ HRD+K N+L+D + A K++DFG +R+ + T +V T Y PE
Sbjct: 121 HR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILL 176
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
S H++ D++S G + E++ ++P+ +SE D+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI-IDESKV-EEFINEVVILSQINHR 434
D + +G+G G VYK GK+VA+KK+++ +DE + + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 435 N-VVKLLGCCLETEVPL------LVYEFISNGTLSQYIDDQNKDFRI--------SWEMR 479
+V+LL E LV+E++ + L +++D + S+ +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLT 538
L + ++ H + HRD+K N+L+D K K++D G R+ ++ T
Sbjct: 119 LLKGV------AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 539 TQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGE 578
++ T Y PE S+H++ D++S G + E+ +
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 384 RILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
++LG+G G V KG E + A+KK ++ + VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 440 LGCCLETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +T+ L V EF++ G L +I D+ R A ++ + +LHS
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I +RD+K N++LD K++DFG + +T GT Y+ PE Q +
Sbjct: 118 I---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKY 173
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
T D +SFGV+L E+L G+ P + +E
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 83/305 (27%), Positives = 132/305 (43%), Gaps = 59/305 (19%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVE---EFINEVVILSQINHR 434
D+F LG G G V K + ++ +K I E K + I E+ +L + N
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKL-IHLEIKPAIRNQIIRELKVLHECNSP 59
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLS---QYID----DQ--NKDFRISWEMRLCIAID 485
+V G F S+G +S +++D DQ K RI + I+I
Sbjct: 60 YIVGFYGA------------FYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
V ++YL I HRD+K +NIL++ + K+ DFG S + +D + GT
Sbjct: 108 VLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTR 162
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR- 604
Y+ PE Q +H+T +SD++S G+ LVE+ G PI +++E +++ +
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 605 ----------------LFEILD------AQILKEGG-KDEFK-MVAKLAKRCLNLNGKKR 640
+FE+LD L G DEF+ V K CL N K+R
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK----CLKKNPKER 278
Query: 641 PTMRE 645
++E
Sbjct: 279 ADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
LG G G VYK E G + A K + E ++E+++ E+ IL+ NH +VKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504
++ EF G + + + ++ ++++ I + A+ YLH S+ I HR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQV-ICRQMLEALQYLH---SMKIIHR 134
Query: 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY-----FQSSHFT 559
D+K+ N+LL K++DFG S + V GT ++ PE + + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 560 EKSDVYSFGVVLVELLTGERP 580
K+D++S G+ L+E+ E P
Sbjct: 194 YKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/225 (25%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 366 KLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDG---KI-VAVKKSKIIDESKVEE 420
++ EL K ++LG G GTV+KG+ + +G KI VA+K I D S +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQT 52
Query: 421 F---INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWE 477
F + ++ + ++H +V+LLG C + L V + G+L ++ Q++D + +
Sbjct: 53 FQEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVR-QHRD-SLDPQ 109
Query: 478 MRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG-ASRSIAVDQTH 536
L + ++ + YL + HR++ + NILL +++DFG A D+ +
Sbjct: 110 RLLNWCVQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
++ + ++ E +T +SDV+S+GV + E+++ G P
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 29/230 (12%)
Query: 366 KLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK---SKIIDESKVEEF 421
+LF ++ EK F+ R +G G G VY + + ++VA+KK S K ++
Sbjct: 6 ELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 422 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
I EV L ++ H N ++ GC L LV E+ G+ S ++ K + E+
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ---EVE-- 116
Query: 482 IAIDVSGAI---SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538
IA GA+ +YLHS I HRD+K+ NILL + K+ DFG++ +A +
Sbjct: 117 IAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV- 172
Query: 539 TQVQGTFGYLDPEY---FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTN 585
GT ++ PE + K DV+S G+ +EL ER L N
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVKK--SKIIDESKVEEF-INEVVILSQINHRNVVKLLG 441
LG+GG G V ++ GK+ A KK K + + K E+ +NE IL +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 442 CCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
ET+ L LV ++ G L +I + + A + G + +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG-LEHLHQRR--- 115
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTE 560
I +RD+K N+LLDD ++SD G + + + GT GY+ PE Q +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 561 KSDVYSFGVVLVELLTGERPIR 582
D ++ G L E++ G P R
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 62/229 (27%), Positives = 112/229 (48%), Gaps = 32/229 (13%)
Query: 379 NFNTNRILGQGGQ---GTVYKGML------EDGKIVAVKKSKIIDESKV---EEFINEVV 426
N +T R + + G+ G VYKG L E + VA+K K D+++ EEF +E +
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAM 60
Query: 427 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-----------DDQNKDFRIS 475
+ S++ H N+V LLG + + +++ + S+ L +++ D +K + +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 476 WEMR--LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AV 532
E + I ++ + +L S + H+D+ + N+L+ DK K+SD G R + A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
D L ++ PE F+ SD++S+GVVL E+ + G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 27/229 (11%)
Query: 363 DKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK---SKIIDESKV 418
+ +LF + EK F R +G G G VY + ++VA+KK S K
Sbjct: 13 EIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW 69
Query: 419 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM 478
++ I EV L +I H N ++ GC L LV E+ G+ S ++ K +
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----- 123
Query: 479 RLCIAIDVSGAI---SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535
+ IA GA+ +YLHS I HRDIK+ NILL + K++DFG++ + +
Sbjct: 124 EVEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIASPANS 180
Query: 536 HLTTQVQGTFGYLDPEY---FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
+ GT ++ PE + K DV+S G+ +EL + P+
Sbjct: 181 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 378 DNFNTNRILGQGGQGTVYK----GMLEDGK----IVAVKKSKIIDESK-VEEFINEVVIL 428
D + LG+G G V + G+ + VAVK K K + + I+E+ ++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 429 SQIN-HRNVVKLLGCCLETEVPLLV-YEFISNGTLSQYID-------DQNKDFRISWEMR 479
I H+N++ LLG C + E PL V E+ + G L +++ D D E +
Sbjct: 72 KLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 480 LCI------AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-AV 532
L A V+ + YL S I HRD+ + N+L+ + K++DFG +R + +
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
D T+ + ++ PE +T +SDV+SFG+++ E+ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 385 ILGQGGQGTVYK------GMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVV 437
++G+G G V K G+ D I +K+ D+ + +F E+ +L ++ H N++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNII 71
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYID-----DQNKDFRI--------SWEMRLCIAI 484
LLG C L E+ +G L ++ + + F I S + L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
DV+ + YL I HRD+ + NIL+ + Y AK++DFG SR V V+ T
Sbjct: 132 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 181
Query: 545 FG-----YLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
G ++ E S +T SDV+S+GV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 384 RILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
++LG+G G V KG E I +KK I+ + V+ + E IL+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 440 LGCCLETEVPLL-VYEFISNGTL------SQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
L CC +T+ L V E+++ G L S+ D+ F A +V+ A+ +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF---------YAAEVTLALMF 111
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LH I +RD+K NILLD + K++DFG + + TT GT Y+ PE
Sbjct: 112 LHRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEI 167
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
Q + D ++ GV++ E++ G+ P N ++
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 59/217 (27%), Positives = 110/217 (50%), Gaps = 30/217 (13%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCC 443
LG+G TVYKG G+IVA+K+ + +E I E+ ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 444 LETEVPL-LVYEFISNGTLSQYID----------DQNKDFRISWEMRLCIAIDVSGAISY 492
+ TE L LV+E++ L +Y+D + K F ++++ + G I++
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSF--TYQL-------LKG-IAF 115
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
H + HRD+K N+L++ + K++DFG +R+ + + +V T Y P+
Sbjct: 116 CHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 553 FQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
S ++ D++S G ++ E++TG TN+E+
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 379 NFNTNRILGQGGQGTVY-----KGMLEDGKIVA---VKKSKIIDESKVEEFI-NEVVILS 429
NF ++LG G G V+ G + GK+ A +KK+ I+ ++K E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 430 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG 488
I + L +T+ L L+ ++I+ G L ++ Q + F+ E+++ ++
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS-QRERFK-EQEVQIYSG-EIVL 116
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
A+ +LH + I +RDIK NILLD ++DFG S+ D+ GT Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 549 DPEYFQ--SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603
P+ + + D +S GV++ ELLTG P T E S A R ++ +
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 380 FNTNRILGQGGQGTV----YKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN--- 432
F +LG+G G V YK E I A+KK II +VE + E I N
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 433 HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAI 490
H +V L C +TE + V E+ + G L +I F E R A V +
Sbjct: 61 HPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFS---EPRAVFYAACVVLGL 114
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS-IAVDQTHLTTQVQGTFGYLD 549
YLH I +RD+K N+LLD + K++DFG + + T+ GT +L
Sbjct: 115 QYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLA 169
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
PE + +T D + GV++ E+L GE P + EE
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 66/258 (25%), Positives = 100/258 (38%), Gaps = 70/258 (27%)
Query: 362 IDKTKL-FTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVE 419
ID K N+LE + +G G G VYK + G ++AVK+ + +
Sbjct: 5 IDGQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN 57
Query: 420 EFI---NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISW 476
+ I +VV+ S + +VK G FI++ D I
Sbjct: 58 KRILMDLDVVLKSH-DCPYIVKCYGY------------FITD-----------SDVFICM 93
Query: 477 E-MRLC-------------------IAIDVSGAISYL---HSAASIPIYHRDIKSTNILL 513
E M C + + + A+ YL H + HRD+K +NILL
Sbjct: 94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILL 148
Query: 514 DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK----SDVYSFGV 569
D K+ DFG S + + T+ G Y+ PE K +DV+S G+
Sbjct: 149 DASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206
Query: 570 VLVELLTGERPIRLTNSE 587
LVEL TG+ P + +E
Sbjct: 207 SLVELATGQFPYKNCKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 82/312 (26%), Positives = 132/312 (42%), Gaps = 87/312 (27%)
Query: 386 LGQGGQGTVYKGMLED---GKIVAVKKSKIIDESKVEEFIN---------EVVILSQI-N 432
LG+G G V+K + D ++VA+KK I D F N E++ L ++ +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKK--IFDA-----FRNATDAQRTFREIMFLQELGD 65
Query: 433 HRNVVKLLGC--------------CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM 478
H N+VKLL +ET++ + I L +D +K +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDL----HAVIRANIL----EDVHKRY------ 111
Query: 479 RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538
I + A+ Y+HS I HRD+K +NILL+ K++DFG +RS++ + +
Sbjct: 112 ---IMYQLLKALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 539 TQVQ----GTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTG-------------ERP 580
V T Y PE S+ +T+ D++S G +L E+L G E+
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225
Query: 581 IRLTN--SEED----KS-LAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCL 633
I + S ED KS AA L ++ + ++L + D ++ K+ L
Sbjct: 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPL--DELLPKASDDALDLL----KKLL 279
Query: 634 NLNGKKRPTMRE 645
N KR T E
Sbjct: 280 VFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKK--SKIIDESKVEEF-INEVVILSQINHRN 435
F R+LG+GG G V + GK+ A KK K I + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 436 VVKLLGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFRISWEMRLCIAIDV 486
VV L ET+ L LV ++ G L +I D+Q F + LC ++
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF---YAAELCCGLE- 116
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
L I +RD+K NILLDD+ ++SD G + I +T + +V GT G
Sbjct: 117 -----DLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVG 166
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
Y+ PE + +T D + G ++ E++ G+ P R
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKK--SKIIDESKVEEF-INEVVILSQINHRN 435
F R+LG+GG G V + GK+ A KK K I + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 436 VVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQ-NKDFRISWEMR-LCIAIDVSGAISY 492
VV L ET+ L LV ++ G L +I + N F E R + A +++ +
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLED 117
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LH I +RD+K NILLDD ++SD G + I +T + +V GT GY+ PE
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
++ +T D + G ++ E++ G+ P R
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRN 435
D++ LG+G TVYKG + +GK+VA+K ++ +E I E +L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+V L E LV+E++ L QY+D ++L + + G +SY+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFLFQLLRG-LSYIHQ 121
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQ 554
I HRD+K N+L+ D K++DFG +R+ +V + +V T Y P+
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLG 177
Query: 555 SSHFTEKSDVYSFGVVLVELLTG 577
S+ ++ D++ G + VE++ G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 48/290 (16%)
Query: 385 ILGQGGQGTVYKGMLE-DG-KIVAVKK--SKIIDESKVEEFINEVVILSQI-NHRNVVKL 439
++G+G G V + M++ DG K+ A K + E+ +F E+ +L ++ +H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYI-------------DDQNKDFRISWEMRLCIAIDV 486
LG C + E+ G L ++ + ++ + L A DV
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
+ + YL I HRD+ + N+L+ + +K++DFG SR V V+ T G
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV-------YVKKTMG 178
Query: 547 -----YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
++ E S +T KSDV+SFGV+L E++ SL M
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV---------------SLGGTPYCGMT 223
Query: 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651
L+E L E ++ V +L ++C +RP ++ ++L+
Sbjct: 224 CAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 380 FNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH-RNVV 437
F ++G G G VYKG ++ G++ A+K + + + EE E+ +L + +H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 438 KLLGCCLETEVP------LLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAI 490
G ++ P LV EF G+++ I + + + W +C ++ +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR--EILRGL 124
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFG 546
S+LH I HRDIK N+LL + K+ DFG S R++ T + GT
Sbjct: 125 SHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 176
Query: 547 YLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPI 581
++ PE + + KSD++S G+ +E+ G P+
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKK----SKIIDESKVEEFINEVVILSQINHRNVVKLL 440
+G G G VY ++VAVKK K +E K ++ I EV L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI---SYLHSAA 497
GC L+ LV E+ G+ S ++ K + + IA GA+ +YLHS
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQ-----EVEIAAITHGALQGLAYLHSHN 141
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY---FQ 554
I HRDIK+ NILL + K++DFG++ + + + GT ++ PE
Sbjct: 142 MI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMD 193
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPI 581
+ K DV+S G+ +EL + P+
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 56/244 (22%)
Query: 378 DNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D+F +++G+G G V+ + G++ A+K KS +I +++ E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISW------EMRLCIAIDV 486
+VKL + E L LV E++ G L + ++ F E+ L
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVL------ 112
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ---- 542
A+ +H I HRDIK NIL+D K++DFG + + +
Sbjct: 113 --ALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMN--KAKDREYYLNDSH 165
Query: 543 --------------------------GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
GT Y+ PE + + + + D +S GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 577 GERP 580
G P
Sbjct: 226 GFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
++F + +G G G VYK + G++ A+K K+ E++++ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQ--YIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
V G L + + EF G+L ++ + +I++ R + + YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLH 123
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF- 553
S + HRDIK NILL D K++DFG S I + + GT ++ PE
Sbjct: 124 SKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAA 179
Query: 554 --QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+ + + D+++ G+ +EL + P+ + L MR LF + +
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPM-------------FDLHPMRA--LFLMTKS 224
Query: 612 QILKEGGKDEFKMVAK---LAKRCLNLNGKKRPT 642
KD+ K K L N KKRPT
Sbjct: 225 NFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 16/223 (7%)
Query: 379 NFNTNRILGQGGQGTVY----KGMLEDGKIVAVK---KSKIIDESKVEEFI-NEVVILSQ 430
NF ++LG G G V+ + GK+ A+K K+ ++ ++K E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ + L +TE L L+ +++S G + ++ +D E+R ++ A
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL--YQRDNFSEDEVRFYSG-EIILA 117
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ +LH + I +RDIK NILLD + ++DFG S+ ++ T GT Y+
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 550 PEYFQSSHFTEKS-DVYSFGVVLVELLTGERPIRLTNSEEDKS 591
PE + K+ D +S G+++ ELLTG P L +S
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 405 VAVKKSKIIDESK-VEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462
VAVK K K + + ++E+ ++ I H+N++ LLG C + ++ E+ S G L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 463 QYI--------DDQNKDFRISWEMRLC-----IAIDVSGAISYLHSAASIPIYHRDIKST 509
+Y+ D ++ E A V+ + YL S I HRD+ +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAAR 163
Query: 510 NILLDDKYCAKVSDFGASRSI-AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFG 568
N+L+ + K++DFG +R + +D TT + ++ PE +T +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 569 VVLVELLT 576
V+L E+ T
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 386 LGQGGQGTVYKG--MLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQIN---HRNVVK 438
+G+G G V+K + G+ VA+K+ ++ +E I EV +L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 439 LLGCCL------ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
L C ET++ L V+E + L+ Y+D + + + E + + + +
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHVDQ-DLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LHS + HRD+K NIL+ K++DFG +R + T V T Y PE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
S + D++S G + E+ +P+ +S+ D+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK-VEEF-INEVVILSQINHRNVVKLLGC 442
+G+G GTV+K E +IVA+K+ ++ D+ + V + E+ +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+ LV+E+ L +Y D N D I E+ + +++ HS +
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSHN---VL 121
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEK 561
HRD+K N+L++ K++DFG +R+ + + +V T Y P+ F + ++
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDK 590
D++S G + EL RP+ N +D+
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQINHRNVVKL 439
+GQG G V+K + +IVA+KK ++ E++ E F + E+ IL + H NVV L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 440 LGCCLETEVP--------LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+ C P LV+EF + L+ + ++N F +S E++ + + ++G +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIKKVMKMLLNG-LY 133
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV---DQTHLTTQVQGTFGYL 548
Y+H I HRD+K+ NIL+ K++DFG +R+ ++ + + T T Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 549 DPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
PE + D++ G ++ E+ T PI N+E+
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQ 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 380 FNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH-RNVV 437
F ++G G G VYKG ++ G++ A+K + ++ + EE E+ +L + +H RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 438 KLLGCCLETEVP------LLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAI 490
G ++ P LV EF G+++ + + + + W +C ++ +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR--EILRGL 134
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFG 546
++LH+ I HRDIK N+LL + K+ DFG S R++ T + GT
Sbjct: 135 AHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 186
Query: 547 YLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPI 581
++ PE + + +SD++S G+ +E+ G P+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 62/236 (26%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 384 RILGQGGQGTVYKGMLED-GKIVA---VKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
R++G+G V L+ +I A VKK + D+ ++ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 440 LGCCLETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +TE L V E+++ G L ++ Q K + E + ++S A++YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG- 116
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE-ILDAQI 613
D ++ GV++ E++ G P + S ++ ED LF+ IL+ QI
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-------EDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGC 442
LG G G VYK ++ ++A +K+ID E ++E+++ E+ IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
++ EF + G + + + + +C A++YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVC--KQTLEALNYLHENK---II 125
Query: 503 HRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFGYLDPEYF----- 553
HRD+K+ NIL K++DFG S R+I + + GT ++ PE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETS 180
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERP 580
+ + K+DV+S G+ L+E+ E P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 386 LGQGGQGTVYK-GMLEDGKIVAVKK--SKIIDESK-VEEFINEVVILSQINHRNVVKLLG 441
LG+GG G V M GK+ A KK K + + K E + E IL++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 442 CCLETEVPLLVYEFISNGTLSQY----IDDQNKDFRISWEMRLCI--AIDVSGAISYLHS 495
+T+ L + I NG +Y +D++N F E R C A +SG + +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISG-LEHLHQ 115
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I +RD+K N+LLD+ ++SD G + + Q+ T GT G++ PE Q
Sbjct: 116 RR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIR 582
+ D ++ GV L E++ P R
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
+GQGG G V+ +D G+IVA+K KS + ++V + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 442 CCLETEVPLLVYEFISNG---TL---SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+ E L E++ G TL + + + F ++ EM A+ LH
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-EM-FE-------AVDALHE 119
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRD+K N L+D K++DFG S+ I V + V G+ Y+ PE +
Sbjct: 120 LGYI---HRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPEVLRG 172
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ D +S G +L E L G P + E
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 379 NFNTNRILGQGGQGTV----YKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR 434
+F LG G G V +KG E I +KK +I+ +V+ E IL +++H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNK---DFRISWEMRLCIAIDVSGAIS 491
+V ++ + + EF+ G L ++ + D + L +A +
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------ 132
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLHS I +RD+K N+LLD+K KV+DFG ++ + T + GT YL PE
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERP 580
QS + D ++ GV+L E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKI--VAVK---KSKIIDESKVEEFINEVVILSQIN 432
++FN R LG G G V ++ VA+K KSKII + +V+ +E IL+ IN
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
H V L G + LV EF+ G ++ ++ R ++ A + Y
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
L S+ I +RD+K N+LLD K++DFG ++ + T + GT Y+ PE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEI 199
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERP 580
+ + +D ++ G+ + E+L G P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 384 RILGQGGQGT---VYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN------- 432
+ILG+ G+GT V K + GK A+K K +S + +V L +I
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-----LEQVNNLREIQALRRLSP 56
Query: 433 HRNVVKLLGCCLE--TEVPLLVYEFISNGTLSQYIDDQNKDF---RISWEMR-LCIAIDV 486
H N+++L+ + T LV+E + + L + I + + R+ M L ++D
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD- 114
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
++H I+HRDIK NIL+ D K++DFG+ R I + T+ T
Sbjct: 115 -----HMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRW 163
Query: 547 YLDPEYFQSS-HFTEKSDVYSFGVVLVELLT 576
Y PE + ++ K D+++ G V E+L+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 384 RILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLL-- 440
R LG G G V+ + D K VAVKK + D V+ + E+ I+ +++H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 441 ----GCCLETEVPLLVYEFISNGTLSQYID-------DQNKDFRISWEMRLCIAIDVSGA 489
G L +V L E S + +Y++ +Q +S E +
Sbjct: 71 LGPSGSDLTEDVGSLT-ELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRG 126
Query: 490 ISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQG--TFG 546
+ Y+HSA + HRD+K N+ ++ + K+ DFG +R + +H +G T
Sbjct: 127 LKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 547 YLDPE-YFQSSHFTEKSDVYSFGVVLVELLTG 577
Y P +++T+ D+++ G + E+LTG
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKII--DESKVEEFINEVVIL---SQINHRNVVKL 439
+G G GTVYK G VA+K ++ ++ + EV +L +H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 440 LGCCL------ETEVPLLVYEFISNGTLSQYID---------DQNKDFRISWEMR--LCI 482
+ C ET+V L V+E + L Y+D + KD MR L
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHVDQ-DLRTYLDKVPPPGLPAETIKDL-----MRQFLR- 119
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542
+ +LH+ I HRD+K NIL+ K++DFG +R I Q LT V
Sbjct: 120 ------GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVV 169
Query: 543 GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
T Y PE S + D++S G + E+ +P+ NSE D+
Sbjct: 170 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCC 443
LG+G G+VYK + G +A+K+ ++ +DESK + I E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ E++ G+L + I ++ I V + +L +I H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126
Query: 504 RDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQGTFGYLDPEYFQSSH-- 557
RD+K TN+L++ K+ DFG S S+A +T++ Q Y+ PE +S
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNIGCQ-----SYMAPERIKSGGPN 179
Query: 558 ----FTEKSDVYSFGVVLVELLTGERP 580
+T +SDV+S G+ ++E+ G P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 37/273 (13%)
Query: 384 RILGQGGQGTV-YKGMLEDGKIVAVKKSKIIDESKVEEFI--NEVVILSQINHRNVVKLL 440
R++G+G G V DGK +KK + + S+ E E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 441 GCCLETEVPLL--VYEFISNGTLSQYIDDQNKDFR-----ISWEMRLCIAIDVSGAISYL 493
E E LL V F G L + +Q + W + ++ A+ YL
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYL 118
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
H I HRD+K+ N+ L KV D G +R + +Q + + + GT Y+ PE F
Sbjct: 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELF 174
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
+ + KSDV++ G + E+ T + N+++ SL ++ I++ +
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAF---NAKDMNSL------------VYRIIEGK- 218
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L KD + +L L+ +KRP+++ +
Sbjct: 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 384 RILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
++LG+G G V KG E I A+KK ++++ VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 440 LGCCLETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +T+ L V E+++ G L +I R A ++ + +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKGI 117
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I +RD+K N+LLD K++DFG + + +T GT Y+ PE + +
Sbjct: 118 I---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKY 173
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
E D +SFGV+L E+L G+ P + +E
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 59/274 (21%), Positives = 119/274 (43%), Gaps = 46/274 (16%)
Query: 388 QGGQGTVYKGMLEDGKIV--AVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445
+ Q ++YKG+ + +++ KK + ++ NE+ L +I+ N++K+ G ++
Sbjct: 30 ENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 446 TEVPL----LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
L L+ E+ + G L + +D + KD +S++ +L +AID + L+ + P
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVLD-KEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS--SHFT 559
++++ S + L+ + Y K+ G + ++ Y + S +T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN----FMVYFSYKMLNDIFSEYT 200
Query: 560 EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK 619
K D+YS GVVL E+ TG+ P ++ EI D I K
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTK-------------------EIYDLIINK---N 238
Query: 620 DEFKMVAK-------LAKRCLNLNGKKRPTMREV 646
+ K+ + + C + + KRP ++E+
Sbjct: 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 63/231 (27%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQINHRNVV 437
+ +G G G V + G+ VA+KK +ID ++ + E+ +L + H N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI---LREIKLLRHLRHENII 62
Query: 438 KLLGCCLETEVPL-----------LVYEFI---------SNGTLS----QYIDDQNKDFR 473
LL ++ +V E + S L+ QY Q
Sbjct: 63 GLL------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ----- 111
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533
L + YLHSA + HRD+K +NIL++ K+ DFG +R + D
Sbjct: 112 -----ILR-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 534 QTHLTTQVQG--TFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
+ + T Y PE SS +T+ D++S G + ELLT +P+
Sbjct: 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 384 RILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
++LG+G G V+ KG + I A+KK ++ + VE + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 440 LGCCLETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +T+ L V E+++ G L +I +K F + A ++ + +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLP--RATFYAAEIICGLQFLHSKG- 116
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I +RD+K NILLD K++DFG + + T GT Y+ PE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
D +SFGV+L E+L G+ P + EE
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 384 RILGQGGQGTVYKGMLE-DGKIVAVK--KSKIIDESKVEEFI--NEVVILSQINHRNVVK 438
+++G+G G V + DGK AVK + KI+ K ++ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAA 497
L TE V +F++ G L ++ + R E R A +++ A+ YLHS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS-- 114
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
I I +RD+K NILLD + ++DFG + + Q+ TT GT YL PE +
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ D + G VL E+L G P + E
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 424 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD-----QNKDFRISWEM 478
E ++L +NH +V+++ LV I+ L Y D + + +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 479 RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538
L I + + YLH+ I HRD+K+ NI ++D + D GA++ V L
Sbjct: 159 ALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575
+ GT PE + K+D++S G+VL E+L
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 56/242 (23%), Positives = 105/242 (43%), Gaps = 17/242 (7%)
Query: 384 RILGQGGQGTVYKGMLEDGKIV----AVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
R++G+G V L+ + VKK + D+ ++ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +T L LV E+++ G L ++ Q K + E A ++ A+++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERG- 116
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I +RD+K N+LLD K++D+G + + T+ GT Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED-----RLFEILDAQI 613
D ++ GV++ E++ G P + D + Y + + E R + + +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233
Query: 614 LK 615
LK
Sbjct: 234 LK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCC 443
LG+G TV+KG + +VA+K+ ++ +E I EV +L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 444 LETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+ TE L LV+E++ + L QY+D N +S + +SY H I
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLD--NCGNLMSMHNVKIFMFQLLRGLSYCHKRK---IL 125
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEK 561
HRD+K N+L+++K K++DFG +R+ +V + +V T Y P+ S+ ++
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 562 SDVYSFGVVLVELLTGERPI 581
D++ G +L E+ TG RP+
Sbjct: 185 IDMWGVGCILYEMATG-RPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 386 LGQGGQGTVYKG--MLEDGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRNVVKLLGC 442
LG+G TVYKG L D +VA+K+ ++ E I EV +L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 443 CLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ TE L LV+E++ + L QY+DD + ++L + + G ++Y H +
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQLLRG-LNYCHRRK---V 125
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTE 560
HRD+K N+L++++ K++DFG +R+ ++ + +V T Y P+ S+ ++
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 561 KSDVYSFGVVLVELLTGERPI 581
+ D++ G + E+ TG RP+
Sbjct: 185 QIDMWGVGCIFYEMSTG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 73/293 (24%), Positives = 118/293 (40%), Gaps = 54/293 (18%)
Query: 386 LGQGGQGTVYKGMLEDGKIVA---VKKSKIIDESKVEE---FINEVVILSQINHRNVVKL 439
+G G G V G G A VK+ + + +E F+ EV ++NH NV++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELR--ASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC--IAIDVSGAISYLHSAA 497
LG C+E+ LLV EF G L Y+ + + +A +V+ + +LH A
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG--YLDPEYFQS 555
I H D+ N L K+ D+G + + + T+ +L PE +
Sbjct: 121 FI---HSDLALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 556 SH-------FTEKSDVYSFGVVLVELLT-GERP---------IRLTNSEEDKSLAAYFLR 598
T+KS+++S GV + EL T ++P ++ E+D L L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236
Query: 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651
DR +E++ +F C L+ + RPT EV LT
Sbjct: 237 LKYSDRWYEVM-----------QF---------CW-LDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 24/184 (13%)
Query: 404 IVAVKKSKIIDESKVEEFINEVVIL-SQINHRNVVKLLGCCLETEVPLLVYEFISNG--- 459
I +KKS +I +++V E I+ Q V KL + LV E+++ G
Sbjct: 26 IKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85
Query: 460 TLSQ---YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK 516
+L + + + W + IA +V + LH I HRDIK N+L+D
Sbjct: 86 SLIKTLGGLPED-------W-AKQYIA-EVVLGVEDLHQRG---IIHRDIKPENLLIDQT 133
Query: 517 YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576
K++DFG SR+ ++ + GT YL PE + SD +S G V+ E L
Sbjct: 134 GHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188
Query: 577 GERP 580
G P
Sbjct: 189 GYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 56/208 (26%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRNVVKLLGCC 443
LG+G TV+KG + +VA+K+ ++ E I EV +L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ LV+E++ + L QY+DD + +++ + + G ++Y H + H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFLYQILRG-LAYCHRRK---VLH 127
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEKS 562
RD+K N+L++++ K++DFG +R+ +V + +V T Y P+ SS ++ +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 563 DVYSFGVVLVELLTGERPIRLTNSEEDK 590
D++ G + E+ +G RP+ ++ ED+
Sbjct: 187 DMWGVGCIFFEMASG-RPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 48/289 (16%)
Query: 385 ILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVE----EFINEVVILSQINHR-NVVKL 439
++G+G G V K ++ + K + E + +F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYID-------------DQNKDFRISWEMRLCIAIDV 486
LG C L E+ +G L ++ + +S + L A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
+ + YL I HRD+ + NIL+ + Y AK++DFG SR V V+ T G
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 171
Query: 547 -----YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
++ E S +T SDV+S+GV+L E++ SL M
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV---------------SLGGTPYCGMT 216
Query: 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
L+E L E + V L ++C +RP+ ++ + L
Sbjct: 217 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 379 NFNTNRILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR 434
+FN +LG+G G V KG E I +KK +I + VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 435 NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+ L C +T L V E+++ G L I R + A +++ + +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFL 117
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS I +RD+K N++LD + K++DFG + D T GT Y+ PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEII 173
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ + D ++FGV+L E+L G+ P + +E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-12
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 384 RILGQGGQGTVYKGMLED---GKIVAVKKSK--IIDESKVEE-FINEVVILSQINHRNVV 437
R++G+GG G VY D + VA+KK + + + +++ F+ E I + + H +V
Sbjct: 8 RLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYI------DDQNKDFRI--SWEMRLCIAIDVSGA 489
+ C + + +I TL + + +K+ S L I +
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT---------- 539
I Y+HS + HRD+K NILL + D+GA+ +++ L
Sbjct: 126 IEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 540 -------QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
++ GT Y+ PE +E +D+Y+ GV+L ++LT P R
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-12
Identities = 58/187 (31%), Positives = 99/187 (52%), Gaps = 16/187 (8%)
Query: 403 KIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462
K+VA K + DE + +E+ L+ +H +VK + LL+ E+ S G L+
Sbjct: 95 KVVA-KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 463 QYIDDQNKD---FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519
+ I + K+ F+ +E+ L + + A+ +HS + HRD+KS NI L
Sbjct: 154 KQIKQRLKEHLPFQ-EYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGII 208
Query: 520 KVSDFGASR----SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575
K+ DFG S+ S+++D + + GT YL PE ++ +++K+D++S GV+L ELL
Sbjct: 209 KLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 576 TGERPIR 582
T RP +
Sbjct: 266 TLHRPFK 272
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 373 LEKATDNFNTNRILGQGGQGTVYK-GMLEDGKIVAVKKSKIIDE-SKVEEFIN-EVVILS 429
L TD + +G+G G VYK +DG + AVK I+D S V+E I E IL
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEIEAEYNILQ 73
Query: 430 QI-NHRNVVKLLGCCLETEVPL-----LVYEFISNGTLSQYIDDQNK-DFRISWEMRLCI 482
+ NH NVVK G + + + LV E + G++++ + R+ M I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM---I 130
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542
+ + GA+ L + I HRD+K NILL + K+ DFG S + + T V
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189
Query: 543 GTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPI 581
GT ++ PE + + DV+S G+ +EL G+ P+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 33/266 (12%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL 444
+G G G VYK L G++ AVK K+ E+ ++ + H N+V G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 445 ETEVPLLVYEFISNGTLSQ--YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
E + E+ G+L ++ + +I++ R + ++YLHS +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKM--- 128
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF---QSSHFT 559
HRDIK NILL D K++DFG + I + + GT ++ PE ++ +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 560 EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK 619
+ D+++ G+ +EL + P+ + L MR LF + + K
Sbjct: 188 QLCDIWAVGITAIELAELQPPM-------------FDLHPMRA--LFLMSKSNFQPPKLK 232
Query: 620 DEFKMVA---KLAKRCLNLNGKKRPT 642
D+ K + K L N KKRPT
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 379 NFNTNRILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR 434
+FN +LG+G G V KG E I +KK +I + VE + E +L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 435 NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+ L C +T L V E+++ G L +I K + A ++S + +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFL 117
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
H I +RD+K N++LD + K++DFG + VD T GT Y+ PE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEII 173
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ + D +++GV+L E+L G+ P + +E
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 74/298 (24%), Positives = 130/298 (43%), Gaps = 37/298 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDG-KIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F +++G+G G V L++ K+ A+K K +++ ++ F E +L ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTL----SQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ + L + LV ++ G L S++ D +D + + IAID
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ Y+H RDIK NIL+D +++DFG+ + D T ++ GT Y+
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 550 PEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
PE Q+ + + D +S GV + E+L GE P +SL + + M
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKE 225
Query: 605 LFEILDAQI--LKEGGKDEFKMVAKLAKRCLNLNG----KKRPTMREVGIELTGIRGC 656
F+ AQ+ + E KD + + + L NG K+ P GI+ IR C
Sbjct: 226 RFQ-FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT--GIDWDNIRNC 280
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 40/232 (17%)
Query: 368 FTSNELEKAT----DNFNTNRILGQGGQGTVYKGMLEDGKI-VAVKKSKIIDESKVEEF- 421
F EL K D + +G G G V VA+KK +S
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHA 58
Query: 422 ---INEVVILSQINHRNVVKLLGC-----CLE--TEVPLLVYEFI----SNGTLSQYIDD 467
E+ +L ++H NV+ LL LE +V LV + +N Q + D
Sbjct: 59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV-YLVTHLMGADLNNIVKCQKLSD 117
Query: 468 QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527
+ F + +R + Y+HSA I HRD+K +NI +++ K+ DFG +
Sbjct: 118 DHIQFLVYQILR---------GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165
Query: 528 RSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGE 578
R + +T V T Y PE H+ + D++S G ++ ELLTG+
Sbjct: 166 RHTDDE---MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 386 LGQGGQGTVYKGMLEDGKIV----AVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
+G+G G V + D + + ++K+ I+ S+V + E +L+Q+N +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
E LV FI+ G L ++ + + F +S R A ++ A+ LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLS-RARFYTA-ELLCALENLHK---FNV 114
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
+RD+K NILLD + + DFG + + + T GT YL PE +T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEE 588
D ++ GV+L E+LTG P N E
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 384 RILGQGGQGTVYKGMLEDG----KIVAVK---KSKIIDESKVEEFIN-EVVILSQINHRN 435
++LG+GG G V++ G KI A+K K+ I+ K E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 436 VVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI-DVSGAISYL 493
+V L+ +T L L+ E++S G L +++ + I E C + ++S A+ +L
Sbjct: 62 IVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHL 116
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
H I +RD+K NILLD + K++DFG + ++ + +T GT Y+ PE
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEIL 172
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--DKSLAA 594
S + D +S G ++ ++LTG P N ++ DK L
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG 215
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 379 NFNTNRILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR 434
+FN +LG+G G V KG E I +KK II + VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 435 NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+ L C +T L V E+++ G L +I K F+ + A +++ + +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEP--HAVFYAAEIAIGLFFL 117
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFGYLDPEY 552
HS I +RD+K N++LD + K++DFG + +I +T T GT Y+ PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPEI 172
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ + D ++FGV+L E+L G+ P + +E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRNVVKLLGCC 443
LG+G TVYKG+ +G++VA+K + E V I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
E V+E++ L+QY+ Q+ + +RL + + G ++Y+H I H
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMI-QHPGGLHPYNVRLFMFQLLRG-LAYIHGQH---ILH 126
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-SSHFTEKS 562
RD+K N+L+ K++DFG +R+ ++ +++V T Y P+ ++ ++
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185
Query: 563 DVYSFGVVLVELLTGE 578
D++ G + +E+L G+
Sbjct: 186 DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 55/248 (22%)
Query: 378 DNFNTNRILGQGGQGTV-YKGMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D+F + +++G+G G V + G I A+K KS+++++ +V E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTL-SQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
VVKL + E L L+ E++ G + + + KD E R IA + AI
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETIL-AID 115
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ--------- 542
+H I HRDIK N+LLD K K+SDFG + ++H T +
Sbjct: 116 SIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSN 170
Query: 543 ------------------------------GTFGYLDPEYFQSSHFTEKSDVYSFGVVLV 572
GT Y+ PE F + + ++ D +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 573 ELLTGERP 580
E+L G P
Sbjct: 231 EMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINE-VVILSQINHRNVVK 438
+++G+G G V DGK AVK K I+ + + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAA 497
L + V ++++ G L ++ + + F E R A +++ A+ YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHS-- 114
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
+ I +RD+K NILLD + ++DFG + ++ + T+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 558 FTEKSDVYSFGVVLVELLTGERP 580
+ D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 46/279 (16%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVKKS----KIIDESK---VEEFINEVVILSQINHRNVV 437
LGQG ++KG+ + G + K+ K++D+S E F ++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
G C+ + ++V E++ G+L Y+ ISW +L +A ++ A+ +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 498 SIPIYHRDIKSTNILL----DDKYCA----KVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ H ++ + N+LL D K K+SD G SI V + + ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLE---RIPWVP 172
Query: 550 PEYFQSS-HFTEKSDVYSFGVVLVELLTG-ERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE ++ + + +D +SFG L E+ +G ++P+ +S+ K L Y EDR
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFY------EDRH-- 222
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L A E +A L +C++ RP+ R +
Sbjct: 223 QLPAPKWTE--------LANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 384 RILGQGGQGTVYKGMLE-DGKIVAVK--KSKIIDESKVEEFI--NEVVILSQINHRNVVK 438
+++G+G G V + + K AVK + K I + K E+ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAA 497
L + V ++I+ G L ++ + R E R A +++ A+ YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS-- 114
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
+ I +RD+K NILLD + ++DFG + ++ T+ GT YL PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
+ D + G VL E+L G P N+ E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 32/234 (13%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED---GKIVA---VKKSKIIDESKVEEFINEVVILSQI 431
+F+ ++G+G G V ++ + G I A +KKS ++ + V F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTL----SQYIDDQNKDFRISWEMRLCIAIDVS 487
N + +L + + LV E+ G L ++Y D ++D + L +AI
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI--- 115
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
HS + HRDIK N+L+D K++DFG++ + ++ + GT Y
Sbjct: 116 ------HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 548 LDPEYFQSSHFTEKS------DVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595
+ PE + + K D +S GV+ E++ G P E S Y
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF-----HEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIV-AVK---KSKIIDESKVEEFINEVV 426
+L ++F+ +++G+G G V + K V A+K K ++I S F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTL----SQYIDDQNKDFRISWEMRLC 481
I++ N +V+L + + L +V E++ G L S Y D + + + +
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVV 152
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD-QTHLTTQ 540
+A+D +HS I HRD+K N+LLD K++DFG + + T
Sbjct: 153 LALDA------IHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 541 VQGTFGYLDPEYFQS----SHFTEKSDVYSFGVVLVELLTGERP 580
V GT Y+ PE +S ++ + D +S GV L E+L G+ P
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 373 LEKATDNFNTNRILGQGGQGTV----YKGMLEDGKIVAVKKSKIIDESKVEEFINEVVIL 428
L+ ++++ +++G+G G V +K + + + K ++I S F E I+
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 429 SQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVS 487
+ N VV+L C + + L +V E++ G L + N D W +V
Sbjct: 98 AFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAK--FYTAEVV 152
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT---HLTTQVQGT 544
A+ +HS I HRD+K N+LLD K++DFG + +D+T T V GT
Sbjct: 153 LALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV-GT 206
Query: 545 FGYLDPEYFQSS----HFTEKSDVYSFGVVLVELLTGERP 580
Y+ PE +S ++ + D +S GV L E+L G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEE 420
KT +F S +D + +G+G G V+K + ++G AVK I + EE
Sbjct: 4 SGKTIIFDS--FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EE 60
Query: 421 FINEVVILSQI-NHRNVVKLLGCCLETEVP-----LLVYEFISNGTLSQYIDDQNKDF-- 472
E IL + +H NVVK G + +V LV E + G+++ D K F
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLK 116
Query: 473 ---RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529
R+ + I + + +LH +I HRD+K NILL + K+ DFG S
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQ 173
Query: 530 IAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPI 581
+ + T V GT ++ PE S + + DV+S G+ +EL G+ P+
Sbjct: 174 LTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 386 LGQGGQGTV---YKGMLEDGKIVAVKK--SKIIDESKVEEFINEVVILSQINHRNVVKLL 440
+G G QG V Y +LE + VA+KK +++ + E+V++ +NH+N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 441 GC-----CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM--RLCIAIDVSGAISYL 493
LE + + + + L Q I + R+S+ + LC I +L
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIKHL 142
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HSA I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 143 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVI 197
Query: 554 QSSHFTEKSDVYSFGVVLVELLTG 577
+ E D++S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK--SKIIDESKVEEFINEVVILSQINHRNVVKLL 440
+ +G G QG V G VAVKK +++ + E+V+L +NH+N++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 441 GC-----CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMR--LCIAIDVSGAISYL 493
LE + + + + L Q I + R+S+ + LC I +L
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-------GIKHL 139
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HSA I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 140 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVI 194
Query: 554 QSSHFTEKSDVYSFGVVLVELLTG 577
+ E D++S G ++ EL+ G
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 45/211 (21%), Positives = 82/211 (38%), Gaps = 23/211 (10%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLG 441
+ + K +VAVKK + + ++ E++ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKD----FRISWEMRLCIAIDVSGAISYLHSAA 497
+ +V ++ G+ + + I++ ++ DV A+ Y+HS
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKG 121
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRS-IAVDQTH-----LTTQVQGTFGYLDPE 551
I HR +K+++ILL +S S S I + +L PE
Sbjct: 122 FI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 552 YFQSS--HFTEKSDVYSFGVVLVELLTGERP 580
Q + + EKSD+YS G+ EL G P
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 41/267 (15%)
Query: 385 ILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
I+G+GG G VY D GK+ A+K +D+ +++ E + L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLAL---NERIMLSLVST- 53
Query: 444 LETEVPLLV---YEFISNGTLSQYIDDQNK---DFRISW-------EMRLCIAIDVSGAI 490
+ P +V Y F + LS +D N + +S EMR A ++ +
Sbjct: 54 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGL 110
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
++H+ + +RD+K NILLD+ ++SD G + + + H + GT GY+ P
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 551 EYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
E Q + +D +S G +L +LL G P R +++ + DR+ +
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------DRMTLTM 214
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLN 636
++ + ++ L +R +N
Sbjct: 215 AVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 385 ILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKLL 440
I+G+GG G VY D GK+ A+K K +I + +NE ++LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 441 GCCLETEVP---LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
P + + ++ G L ++ Q+ F EMR A ++ + ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFS-EKEMRF-YATEIILGLEHMHNRF 117
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-S 556
+ +RD+K NILLD+ ++SD G + + + H + GT GY+ PE Q +
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIR 582
+ +D +S G +L +LL G P R
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 68/267 (25%), Positives = 108/267 (40%), Gaps = 68/267 (25%)
Query: 378 DNFNTNRILGQGGQGTV-YKGMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F+T +++G+G G V + GKI A+K KS++ + ++ E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM------RLCIAIDVS 487
VV L + + L+ EF+ G L + I ++ R +A +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECV 111
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS-------------------- 527
AI +H I HRDIK NIL+D K+SDFG S
Sbjct: 112 LAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 528 --------RSIAVDQTHLTT----QVQ--------------GTFGYLDPEYFQSSHFTEK 561
S+AVD +LT Q+ GT Y+ PE F + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEE 588
D +S G ++ E L G P NS E
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 20/236 (8%)
Query: 384 RILGQGGQGTVYKGMLE-DGKIVA---VKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439
R++G+G V L+ +I A +KK + D+ ++ E + ++ +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L C +TE L V EF+S G L ++ Q K + E + ++S A+++LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNFLHERG- 116
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE-ILDAQI 613
D ++ GV++ E++ G P + ++ ED LF+ IL+ QI
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT-------EDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 69/249 (27%), Positives = 109/249 (43%), Gaps = 35/249 (14%)
Query: 385 ILGQGGQGT---VYKGML---EDGKIVAVKKSKIIDESKVEEF-------INEVVILSQI 431
I G G+GT VYK +DGK A+KK K E++ E+ +L ++
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK----GDKEQYTGISQSACREIALLREL 59
Query: 432 NHRNVVKLLGCCLE-TEVPL-LVYEFISNGTLSQYIDD--QNKDFRISWEMRLCIAIDVS 487
H NVV L+ LE + + L++++ + L Q I Q K I M + +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 488 GAISYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAVDQTHLTT--QV 541
+ YLHS + HRD+K NIL+ ++ K+ D G +R L V
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 542 QGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
T Y PE + H+T+ D+++ G + ELLT PI + K + +
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIKKSNPFQRDQL 234
Query: 601 REDRLFEIL 609
+R+FE+L
Sbjct: 235 --ERIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 46/216 (21%)
Query: 384 RILGQGGQGTV---YKGMLEDGKIVAVKKSKIIDESKVEEFIN---------EVVILSQI 431
+ +G G QG V Y + G+ VA+KK F N E+V++ +
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLV 72
Query: 432 NHRNVVKLLGC-----CLET--EVPLLVYEFISNGTLSQYIDDQNKDFRIS---WEMRLC 481
NH+N++ LL LE +V LV E + + L Q I R+S ++M LC
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHERMSYLLYQM-LC 129
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
I +LHSA I HRD+K +NI++ K+ DFG +R A +T V
Sbjct: 130 -------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV 178
Query: 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG 577
T Y PE + E D++S G ++ E++ G
Sbjct: 179 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 29/257 (11%)
Query: 390 GQGTVYKGML----EDGKIVA---VKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
G+GT K +L GK A +KK II + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAASIPI 501
+ V E+++ G L ++ + R+ E R ++ A+ YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGK---I 116
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
+RD+K N++LD K++DFG + D + T GT YL PE + + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF-----EILDAQILKE 616
D + GVV+ E++ G P N + +K + ++ R +L ++K+
Sbjct: 176 VDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKD 233
Query: 617 ------GGKDEFKMVAK 627
GG D+ K + +
Sbjct: 234 PNKRLGGGPDDAKEIMR 250
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRNVVKLLGCC 443
LG+G TVYKG + G++VA+K+ ++ E I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ LV+E++ L QY+DD + +RL + + G ++Y H + H
Sbjct: 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRLFLFQLLRG-LAYCHQRR---VLH 126
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEKS 562
RD+K N+L+ ++ K++DFG +R+ +V + +V T Y P+ S+ ++
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSL 185
Query: 563 DVYSFGVVLVELLTGERP 580
D++ G + E+ TG RP
Sbjct: 186 DMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 28/203 (13%)
Query: 386 LGQGGQGTV---YKGMLEDGKIVAVKK--SKIIDESKVEEFINEVVILSQINHRNVVKLL 440
+G G QG V Y +L+ + VA+KK +++ + E+V++ +NH+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 441 GCCL------ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM--RLCIAIDVSGAISY 492
E + LV E + + L Q I + R+S+ + LC I +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC-------GIKH 134
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LHSA I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189
Query: 553 FQSSHFTEKSDVYSFGVVLVELL 575
+ E D++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVV------ILSQINHRNVVK 438
LG+GG G V +++ GK+ A KK +D+ ++++ E + IL ++N +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 439 LLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI--AIDVSGAISYLHS 495
L E++ L LV ++ G L +I + + EM I + ++ I +LHS
Sbjct: 58 L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLHS 113
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
+ I +RD+K N+LLDD+ ++SD G + + + TQ GT GY+ PE +
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKE 168
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIR 582
++ D ++ G + E++ G P +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 66/241 (27%), Positives = 102/241 (42%), Gaps = 44/241 (18%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D+F + +++G+G G V +D G I A+K K+ ++++ +V E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
VVK+ + L+ EF+ G + + KD + IA V AI +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVL-AIDAI 117
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFG-------ASRS-IAVDQTH--------- 536
H I HRDIK N+LLD K K+SDFG A R+ + TH
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 537 -----------------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGER 579
L GT Y+ PE F + + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 580 P 580
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 384 RILGQGGQGTVYKGMLE-DGKIVAVK--KSKIIDESKVEEFI--NEVVILSQINHRNVVK 438
+++G+G G V + DG AVK + K I + K + I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAA 497
L E V ++++ G L ++ + R E R A +V+ AI YLHS
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
+ I +RD+K NILLD + ++DFG + V+ T+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 558 FTEKSDVYSFGVVLVELLTGERP 580
+ D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 8/103 (7%)
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
IA+ + A+ YLHS S+ HRD+K +N+L++ K+ DFG S + VD T
Sbjct: 108 IAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA 164
Query: 542 QGTFGYLDPEYF----QSSHFTEKSDVYSFGVVLVELLTGERP 580
G Y+ PE + KSDV+S G+ ++EL TG P
Sbjct: 165 -GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN-----EVVILSQINHRNVVKL 439
+G+G G V+K E G+IVA+KK ES+ + I E+ +L Q+ H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYID------DQNKDFRISWEMRLCIAIDVSGAISYL 493
+ LV+E+ + L++ ++ ++ +I W+ A+++
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQ--------AVNFC 116
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
H I HRD+K NIL+ + K+ DFG +R + T V T Y PE
Sbjct: 117 HKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL 172
Query: 554 -QSSHFTEKSDVYSFGVVLVELLTGE 578
+ + DV++ G V ELLTG+
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 59/234 (25%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF---------INEVVI 427
+ +G+G G V G VA+KK + F + E+ I
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKI 56
Query: 428 LSQINHRNVVKLLG-----------------CCLETEVPLLVYEFISNGTLSQYIDDQNK 470
L + H N++ +L +ET++ Y+ I LS +D +
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDL----YKLIKTQHLS---NDHIQ 109
Query: 471 DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530
F + +R + Y+HSA + HRD+K +N+LL+ K+ DFG +R
Sbjct: 110 YF-LYQILR---------GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIA 156
Query: 531 AV--DQTHLTTQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
D T T+ T Y PE S +T+ D++S G +L E+L+ RP+
Sbjct: 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-10
Identities = 64/260 (24%), Positives = 115/260 (44%), Gaps = 52/260 (20%)
Query: 413 IDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFISNGTLSQYIDDQNK 470
+ E + + + EV ++ ++ H+N+V+ + L + ++ EF G LS+ I K
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110
Query: 471 DF-RISWEMRLCIAIDVSGAISYLHSAASIP----IYHRDIKSTNILL------------ 513
F +I + I + A++Y H+ P + HRD+K NI L
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 514 -----DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF--QSSHFTEKSDVYS 566
+ + AK+ DFG S++I ++ + GT Y PE ++ + +KSD+++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 567 FGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG----KDEF 622
G ++ EL +G+ P N+ F + + E LK G K +
Sbjct: 229 LGCIIYELCSGKTPFHKANN---------FSQLISE-----------LKRGPDLPIKGKS 268
Query: 623 KMVAKLAKRCLNLNGKKRPT 642
K + L K LNL+ K+RP+
Sbjct: 269 KELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 378 DNFNTNRILGQGGQGTVY----KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH 433
++F T +++ G G VY K + + + K +I +++++ E IL+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNG---TLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
VV + C ET+ L +V E++ G TL + I D R+ A V A
Sbjct: 61 PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-----ARMYFAETVL-A 113
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-------------SIAVD-QT 535
+ YLH+ I HRD+K N+L+ K++DFG S+ I D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
L QV GT Y+ PE + + D ++ G++L E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 372 ELEKATDNFNTNRILGQGGQGTV----YKGMLEDGKIVAVKKSKIIDESKVEEFINEVVI 427
+L +++ +++G+G G V +K + + + K ++I S F E I
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 428 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVS 487
++ N VV+L + +V E++ G L + N D W R A +V
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA-EVV 152
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
A+ +HS I HRD+K N+LLD K++DFG + + GT Y
Sbjct: 153 LALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 548 LDPEYFQSS----HFTEKSDVYSFGVVLVELLTGERP 580
+ PE +S ++ + D +S GV L E+L G+ P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 40/226 (17%)
Query: 379 NFNTNRILGQGGQGTV----YKGMLEDGKIVAVKKSKIIDESKV--EEFINEVVILSQI- 431
+ + LGQG G V + + VA+KK + K+ + + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 432 NHRNVVKLLGCCLETEVP-------LLVYEFISNGTLSQYI--DDQNKDFRISWEMR--L 480
H+N+ C + ++ L +YE + L Q I D + L
Sbjct: 60 GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD----QTH 536
C + Y+HSA + HRD+K N+L++ K+ DFG +R + +
Sbjct: 116 C-------GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 537 LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPI 581
+T V T Y PE S +T+ DV+S G +L ELL G +P+
Sbjct: 166 MTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 378 DNFNTNRILGQG--GQGTVYKGMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
D+F +++G+G G+ V K M G++ A+K K +++ ++ F E +L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGT----LSQYIDDQNKDFRISWEMRLCIAIDVSG 488
R + L + LV ++ G LS++ D +D + + +AID
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+ Y+H RDIK N+LLD +++DFG+ + D T + GT Y+
Sbjct: 120 QLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 549 DPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERP 580
PE Q+ + + D +S GV + E+L GE P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/251 (23%), Positives = 129/251 (51%), Gaps = 27/251 (10%)
Query: 343 FKRNGGLLLQQELS--SNEGGIDKTKLFTSNELEKATD-NFNTNRILGQGGQGTVYKGM- 398
F+ N L ++E S +N G + + N++ ++ + ++ I+G G G VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 399 LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL-----LGCCLETEVPL--- 450
++ + VA+KK ++ + + + E++I+ +NH N++ L C + E +
Sbjct: 88 IDTSEKVAIKK--VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143
Query: 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLC--IAIDVSGAISYLHSAASIPIYHRDIKS 508
+V EFI T+ +Y+ ++ + + L + + A++Y+HS I HRD+K
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNH-ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKP 198
Query: 509 TNILLDDK-YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEKSDVYS 566
N+L+D + K+ DFG+++++ Q + + + F Y PE ++++T D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRF-YRAPELMLGATNYTTHIDLWS 256
Query: 567 FGVVLVELLTG 577
G ++ E++ G
Sbjct: 257 LGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 70/291 (24%), Positives = 129/291 (44%), Gaps = 66/291 (22%)
Query: 386 LGQGGQGTVYKGML-----EDGKIVAVKKS-----KIIDESKVE---EFINEVVILSQIN 432
LG+G + +Y G+L ++ + +K K++D S + F ++ Q++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
H+++V L G C+ ++V EF+ G L ++ ++ W+ + +A ++ A+SY
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASALSY 120
Query: 493 LHSAASIPIYHRDIKSTNILLD----DKYCA---KVSDFGA-----SRSIAVDQTHLTTQ 540
L + H ++ + NILL D C K+SD G SR V++
Sbjct: 121 LEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------ 171
Query: 541 VQGTFGYLDPEYFQ-SSHFTEKSDVYSFGVVLVEL-LTGERPIRLTNSEEDKSLAAYFLR 598
++ PE + S + + +D +SFG L E+ GE P++ DK+LA
Sbjct: 172 ----IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKTLA----- 216
Query: 599 AMREDRLFE---ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
++R +E +L KE +A L C+N + +RP R +
Sbjct: 217 --EKERFYEGQCMLVTPSCKE--------LADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 65/285 (22%), Positives = 122/285 (42%), Gaps = 47/285 (16%)
Query: 386 LGQGGQGTVYKGMLE---DGKIVAVKKS-----KIIDESKV--EEFINEVVILSQINHRN 435
LGQG +YKG+L D IV + K++ F ++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+VKL G C+ E ++V E++ G L ++ + + + W++ + A ++ A+ YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 496 AASIPIYHRDIKSTNILL-----DDKY--CAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+ H ++ NIL+ ++ Y K+SD G ++ + + ++
Sbjct: 120 KKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERIPWI 171
Query: 549 DPEYFQ--SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
PE + + T +D +SFG L+E+ +N EE L+ R +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI--------CSNGEEP--LSTLSSSEKE--RFY 219
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651
+ D L E +A L +C + KRP+ R + +L
Sbjct: 220 Q--DQHRLPMPDCAE---LANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 4/87 (4%)
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLHSA I HRDIK N+L++ K+ DFG +R D++ TQ T Y PE
Sbjct: 118 YLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 552 YFQSS-HFTEKSDVYSFGVVLVELLTG 577
S H+T D++S G + ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 66/248 (26%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 384 RILGQGGQGTVY------KGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
++LG+G G V G KI+ +K II + +V + E +L H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSA 496
L + V E+ + G L ++ + R+ E R ++ A+ YLHS
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR 114
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
+ +RDIK N++LD K++DFG + D + T GT YL PE + +
Sbjct: 115 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 557 HFTEKSDVYSFGVVLVELLTGERP-----------------IRL--TNSEEDKSLAAYFL 597
+ D + GVV+ E++ G P IR T S E KSL A L
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 230
Query: 598 RAMREDRL 605
+ + RL
Sbjct: 231 KKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 44/241 (18%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F + +++G+G G V +D G + A+K K+ ++++ +V E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
VVK+ + L+ EF+ G + + KD E + IA V AI +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVL-AIDSI 117
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFG----------------ASRSIAVDQT-- 535
H I HRDIK N+LLD K K+SDFG + S+ D T
Sbjct: 118 HQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 536 ----------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGER 579
L GT Y+ PE F + + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 580 P 580
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 70/306 (22%), Positives = 128/306 (41%), Gaps = 74/306 (24%)
Query: 386 LGQGGQGTVYKGML--------EDGKIVAVKKS--------------KIIDESKVE---E 420
LGQG + +Y G L E+ ++ K++D S +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 421 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
F ++SQ++H ++ + G C+ ++V EF+ +G L + + ++W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI-- 120
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-------KVSD----FGA-SR 528
+A ++ A+SYL + H ++ + NILL A K+SD F A SR
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 529 SIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVEL-LTGERPIR-LTN 585
V++ ++ PE + + +D +SFG L+E+ GE P++ T
Sbjct: 178 EERVER----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
Query: 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
SE+++ F ++ RL E K +A L +CL +RP+ R
Sbjct: 228 SEKER-----FYE--KKHRLPE------------PSCKELATLISQCLTYEPTQRPSFRT 268
Query: 646 VGIELT 651
+ +LT
Sbjct: 269 ILRDLT 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKV-EEFINEVVILSQINHR 434
+ +G G G V + GK VA+KK D + + + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 435 NVVKLLGCCLETEVPL-----LVYEFI---------SNGTLSQYIDDQNKDFRISWEMRL 480
N++ + L +V + + S+ L+ + R L
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT------EEHIRYFLYQLL 117
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA---VDQTHL 537
+ Y+HSA + HRD+K +N+L+++ ++ DFG +R ++ + +
Sbjct: 118 R-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 538 TTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPI 581
T+ T Y PE S +T D++S G + E+L G R +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 6/129 (4%)
Query: 463 QYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522
+ D+ K+ ++ E + + V+ + +L S I HRD+ + NILL + K+
Sbjct: 160 EEGDELYKEP-LTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKIC 215
Query: 523 DFGASRSIAVDQTHLTT-QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
DFG +R I D ++ + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 216 DFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
Query: 581 IRLTNSEED 589
+E+
Sbjct: 276 YPGVQIDEE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 378 DNFNTNRILGQGGQGTVYK-GMLEDGKIVAVKKSKIIDESK--VEEFINEVVILSQINHR 434
+ F ++G+G G V K E +IVA+KK K +E++ E + E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQN---KDFRISWEMRLCIAIDVSGAIS 491
N+V+L LV+E++ L + N + S+ +L AI
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI------- 113
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
H I HRDIK N+L+ K+ DFG +R+++ T+ T Y PE
Sbjct: 114 --HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
+ + + D++S G +L EL G+ P+ SE D+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ-PLFPGESEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 466 DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525
+D K ++ E +C + V+ + +L S I HRD+ + NILL + K+ DFG
Sbjct: 169 EDLYKKV-LTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFG 224
Query: 526 ASRSIAVDQTHLTT-QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+R I D ++ + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 225 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 31/250 (12%)
Query: 386 LGQGGQGTVYKGMLEDG---KIVAVKKSKIIDESKVEE---FINEVVILSQINHRNVVKL 439
+G G G V G + G V VK+ ++ + V+E F+ E + H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV--SASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC--IAIDVSGAISYLHSAA 497
LG C E LLV EF G L Y+ K ++ + +A +++ + +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT-QVQGTFGYLDPEYFQSS 556
I H D+ N LL K+ D+G S + + ++T Q+ ++ PE
Sbjct: 121 FI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 557 HF-------TEKSDVYSFGVVLVELLT-GERPIR---------LTNSEEDKSLAAYFLRA 599
H T++S+V+S GV + EL G +P R T E+ L L+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 600 MREDRLFEIL 609
DR +E++
Sbjct: 238 PLSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 27/242 (11%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRNVVKLLGCCL 444
+G+G G VYK +DGK K I+ + + E+ +L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 445 ---ETEVPLL-------VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+ +V LL ++ I S+ K ++ M + + I YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 495 SAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAVDQTHLTT--QVQGTFGYL 548
+ + HRD+K NIL+ ++ K++D G +R L V TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 549 DPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE + H+T+ D+++ G + ELLT E PI E+ K+ + + DR+F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPFHHDQL--DRIFS 239
Query: 608 IL 609
++
Sbjct: 240 VM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 27/242 (11%)
Query: 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVE-EFINEVVILSQINHRNVVKLLGCCL 444
+G+G G VYK +DGK K I+ + + E+ +L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 445 ---ETEVPLL-------VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+ +V LL ++ I S+ K ++ M + + I YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 495 SAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAVDQTHLTT--QVQGTFGYL 548
+ + HRD+K NIL+ ++ K++D G +R L V TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 549 DPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE + H+T+ D+++ G + ELLT E PI E+ K+ Y + DR+F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQL--DRIFN 239
Query: 608 IL 609
++
Sbjct: 240 VM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 15/222 (6%)
Query: 390 GQGTVYKGMLEDGKIVA-------VKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
G+GT K +L K +KK I+ + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+ V E+ + G L ++ +++ S + ++ A+ YLHS ++
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKNV--V 118
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
+RD+K N++LD K++DFG + D + T GT YL PE + + +
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 177
Query: 563 DVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
D + GVV+ E++ G P N + +K + +R R
Sbjct: 178 DWWGLGVVMYEMMCGRLP--FYNQDHEKLFELILMEEIRFPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 17/219 (7%)
Query: 386 LGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKLLG 441
+G+G G VY+ +D +I A+K K +I+ + +V I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 442 CCLETEVP---LLVYEFISNGTLSQYIDDQNKDFRISWE-MRLCIAIDVSGAISYLHSAA 497
+ LV +++S G L ++ K+ R S + + IA ++ A+ +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIA-ELVLALEHLHKY- 115
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSS 556
I +RD+K NILLD + DFG S++ D T GT YL PE
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEK 172
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595
+T+ D +S GV++ E+ G P ++++ A+
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 390 GQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
G+GT K +L GK A+K K II + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAISYLHSAASIPI 501
+ V E+ + G L ++ + R+ E R ++ A+ YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCD---V 116
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
+RD+K N++LD K++DFG + D + T GT YL PE + + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 562 SDVYSFGVVLVELLTGERP 580
D + GVV+ E++ G P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLG 441
++G+G G V + G+ VA+KK + E S + E+ +L + H ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 442 CCL-----ETEVPLLVYEFISNGTLSQYI---DDQNKD---FRISWEMRLCIAIDVSGAI 490
L E + +V+E + + L Q I DD + F + +R A+
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR---------AL 116
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD--QTHLTTQVQGTFGYL 548
Y+H+A ++HRD+K NIL + K+ DFG +R D T T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 549 DPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPI 581
PE S S +T D++S G + E+LTG +P+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 424 EVVILSQINHRNVVKLLGCCLETEVPLLV---YEFISNGTLSQYIDDQNKDFRISWEMRL 480
E+ IL I+HR ++ L+ +V Y+ L Y+D + E +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSGP---LPLEQAI 188
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
I + A++YLH I HRD+K+ NI LD+ A + DFGA + +D T Q
Sbjct: 189 TIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDTPQ 243
Query: 541 VQGTFGYLD---PEYFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
G G L+ PE + K+D++S G+VL E+ +
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 423 NEVVILSQINHRNVVKLLGCC--------LETEVPLLVYEFISNGTLSQYIDDQNKDFRI 474
NE++ L ++NH N++K+ + + +Y F+ + KD +
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534
+ R I + A+ Y+H I HRDIK NI L+ + DFG + ++
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
GT PE + E +D++S G++L+++L+ +
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
+HS + HRDIK N+LLD +++DFG+ + D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 553 FQS-----SHFTEKSDVYSFGVVLVELLTGERP 580
Q+ + + D +S GV + E+L GE P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 5/109 (4%)
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533
++ E +C + V+ + +L S I HRD+ + NILL + K+ DFG +R I D
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 534 QTHLTT-QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
++ + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 65/244 (26%), Positives = 106/244 (43%), Gaps = 38/244 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+F ++LG+G G V+ L+ GK+ A+K K ++I +KV+ + E IL+ ++H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
+ L +TE L LV ++ G L + + Q +S E+ A +V A+ Y
Sbjct: 61 PFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGK-CLSEEVARFYAAEVLLALEY 118
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDF-------------------GASRSIAVD 533
LH I +RD+K NILL + +SDF G+ RS
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 534 QTHLTTQVQ---------GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLT 584
T + GT Y+ PE D ++ G++L E+L G P + +
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 585 NSEE 588
N +E
Sbjct: 236 NRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 41/214 (19%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQINHRNVVKL 439
+G+G G V E + VA+KK ID + + E+ +L ++H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT---LREIKLLRHLDHENVIAI 69
Query: 440 LGCCLET-----EVPLLVYEFI---------SNGTLSQYIDDQNKDFRISWEMRLCIAID 485
+VYE + S+ TLS DD + F + +R
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS---DDHCQYF-LYQLLR------ 119
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
+ Y+HSA + HRD+K +N+LL+ K+ DFG +R+ + +T V T
Sbjct: 120 ---GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 546 GYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGE 578
Y PE S +T DV+S G + ELL +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQINHRNVVKL 439
+G G G+V + G VAVKK II + E+ +L + H NV+ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 81
Query: 440 L-----GCCLE--TEVPLLVYEF---ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
L LE +V L+ + ++N Q + D + F I +R
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------G 132
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ Y+HSA I HRD+K +N+ +++ K+ DFG +R + T T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRA 185
Query: 550 PEYFQS-SHFTEKSDVYSFGVVLVELLTG 577
PE + H+ + D++S G ++ ELLTG
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHRNVVKLLGC 442
+G G G+V + G+ VA+KK +S++ + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 443 CLETEVPLLVYEFISNGTLSQ---YIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAAS 498
+ + + + L D Q +S + + + + Y+HSA
Sbjct: 81 --DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SH 557
I HRD+K N+ +++ K+ DFG +R + T T Y PE + H
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILNWMH 191
Query: 558 FTEKSDVYSFGVVLVELLTGE 578
+ + D++S G ++ E+LTG+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 20/96 (20%)
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ Y+HSA + HRD+K +NIL+++ K+ DFG +R + +T GY+
Sbjct: 121 LKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVS 167
Query: 550 PEYFQS-------SHFTEKSDVYSFGVVLVELLTGE 578
Y+++ + + D++S G + E+L G+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK 516
S + S+ +D + + + L + V+ + +L S I HRD+ + N+LL D
Sbjct: 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDG 248
Query: 517 YCAKVSDFGASRSIAVDQTHLTTQVQGT----FGYLDPEYFQSSHFTEKSDVYSFGVVLV 572
AK+ DFG +R I D ++ V+G ++ PE +T +SDV+S+G++L
Sbjct: 249 RVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 305
Query: 573 ELLT-GERP 580
E+ + G+ P
Sbjct: 306 EIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 386 LGQGGQGTVYKGMLEDGKIVA---VKKSKIIDESK-VEEFINEVVILSQINHRNVVKLLG 441
+G G G V + VA VK+ K SK EF+ + + H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAISYLHSAASIP 500
C+E LLV+E+ G L Y+ + R S + L +A +++ ++++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL- 121
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG--YLDPEYFQSSH- 557
H D+ N L KV D+G S + ++ T+ +L PE H
Sbjct: 122 --HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 558 ------FTEKSDVYSFGVVLVELL 575
T+ S+V++ GV L EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 42/192 (21%)
Query: 468 QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527
+ + + E L + V+ +S+L S I HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261
Query: 528 RSIAVDQTHLTTQVQGT----FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRL 583
R I D ++ V+G ++ PE + +T +SDV+S+G++L E+
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF-------- 310
Query: 584 TNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVA---------KLAKRCLN 634
SL + M D F +++KEG ++M++ + K C +
Sbjct: 311 -------SLGSSPYPGMPVDSKF----YKMIKEG----YRMLSPECAPSEMYDIMKSCWD 355
Query: 635 LNGKKRPTMREV 646
+ KRPT +++
Sbjct: 356 ADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 422 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
E IL INH ++++L G + L+ L Y+ + I+ L
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKR---NIAICDILA 186
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT-HLTTQ 540
I V AI YLH I HRDIK+ NI ++ + DFGA+ VD +
Sbjct: 187 IERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
GT PE + D++S G+VL E+ T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 42/150 (28%), Positives = 60/150 (40%), Gaps = 24/150 (16%)
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+V L + + LV + G L +I +K I E A ++ A+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI---SKFLNIPEECVKRWAAEMVVALDALH 102
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI-------AVDQTHLTTQVQGTFGY 547
I RD+ NILLDD+ +++ F + AV+ Y
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----------Y 148
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTG 577
PE S TE D +S G +L ELLTG
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 368 FTSNELEKAT----DNFNTNRILGQGGQGTVYKGMLEDGKI---VAVKKSKIIDESKVE- 419
F EL K + + +G G G+V D ++ VAVKK +S +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHA 58
Query: 420 -EFINEVVILSQINHRNVVKLL-----GCCLE--TEVPL---LVYEFISNGTLSQYIDDQ 468
E+ +L + H NV+ LL +E EV L L+ ++N Q + D+
Sbjct: 59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE 118
Query: 469 NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528
+ F I +R + Y+HSA I HRD+K +N+ +++ ++ DFG +R
Sbjct: 119 HVQFLIYQLLR---------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
Query: 529 SIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGE 578
+ T T Y PE + H+ + D++S G ++ ELL G+
Sbjct: 167 QADDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
++ N +KL + +L+ ++I +G L + + + E++ I + A++
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALN 123
Query: 492 YLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
LH I H DIK N+L D K + D+G + I + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
E + ++ D ++ GV+ ELLTG+ P + EE
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 28/83 (33%), Positives = 47/83 (56%), Gaps = 5/83 (6%)
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF---GYLDPEYF 553
AS HRD+ + N+L+ + K+ DFG +R I D +++ TF ++ PE
Sbjct: 256 ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTFLPLKWMAPESI 313
Query: 554 QSSHFTEKSDVYSFGVVLVELLT 576
++ +T SDV+SFG++L E+ T
Sbjct: 314 FNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 386 LGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKV--EEFINEVVILSQINHRNVVKLLGC 442
+G G GTV + G VA+KK +S++ + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 443 CLETEVPLLVYEFISNGTLSQYID----------DQNKDF---RISWEMRLCIAIDVSGA 489
F + +L ++ D D K ++S + + +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG---TFG 546
+ Y+H+A I HRD+K N+ +++ K+ DFG +R +++ G T
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180
Query: 547 YLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPI 581
Y PE + H+T+ D++S G ++ E+LTG +P+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF---GYLDPEYF 553
AS HRD+ + N+LL K+ DFG +R I D +++ TF ++ PE
Sbjct: 254 ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTFLPVKWMAPESI 311
Query: 554 QSSHFTEKSDVYSFGVVLVELLT 576
+ +T SDV+S+G++L E+ +
Sbjct: 312 FDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYK----GMLEDGKI--VAVKKSKI-ID 414
ID T+L + + E DN + LG G G V + G+ ++ + VAVK K
Sbjct: 22 IDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81
Query: 415 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTL 461
+ E ++E+ ILS + H+N+V LLG C L++ E+ G L
Sbjct: 82 TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 39/144 (27%), Positives = 57/144 (39%), Gaps = 46/144 (31%)
Query: 479 RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG------------- 525
R IA +++ AI +H I HRDIK NIL+D K++DFG
Sbjct: 104 RFYIA-ELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 526 --------------ASRSIAVDQTHLTT-------QVQ--------GTFGYLDPEYFQSS 556
+ +D+ L Q Q GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 557 HFTEKSDVYSFGVVLVELLTGERP 580
+T+ D +S GV+L E+L G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 64/226 (28%)
Query: 407 VKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYID 466
++K +++ ++V E IL++ ++ VVKL + + V ++I G + +
Sbjct: 34 LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92
Query: 467 DQNKDFRISWEM------RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAK 520
I E+ R IA +++ AI +H I HRDIK NIL+D K
Sbjct: 93 -------IRMEVFPEVLARFYIA-ELTLAIESVHKMGFI---HRDIKPDNILIDLDGHIK 141
Query: 521 VSDFG----------------------------------------------ASRSIAVDQ 534
++DFG R+ Q
Sbjct: 142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201
Query: 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
L + GT Y+ PE +T+ D +S GV+L E+L G+ P
Sbjct: 202 RCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 14/92 (15%)
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA------SRSIAVDQTHLTTQV 541
AI Y+H I HRDIK+ N+L++ + DFGA S S T +
Sbjct: 271 SAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-----TPFHYGI 322
Query: 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVE 573
GT PE +T D++S G+V+ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 22/151 (14%)
Query: 388 QGGQGTVYKGMLE-DGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+G G VY G + + K+ AVK K+ +I+++ V + E L+ +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 444 LETEVPLLVYEFISNGTLSQ------YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
LV E++ G + Y D++ IS E+ L A+ YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVAL--------ALDYLHRHG 124
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528
I HRD+K N+L+ ++ K++DFG S+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 9/108 (8%)
Query: 374 EKATDNFNTNRILGQGGQGTVYK------GMLEDGKIVAVKKSKI-IDESKVEEFINEVV 426
E D + LG+G G V + + VAVK K S+ + + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62
Query: 427 ILSQI-NHRNVVKLLGCCLETEVPLLV-YEFISNGTLSQYIDDQNKDF 472
IL I +H NVV LLG C + PL+V E+ G LS Y+ + + F
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 34/104 (32%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKG------MLEDGKIVAVKKSKI-IDESKVEEFINEVVILSQ 430
D + LG+G G V + + VAVK K S+ ++E+ IL
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 66
Query: 431 INHR-NVVKLLGCCLETEVPLLV-YEFISNGTLSQYIDDQNKDF 472
I H NVV LLG C + PL+V EF G LS Y+ + +F
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQG-----TVYKGMLEDGKI-VAVKKSKIIDE 415
ID T+L ++ E + + + LG G G T Y D + VAVK K
Sbjct: 19 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 416 S-KVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF 472
+ E ++E+ +LS + NH N+V LLG C L++ E+ G L ++ + F
Sbjct: 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 17/103 (16%)
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF---------GASRSIAVDQTHLTT 539
++YLH I HR+IK+++IL+ +S G + D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 540 QVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERP 580
V +L PE + + KSD+YS G+ EL TG P
Sbjct: 170 SVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 44/183 (24%)
Query: 378 DNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKIIDESKVEEFINEVVILSQI 431
D+F + LG+G G VYK L ++GK V +KK+ + VE ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185
Query: 432 NHRN-VVKLLGCCLET-----EVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI 484
N + LE E LV+ + TL+ + Q+K+F + E L +
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPYLLGKV 243
Query: 485 D-------------------VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-KVSDF 524
+ A+ LHS I HRD+K NI+ + + K+ D
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 525 GAS 527
GA+
Sbjct: 301 GAA 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 708 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.34 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.26 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.14 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 96.89 | |
| PLN02236 | 344 | choline kinase | 96.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.73 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.62 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 96.13 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.06 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.99 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.85 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.68 | |
| PHA03099 | 139 | epidermal growth factor-like protein (EGF-like pro | 95.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.47 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 95.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.16 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.75 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.74 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-57 Score=480.72 Aligned_cols=291 Identities=46% Similarity=0.744 Sum_probs=259.9
Q ss_pred cccccChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceE
Q 047038 364 KTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443 (708)
Q Consensus 364 ~~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 443 (708)
..+.|++.|+++||++|...++||+|+||+||+|.+.+|+.||||++.........+|.+|+.+|++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988764433145699999999999999999999999
Q ss_pred eeCC-cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEe
Q 047038 444 LETE-VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522 (708)
Q Consensus 444 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~ 522 (708)
.+.+ .++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999987654 78999999999999999999999998899999999999999999999999
Q ss_pred eccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 523 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
|||+++..........+...||.+|+|||++..+.+++|+|||||||+|+||+||++|.+.........+..|....+.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999766541222222117999999999999999999999999999999999999999877666666799999999999
Q ss_pred chhhhhhhhhhh-ccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 603 DRLFEILDAQIL-KEGGK-DEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 603 ~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+.+.+++|+.+. .+... ++...+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999987 55553 678889999999999999999999999999977665
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=403.03 Aligned_cols=258 Identities=34% Similarity=0.550 Sum_probs=214.1
Q ss_pred CcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-cceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~ 456 (708)
+...+.||+|+||+||+|.++....||||++...+ ....++|.+|+.+|++++|||||+++|+|.+.. ...||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999866669999987633 233679999999999999999999999999888 789999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCcccCcCCc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~~~~~~ 535 (708)
++|+|.++|+.. ....+++..+++||.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999985 33479999999999999999999999884 99999999999999997 99999999998765332
Q ss_pred ceeecccccccccCccccc--cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQ--SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~--~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....... ........+ .
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~---------~ 263 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGG---------L 263 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC---------C
Confidence 2334467999999999999 5699999999999999999999999997544311 111111111 1
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
....+...++.+..|+.+||+.||+.||++.|++..|+.+...
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1222333667799999999999999999999999999999774
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=379.94 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=208.2
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-ceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV-PLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~ 456 (708)
++..+.||+|..|+|||+.++ +++.+|+|.+.. .++...+++.+|++++++.+||+||++||.|..... ..|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344578999999999999987 688999999854 456677899999999999999999999999999985 99999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
++|+|++++...+ .+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|++||+|||.++.+...
T Consensus 161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998763 69999999999999999999996 65 999999999999999999999999999876543
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
....++||..|||||.+++..|+.++||||||++++|+++|+.||....... ...... +..+++... .
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~L---------l~~Iv~~pp-P 300 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFEL---------LCAIVDEPP-P 300 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHH---------HHHHhcCCC-C
Confidence 4566789999999999999999999999999999999999999997541111 111111 112222111 1
Q ss_pred cCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGK-DEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+. ..+++++.++..||++||.+||+++|+++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122 35677999999999999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=398.20 Aligned_cols=258 Identities=30% Similarity=0.452 Sum_probs=223.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
...+...+.||+|-||+||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+|+|+|..++.++||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3445566889999999999999988889999998764 334578999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
+.|+|.++|+.. .+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||++....+...
T Consensus 284 ~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999999973 2346899999999999999999999999 999999999999999999999999999966655555
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+ +.+.++...+-
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~le~GyRl 423 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELLERGYRL 423 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHHhccCcC
Confidence 5555666789999999999999999999999999999999 999986544433 23333333334
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..+...+..+.+|+..||+.+|++|||++.+...|+.+..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 4466778889999999999999999999999999998876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=371.44 Aligned_cols=204 Identities=31% Similarity=0.545 Sum_probs=184.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..+|...+.||+|+|++||+|+++ ++..||||.+... ..+..+.+..|+++|+.++|||||+|+++++.++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999975 6889999987664 6677888999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC------CcEEEeeccCC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK------YCAKVSDFGAS 527 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~------~~~kl~DFGls 527 (708)
|||.+|+|.+|++.++ .+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||++
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999875 6999999999999999999999999 9999999999999865 56899999999
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~ 588 (708)
+.+.. .....+..|++.|||||+++.++|+.|+|+||+|++||++++|+.||+.....+
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 98763 334566789999999999999999999999999999999999999997554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=411.85 Aligned_cols=262 Identities=29% Similarity=0.466 Sum_probs=225.7
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
..+.+....+.||+|+||+||+|+.. +...||||.++...+. ..++|.+|+++|..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34456667789999999999999954 3457999999986655 7889999999999999999999999999999
Q ss_pred cceEEEEeccCCCccccccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNK-----------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK 516 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~ 516 (708)
..++|+|||..|+|.+||....+ ..+|+..+.+.||.|||.||+||-++. ++||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999976442 123889999999999999999999998 9999999999999999
Q ss_pred CcEEEeeccCCcccCcCCcceee-cccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHH
Q 047038 517 YCAKVSDFGASRSIAVDQTHLTT-QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 517 ~~~kl~DFGls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 594 (708)
..|||+||||+|.+...+.+... ...-..+||+||.|..++||.+||||||||+|||+++ |+.||.+...++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 99999999999987655554433 4456789999999999999999999999999999999 999997666554
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+...++.+++ .+.+...+.++.+|+.+||+.+|++||+++||-..|+....
T Consensus 714 -VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 -VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3444454443 33466778889999999999999999999999999998876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=386.34 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=212.5
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.+|...++||+|||+.+|+++. ..|+.||+|++.. ......+...+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999997 7899999998755 45667788999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
|++++++|.++++... .+++.++..+..||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998443 6999999999999999999999999 999999999999999999999999999887654
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.. ...+..|||.|+|||++.....+..+||||+|||||-||.|++||+...-.+.. ..++....
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~~~Y-------- 235 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKLNEY-------- 235 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHhcCc--------
Confidence 33 234567999999999999999999999999999999999999999754333211 11221111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+.....+..+||.++|+.||.+|||+++|+.
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 113344556789999999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=356.81 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=209.5
Q ss_pred ccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeec-eEeeCCc-ceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLG-CCLETEV-PLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~l 451 (708)
..+|++.++||+|.||+|||+. +.+|..||.|.++- .+....++...|+.+|++|+|||||++++ -+.++.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3467888999999999999999 56899999998764 56677889999999999999999999999 4555444 899
Q ss_pred EEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 452 VYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAA-SIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~-~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
|||++..|+|..+++... ....+++..+|+++.|++.||.++|+.- ...|+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999997543 3446999999999999999999999932 12399999999999999999999999999998
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
+..... .....+|||.||+||.+....|+.||||||+||++|||..-++||.+.+-. . .-..+..+....+.
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------~-L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------S-LCKKIEQGDYPPLP 249 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH------H-HHHHHHcCCCCCCc
Confidence 865433 355678999999999999999999999999999999999999999865221 1 11222333221111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+..+.+||.-|+..||+.||+...++..
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 13456779999999999999999995444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=369.32 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=205.5
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC-------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID-------ESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||.++... ........+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345678889999999999999995 479999999876521 112234579999999999999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEeec
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDF 524 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DF 524 (708)
..|||||||+||+|.+.+-.+. .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999998765 4677777889999999999999999 9999999999999766 78999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCC---CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
|+|+... ....+.+..||+.|.|||++.+.. +..|+|+||+||+||-+++|.+||....... ++ .+.+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl----~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL----KEQIL 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH----HHHHh
Confidence 9999765 444577789999999999997654 3458899999999999999999997544332 11 12233
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+++... .....+..++..+||.+||..||++|||+.|+++
T Consensus 396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3332211 0113455677899999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=363.43 Aligned_cols=242 Identities=28% Similarity=0.407 Sum_probs=205.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.++||+|+||+||.++.+ +++.+|+|.++. ....+.+....|..||.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 568999999999999999999954 689999998765 3445677899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
+||+.||.|..+|++.. .+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 5999999999999999999999999 99999999999999999999999999986443
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. ...+.++.||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.... .+.+..++
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGK-------- 241 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCc--------
Confidence 3 2345558899999999999999999999999999999999999999976553321 12222222
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRP 641 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP 641 (708)
....+.-...+.++++.+.|+.||++|.
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111222445688999999999999996
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=393.19 Aligned_cols=256 Identities=24% Similarity=0.428 Sum_probs=221.2
Q ss_pred CCcccceEeeeccEEEEEEEEcC----CcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
...+.++||.|.||+|++|+++- ...||||.++. ..++++.+|+.|+.||.++.||||++|.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34677899999999999999862 34799999998 44667789999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
|||+||+|+.+|+.+.. .+++.+...++.+||.||.||-+.+ ++||||..+|||++.+...|++||||+|.+..+
T Consensus 710 EyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999998764 5899999999999999999999999 999999999999999999999999999987655
Q ss_pred Ccceee--cccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 534 QTHLTT--QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 534 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.....+ .-.-..+|.|||.+...++|.+|||||||++|||.++ |.+|+=... ...+...++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQdVIkaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQDVIKAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hHHHHHHHH
Confidence 432222 2334679999999999999999999999999999998 999973222 222333444
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.......+++.+..|.+|++.||++|-.+||.+.||+..|+.+..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 455556688889999999999999999999999999999999876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=340.72 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=208.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
+.|+...++|+|+||+|||.+.+ +|+.||||++...+ +.-.+-.++||++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777789999999999999976 59999999987643 3344568999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|++.--| +-|..... -++......++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.. .
T Consensus 82 ~~dhTvL-~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHH-HHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9988444 44444433 4888999999999999999999999 99999999999999999999999999998874 3
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------HHHhhhchh
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF--------LRAMREDRL 605 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~~~~~~~~~ 605 (708)
....+..+.|..|+|||.+.+ .+|+..+|||++||++.||++|.+-|.+...-+.--+.... ......+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344567778999999999987 78999999999999999999999999876554432222221 222222222
Q ss_pred h------hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 F------EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+ +.-+++.++..-+....-+.++++.||+.||.+|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 111222222222334456889999999999999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=360.13 Aligned_cols=266 Identities=28% Similarity=0.385 Sum_probs=213.5
Q ss_pred ccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 451 (708)
.+.|+.+++||+|.||.||||+ ..+|+.||+|++.... +.......+||.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457777889999999999999 5689999999987644 45566788999999999999999999999876 68999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|+|||++ +|.-++... ...+++.++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+||||++.+.
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 888888764 346999999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh----
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF---- 606 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 606 (708)
.......+..+-|..|.|||.+.+ ..|+.+.|+||.||||.||++|++.|++..+.++...+-..-....++-+.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 777766777788999999999987 479999999999999999999999998776544332222211111111111
Q ss_pred ---hhhhh-----hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 607 ---EILDA-----QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 607 ---~~~d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+.+ +...+.....+....+|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 0111112233456789999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.00 Aligned_cols=255 Identities=30% Similarity=0.457 Sum_probs=207.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC--cceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 453 (708)
..++...+.||+|+||+||++...+ |+..|||.+...+....+.+.+|+.+|++++|||||+.+|.....+ ...++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778899999999999999764 8999999887755444778999999999999999999999855544 688999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~~~~~ 532 (708)
||+++|+|.+++.+... .+++..+..++.||++||+|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999998754 6999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CCcceeecccccccccCccccccCC-CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 --DQTHLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 --~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.........+||+.|||||++..+. ...++|||||||+++||+||++||... .....+..........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~---- 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL---- 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC----
Confidence 2222244578999999999999643 335999999999999999999999643 1111222222222211
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
.+.+...+....+++.+|++.+|++|||++|+++..
T Consensus 242 -----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 -----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 133444556789999999999999999999998544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=366.47 Aligned_cols=262 Identities=27% Similarity=0.461 Sum_probs=208.3
Q ss_pred hccCCcccceEeeeccEEEEEEEE------cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKIID-ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 447 (708)
..++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+|+++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456889999999999999999974 235689999987532 34556799999999999 8999999999887644
Q ss_pred -cceEEEEeccCCCccccccccCC--------------------------------------------------------
Q 047038 448 -VPLLVYEFISNGTLSQYIDDQNK-------------------------------------------------------- 470 (708)
Q Consensus 448 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 470 (708)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999875321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-eeccccccc
Q 047038 471 ---DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFG 546 (708)
Q Consensus 471 ---~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~ 546 (708)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 124788899999999999999999998 9999999999999999999999999998654332221 223446788
Q ss_pred ccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHH
Q 047038 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMV 625 (708)
Q Consensus 547 y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 625 (708)
|+|||++.+..++.++||||||++||||++ |..||......+. +...+..+.. ...+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR---------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC---------CCCCCCCCHHH
Confidence 999999999999999999999999999997 9999975443221 1111111111 01122334568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 626 AKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 626 ~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=362.82 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=212.8
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
..|....+||+|+.|.||.+.. .+++.||||++........+-+++|+.+|+..+|+|||++++.+...+.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4566778899999999999994 478899999999888888888999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.+.+... .+++.++..|..++++||+|||..+ |+|||||.+||||+.++.+||+|||++..+......
T Consensus 353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999999765 4899999999999999999999999 999999999999999999999999999887655543
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
....+||+.|||||+.....|+.|.||||||++++||+-|.+||-..+.-. + ...+..+...+ ..
T Consensus 426 -R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----A---lyLIa~ng~P~-------lk 490 (550)
T KOG0578|consen 426 -RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----A---LYLIATNGTPK-------LK 490 (550)
T ss_pred -cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----H---HHHHhhcCCCC-------cC
Confidence 445679999999999999999999999999999999999999985422211 1 11122111111 12
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
........+.+++.+||+.|+++||+++|+|+
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 24455677999999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=390.71 Aligned_cols=262 Identities=31% Similarity=0.529 Sum_probs=220.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC--Cc----EEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED--GK----IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
..+.+..+.||+|+||.||+|+..+ |. .||||.++. .+..+..+|.+|..+|++++|||||+++|++.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999999753 43 489998876 5677888999999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 450 LLVYEFISNGTLSQYIDDQNK----DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
+|++|||++|+|..+|++.+. ...++....+.++.|||+|+.||++++ +|||||..+|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999988632 336889999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecc-cccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 526 ASRSIAVDQTHLTTQV-QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
||+.+.....+..... .-...|||||.+..+.+|.|+|||||||+|||++| |..||...+..+. +....+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC
Confidence 9996655444433322 34568999999999999999999999999999999 9999975554331 22223333
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
++ +.+...+..+.+|+.+||+.+|++||++..+++.+..+....
T Consensus 922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 22 235666778999999999999999999999999998887643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=357.96 Aligned_cols=266 Identities=26% Similarity=0.335 Sum_probs=211.5
Q ss_pred hccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChH-HHHHHHHHHHHHHhcC-CCceeeeeceEeeCC-cceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDES-KVEEFINEVVILSQIN-HRNVVKLLGCCLETE-VPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~l 451 (708)
..++|...++||.|.||.||+|+ ..+|+.||||+++..-.. +.-.=++|++.|++|+ |||||+|..++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34688999999999999999999 457899999998763222 2222468999999999 999999999999988 9999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|||||+. +|++++++.+ ..+++..+..|+.||++||+|+|.+| ++|||+||+|||+..+..+||+||||+|.+.
T Consensus 88 VfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999975 9999999874 47999999999999999999999999 9999999999999999999999999999765
Q ss_pred cCCcceeecccccccccCccccc-cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh---
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQ-SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE--- 607 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 607 (708)
. ....+..+.|..|+|||++. .+-|+.+.|+|++|||++|+.+-++-|.+..+.++....-.+........+.+
T Consensus 162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 3 33457778899999999875 57799999999999999999999999987665444333333322222221111
Q ss_pred ---hhhhhh-------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 608 ---ILDAQI-------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 608 ---~~d~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.+.-.+ ....-.....+..+|+.+|+++||.+|||+.|.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111000 111112255778999999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=326.17 Aligned_cols=264 Identities=25% Similarity=0.294 Sum_probs=209.5
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChH--HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDES--KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|...++||+|.||.||+|+. .+|+.||||+++..+.. -....++||+.|+.++|+||+.|+++|-+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999995 57999999998875432 24568999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
||+. +|+..+++... .++..+...++.++++||+|||++. |+||||||.|+|+++++.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9976 99999987653 6889999999999999999999999 9999999999999999999999999999887554
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh-----
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI----- 608 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 608 (708)
..... .+-|..|.|||.+.+ ..|+...|+||.|||+.||+-|.+-|.+..+-++-...-.......++.+.+.
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 43333 267999999998876 56999999999999999999998888765544322222111111122222111
Q ss_pred -hh-----hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 -LD-----AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 -~d-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+ .......-........+|+..++..||.+|+++.|+++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11 11111122334566799999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=355.52 Aligned_cols=253 Identities=29% Similarity=0.410 Sum_probs=213.3
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCc
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV 448 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 448 (708)
++..++|...+.||+|+|++|++|+.. .++.+|||++.. ..+...+....|-.+|.+| +||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455678999999999999999999954 689999998754 3345566778899999999 89999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
+|+|+||.++|+|.++|+..+ .+++.....++.||+.||+|||+.| ||||||||+|||||+++++||+|||.++
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999999875 6999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCcCCcc----------ee--ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH
Q 047038 529 SIAVDQTH----------LT--TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 529 ~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 596 (708)
.+...... .. ..++||..|.+||++..+..+..+|+|+||||||+|+.|++||...++-- .|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HH
Confidence 87532211 12 45889999999999999999999999999999999999999997544321 11
Q ss_pred HHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.+ +++ +.-+++...++...+|+.+.|..||.+|+|..||-+.
T Consensus 297 qk---------I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QK---------IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH---------HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 111 1123344455678999999999999999999888754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=326.60 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=215.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||.|+||.|.+++.+ +|..+|+|.++. ....+.+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999965 688899998876 34556778899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||++||.|.++|++.+ ++++.....+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+++.....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999765 6999999999999999999999999 999999999999999999999999999876432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
+-+..|||.|+|||+++...+..++|.|+|||++|||+.|.+||...+... ....+-++.+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v-------- 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV-------- 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc--------
Confidence 455779999999999999999999999999999999999999997655421 1111111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCCCcccCCCCceeee
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVHQGCFEEIH 672 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~~~~~~~~~~~~~ 672 (708)
..+.-....+.+|+...|+.|-.+| +-.++ ++...++.|+||..+.
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R---------~gnlk--nG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR---------FGNLK--NGVEDIKNHPWFKGVD 304 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh---------hcCcC--CCccccccCccccccc
Confidence 1234445568999999999998888 22322 3457788899988764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=363.45 Aligned_cols=264 Identities=30% Similarity=0.468 Sum_probs=217.5
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcC--C--cE-EEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLED--G--KI-VAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCL 444 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 444 (708)
++..-++....++||+|+||+||+|.+.. + .. ||||..+. .......+|++|+++|++++|||||++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44444555666899999999999999763 2 23 89998885 45778899999999999999999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
....++||||++.||+|.++|+.... .++..+++.++.++|.||+|||+++ +|||||..+|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999998754 5999999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCcCCcceee-cccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 525 GASRSIAVDQTHLTT-QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 525 Gls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
||++.... ..... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....+. ...+
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------~~kI-- 375 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------KAKI-- 375 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------HHHH--
Confidence 99886531 11111 2235679999999999999999999999999999999 8999976554321 1111
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
+........+...+..+..++.+||..+|++||+|.++.+.|+.+.+...
T Consensus 376 ------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 ------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11111122233556678889999999999999999999999999988543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.87 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=206.8
Q ss_pred ccccChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChH---HHHHHHHHHHHHHhcCCCceeeeec
Q 047038 365 TKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES---KVEEFINEVVILSQINHRNVVKLLG 441 (708)
Q Consensus 365 ~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g 441 (708)
.+.++.++++. .....||+|++|.||+|.. +|+.||||+++..... ..+.|.+|+.+|++++|||||+++|
T Consensus 12 ~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 44455555532 2235799999999999998 6889999998764322 2577889999999999999999999
Q ss_pred eEee----CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCC
Q 047038 442 CCLE----TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDK 516 (708)
Q Consensus 442 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~ 516 (708)
++.+ ....++||||+++|+|.+++.... .+++...+.++.|++.||.|||+. + ++||||||+|||++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 9977 346789999999999999998643 589999999999999999999985 5 7899999999999999
Q ss_pred CcEEEeeccCCcccCcCCcceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 517 YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 517 ~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
+.+||+|||+++...... ....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ...
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~ 232 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD 232 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence 999999999988653221 23457899999999976 689999999999999999999999997543221 111
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+. ....+...+..+.+++.+||+.||++|||++||++.|+.++.
T Consensus 233 ---~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 ---LIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---HHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111110 011122345679999999999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.62 Aligned_cols=266 Identities=24% Similarity=0.368 Sum_probs=203.5
Q ss_pred CCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeeCC----cceEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQ--INHRNVVKLLGCCLETE----VPLLV 452 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~lV 452 (708)
..+..++||+|.||.||||.+.+ +.||||++. ..+.+.|.+|-+|++. ++|+||+++++.-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34556789999999999999964 899999876 5667789999999886 58999999999977655 78999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA------SIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~------~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
+||.++|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||..+++.-|+||||
T Consensus 287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999876 5999999999999999999999843 57899999999999999999999999999
Q ss_pred CcccCcCCcce-eecccccccccCccccccCC-CC-----ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhH-------
Q 047038 527 SRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSH-FT-----EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSL------- 592 (708)
Q Consensus 527 s~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~t-----~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~------- 592 (708)
|..+....... ....+||.+|||||++.+.- +. .+.||||+|.|||||+++..-++.....+-+..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98886544332 34478999999999997632 22 368999999999999997655432111110000
Q ss_pred ---HHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 593 ---AAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 593 ---~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...+-..+....+...... ...+..|.+.+..||..|++.|.|+.=|.+++.++..
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00011111111111111111111 2345679999999999999999999999999988876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=340.13 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=209.9
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..+.|++.++||.|.-++||+|+. ..++.||||++.... ....+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 456799999999999999999994 467999999987733 334789999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
.||.+|++.+++...-+. -+++..+..|..++++||.|||..| .||||||+.||||+++|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999876544 4899999999999999999999999 999999999999999999999999987655433
Q ss_pred Ccce---eecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 534 QTHL---TTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 534 ~~~~---~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.... ....+||+.|||||++.. ..|+.|+||||||++..||.+|..||....+-. .+. ..+.... ...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl----~tLqn~p-p~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLL----LTLQNDP-PTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHH----HHhcCCC-CCc
Confidence 2211 255789999999999543 469999999999999999999999996433221 111 1111111 000
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+..+...+.+.+++..||++||++|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0011112223444567999999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.03 Aligned_cols=268 Identities=26% Similarity=0.456 Sum_probs=216.2
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
...++++...+.+.+...||+|.||+||+|.+. ..||||+++.. .+.+.+.|.+|+.+|++-+|.||+-+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344667777778888999999999999999985 35999998763 45678899999999999999999999999998
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
... .||..+++|-+|+.+||.... .+...+.+.||.||++|+.|||.++ |||||||..||+|.+++.|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 999999999999999998653 6888899999999999999999999 9999999999999999999999999
Q ss_pred CCcccCc-CCcceeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 526 ASRSIAV-DQTHLTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 526 ls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
|+..... ..........|...|||||+++. .+|++.+||||||+|+|||++|..||.....+. ..-++.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEec
Confidence 9864321 11122233457889999999864 579999999999999999999999997322221 001111
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+-+ ..|.. ......+++|.+|+..||..++++||.+.+|+..|+.+..
T Consensus 607 rG~l--~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 RGYL--MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccc--Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111 11111 1123445679999999999999999999999998888876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.82 Aligned_cols=256 Identities=22% Similarity=0.400 Sum_probs=207.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.++|++.++||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999864 35689999987643 3445679999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999997643 25899999999999999999999998 9999999999999999999999999876543
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~----- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFR----- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC-----
Confidence 222111222335678999999999999999999999999999876 999996543221 1111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
...+...+..+.+++.+||+.+|++||+++||.+.|+++
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111233456689999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=347.32 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=209.7
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..|+..++||+|.||.||||.. ..++.||+|.+... ...+.+++.+|+.+|.+++++||.++||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566778999999999999995 47899999998773 455678899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+.+|++.+.|+... .+.+....-|..+++.||.|||+++ .+|||||+.|||+..++.+||+|||++-.+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999998654 3577777788999999999999999 99999999999999999999999999987765544
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.. .+++||+.|||||++....|+.|+||||||++.+||++|.+|+....+. ++.-++......
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCC
Confidence 43 6688999999999999889999999999999999999999998643331 111222222222
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+.+.+++..||.+||+.||+++++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 223345566999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=348.46 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=211.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.. ..+++.+.+.+|++|++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999976 688999998755 445677889999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+.+ +|..+|.... .++++.+..|+.+++.||.|||+.+ |+|||+||.||||+..+.+|++|||+++.+.. .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9987 9999998654 5999999999999999999999998 99999999999999999999999999998764 4
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
+...+.+.|||.|||||...+++|+..+|.||+||+|||+++|++||... +..........+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~----------- 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP----------- 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC-----------
Confidence 45567788999999999999999999999999999999999999999421 1111111111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+++...|.+||.+|.+..+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1123456677999999999999999999999763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=346.36 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=204.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-----------------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceee
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-----------------GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVK 438 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~ 438 (708)
.++|...++||+|+||.||++.+++ +..||+|.+... ......+|.+|+++|++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999998532 336999988764 3445678999999999999999999
Q ss_pred eeceEeeCCcceEEEEeccCCCccccccccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 047038 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQN----------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502 (708)
Q Consensus 439 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ii 502 (708)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999886432 1124788999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh--CCC
Q 047038 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT--GER 579 (708)
Q Consensus 503 HrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt--g~~ 579 (708)
||||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865432221 1223445789999999998899999999999999999987 556
Q ss_pred CCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 580 PIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 580 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
||......+. ............. ......+...+..+.+|+.+||+.+|++|||+.||.+.|+.
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7754332221 1111111111100 00011122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=358.22 Aligned_cols=263 Identities=25% Similarity=0.412 Sum_probs=208.2
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEE------cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhc-CCCceeeeeceEe
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKIID-ESKVEEFINEVVILSQI-NHRNVVKLLGCCL 444 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 444 (708)
++...++|+..+.||+|+||+||+|.. .++..||||+++... ....+.+.+|+.+|+.+ +|||||++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 334456788999999999999999973 245689999987532 34556799999999999 8999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCC------------------------------------------------------
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNK------------------------------------------------------ 470 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 470 (708)
+.+..++||||+++|+|.++++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999998864321
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 471 ------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 471 ------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 533 DQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 533 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... . +...+..+.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~------ 334 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGY------ 334 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCc------
Confidence 32211 122335678999999999999999999999999999998 889986543221 1 111122111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
....+...+.++.+|+.+||+.||++||+++||++.|++.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011122245689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.63 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=204.6
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
...++|+.+.+||+|+||.||+++-+ +|+.+|+|+++..+ ..+.+....|-.+|...++|.||+||-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34678999999999999999999954 69999999988743 456778899999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||++||++..+|.... .|++......+.+++-|++-||+.| +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999998765 6999999999999999999999999 999999999999999999999999998532
Q ss_pred Cc-----------------------CCc-----c------------------eeecccccccccCccccccCCCCccchh
Q 047038 531 AV-----------------------DQT-----H------------------LTTQVQGTFGYLDPEYFQSSHFTEKSDV 564 (708)
Q Consensus 531 ~~-----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv 564 (708)
.. +.. . .....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 000 0 0112569999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 047038 565 YSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642 (708)
Q Consensus 565 ~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 642 (708)
|||||||||||.|.+||...++.+.-..+......+.. ........+..+||.++|. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------------P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------------PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999877765533222222111111 1122223668899999999 9999965
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.20 Aligned_cols=244 Identities=29% Similarity=0.492 Sum_probs=203.6
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
..++-||.|+.|.||+|+++ ++.||||+++...+ .+|+.|++|+|+||+.+.|+|.....++|||||+..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34567999999999999996 57899998764322 46888999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeec
Q 047038 461 LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540 (708)
Q Consensus 461 L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~ 540 (708)
|.+.|+..+ .++......|..+||.||.|||.+. |||||||+-||||..+..|||+|||-++..... .....
T Consensus 199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 999998765 5888888999999999999999998 999999999999999999999999999866433 22345
Q ss_pred ccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHH
Q 047038 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620 (708)
Q Consensus 541 ~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 620 (708)
+.||..|||||++.+.+.++|+|||||||||||||||..||...+... +.| .+..+. +....+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw---GVGsNs--------L~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW---GVGSNS--------LHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE---eccCCc--------ccccCccc
Confidence 779999999999999999999999999999999999999985433211 111 011111 11223455
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 621 EFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 621 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.++.+.-|+++||+..|.+||++++++..|+-...
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 66779999999999999999999999999986543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.03 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=208.0
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 445 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 445 (708)
.-..++|++.+.||+|+||.||++... +++.||||+++.. .....+.+.+|+.+++.+ +|+|||++++++.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567899999999999999998842 3457999998753 344567799999999999 89999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCC-------------------------------------------------------
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNK------------------------------------------------------- 470 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 470 (708)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998854210
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-
Q 047038 471 ------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL- 537 (708)
Q Consensus 471 ------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~- 537 (708)
...+++.++++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 124788899999999999999999998 9999999999999999999999999987654332211
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....++..|||||++.+..++.++||||||+++|||++ |+.||........ +......+ ....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~---------~~~~ 335 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRG---------YQMS 335 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcc---------cCcc
Confidence 222335678999999999999999999999999999997 9999965332211 11111111 0001
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.+...+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11122456899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=337.21 Aligned_cols=256 Identities=22% Similarity=0.402 Sum_probs=209.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578889999999999999999888889999987653 334678999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999997643 236889999999999999999999988 999999999999999999999999999876433222
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||++....++.++||||||+++|||++ |+.||......+ ... .+.... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~----~~~~~~---------~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS----ALQRGY---------RM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH----HHHcCC---------CC
Confidence 2233446778999999998889999999999999999998 999996433221 111 111110 00
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
......+..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.33 Aligned_cols=265 Identities=24% Similarity=0.381 Sum_probs=216.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
+.+.....++||+|-||+|.+.....+..||||+++..... .+.+|..|+++|.+++|||||.|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34556778899999999999999988899999999885544 45899999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
||++|+|.++|.++.... +.-..-.+|+.||+.||+||.+.. ++||||.++|+|+|.++++||+|||+++.+....
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999998875432 455566779999999999999999 9999999999999999999999999999765544
Q ss_pred cce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh--CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 535 THL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT--GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 535 ~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.+. ....+-..+|||||.+.-+++|.++|||+||++|||+++ ...||.....+... ...-...+.+. .
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~------~ 762 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQG------R 762 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCC------c
Confidence 443 334566889999999999999999999999999999976 88888644332211 11111111111 1
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
......+...+..+.+|+.+||+.+-++||+++++...|.+.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111223455667799999999999999999999999888764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=348.34 Aligned_cols=256 Identities=27% Similarity=0.363 Sum_probs=209.9
Q ss_pred hhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC----Ch-HHHHHHHHHHHHHHhcC-CCceeeeeceEeeCC
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII----DE-SKVEEFINEVVILSQIN-HRNVVKLLGCCLETE 447 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 447 (708)
...++|...+.||+|+||+|++|.. .+++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999985 47899999965542 11 23456678999999998 999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeeccC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGA 526 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGl 526 (708)
..++||||+.+|+|.+++.... ++.+.....++.|++.|++|+|+.+ |+||||||+|||||.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998843 6888999999999999999999999 9999999999999999 9999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCC-CC-ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH-FT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+.... ..........||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..+. ...+.. +..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcCC
Confidence 98764 2333456678999999999999877 75 789999999999999999999975221 111111 22221
Q ss_pred hhhhhhhhhhccCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 605 LFEILDAQILKEGGKDE-FKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+ ..+... ...+..|+.+||..||.+|+++.|++ +-.-++.
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 111222 56789999999999999999999998 4444443
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=337.55 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=214.9
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
....+|+..++||+|+||+||+|...+++.+|+|.+........+++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45567889999999999999999988899999999887666667789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999998653 236899999999999999999999998 9999999999999999999999999997654322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. ......++..|++||.+....++.++||||||+++++|++ |+.||......+. .. .+.. ..
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~----~~~~---------~~ 221 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YD----QITA---------GY 221 (261)
T ss_pred c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH----HHHh---------CC
Confidence 1 1223346778999999998899999999999999999998 8999965432211 11 1111 11
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
....+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112234456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=341.73 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=203.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|++.+.||+|+||+||+++.+ +++.||+|+++... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999976 57899999886532 3345678899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|++++++..+.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987776554322 25899999999999999999999998 9999999999999999999999999998764333
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch---------h
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR---------L 605 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------~ 605 (708)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......+................ .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 3233445689999999999988899999999999999999999999976443221111111000000000 0
Q ss_pred hhhhhhhh------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDAQI------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+.. ........+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00001123456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.63 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=210.3
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
...++|++.+.||+|++|.||+|...+++.||+|.++... ...++|.+|+.++++++|+||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456788999999999999999998888899999987533 345679999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997653 336899999999999999999999998 9999999999999999999999999998765322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.........+..|+|||++.+..++.++||||||++++||++ |+.||....... .. ..+....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~--------- 221 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL----QQVDQGY--------- 221 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCC---------
Confidence 221222223468999999999999999999999999999999 999986443221 11 1111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
........+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0011223446699999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.03 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=202.1
Q ss_pred CCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999996 478999999876422 2334568899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886542 225899999999999999999999998 9999999999999999999999999998653222
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......||..|+|||++.+..++.++||||||+++|||++|+.||.......... .....+... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~----------~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKED----------Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhcc----------c
Confidence 2234568999999999999999999999999999999999999997654322111 111111110 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
..........+.+|+.+||+.||++||+ ++|+++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1122334566899999999999999997 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=348.70 Aligned_cols=263 Identities=29% Similarity=0.486 Sum_probs=227.8
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
++++-...+....++||.|.||.||.|.++. .-.||||.++. +....++|+.|+.+|+.++|||+|+|+|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5566666777788999999999999999875 45799999885 456788999999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
|||.|||..|+|.+||++.+.. .++....+.+|.||+.||+||..++ +|||||..+|.|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999987543 5788888999999999999999999 99999999999999999999999999999
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
+..+...........+.|.|||.+....++.|+|||+|||+|||+.| |.-||.+.+... +.++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHH
Confidence 88766555555556789999999999999999999999999999999 999986544322 2334
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
+.....-+.+...++.+.+|++.||+++|.+||++.|+-+.|+.+-
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 4444444556677888999999999999999999999999998763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.75 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=208.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.+|...+.||+|+||.||+|... .++.||+|.++.. ....+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999965 5888999988753 444678999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999987643 235899999999999999999999998 999999999999999999999999998866433222
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. . ..+... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~----~~~~~~---------~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----ELLEKG---------YRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHCC---------CCC
Confidence 2222334678999999999999999999999999999998 9999865432211 1 111111 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
+.+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.39 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=204.8
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|+..+.||+|+||.||++.+.++..+|+|.++.. ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999988889999987643 2334678999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|+|.++++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999875432 5899999999999999999999998 9999999999999999999999999987654322222
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+. .. .+..+.. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~----~i~~~~~---------~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VE----MISRGFR---------LY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHCCCC---------CC
Confidence 223345678999999998889999999999999999999 8999864432211 11 1111110 00
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11123356899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=335.31 Aligned_cols=267 Identities=26% Similarity=0.343 Sum_probs=210.3
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh--------------HHHHHHHHHHHHHHhcC
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE--------------SKVEEFINEVVILSQIN 432 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--------------~~~~~~~~Ei~~l~~l~ 432 (708)
+...+-.+..++|++.+.||+|.||.|-+|+.. +++.||||++..... ...+...+||.||++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 344445566789999999999999999999965 789999998654211 22468899999999999
Q ss_pred CCceeeeeceEee--CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 433 HRNVVKLLGCCLE--TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 433 H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
|||||+|+.+..+ .+.+|||+||+..|.+...=... ..+++.+.++++.+++.||+|||.++ ||||||||+|
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~---~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN 240 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN 240 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc---ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 9999999999875 56789999999988776543322 13899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcC----CcceeecccccccccCccccccCC----CCccchhHhHHHHHHHHHhCCCCCC
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVD----QTHLTTQVQGTFGYLDPEYFQSSH----FTEKSDVYSFGVVLVELLTGERPIR 582 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDv~SlGvvl~elltg~~P~~ 582 (708)
+||++++++||+|||.+...... ........+|||.|+|||...++. -+.+.||||+||+||.|+.|+.||.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999999999998866321 111223467999999999987632 3578999999999999999999996
Q ss_pred CCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..... ..+ ..|+...+.-...+++.+.+.+||+++|.+||++|.+..+|.......+.
T Consensus 321 ~~~~~------~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 321 DDFEL------ELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cchHH------HHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 43221 111 12222333223344566789999999999999999999999877766655
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=389.95 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=211.8
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
...|...++||+|+||+||+|+. .+++.||||+++..... ...|++++++++|||||+++|++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34677888999999999999997 47899999988653322 23468899999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++|+|.++++ .++|..+.+++.|+++||+|||+...++|+||||||+||+++.++..++. ||.......+
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999995 38899999999999999999997655669999999999999999988875 6665433211
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
....+|+.|+|||++.+..++.|+|||||||++|||++|+.||..... .......|...........+.+|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 223578999999999999999999999999999999999999854322 2234445544444444444455554432
Q ss_pred --cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 616 --EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 616 --~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....++..++.+++.+||+.+|++||+|+||+++|+.+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2345566788999999999999999999999999999866
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.36 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=209.0
Q ss_pred cCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++|++.+.||+|+||.||+|.... .+.||+|.++... ....++|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998643 2579999886533 344567999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 451 LVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975421 135889999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHH
Q 047038 518 CAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 595 (708)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986543221 22333456889999999998899999999999999999998 999987544322
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
....+..+. ....+...+..+.+|+.+||+.+|.+||+++||++.|+.+
T Consensus 235 ~~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111121111 1112334557799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.60 Aligned_cols=249 Identities=37% Similarity=0.589 Sum_probs=196.4
Q ss_pred ccceEeeeccEEEEEEEEc-----CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 382 TNRILGQGGQGTVYKGMLE-----DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+.||.|.||.||+|.+. .+..|+||.++.. .....++|.+|++++++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 2568999999663 344588999999999999999999999999988889999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++|+|.++|+... ...+++.+++.|+.||++||.|||+.+ ++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999872 236899999999999999999999998 99999999999999999999999999987632222
Q ss_pred -ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 536 -HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 536 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
...........|+|||.+....++.++||||||+++|||++ |+.||......+ +...+.++..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccc--------
Confidence 22333457789999999999889999999999999999999 788875442211 1111122111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
...+...+..+.+++.+||+.+|++||++++++++|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223345688999999999999999999999887
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.21 Aligned_cols=245 Identities=28% Similarity=0.386 Sum_probs=208.3
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCc
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEV 448 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 448 (708)
....++|...++||+|.||+|+++..+ +++.+|||.++. ...++.+..+.|.+|+...+ ||.++.|+.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999976 578999999876 34667888999999998885 9999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
+++||||+.||++..+.+.. .+++..+..+|.+|+.||+|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999966655533 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.... ....+.++.|||.|||||++....|+.++|.|||||+|||||.|..||.+.++++. |...+.++
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~----- 584 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDE----- 584 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCC-----
Confidence 6542 23356778999999999999999999999999999999999999999987665542 21122111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
..++.-.+.+..++++++|.++|++|.-+
T Consensus 585 ------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12244556678899999999999999766
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=343.23 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=206.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|+..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999976 6888999987653 34456789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997643 5899999999999999999999853 2999999999999999999999999998765322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh------------
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE------------ 602 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 602 (708)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+......
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccCcc
Confidence 12345689999999999999999999999999999999999999965433221 1111000000
Q ss_pred ------------------chhhhhhhhh----hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 603 ------------------DRLFEILDAQ----ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 603 ------------------~~~~~~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+..+.. ............+.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000111100 0000111245679999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.85 Aligned_cols=264 Identities=24% Similarity=0.318 Sum_probs=201.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|...++||+|+||+||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68899999886533 23345788999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++ +|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 89888865432 5789999999999999999999998 99999999999999999999999999876432221
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh-------
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE------- 607 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 607 (708)
......+++.|+|||.+.+ ..++.++||||||+++|||++|++||......+................+..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1233458999999999865 5689999999999999999999999976544332211111100000000000
Q ss_pred --hhhhhhhc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 --ILDAQILK----EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 --~~d~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+.... ...........+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 001122356789999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=331.57 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=208.0
Q ss_pred cCCcccceEeeeccEEEEEEEEcC----CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
++|+..+.||+|+||+||+|.+.. ...||||.++.. ......+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999752 357999988753 344567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999976543 6899999999999999999999988 99999999999999999999999999987652
Q ss_pred CCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 533 DQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 533 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
... .......++..|+|||.+.+..++.++||||||++++||++ |..||......+ ....+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------ 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGY------ 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 222 12222345678999999999899999999999999999998 999985432211 111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
....+...+..+.+++.+||+.+|++||+++||++.|+.+
T Consensus 226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.67 Aligned_cols=259 Identities=26% Similarity=0.461 Sum_probs=211.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999852 345689999887666777889999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 452 VYEFISNGTLSQYIDDQN----------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999987543 1235899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHH
Q 047038 522 SDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 522 ~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||......+ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 999999865432211 1223345778999999998899999999999999999998 999986443221 1111
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+..+... ..+...+..+.+|+.+||+.+|.+|||+.||++.|+.+.+
T Consensus 235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1222111 1112234568999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=311.61 Aligned_cols=266 Identities=26% Similarity=0.364 Sum_probs=218.0
Q ss_pred HhhccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc----
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV---- 448 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 448 (708)
....++|.+.++||+|||.-||.++ ..+++.+|+|++......+.+..++|++..++++||||++++++...+..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456789999999999999999999 67899999999988888889999999999999999999999999875444
Q ss_pred -ceEEEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 449 -PLLVYEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 449 -~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
.||+++|...|+|.+.+..... +..+++.+.+.|+.+|++||++||+.. +|+.||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999976543 337999999999999999999999987 4799999999999999999999999999
Q ss_pred CcccCcCCcce--------eecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH
Q 047038 527 SRSIAVDQTHL--------TTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 527 s~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~ 595 (708)
+.......... -....-|..|.|||.+. +...++++|||||||+||+|+.|.-||+.....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------- 247 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------- 247 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence 87654321111 11234688999999985 456889999999999999999999999643221
Q ss_pred HHHHhhhchhh-hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 596 FLRAMREDRLF-EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 596 ~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.+.+. .+...++........++.+.+++++||+.||.+||++.+++..++.+.
T Consensus 248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 122223333333447788999999999999999999999999988763
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.94 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=206.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 5889999988652 2334567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 5889999999999999999999998 99999999999999999999999999875532
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+........ . ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~---~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW------K---ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc------c---ccccCCC
Confidence 233456899999999999999999999999999999999999999755433211111100 0 0000000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
...........+.+++.+||+.+|++||+++|+++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000012335668999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=350.46 Aligned_cols=265 Identities=25% Similarity=0.384 Sum_probs=210.5
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcC-CCceeeeeceEe
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQIN-HRNVVKLLGCCL 444 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 444 (708)
++...++|.+.++||+|+||+||+|... .+..||||+++.. .....+.|.+|+++|++++ |||||++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678899999999999999999853 1346999998753 3344578999999999996 999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCC------------------------------------------------------
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNK------------------------------------------------------ 470 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 470 (708)
+.+..+|||||+++|+|.++|+....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999988864310
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 471 ---------------------------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 471 ---------------------------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 124788889999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchh
Q 047038 512 LLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEED 589 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~ 589 (708)
|+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 99999999999999998654332221 223446788999999999999999999999999999997 9999864322211
Q ss_pred hhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 590 KSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+...+..+. ....+...+..+.+++.+||+.+|++||++.+|.++|+++..
T Consensus 349 ------~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ------FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111110 111122345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=329.24 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=213.3
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
...+|++.+.||+|.||.|-+++. ..|+.||||.++. .++.+.-.+.+||+||+.|+||||++++.+|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346788889999999999999995 6899999997654 556677789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||..+|.|++|+.+.+ .|++.+...++.||..|+.|.|.++ ++|||||.+|||||+++++||+||||+.++.
T Consensus 131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999765 5999999999999999999999998 9999999999999999999999999998775
Q ss_pred cCCcceeecccccccccCccccccCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.+ ...+++.|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+... +.+.+..+...+
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrE--- 272 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYRE--- 272 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccC---
Confidence 43 346778899999999999998874 78999999999999999999997654322 233333333322
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
++.+....-||+|||..||++|.|+.+|...-
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 12233466799999999999999999997544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.13 Aligned_cols=241 Identities=23% Similarity=0.303 Sum_probs=198.0
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
++||+|+||.||++... +|+.||||.++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6899999987642 2345567889999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceee
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 539 (708)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9999987543 5899999999999999999999998 9999999999999999999999999987532221 1233
Q ss_pred cccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCH
Q 047038 540 QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK 619 (708)
Q Consensus 540 ~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 619 (708)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+... .. ..+..+. ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~----~~~~~~~----------~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILMEE----------IRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HH----HHHHcCC----------CCCCC
Confidence 4569999999999999999999999999999999999999996433221 10 1111110 01123
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 620 DEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 620 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.....+.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3456689999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=339.49 Aligned_cols=243 Identities=26% Similarity=0.352 Sum_probs=201.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68899999876422 234567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997653 5899999999999999999999998 999999999999999999999999998765322
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~-------- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-------YEKILAGKL-------- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCc--------
Confidence 2234689999999999998899999999999999999999999975432211 111111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVG 647 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~ 647 (708)
..+......+.+|+.+||+.||.+||+ ++|++
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 112223456899999999999999995 77765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=330.76 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=204.8
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|+..+.||+|+||+||+|...++..+|+|.++... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577888999999999999998777789999877533 334679999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999976433 5899999999999999999999998 9999999999999999999999999987654332222
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....++..|++||.+....++.++||||||+++|||++ |+.||......+ ... .+..+.. ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~---------~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE----KVSQGLR---------LY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHhcCCC---------CC
Confidence 222345678999999998889999999999999999999 999986443221 111 1111110 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.....+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11223467899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=335.05 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=208.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|+++|++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998643 478999998764444 567899999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 450 LLVYEFISNGTLSQYIDDQNK-----------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999975431 235789999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHH
Q 047038 519 AKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 596 (708)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------- 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence 99999999876532221 11223346788999999999999999999999999999998 9999865443221
Q ss_pred HHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
...+..+.. ...+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111111 11122344668999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=334.43 Aligned_cols=259 Identities=28% Similarity=0.458 Sum_probs=206.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
..+++|+..+.||+|+||.||+|... .++.||||++... ......+|.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999753 2567999987643 2345567999999999999999999999999999
Q ss_pred cceEEEEeccCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNK-------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAK 520 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~k 520 (708)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999875332 224678899999999999999999988 99999999999999999999
Q ss_pred EeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHH
Q 047038 521 VSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 598 (708)
|+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 99999987654322211 122345788999999999899999999999999999999 788986543221 111
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
........ ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 1122334568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=335.29 Aligned_cols=264 Identities=29% Similarity=0.470 Sum_probs=207.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-----CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-----DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 450 (708)
++|+..+.||+|+||+||++... +++.||+|+++.......+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999743 578999999887777777899999999999999999999998754 34678
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999975432 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc-----
Q 047038 531 AVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED----- 603 (708)
Q Consensus 531 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----- 603 (708)
....... .....++..|+|||++.+..++.++||||||++++||++|..|+...... +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence 4332221 11222345699999999889999999999999999999988775432211 01101100
Q ss_pred ---hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 604 ---RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 604 ---~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.+.+.+............+..+.+|+.+||+.+|++|||++||++.|+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 011111111111112334467999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.44 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=212.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.+|...+.||+|+||.||++... ++..+++|.++.......+.|.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999842 355799999887666667889999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 452 VYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975431 235899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHH
Q 047038 519 AKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 596 (708)
+||+|||++........ .......++..|+|||++....++.++||||||+++|||++ |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999876543221 11233456788999999999999999999999999999999 999986543322 1
Q ss_pred HHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+..+... ......+..+.+++.+||+.+|++||++++|+++|+.+.+
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1112222111 1122345668999999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.84 Aligned_cols=256 Identities=24% Similarity=0.459 Sum_probs=205.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.+|+..+.||+|+||+||+|.+. +++ .||+|.++.. .....++|.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 343 3899998753 345567899999999999999999999999864 5789
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999986532 5889999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ +......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER---- 229 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCC----
Confidence 433222 122334678999999999999999999999999999998 999986433221 1111111100
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+......+.+++.+||+.+|++||++.+++..|..+..
T Consensus 230 -----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 01112233468899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=356.35 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=218.0
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcCC-cEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeece-Eee----
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLEDG-KIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGC-CLE---- 445 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~---- 445 (708)
++....++++.++|.+|||+.||.+....+ ..+|+|++-..++...+...+||.+|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345567788899999999999999998766 999999998889999999999999999996 9999999993 221
Q ss_pred --CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 446 --TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 446 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.-+.+|+||||++|.|-+++...... .|++.++++|+.|+++|+++||... +||||||||-+||||+.+++.||+|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 12568999999999999999866544 4999999999999999999999986 6799999999999999999999999
Q ss_pred ccCCcccCcCCc-ce-------eecccccccccCcccc---ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhH
Q 047038 524 FGASRSIAVDQT-HL-------TTQVQGTFGYLDPEYF---QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSL 592 (708)
Q Consensus 524 FGls~~~~~~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~ 592 (708)
||.+.-...... .. .....-|+.|+|||.+ .+...++|+|||+|||+||-|.....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 999864322211 00 0112368999999986 567899999999999999999999999964321
Q ss_pred HHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 593 AAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..|++....-.........|.+||+.||+.||++||++-+|+.++-.++.
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 23444444334446788899999999999999999999999999998876
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.70 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=204.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 6889999988752 2334567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999976532 5899999999999999999999998 999999999999999999999999999876544
Q ss_pred CcceeecccccccccCccccc------cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQ------SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+...+.......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccC
Confidence 433344457899999999986 4567899999999999999999999996543322 1111111111100
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+|+.+||+ +|++||++.+++.
T Consensus 230 -------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 -------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 01112234568899999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=328.74 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=206.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..++|++.++||+|+||.||++...++..+|+|.++.... ..+.|.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3457888999999999999999988888899998875333 3467999999999999999999999875 4568999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.++++... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999997643 235899999999999999999999998 99999999999999999999999999986543322
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......++..|+|||.+.+..++.++||||||++++||++ |..||......+ ... .+... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~---------~~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE----QVERG---------YR 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcC---------CC
Confidence 22223345678999999988889999999999999999999 899986433211 111 11111 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
...+...+..+.+|+.+||+.+|++|||+.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11123345669999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=343.13 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=207.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC-
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQI-NHRNVVKLLGCCLET- 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~- 446 (708)
..++|++.++||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4467999999999999999999742 35789999987532 34456788999999999 899999999988754
Q ss_pred CcceEEEEeccCCCccccccccCC--------------------------------------------------------
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNK-------------------------------------------------------- 470 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 470 (708)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999998864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-eecccccccc
Q 047038 471 --DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGY 547 (708)
Q Consensus 471 --~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y 547 (708)
...++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999998 9999999999999999999999999998764332222 2234467789
Q ss_pred cCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHH
Q 047038 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVA 626 (708)
Q Consensus 548 ~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 626 (708)
+|||++.+..++.++|||||||+|+||++ |..||......+. +...+..+.. ...+......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCHHHH
Confidence 99999999999999999999999999998 9999865432221 1111111110 111223345689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 627 KLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 627 ~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+++.+||+.+|++||++.||+++|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.94 Aligned_cols=244 Identities=26% Similarity=0.339 Sum_probs=201.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 6889999987642 2334567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997653 5888999999999999999999998 999999999999999999999999999865432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+.+
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~-------- 232 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL-------- 232 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc--------
Confidence 1 23468999999999999999999999999999999999999996433211 1111111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
..+......+.+|+.+||+.||++||+ +++++.
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111123356889999999999999997 576653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.30 Aligned_cols=256 Identities=26% Similarity=0.460 Sum_probs=205.5
Q ss_pred cCCcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|+..+.||+|+||+||+|.. .+++.||+|.++.. ......+|.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999984 24678999998753 34455789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 452 VYEFISNGTLSQYIDDQNK--------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
||||+++++|.+++..... ...+++.+.+.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853321 235789999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHH
Q 047038 518 CAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 595 (708)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976543221 12233445778999999998889999999999999999998 999986443211
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
....+..... ...+...+..+.+++.+||+.+|++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 11122334568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=328.77 Aligned_cols=257 Identities=23% Similarity=0.418 Sum_probs=208.4
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
...++|++.++||+|+||.||+|...+++.||+|.+.... ...++|.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3456788999999999999999998889999999887533 33468999999999999999999999864 567899999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999987643 236899999999999999999999988 9999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
........++..|+|||++....++.++||||||++++||++ |+.||......+ .. ..+....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~--------- 220 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI----QNLERGY--------- 220 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH----HHHHcCC---------
Confidence 222233446778999999998889999999999999999999 999996543221 11 1111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
........+.++.+++.+||+.+|++||++++++..|+.+
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0111222345699999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.15 Aligned_cols=252 Identities=26% Similarity=0.448 Sum_probs=211.8
Q ss_pred ccceEeeeccEEEEEEEEc-CCc----EEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 382 TNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..++||+|+||+||||.+- .|+ +||||.+.. ...+..+++++|+-+|.+++|||+++|+|+|..+. +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 4578999999999999953 343 689998765 44556789999999999999999999999999876 8899999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
|+.|+|.+|++.++. .+..+..+.|..|||+||.|||.+. ++||||..+|||+..-..+||.|||++++...+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998754 5888999999999999999999988 99999999999999999999999999999876655
Q ss_pred cee-ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 536 HLT-TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 536 ~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
... ....-.+.|||-|.+....++.++|||||||++||++| |..|+++...++..++. ....
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hccc
Confidence 443 23334678999999999999999999999999999999 99999877665533222 2111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+..-++-....+..++.+||..|+..||+++++..++.+...
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 122245556678999999999999999999999998876643
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=328.57 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=203.4
Q ss_pred CCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
+|+..+.||+|+||.||++..++++.+|+|.+.... ...++|.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998877889999876422 2345788999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999976433 6899999999999999999999998 99999999999999999999999999876543222212
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+. . ..+... .....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~---------~~~~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V----ESVSAG---------YRLYR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H----HHHHcC---------CcCCC
Confidence 22234568999999999999999999999999999999 8999865433221 1 111111 01111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 223456799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.92 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=205.4
Q ss_pred CCcccceEeeeccEEEEEEEEc-C-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-D-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.|.+.++||+|+||.||++... + ++.||+|.+..........+.+|+.+|+.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 3 6788999877666666678899999999999999999999999999999999999
Q ss_pred cCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 457 SNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 457 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
++|+|.++++... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886532 2346889999999999999999999998 99999999999999999999999999987643222
Q ss_pred -ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 -HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+..+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~-~~~~~~~~--------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IM-QQVLYGKY--------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC---------
Confidence 12344569999999999999999999999999999999999999996433211 11 11111110
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+++.+||+.+|++||++++++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0112233456899999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.99 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=197.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc--CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhc---CCCceeeeeceEee-----
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE--DGKIVAVKKSKIID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCLE----- 445 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 445 (708)
++|++.+.||+|+||+||+|... +++.||+|+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999876532 23345667788877766 69999999999863
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
....++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 589988875432 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh---h
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR---E 602 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~ 602 (708)
+++..... .......||+.|+|||.+....++.++||||||+++|||++|++||......+.. ........ .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCCh
Confidence 99765432 2233456899999999999889999999999999999999999999765433211 11111110 0
Q ss_pred chhhhhh--hhhh--------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 DRLFEIL--DAQI--------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 ~~~~~~~--d~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+.... .... ...........+.+|+.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 0000 00011123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.07 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=212.0
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceE
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCC 443 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 443 (708)
+++...++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.+++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345556788899999999999999998642 367999988753 344556799999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
...+..+++|||+++|+|.++++... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 99999999999999999999986531 2346899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcch
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~ 588 (708)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999999998664322211 222335678999999998899999999999999999998 999986443222
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
. ...+..+. ....+......+.+|+.+||+.+|++|||++|+++.|+.+.
T Consensus 243 ~-------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L-------FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-------HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 11111111 11122334466899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.55 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=206.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.++|++.++||+|+||+||+|.+.+...||+|+++.... ..++|.+|+.++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 457889999999999999999987777899999875332 3467899999999999999999999875 45689999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999997643 235799999999999999999999998 999999999999999999999999999766433322
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. . ...... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~----~~~~~~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L----DQVERG---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H----HHHhcC---------CCC
Confidence 2223446778999999998899999999999999999999 8888864432211 1 111110 001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
....+.+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11234456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.21 Aligned_cols=251 Identities=28% Similarity=0.394 Sum_probs=215.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-ceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV-PLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 453 (708)
++|...+++|+|+||.++..+.+ +++.+++|++.... +...+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998865 67889999877633 4445578999999999999999999999999998 99999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
+|++||+|.+.+...+ +..++++++.+++.|++.|+.|||+.. |+|||||+.|||++.+..|||.|||+++.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998875 457999999999999999999999887 999999999999999999999999999988755
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..+ + .....+ ..
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L---i~ki~~----------~~ 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L---ILKINR----------GL 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H---HHHHhh----------cc
Confidence 4 24556789999999999999999999999999999999999999997554432 1 111111 11
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+.....++..|+..||+.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233456667789999999999999999999999876
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.54 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=197.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----cce
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 450 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 450 (708)
+|++.++||+|+||.||+|... +++.||||+++.. .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 6899999987642 2344567899999999999999999999986433 479
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||++ ++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 68888886543 5899999999999999999999998 999999999999999999999999999865
Q ss_pred CcCCc--ceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------HH
Q 047038 531 AVDQT--HLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF--------LR 598 (708)
Q Consensus 531 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~~ 598 (708)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 11234568999999999876 67899999999999999999999999754432211111000 00
Q ss_pred Hhhhchhhhhhhh---hh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 599 AMREDRLFEILDA---QI---LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 599 ~~~~~~~~~~~d~---~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+......+.+.. .. ..+........+.+++.+||+.+|++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0111111111100 00 00000112355789999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.33 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=206.8
Q ss_pred CCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
+|++.+.||+|+||+||+|... ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578998876533 4456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 452 VYEFISNGTLSQYIDDQN---------------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999876421 1135889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcch
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~ 588 (708)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||.....++
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987654322211 222345678999999998889999999999999999999 999986443221
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+. ...... .....+...+..+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 238 ---~~----~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LF----NLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HH----HHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 111111 1111123344568999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.08 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=197.4
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
++||+|+||.||++... +|+.||+|.++.. .......+.+|+.++++++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 6899999987652 3345567889999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceee
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 539 (708)
+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9998887543 5899999999999999999999998 9999999999999999999999999987532221 1223
Q ss_pred cccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCH
Q 047038 540 QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK 619 (708)
Q Consensus 540 ~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 619 (708)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...... .. ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~-~~----------~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILM-EE----------IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-CC----------CCCCC
Confidence 45689999999999999999999999999999999999999964432211 000010 00 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 620 DEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 620 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3446689999999999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.17 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=203.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|+..++||+|+||+||++... ++..+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 6788999987653 34456779999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... .+++.....++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999997643 5889999999999999999999752 2999999999999999999999999998755321
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH----------------
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR---------------- 598 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~---------------- 598 (708)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.................
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 12334689999999999998899999999999999999999999975432211100000000
Q ss_pred ----Hhhh-----chhhhhhhhhhhc---cC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 599 ----AMRE-----DRLFEILDAQILK---EG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 599 ----~~~~-----~~~~~~~d~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.... .....+.+..... .. ......++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 0000001100000 00 0113456899999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.90 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=203.8
Q ss_pred CcccceEeeeccEEEEEEEEcC----CcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-----
Q 047038 380 FNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----- 448 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 448 (708)
|++.+.||+|+||.||+|.+.. +..||+|+++.. .....+.+.+|+++++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999999642 367999988753 34456789999999999999999999999876554
Q ss_pred -ceEEEEeccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 449 -PLLVYEFISNGTLSQYIDDQN---KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 449 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
.++||||+++++|..++.... ....+++...+.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985532 2236899999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 525 GASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 525 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
|+++......... .....++..|+|||++....++.++||||||+++|||++ |..||......+ .. ..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~----~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IY----DYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHc
Confidence 9998664333221 122335678999999998899999999999999999999 889986433211 11 11111
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
+.. ...+......+.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 111233456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.97 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=205.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678999999999999999999753 5679999876533 4445679999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEE
Q 047038 449 PLLVYEFISNGTLSQYIDDQNK----DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY---CAKV 521 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl 521 (708)
.++||||+++++|.++++.... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 235899999999999999999999998 99999999999998654 6999
Q ss_pred eeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHH
Q 047038 522 SDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
+|||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......+. . ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~----~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---M----EF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HH
Confidence 9999998663222111 112233568999999999999999999999999999997 9999975433221 1 11
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
+... ...+.+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 011122334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=322.07 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=201.0
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCcc
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 462 (708)
++||+|+||.||+|...+++.+|+|.++... ......|.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999877543 334457999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeeccc
Q 047038 463 QYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542 (708)
Q Consensus 463 ~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~ 542 (708)
+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99875432 5789999999999999999999998 999999999999999999999999998754322221122234
Q ss_pred ccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 543 GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 543 gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
++..|+|||++.+..++.++||||||+++|||++ |..||........ . ..+... .........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~----~~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R----EQVEKG---------YRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H----HHHHcC---------CCCCCCCCC
Confidence 4678999999999999999999999999999998 9999864432211 1 111111 001112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
+..+.+++.+||+.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.32 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=211.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEcC-----CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEee-CCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLED-----GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 448 (708)
..++|+..++||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999765 688999987753 45567789999999999999999999998776 567
Q ss_pred ceEEEEeccCCCccccccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKD-----FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 46899999999999999999999988 99999999999999999999999
Q ss_pred ccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 524 FGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 524 FGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +..+ +.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY----LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH----HH
Confidence 99998664333222 223346778999999998889999999999999999999 999996543221 1111 11
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+. ........+..+.+++.+||+.+|++|||+.||++.|+.+.+
T Consensus 234 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 001112234568999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.50 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=198.4
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
+.||+|+||.||+|... +++.||+|..... .......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 7899999987643 344567899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee-ec
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT-TQ 540 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~-~~ 540 (708)
.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99987543 25899999999999999999999998 99999999999999999999999999875432111111 11
Q ss_pred ccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCH
Q 047038 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK 619 (708)
Q Consensus 541 ~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 619 (708)
...+..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+. .......+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~---------~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIE---------QGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHH---------cCCCCCCcc
Confidence 123457999999999999999999999999999998 8888854332211 01111 111111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 620 DEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 620 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
..+..+.+++.+||+.+|++|||+.||+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=341.92 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=209.4
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.-|++.+-||+|+-|.|-.|++ .+|+.+|||.+... .......+.+||.||+-++||||++||+++++...+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477788999999999999995 47999999987653 3344567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|-|.++|-.++ ++++.+..+++.||+.|+.|.|..+ |+||||||+|+|||.++++||+|||+|.+...+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999998775 5999999999999999999999999 999999999999999999999999999865433
Q ss_pred CcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
....+..|.+.|.+||++.+.+| +.++||||.|||||.||||+.||+..+. ......++.+.+
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVF------- 229 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcc-------
Confidence 34556679999999999999887 4789999999999999999999963221 112233333322
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
+.+...+.+..+|+++||..||++|.|++||++.
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2244556678999999999999999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.23 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=200.3
Q ss_pred CCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccC----ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKII----DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 449 (708)
+|++.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.+++++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998853 5789999987642 223456788999999999 599999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 5899999999999999999999998 99999999999999999999999999986
Q ss_pred cCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.............||+.|+|||++.+. .++.++||||||+++|||++|+.||........... +...+..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~------ 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---VSRRILK------ 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---HHHHHhc------
Confidence 543333333445799999999999865 478999999999999999999999965433221111 1111110
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.++ ..+......+.+++.+||+.||++|| +++++++
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011 11223345688999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.94 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=198.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+|++.+.||+|+||.||++... +++.||+|... .+.+.+|+++|++++|||||++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999964 68899999643 34578999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 68888876543 5899999999999999999999998 99999999999999999999999999975432222
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchh----hhHHHHHHHHhhh---------
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED----KSLAAYFLRAMRE--------- 602 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~----~~~~~~~~~~~~~--------- 602 (708)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 223345799999999999999999999999999999999999988754321110 0111111111000
Q ss_pred -chhhhhh---hhh-hh--c-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 -DRLFEIL---DAQ-IL--K-----EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 -~~~~~~~---d~~-~~--~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+.+.. ... .. . ......+..+.+|+.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 000 00 0 001123557899999999999999999999973
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.43 Aligned_cols=267 Identities=28% Similarity=0.419 Sum_probs=205.2
Q ss_pred CcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceE
Q 047038 380 FNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 451 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 451 (708)
|+..+.||+|+||+||++.. .+++.||+|.++... ....+.|.+|+++|++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 357789999887543 34567899999999999999999999998764 35789
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++... .+++.+++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999754 4899999999999999999999998 9999999999999999999999999988664
Q ss_pred cCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... .....++..|+|||.+....++.++||||||++++||++|..|+........ ..............+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 322211 1223356679999999988899999999999999999999999864332110 0010000001111122222
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
+.......+...+..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222111223334567999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.16 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=206.1
Q ss_pred cCCcccceEeeeccEEEEEEEEcC-Cc--EEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED-GK--IVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
++|++.++||+|+||.||+|...+ +. .+++|.++. ......+.|.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999753 33 478888775 3345567899999999999 799999999999999999999
Q ss_pred EEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 453 YEFISNGTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
+||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1125889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHH
Q 047038 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 598 (708)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+ ...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~---- 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE---- 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----
Confidence 99999998643211 11111223567999999998899999999999999999998 999996543222 111
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
.... ......+...+..+.+|+.+||+.+|.+||++.++++.|+.+....
T Consensus 230 ~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 1111112234456899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.38 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=210.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.++||+|+||.||+|+.. +++.||||.++. .+......|.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999965 789999997654 33455567999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988864322 235889999999999999999999998 99999999999999999999999999886543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||....... .. ....+.....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~-~~~~~~~~~~------- 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FS-LCQKIEQCDY------- 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HH-HHHHHhcCCC-------
Confidence 221 1223458889999999998889999999999999999999999985432211 11 1111111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
...........+.+++.+||+.+|++||++.||++.|++++
T Consensus 226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01111234466899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.12 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=209.9
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcC-CCceeeeeceE
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQIN-HRNVVKLLGCC 443 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~ 443 (708)
+++...++|.+.++||+|+||.||+|.+. .++.||||+++... ....+.+.+|+++|.++. |||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 34555667888999999999999999864 34679999987632 334567999999999997 99999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCC-----------------------------------------------------
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNK----------------------------------------------------- 470 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------- 470 (708)
...+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999865321
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 047038 471 ------------------------------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKS 508 (708)
Q Consensus 471 ------------------------------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp 508 (708)
...+++...+.++.|++.||+|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 124678888999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCc
Q 047038 509 TNILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNS 586 (708)
Q Consensus 509 ~NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~ 586 (708)
+|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||++++||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986532221 11223346788999999998889999999999999999998 8999864432
Q ss_pred chhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 587 EEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.+. ....+..+ .....+......+.+|+.+||+.+|++||+++||++.|+.+.
T Consensus 348 ~~~------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ------FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH------HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 211 11111111 001112233467999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.43 Aligned_cols=245 Identities=26% Similarity=0.337 Sum_probs=201.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC--CcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED--GKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.++|++.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998653 368999987542 23456678999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997653 5899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..+..
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~~------ 245 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGII------ 245 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC------
Confidence 22 2335689999999999998899999999999999999999999975432210 111111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
..+......+.+++.+||+.+|++|+ +++|+++
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11222335578999999999999995 7888764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.09 Aligned_cols=237 Identities=25% Similarity=0.326 Sum_probs=193.7
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||+|+||+||++... +++.||+|.++. ........+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 588999998764 2344567789999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecc
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 541 (708)
.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 99997643 5899999999999999999999998 9999999999999999999999999987543222 223345
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
.||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+..... .. ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EP----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CC----------CCCCCcC
Confidence 69999999999999999999999999999999999999996433211 1111111 10 0112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPTMREV 646 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt~~ev 646 (708)
...+.+++.+||+.||++||++.++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 4568899999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.64 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=207.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CC---cEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DG---KIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.++|+..+.||+|+||.||+|.+. ++ ..+|+|.++.. .....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999975 33 37999988754 34556789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997643 25899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCccee--ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 532 VDQTHLT--TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 532 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
....... .....+..|+|||++....++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcC-----
Confidence 3222111 11223567999999998889999999999999999998 999986433211 11111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
.........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223456689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.40 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=198.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.+.||+|+||+||+|... +++.||||.++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 688999998865332 234567899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 57877776543 25888999999999999999999998 9999999999999999999999999987543221
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chhhh---
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRLFE--- 607 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 607 (708)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ........... ..+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhh
Confidence 12233558999999999865 4588999999999999999999999975432211 11111111100 00000
Q ss_pred --hhhhh---------hhccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 --ILDAQ---------ILKEG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 --~~d~~---------~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..++. +.... .......+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00000 0011245789999999999999999999963
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.88 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=209.7
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
...++|.+.++||+|+||+||++..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3457899999999999999999998888899999887533 345679999999999999999999999999899999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999997653 236899999999999999999999998 9999999999999999999999999988664322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
........++..|+|||.+.+..++.++||||||++++||++ |+.||....... ... .+..+ .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~---------~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE----QVERG---------Y 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcC---------C
Confidence 222222335678999999998889999999999999999999 999986433221 111 11110 0
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
....+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011122234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.18 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=195.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..++||+|+||+||++... +++.||||.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999965 6899999988653 334456799999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 3566778889999999999999998 9999999999999999999999999998654322
Q ss_pred ceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.......||..|+|||++.. ...+.++||||||+++|||++|+.||......+...+... ....
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~------- 291 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICMS------- 291 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhcc-------
Confidence 12234568999999998753 2345689999999999999999999974332221111100 0000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+........+.+|+.+||+.||++||++.|+++
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112334566999999999999999999999975
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.18 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=204.6
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
....++|+..++||+|+||+||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999965 6889999988642 233445688999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999998653 4788888899999999999999998 99999999999999999999999999986
Q ss_pred cCcCCcceeecccccccccCccccccC----CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSS----HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
.............||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .+........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~- 264 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKN- 264 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCC-
Confidence 543332223445799999999998653 47899999999999999999999997543221 1111111100
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIE 649 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 649 (708)
.+........+..+.+|+.+||+.+|++ ||+++|+++.
T Consensus 265 ------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000111234567899999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.16 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=203.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|+..+.||+|+||+||+|.+. +++ .+++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677789999999999999964 444 47888775432 334567888999999999999999999875 456789
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
++||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999976432 5899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~--- 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL--- 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC---
Confidence 3322 22334557789999999998899999999999999999998 9999965433221 1111111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..+......+.+++.+||..+|++|||+.|++++|..+..
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0011123457889999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.11 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=205.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|.+.+.||+|+||+||++... +++.||||+++.. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 6899999988652 2245567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998652 5899999999999999999999988 999999999999999999999999999865433
Q ss_pred C----------------------------cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 047038 534 Q----------------------------THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 534 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~ 585 (708)
. ........||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999997544
Q ss_pred cchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047038 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-MREVGIE 649 (708)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~ 649 (708)
..+. ........ ...........++.+.+|+.+||+ +|.+||+ ++|+++.
T Consensus 235 ~~~~------~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2211 11111100 000000111135668999999998 9999999 9999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=320.58 Aligned_cols=268 Identities=24% Similarity=0.339 Sum_probs=212.4
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcc--cCChHHHHHHHHHHHHHHhcCCCceeeeeceEee-----
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSK--IIDESKVEEFINEVVILSQINHRNVVKLLGCCLE----- 445 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~--~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----- 445 (708)
......|...+.||+|+||.|..+... +|+.||||++. ..+....++-.+|+++|+.++|+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344556666789999999999999965 78999999987 3567778899999999999999999999999875
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
-+..|+|+|+|+ -+|...++... .++......+..|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 346799999994 58999998654 4999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcC-CcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 526 ASRSIAVD-QTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 526 ls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
|++..... .....+..+-|..|.|||.+.+ ..||.+.||||.||||.||++|++-|.+.+.-+...+.........++
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987543 1223467778999999999865 679999999999999999999999998877665554444433222222
Q ss_pred hhhhhhhhhh---h-----------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 RLFEILDAQI---L-----------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ~~~~~~d~~~---~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+..+-.... . ...-+.......+|+.+||..||.+|+|++|.++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2222111000 0 0001122355789999999999999999999874
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=325.25 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=200.5
Q ss_pred CcccceEeeeccEEEEEEEEcC-Cc--EEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC------Cc
Q 047038 380 FNTNRILGQGGQGTVYKGMLED-GK--IVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET------EV 448 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 448 (708)
|.+.++||+|+||.||+|.+.+ +. .||+|.++.. .....+.|.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466889999999999999764 33 5899987653 455678899999999999999999999987532 24
Q ss_pred ceEEEEeccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 449 PLLVYEFISNGTLSQYIDDQN---KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.+++|||+++|+|.+++.... ....+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 2235899999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 526 ASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 526 ls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+++......... .....+++.|++||++....++.++||||||+++|||++ |+.||......+ . ...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcC
Confidence 998764332211 122345678999999999999999999999999999999 889986432211 1 1111211
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
... ......+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 11223345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.97 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=209.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc--------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE--------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 446 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 446 (708)
.++|.+.+.||+|+||.||++... +...+|+|.++.. .....+++.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467899999999999999999853 2346999988753 344567799999999999 799999999999999
Q ss_pred CcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL 513 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll 513 (708)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976432 235899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhh
Q 047038 514 DDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKS 591 (708)
Q Consensus 514 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~ 591 (708)
++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....++
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 99999999999998765422111 1222234578999999998889999999999999999998 889986433221
Q ss_pred HHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 592 LAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
+...+.... ..+.+......+.+|+.+||+.+|++||++.||++.|+.+...
T Consensus 251 ----~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 1111223346788999999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.70 Aligned_cols=259 Identities=27% Similarity=0.340 Sum_probs=207.8
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE- 447 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~- 447 (708)
+.+...++|.+.++||+|+||+||++.. .+++.||||.+.. ........+.+|+.++..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445567999999999999999999985 4789999998765 34556678899999999999999999988776433
Q ss_pred -------cceEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 448 -------VPLLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 448 -------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
..++||||+++|+|.++++... ....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2579999999999999987543 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCC-cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH
Q 047038 520 KVSDFGASRSIAVDQ-THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 520 kl~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 598 (708)
||+|||+++...... ........||+.|+|||++.+..++.++||||||++||||++|+.||......+ .+.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~- 255 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMH- 255 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHH-
Confidence 999999998654322 122344569999999999999999999999999999999999999996543221 111
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+.. ...+...+..+.+|+.+||+.+|++||++.++++.
T Consensus 256 ~~~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 11123345669999999999999999999999763
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=323.26 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=205.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.++|.+.+.||+|++|.||++...++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998877789999876533 23467899999999999999999999875 45689999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.++++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999997643 235899999999999999999999998 999999999999999999999999999765433222
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ..+..+. ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~---------~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL----EQVERGY---------RM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC---------CC
Confidence 2223346778999999998899999999999999999999 999986543221 11 1111110 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
..+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.79 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=198.1
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
++||+|+||.||++... +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 6899999988642 3345678899999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceee
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 539 (708)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 9998887543 5899999999999999999999998 9999999999999999999999999987543221 1223
Q ss_pred cccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCH
Q 047038 540 QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK 619 (708)
Q Consensus 540 ~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 619 (708)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . ..+.... . ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~-~~~~~~~------~----~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------F-ELILMED------I----KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------H-HHhccCC------c----cCCC
Confidence 45699999999999999999999999999999999999999965432211 1 1111000 0 1122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047038 620 DEFKMVAKLAKRCLNLNGKKRP-----TMREVGIE 649 (708)
Q Consensus 620 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 649 (708)
.....+.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3345688999999999999997 89988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=337.46 Aligned_cols=260 Identities=27% Similarity=0.479 Sum_probs=221.0
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcC---Cc--EEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLED---GK--IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~--~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
+.........++||.|-||.||+|...+ |+ .||||..+. ...++.+.|+.|..+|++++|||||+|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3334445667899999999999999653 22 589999887 556778899999999999999999999999976 5
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..|||||..+-|.|.+||+.... .++......++.||..||+|||+.. ++||||..+|||+....-+||+||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999998654 6888899999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
+.+..+..+..+...-...|||||.+.-.++|.++|||-|||.+||++. |.+||.+....+..
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------- 602 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------- 602 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------
Confidence 9988777766666666789999999999999999999999999999998 99999876544311
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
-.+...-+...+...+..|..|+.+||..+|.+||.+.|+...|..++.
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111111223456677889999999999999999999999999988765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=334.69 Aligned_cols=241 Identities=26% Similarity=0.355 Sum_probs=195.9
Q ss_pred ceEeeeccEEEEEEEE----cCCcEEEEEEcccC----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGML----EDGKIVAVKKSKII----DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++||+|+||.||++.. .+++.||||.++.. .......+.+|+.+|++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 35789999987642 223445678999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... .+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999987643 5788888999999999999999998 9999999999999999999999999987543222
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ..+..+. .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~-~~~~~~~----------~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TI-DKILKGK----------L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCC----------C
Confidence 12334568999999999999889999999999999999999999996543221 11 1111111 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
..+......+.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11223345689999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.08 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=207.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.++|+..+.||+|+||.||++... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888899999999999999875 78899999876544 5678999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999999976532 25899999999999999999999998 9999999999999999999999999998663221
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.....+..|+|||++....++.++||||||++++||++ |..||......+ +. .....+ ...
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~ 218 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVEKG---------YRM 218 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhcC---------CCC
Confidence 12335678999999998899999999999999999997 999986443221 11 111111 011
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
..+...+..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.58 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=207.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.+|...++||+|+||+||++... ++..+|+|.++.......+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999742 356899999887777778899999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 452 VYEFISNGTLSQYIDDQNK------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999876432 125889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHH
Q 047038 520 KVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 597 (708)
||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |++||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H----
Confidence 999999987654322211 222335778999999999999999999999999999998 9999854332211 1
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
.....+. ....+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111110 011122334568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.34 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=198.2
Q ss_pred eEeeeccEEEEEEEEc---CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 385 ILGQGGQGTVYKGMLE---DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
.||+|+||+||+|.++ +++.+|+|+++... ....++|.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999876532 345678999999999999999999999875 45678999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce--
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL-- 537 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~-- 537 (708)
+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 5899999999999999999999998 9999999999999999999999999998764333221
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~---------~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGER---------ME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC---------CC
Confidence 122234678999999988889999999999999999998 999996443221 1111221111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
.+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1223446689999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.38 Aligned_cols=265 Identities=24% Similarity=0.415 Sum_probs=210.6
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcC--------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLED--------GKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCC 443 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 443 (708)
+....+|++.+.||+|+||.||++.... ...||+|..+.. .....+++.+|+++++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3344578899999999999999997421 236899987753 344567899999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
.+.+..+++|||+++|+|.+++.... ....+++.+++.++.|++.||.|||+.+ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999987532 1235889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcch
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~ 588 (708)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987654322111 222334568999999999999999999999999999998 889986543222
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
+...+..... ...+......+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 245 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -------LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111111111 1112233456899999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.02 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=208.3
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLET 446 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 446 (708)
+...++|++.++||+|+||.||+|..+ .+..||+|.++... ......+.+|+.+++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456778999999999999999999754 24579999876533 33455788999999999999999999999999
Q ss_pred CcceEEEEeccCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNK-------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 234577888999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHH
Q 047038 520 KVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 597 (708)
||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||.....++ ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~---- 231 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL---- 231 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----
Confidence 999999988654322211 122345678999999999999999999999999999998 788986533221 11
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..+..+.. ...+...+..+.+++.+||+.+|++|||+.++++.|+....
T Consensus 232 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 232 KFVMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11111110 01122234679999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.03 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=203.4
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
++....++|+..++||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999975 578999998754 22334556889999999999999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999998653 4788899999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCccccccC----CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSS----HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+..............||+.|+|||++... .++.++||||||++||||++|+.||....... .+...+...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~ 263 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHK 263 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC
Confidence 87643332223456799999999998754 37899999999999999999999996543221 111111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIE 649 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 649 (708)
.. +...........+.+++.+||+.++.+ ||++.|+++.
T Consensus 264 ~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 000111233566889999999865543 8899998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.24 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=211.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||.||+|... +++.||+|.++. .+....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 789999998754 23444678999999999999999999999999999999999
Q ss_pred EeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
||+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2345899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .... ......+..
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~------- 225 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKCDY------- 225 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcCCC-------
Confidence 221 122345888999999999888999999999999999999999998643311 1111 111111111
Q ss_pred hhccCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 613 ILKEGG-KDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 613 ~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
...+ ......+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 134456899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=322.32 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=208.6
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
...++|++.+.||+|+||.||++...++..+|+|.++.. ....+.|.+|+.++++++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345678899999999999999999877888999987753 3345789999999999999999999999887 77899999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999997643 236889999999999999999999988 9999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
........++..|+|||++....++.++|+||||+++++|++ |+.||........ ...+..+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~--------- 220 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGY--------- 220 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhCCC---------
Confidence 222223345678999999998889999999999999999999 9999864332211 11111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
..+.....+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0111223445689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.86 Aligned_cols=262 Identities=25% Similarity=0.428 Sum_probs=210.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc--------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE--------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 445 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 445 (708)
..++|.+.+.||+|+||.||+++.. ++..||+|..... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888899999999999999742 2457999988643 345567899999999999 89999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIl 512 (708)
....++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999976421 235788999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhh
Q 047038 513 LDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDK 590 (708)
Q Consensus 513 l~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~ 590 (708)
+++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 9999999999999998764322221 223346778999999998889999999999999999998 888885433221
Q ss_pred hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
....+..+.. ...+...+..+.+++.+||+.+|++||++.||++.|+++...
T Consensus 248 -----~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 -----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -----HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111 111223446689999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.41 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=209.3
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 445 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 445 (708)
+...++|...+.||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 334467999999999999999999742 34579999887543 44557899999999999 79999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.+..++||||+++|+|.++++.... ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999976432 24899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 526 ASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 526 ls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+. +......+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcC
Confidence 99865433221 1222346778999999999999999999999999999998 9999865433221 11111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
.....+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus 261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111122345699999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=327.50 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=202.2
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
+|+..++||+|+||+||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999965 68899999886422 2234567899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886542 235899999999999999999999998 9999999999999999999999999988654322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||......... ..+...+... .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------Q 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------c
Confidence 1 23346899999999999889999999999999999999999999754332111 1111111110 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
...+...+..+.+|+.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 112233456689999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.67 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=204.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc--EEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK--IVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
++|++.+.||+|+||.||+|.++ ++. .+|+|.++.. .....+.|.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999965 454 4688876643 344567899999999999 899999999999999999999
Q ss_pred EEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 453 YEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
|||+++++|.++++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975431 235889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHH
Q 047038 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 598 (708)
||+|||+++..... .......++..|+|||++....++.++||||||++++||+| |..||......+. . .
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y----E 234 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H----H
Confidence 99999998643211 11111234668999999988889999999999999999998 9999964432211 1 1
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+... ...+.+...+..+.+|+.+||+.+|++||++.++++.|+++..
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 0111122234568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=302.12 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=206.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|-||.||.|+.+ ++-.||+|++.... ..-..++.+|++|-+.|+||||+++|++|.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 457889999999999999999965 67889999876522 23346799999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
+||..+|.|...|.+... .++++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999986543 36888888999999999999999998 9999999999999999999999999886543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
........||..|++||...+...+.++|+|++|++.||++.|.+||......+. . ..+.. .++
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---Y----krI~k---~~~---- 239 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---Y----KRIRK---VDL---- 239 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---H----HHHHH---ccc----
Confidence 2223456799999999999999999999999999999999999999964432211 1 11111 111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+.......+++|.+|+..+|.+|.+..||++.
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1123445668999999999999999999999753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.58 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=201.1
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----cce
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 450 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 450 (708)
+|+..++||+|+||+||++... +++.||||++... +....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 7899999987642 3345678999999999999999999999998776 789
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 47777775432 5899999999999999999999998 999999999999999999999999999865
Q ss_pred CcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh---
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF--- 606 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--- 606 (708)
............+|+.|+|||.+.+. .++.++||||||++++||++|+.||............ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHH
Confidence 44333333445689999999998774 5789999999999999999999999765433221111 1111000000
Q ss_pred -------hhhhhh--------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 607 -------EILDAQ--------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 607 -------~~~d~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+... ..........+.+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0001112234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.68 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=204.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.+|++.+.||+|+||+||+|... +++.||+|+++.... ...+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677789999999999999864 257899999876433 33567899999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 451 LVYEFISNGTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
+++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1235888999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHH
Q 047038 518 CAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 595 (708)
.+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999886543221 11233446789999999988889999999999999999998 888886433221
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
....+..... ...+...+..+.+|+.+||+.+|++||+++||+..|+.
T Consensus 235 ~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 11123345668999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.65 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=198.4
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.|+..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++|+|||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888899999999999999964 6889999998652 33456679999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987653 5889999999999999999999998 9999999999999999999999999976431100
Q ss_pred c----------------------------------------------ceeecccccccccCccccccCCCCccchhHhHH
Q 047038 535 T----------------------------------------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFG 568 (708)
Q Consensus 535 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlG 568 (708)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHh--cccCCCCCCCHHHH
Q 047038 569 VVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRC--LNLNGKKRPTMREV 646 (708)
Q Consensus 569 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~c--l~~~p~~RPt~~ev 646 (708)
|++|||++|+.||......+.. ......... ...........++.+|+.++ +..++..||+++|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999754432211 011100000 00001112345678888884 45566669999999
Q ss_pred HHH
Q 047038 647 GIE 649 (708)
Q Consensus 647 ~~~ 649 (708)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=323.23 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=206.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-C---CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-D---GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.+|++.+.||+|+||.||+|... + +..+|+|.++.. .....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888899999999999999864 2 347999988653 244567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976532 5899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccee--ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 DQTHLT--TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... ....++..|++||++.+..++.++||||||++++|+++ |..||......+ . ...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~----- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY----- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC-----
Confidence 332222 12223568999999998899999999999999999887 999986443221 1 11111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
........+..+.+++.+||+.+|++||+|.++++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011223345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=320.88 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=197.3
Q ss_pred eEeeeccEEEEEEEEc---CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 385 ILGQGGQGTVYKGMLE---DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
.||+|+||.||+|.+. .+..||+|.+.... ....+.|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 35579999887643 334567999999999999999999999875 457899999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee--
Q 047038 461 LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT-- 538 (708)
Q Consensus 461 L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~-- 538 (708)
|.+++..... .+++..+++++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....+.....
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999875432 5899999999999999999999998 99999999999999999999999999986543322211
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
....++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+..+. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGK---------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC---------CCCC
Confidence 11223578999999998889999999999999999997 999996543221 111111111 1112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
+...+..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 233456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.65 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=204.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHH--HHHHHHHHHHHHhcCCCceeeeeceEee--CCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESK--VEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 451 (708)
.+.|+..+.|++|.||.||+|+++ +++.||+|+++...+.. --.-++||.+|.+.+|||||.+-.+..- -+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 346778899999999999999965 68999999988643221 2246899999999999999999888764 346899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||++. +|..+++... .++...++..+..|+++|++|||... |+|||||++|+|+.+.|.+||+||||||.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999987 8999998765 36888999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
... ...+..+-|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+....++.+..-.......+..+..+..
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 442 33556668999999999887 4699999999999999999999999977654433222222111111111111111
Q ss_pred --------------hhhhccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 --------------AQILKEGGKD-EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 --------------~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...+... ..+.-.+|+..+|..||.+|.|++|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0111111111 2355678999999999999999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.22 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=207.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.++|.+.+.||+|+||.||+|...+ ++.||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998652 3689999986543 34566899999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEe
Q 047038 450 LLVYEFISNGTLSQYIDDQNK-------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~ 522 (708)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999875432 124789999999999999999999988 9999999999999999999999
Q ss_pred eccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHh
Q 047038 523 DFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 523 DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~----~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VL----KFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HH----HHH
Confidence 99998765433221 1233446789999999998889999999999999999998 999986433222 11 111
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
..+.. ...+...+..+.+++.+||+.+|++|||+.|++..|+.
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 11122235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.36 Aligned_cols=244 Identities=27% Similarity=0.363 Sum_probs=195.0
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHH---HhcCCCceeeeeceEeeCCcceEE
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVIL---SQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
|++.+.||+|+||+||++... +++.||||.++.. .....+.+.+|++++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 6899999998642 233445677777665 466899999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|..+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888643 5899999999999999999999998 99999999999999999999999999875332
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. . ..+....
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~-~~i~~~~-------- 217 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------F-DSIVNDE-------- 217 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhCC--------
Confidence 21 123345689999999999999999999999999999999999999975432211 1 1111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
...+...+..+.+++.+||+.||++||+ +.++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0112233456889999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=328.56 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=204.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC---------------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeee
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED---------------GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLL 440 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~ 440 (708)
.++|++.+.||+|+||.||++.... ...||+|.++.. .....+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578899999999999999987542 235899988653 344566899999999999999999999
Q ss_pred ceEeeCCcceEEEEeccCCCccccccccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNK---------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 441 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999865321 124788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh--CCCCCCCCCcch
Q 047038 512 LLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT--GERPIRLTNSEE 588 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt--g~~P~~~~~~~~ 588 (708)
++++++.+||+|||++.......... .....++..|+|||++....++.++||||||++++||++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999987654322211 222345778999999998899999999999999999998 667776443322
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
.......+ .... ........+...+..+.+|+.+||+.+|++||++.+|++.|++
T Consensus 241 ~~~~~~~~---~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEF---FRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHh---hhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111 1100 0000011122234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.79 Aligned_cols=242 Identities=22% Similarity=0.288 Sum_probs=196.9
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
+.||+|+||+||++... +++.||+|.++.. .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6899999987652 2345567889999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
+|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9998887543 58999999999999999999997 67 99999999999999999999999999875432221 22
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.....++.. ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-------~~i~~~~----------~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEE----------IRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-------HHHhcCC----------CCCC
Confidence 3456999999999999999999999999999999999999999654322110 1111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRP-----TMREVGIE 649 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 649 (708)
......+.+++.+||+.||++|+ +++++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22345688999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=324.95 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=205.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.++|+..++||+|+||+||+|.+. +++ .||+|.++.. .....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356788899999999999999853 444 4899988653 34456789999999999999999999999875 4578
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+++||+++|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999976432 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 531 AVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 531 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... +.. .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~--- 229 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD----LLEKGER--- 229 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCc---
Confidence 5332221 122335678999999999999999999999999999998 999986433221 111 1111110
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...+..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 230 ------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11122334568899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=322.66 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=209.8
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||.||++.. .+++.+|||.+.. .+....++|.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 4789999998754 23345578999999999999999999999999999999999
Q ss_pred EeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887432 2346899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||....... .... ..+.... .+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~~-----~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC----KKIEQCD-----YPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHh----hhhhcCC-----CCC
Confidence 221 1233458899999999998889999999999999999999999986433211 1111 1111100 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 ---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011234567999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.50 Aligned_cols=246 Identities=27% Similarity=0.326 Sum_probs=204.7
Q ss_pred cCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
+.|+..+.||.|.-|+||++.+++ +..+|+|++... ......+...|-+||+.++||.++.||+.++.++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778899999999999999874 588999988653 3455667788999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc-
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV- 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~- 532 (708)
|||+||+|..+++++.. ..+++..+..++.+|+-||+|||..| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999988754 47999999999999999999999999 99999999999999999999999999754311
Q ss_pred --------------------------------CCc----------------------ceeecccccccccCccccccCCC
Q 047038 533 --------------------------------DQT----------------------HLTTQVQGTFGYLDPEYFQSSHF 558 (708)
Q Consensus 533 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 558 (708)
... ..+..++||-.|+|||++.+..-
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01223679999999999999999
Q ss_pred CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCC
Q 047038 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGK 638 (708)
Q Consensus 559 t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~ 638 (708)
+.++|.|.|||+||||+.|..||.+.+.++. +..++-..+.-......+....+||++.|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999988776542 2222222222222335567799999999999999
Q ss_pred CCCC
Q 047038 639 KRPT 642 (708)
Q Consensus 639 ~RPt 642 (708)
+|.-
T Consensus 378 kRlg 381 (459)
T KOG0610|consen 378 KRLG 381 (459)
T ss_pred hhhc
Confidence 9987
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.88 Aligned_cols=249 Identities=26% Similarity=0.421 Sum_probs=205.7
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|...+.||+|++|.||++... +++.|++|.+.. ......+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999975 688999998764 3455677899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.++++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998652 236899999999999999999999988 99999999999999999999999999886543322
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......|++.|+|||++.+..++.++||||||++++||++|+.||......+ .. .....+. ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~---------~~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LI----LKIIRGV---------FP 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCC---------CC
Confidence 2233458899999999999999999999999999999999999996544211 11 1111111 11
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 112234466899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=333.81 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=196.9
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +++.||+|.++.. .....+.+..|+.+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 6889999988752 234456788999999998 799999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99998886543 5999999999999999999999998 9999999999999999999999999987432111 123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch--hhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--DKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34568999999999999999999999999999999999999996433221 11111122222211111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPT------MREVG 647 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~ 647 (708)
.+......+.+++.+||+.||.+||+ +++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 12233456899999999999999998 56664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.37 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=200.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..++||+|+||+||++... +++.||||++... .......+.+|+.+|+.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 6899999998652 2344567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 5899999999999999999999998 999999999999999999999999998754321
Q ss_pred Ccc-------------------------------------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh
Q 047038 534 QTH-------------------------------------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576 (708)
Q Consensus 534 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt 576 (708)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112458999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 047038 577 GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT---MREVGI 648 (708)
Q Consensus 577 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~ 648 (708)
|..||......+. .......... +.........+.+.+|+.+|+. +|.+|++ ++|+++
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWKET-------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCc-------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999975432211 1111110000 0000011234568899999996 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.30 Aligned_cols=261 Identities=24% Similarity=0.425 Sum_probs=208.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc--------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE--------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 445 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 445 (708)
..++|.+.+.||+|+||.||+++.. ....+|+|.++.. ......++.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467888999999999999999742 2457899987753 344567899999999999 69999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIl 512 (708)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 9999999999999999999965421 235899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhh
Q 047038 513 LDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDK 590 (708)
Q Consensus 513 l~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~ 590 (708)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998654322111 122234567999999998899999999999999999999 899986443221
Q ss_pred hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+...+..+.. ...+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 245 -----~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 -----LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -----HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111111 11122334568899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=340.67 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=198.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.++||+|+||+||++... +++.||||.+... .....+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 7899999987542 2344567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997543 5889999999999999999999998 999999999999999999999999998643210
Q ss_pred Cc----------------------------------------------ceeecccccccccCccccccCCCCccchhHhH
Q 047038 534 QT----------------------------------------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSF 567 (708)
Q Consensus 534 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~Sl 567 (708)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 047038 568 GVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKR---PTMR 644 (708)
Q Consensus 568 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ 644 (708)
||++|||++|+.||......+. +......... +...........+.+++.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~-------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET------YRKIINWRET-------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH------HHHHHccCCc-------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999965443221 1111110000 0000011234568899999997 67765 5999
Q ss_pred HHHHH
Q 047038 645 EVGIE 649 (708)
Q Consensus 645 ev~~~ 649 (708)
|++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=326.70 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=206.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..++|+..+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567899999999999999999863 46789999887543 3445679999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 047038 449 PLLVYEFISNGTLSQYIDDQNK-------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKST 509 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~ 509 (708)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 9999999999999999974321 124788999999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcc
Q 047038 510 NILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSE 587 (708)
Q Consensus 510 NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~ 587 (708)
|||+++++.+||+|||+++........ .......+..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765322211 1222334678999999998999999999999999999998 88888543322
Q ss_pred hhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
+ ....+..+... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E-------VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 11111111111 1122334669999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=332.89 Aligned_cols=243 Identities=25% Similarity=0.400 Sum_probs=193.7
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 6789999988652 334556788899998877 899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|..++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 99998886543 5899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch--hhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--DKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34568999999999999999999999999999999999999996432211 11111222222211111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
.+......+.+++.+||+.||++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 123334568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=317.33 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=205.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh--HHHHHHHHHHHHHHhcCCCc-eeeeeceEeeCC------
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRN-VVKLLGCCLETE------ 447 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------ 447 (708)
..|...++||+|+||+||+|+.. +|+.||+|++....+ .-....++|+.+|++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666678999999999999954 789999999877433 23456789999999999999 999999999877
Q ss_pred cceEEEEeccCCCccccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
..++|+||++. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999975 999999876532 34677889999999999999999999 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH--HHhhhc
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL--RAMRED 603 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~ 603 (708)
++........ .+..++|..|.|||++.+. .|+...||||+||+++||+++++-|.+..+.+ ++...|. ....+.
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCcc
Confidence 9976644332 4556689999999999876 79999999999999999999999887665422 2222221 111112
Q ss_pred hhhhhh---hhh--hhccC-CH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 604 RLFEIL---DAQ--ILKEG-GK-------DEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 604 ~~~~~~---d~~--~~~~~-~~-------~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.+.... +-. ..... .. .......+++.+||+.+|.+|.|++.++.+
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 221111 000 00000 11 111367899999999999999999998765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=338.78 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=197.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||+||++... +++.||||.++.. .....+.+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999865 5889999988642 2334567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 5899999999999999999999998 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCC
Q 047038 534 QT----------------------------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGER 579 (708)
Q Consensus 534 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~ 579 (708)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123569999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 047038 580 PIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLN--LNGKKRPTMREVGIE 649 (708)
Q Consensus 580 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~ev~~~ 649 (708)
||......+. +.......... .+. . .......+.+++.+++. .++..||+++||++.
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~-~~p----~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQET------YKKVMNWKETL-IFP----P--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHH------HHHHHcCcCcc-cCC----C--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9975443221 11111100000 000 0 11123457778877654 233456899999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.41 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=207.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.++|...++||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567888999999999999998653 2468999877644 5566789999999999999999999998875 56789
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 5899999999999999999999998 9999999999999999999999999988665
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
...........++..|+|||.+....++.++||||||++++||++ |..||......+. ... +..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~~----- 226 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IENGER----- 226 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCCc-----
Confidence 443322333345678999999988889999999999999999996 9999965433221 111 111100
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...+..+.+++.+|+..+|++|||+.++++.|+.++.
T Consensus 227 ----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 227 ----LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01122334579999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.65 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=201.8
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEe-eCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 456 (708)
++|+..+.||+|+||.||++... ++.||+|..+.. ...+.|.+|+.++++++|+|++++++++. +.+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999865 778999987643 34567999999999999999999999765 456789999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999876432 35889999999999999999999998 9999999999999999999999999987543221
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
....++..|+|||++....++.++||||||+++|||++ |+.||......+ +. ..+..+. ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~----~~~~~~~---------~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGY---------KM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCC---------CC
Confidence 22335678999999998899999999999999999998 999986432211 11 1111110 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11223456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.88 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=189.0
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||+++.. +++.||+|.+... ......++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 6889999987642 2233445666654 67889999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 99988886543 5888889999999999999999998 999999999999999999999999998753221 1223
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+... .. ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~-~~i~~~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MY-DNILHKP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HH-HHHhcCC----------CCCC
Confidence 34568999999999999899999999999999999999999996543211 11 1111110 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMR 644 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ 644 (708)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23445689999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.60 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=197.7
Q ss_pred ceEeeeccEEEEEEEEcC-Cc--EEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLED-GK--IVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~-~~--~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||.||+|.+.+ +. .+|+|.++. ......+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 468888775 3345567899999999999 899999999999999999999999999
Q ss_pred CCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 459 GTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 459 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999987542 1124789999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+++..... ........+..|+|||++....++.++||||||++++||++ |..||......+ .. ..+..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~- 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY----EKLPQG- 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HH----HHHhCC-
Confidence 98633211 11111223567999999988899999999999999999997 999986432211 11 111111
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
...+........+.+|+.+||+.+|.+|||+.|+++.|+++.
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011112223456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.41 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=203.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999964 68999999875422 2234678999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987653 5889999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCccee--ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHLT--TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~------- 222 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQ------- 222 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhcc-------
Confidence 2211111 234578899999999998899999999999999999999999864322111 0011100
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
......+......+.+++.+||+.+|++|||+.|+++.
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 --PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111223344568999999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.35 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=207.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-----------------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceee
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-----------------GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVK 438 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~ 438 (708)
.++|++.+.||+|+||.||++...+ +..||+|.+... .....++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678899999999999999988542 246899987753 3455678999999999999999999
Q ss_pred eeceEeeCCcceEEEEeccCCCccccccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNK--------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 439 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
+++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999876431 125899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh--CCCCCCCCCcc
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT--GERPIRLTNSE 587 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt--g~~P~~~~~~~ 587 (708)
|++++++.+||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543222 12233456788999999998889999999999999999998 67777543321
Q ss_pred hhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
+ .........+.... ......+...+..+.+++.+||+.+|++|||+.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q---VIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 11111111111110 00111122334679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=330.21 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=200.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|...+.||+|+||+||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999887533 23345688999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 88887765432 5788999999999999999999998 99999999999999999999999999876433221
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh------
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI------ 608 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 608 (708)
......+|+.|+|||.+.+ ..++.++||||||++++||++|+.||......+................+..+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999998865 56899999999999999999999999765543322221111100000000000
Q ss_pred hhhhhhc-------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILK-------EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+..... .........+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 001123456889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.74 Aligned_cols=255 Identities=26% Similarity=0.458 Sum_probs=204.5
Q ss_pred cCCcccceEeeeccEEEEEEEEcC-C---cEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED-G---KIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
..|++.+.||+|+||.||+|.... + ..||||.++.. .....++|..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999753 3 36999998754 455677899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999976532 5899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcce--eeccc--ccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 533 DQTHL--TTQVQ--GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 533 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..... ..... .+..|+|||++....++.++||||||+++|||++ |..||......+ +...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~~--- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQDY--- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---
Confidence 22111 11111 2457999999999999999999999999999987 999986443221 111111110
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
....+.+.+..+.+++.+||+.+|++||++++|+..|+.+
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011223345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=330.97 Aligned_cols=238 Identities=25% Similarity=0.369 Sum_probs=191.9
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||+|... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999987642 234455667777777754 899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999887643 5899999999999999999999998 9999999999999999999999999997543222 223
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~----~~i~~~~----------~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LF----DSILNDR----------PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCC----------CCCC
Confidence 34568999999999999899999999999999999999999997543221 11 1111110 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~e 645 (708)
......+.+++.+||+.+|++||++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 223456889999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=338.67 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=205.7
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
..+++...++|++.+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999976 678999998754 223345568899999999999999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998653 4788889999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccC----CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS----HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+++..............||+.|+|||++... .++.++||||||+++|||++|+.||....... .+...+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 9987654333333456799999999998754 37899999999999999999999997543221 1111111
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIEL 650 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~L 650 (708)
......+ .........+.+++.+||+.++.+ ||+++|+++..
T Consensus 262 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110000 111234566889999999844433 78888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.29 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=206.1
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
|++.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45667778888889999999999999955 67889999887766677788999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccCCcc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRS 529 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~~ 529 (708)
+|+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999986533222378888999999999999999998 999999999999986 67999999999876
Q ss_pred cCcCCcceeecccccccccCccccccCC--CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
...... ......+++.|+|||++.... ++.++||||||+++++|++|+.||......... .......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~~~------ 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVGMF------ 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hhhhhhh------
Confidence 532221 122345789999999987643 789999999999999999999998643221110 0000000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......+......+.+++.+||+.+|++|||+.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011122334456899999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.81 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=203.0
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
.+|+..+.||+|+||.||++.+.+++.+|+|.+.... ...++|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677789999999999999998778899999876432 234578999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999876432 5789999999999999999999998 9999999999999999999999999987654322211
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+. ...
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF---------RLY 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC---------CCC
Confidence 222335678999999998899999999999999999998 999986433221 111111110 000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
.+...+..+.+|+.+||+.+|++||++.|++++|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1112346699999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.77 Aligned_cols=238 Identities=28% Similarity=0.390 Sum_probs=193.7
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +++.||||.++.. .....+.+..|+.+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5889999987642 234556788899999876 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999887653 5899999999999999999999998 9999999999999999999999999987543222 123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCC----------CCC
Confidence 345689999999999999999999999999999999999999975443221 111111110 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~e 645 (708)
......+.+++.+||+.||++||++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 223456889999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=341.17 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=198.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||++... +++.||||.+.... ....+.+.+|+.+|++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999965 68899999876422 234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997653 5888899999999999999999998 999999999999999999999999997532100
Q ss_pred C------------------------------------------cceeecccccccccCccccccCCCCccchhHhHHHHH
Q 047038 534 Q------------------------------------------THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVL 571 (708)
Q Consensus 534 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl 571 (708)
. ........||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 047038 572 VELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP---TMREVGI 648 (708)
Q Consensus 572 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~ev~~ 648 (708)
|||++|+.||......+... ....... .............+.+++.+|+ .+|++|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~------~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL------KVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH------HHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999997554322111 0000000 0000111123455778888876 5999999 8888875
Q ss_pred H
Q 047038 649 E 649 (708)
Q Consensus 649 ~ 649 (708)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.91 Aligned_cols=270 Identities=24% Similarity=0.291 Sum_probs=203.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----cce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 450 (708)
+-.|...+++|.|+||.||+|.+. +++.||||+.-.... .-.+|+++|+.+.|||||+|+-+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345777899999999999999965 578999998754322 2246899999999999999999887432 245
Q ss_pred EEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeeccCCc
Q 047038 451 LVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGASR 528 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGls~ 528 (708)
||||||+. +|.+.++... .+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 8998887421 2336888888889999999999999988 9999999999999976 999999999999
Q ss_pred ccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh-
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF- 606 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 606 (708)
.+..+... ....-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....++-............+.+.
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 87655443 44557889999999877 569999999999999999999999998755444322222222111111111
Q ss_pred ------hhhhhhhhcc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHccccc
Q 047038 607 ------EILDAQILKE-----GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI--ELTGIRGC 656 (708)
Q Consensus 607 ------~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~--~L~~l~~~ 656 (708)
+...+.+... .......+..+|+.++|+.+|.+|.++.|++. .++.++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111111111 23445577899999999999999999999873 45666653
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.58 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=204.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-----------------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceee
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-----------------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVK 438 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~ 438 (708)
.++|++.+.||+|+||+||++... +...||+|.++.. .....++|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357889999999999999998532 2346899998753 3445678999999999999999999
Q ss_pred eeceEeeCCcceEEEEeccCCCccccccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNK--------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 439 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
+++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999876431 124788899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh--CCCCCCCCCcc
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT--GERPIRLTNSE 587 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt--g~~P~~~~~~~ 587 (708)
||+++++.+||+|||+++.+....... .....++..|++||....+.++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999988654322211 122334678999999888889999999999999999998 77887543332
Q ss_pred hhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
+.. ............ ......+...+..+.+|+.+||+.||++||++.||.+.|++
T Consensus 241 ~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVI---ENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH---HHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211 111111111000 00011122334678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.63 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=195.3
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||+|+||+||++... +++.||+|.+.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 68899999876422 23346788999999999999999999999999999999999999999
Q ss_pred cccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeec
Q 047038 462 SQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540 (708)
Q Consensus 462 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~ 540 (708)
.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 98875432 2346899999999999999999999998 99999999999999999999999999876543222 2334
Q ss_pred ccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHH
Q 047038 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620 (708)
Q Consensus 541 ~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 620 (708)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......... . ...... .... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~-~~~~~~--------~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--K-ELKQRI--------LNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--H-HHHHhh--------cccC--CCCccc
Confidence 56899999999999999999999999999999999999999754322110 0 000000 0000 011233
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 621 EFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 621 ~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.+..+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 456689999999999999999 5566653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=333.28 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=210.8
Q ss_pred ccceEeeeccEEEEEEEEc--CCc--EEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 382 TNRILGQGGQGTVYKGMLE--DGK--IVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~--~~~--~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
..++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....||+|+.
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999986 354 5899999875544 67899999999999999999999999988 7889999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
+.|+|.+.|++. ....+.......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.+.+.....+
T Consensus 193 plGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999983 3446778888899999999999999998 999999999999999999999999999988654433
Q ss_pred e-ee-cccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 537 L-TT-QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 537 ~-~~-~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .. ...-..-|+|||.+....++.++|||+|||+||||+| |..||.+.... .+.+.+|..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccccc
Confidence 3 22 2234567999999999999999999999999999999 99999764432 2334444444
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
+...++..++.+.+++++||..+|++|||+..|.+.+-.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 445578888999999999999999999999999755433
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.73 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=195.7
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCC-ceeeeeceEeeCCcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHR-NVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 453 (708)
+|++.+.||+|+||.||+|... +++.||||.++.. .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 5789999987642 334567788999999999765 6888999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887543 5889999999999999999999998 999999999999999999999999998753222
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . ..+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~----~~i~~~~--------- 217 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F----QSIMEHN--------- 217 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H----HHHHcCC---------
Confidence 1 123345689999999999999999999999999999999999999975432211 1 1111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
...+......+.+++.+||+.+|.+|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122334568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.69 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=204.6
Q ss_pred cCCcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccc
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 449 (708)
..|++.+.||+|+||.||++.. .+++.||+|.++... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567889999999999999984 257889999987543 44557899999999999999999999998875 567
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999865432 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch--------hhhHHHHHHHH
Q 047038 530 IAVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--------DKSLAAYFLRA 599 (708)
Q Consensus 530 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~--------~~~~~~~~~~~ 599 (708)
....... ......++..|+|||++.+..++.++||||||++++||++++.|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 1223456778999999998889999999999999999999877643211100 00000111111
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
+..+ .........+..+.+|+.+||+.+|++||+++++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 01111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=340.15 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=196.4
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
+|+..++||+|+||+||+|... +++.||+|.+... .....+.+.+|+.++++++|+|||++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 6889999987642 23445678999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987653 5888899999999999999999998 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------cceeecccccccccCccccccCCCCccchhHhHH
Q 047038 535 ----------------------------------------------THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFG 568 (708)
Q Consensus 535 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlG 568 (708)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 047038 569 VVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT---MRE 645 (708)
Q Consensus 569 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e 645 (708)
|+||||++|+.||......+.. ....... ................+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ------MKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH------HHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999999754432211 0001000 00000111223455778888876 59999997 777
Q ss_pred HHH
Q 047038 646 VGI 648 (708)
Q Consensus 646 v~~ 648 (708)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.64 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=195.9
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 5789999998752 234556788999999988 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|..++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99998886543 5899999999999999999999998 9999999999999999999999999987532211 123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||++||||++|+.||..................+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3456999999999999999999999999999999999999999754433222222222222221110 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMR 644 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ 644 (708)
......+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23345688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.86 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=205.0
Q ss_pred hccCCcccceEeeeccEEEEEEEE------cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC-
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKIID-ESKVEEFINEVVILSQI-NHRNVVKLLGCCLET- 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~- 446 (708)
..++|++.++||+|+||+||+|.. .+++.||||+++... ......+.+|+.+|.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346799999999999999999973 357889999987532 34556789999999999 789999999988654
Q ss_pred CcceEEEEeccCCCccccccccCC--------------------------------------------------------
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNK-------------------------------------------------------- 470 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 470 (708)
...++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998864321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-eecc
Q 047038 471 --------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL-TTQV 541 (708)
Q Consensus 471 --------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~ 541 (708)
...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123688899999999999999999998 9999999999999999999999999987653322211 1223
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 620 (708)
.++..|+|||.+.+..++.++||||||+++|||++ |..||......+. +...+..+... ..+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCC---------CCCCC
Confidence 45678999999998899999999999999999997 9999865432211 11111111110 01111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 621 EFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 621 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23468899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.54 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=199.0
Q ss_pred ceEeeeccEEEEEEEEcC----CcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLED----GKIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.++++++|+|||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899998875433 35678999999999999999999999876 4567999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998654 5899999999999999999999998 99999999999999999999999999986643332211
Q ss_pred --ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 539 --TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 539 --~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
....++..|+|||.+....++.++||||||+++|||++ |..||......+ ... .+..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~----~~~~~~~---------~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIA----MLESGER---------L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHHcCCc---------C
Confidence 12224568999999998899999999999999999998 999986433211 111 1111110 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
..+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 112233456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.54 Aligned_cols=252 Identities=33% Similarity=0.535 Sum_probs=201.3
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHH--HHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVE--EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
|+..+.||+|+||+||++... +++.+|+|.+......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999976 5678999998876544433 4567999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++.... .+++..++.++.|+++||.+||+.+ |+|+||||+||++++++.++|+|||++.... ....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 9999999998332 5899999999999999999999998 9999999999999999999999999987542 2222
Q ss_pred eeecccccccccCccccc-cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQ-SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||.+. ....+.++||||||+++++|++|..||........... ....... . .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~----~-~~~~~~~ 225 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKR----P-LPSSSQQ 225 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHT----H-HHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccc----c-ccccccc
Confidence 344566899999999998 88899999999999999999999999975421111111 1111100 0 0000000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+.+++.+||+.||++||++.++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111267999999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.12 Aligned_cols=267 Identities=22% Similarity=0.343 Sum_probs=196.5
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-------
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET------- 446 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 446 (708)
....+|+..++||+|+||+||+|... +++.||||++.... ....+|+.+|++++|||||++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34568999999999999999999965 68899999875422 2345799999999999999999887532
Q ss_pred -CcceEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEee
Q 047038 447 -EVPLLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSD 523 (708)
Q Consensus 447 -~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~D 523 (708)
...++||||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 135689999985 676666532 12346899999999999999999999998 99999999999999664 799999
Q ss_pred ccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
||+++....... .....||+.|+|||++.+ ..++.++|||||||+||||++|.+||......+. +.. .......
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~ 289 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGT 289 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCC
Confidence 999986543222 233568999999999865 4689999999999999999999999976543321 111 1111100
Q ss_pred ---chhh------------hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHccc
Q 047038 603 ---DRLF------------EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI--ELTGIR 654 (708)
Q Consensus 603 ---~~~~------------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~--~L~~l~ 654 (708)
+.+. .+....+....+...+.++.+|+.+||+.+|.+|||+.|+++ .++.++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000 000001111112223457899999999999999999999983 344443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.97 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=193.8
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||+|+||+||++... +|+.||+|.+.... ......+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 68999999876421 22334567799999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecc
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 541 (708)
.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 98886543 235889999999999999999999998 9999999999999999999999999987654322 22345
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
.|+..|+|||++.+..++.++||||||+++|||++|+.||......... .... ...... ... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~-~~~~~~--------~~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELK-RRTLED--------EVK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHH-HHhhcc--------ccc-cccccC
Confidence 6899999999999988999999999999999999999999644322111 0100 111000 000 001123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
...+.+|+.+||+.||++||+++|++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccch
Confidence 45689999999999999999998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.55 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=200.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||++... +++.||+|.+.. ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 678899998764 22334556889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976432 5889999999999999999999998 999999999999999999999999999876544
Q ss_pred CcceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.........||+.|+|||++.+ ..++.++||||||++||||++|+.||......+ .............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-
Confidence 3333334569999999999875 567889999999999999999999996443221 1111111110000
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIE 649 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 649 (708)
. .......++.+.+++.+||...+++ |++++++++.
T Consensus 229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0111223466889999999866544 4678887643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.92 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=199.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||++... +++.||+|.+.. ......+.|.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 588999998764 22344567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997543 25889999999999999999999998 999999999999999999999999998765433
Q ss_pred CcceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+ .............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence 3322333568999999999863 457889999999999999999999996433221 11111111110000
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGK--KRPTMREVGIE 649 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~ev~~~ 649 (708)
.......+..+.+++.+||..+++ .||+++++++.
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001112345688899998865443 37899988755
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.28 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=203.0
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999996 46889999998765555566788999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.++++... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999987543 5899999999999999999999998 99999999999999999999999999986532211
Q ss_pred ceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
......++..|+|||.+. ...++.++||||||++++||++|+.||......+.. . .+...... .+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~-~~~~~~~~---~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMSKSNFQ---PPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------e-eeecCCCC---CCC
Confidence 123345889999999884 345788999999999999999999998533221110 0 00000000 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
. ......+..+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00122346789999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.27 Aligned_cols=237 Identities=24% Similarity=0.349 Sum_probs=190.2
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +++.||+|.+... .....+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 6899999987642 2223445566655 56789999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 99999887643 5889999999999999999999998 999999999999999999999999998753222 1223
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .... +..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~-i~~~~~----------~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDN-ILNKPL----------RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHH-HHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999996543221 1111 111100 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMR 644 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ 644 (708)
......+.+++.+||+.||++||+++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22356689999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.66 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=195.9
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 453 (708)
+|+..+.||+|+||+||+|... +++.||||.++.. .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999966 5789999987642 233455678888888877 5899999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998887543 5889999999999999999999998 999999999999999999999999998754322
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .......||+.|+|||++....++.++||||||+++|||++|+.||......+ +.. .+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~----~i~~~~--------- 217 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ----SIMEHN--------- 217 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCC---------
Confidence 2 12334568999999999999999999999999999999999999997543221 111 111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
...+......+.+++.+||+.+|++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122344568999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.20 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=199.5
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
|+..++||+|+||+||++... +++.||+|.+.... ....+.+.+|+++|++++|+||+++++++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999965 68899999876432 23345678999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988875432 35999999999999999999999998 9999999999999999999999999987653222
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......|+..|+|||++.+..++.++|+||||++++||++|..||........... ......... .
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~----------~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE----------E 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc----------c
Confidence 12334689999999999988999999999999999999999999975433221111 111111100 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
.........+.+|+.+||+.+|++||+ ++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 112233456889999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.16 Aligned_cols=240 Identities=23% Similarity=0.412 Sum_probs=191.5
Q ss_pred ceEeeeccEEEEEEEEcC-------------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 384 RILGQGGQGTVYKGMLED-------------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
+.||+|+||.||+|++.+ ...||+|.+..........|.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258899877655566678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-------EEEee
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC-------AKVSD 523 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~-------~kl~D 523 (708)
+||||+++++|..++..... .+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998875432 5899999999999999999999998 999999999999987654 89999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccc-cCCCCccchhHhHHHHHHHHH-hCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-SSHFTEKSDVYSFGVVLVELL-TGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~SlGvvl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|..||......+.. ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHHh
Confidence 9998654321 2245788999999987 467899999999999999998 588887543322110 0000
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
... .........+.+|+.+||+.||++||++++|++.|+
T Consensus 224 -~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 -GQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -cCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 001122356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.25 Aligned_cols=271 Identities=27% Similarity=0.411 Sum_probs=208.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-----CCcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEee--CCcc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-----DGKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLE--TEVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 449 (708)
..|+..+.||+|+||.||++.+. +++.+|||.++..... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999854 3678999998764443 56789999999999999999999999887 5578
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999976543 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
........ .....++..|++||.+....++.++||||||++++||++|+.|+............. .........+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 65322211 112345667999999998899999999999999999999999985433221100000 000000000111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.+........+...+.++.+|+.+||+.+|++||++.||+++|+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111111112233467999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.00 Aligned_cols=241 Identities=25% Similarity=0.355 Sum_probs=195.4
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||+|+.. +++.||||.++.. .....+.+..|+++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 5789999987652 234556788899999876 799999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 99998887543 5899999999999999999999998 9999999999999999999999999987543222 123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...... +.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~-~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILH-DDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHc-CCC----------CCC
Confidence 345689999999999999999999999999999999999999975443221 111111 110 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRP-------TMREVGI 648 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RP-------t~~ev~~ 648 (708)
......+.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12345688999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.18 Aligned_cols=251 Identities=30% Similarity=0.480 Sum_probs=196.2
Q ss_pred ceEeeeccEEEEEEEEcC----CcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEe-eCCcceEEEEecc
Q 047038 384 RILGQGGQGTVYKGMLED----GKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEFIS 457 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~ 457 (708)
++||+|+||.||+|.+.+ ...||+|++.. ......+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 35799998754 34456778999999999999999999999876 4556899999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976432 4678888999999999999999988 9999999999999999999999999987654321111
Q ss_pred ---eecccccccccCccccccCCCCccchhHhHHHHHHHHHhC-CCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 538 ---TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG-ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 538 ---~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....++..|+|||.+....++.++||||||+++|||++| .+||...... .+... +..+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~----~~~~~~-------- 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY----LLQGRR-------- 220 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HhcCCC--------
Confidence 1233467789999999988999999999999999999995 5666432211 11111 111100
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...+..+.+++.+||+.+|++||++.||+++|+.+..
T Consensus 221 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 -LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111234568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.86 Aligned_cols=238 Identities=26% Similarity=0.317 Sum_probs=194.1
Q ss_pred ceEeeeccEEEEEEEE----cCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 384 RILGQGGQGTVYKGML----EDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
+.||+|+||+||++.. .+|+.||+|.++... ......+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999886522 2344567889999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999986543 5899999999999999999999998 9999999999999999999999999987654322 22
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
.....||+.|+|||.+....++.++||||||+++|||++|+.||......+. . ..+.... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~----~~i~~~~----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---M----TMILKAK----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---H----HHHHcCC----------CCC
Confidence 3345689999999999988899999999999999999999999965432211 1 1111111 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~e 645 (708)
+......+.+|+.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2233456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.34 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=205.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888899999999999999954 6889999988776556667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999998643 4789999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ....... . ..
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~----~~~~~~~-~-------~~ 236 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATNGT-P-------EL 236 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH----HHhcCCC-C-------CC
Confidence 1 223458899999999998889999999999999999999999996443211 111 0111100 0 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+......+.+++.+||..+|++||++.|+++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112334466889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.76 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=193.1
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
+.||+|+||+||+|... +++.||||.++.. .....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999987652 233455677888888864 899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 99999987543 5889999999999999999999998 99999999999999999999999999875322211 22
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ...+.... + ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~----~~~i~~~~------~----~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L----FQSIRMDN------P----CYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCC------C----CCC
Confidence 34568999999999999999999999999999999999999997543221 1 11111110 0 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMR-EVG 647 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 647 (708)
......+.+++.+||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 22335588999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.84 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=202.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..+.||+|+||.||++... +++.+|+|.++.. .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 6788999987653 344556799999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.++++... .+++..+..++.|+++||.|||+. + ++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997653 589999999999999999999984 5 999999999999999999999999998754322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh------------
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE------------ 602 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 602 (708)
......++..|+|||.+.+..++.++||||||++++||++|+.||.....................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 123346889999999998888999999999999999999999998644322111100000000000
Q ss_pred -----chhhhhhhhhhhc---cC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 603 -----DRLFEILDAQILK---EG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 603 -----~~~~~~~d~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+..+..... .. .......+.+++.+||+.+|++||+++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111100000 00 01134568999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.31 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=201.3
Q ss_pred ceEeeeccEEEEEEEEcC--C--cEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLED--G--KIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.|.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3689999877555 667789999999999999999999999988 889999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL- 537 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~- 537 (708)
++|.+++..... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999987543 36899999999999999999999998 9999999999999999999999999998765422211
Q ss_pred -eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 538 -TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 538 -~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.....++..|+|||++....++.++||||||++++||++ |+.||......+ ..... ..... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~~~---------~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKI---DKEGE---------RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HhcCC---------cC
Confidence 123457789999999999999999999999999999999 999986443221 11110 00000 00
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
..+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112233467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=353.94 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=206.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.++||+|+||+||+|... +++.||||++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 5899999987642 2334567999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 454 EFISNGTLSQYIDDQNK--------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 124667888999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCc-----------------ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch
Q 047038 526 ASRSIAVDQT-----------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588 (708)
Q Consensus 526 ls~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~ 588 (708)
+++....... .......||+.|+|||++.+..++.++||||||++++||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01122469999999999999999999999999999999999999996532211
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcccc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-TMREVGIELTGIRG 655 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~ 655 (708)
. . . .... .++... ....+.+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 239 i---~--~-----~~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 I---S--Y-----RDVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h---h--h-----hhhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 0 0000 000000 00123445688999999999999995 67778888887755
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.16 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=206.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++|+..+.||+|+||+||+|+.+ +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999964 3467999987654433 5678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 451 LVYEFISNGTLSQYIDDQNKD------FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
+||||+++++|.++++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 25899999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
|+++..............++..|+|||.+.+...+.++||||||+++++|++ |..||....... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcC
Confidence 9987543332222333456788999999988888999999999999999999 888885432211 11111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.+. .......+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 1112233457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.53 Aligned_cols=247 Identities=27% Similarity=0.473 Sum_probs=200.5
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCcc
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 462 (708)
++||+|+||.||++...+++.||+|....... ...+.|.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998776443 35678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee-ecc
Q 047038 463 QYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT-TQV 541 (708)
Q Consensus 463 ~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~-~~~ 541 (708)
+++..... .+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.......... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99876432 5789999999999999999999998 99999999999999999999999999876532211111 122
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 620 (708)
..+..|+|||.+.+..++.++||||||++++||++ |..||......... ..+... .....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcC---------CCCCCCcc
Confidence 34667999999998899999999999999999999 88888654322111 111110 00111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 621 EFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 621 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.+..+.+++.+||+.+|++||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.54 Aligned_cols=249 Identities=33% Similarity=0.507 Sum_probs=205.0
Q ss_pred ceEeeeccEEEEEEEEcC----CcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLED----GKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||.||++.... +..||+|.++..... ..+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 788999998764433 477899999999999999999999999999999999999999
Q ss_pred CCccccccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 459 GTLSQYIDDQNK------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 459 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 246999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 533 DQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 533 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
... .......++..|+|||.+....++.++||||||++++||++ |..||......+ ....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 321 12334557889999999998899999999999999999999 699997553221 111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
....+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112333567999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.83 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=198.9
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..++||+|+||.||+|.. .+++.||+|.+... .....++|.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999996 47889999987653 344556799999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986542 4678888999999999999999998 999999999999999999999999998765322
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......||..|+|||++.+..++.++||||||+++|+|++|+.||..................+.... .+..
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-- 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence 12335689999999999999999999999999999999999999964332211111101111110000 0000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
........+.+++.+||+.+|++||+++|+++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234568999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.35 Aligned_cols=241 Identities=25% Similarity=0.381 Sum_probs=196.0
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +++.||||.++.. .....+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 5789999988642 234556788899999888 799999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 99998887653 5899999999999999999999998 99999999999999999999999999875322221 22
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence 33568999999999999999999999999999999999999996543221 1111111110 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTM-----REVGI 648 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 648 (708)
......+.+|+.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2334568999999999999999999 77653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.56 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=199.9
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
|+..++||+|+||+||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999965 68899999876422 22345678899999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 35899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||..............+.... ..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-------------~~ 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------------QE 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-------------hh
Confidence 223468999999999999999999999999999999999999997543221111111110000 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
.........+.+|+.+||+.||++||| ++|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 112223455889999999999999999 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.29 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=203.8
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+|++.+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 688999998764 23455678899999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++.... ...+++...+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999999886542 235789999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
......|++.|+|||++.+..++.++|+||||+++++|++|+.||........ ......+... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~---------~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-------ILKVCQGSYK---------P 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-------HHHHhcCCCC---------C
Confidence 22345688999999999998899999999999999999999999964332110 1111111111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.+......+.+++.+||+.+|++||++.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=315.80 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=193.8
Q ss_pred ceEeeeccEEEEEEEEcC---CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 384 RILGQGGQGTVYKGMLED---GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
+.||+|+||.||+|...+ +..+|+|+++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4579999887643 334457999999999999999999999999999999999999999
Q ss_pred CccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 460 TLSQYIDDQNK--DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 460 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|.++++.... ....++..++.++.|++.||+|||+.+ ++||||||+||++++++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 234677888899999999999999998 9999999999999999999999999987543322211
Q ss_pred -eecccccccccCccccccC-------CCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 538 -TTQVQGTFGYLDPEYFQSS-------HFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 538 -~~~~~gt~~y~aPE~~~~~-------~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+. ... ..... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~~~-~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVREQ-QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhhcc-cCCC
Confidence 2234577889999998642 35789999999999999996 9999965433221 111 01111 1111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.++.+ .....+.+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123345788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=327.56 Aligned_cols=244 Identities=27% Similarity=0.429 Sum_probs=200.5
Q ss_pred CCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.|..++.||.|+||.||.++. ++.+.||||++.-. ....+++++.||..|++++|||++.+-||+..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678899999999999995 57889999998763 34567889999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
||- |+-.+++.-+.+ ++-+..+..|..+.+.||+|||+++ .||||||..||||++.+.|||+|||.+....+
T Consensus 107 YCl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 996 488888876544 6889999999999999999999999 99999999999999999999999999876543
Q ss_pred cceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
...++|||.|||||++. .++|+.|+||||||++..||.-.++|+...+.-. ....+..+. +
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNe------s 242 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNE------S 242 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcC------C
Confidence 34578999999999974 5789999999999999999999999975332111 111111111 1
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+. ..+-...+.+++..||++-|.+|||..++++
T Consensus 243 PtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111 2344567999999999999999999987653
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.09 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=200.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999965 67899999886533 33345678999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
++ ++|.+++..... .+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588888876433 5889999999999999999999998 99999999999999999999999999876433221
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh---
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA--- 611 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--- 611 (708)
......+++.|+|||.+.+ ..++.++||||||+++|||++|++||......+................+..+++.
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1223457889999999865 45788999999999999999999999765433221111111000001111111110
Q ss_pred ------hhh----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 ------QIL----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ------~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ..........+.+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0011123456889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.32 Aligned_cols=239 Identities=24% Similarity=0.428 Sum_probs=189.3
Q ss_pred eEeeeccEEEEEEEEcC-------------------------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeee
Q 047038 385 ILGQGGQGTVYKGMLED-------------------------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKL 439 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 439 (708)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998521 13588998876555556789999999999999999999
Q ss_pred eceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC--
Q 047038 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-- 517 (708)
Q Consensus 440 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-- 517 (708)
++++.+....++||||+++|+|..++..... .+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999875432 5889999999999999999999988 99999999999997643
Q ss_pred -----cEEEeeccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHH-hCCCCCCCCCcchhh
Q 047038 518 -----CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELL-TGERPIRLTNSEEDK 590 (708)
Q Consensus 518 -----~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~ell-tg~~P~~~~~~~~~~ 590 (708)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 4899999987643221 12346788999998875 56899999999999999995 699998654332211
Q ss_pred hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
..+ ... . ..+......+.+++.+||+.+|++||++++|++.|.
T Consensus 232 ---~~~----~~~-------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 ---RFY----EKK-------H----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHH----Hhc-------c----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 110 000 0 001112245889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.77 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=199.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.++||+|+||+||++... +++.+|+|.+... .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999976 5778999987542 2334456889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 5899999999999999999999998 999999999999999999999999998765433
Q ss_pred CcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcccc-
Confidence 333334456999999999986 3468899999999999999999999996543222 1111111110000
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIE 649 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 649 (708)
. ..........+.+|+.+|+..++.+ |++++|+++.
T Consensus 229 ----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0111233566889999988654444 6889988755
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=330.75 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=197.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----- 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 447 (708)
..++|+..+.||+|+||.||++... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999965 688999998864 33455678889999999999999999999987543
Q ss_pred -cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 448 -VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 448 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
..++||||+++ +|.+.++. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999976 56555532 3788889999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--- 603 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 603 (708)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+. ...........
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcHH
Confidence 9754322 123345689999999999999999999999999999999999999975543211 00010000000
Q ss_pred -------hhhhhhhh---------------hh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 -------RLFEILDA---------------QI---LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 -------~~~~~~d~---------------~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
........ .. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00 00011112356899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.93 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=200.1
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|++|+||+|... +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68899999876532 33456788999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
++ ++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888876544457899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh--hchh---hhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR--EDRL---FEIL 609 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~ 609 (708)
......+++.|+|||.+.+ ..++.++||||||++++||++|+.||....... .....+..... +..+ ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 1223457889999998865 457899999999999999999999997543221 11111100000 0000 0000
Q ss_pred h--h-------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 D--A-------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d--~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+ . ............++.+++.+||+.||++|||+++|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0 0000001123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.04 Aligned_cols=240 Identities=26% Similarity=0.384 Sum_probs=193.1
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||.||++... +++.||+|.++.. .....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 6889999988652 123455677888888764 899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999887643 5889999999999999999999998 9999999999999999999999999987432211 123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ...+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~----~~~~~~~~----------~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L----FESIRVDT----------PHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCC----------CCCC
Confidence 44568999999999999999999999999999999999999996543221 1 11111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMR-EVG 647 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 647 (708)
......+.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.02 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=200.8
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC-----
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET----- 446 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----- 446 (708)
+.+++.|+..+.||+|+||+||+|... +++.||+|...... ....++.+|+.+++++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456788999999999999999999965 58899999886543 3446788999999998 799999999998753
Q ss_pred -CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 447 -EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 447 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999987643 236899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
+++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ ... .
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~--~ 228 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL--I 228 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHH--H
Confidence 9876543221 223456899999999986 34588899999999999999999999853321111 000 0
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... . .......+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 229 ~~~~~-----~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPA-----P---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCC-----C---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 0 0011223456899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.43 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=204.8
Q ss_pred eEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCccc
Q 047038 385 ILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQ 463 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 463 (708)
+||+|.||+||-|++.+ ...+|||-+...+....+-+..||.+-++++|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999654 56789999888778888889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCcccCcCCcceeeccc
Q 047038 464 YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQ 542 (708)
Q Consensus 464 ~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~~~~~~~~~~~~~~~ 542 (708)
+|+..-....-.+.+.-.+..||++||.|||+.. |+|||||-+|||++ -.|.+||+|||-++.+.. -...+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 9988665433478888889999999999999998 99999999999997 578999999999987642 223455677
Q ss_pred ccccccCccccccC--CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHH
Q 047038 543 GTFGYLDPEYFQSS--HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620 (708)
Q Consensus 543 gt~~y~aPE~~~~~--~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 620 (708)
||..|||||++..+ .|+.++|||||||++.||.||++||....+.. .++.-..+.+. -...+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyKv-----------HP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYKV-----------HPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhcceec-----------CCCCcHH
Confidence 99999999999775 48899999999999999999999996433221 11111111111 1233566
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 621 EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 621 ~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+..++|.+|+.++|.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6778899999999999999999999874
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.20 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=194.5
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhc---CCCceeeeeceEeeC-----C
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCLET-----E 447 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~ 447 (708)
+|+..+.||+|+||+||+|... +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 68899999876532 22234566777777665 799999999998653 3
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999985 88888875432 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh---hch
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR---EDR 604 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~ 604 (708)
+...... ......||..|+|||++.+..++.++||||||++++||++|++||......+. +. ....... ...
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~-~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LG-KIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HH-HHHHHhCCCChhh
Confidence 8654221 22345689999999999988999999999999999999999999965433221 11 1111110 000
Q ss_pred hhhhh-------h---hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEIL-------D---AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~-------d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.... . ............+.+.+|+.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0 00000111233456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.68 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=207.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|++.+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999965 68899999876532 44567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++.... .+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999887643 58999999999999999999997 45 9999999999999999999999999986542211
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh-----hHHHHHHHHhhhchhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK-----SLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 609 (708)
.....|+..|+|||++.+..++.++||||||+++++|++|+.||......++. .....+...+..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 228 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------- 228 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence 22346899999999998889999999999999999999999999754432111 111111111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....-.....+..+.+|+.+||+.||++||++.||+++..-++.
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 229 --PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00000011244568999999999999999999999987655544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.86 Aligned_cols=242 Identities=25% Similarity=0.348 Sum_probs=192.2
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||++... +|+.||+|.+... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 6899999987642 2334455666665 46779999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence 99998887543 5899999999999999999999998 999999999999999999999999998753221 1123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+..... ..+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~-~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILH-KPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHc-CCc----------cCC
Confidence 34569999999999999999999999999999999999999996543221 1111111 100 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
......+.+++.+||+.+|++||++++.+++
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 2234568899999999999999998744433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.99 Aligned_cols=192 Identities=24% Similarity=0.400 Sum_probs=164.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
...+|++.+.||+|+||.||+|... +++.||+|.... .....|+.++++++|+||+++++++.+.+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999975 567899997543 234569999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
++. ++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 58888886543 36899999999999999999999998 9999999999999999999999999987532211
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCC
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPI 581 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~ 581 (708)
......||+.|+|||++.+..++.++||||||+++|||+++..|+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456899999999999999999999999999999999965554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=298.28 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=207.1
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhc-CCCceeeeeceE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--------ESKVEEFINEVVILSQI-NHRNVVKLLGCC 443 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 443 (708)
+...+.|...++||.|..++|-+...+ +|+..|+|++.... ..-.+.-.+|+.||+++ .||+|++|.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567788899999999999888855 68889999865421 12245567899999998 699999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
+.+...++|+|.|+.|.|.++|...- .++++...+|+.|+.+|++|||... |+||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999998654 6999999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccCcCCcceeecccccccccCcccccc------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
||++..+.... ..+...|||+|+|||.+.. ..|+...|+|+.||+||.|+.|.+||-.. ....+.
T Consensus 167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlML 237 (411)
T KOG0599|consen 167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLML 237 (411)
T ss_pred cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHH
Confidence 99998776443 4567789999999999864 34788999999999999999999998421 111223
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.+.++... ...+.-.+......+||.+||+.||++|.|++|+++
T Consensus 238 R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 333333321 112223455677899999999999999999999875
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=317.24 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=206.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.+|+..+.||+|+||+||+|... +++ .+|+|..+... ....+++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999964 333 58999876543 4456789999999999999999999999987 78899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999976533 4899999999999999999999988 9999999999999999999999999998765
Q ss_pred cCCccee-ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHLT-TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
....... ....++..|+|||.+....++.++||||||++++||++ |+.||......+ +...+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCC----
Confidence 3322211 12224568999999988899999999999999999999 999996543322 1111111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+......+.+++.+||..+|++||++.++++.|+.+.+
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01112233458899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.22 Aligned_cols=250 Identities=25% Similarity=0.454 Sum_probs=202.0
Q ss_pred CCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
+|+..+.||+|+||+||+|...+++.+|+|.++... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999876422 22345689999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 5789999999999999999999988 99999999999999999999999999875432
Q ss_pred CC-----cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 533 DQ-----THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 533 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
.. ........++..|+|||++.+..++.++||||||++++||++|+.||...+..+.. ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~--- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRG--- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccC---
Confidence 11 11123356889999999999988999999999999999999999999643322110 00000000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+......+.+++++||+.+|++||++.|++.
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011112234466899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.50 Aligned_cols=250 Identities=30% Similarity=0.417 Sum_probs=205.9
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..++||+|+||.||.+... +++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999999854 6889999987653 355667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997653 336899999999999999999999998 99999999999999999999999999886643332
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......+++.|+|||.+.+..++.++||||||++++||++|..||......+ ...... .+.. .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~---------~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV-QGNY---------T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCC---------C
Confidence 2334568999999999998889999999999999999999999986433221 111111 1111 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.........+.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.67 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=195.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 453 (708)
+|+..+.||+|+||+||++... +++.||+|.++.. .....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999965 6889999987642 2344567888999998885 577888999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987543 5899999999999999999999998 999999999999999999999999998754322
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ..+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~----~~i~~~~--------- 217 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LF----QSIMEHN--------- 217 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCC---------
Confidence 2 12334568999999999999999999999999999999999999997543221 11 1111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 644 (708)
...+......+.+++.+||+.+|.+|++..
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011223345688999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.61 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=198.9
Q ss_pred ceEeeeccEEEEEEEEcC-------CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGMLED-------GKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+.||+|+||.||+|...+ ++.+|||.+.... ......|.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999875432 34567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-----cEEEeeccC
Q 047038 456 ISNGTLSQYIDDQN----KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-----CAKVSDFGA 526 (708)
Q Consensus 456 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-----~~kl~DFGl 526 (708)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997542 1234789999999999999999999988 99999999999999877 899999999
Q ss_pred CcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 527 SRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 527 s~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ... .+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQ----HVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHH----HHhcCC
Confidence 8765432211 1122345778999999999999999999999999999998 999986433211 111 111111
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
........+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011123345678999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=329.89 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=198.9
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC----
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE---- 447 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 447 (708)
...++|+..+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 6889999988652 3445678889999999999999999999986433
Q ss_pred --cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 448 --VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 448 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999975 56665542 4788899999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH--------HH
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY--------FL 597 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~--------~~ 597 (708)
+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....... +.
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99864322 223345689999999999999999999999999999999999999975442221100000 00
Q ss_pred HHhhhchhhhhhh----------hhh--------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 598 RAMREDRLFEILD----------AQI--------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 598 ~~~~~~~~~~~~d----------~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+.. .+...++ +.. ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcH-HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0000000 000 000111224568999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.62 Aligned_cols=240 Identities=22% Similarity=0.415 Sum_probs=192.1
Q ss_pred ceEeeeccEEEEEEEEcC--------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGMLED--------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+.||+|+||+||+|.... ...+|+|.+........+.|.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 234888887665556667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--------EEEeeccCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC--------AKVSDFGAS 527 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~--------~kl~DFGls 527 (708)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999986543 5899999999999999999999998 999999999999987765 699999988
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCC-CCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGE-RPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+......... .....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~~--- 220 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYED--- 220 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHHc---
Confidence 65432 123457889999999987 45799999999999999999985 555432221110 00000
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
....+......+.+|+.+||+.+|++|||+++++++|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112223356899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=318.86 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=200.8
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999976 5778899998776677788899999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|..++.... ..+++..+..++.|+++||.|||+.+ ++||||||+|||++.++++||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 99998876532 26899999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred ecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 539 TQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
....++..|+|||++. ...++.++||||||+++|||++|++||......+ ......... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~----- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE-PPTL----- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcC-CCCC-----
Confidence 3356899999999984 3457889999999999999999999986433211 111111110 0000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112233456899999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.34 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=202.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|++.+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 7899999987653 445567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987643334689999999999999999999974 6 999999999999999999999999998765322
Q ss_pred cceeecccccccccCccccccC------CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSS------HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ...... .+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~---------~~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLS---------AI 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHH---------HH
Confidence 12334578899999998553 35889999999999999999999996432211 111111 01
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+. .....+......+.+++.+||+.+|++||++++++.
T Consensus 223 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 110 011123335567899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.66 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=201.9
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee-CCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 454 (708)
+|++.+.||+|++|.||++... +++.||+|++... .....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 5788999987652 34456679999999999999999999998764 445789999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999997643 235899999999999999999999998 9999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...+... .... ...+.+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~-~~~~~~--------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYR-IIEGKL--------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHH-HHhcCC---------
Confidence 22334558899999999999999999999999999999999999986433211 1111 111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+++.+||+.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122344567999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.22 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=191.4
Q ss_pred eEeeeccEEEEEEEEcC---CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 385 ILGQGGQGTVYKGMLED---GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
.||+|+||+||+|...+ ...+|+|.+... .......|.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 346888876543 23445678999999999999999999999999999999999999999
Q ss_pred ccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-
Q 047038 461 LSQYIDDQNK--DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL- 537 (708)
Q Consensus 461 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~- 537 (708)
|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976542 223567888999999999999999998 9999999999999999999999999987543322111
Q ss_pred eecccccccccCcccccc-------CCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 538 TTQVQGTFGYLDPEYFQS-------SHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ . ......... ..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~~~-~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVREQD-IKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhccC-ccCC
Confidence 223345778999998743 456889999999999999999 788886443221 1 111111111 1111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
++. .....+..+.+++..|+ .||++|||++||++.|.
T Consensus 232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 12233455778888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.26 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=191.5
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHH-HHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
+.||+|+||+||++... +++.||+|.+.... .....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57889999876421 222334555544 56789999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 99999987643 4788888899999999999999998 9999999999999999999999999987543221 123
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. +.. +.... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~-i~~~~----------~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDN-ILNKP----------LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHH-HHhCC----------cCCC
Confidence 345699999999999999999999999999999999999999965432211 111 11110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
......+.+++.+||+.+|.+||++.+.+.++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 23445689999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=320.79 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=205.4
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999996 47899999998776666667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999998643 4789999999999999999999998 99999999999999999999999999876543322
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... . .....+ .. ..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~----~~~~~~-~~-------~~ 235 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-TP-------EL 235 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--e----eeccCC-CC-------CC
Confidence 1 22345888999999999988999999999999999999999999654322110 0 000000 00 00
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+......+.+++.+||+.+|++||++++|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.74 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=205.0
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.+|+..+.||.|++|+||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 478999999887655556678999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++... .+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999988643 4899999999999999999999998 999999999999999999999999998765433221
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... . ...... .. ...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~----~~~~~~-~~-------~~~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-TP-------ELQ 236 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHHhcC-Cc-------ccC
Confidence 22345888999999999988999999999999999999999999654432211 0 000000 00 001
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+......+.++|.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 12233456889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.01 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=204.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|+..+.||+|+||.||+|...+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578889999999999999999764 78999998875322 67899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999987543 36899999999999999999999998 99999999999999999999999999886643321
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||++.+..++.++||||||+++++|++|+.||......... ........ . ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-----~--~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP-----P--TL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC-----C--CC
Confidence 223344788999999999989999999999999999999999998643322110 00000000 0 00
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+......+.+++.+||+.+|++|||++||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112233456899999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.68 Aligned_cols=252 Identities=28% Similarity=0.355 Sum_probs=213.1
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCCh---HHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcc
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDE---SKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVP 449 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 449 (708)
.....|++.+.||+|.||.||+++... |+.+|+|.+..... ...+.+.+|+.+|+++. |||||.+++.+++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999999764 99999998765332 34578999999999998 99999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CcEEEeecc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK----YCAKVSDFG 525 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~----~~~kl~DFG 525 (708)
++|||++.||.|.+.+... .+++.....++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999876 2899999999999999999999998 9999999999999633 579999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
++..... ........||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+..+.+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 9998765 445667889999999999999999999999999999999999999997665443221 1111211
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+.-........++++++|..||.+|+|+.++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1222333445677899999999999999999999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.08 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=203.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+.|++.++||+|+||.||+|... +++.||+|.+...+....+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999975 58899999988777777888999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|..++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999888765432 5899999999999999999999988 999999999999999999999999998754322 11
Q ss_pred eeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 537 LTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
......+++.|+|||++. ...++.++||||||+++|||++|+.||....... ......... ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~---- 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE-PPT---- 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcCC-Ccc----
Confidence 123345888999999984 3457889999999999999999999986433211 111111110 000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+++.+||+.+|++||+++|+++
T Consensus 235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 ---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0112233456889999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.78 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=196.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 6889999988642 2344567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997643 5899999999999999999999998 999999999999999999999999998754211
Q ss_pred Cc----------------------------------ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCC
Q 047038 534 QT----------------------------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGER 579 (708)
Q Consensus 534 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~ 579 (708)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 00123469999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 047038 580 PIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT---MREVG 647 (708)
Q Consensus 580 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~ 647 (708)
||......+. ............ +. . .......+.+|+.+++. +|++|++ +.|++
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~~-~p----~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 235 PFCSETPQET------YRKVMNWKETLV-FP----P--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCCHHHH------HHHHHcCCCcee-cC----C--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 9975443221 111111000000 00 0 11133567888888774 9999986 55554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.22 Aligned_cols=247 Identities=29% Similarity=0.468 Sum_probs=199.8
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|++.+.||+|+||.||++.. +++.||+|..+.. ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588889999999999999975 5788999988653 2346789999999999999999999998754 5799999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999997653 235899999999999999999999988 999999999999999999999999998754321
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
......+..|+|||.+.+..++.++|+||||++++||++ |+.||......+. ......+. ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGY---------RME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCC---------CCC
Confidence 112234568999999998899999999999999999998 9999865433221 11111111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
.....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122344668899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.06 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=198.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC------
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 446 (708)
..++|+..+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 6889999988652 344567789999999999999999999987643
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999975 67666642 3788899999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc--h
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--R 604 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~ 604 (708)
++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||...+..+.... ........ .
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---VIEQLGTPCPE 247 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCHH
Confidence 9865322 223345689999999999999999999999999999999999999976543221111 11100000 0
Q ss_pred h--------hhhhh--------------hhhh----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 L--------FEILD--------------AQIL----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~--------~~~~d--------------~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+ ...+. +... .+........+.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000 0000 0001112356889999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.68 Aligned_cols=256 Identities=25% Similarity=0.472 Sum_probs=202.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|+..+.||+|+||.||+|.+. +++ .||+|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999864 444 57889876533 34445789999999999999999999998754 4679
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
++||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999876532 5889999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~--- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGERL--- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCCC---
Confidence 332211 222345778999999998999999999999999999998 9999864432211 1111111100
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..+......+.+++.+||..+|++||+++++++.|+.+..
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111223468899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.88 Aligned_cols=197 Identities=26% Similarity=0.401 Sum_probs=161.1
Q ss_pred cceEeeeccEEEEEEEEc---CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcceEEEEecc
Q 047038 383 NRILGQGGQGTVYKGMLE---DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIS 457 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 457 (708)
.++||+|+||+||+|... +++.||+|.++... ....+.+|+.+|++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 367999999999999964 46789999886532 23457889999999999999999999864 446789999986
Q ss_pred CCCccccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEeeccCC
Q 047038 458 NGTLSQYIDDQN------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGAS 527 (708)
Q Consensus 458 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGls 527 (708)
+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7877765321 1235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCcCCc--ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 047038 528 RSIAVDQT--HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 528 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~ 585 (708)
+....... .......||+.|+|||++.+ ..++.++||||||++++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 12234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.90 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=196.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|||++++++...+..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 57889999643 23467899999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+. ++|.+++..... .++|.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688888765432 6999999999999999999999998 99999999999999999999999999986543222
Q ss_pred c-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcc-hhhhHHHHHHHHhhhchh--------
Q 047038 536 H-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE-EDKSLAAYFLRAMREDRL-------- 605 (708)
Q Consensus 536 ~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~-------- 605 (708)
. ......||..|+|||++.+..++.++|||||||+||||++|..|+...... ........+.+.++....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 223456999999999999999999999999999999999988765432211 111111111111111110
Q ss_pred -----hhhhhhhh----hccCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 -----FEILDAQI----LKEGG-------KDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 -----~~~~d~~~----~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
........ ..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000000 00000 011235789999999999999999999975
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.05 Aligned_cols=248 Identities=26% Similarity=0.496 Sum_probs=200.2
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh---------HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE---------SKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677789999999999999964 678999998754221 123578899999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997653 5889999999999999999999998 9999999999999999999999999988
Q ss_pred ccCcCCcc-----eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 529 SIAVDQTH-----LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 529 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
........ ......|+..|+|||.+.+..++.++||||||+++++|++|+.||........ ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFK-IGE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHH-Hhc-
Confidence 66422111 11224578899999999988899999999999999999999999964322110 000 000
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......+...+..+.+++.+||+.+|++||++.||++
T Consensus 227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011122334567899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=309.84 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=207.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.-|.+..+||+|+||.|||+.++ .|+.||||++.. +.+.++++.|+.||++.+.+++|++||.+.....+|+||||+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34778889999999999999965 699999999876 567889999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
.-|++.+.++..++ ++++.++..++...++||+|||... -||||||..||||+.+|.+||+|||.+..+.... .
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 99999999987654 7999999999999999999999988 8999999999999999999999999997664322 2
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc-
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK- 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~- 615 (708)
....+.||+.|||||+++.-.|..++||||||++..||..|++||....+-. . ++ .+......
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------------A--IF-MIPT~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------------A--IF-MIPTKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------------e--eE-eccCCCCCC
Confidence 2345789999999999999999999999999999999999999985332111 0 00 01111111
Q ss_pred -cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 616 -EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 616 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+..-..++-++++.||-++|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1133345678999999999999999999887653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.48 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=201.5
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566778999999999999865 57889999876533 445678999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++... .+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999988643 5889999999999999999999988 99999999999999999999999999876543221
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
......++..|+|||++.+..++.++||||||++++||++|+.|+........ ....... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~---------~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKN---------SPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcC---------CCCC
Confidence 12234578899999999998999999999999999999999999864322110 0001111 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.....+..+.+++.+||+.+|++||++.||++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122345668999999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.98 Aligned_cols=267 Identities=19% Similarity=0.257 Sum_probs=196.0
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC------Cceeeeece
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINH------RNVVKLLGC 442 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~ 442 (708)
.+++...+++|++.++||+|+||+||+|... .++.||||+++... ....++..|+.+++.++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3445566789999999999999999999965 57889999986432 233456677877777654 458899998
Q ss_pred EeeC-CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCC---
Q 047038 443 CLET-EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKY--- 517 (708)
Q Consensus 443 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~--- 517 (708)
+... ...++|||++ +++|.+++.... .+++..+..|+.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 8764 4678999988 668888887543 58999999999999999999998 47 99999999999998765
Q ss_pred -------------cEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 047038 518 -------------CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLT 584 (708)
Q Consensus 518 -------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~ 584 (708)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999876432 1234467999999999999999999999999999999999999999765
Q ss_pred CcchhhhHHHHHHHHhhh--------chhhhhh----------hhhh----hccC---CHHHHHHHHHHHHHhcccCCCC
Q 047038 585 NSEEDKSLAAYFLRAMRE--------DRLFEIL----------DAQI----LKEG---GKDEFKMVAKLAKRCLNLNGKK 639 (708)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~--------~~~~~~~----------d~~~----~~~~---~~~~~~~l~~li~~cl~~~p~~ 639 (708)
...+...........+.. ....++. ++.. .... .......+.+||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 543222211111000000 0000000 0000 0000 0011345789999999999999
Q ss_pred CCCHHHHHH
Q 047038 640 RPTMREVGI 648 (708)
Q Consensus 640 RPt~~ev~~ 648 (708)
|||++|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999974
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.01 Aligned_cols=238 Identities=25% Similarity=0.463 Sum_probs=191.4
Q ss_pred ceEeeeccEEEEEEEEcCCc-----------EEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 384 RILGQGGQGTVYKGMLEDGK-----------IVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 5788876654333 6789999999999999999999999988 788999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-------cEEEeecc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-------CAKVSDFG 525 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-------~~kl~DFG 525 (708)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999986543 5899999999999999999999988 99999999999999887 79999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccC--CCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS--HFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..||......+... .+. ..
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~---~~ 222 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ---DQ 222 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh---cC
Confidence 9876532 2223467789999999876 78999999999999999999 577775543221110 000 00
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.. .+......+.+++.+||..+|++||++.||++.|+
T Consensus 223 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 01111256899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.31 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=203.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999965 68899999886543 45567889999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998754 5899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.......+++.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.... ..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~---------~~ 216 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNN---------PP 216 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcC---------CC
Confidence 12233468889999999999889999999999999999999999996433211 001111110 00
Q ss_pred cCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKD-EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... .+..+.+++.+||+.+|++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 4456899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.16 Aligned_cols=251 Identities=32% Similarity=0.521 Sum_probs=203.3
Q ss_pred CcccceEeeeccEEEEEEEEcC-----CcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 380 FNTNRILGQGGQGTVYKGMLED-----GKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
|++.+.||.|+||.||++...+ +..||+|.++..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999754 378999998764433 6778999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++...... .+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999765421 2899999999999999999999998 999999999999999999999999999876544
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.........+++.|+|||.+....++.++||||||++++||++ |+.||....... .. ........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~------- 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VL----EYLKKGYR------- 222 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCC-------
Confidence 2222222347789999999988889999999999999999998 888886432211 11 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
.......+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222456689999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.17 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=206.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|+..+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999965 5788999998876666778999999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999987652 25899999999999999999999998 99999999999999999999999999876543211
Q ss_pred ceeecccccccccCccccccC---CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSS---HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
......++..|+|||.+... .++.++||||||++++||++|+.||........ ... .....+ .+.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~-----~~~~~~----~~~ 224 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL-----ISKSNF----PPP 224 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhccC----CCc
Confidence 12334578899999999776 889999999999999999999999864332211 110 000000 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. .......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 225 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 K-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0112334567899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.85 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=202.3
Q ss_pred CCcccceEeeeccEEEEEEEEcC--CcEEEEEEcccC----------ChHHHHHHHHHHHHHHh-cCCCceeeeeceEee
Q 047038 379 NFNTNRILGQGGQGTVYKGMLED--GKIVAVKKSKII----------DESKVEEFINEVVILSQ-INHRNVVKLLGCCLE 445 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 445 (708)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999765 688999976532 23345678889998875 799999999999999
Q ss_pred CCcceEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+ ++|+||||+|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999885421 23468999999999999999999996 55 99999999999999999999999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
||++....... ......++..|++||.+.+..++.++||||||+++|||++|+.||........ . ..+...
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~----~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---A----TKIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---H----HHHhhc
Confidence 99998654332 23345688999999999988899999999999999999999999854322110 1 111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
... ..........+.+++.+||+.||++||++.||..+|+
T Consensus 229 ~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 110 0011123456899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=315.60 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=202.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|+..+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 347788899999999999999964 6889999998776666667789999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... .
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-I 160 (267)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-c
Confidence 99999999987543 5899999999999999999999998 999999999999999999999999998755322 1
Q ss_pred ceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.......|+..|+|||++. ...++.++||||||+++|||++|+.||......... . ..... ... .+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~~~~-~~~---~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LMTKS-NFQ---PPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hhhcc-CCC---CCc
Confidence 1223456899999999974 456889999999999999999999998543321110 0 00000 000 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. .. ....+..+.+++.+||+.+|++||++++|++
T Consensus 231 ~-~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 L-KD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c-cc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 00 1122346889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.50 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=204.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677788999999999999975 58899999876533 45567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999998643 4888999999999999999999988 99999999999999999999999999976543221
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......++..|+|||++.+..++.++|+||||+++|||++|+.||......... ... ......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~---------~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLI---------PKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhh---------hcCCCC
Confidence 223345788999999999888999999999999999999999998643322110 000 011111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
......+..+.+++.+||+.+|++||++++++..-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 22344567799999999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.53 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=196.1
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET----- 446 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 446 (708)
...++|+..+.||+|+||+||++... +++.||||++... .....+.+.+|+.+|++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999964 6889999988652 223456788999999999999999999988643
Q ss_pred -CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 447 -EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 447 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
...++++|++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 67888877542 5899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh---
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR--- 601 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 601 (708)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .........
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 99865422 233468999999999877 5689999999999999999999999965432211 111110000
Q ss_pred --------hchhhhhhhh--hh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 --------EDRLFEILDA--QI----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 --------~~~~~~~~d~--~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+.. .. .........+.+.+|+.+||+.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 00 00000011234789999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.22 Aligned_cols=261 Identities=23% Similarity=0.275 Sum_probs=200.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc---CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE---DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..+|.+.+.||+|+||.||++... .++.||+|.+... +.+.+|+++|++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999987542 24568999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
|++. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 5888888433 36899999999999999999999998 999999999999999999999999999765433
Q ss_pred Cc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh------
Q 047038 534 QT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF------ 606 (708)
Q Consensus 534 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------ 606 (708)
.. .......||+.|+|||++....++.++||||||+++|||++|+.||..................+......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22 12234579999999999999999999999999999999999999997655433222222222211111000
Q ss_pred ----hhh---hhhhhccC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 607 ----EIL---DAQILKEG-------GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 607 ----~~~---d~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+ ........ .......+.+++.+||+.||++||++.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000000 01123457889999999999999999999743
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.06 Aligned_cols=256 Identities=28% Similarity=0.500 Sum_probs=200.9
Q ss_pred CcccceEeeeccEEEEEEEEc----CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 047038 380 FNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 447 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 447 (708)
|.+.+.||+|+||+||+|.+. +++.||||.++. ......+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999864 367899998765 24556778999999999999999999999886542
Q ss_pred cceEEEEeccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 448 VPLLVYEFISNGTLSQYIDDQN---KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
..++++||+++|+|.+++.... ....+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988875322 2235789999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 525 GASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 525 Gls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |++||......+ ...+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~---~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL---IKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH---HcC
Confidence 998865432221 1222345678999999998889999999999999999999 889986433221 11111 111
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
... ......+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 232 ~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 232 NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 100 111233467999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.74 Aligned_cols=265 Identities=26% Similarity=0.340 Sum_probs=204.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 5889999987653 33445789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|++++.+..++... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776655433 24899999999999999999999998 9999999999999999999999999988765443
Q ss_pred cceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH--------hhhc--
Q 047038 535 THLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA--------MRED-- 603 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--------~~~~-- 603 (708)
........++..|+|||++... .++.++||||||+++++|++|++||......+........... ....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233445678899999999887 8899999999999999999999999754332211111000000 0000
Q ss_pred ----hhhhhhhhh-hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 ----RLFEILDAQ-ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ----~~~~~~d~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.+..+.. .....+...+..+.+++++||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000010000 001112223577999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.02 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=200.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 58999999876432 2234568899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|..++.... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988888765432 5899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH-HHhh-------hchh
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL-RAMR-------EDRL 605 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~-------~~~~ 605 (708)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+......... .... ....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 1223457889999999876 567899999999999999999999997544332111111000 0000 0000
Q ss_pred hh-hhhhhhh-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FE-ILDAQIL-----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~-~~d~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ...+... ..........+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000000 0001122466889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.93 Aligned_cols=263 Identities=24% Similarity=0.396 Sum_probs=203.7
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--C
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET--E 447 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~ 447 (708)
.+...++|.+.+.||+|+||+||++... +++.||+|.+.. ........|..|+.+|++++|||||++++++.+. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999965 577899998765 3345567899999999999999999999998653 4
Q ss_pred cceEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEEcC-------
Q 047038 448 VPLLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAAS----IPIYHRDIKSTNILLDD------- 515 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~----~~iiHrDikp~NIll~~------- 515 (708)
.++|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999997532 22369999999999999999999998542 34999999999999964
Q ss_pred ----------CCcEEEeeccCCcccCcCCcceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCC
Q 047038 516 ----------KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRL 583 (708)
Q Consensus 516 ----------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~ 583 (708)
...+||+|||++....... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3358999999998654322 2334569999999999854 4588999999999999999999999964
Q ss_pred CCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHHcc
Q 047038 584 TNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG--IELTGI 653 (708)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~--~~L~~l 653 (708)
..... .+...+.... .+. ....+..+.+||.+||+.+|.+||++.|++ ..|..+
T Consensus 246 ~~~~~------qli~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFS------QLISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHH------HHHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 33211 1111111110 000 112245689999999999999999999998 344433
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.82 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=203.5
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|+||+||++... +++.||+|.+... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999964 6889999987642 344567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998875432 35789999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......|++.|+|||++.+...+.++|+||||+++++|++|+.||......+ ........ .. .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~-~~---------~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIRG-SY---------P 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhcC-CC---------C
Confidence 1223458889999999999899999999999999999999999986432211 11111111 00 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+......+.+++.+||+.+|++||+++||++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112234556899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.44 Aligned_cols=247 Identities=24% Similarity=0.426 Sum_probs=201.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
+|+..+.||+|++|+||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999876533 34567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997643 5889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCC-CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ......++..|++||.+.... ++.++|+||||+++++|++|+.||....... ..........
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~------- 219 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKE------- 219 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhccc-------
Confidence 22 233456889999999988776 8999999999999999999999986433111 0111111000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+......+.+++.+||+.+|++||++++++.
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01112233466889999999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.37 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=190.5
Q ss_pred eEeeeccEEEEEEEEcCC---cEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 385 ILGQGGQGTVYKGMLEDG---KIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
.||+|+||+||+|...++ ..+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985543 346677665433 3456789999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC-ccee
Q 047038 461 LSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ-THLT 538 (708)
Q Consensus 461 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~-~~~~ 538 (708)
|.++++.... ...+++...+.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976432 234677788899999999999999988 9999999999999999999999999976432111 1122
Q ss_pred ecccccccccCcccccc-------CCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 539 TQVQGTFGYLDPEYFQS-------SHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~-------~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ . ....+.+. .....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~~-~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---V---LNHVIKDQ-QVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHhhc-ccccCC
Confidence 34457889999999753 345789999999999999997 577875433211 1 11111111 112222
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
+.+. ......+.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222 123356788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.89 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=205.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeeCC----cc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQ--INHRNVVKLLGCCLETE----VP 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~ 449 (708)
...+..+.+.||+|.||+||+|.++ |+.||||++...++ +.+.+|.+|.+. |+|+||+.+++.-..++ .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3466788899999999999999996 78899999876443 467889999986 49999999999876544 57
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-----AASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-----~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
+||.+|.++|+|.|||... +++....++++..+|.||++||. +++|.|.|||||+.|||+..++..-|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 9999999999999999874 68999999999999999999996 56789999999999999999999999999
Q ss_pred cCCcccCcCCcce---eecccccccccCccccccCC----C--CccchhHhHHHHHHHHHhC----------CCCCCCCC
Q 047038 525 GASRSIAVDQTHL---TTQVQGTFGYLDPEYFQSSH----F--TEKSDVYSFGVVLVELLTG----------ERPIRLTN 585 (708)
Q Consensus 525 Gls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--t~ksDv~SlGvvl~elltg----------~~P~~~~~ 585 (708)
|||.....+.... ....+||.+|||||++...- + -..+||||||.|+||+..+ +.||....
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9997765443222 23467999999999986532 1 1369999999999999752 34553322
Q ss_pred cchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+.+. ..+.+.+.+-..++...++.+ -...+.+..+.+|++.||..||.-|.|+-.+-+.|.++..
T Consensus 441 p~DP--s~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDP--SFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCC--CHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1110 111111112222222222211 1245677889999999999999999999999999988865
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.02 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=204.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|++.+.||+|+||+||++... +++.+|+|..........+.|.+|++++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457888999999999999999975 6889999998877777788999999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999876432 5899999999999999999999998 99999999999999999999999999875432221
Q ss_pred ceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
......+++.|++||.+. ...++.++||||||+++|||++|+.||....... .... +.....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~----- 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLK-ILKSEP----- 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHH-HhcCCC-----
Confidence 123345899999999875 3457789999999999999999999986432211 0111 111100
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+. ...+......+.+++.+||+.+|.+||++.+|++
T Consensus 226 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00 0011223456889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.32 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=203.4
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999965 68999999887643 34457899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+ +++|.+++.... ..+++.+++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987654 36899999999999999999999998 99999999999999999999999999887654332
Q ss_pred ceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---hhhh---h
Q 047038 536 HLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---RLFE---I 608 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~ 608 (708)
.......++..|+|||.+.+. .++.++||||||++++||++|++||......+ ............ ...+ .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCc
Confidence 223345689999999998654 46899999999999999999988876443221 111111111100 0000 0
Q ss_pred hh----------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LD----------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+ .....+...+....+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000111223477899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.70 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=204.5
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEe-
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCL- 444 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~- 444 (708)
+..+.+..+.++|++.+.||+|+||+||++... +++.+|+|..+... ...+++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 345677788999999999999999999999965 57899999876432 2235788999999999 6999999999885
Q ss_pred ----eCCcceEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 445 ----ETEVPLLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 445 ----~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
.++..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 3456899999999999999876432 2336889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
||+|||+++....... ......|++.|+|||++.. ..++.++||||||+++|||++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 9999999876543221 2233468999999999853 4578899999999999999999999864332110
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
... ..........+ +......+.+|+.+||+.+|++|||++||++.
T Consensus 238 -~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 -LFK-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -Hhh-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 00000000000 11123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.26 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=196.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-----DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 449 (708)
.+|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 6889999987542 123456789999999999999999999998753 567
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 4889999999999999999999988 99999999999999999999999999876
Q ss_pred cCcCCc--ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQT--HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC----
Confidence 532111 112234588999999999998899999999999999999999999964321110 10111000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+....+.+.+++ +||..+|++||+++||++
T Consensus 226 -----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00111223345567777 688899999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.55 Aligned_cols=240 Identities=25% Similarity=0.311 Sum_probs=188.3
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc---CCCceeeeeceEeeCCcceEEEEeccC
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI---NHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
||+|+||+||+|... +++.||||++... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 6899999987542 223344566777777765 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99998887543 5899999999999999999999998 9999999999999999999999999987543222 123
Q ss_pred ecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 539 TQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ....+..+.. .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------~~~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV------RFP--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC------CCC---
Confidence 345699999999998764 48999999999999999999999996543221 1111111110 000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRP----TMREVGI 648 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RP----t~~ev~~ 648 (708)
.......+.+++.+||+.||++|| ++.|+++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112345688999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.84 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=201.3
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
.|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444467999999999999965 688999999876666667789999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........ .
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 99999988543 4889999999999999999999998 99999999999999999999999999875532221 1
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||........ . ..+.. .+..... .
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~----~~~~~-----~~~~~~~--~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M----RRIRD-----NLPPRVK--D 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHh-----cCCCccc--c
Confidence 2334588999999999988899999999999999999999999864332111 0 01110 0111110 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.......+.+++.+||+.+|++|||++|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.52 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=200.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..++||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999976 58899999875422 2345678899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.++..... .+++.+++.++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988765432 4899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH-H-------HHHhhhchh
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY-F-------LRAMREDRL 605 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~-~-------~~~~~~~~~ 605 (708)
.......++..|+|||++.+ ..++.++||||||++++||++|++||......+....... . .........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22333457889999999875 4578899999999999999999999865432211000000 0 000000000
Q ss_pred hh-hhhhhh-----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FE-ILDAQI-----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~-~~d~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ...+.. ........+..+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000 00001233566999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.31 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=194.5
Q ss_pred ccceEeee--ccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 382 TNRILGQG--GQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 382 ~~~~lG~G--~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+.++||+| +|++||++..+ +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999864 7899999998653 2344567788999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999975432 24899999999999999999999998 999999999999999999999999865433211100
Q ss_pred ------eeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 537 ------LTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 537 ------~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
......++..|+|||++.+ ..++.++||||||++++||++|+.||........ .... .. +.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~----~~-~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK----LN-GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHH----hc-CCcccc
Confidence 1122346778999999976 4689999999999999999999999964332110 0000 00 000000
Q ss_pred hh------------------------------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LD------------------------------------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
++ ..............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00000112233457899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.54 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=206.2
Q ss_pred ccChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEe
Q 047038 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCL 444 (708)
Q Consensus 367 ~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 444 (708)
+++..++.+++++|...+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4666778888999999999999999999999964 68899999876532 2345678899999999 8999999999987
Q ss_pred eCC-----cceEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 445 ETE-----VPLLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 445 ~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
..+ ..++||||+++++|.++++... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 543 5799999999999999886432 2336899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcccCcCCcceeecccccccccCccccccC-----CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHH
Q 047038 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-----HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA 593 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~ 593 (708)
+||+|||+++....... ......|+..|+|||.+... .++.++||||||+++|||++|+.||........ +
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L- 242 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H-
Confidence 99999999876542221 12234588999999998653 368899999999999999999999864332111 1
Q ss_pred HHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 594 AYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 594 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. +.......+ .........+.+++.+||+.+|++||++.|+++
T Consensus 243 ---~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 ---FK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 111111001 011223456899999999999999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=317.83 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=200.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh---HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE---SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||+||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 489999998765332 35567999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+.+++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987543 236899999999999999999999998 999999999999999999999999998754321
Q ss_pred Ccc----------------------------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 047038 534 QTH----------------------------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 534 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~ 585 (708)
... ......||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1113457889999999999889999999999999999999999996543
Q ss_pred cchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047038 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646 (708)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 646 (708)
.... +.. +.+...........+..+.+++.+||+.+|++||+++..
T Consensus 237 ~~~~------~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 237 RDET------FSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred hHHH------HHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 2211 111 111111111112245679999999999999999994333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=307.74 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=197.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-----DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 449 (708)
.+|++.++||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 5899999987532 123456889999999999999999999998764 457
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++.... .+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 4788889999999999999999998 99999999999999999999999999876
Q ss_pred cCcCCc--ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQT--HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC----
Confidence 532111 11233458899999999988889999999999999999999999986432111 0 11111000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111233445668899999995 9999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.43 Aligned_cols=197 Identities=26% Similarity=0.405 Sum_probs=160.5
Q ss_pred cceEeeeccEEEEEEEEc---CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcceEEEEecc
Q 047038 383 NRILGQGGQGTVYKGMLE---DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIS 457 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 457 (708)
..+||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999965 35789999876532 23467899999999999999999999864 456789999987
Q ss_pred CCCccccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEeeccCC
Q 047038 458 NGTLSQYIDDQN------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGAS 527 (708)
Q Consensus 458 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGls 527 (708)
+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7776664321 1235889999999999999999999998 9999999999999 56678999999999
Q ss_pred cccCcCCcc--eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 047038 528 RSIAVDQTH--LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 528 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~ 585 (708)
+........ ......||+.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876432221 1234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.00 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=203.6
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee-
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE- 445 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 445 (708)
+..++..+.+.|+..+.||+|+||+||+|... +++.+|+|..... .....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566677889999999999999999999964 6889999987653 33456788999999998 79999999999863
Q ss_pred -----CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 047038 446 -----TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAK 520 (708)
Q Consensus 446 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~k 520 (708)
.+..+++|||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 4567999999999999999876432 35888889999999999999999998 99999999999999999999
Q ss_pred EeeccCCcccCcCCcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH
Q 047038 521 VSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~ 595 (708)
|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.........
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999875532211 122345889999999886 346788999999999999999999999643221110
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. .... ...........+..+.+++.+||+.||.+||++.|+++
T Consensus 236 ~-~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 F-LIPR---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-hHhh---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000 00000111234456999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=307.74 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=202.8
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 453 (708)
+|+..+.||.|+||.||++... +++.||+|.++. ......+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999954 688999998764 345556789999999999999999999998764 34578999
Q ss_pred EeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 454 EFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLH-----SAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH-----~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
||+++++|.+++.... ....+++..++.++.|++.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997642 2346899999999999999999999 555 999999999999999999999999998
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
........ ......+++.|+|||.+....++.++||||||+++++|++|+.||......+ +...+....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~--- 226 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGK--- 226 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhcCC---
Confidence 87653332 1233468999999999999889999999999999999999999997544211 111111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+......+.+++.+||+.+|++||++++|++
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11223344567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=308.35 Aligned_cols=256 Identities=28% Similarity=0.426 Sum_probs=206.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999954 67899999886532 33667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.++++.......+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986544346899999999999999999999998 99999999999999999999999999876654322
Q ss_pred c---eeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 536 H---LTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 536 ~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
. ......|+..|+|||++... .++.++|+||||++++||++|+.||....... .+....... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CC
Confidence 2 22334588999999998876 78999999999999999999999996433221 111111111 00
Q ss_pred hhhccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...... ....+..+.+++.+||+.||++||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 010000 1234567899999999999999999999974
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.22 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=197.2
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|+||+||+|... +|+.||+|+++... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 68899999876532 22345688899999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++ +|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 7877776533 25899999999999999999999998 99999999999999999999999999886543221
Q ss_pred ceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chh---hhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRL---FEI 608 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~ 608 (708)
......++..|+|||.+.+. .++.++||||||++++||++|..|+......+ ..+. ........ ..+ .+.
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLK-RIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHH-HHHHHhCCCChHHhHHhhhc
Confidence 12334578899999998764 47899999999999999999998864333221 1111 11111100 000 000
Q ss_pred hhhhhh---------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQIL---------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.... .+........+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0111223467889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.31 Aligned_cols=242 Identities=27% Similarity=0.489 Sum_probs=196.6
Q ss_pred cccceEeeeccEEEEEEEEc-CCcEEE---EEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc--ceEEE
Q 047038 381 NTNRILGQGGQGTVYKGMLE-DGKIVA---VKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV--PLLVY 453 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~-~~~~vA---vK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 453 (708)
+...+||+|+|-+||||.+. +|..|| ||.-+. ..+...+.|..|+.+|+.|+|+|||++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999975 466665 332222 345667899999999999999999999999987665 78999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGls~~~~~ 532 (708)
|.+..|+|..|+++++ .++.+....|+.||++||.|||++. |||||||||=+||+|+.+ |.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999999876 5888999999999999999999986 789999999999999865 8999999999987754
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH---hhhchhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA---MREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 609 (708)
.. ...+.|||.|||||.+. ..|.+.+||||||+.|+||+|+..||. +..+.++..... ++...+..+-
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCCCHHHhhccC
Confidence 33 33478999999999988 789999999999999999999999985 333333332222 2222222222
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
| .+++++|.+||.. .++|||+.|+++
T Consensus 270 d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 D------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2 3488999999999 999999999974
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.67 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=197.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..+.||+|++|+||+|..+ +++.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 68899999876532 22234578899999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++ +|.+++..... .+++...+.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 89988876533 5889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh---hchhhhhh--
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR---EDRLFEIL-- 609 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 609 (708)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ........+. ........
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhc
Confidence 1222346889999999865 4588999999999999999999999965432111 1111111111 00000000
Q ss_pred ------------hhhhhccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 ------------DAQILKEG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 ------------d~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0111256789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=297.25 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=202.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++.|++-++||+|.|+.||+.... +|+.+|+|.+.. ......+++.+|+.|.+.|+|||||+|.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3467888889999999999998854 688899987654 3344678899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGls~~ 529 (708)
+|+|.|++|..-+-.. ...++..+-..+.||++||.|.|..+ |+|||+||+|+||-. .--+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999986555433 35788888899999999999999999 999999999999953 34599999999998
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
+. ....-....|||+|||||++...+|+..+|||+-||+||-|+.|.+||....... .+.+.+ .+..
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye~I~-~g~y---- 229 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYEQIK-AGAY---- 229 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHHHHh-cccc----
Confidence 76 2333455679999999999999999999999999999999999999996533221 111111 1111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
| .....-....++..+|+++||..||.+|.|+.|.+.
T Consensus 230 d--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 D--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred C--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 011112234456889999999999999999998763
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.81 Aligned_cols=252 Identities=24% Similarity=0.444 Sum_probs=202.1
Q ss_pred CCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 379 NFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
+|+..++||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999995 578899999876422 2245789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCccc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSI 530 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~ 530 (708)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997543 5889999999999999999999998 99999999999998775 6999999998766
Q ss_pred CcCCcc---eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 531 AVDQTH---LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 531 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~-------- 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKI-------- 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHH--------
Confidence 432111 1223457899999999988889999999999999999999999986433221111 10000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+......+.+++.+||+.+|++||++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 -ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000111223344567899999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.91 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+|+..+.||+|++|.||+|+.. +++.||||.++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999975 68899999887643 234567889999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++ +|.+++........+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888876554456899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh-----
Q 047038 537 LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD----- 610 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 610 (708)
......++..|++||.+.+ ..++.++||||||++++||++|+.||......+................+..+.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1223457889999998865 4578999999999999999999999976544322111100000000000000000
Q ss_pred h-------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 A-------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. .............+.+++.+||+.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000111123456889999999999999999999973
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=308.88 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=199.4
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC----------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID----------ESKVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~----------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
+|...+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 68899999875311 112356889999999999999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 5899999999999999999999988 999999999999999999999999998
Q ss_pred cccCcCCcc-eeecccccccccCccccccCC--CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 528 RSIAVDQTH-LTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 528 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+........ ......++..|+|||.+.... ++.++|+||||++++||++|..||......+ ..+ ..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~-~~~~~-~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMF-KLGNK-R 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHH-Hhhcc-c
Confidence 765322111 123456889999999987654 8899999999999999999999985322111 111 11100 0
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+ ..+.....+..+.+++.+||+.+|++||++++|++
T Consensus 229 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 01111 11112234567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.45 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=201.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 6888999987653 344567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 235899999999999999999999998 9999999999999855 468999999988654322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......++..|+|||.+....++.++||||||+++++|++|+.||...+... . ...... ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~---~~~~~~-~~~--------- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L---VLKIMS-GTF--------- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H---HHHHHh-cCC---------
Confidence 1223458889999999998889999999999999999999999986543221 1 111111 100
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+++.+||+.+|++|||++|+++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112223456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.70 Aligned_cols=251 Identities=28% Similarity=0.472 Sum_probs=202.2
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh--HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999965 688999999876443 4678899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997643 4788999999999999999999998 99999999999999999999999999887654332
Q ss_pred ceee---cccccccccCccccccCC---CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 536 HLTT---QVQGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 536 ~~~~---~~~gt~~y~aPE~~~~~~---~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.... ...++..|++||++.... .+.++||||||++++||++|+.||........ .. + . ...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~--~-~-~~~~~~---- 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM--F-H-VGAGHK---- 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH--H-H-HhcCCC----
Confidence 2211 345788999999998766 88999999999999999999999964321110 00 0 0 000100
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.+. ........+.+++.+||+.+|++||++.|++.
T Consensus 225 -~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 -PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 01122456789999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.76 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=201.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 57899999876532 234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997643 5899999999999999999999998 999999999999999999999999998642110
Q ss_pred C--------------cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH
Q 047038 534 Q--------------THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 534 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
. ........++..|+|||.+....++.++|+||||+++|||++|..||......+ .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~-~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LF-GQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HH
Confidence 0 001122457889999999988889999999999999999999999996433221 11 11
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
...+.. ..+ ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDI---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhccc---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111100 000 0011234568999999999999999997666655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.58 Aligned_cols=200 Identities=29% Similarity=0.380 Sum_probs=173.9
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-C-----CceeeeeceEeeCCcceE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-H-----RNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 451 (708)
+|.+.++||+|.||.|.|+... +++.||||+++. ...-..+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999954 699999999986 3445567788999999997 4 489999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--CcEEEeeccCCcc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK--YCAKVSDFGASRS 529 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~--~~~kl~DFGls~~ 529 (708)
|+|.++. +|.++|+.+.-. .++...+..|+.||+.||.+||+.+ |||.||||+||||.+. ..+||+|||+|..
T Consensus 266 VfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999965 999999877533 5899999999999999999999998 9999999999999754 3699999999986
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~ 588 (708)
....- . ....+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+
T Consensus 341 ~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 341 ESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 54221 2 4456788999999999999999999999999999999988887666444
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=310.69 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=198.1
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|++|.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999965 68899999876532 23346789999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 58888886543 236899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccccCC-CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh-chh----hhh-
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE-DRL----FEI- 608 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~- 608 (708)
......++..|+|||.+.+.. ++.++||||||++++||+||+.||......+ .+.......-.. ... ..+
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence 122334688999999887644 6889999999999999999999997543221 111111100000 000 000
Q ss_pred -----hh---hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 -----LD---AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 -----~d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+. ..............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00000001122355789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=312.08 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=205.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888999999999999999854 6789999998765556667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999998753 4789999999999999999999998 99999999999999999999999998876543322
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......+++.|++||.+....++.++||||||+++|+|++|+.||......+... .....+. ...
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~--------~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC--------CCC
Confidence 1223458889999999988889999999999999999999999996543321100 0000000 000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.........+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334568899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.62 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=207.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..+.||+|++|.||++... +++.||||++..... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 589999998876443 5567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999765 268999999999999999999999 88 9999999999999999999999999988664332
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||............... .... .
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~---------~ 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGP---------P 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCC---------C
Confidence 22 22345788999999999999999999999999999999999999655421111111111 1110 0
Q ss_pred ccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKD-EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...... .+..+.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111222 4567999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.63 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=201.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
-|+..+.||+|+||.||+|... +++.||+|...... ....+.|.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 68899999876433 345578999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999998643 5899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
......++..|+|||.+.+..++.++||||||+++++|++|..||....... ....+.... ...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNN---------PPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCC---------CCC
Confidence 1223457889999999998889999999999999999999999986432211 000111110 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122345668899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.28 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=194.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHH-HHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVI-LSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 68999999886532 2334556667765 566799999999999999999999999
Q ss_pred eccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 455 FISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|++ ++|.+++.... ....+++..++.++.||+.||+|||+. + ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 68888776432 234689999999999999999999986 6 99999999999999999999999999876532
Q ss_pred CCcceeecccccccccCcccccc----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQS----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.. ..+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... . ......... .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~----~~~~~~~~~-~--- 225 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-Q----QLKQVVEEP-S--- 225 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-H----HHHHHHhcC-C---
Confidence 21 1233458889999998864 456889999999999999999999985322111 0 011111100 0
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.+ .....+..+.+++.+||+.+|++||+++++++
T Consensus 226 --~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 --PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01123456899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.82 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=199.8
Q ss_pred ccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 382 TNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999965 688999999876555566789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeec
Q 047038 461 LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540 (708)
Q Consensus 461 L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~ 540 (708)
|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 105 LTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 99887542 5899999999999999999999998 99999999999999999999999999875543221 1233
Q ss_pred ccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHH
Q 047038 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKD 620 (708)
Q Consensus 541 ~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 620 (708)
..|+..|+|||++.+..++.++||||||++++||++|+.||......+. . ..+..... .. ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~----~~~~~~~~-----~~--~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---M----KRLRDSPP-----PK--LKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHhccCC-----CC--ccccCC
Confidence 5689999999999988899999999999999999999999964332211 1 11111100 00 001112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 621 EFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 621 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+.+++.+||+.+|++||+++|+++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 34568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.04 Aligned_cols=260 Identities=27% Similarity=0.353 Sum_probs=199.7
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh-----HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE-----SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
+|+..+.||+|+||.||+|... +++.||||.++.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 689999999875332 2345678899999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+ +++|.+++.... ..+++..++.++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997653 25899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---h----
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---R---- 604 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~---- 604 (708)
... ......+++.|+|||.+.+ ..++.++||||||++++||++|.+||......+. +...+ ...... .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIF-EALGTPTEENWPGV 230 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHH-HHcCCCchhhhhhc
Confidence 321 1223346788999998854 4678999999999999999999888765443221 11111 111000 0
Q ss_pred --hhhhhhhhh-----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 --LFEILDAQI-----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 --~~~~~d~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+........ ...........+.+++.+||+.+|++|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000 00011223467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=307.81 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=203.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 68899999876643 45567899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++.... ..+++.....++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999998653 368899999999999999999999 77 9999999999999999999999999987653222
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ...............
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~---------- 221 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP---------- 221 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC----------
Confidence 1 12568889999999999999999999999999999999999986443211 111111111111100
Q ss_pred ccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKD-EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...... ....+.++|.+||..+|++|||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011111 4556899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.02 Aligned_cols=263 Identities=21% Similarity=0.325 Sum_probs=197.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCc-----
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEV----- 448 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 448 (708)
++|+..+.||+|+||.||+|... +++.||+|..+... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 68999999876532 223467889999999995 6999999999987666
Q ss_pred ceEEEEeccCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeecc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNK--DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFG 525 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFG 525 (708)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888765432 246899999999999999999999998 999999999999998 8999999999
Q ss_pred CCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc-
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED- 603 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~- 603 (708)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......+. +.. +.......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCCC
Confidence 9876533211 1222346888999998865 4578999999999999999999999975433221 111 11111000
Q ss_pred --hhhhhh-----------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 --RLFEIL-----------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 --~~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...... .+.............+.++|.+||+.+|.+||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 000001111234566899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.15 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCC----
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE---- 447 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~---- 447 (708)
..++++|++.+.||+|++|.||+|... +++.+++|.+..... ..++|.+|+.+++++ +|+||+++++++.+..
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 356789999999999999999999975 578899998776443 446799999999999 7999999999997655
Q ss_pred --cceEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 448 --VPLLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 448 --~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 3799999999999999987533 2346899999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCcCCcceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
|++....... .......++..|+|||++.. ..++.++||||||++|++|++|+.||....... .. ..
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~~- 229 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--AL----FK- 229 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HH----HH-
Confidence 9987543222 12233458899999998753 346789999999999999999999996332111 00 01
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+...... . ..........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~-----~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPP-----T--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCC-----C--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111000 0 0111224467899999999999999999999974
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.16 Aligned_cols=243 Identities=28% Similarity=0.369 Sum_probs=200.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|+..+.||+|+||.||++... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 6899999987642 2345677999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 5899999999999999999999988 999999999999999999999999998876433
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.||....... .. .....+..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~-------- 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IY----EKILEGKV-------- 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcCCc--------
Confidence 233458899999999988889999999999999999999999996443111 00 11111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVG 647 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~ 647 (708)
..+......+.+++.+||+.+|.+|| +++|++
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11222345688999999999999998 666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.41 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=197.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999864 68899999886533 223346789999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67766665432 25788888999999999999999998 999999999999999999999999998754322
Q ss_pred CcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---c------
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---D------ 603 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~------ 603 (708)
.. ......+++.|+|||.+.+. .++.++||||||++++||++|+.||........ ........... .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhh
Confidence 21 12233478899999998754 578899999999999999999999975443211 11111110000 0
Q ss_pred hh----hhhhh---hhhhcc--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 RL----FEILD---AQILKE--GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ~~----~~~~d---~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+ .+... +..... ........+.+++.+|++.||++|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00000 000000 00112356889999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.82 Aligned_cols=258 Identities=27% Similarity=0.353 Sum_probs=201.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 453 (708)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 57889999877533 34567799999999999999999999998654 3679999
Q ss_pred EeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
||+++++|.+++.... ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876422 2345889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcc--hhhhHHHHHHHHhhhchhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE--EDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......+ ........+ .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~-~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPEL-K 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhh-c
Confidence 21 12344788999999999999999999999999999999999999755321 11111111 111111111 0
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... .......+.+.+++.+||+.+|++|||+.||++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 001223467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.32 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=201.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|+||.||+|... +|+.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 5888999987653 224456788999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++..... ..+++..++.++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876432 35799999999999999999999998 99999999999999885 56999999987654322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......|++.|+|||++.+..++.++||||||++++||++|+.||......+ ....... +..
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~--------- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYF--------- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccC---------
Confidence 12233458899999999988889999999999999999999999986433211 1111111 111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+++.+||+.+|++|||+.||++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112233456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.96 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=198.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.+.|+..+.||+|+||+||+|... +++.||+|.+... .....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999965 6889999987642 234456799999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||++ |+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 577776654332 5899999999999999999999998 99999999999999999999999999875532
Q ss_pred CCcceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||........ . . . ......
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~--~-~-~~~~~~---- 231 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L--Y-H-IAQNDS---- 231 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---H--H-H-HhcCCC----
Confidence 2 2345788999999874 45688999999999999999999999864332111 0 0 0 000000
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
...........+.+++.+||+.+|++||++.+|+...
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0001122345689999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=307.30 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=210.7
Q ss_pred ccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..-|.+.+.||+|.|..|-+++ .-+|..||||++... +......+++|++.|+-++|||||+||.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4557777889999999999998 458999999998663 3444567999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~~~~~ 532 (708)
|+-++|+|.+|+-++.. -+.+....+++.||+.|+.|.|+.. ++||||||+||.+- .-|-+||.|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999988765 4899999999999999999999999 99999999998775 568899999999987765
Q ss_pred CCcceeecccccccccCccccccCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ..+...|...|-|||++.+..|+ +++||||||||||-|++|++||+..+..+ .+..++|-
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence 43 34566799999999999998775 68999999999999999999997655443 23334443
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. ...+.....+..+||..||..||++|.+.+||+.
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 2345667788999999999999999999999863
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.45 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=200.3
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceEEEE
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYE 454 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 454 (708)
|+..+.||+|+||.||+|... +++.+|+|++... .....+.+.+|+.++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 5889999998764 244456789999999999999999999999988 88999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++ +|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888886543 36899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh---hchhh----
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR---EDRLF---- 606 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 606 (708)
....+...++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... ....... .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhcccccc
Confidence 222334457889999998764 467899999999999999999999997554322111 1111100 00000
Q ss_pred ----------hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 607 ----------EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 607 ----------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......+........+..+.+++++||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000001111112567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.77 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=201.5
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999964 6889999998766666677899999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ ..
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999998762 5899999999999999999999998 99999999999999999999999998875543221 12
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....|++.|+|||.+.+..++.++||||||++++||++|+.||...+..+. . ....... .+.. ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~----~~~~~~~-----~~~~--~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---M----KRIRDNL-----PPKL--KNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---H----HHHHhcC-----CCCC--ccc
Confidence 334588999999999988899999999999999999999999864332111 1 1111110 0000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 123456999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.55 Aligned_cols=266 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred CCcccceEeeeccEEEEEEEEc---CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccce
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE---DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPL 450 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 450 (708)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999965 47899999887632 44456788999999999999999999999988 7899
Q ss_pred EEEEeccCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC----CCcEEEeec
Q 047038 451 LVYEFISNGTLSQYIDDQNK--DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD----KYCAKVSDF 524 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~----~~~~kl~DF 524 (708)
+||||+++ +|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666643322 236899999999999999999999998 999999999999999 999999999
Q ss_pred cCCcccCcCCc--ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh------hHHHH
Q 047038 525 GASRSIAVDQT--HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK------SLAAY 595 (708)
Q Consensus 525 Gls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~------~~~~~ 595 (708)
|+++....... .......++..|+|||.+.+ ..++.++||||||++++||++|++||......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543222 11234567899999998876 45789999999999999999999999765433200 00001
Q ss_pred HHHHhhhc------------hhhhhhhhhhhccCC-----------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 596 FLRAMRED------------RLFEILDAQILKEGG-----------KDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 596 ~~~~~~~~------------~~~~~~d~~~~~~~~-----------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+...+... ......+........ ......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 000000000000000 023356889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.71 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=200.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 452 (708)
++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 58899999887533 22334678899999999999999999999877 889999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++ +|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 89888876443 5899999999999999999999998 99999999999999999999999999886643
Q ss_pred CCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---------
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE--------- 602 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------- 602 (708)
... ......+++.|+|||.+.+. .++.++|+||||++++||++|+.||......+..............
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 321 12334578899999998754 4689999999999999999999999754432211111000000000
Q ss_pred -----chhhhhhhhhhhccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 -----DRLFEILDAQILKEGGKD-EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 -----~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+....+.. ..+.+.+++++||+.+|++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000001111111111 3566889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.24 Aligned_cols=269 Identities=23% Similarity=0.336 Sum_probs=201.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----c
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----V 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~ 448 (708)
.+++|++.++||+|+||+||+|... +++.||||.++... ......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999964 68999999886432 334567889999999999999999999876543 4
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++|+||+++ +|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 7899999975 777777543 5899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCcCCcc--eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---
Q 047038 529 SIAVDQTH--LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE--- 602 (708)
Q Consensus 529 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--- 602 (708)
........ ......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||........ ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 65432211 1233568899999998755 5689999999999999999999999965432211 1111111110
Q ss_pred chhhhhhhhhh-------h-------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcccc
Q 047038 603 DRLFEILDAQI-------L-------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIRG 655 (708)
Q Consensus 603 ~~~~~~~d~~~-------~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~ 655 (708)
+.+..+.+... . ..........+.+++.+||+.+|++|||+.|+++. |+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00111110000 0 00011224568899999999999999999999865 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=297.65 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=205.2
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
.|+..+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999976 688999999887655677889999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 36899999999999999999999988 99999999999999999999999999876654332
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
.....++..|++||.+.....+.++||||||+++++|++|+.||......... ... ........ ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~~~~~~~-------~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---FKI----ATNGPPGL-------RN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHH----HhcCCCCc-------Cc
Confidence 33456889999999999888999999999999999999999998643321110 000 00000000 00
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456899999999999999999999974
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.08 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=206.4
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..++.|+..+.||+|++|.||+|... +++.||+|.+..... ..+.+.+|++++++++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667888899999999999999976 688999999876544 5678999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999998754 36899999999999999999999988 999999999999999999999999987654322
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.. ......++..|++||.+.+..++.++||||||+++|+|++|+.||........ ...... .....
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~------ 235 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITT-KGIPP------ 235 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-cCCCC------
Confidence 11 12234578899999999988899999999999999999999999864332211 001001 00000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+..+.+++.+||+.+|.+||++.+|++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111123456899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.34 Aligned_cols=257 Identities=18% Similarity=0.268 Sum_probs=186.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEcccCChHH-----------HHHHHHHHHHHHhcCCCceeeeec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKIIDESK-----------VEEFINEVVILSQINHRNVVKLLG 441 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g 441 (708)
.++|++.++||+|+||+||+|...+ ++.+|+|......... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999654 4566777543322111 112234445566778999999999
Q ss_pred eEeeCC----cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 442 CCLETE----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 442 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
++.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 23567776643 5555554332 3578888999999999999999998 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhh
Q 047038 518 CAKVSDFGASRSIAVDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS 591 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~ 591 (708)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||++|+||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999866432211 1123469999999999999999999999999999999999999997653322110
Q ss_pred H--HHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 592 L--AAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 592 ~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
. ...+...+..+ ... ....++.+.+++..|++.+|++||++.++.+.|+
T Consensus 244 ~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEG--------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhh--------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 01111111111 111 1122466899999999999999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.86 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=198.1
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
|+..+.||.|++|+||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999965 79999999876532 233467889999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
+ ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689998876532 35899999999999999999999988 999999999999999999999999999765432211
Q ss_pred eeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc--h------hhh
Q 047038 537 LTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--R------LFE 607 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~------~~~ 607 (708)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ +...+....... . +.+
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 1223468899999988664 578999999999999999999999965433211 111111000000 0 000
Q ss_pred hhh------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILD------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ..............+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00000111223356889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.03 Aligned_cols=247 Identities=23% Similarity=0.424 Sum_probs=199.9
Q ss_pred CCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeCCcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII-DESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 453 (708)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 47899999987653 3455678899999999996 999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++... .+++...+.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988653 5899999999999999999999998 999999999999999999999999998766543
Q ss_pred CcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||......... ....... .+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~-----~~~ 221 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSK-----PPR 221 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCC-----CCC
Confidence 32 22334688999999998754 4689999999999999999999999643322110 0000000 011
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.. ...+..+.+++.+||+.+|++||++.|++.
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 113456899999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.81 Aligned_cols=247 Identities=27% Similarity=0.348 Sum_probs=203.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
+|+..+.||.|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999976 5889999987642 23456789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++... ..+++.....++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 26899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......|+..|+|||.+.+..++.++|+||||+++++|++|+.||......... .+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc----------cc
Confidence 223456888999999999888999999999999999999999999765443111 11111111 00
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTM--REVG 647 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~ev~ 647 (708)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122334678999999999999999999 6553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=309.54 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=200.4
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC---
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE--- 447 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--- 447 (708)
+...++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999975 58899999886532 233456788999999999999999999987655
Q ss_pred -------cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 047038 448 -------VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAK 520 (708)
Q Consensus 448 -------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~k 520 (708)
..++|+||+++ +|..++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999986 6767666542 25899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH
Q 047038 521 VSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
|+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|++||......+ ....+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence 99999998765433222233346788999998865 457899999999999999999999996433221 11111111
Q ss_pred hhhc---hhhhhh--------hh------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 600 MRED---RLFEIL--------DA------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 600 ~~~~---~~~~~~--------d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.... ...++. +. .... .....+..+.+++.+||+.+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110 000000 00 0000 01123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.99 Aligned_cols=271 Identities=22% Similarity=0.324 Sum_probs=203.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE----- 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 447 (708)
..++|.+.+.||+|+||+||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467899999999999999999964 6899999987642 2334567889999999999999999999886543
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+. ++|.+++.... .+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 68888886543 5899999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH--------
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR-------- 598 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-------- 598 (708)
+...... .......++..|+|||.+.. ..++.++||||||+++++|++|+.||......+..........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8654332 22234457889999998865 4688999999999999999999999975432221111111100
Q ss_pred Hhhhchhhhhhh-------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcccc
Q 047038 599 AMREDRLFEILD-------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIRG 655 (708)
Q Consensus 599 ~~~~~~~~~~~d-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~ 655 (708)
.+........+. ... ..........+.+++++||+.+|++|||++|+++. |..++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000000000000 000 00112345668999999999999999999999866 655544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.04 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=201.7
Q ss_pred CCcccceEeeeccEEEEEEEEcCCc-EEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGK-IVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~-~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
.|.++..||.|+||.|||+..++.. ..|.|.+........++|+-||+||....||+||+|++.|...+.++|+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3555667999999999999977544 456788888888899999999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
||-++..+-.... .|.+.++.-++.|++.||.|||+.. |||||||..|||++-+|.++|+|||.+-... .....
T Consensus 113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 9999988876544 6999999999999999999999999 9999999999999999999999999875321 11122
Q ss_pred eecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 538 TTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
...+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|-...+. ..+.-.+.... +.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSe------PP 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE------PP 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcC------CC
Confidence 34578999999999864 56899999999999999999999999542221 11111111111 11
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.+ +..-...+.+++.+||.+||..||++.++++
T Consensus 254 TLlq-PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLLQ-PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cccC-cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111 2233456899999999999999999999874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=327.61 Aligned_cols=267 Identities=20% Similarity=0.286 Sum_probs=191.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEcC--CcEEEEE------------------EcccCChHHHHHHHHHHHHHHhcCCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLED--GKIVAVK------------------KSKIIDESKVEEFINEVVILSQINHRN 435 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~n 435 (708)
..++|++.+.||+|+||+||++..+. +...++| +++ ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 12234457889999999999999
Q ss_pred eeeeeceEeeCCcceEEEEeccCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 047038 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNK--DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL 513 (708)
Q Consensus 436 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll 513 (708)
||++++++.+.+..++|+|++. ++|.+++..... ...........++.||+.||.|||+.+ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 467776654321 112345667789999999999999998 9999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCC-CCCCCCcchhhhH
Q 047038 514 DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGER-PIRLTNSEEDKSL 592 (708)
Q Consensus 514 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~-P~~~~~~~~~~~~ 592 (708)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||+||||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765443333344679999999999999999999999999999999999875 4433322222222
Q ss_pred HHHHHHHhh--hc-------hhhhhhhhhhhccC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 593 AAYFLRAMR--ED-------RLFEILDAQILKEG---------GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 593 ~~~~~~~~~--~~-------~~~~~~d~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... .+. .. .+.+.++....... .......+.+++.+||+.||++|||+.|++.
T Consensus 381 ~~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 22111 100 00 01111111000000 0012245678899999999999999999975
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.39 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=197.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 451 (708)
.++|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999975 68999999876532 22234567899999999999999999998765 46799
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++ +|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 7888876543 36899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh--chhh-h
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE--DRLF-E 607 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~-~ 607 (708)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ......... .... .
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhchh
Confidence 3321 1223345788999999865 55789999999999999999999999754432211 111111100 0000 0
Q ss_pred h--------h--hhhh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 I--------L--DAQI---LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~--------~--d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. . .... .........+.+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0 0000 00000112456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.87 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=199.9
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.|+..+.||+|+||.||++... ++..||+|.+... .....+.+.+|++++++++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999964 6889999987642 23445679999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+.+ +|.+++.... ..+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9974 7777775433 25899999999999999999999998 99999999999999999999999999875432
Q ss_pred cceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.....+++.|+|||++. .+.++.++||||||++++||++|+.||........ ........
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~-------- 240 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-------- 240 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhcc--------
Confidence 22345888999999974 45689999999999999999999999864321111 00011100
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
............+.+++.+||+.+|.+||++.+|++.+..+..
T Consensus 241 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 241 -SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0011122334568999999999999999999999987666554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.33 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=204.8
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|++.+.||+|+||.||++... +++.+|+|.+... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 6889999987653 345567889999999999999999999999999999999999
Q ss_pred ccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 1246899999999999999999999998 999999999999999999999999999876543
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......+++.|++||.+.+..++.++|+||||++++||++|+.||......+ +.........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKY--------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC---------
Confidence 2223457889999999999999999999999999999999999996544321 1111111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+++.+||+.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122344566999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.04 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=206.0
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceEEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVY 453 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 453 (708)
+|+..+.||+|++|.||+|... +++.|++|...... ....+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 68899999876644 35677899999999999999999999999988 8899999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998654 6899999999999999999999988 999999999999999999999999998876543
Q ss_pred Ccc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
... ......++..|++||.+.....+.++||||||+++++|++|..||...... ......... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~---------~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGS---------SG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccc---------cC
Confidence 321 123356889999999999888999999999999999999999999754411 111111110 01
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+...+..+.+++.+||+.+|++||++.|++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122333567999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=303.91 Aligned_cols=257 Identities=22% Similarity=0.279 Sum_probs=193.8
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeC--CcceEEEE
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQIN-HRNVVKLLGCCLET--EVPLLVYE 454 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 454 (708)
|++.+.||+|+||.||+|... +++.||+|+++.. .........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999965 6889999987653 2223334568999999885 99999999999987 88999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58877776543 26899999999999999999999998 999999999999999 999999999998654322
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh-----------h
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR-----------E 602 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----------~ 602 (708)
. .....++..|+|||.+.. ..++.++||||||++++||++|+.||...+..+. ......... .
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence 1 223457889999997654 5678999999999999999999999976543221 111111000 0
Q ss_pred chhhhhhhhhh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 DRLFEILDAQI----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 ~~~~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
........+.. ........+..+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000 00001234577999999999999999999999974
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.92 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=203.9
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcce
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 450 (708)
......|+++++||+||.+.||++...+.+.+|+|++.. .+.....-|.+|+..|.+| .|.+||+|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 444567899999999999999999998889999997654 6677888999999999999 4999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
||||+=+ .+|..+|...... ...| .+..+..|++.|+.++|.++ |||.||||.|+|+-. |.+||+|||+|..+
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEeeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999864 5899999876542 2334 66778899999999999999 999999999999875 57999999999988
Q ss_pred CcCCccee-ecccccccccCccccccC-----------CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH
Q 047038 531 AVDQTHLT-TQVQGTFGYLDPEYFQSS-----------HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 531 ~~~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 598 (708)
..+.+... ...+||+.||+||.+... +.++++||||||||||+|+.|+.||. +.......
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aK--- 581 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAK--- 581 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHH---
Confidence 87766553 346799999999988532 25689999999999999999999984 22222222
Q ss_pred HhhhchhhhhhhhhhhccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 599 AMREDRLFEILDAQILKEGGK-DEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+..+.|+...-+++. ....++.++++.||++||++||++.|+++
T Consensus 582 ------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 334444432222211 11123899999999999999999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.50 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=198.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC------
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 446 (708)
..++|+..+.||+|+||+||++... +++.||||.+.. .+....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 789999998754 3344556788999999999999999999998643
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999964 78777753 2788899999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh--ch
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE--DR 604 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~ 604 (708)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+..... ......... ..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW---NKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCCHH
Confidence 98654322 123345788999999999999999999999999999999999999754422111 000000000 00
Q ss_pred -----------------------hhhhhhhhhh----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 -----------------------LFEILDAQIL----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 -----------------------~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.+....... ..........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000 0001233566889999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=306.19 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=197.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..+.||+|++|+||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 68899999876532 2344678899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccCCcccCcC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~~~~~~ 533 (708)
|++ ++|.+++.... ...+++.....++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 47877775433 234688888899999999999999998 999999999999985 567999999999765432
Q ss_pred CcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---hh----
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---RL---- 605 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~---- 605 (708)
. .......+++.|+|||++.+ ..++.++||||||+++++|++|+.||......+. ... ........ .+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVT 232 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhccccc
Confidence 1 11233457889999998866 4578999999999999999999999975433221 111 11111100 00
Q ss_pred --hhhh------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 --FEIL------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 --~~~~------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.. ...............+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000011223456889999999999999999999974
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=313.33 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=199.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC--Ccc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~ 449 (708)
..++|+..+.||+|+||.||+|... +++.+|+|++.. ........+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999975 688999998754 2344556788999999999 999999999998654 367
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 4898888653 5889999999999999999999998 99999999999999999999999999986
Q ss_pred cCcCCc----ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH-------
Q 047038 530 IAVDQT----HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL------- 597 (708)
Q Consensus 530 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~------- 597 (708)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12234568999999998765 557899999999999999999999996544322111100000
Q ss_pred -HHhhhchhhhhhhh------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 598 -RAMREDRLFEILDA------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 598 -~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+......++++. .............+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000001100 00001111235678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.36 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=196.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-----
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----- 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 448 (708)
.++|+..+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999965 68999999875432 2233456789999999999999999999876544
Q ss_pred ---ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 449 ---PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 449 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.++||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 7877776543 25899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcc---eeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 526 ASRSIAVDQTH---LTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 526 ls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
++......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432211 12234578899999988664 478899999999999999999999976543322222221111100
Q ss_pred hchhhh-----hhhhh-hhccC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 EDRLFE-----ILDAQ-ILKEG---------GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 ~~~~~~-----~~d~~-~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.... ..+.. ..... .......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 00000 00000 0011245679999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.06 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=204.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.+.|..-++||+||||+||-.+.+ +|+.+|.|++.... .....-.++|-.||++++.+.||.+--.|+..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356788899999999999999865 69999999775422 22334578999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
+..|.||+|.-+|...+. .-+++..++.+|.+|+-||++||... ||.|||||+|||||+.|+++|+|+||+..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999988764 36899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.+. .+..+||.+|||||++++..|+...|.|||||+||||+.|+-||........ .+-+|..
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdrr 401 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDRR 401 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHHH
Confidence 543 3344799999999999999999999999999999999999999965433221 1112222
Q ss_pred hh---ccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047038 613 IL---KEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644 (708)
Q Consensus 613 ~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 644 (708)
+. .+++...+++..+|.+..|++||++|.-.+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11 233455567788999999999999996443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.03 Aligned_cols=243 Identities=27% Similarity=0.424 Sum_probs=197.9
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCcc
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLS 462 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 462 (708)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 78999999987655566778999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeeccc
Q 047038 463 QYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542 (708)
Q Consensus 463 ~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~ 542 (708)
+++... .+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 987543 4789999999999999999999998 99999999999999999999999999876543221 123345
Q ss_pred ccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHH
Q 047038 543 GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEF 622 (708)
Q Consensus 543 gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 622 (708)
+++.|++||.+.+..++.++|+||||++++||++|..||......+.. . ..... +..... ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~----~~~~~-----~~~~~~--~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIRDN-----LPPKLK--NLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhh-----CCcccC--CcccCC
Confidence 889999999998888999999999999999999999998643322111 1 11100 000000 011234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 623 KMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 623 ~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 55889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=302.91 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=201.3
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh--HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
|+..+.||+|++|.||++... +++.+|+|.++.... .....+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999965 788999998765332 34568889999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++ +|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 8888887643 36899999999999999999999998 9999999999999999999999999987765433 1
Q ss_pred eeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chhhhhhh--
Q 047038 537 LTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRLFEILD-- 610 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 610 (708)
......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+..... ...... ..+....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhhh
Confidence 22334578899999998876 7899999999999999999999999655433221111 111000 00000000
Q ss_pred ----hh-------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 ----AQ-------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ----~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ...+........+.+++.+||+.+|.+||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 000111234567999999999999999999999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.57 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=194.3
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|...++||+|+||+||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999965 68999999876532 345667899999999996 99999999999999999999999
Q ss_pred ccCCCcccccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 456 ISNGTLSQYID---DQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 456 ~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
+.. +|.++.. .. ....+++.....++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 5544332 22 123689999999999999999999975 6 9999999999999999999999999987654
Q ss_pred cCCcceeecccccccccCccccccC---CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSS---HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||.... .............
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~----- 227 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD----- 227 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-----
Confidence 3221 2233588999999999776 68999999999999999999999986432 1111111111110
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.+........+..+.+|+.+||+.+|++|||++||++
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111222335567999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.51 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=200.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEee----CCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 449 (708)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478899999999999999999965 68999999876532 2345678899999999999999999998763 3457
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58988886543 4899999999999999999999998 99999999999999999999999999876
Q ss_pred cCcCCc---ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------H
Q 047038 530 IAVDQT---HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF--------L 597 (708)
Q Consensus 530 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~ 597 (708)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||............... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 543221 11234568899999999865 46889999999999999999999999654432211111110 0
Q ss_pred HHhhhchhhhhhhhhh-h-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 598 RAMREDRLFEILDAQI-L-----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~-~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.....+.+.+..+... . .+.....+..+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111111111111000 0 00012235679999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.68 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=187.3
Q ss_pred eEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHh---cCCCceeeeeceEeeCCcceEEEEecc
Q 047038 385 ILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQ---INHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999965 68899999875421 2222344555544443 479999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999887543 5899999999999999999999998 9999999999999999999999999987553221
Q ss_pred eecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....|+..|+|||.+.+ ..++.++||||||++++||++|+.||............. ... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTL----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhh----------cCCcC
Confidence 223458999999999864 558899999999999999999999997543322111110 000 00011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.+...+..+.+++.+||+.||++|| +++|+++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1233456689999999999999999 5888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.81 Aligned_cols=250 Identities=31% Similarity=0.433 Sum_probs=205.8
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||.|+||.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 68899999987643 35667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 1246899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......|++.|+|||.+....++.++||||||+++++|++|+.||......+ ....... .. .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~---------~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK-GQ---------Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc-CC---------C
Confidence 22333468899999999998889999999999999999999999986443211 1111111 11 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112233456899999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.61 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=198.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-----DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 449 (708)
.+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 6899999986431 234456899999999999999999999998764 457
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++|+||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 4788999999999999999999998 99999999999999999999999999986
Q ss_pred cCcCC--cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQ--THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..... ........++..|+|||.+.+..++.++|+||||++++||++|+.||....... .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~------ 223 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIAT------ 223 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHc------
Confidence 53211 111233558899999999998889999999999999999999999996432111 0111110
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+....+.+.+++.+||+ +|..||+..+++.
T Consensus 224 ---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 ---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111112234455679999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.42 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=201.8
Q ss_pred CCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccCC----hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKIID----ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 449 (708)
+|+..+.||+|++|.||++... +++.||||.++... ....+.+.+|+.+++++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777899999999999999842 57889999876422 23345788999999999 699999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++.... .+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 5889999999999999999999988 99999999999999999999999999887
Q ss_pred cCcCCcceeecccccccccCccccccCC--CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
.............|+..|+|||.+.+.. .+.++||||||++++||++|..||........ . ......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~-~~~~~~~~~~---- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--Q-SEISRRILKS---- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--H-HHHHHHHHcc----
Confidence 6544333333456889999999987655 78899999999999999999999864322111 0 1111111000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
. ...+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 228 --~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 111222345688999999999999999999887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.13 Aligned_cols=241 Identities=26% Similarity=0.328 Sum_probs=195.0
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||.|++|.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 4889999987642 234456799999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecc
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 541 (708)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997653 4899999999999999999999988 9999999999999999999999999998664332 22334
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
.++..|++||.+....++.++|+||||+++|+|++|..||........ ........ .......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILK---------GNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhc---------cCCCCCCCccc
Confidence 578899999999888899999999999999999999999975542111 11111110 00011112222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPT-----MREVG 647 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt-----~~ev~ 647 (708)
...+.+++.+||+.+|++||+ ++|++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~ 250 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIK 250 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHh
Confidence 567999999999999999999 56554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=299.65 Aligned_cols=245 Identities=26% Similarity=0.373 Sum_probs=197.1
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccCCh---HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE---SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999998865332 4567899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc------
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT------ 535 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~------ 535 (708)
.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99998654 5899999999999999999999998 99999999999999999999999999875543211
Q ss_pred -ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 -HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......++..|++||.+.....+.++||||||++++||++|+.||......+ .+.. +..+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~-------- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQN-ILNGKIE-------- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhcCCcC--------
Confidence 12233457889999999988889999999999999999999999996443221 1111 1111110
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.......+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0001112567899999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.22 Aligned_cols=270 Identities=24% Similarity=0.334 Sum_probs=206.9
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----cce
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 450 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 450 (708)
+|++.+.||+|++|.||++... +++.||||++.... ....+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999975 58999999887633 445678999999999999999999999998775 789
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++ +|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 8888887543 6999999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCc--ceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh------
Q 047038 531 AVDQT--HLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR------ 601 (708)
Q Consensus 531 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------ 601 (708)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 123344578899999999887 789999999999999999999999976654322111111000000
Q ss_pred --hchhhhhhhh------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcccc
Q 047038 602 --EDRLFEILDA------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIRG 655 (708)
Q Consensus 602 --~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~ 655 (708)
.....+.+.. .-..+........+.+++.+||+.+|++||+++++++. |++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000 00000112234668999999999999999999999864 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.86 Aligned_cols=247 Identities=27% Similarity=0.451 Sum_probs=203.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh--HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..+.||+|++|.||++... +++.||+|....... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999876543 5667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987652 6899999999999999999999998 99999999999999999999999999987653332
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
. .....++..|+|||.......+.++||||||+++++|++|+.||....... ... .... .. ..
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~-~~~~-~~---------~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALF-RIVQ-DD---------HP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHH-HHhc-cC---------CC
Confidence 1 233458899999999988888999999999999999999999986433111 000 1000 00 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+......+.+++.+||+.+|++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112233466899999999999999999999873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.49 Aligned_cols=241 Identities=25% Similarity=0.326 Sum_probs=191.6
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||+|+||+||++... +|+.||+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999875422 23345678899999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecc
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 541 (708)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999876543 35899999999999999999999998 9999999999999999999999999987654321 22334
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
.++..|+|||++.+..++.++||||||+++++|++|+.||.......... ........ .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~----------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE----------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc----------ccccCCccC
Confidence 57889999999988889999999999999999999999996544321110 00000000 001112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt~~e 645 (708)
...+.+++.+||+.+|++||+.+|
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 566899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.12 Aligned_cols=266 Identities=22% Similarity=0.337 Sum_probs=196.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 447 (708)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 6899999987642 2333456889999999999999999999987543
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 6665542 24889999999999999999999998 999999999999999999999999998
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH--------HHH
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY--------FLR 598 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~--------~~~ 598 (708)
+..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.............. +..
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 764321 223457889999999876 4688999999999999999999999975432211100000 000
Q ss_pred Hhhhchhhhhhhh--hhh-c---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcccc
Q 047038 599 AMREDRLFEILDA--QIL-K---EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIRG 655 (708)
Q Consensus 599 ~~~~~~~~~~~d~--~~~-~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~ 655 (708)
............. ... . .........+.+++.+||+.||++||++.|++.. ++.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000000000 000 0 0001123568899999999999999999999844 555544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.27 Aligned_cols=269 Identities=28% Similarity=0.428 Sum_probs=208.8
Q ss_pred CcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC------CcceE
Q 047038 380 FNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLET------EVPLL 451 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 451 (708)
+...+.||+||||.||+|+. ..|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567899999999999995 47999999988763 345567899999999999999999999986654 36789
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc----CCCcEEEeeccCC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD----DKYCAKVSDFGAS 527 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~----~~~~~kl~DFGls 527 (708)
||||+.+|+|...|.+..+..-|++.+.+.+..+++.||.|||+++ |+||||||.||++- ....-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998877778999999999999999999999998 99999999999994 2334799999999
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh----
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---- 602 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 602 (708)
+....+. ..+...||..|++||.+.+ ..|+..+|.|||||++|+.+||..||..........-..|....-+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9876544 5677889999999999995 88999999999999999999999999755433211111111110000
Q ss_pred --------chh--hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHcccc
Q 047038 603 --------DRL--FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP--TMREVGIELTGIRG 655 (708)
Q Consensus 603 --------~~~--~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~ev~~~L~~l~~ 655 (708)
+++ ...+. ...+........+-.++..+|..+|++|- ...+...++..|..
T Consensus 250 i~~~~~eNgpv~~s~~lP--~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLP--QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred EeeecccCCceeeeccCC--CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 000 00000 01122234445566778888888999997 77777777777765
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.15 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=193.0
Q ss_pred ceEeee--ccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQG--GQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G--~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
..||+| +||+||++... +++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999964 7899999987652 344567899999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL- 537 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~- 537 (708)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+............
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876532 25899999999999999999999998 9999999999999999999999998654322111100
Q ss_pred -----eecccccccccCccccccC--CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH------------
Q 047038 538 -----TTQVQGTFGYLDPEYFQSS--HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR------------ 598 (708)
Q Consensus 538 -----~~~~~gt~~y~aPE~~~~~--~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~------------ 598 (708)
.....++..|+|||++.+. .++.++||||||++++||++|+.||........ .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 0112345679999999763 478999999999999999999999965432211 0000000
Q ss_pred ----Hhh-----------hch-----hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 599 ----AMR-----------EDR-----LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 599 ----~~~-----------~~~-----~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+. +.. .....+..+...........+.+|+++||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000 00000111111112345677899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=328.42 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=217.4
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEcC--------CcEEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeec
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLED--------GKIVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLG 441 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g 441 (708)
.++...++..+.+.||+|.||.|++|.... ...||||.++. ....+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 566666777777899999999999998541 34699999875 4456788999999999998 6999999999
Q ss_pred eEeeCCcceEEEEeccCCCccccccccC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 047038 442 CCLETEVPLLVYEFISNGTLSQYIDDQN-------K----D--FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKS 508 (708)
Q Consensus 442 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp 508 (708)
+|.+.+..++|+||++.|+|.++|+..+ . . ..++....+.++.|||.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 0 0 13889999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEeeccCCcccCcCCcceeecccc--cccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCC
Q 047038 509 TNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG--TFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTN 585 (708)
Q Consensus 509 ~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~ 585 (708)
+|||+.++..+||+|||+++.......+......+ ...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999766555544333333 456999999999999999999999999999999 999986522
Q ss_pred cchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
..+ .+ ...++++. ..+.+.....++.++++.||+.+|++||++.|+.+.|+.+.
T Consensus 527 ~~~--~l----~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTE--EL----LEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHH--HH----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 11 12233322 22234445677899999999999999999999999999854
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.81 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=196.8
Q ss_pred CCcccceEeeeccEEEEEEEE----cCCcEEEEEEcccCC----hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcc
Q 047038 379 NFNTNRILGQGGQGTVYKGML----EDGKIVAVKKSKIID----ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 449 (708)
+|++.+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368899999876522 23346788999999999 699999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++.... .+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987643 5888999999999999999999988 99999999999999999999999999986
Q ss_pred cCcCCcceeecccccccccCccccccC--CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSS--HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
.............|+..|+|||.+... .++.++||||||+++++|++|+.||........ ............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC----
Confidence 543332223345688999999998753 468899999999999999999999864322111 111111111100
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVG 647 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~ 647 (708)
...+......+.+++.+||+.+|++|| ++++++
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 111223445688999999999999997 566664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=297.73 Aligned_cols=259 Identities=26% Similarity=0.357 Sum_probs=196.9
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhc---CCCceeeeeceEeeCCc-----
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCLETEV----- 448 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 448 (708)
|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 48999999986432 23345677888877766 59999999999998776
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+++|||+.+ +|.+++..... ..+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 88888865432 35899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc-h--h
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED-R--L 605 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~--~ 605 (708)
....... .....++..|+|||++.+..++.++||||||++++||++|++||......+. ...+....... . .
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhc
Confidence 7643321 2233478899999999998999999999999999999999999875443221 11111111000 0 0
Q ss_pred h-------hhhhh---hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 F-------EILDA---QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~-------~~~d~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. ..... .............+.+++.+||+.+|++||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000 0001111234567889999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=301.71 Aligned_cols=259 Identities=19% Similarity=0.251 Sum_probs=193.0
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666554 6899999998653 45567789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc-----
Q 047038 461 LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT----- 535 (708)
Q Consensus 461 L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~----- 535 (708)
|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999986532 25889999999999999999999998 99999999999999999999999998865432111
Q ss_pred -ceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh----hhch----
Q 047038 536 -HLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM----REDR---- 604 (708)
Q Consensus 536 -~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~~~---- 604 (708)
.......++..|+|||++.. ..++.++||||||++++||++|+.||....... .+........ ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 11223457788999999876 358899999999999999999999997543221 1111110000 0000
Q ss_pred ---hhh----hhhh----hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 ---LFE----ILDA----QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ---~~~----~~d~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ..+. .............+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 0000 0011112334467889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.14 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=197.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
+.|+..+.||+|+||+||+|... +++.+|+|.+.. ......+++.+|++++++++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999965 678899998754 23345567889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 58877775433 25889999999999999999999998 999999999999999999999999998765322
Q ss_pred CcceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
....+++.|+|||.+. ...++.++||||||++++||++|+.||......+.. ........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-------HHHhhcCC-----
Confidence 2345788999999974 356788999999999999999999998543221110 00111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
...........+.+|+.+||+.+|++||++.+|++....+
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0111223445689999999999999999999998654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.03 Aligned_cols=269 Identities=22% Similarity=0.327 Sum_probs=200.6
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCL 444 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 444 (708)
....++..++++|...+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566778889999999999999999999985 47889999988652 2334567889999999999999999999886
Q ss_pred eC------CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 445 ET------EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 445 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
.. ...+++++++ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 43 2357788876 77898877543 4899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH--
Q 047038 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY-- 595 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~-- 595 (708)
+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..............
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998754321 233457889999999866 5688999999999999999999999965433221110000
Q ss_pred ------HHHHhhhchhhhhhh--hhh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 596 ------FLRAMREDRLFEILD--AQI----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 596 ------~~~~~~~~~~~~~~d--~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+........+. +.. ...........+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000000000000 000 00000112456889999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.75 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=196.8
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
|++.+.||+|++|+||+|... +++.||||++.... ........+|+..+++++ |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999976 57889999876532 223334567999999999 999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
+++|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 789998887654 236899999999999999999999998 9999999999999999999999999987654322
Q ss_pred eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH---------HHHh-hhchh
Q 047038 537 LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF---------LRAM-REDRL 605 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~---------~~~~-~~~~~ 605 (708)
......++..|+|||.+.. ..++.++|+||||++++||++|++||......+........ .... .....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 1233457889999998754 55789999999999999999999999655432211100000 0000 00000
Q ss_pred hhhhhh---hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDA---QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+.. .............+.+++++||+.+|++|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000 0000001112466899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=289.48 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=218.0
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceE
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCC 443 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 443 (708)
.|+.....+++...++-+|.||.||+|.+++ .+.|-+|.++. .++-+...++.|...|..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3445556778888999999999999997653 34577787765 5566778899999999999999999999998
Q ss_pred ee-CCcceEEEEeccCCCcccccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 444 LE-TEVPLLVYEFISNGTLSQYID-----DQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 444 ~~-~~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
.+ .+.++++|.++.-|+|..+|. +....+.++..+...++.|++.|++|||+++ |||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 75 567899999999999999998 4444457888889999999999999999999 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHH
Q 047038 518 CAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 595 (708)
++||+|-.|+|.+-+.+.+- .........||+||.+.+..|+.++|||||||+||||+| |+.|+...++.|..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 99999999999876544443 334446778999999999999999999999999999999 99998655544421
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..++ ...+..-+...+++|..++.-||...|++||+++|++.-|.+.-.
T Consensus 509 --~ylk---------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 509 --HYLK---------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred --HHHh---------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1111 122223355677889999999999999999999999998876543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.27 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=194.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCC-hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIID-ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 453 (708)
.++|+..+.||+|+||+||+|...+ ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4568888999999999999999764 8999999987533 344566777888777764 999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
||+++ +|.+++..... .+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 77776655332 689999999999999999999974 6 99999999999999999999999999876532
Q ss_pred CCcceeecccccccccCccccccCC----CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSH----FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .......... ..
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~-~~-- 237 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEE-PP-- 237 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCC-CC--
Confidence 221 22334788999999987553 7899999999999999999999985422111 0111111111 00
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
. ..........+.+++.+||+.+|++||++.++++.
T Consensus 238 ---~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 ---S--LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---C--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00011234568999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=292.95 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=189.6
Q ss_pred HhhccCCcccceE--eeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcc
Q 047038 374 EKATDNFNTNRIL--GQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 374 ~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 449 (708)
....++|++.+.+ |+|+||.||++... +++.+|+|.......... |+.....+ +|+||+++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334566666665 99999999999964 688899998764321111 22222222 799999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASR 528 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~ 528 (708)
++||||+++++|.+++.... .+++.+++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999997653 6899999999999999999999998 99999999999999998 99999999987
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
..... ....++..|+|||++.+..++.++||||||++++||++|+.||......+ .....+.. ... .
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-~~~-~----- 225 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK-RQQ-K----- 225 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH-hhc-c-----
Confidence 65322 22358899999999999899999999999999999999999997443222 11111111 110 0
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-MREVG 647 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~ 647 (708)
...........+.+++.+||+.+|.+||+ ++|++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00112234566899999999999999996 68886
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.23 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=195.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 447 (708)
.++|++.++||+|+||.||+|... +++.+|||++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 68899999875432 222346789999999999999999999876543
Q ss_pred --cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 448 --VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 448 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
..++|+||+.+ +|...+.... ..+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999975 6766665432 36999999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCc----------ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 526 ASRSIAVDQT----------HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 526 ls~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
+++....... ...+...+++.|+|||.+.+ ..++.++||||||++++||++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976542211 11233457888999998765 458899999999999999999999997544332111111
Q ss_pred HHHHHhhhch------hhhhh--------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 595 YFLRAMREDR------LFEIL--------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 595 ~~~~~~~~~~------~~~~~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......... +.... .+.+.. ........+.+++.+||+.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000000000 00000 000000 00112256889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.14 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=189.3
Q ss_pred ceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHH-HhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVIL-SQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++ .+.+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 68899999876532 22233455565544 456899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997643 5889999999999999999999998 99999999999999999999999999875432 2
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
....++..|++||.+.+..++.++||||||++++||++|..||........ + ..+...... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------F-DNILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------H-HHHHhcccC------CCCccc
Confidence 234578899999999888899999999999999999999999964432211 1 111111100 000111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 619 KDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 619 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
...+..+.+++.+||+.+|++||++.++.+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 1234668999999999999999987666443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=328.42 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=190.5
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC------
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 446 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 446 (708)
+...+|+..++||+||||.|||++.+ ||+.+|||++... .......+.+|++.|++|+|||||+++..+.++
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45567899999999999999999977 8999999998764 344456789999999999999999887533110
Q ss_pred --------------------------------------------------------------------------------
Q 047038 447 -------------------------------------------------------------------------------- 446 (708)
Q Consensus 447 -------------------------------------------------------------------------------- 446 (708)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 047038 447 ---------------------------------EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493 (708)
Q Consensus 447 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yL 493 (708)
..+||-||||+..+|.++++++... -.-...++++.+|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0135778888887777777665321 13567789999999999999
Q ss_pred HhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC-----------------cCCcceeecccccccccCccccccC
Q 047038 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA-----------------VDQTHLTTQVQGTFGYLDPEYFQSS 556 (708)
Q Consensus 494 H~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~ 556 (708)
|+.+ ||||||||.||+||++..|||+|||++.... .......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998621 0111124557799999999999764
Q ss_pred ---CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhc
Q 047038 557 ---HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCL 633 (708)
Q Consensus 557 ---~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 633 (708)
.|+.|+|+||||+||+||+. ||.... + .......++.+.+... ..+..+....=+.+|++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--E----Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--E----RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--H----HHHHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 59999999999999999994 553211 1 1122333344333322 1112222334568999999
Q ss_pred ccCCCCCCCHHHHHH
Q 047038 634 NLNGKKRPTMREVGI 648 (708)
Q Consensus 634 ~~~p~~RPt~~ev~~ 648 (708)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999873
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.80 Aligned_cols=266 Identities=20% Similarity=0.297 Sum_probs=200.4
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee-CC
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TE 447 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 447 (708)
++..++++|+..+.||+|+||.||++... +++.||||++.. ......+.+.+|+.++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44567889999999999999999999955 789999998753 223345678899999999999999999999876 55
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++|+||+ +++|.+++... .+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 45888887643 4788888899999999999999998 999999999999999999999999998
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------HH
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF--------LR 598 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~~ 598 (708)
...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||............... ..
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754321 123457889999999866 56899999999999999999999999754432211111100 00
Q ss_pred Hhhhchhhhhhhhh-hhcc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 599 AMREDRLFEILDAQ-ILKE-----GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 599 ~~~~~~~~~~~d~~-~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
........+.+... .... ........+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000001110000 0000 011234678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.63 Aligned_cols=243 Identities=26% Similarity=0.385 Sum_probs=193.2
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
|...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999964 6889999987642 234456789999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+. ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777775433 25899999999999999999999998 99999999999999999999999998864321
Q ss_pred ceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.....|+..|+|||++. ...++.++||||||++++||++|..||......... ....... ..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-~~------ 238 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND-SP------ 238 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-CC------
Confidence 22346889999999984 456888999999999999999999998644321111 0111100 00
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+++.+||+.+|++||++.+++.
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 239 --TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111222345889999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.39 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=198.5
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE- 447 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~- 447 (708)
++....++|+..+.||+|+||+||++... +++.||||++... .....+.+.+|+.+|++++|+||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34556788999999999999999999854 7899999987542 2334567889999999999999999999987654
Q ss_pred -----cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEe
Q 047038 448 -----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522 (708)
Q Consensus 448 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~ 522 (708)
..++||||+ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 348999998 67888887642 5899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHH--------
Q 047038 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA-------- 593 (708)
Q Consensus 523 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~-------- 593 (708)
|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||............
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99998765322 223457889999999876 45889999999999999999999999754322110000
Q ss_pred HHHHHHhhhchhhhhhhh--h----hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 594 AYFLRAMREDRLFEILDA--Q----ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 594 ~~~~~~~~~~~~~~~~d~--~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..+...+........... . ............+.+++.+||+.||++|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000000000000000000 0 00001112344588999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.43 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=195.5
Q ss_pred cCCc-ccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHH--------------HHHHHHHHHHHHhcCCCceeeeec
Q 047038 378 DNFN-TNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESK--------------VEEFINEVVILSQINHRNVVKLLG 441 (708)
Q Consensus 378 ~~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 441 (708)
++|. +.+.||+|+||+||+|... +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3577999999999999965 68899999876532211 125789999999999999999999
Q ss_pred eEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 442 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
++...+..++||||++ ++|.+++.... .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 58988886532 5899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcccCcCC-------------cceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcc
Q 047038 522 SDFGASRSIAVDQ-------------THLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587 (708)
Q Consensus 522 ~DFGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~ 587 (708)
+|||+++...... ........++..|+|||.+.+. .++.++||||||++++||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654111 1111223468889999998764 4789999999999999999999999755433
Q ss_pred hhhhHHHHHHHHhhhch---hhhhhh-----------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 588 EDKSLAAYFLRAMREDR---LFEILD-----------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~---~~~~~d-----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+. ............ +.+..+ +.............+.+++.+||+.+|++||+++|++.
T Consensus 241 ~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 21 111111111000 000000 00000001122456889999999999999999999974
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=296.62 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=202.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 452 (708)
++|...+.||+|+||.||++... +++.||+|.... ......+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 789999998754 23344567899999999998 99999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
||++++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 6999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCc-------------------ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHH
Q 047038 533 DQT-------------------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA 593 (708)
Q Consensus 533 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~ 593 (708)
... .......++..|++||.+....++.++||||||+++++|++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 221 11223457889999999998889999999999999999999999997543111
Q ss_pred HHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 047038 594 AYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM----REVG 647 (708)
Q Consensus 594 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~ev~ 647 (708)
.+..... .....+...++.+.+++.+||+.+|++||++ ++++
T Consensus 230 -~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 230 -TFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred -HHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1111110 0111223335668999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=284.03 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=207.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|+.+++||+|.||.|-+++-+ .++.+|+|+++. ...++...-+.|-++|+..+||.+..|.-.|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467889999999999999999855 789999998876 345566677889999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||..||.|.-+|.... .+++........+|+.||.|||+.+ |+.||||.+|+|||.+|++||+||||.+.-.
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999998754 5888888889999999999999998 9999999999999999999999999998543
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.....+..+.|||.|+|||++....|+.++|.|.+||+||||++|+.||...+.+. +++++-.
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~ 382 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILM 382 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHh
Confidence 23345677899999999999999999999999999999999999999997544332 2222211
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.- ..++....++...|+...|.+||.+|. +++||.+
T Consensus 383 ed-~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 383 ED-LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hh-ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 10 122444455678899999999999994 5666653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.67 Aligned_cols=250 Identities=27% Similarity=0.356 Sum_probs=207.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.-...|.+...||+|.|++|..|+.. ++..||||.+.. .+....+.+.+|+++|+.++|||||+|+.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567889999999999999999954 689999998765 334455669999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||..+|.+.+||..+. .+.+.....++.|+..|++|+|++. |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999999876 4666888889999999999999999 9999999999999999999999999998775
Q ss_pred cCCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.........|++.|.|||++.+..| ++++|+||+|++||-|+.|..||++....+-..- .-.++
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-------vl~gk------ 271 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-------VLRGK------ 271 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-------heeee------
Confidence 3344566789999999999998765 6799999999999999999999986554331100 00000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
-..+.-...+..+|++++|-++|.+|++++++.+.
T Consensus 272 ----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 ----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 01122233457889999999999999999998653
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.92 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=187.1
Q ss_pred eEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHH---HHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 385 ILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVV---ILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
+||+|+||.||++... +++.||+|.+.... ......+..|.. .++..+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68899999875422 122223444544 3444579999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999886543 5999999999999999999999988 9999999999999999999999999987553221
Q ss_pred eecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....|+..|+|||.+.++ .++.++||||||++++||++|+.||........... ...... .. .+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~----~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MA----VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cC----CC
Confidence 2234589999999999754 689999999999999999999999975432221110 000000 00 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
.+...+..+.+++.+||..+|.+|| ++.|+++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222346799999999999999999 8999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=296.01 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=199.9
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999976 58999999887643 344567889999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
+ ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999998653 25899999999999999999999998 99999999999999999999999999886643322
Q ss_pred eeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh---hchhhhhhh--
Q 047038 537 LTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR---EDRLFEILD-- 610 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d-- 610 (708)
......++..|+|||.+.+. .++.++||||||++++||++|++||......+.. ........ +..+.++.+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhcccc
Confidence 12233457789999998776 7899999999999999999999999654432211 11111110 000000000
Q ss_pred ----------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 ----------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..............+.+++.+||+.+|++||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000001122467999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.05 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=204.7
Q ss_pred HHhhccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
+...+-+++....||.|.||.||-+. +++|...|+|-++..+ ........+|..+|..++|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34556678888999999999999999 5679999999776643 33456788999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+|.||||++|+|.+++...+ -.++.....+..|++.|+.|||+++ ||||||||.||||+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999997543 3566666778889999999999999 99999999999999999999999999987
Q ss_pred cCcCCcce---eecccccccccCccccccCC---CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 530 IAVDQTHL---TTQVQGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 530 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+....... .....||+.|||||++.+.. -..++||||+|||++||+||++||...+.+ ...++...+...
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHK- 1459 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCC-
Confidence 76442111 23467999999999997643 457899999999999999999999643322 122222222221
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.+.....+=.+++.+||+.||++|-++.|+++
T Consensus 1460 -----------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 -----------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -----------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2223445666789999999999999988876653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.08 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=195.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC---------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET--------- 446 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------- 446 (708)
..+|...+.||+|+||+||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368899999999999999999965 6889999998776666677899999999999999999999876653
Q ss_pred -----CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEE
Q 047038 447 -----EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAK 520 (708)
Q Consensus 447 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~k 520 (708)
...++||||++ ++|.+++... .+++...+.++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999997 4888877542 5889999999999999999999998 99999999999997 456789
Q ss_pred EeeccCCcccCcCCcc--eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 521 VSDFGASRSIAVDQTH--LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 521 l~DFGls~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
|+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+.... ..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL---IL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence 9999998765322111 1123457889999998654 5688899999999999999999999965443221111 00
Q ss_pred HHhhh------chhhhhhhhhhh----------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMRE------DRLFEILDAQIL----------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~------~~~~~~~d~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... ............ .........++.+++.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 000000000000 0001123356889999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.67 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=192.3
Q ss_pred CCcccceEeeeccEEEEEEEEc-C--CcEEEEEEcccC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC----Cc
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-D--GKIVAVKKSKII--DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET----EV 448 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 448 (708)
+|++.+.||+|+||.||++... . ++.||+|++... .....+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 3 678999987642 223456788999999999 599999999976432 35
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++++||+. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 58888886543 5899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCCcc---eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------
Q 047038 529 SIAVDQTH---LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-------- 596 (708)
Q Consensus 529 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~-------- 596 (708)
........ ......||..|+|||++.+ ..++.++||||||+++++|++|+.||...............
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1233568999999998765 46899999999999999999999999754422111100000
Q ss_pred HHHhhhchhhhhhhh------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 597 LRAMREDRLFEILDA------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
...+........... .............+.+++.+||+.+|++|||+.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000000000 000000111245689999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=291.35 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=195.0
Q ss_pred CCcccceEeeeccEEEEEEEEcC-CcEEEEEEccc-----CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKI-----IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~-----~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
+|.+.+.||+|+||+||++.... +..+++|.++. .......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998653 44455555433 1223445677899999999999999999999999999999
Q ss_pred EEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 453 YEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886532 2346899999999999999999999998 999999999999986 469999999987654
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
... .......|++.|+|||.+....++.++|+||||+++++|++|..||...... ........ +
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~-~-------- 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIVE-G-------- 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHc-C--------
Confidence 322 2223455888999999998888899999999999999999999998532211 11111111 1
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+...+..+.+++.+||+.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011123344567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.60 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=198.4
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc---
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV--- 448 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 448 (708)
...++|+..+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 5789999987642 23445678899999999999999999998876654
Q ss_pred ---ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 449 ---PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 449 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.++|+||+ +++|.+++... .+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 56898888652 5899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-------- 596 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~-------- 596 (708)
++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 98765322 233457889999999865 46789999999999999999999999654332211100000
Q ss_pred HHHhhhchhhhhhhhhh-h-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 597 LRAMREDRLFEILDAQI-L-----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~~~-~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+........+.... . .+........+.+++.+||+.+|++|||+.||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000000 0 0000112467899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=276.23 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=194.7
Q ss_pred ccceEeeeccEEEEEEEEc-CCcEEEEEEccc-CChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEeccC
Q 047038 382 TNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI-IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
.+..||.|.-|.|++.+.+ .|...|||.+.. .+..+.++++..+.++..-+ .|.||+.+|||..+...++.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3456999999999999965 589999998866 45566778888888777654 89999999999999999999999853
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
-++.+|+.... ++++...-++...++.||.||.++. +|+|||+||+|||+|+.|++||+|||++..+-... ..
T Consensus 176 -C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah 248 (391)
T KOG0983|consen 176 -CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH 248 (391)
T ss_pred -HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence 56666665433 6888888889999999999999876 49999999999999999999999999997664332 34
Q ss_pred ecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh---hh
Q 047038 539 TQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD---AQ 612 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---~~ 612 (708)
+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||..-+.+-+. +..+++ +.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--------------ltkvln~ePP~ 314 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--------------LTKVLNEEPPL 314 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--------------HHHHHhcCCCC
Confidence 45569999999999864 46889999999999999999999999865543211 111111 11
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.. .......+.+++..||++|+.+||...++++
T Consensus 315 L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111 1225677999999999999999999999874
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=325.01 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=209.2
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
..++....++|.+.++||+|+||.|..++++ +++++|+|+++. ....+..-|..|-.+|..-+.+-||+|.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3456666789999999999999999999976 688999999876 334455679999999999999999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
...+|+|||||+||+|-.+|.+.. ++++..+..++.+|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999998765 5999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
.+..+..+..-.....+|||.|++||+++. +.|+...|.||+||++|||+.|..||.... ++.-....+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHh
Confidence 998888777777778899999999999853 578999999999999999999999996332 332222222
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 642 (708)
.......+. ...+.+++..+||.+.+. +|+.|..
T Consensus 295 ~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 295 NHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred chhhhcCCC-------cccccCHHHHHHHHHHhc-Chhhhcc
Confidence 221111111 123466778889988774 5666655
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=279.46 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=206.3
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 447 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 447 (708)
.+++-+.|+ ++||+|+|+.|--+. +.+|..+|||++.......+.+..+|++++.+. .|+||++|+.+|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455555554 679999999999888 678999999999887777788999999999998 5999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEeec
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDF 524 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DF 524 (708)
..|||||-|.||+|..+++.+. .+++.++.++..+|+.||.|||.++ |.||||||+|||-.+.. -+||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999998765 5999999999999999999999999 99999999999997654 3899999
Q ss_pred cCCcccCcC------CcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch-----
Q 047038 525 GASRSIAVD------QTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE----- 588 (708)
Q Consensus 525 Gls~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~----- 588 (708)
.|..-+... .+....+.+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-.++
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 987543211 111233466888999999863 3458889999999999999999999998654322
Q ss_pred ---hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 589 ---DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 589 ---~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...-.......+.++.. ++.| ..-...+.+-.+|+...|..++.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-eFPd-----kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-EFPD-----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-cCCh-----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11222223333333332 1111 111234456678999999999999999998875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=276.03 Aligned_cols=205 Identities=26% Similarity=0.373 Sum_probs=172.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-----CcEEEEEEcccCCh--HHHHHHHHHHHHHHhcCCCceeeeeceEee-CCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-----GKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLE-TEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 448 (708)
...|+....||+|.||.|||+...+ .+.+|||+++...+ .--....+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468888999999999999997542 23689999876422 223467899999999999999999999988 778
Q ss_pred ceEEEEeccCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CcEEEe
Q 047038 449 PLLVYEFISNGTLSQYIDDQN--KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK----YCAKVS 522 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~----~~~kl~ 522 (708)
.+|++||.+. +|.+.++-+. ....++..++..|+.||+.|+.|||+.= |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 8888886543 2346899999999999999999999998 9999999999999877 999999
Q ss_pred eccCCcccCcCCcc--eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 047038 523 DFGASRSIAVDQTH--LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 523 DFGls~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~ 585 (708)
|||+++.+...-.. ....++-|..|.|||.+.+ ..||.+.|||+.|||+.||+|-++-|....
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999988643322 2445778999999999887 569999999999999999999988886543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=287.19 Aligned_cols=256 Identities=28% Similarity=0.446 Sum_probs=199.8
Q ss_pred ccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCCh-------HHHHHHHHHHHHHHhcCCCceeeeeceEe-eCC
Q 047038 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDE-------SKVEEFINEVVILSQINHRNVVKLLGCCL-ETE 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~ 447 (708)
.++|-.+++||+|||++|||+. +...+-||||+-..... .-.+...+|..|-+.|.||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3467778899999999999999 55678899997544211 11345788999999999999999999997 566
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeec
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDF 524 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DF 524 (708)
.++-|+||++|.+|+-||+.+. .++++++..|+.||+.||.||.+.. +||||-||||.||||-+ -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 7889999999999999998765 5899999999999999999999986 67999999999999954 478999999
Q ss_pred cCCcccCcCCc------ceeecccccccccCcccccc----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 525 GASRSIAVDQT------HLTTQVQGTFGYLDPEYFQS----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 525 Gls~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
||++.+..+.. ..+....||..|++||.+.- .+.+.|+||||.|||+|+.+.|++||.......+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd----- 692 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD----- 692 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-----
Confidence 99998864433 23455779999999998753 3578899999999999999999999975443321
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.+.++.+...-.... ...+....+...+|++||+..-++|.+..++.
T Consensus 693 ----ILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ----ILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----HHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 122222111111111 11223345678899999999999998888774
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.21 Aligned_cols=236 Identities=31% Similarity=0.375 Sum_probs=193.6
Q ss_pred EeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 386 LGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 58899999876532 23566899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecc
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 541 (708)
.+++.... .+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99997653 5899999999999999999999988 9999999999999999999999999987654322 123345
Q ss_pred cccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 542 ~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
.++..|++||.+.+...+.++|+||||++++||++|+.||....... .. ..+.... ...+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~----~~~~~~~----------~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY----EKILKDP----------LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHhcCC----------CCCCCCC
Confidence 67889999999998889999999999999999999999996433211 11 1111111 1112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt~~e 645 (708)
+..+.+++++||..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 566899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=253.54 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=199.4
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+|+..++||+|.||+||||+.+ +++.||+|+++..+ +.-....++||-+|+.++|.|||++++....+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566678999999999999955 68899999987643 33356789999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+.. +|..+....+. .++......++.|+++||.|.|++. +.|||+||.|.||+.+|++||+|||+++.+...-.
T Consensus 83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 88888876654 5888888999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHH--Hhhhchhhhh---
Q 047038 536 HLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLR--AMREDRLFEI--- 608 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--- 608 (708)
. ....+-|..|.+|.++.+. -|+...|+||-||++.||.. |++-|.+.+..+ ++...|+. ...++.+..+
T Consensus 157 c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCCccccC
Confidence 3 2334569999999998875 48899999999999999998 666665544332 33333322 2223222211
Q ss_pred hhhhhhc---------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 609 LDAQILK---------EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 609 ~d~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.|-.... +.-+.....=++|+++.|.-+|.+|.++++.+
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 1111000 00111223346888899999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=316.56 Aligned_cols=145 Identities=27% Similarity=0.383 Sum_probs=131.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|.+.++||+|+||+||+|... +++.||||+++.. .....+.+..|+.+++.++|+||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999976 6889999988642 3444578899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
||+.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 5888999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.53 Aligned_cols=240 Identities=26% Similarity=0.379 Sum_probs=199.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
.+|+.+.+||+|+||.|.++..+ +.+.+|||+++. ...++.+--+.|-++|.-. +-|.+++|..+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999876 456799998876 2334455556677777766 578999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+.||+|--+++.-+ .+.+..+..+|.+||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999988665 4778888999999999999999999 99999999999999999999999999985332
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
+ ...+.++.|||.|+|||++..++|+..+|.|||||+||||+.|++||++.+.++. |. .+.+..
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F~---------aI~ehn 566 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQ---------AIMEHN 566 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HH---------HHHHcc
Confidence 2 3345678899999999999999999999999999999999999999987665442 11 122221
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRP 641 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP 641 (708)
-.+++..+.+...+++..|.++|.+|.
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 123555666788899999999999994
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.21 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=193.0
Q ss_pred CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHh-cCCCceeeeeceEeeCCcceEEEEec
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQ-INHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
.+.+..||.|+||+|+|-..+ .|+..|||++.... ..+.++++.|.+...+ -+.||||++||.+..++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344567999999999999865 69999999988754 4677789999876554 58999999999999999999999999
Q ss_pred cCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 457 SNGTLSQYIDDQN--KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 457 ~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+- +|+.+...-- ....+++...-.|..-.+.||.||...- .||||||||+|||||..|.+||+|||++..+..
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 63 6665543211 2336888888889999999999998765 399999999999999999999999999876532
Q ss_pred cceeecccccccccCccccccC--CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSS--HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
+...+.-.|-..|||||.+... .|+.+|||||||++|+|+.||+.|++.-.+ ...+....+.. |+.
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g-------dpp 288 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG-------DPP 288 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC-------CCC
Confidence 2223344588899999999653 488999999999999999999999863322 11111111111 111
Q ss_pred hh--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 IL--KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+ .....+....+..+|..||.+|-.+||.+.++.+
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11 1122445677999999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=296.72 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=183.8
Q ss_pred hccCCcccceEeeeccEEEEEEEE-----------------cCCcEEEEEEcccCChHHHHHHH--------------HH
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-----------------EDGKIVAVKKSKIIDESKVEEFI--------------NE 424 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~~~~~--------------~E 424 (708)
..++|++.++||+|+||+||+|.+ .+++.||||+++.......++|. .|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999974 23568999998765444344444 46
Q ss_pred HHHHHhcCCCce-----eeeeceEee--------CCcceEEEEeccCCCccccccccCC---------------------
Q 047038 425 VVILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFISNGTLSQYIDDQNK--------------------- 470 (708)
Q Consensus 425 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 470 (708)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766654 678888753 3567999999999999999875321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCc
Q 047038 471 DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550 (708)
Q Consensus 471 ~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aP 550 (708)
...++|..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567888999999999999999998 99999999999999999999999999976543222222223358899999
Q ss_pred cccccCC----------------------CCccchhHhHHHHHHHHHhCCC-CCCCCCcchhh----hHHHHHHHHhhhc
Q 047038 551 EYFQSSH----------------------FTEKSDVYSFGVVLVELLTGER-PIRLTNSEEDK----SLAAYFLRAMRED 603 (708)
Q Consensus 551 E~~~~~~----------------------~t~ksDv~SlGvvl~elltg~~-P~~~~~~~~~~----~~~~~~~~~~~~~ 603 (708)
|.+.... ...+.||||+||+++||++|.. |+......... ......++.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1235799999999999999875 66432111100 0000001111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNG---KKRPTMREVGI 648 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~ev~~ 648 (708)
.. +- ...........+|+.++|..+| .+|+|++|+++
T Consensus 460 ~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 10 00 0112234568899999999866 68999999963
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=302.90 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=172.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-C----CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeece------Ee
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-D----GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC------CL 444 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 444 (708)
..++|+..++||+|+||+||+|.+. + ++.||||++..... .+.+.+| .+.+..+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999975 4 68999998764322 1222222 1222223333333222 23
Q ss_pred eCCcceEEEEeccCCCccccccccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNKD-----------------FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDik 507 (708)
+....+|||||+++++|.++++..... ....+..+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999998754311 01123345679999999999999998 9999999
Q ss_pred CCcEEEcC-CCcEEEeeccCCcccCcCCcceeecccccccccCccccccC----------------------CCCccchh
Q 047038 508 STNILLDD-KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS----------------------HFTEKSDV 564 (708)
Q Consensus 508 p~NIll~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDv 564 (708)
|+||||++ ++.+||+|||+++.+............+|+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654444444556789999999965322 24456799
Q ss_pred HhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh-hchhhhhhhhhhhcc------CCHHHHHHHHHHHHHhcccCC
Q 047038 565 YSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR-EDRLFEILDAQILKE------GGKDEFKMVAKLAKRCLNLNG 637 (708)
Q Consensus 565 ~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~------~~~~~~~~l~~li~~cl~~~p 637 (708)
|||||+||||+++..|+.. +.......+...-. ...+...+.+....+ ..........+|+.+||+.||
T Consensus 363 wSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999999999997766421 11111111100000 000111111100000 000012235689999999999
Q ss_pred CCCCCHHHHHHH
Q 047038 638 KKRPTMREVGIE 649 (708)
Q Consensus 638 ~~RPt~~ev~~~ 649 (708)
++|||++|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-34 Score=268.71 Aligned_cols=266 Identities=22% Similarity=0.352 Sum_probs=200.7
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee--------CC
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE--------TE 447 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~~ 447 (708)
.|....+||+|.||+||+++.+ .|+.||+|+.-.. ...-....++|+++|..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999965 5778899875432 22334567899999999999999999998864 23
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
.++|||++++. +|.-+|.... .+++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999987 8888887653 36888999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCc---ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 528 RSIAVDQT---HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 528 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+.+..... ...+..+-|..|++||.+.+ ..|+.+.|||.-||||.||+||.+-+++........+....-..+..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87653221 12344556999999999876 569999999999999999999999987766554444444433333322
Q ss_pred hhhhhhhhhhh--------ccCC----HHHH------HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 604 RLFEILDAQIL--------KEGG----KDEF------KMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 604 ~~~~~~d~~~~--------~~~~----~~~~------~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
.+.....-.+. .+.. ++.. +.-.+|+.++|..||.+|+++.+++..-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 22211111110 0000 1111 2567899999999999999999987544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=274.77 Aligned_cols=221 Identities=23% Similarity=0.179 Sum_probs=177.6
Q ss_pred eccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCccccccc
Q 047038 389 GGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD 467 (708)
Q Consensus 389 G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 467 (708)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999886532 234455556667899999999999999999999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccc
Q 047038 468 QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547 (708)
Q Consensus 468 ~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 547 (708)
.. .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 43 4899999999999999999999998 999999999999999999999999987654321 1223457789
Q ss_pred cCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHH
Q 047038 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAK 627 (708)
Q Consensus 548 ~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 627 (708)
+|||.+....++.++||||+|++++||++|+.|+....... ... .. ...+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~----~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TT----LNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cc----cCCcccCCHHHHH
Confidence 99999988889999999999999999999998874321110 000 00 0112223456889
Q ss_pred HHHHhcccCCCCCCCHHH
Q 047038 628 LAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 628 li~~cl~~~p~~RPt~~e 645 (708)
++.+||+.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=267.03 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=198.0
Q ss_pred hccCCccc-ceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee----CCc
Q 047038 376 ATDNFNTN-RILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE----TEV 448 (708)
Q Consensus 376 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~ 448 (708)
.+++|.+. ++||-|-.|.|-....+ +++.+|+|.+... ....+|+++--.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666553 68999999999988865 6889999987642 3456788765554 69999999999864 446
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeecc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFG 525 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFG 525 (708)
+++|||.|+||.|.+.+++++. ..+++.++-.|..||..|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999988754 47999999999999999999999999 999999999999964 5579999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
+++.... ........-|+.|.|||++...+|+...|+||+||++|-|++|.+||...... .+..-+...++.+..
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc
Confidence 9986432 22344566799999999999999999999999999999999999999643221 111122233333322
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. + ..+.-...++...++|+.+|..+|++|.|+.|++.
T Consensus 285 ~-F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 E-F-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c-C-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 1 11112345677889999999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=274.33 Aligned_cols=274 Identities=22% Similarity=0.314 Sum_probs=206.8
Q ss_pred CcccccChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC--C----c
Q 047038 363 DKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINH--R----N 435 (708)
Q Consensus 363 ~~~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----n 435 (708)
+...+|...+.. +++|.+...+|+|.||.|-+...+ .+..||||+++.... -.+..+-|+++|+++++ | -
T Consensus 76 dGH~v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 76 DGHYVYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CceEEEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceE
Confidence 344455555443 789999999999999999999865 468899999887543 34567789999999942 2 3
Q ss_pred eeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-
Q 047038 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD- 514 (708)
Q Consensus 436 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~- 514 (708)
+|++.++|...++.+||+|.+ |-++.++|..++ -.+++...+..++.|++++++|||+.+ ++|-||||+|||+-
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvs 227 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVS 227 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEec
Confidence 788999999999999999998 559999998764 347889999999999999999999999 99999999999993
Q ss_pred -------------------CCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHH
Q 047038 515 -------------------DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575 (708)
Q Consensus 515 -------------------~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ell 575 (708)
.+..+||+|||.+....... ...+.|..|.|||++.+-.++.++||||+||||+||.
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 23459999999998654333 4456799999999999999999999999999999999
Q ss_pred hCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh----------hh---------------h----hhhccCCHHHHHHHH
Q 047038 576 TGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI----------LD---------------A----QILKEGGKDEFKMVA 626 (708)
Q Consensus 576 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~d---------------~----~~~~~~~~~~~~~l~ 626 (708)
+|..-|+..+..|.-.+-+.....+....+... +| . .........+...|.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 999999876643321111111110000000000 00 0 000011233446699
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047038 627 KLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 627 ~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+|+++||..||.+|+|++|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=296.09 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=207.4
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee--
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE-- 445 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-- 445 (708)
++.+-..++.|.+.+.||+|.+|.||+++ .++++.+|+|++... ....+++..|.+||+.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34445567789999999999999999999 457888999987653 34446778899999988 79999999999874
Q ss_pred ---CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEe
Q 047038 446 ---TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522 (708)
Q Consensus 446 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~ 522 (708)
++.+|||||||.+|+..++++... +..+.|..+..|+.+++.||.+||... ++|||||=.||||+.++.|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 568999999999999999998876 668999999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCcCCcceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 523 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
|||++..+..... ...+..||+.|||||++.. ..|+.++|+||||++..||.-|.+|+...-+. .+
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------ra- 236 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------RA- 236 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------hh-
Confidence 9999987653322 2344679999999999964 34778999999999999999999997422111 01
Q ss_pred HHhhhchhhhhhh-hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMREDRLFEILD-AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~~~~~~~~d-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
++.+.. +......+..-.+++-++|..||.+|-++||++.++++
T Consensus 237 -------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 -------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111111 11111123445677999999999999999999998864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=269.24 Aligned_cols=238 Identities=30% Similarity=0.415 Sum_probs=193.8
Q ss_pred ccEEEEEEEEc-CCcEEEEEEcccCChHH-HHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCccccccc
Q 047038 390 GQGTVYKGMLE-DGKIVAVKKSKIIDESK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD 467 (708)
Q Consensus 390 ~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 467 (708)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987655444 78999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccc
Q 047038 468 QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547 (708)
Q Consensus 468 ~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 547 (708)
.. .+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 53 2889999999999999999999998 9999999999999999999999999988765432 23345578899
Q ss_pred cCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHH
Q 047038 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAK 627 (708)
Q Consensus 548 ~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 627 (708)
++||.+....++.++||||||+++++|++|..||......+ .. ........... ..........+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--EL----FKKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH----HHHHhccCCCC-------ccccccCCHHHHH
Confidence 99999998889999999999999999999999986432111 11 11111111000 0000004466899
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047038 628 LAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 628 li~~cl~~~p~~RPt~~ev~~ 648 (708)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=288.53 Aligned_cols=240 Identities=23% Similarity=0.277 Sum_probs=193.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.++.|.....+|.|+|+.|-++... +++..+||++... ..+-.+|+.++... +||||+++.+.+.+....++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3667888888999999999998855 6788999988654 12234567666655 7999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL-DDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll-~~~~~~kl~DFGls~~~~~ 532 (708)
|.+.++-|.+.+.... .....+..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988777766543 222677789999999999999998 9999999999999 5889999999999987754
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
+ .....-|..|.|||+.....|++++|+||||++||+||+|+.||....... .....+..++
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~~-------- 530 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMPK-------- 530 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCCc--------
Confidence 4 223345889999999999999999999999999999999999997654431 1122222221
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.....+...++|+.+||+.||.+||+|.++..
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 12445566889999999999999999999853
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=283.98 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=193.1
Q ss_pred cceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 383 NRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
.++||.|.||+||-|+.+ +|+.||||.+.. ...++..++.+|+.||++++||.||.|.-.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999954 799999998755 33455578999999999999999999999999999999999999654
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEeeccCCcccCcCCcc
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGls~~~~~~~~~ 536 (708)
-|+-.|.... .++++.....+..||+.||.|||.++ |+|.||||+||||... -++||+|||.++.+.. ..
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ks 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KS 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch--hh
Confidence 4444444332 36899888999999999999999999 9999999999999654 4799999999998753 33
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
....++||+.|+|||++++..|...-|+||.||++|--++|..||.....-.++ .+...-+...+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMyPp~P------------ 787 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMYPPNP------------ 787 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccccccCCCc------------
Confidence 456788999999999999999999999999999999999999999633222111 111000111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
-.+......+||...|+..-.+|-+.+.-+
T Consensus 788 -W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 233445577899999999999998877543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=260.91 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=201.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 451 (708)
.++|.++++||+|+|..|..+++. +.+.+|+|+++. .+..+++-...|-.+..+- +||.+|.|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999965 578899998765 3344555566677777765 89999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|.||+++|+|--+++.++ .++++.+..+..+|.-||.|||+.+ ||.||||..|||||.++++||.|+|+.+.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999998888765 5999999999999999999999999 9999999999999999999999999987533
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcch-hhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE-DKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.....+.++.|||.|+|||++++..|+...|.|+|||+|+||+.|+.||+....+. +.+...+..+.+-+.++
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 23345667889999999999999999999999999999999999999998654332 33333444333332221
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRP 641 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 641 (708)
. .+...+-+...+++.-|++||.+|.
T Consensus 477 ---r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ---R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 1222233456788889999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=279.93 Aligned_cols=242 Identities=25% Similarity=0.300 Sum_probs=203.6
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCc-EEEEEEcc---cCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGK-IVAVKKSK---IIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vAvK~~~---~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.+++.+.-||-||||.|-++...+.+ .+|+|.++ ..+..+.+....|-.||.+.+.|.||+||.-|.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999999876544 36777654 467778888999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
|-|-||.|...|++.+ .++......++..+.+|++|||+++ ||.|||||+|.+||.+|-+||.|||+++.+...
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999765 5888888899999999999999999 999999999999999999999999999987644
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .+-++.||+.|.|||++.+...+.++|.||||++++||++|.+||+..++-...++.-.-.+
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------------- 636 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------------- 636 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------
Confidence 3 35567899999999999999999999999999999999999999987665443322221111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt 642 (708)
..+.+....+.-.+|+++....+|.+|.-
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 12335556667889999999999999954
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=278.11 Aligned_cols=206 Identities=25% Similarity=0.384 Sum_probs=176.8
Q ss_pred cCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.-|..++-||-|+||+|-++. .++...+|+|.++..+ ..+......|-.||..-..+-||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458888999999999999998 4556789999887644 345566788999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc-
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV- 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~- 532 (708)
||++||++-.+|.+.+ .+++..+..++.++.-|+++.|..| +|||||||+|||||.+|++||.||||..-+.-
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999998765 5788888889999999999999999 99999999999999999999999999753310
Q ss_pred -------CC---------------------------------cceeecccccccccCccccccCCCCccchhHhHHHHHH
Q 047038 533 -------DQ---------------------------------THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLV 572 (708)
Q Consensus 533 -------~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ 572 (708)
.. .......+||+.|+|||++....++.-.|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 00112356999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcchh
Q 047038 573 ELLTGERPIRLTNSEED 589 (708)
Q Consensus 573 elltg~~P~~~~~~~~~ 589 (708)
||+.|+.||-.....+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999987666554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.47 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=188.6
Q ss_pred CCcccceEeeeccEE-EEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEec
Q 047038 379 NFNTNRILGQGGQGT-VYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
-|...+++|.|..|+ ||+|..+ |+.||||++-. .......+||..|+.- +|||||++++.-.+....||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355667899999986 7999984 78999998753 3344567899999987 6999999999999999999999999
Q ss_pred cCCCccccccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEeeccCCccc
Q 047038 457 SNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-----KYCAKVSDFGASRSI 530 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGls~~~ 530 (708)
. .+|.+++....... ...-...+.+..|++.||++||+.+ |+||||||.||||+. ..+++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 49999998742111 1111345677889999999999988 999999999999975 368999999999988
Q ss_pred CcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 531 AVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 531 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..+.... .....||.+|+|||.+....-+.++||||||||+|+.++ |.+||...-..+. ..+..+.-..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee
Confidence 7665544 345779999999999999888899999999999999999 5999963322110 1111110000
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
. +.. ..+. +..+||.+|++.+|..||++.+|+
T Consensus 734 ~-----L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 H-----LEP-LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e-----ecc-CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 001 1111 578999999999999999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=242.95 Aligned_cols=207 Identities=26% Similarity=0.392 Sum_probs=170.9
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcc
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 449 (708)
++...+.......||+|++|.|-+-++ .+|...|+|++.. .+....++.++|+.+..+- ..|.+|.+||...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 555566666778899999999988885 4799999999876 4455667888999877654 799999999999999999
Q ss_pred eEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 450 LLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
++.||.|.- +|+.+...- ..+..+++...-+||..+.+||.|||++-+ +||||+||+||||+.+|++|++|||++-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 999999964 777665432 234579999999999999999999999764 9999999999999999999999999987
Q ss_pred ccCcCCcceeecccccccccCcccccc----CCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQS----SHFTEKSDVYSFGVVLVELLTGERPIRLT 584 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDv~SlGvvl~elltg~~P~~~~ 584 (708)
.+...-. .+...|-..|||||.+.. ..|+.|+||||||+++.||.+++.|++.-
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 6543221 222347889999998853 36899999999999999999999998643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=256.54 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=201.1
Q ss_pred ccceEeeeccEEEEEEEE-cCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----CcceEEE
Q 047038 382 TNRILGQGGQGTVYKGML-EDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EVPLLVY 453 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 453 (708)
..+.||-|+||.||.+.+ ++|+.||+|++... +-..-+.+.+|+++|.-++|.|++..++...-. +++|++.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 346799999999999985 58999999987652 334557899999999999999999998876543 2467889
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
|.|.. +|...+-... .++...+.-+..||++||.|||+.+ |.||||||.|.|++.+-.+||+|||+++....+
T Consensus 137 ELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 98865 8888876543 5888888889999999999999999 999999999999999999999999999988877
Q ss_pred CcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh--------hch
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR--------EDR 604 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------~~~ 604 (708)
+....+..+-|..|.|||.+.+ ..|+.+.||||.||++.||+.++.-|+...+.+.-++......... ++-
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 7777777778999999999987 5699999999999999999999988876665554444433321111 111
Q ss_pred hhhhhhhh-------hhc--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 605 LFEILDAQ-------ILK--EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 605 ~~~~~d~~-------~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
-..++... .+- ..+.....+-..+..+++..+|++|.+..+.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111100 000 00112223456788899999999999998887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=235.94 Aligned_cols=257 Identities=19% Similarity=0.314 Sum_probs=194.3
Q ss_pred hccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEee--CCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLE--TEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~l 451 (708)
..++|++.+++|+|-+++||.|. ..+.+.++||.++. -..+.+.+|++||..+. ||||++|++...+ +..+.|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45688999999999999999999 45778899999875 44567889999999997 9999999999876 457889
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeeccCCccc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGASRSI 530 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGls~~~ 530 (708)
|+||+.+.+...+.. .++...+...+.|++.||.|.|+.| |+|||+||.|++||.. ..++|+|+||+..+
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999977766553 4677778889999999999999999 9999999999999965 56999999999887
Q ss_pred CcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH--------Hhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR--------AMR 601 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--------~~~ 601 (708)
.+...... .+.+..|.-||.+-. +.|+..-|+|||||+|..|+..+.||....+.. .+++....- .+.
T Consensus 184 Hp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHH
Confidence 65544332 234667889999866 457889999999999999999999986544322 222221110 010
Q ss_pred ------hchhhhhhhhhhh--------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 602 ------EDRLFEILDAQIL--------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 602 ------~~~~~~~~d~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..++.+++..... .+...-..++..+++.+.|..|-++|||++|.+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 0111122211100 011112236688999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=240.19 Aligned_cols=210 Identities=37% Similarity=0.592 Sum_probs=184.0
Q ss_pred EeeeccEEEEEEEEcC-CcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCccc
Q 047038 386 LGQGGQGTVYKGMLED-GKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQ 463 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 463 (708)
||+|++|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999998764432 45789999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccCCcccCcCCcceeeccc
Q 047038 464 YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAVDQTHLTTQVQ 542 (708)
Q Consensus 464 ~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~~~~~~~~~~~~~~~ 542 (708)
++.... ..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987653 25899999999999999999999998 999999999999999 89999999999876543321 123345
Q ss_pred ccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHH
Q 047038 543 GTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621 (708)
Q Consensus 543 gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 621 (708)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999887 888999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 622 FKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 622 ~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=245.21 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=195.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 447 (708)
..+|...+.+|.|.. .|--+.+. .+++||+|++.. .+....+...+|..++..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788899988 55555533 588999998654 34555677889999999999999999999987433
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..|+|||+|.. +|...++- .++-.....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 56899999964 88888772 4677888899999999999999999 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH--------HHHH
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY--------FLRA 599 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~--------~~~~ 599 (708)
+....+ ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+--|.+...-+.-..... |...
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865433 456777889999999999998899999999999999999999988875432211111000 0000
Q ss_pred h--------h---hc---hhhhhhhhh---hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 600 M--------R---ED---RLFEILDAQ---ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 600 ~--------~---~~---~~~~~~d~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+ + +. ...+.+... ...+.++.......+|+.+||-.+|++|.+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 0 00 001111111 011222233456789999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=243.21 Aligned_cols=132 Identities=27% Similarity=0.369 Sum_probs=111.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-----C---CceeeeeceEee--
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-----H---RNVVKLLGCCLE-- 445 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~-- 445 (708)
..+|.+.++||-|.|+|||++.+. +.+.||+|+.+.. ..-.+..+.||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368899999999999999999954 6788999998763 333467889999999984 3 479999999986
Q ss_pred --CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 047038 446 --TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL 513 (708)
Q Consensus 446 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll 513 (708)
+.+.+||+|++ |.+|..+|.....+ -++...+..|+.||+.||.|||... +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 44789999999 55888888766433 5899999999999999999999987 49999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=254.68 Aligned_cols=272 Identities=21% Similarity=0.243 Sum_probs=211.7
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC------CCceeeeec
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN------HRNVVKLLG 441 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g 441 (708)
.+.-.+....+|.+.-..|+|-|++|.+|... .|..||||++.. ++...+.=+.|++||++|+ --|+++|+.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33344566788999999999999999999965 477999999876 3444556678999999996 458999999
Q ss_pred eEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEE
Q 047038 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAK 520 (708)
Q Consensus 442 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~k 520 (708)
.|...++++||+|.+. -+|.+.|+..+...-|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 9999999999999885 599999998877777888999999999999999999999 9999999999999876 5689
Q ss_pred EeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH--
Q 047038 521 VSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR-- 598 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-- 598 (708)
|+|||.|.....+. .+.+.-+..|.|||++.+-+|+...|+||.||.||||.||+.-|.+......-.+.+....
T Consensus 578 LCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 578 LCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 99999987654333 2223345579999999999999999999999999999999999987665433333222211
Q ss_pred ---Hhhhchh--------------------------------------hhhhhhhhhccCCHHHHHHHHHHHHHhcccCC
Q 047038 599 ---AMREDRL--------------------------------------FEILDAQILKEGGKDEFKMVAKLAKRCLNLNG 637 (708)
Q Consensus 599 ---~~~~~~~--------------------------------------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p 637 (708)
+++.+.+ .+++..+............|.+|+.+||.+||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 1111100 01111111222345566789999999999999
Q ss_pred CCCCCHHHHHH
Q 047038 638 KKRPTMREVGI 648 (708)
Q Consensus 638 ~~RPt~~ev~~ 648 (708)
++|.|..+.++
T Consensus 735 ~KRit~nqAL~ 745 (752)
T KOG0670|consen 735 EKRITVNQALK 745 (752)
T ss_pred hhcCCHHHHhc
Confidence 99999998863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=235.64 Aligned_cols=199 Identities=37% Similarity=0.542 Sum_probs=173.8
Q ss_pred CcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 380 FNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
|...+.||+|++|+||++...+ ++.+|+|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 889999998765554 67889999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+++|.+++..... .+++.....++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999986542 1789999999999999999999998 9999999999999999999999999988765432112
Q ss_pred eecccccccccCcccc-ccCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 047038 538 TTQVQGTFGYLDPEYF-QSSHFTEKSDVYSFGVVLVELLTGERPIRL 583 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~-~~~~~t~ksDv~SlGvvl~elltg~~P~~~ 583 (708)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578889999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=257.41 Aligned_cols=196 Identities=26% Similarity=0.378 Sum_probs=167.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--------ChHHHHHHHHHHHHHHhcC---CCceeeeeceEee
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--------DESKVEEFINEVVILSQIN---HRNVVKLLGCCLE 445 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--------~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 445 (708)
.+|...+.||+|+||.|+.+.++ +...|+||.+... .+.+.-..-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788999999999999999976 4667899976541 1112223567999999997 9999999999999
Q ss_pred CCcceEEEEecc-CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 446 TEVPLLVYEFIS-NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 446 ~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
++..||+||... +-+|.+++..+. .+++.+...|+.||+.|+++||+.+ |+|||||-+||.+|.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999765 558999998765 5999999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCC
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIR 582 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~ 582 (708)
|.+..... .....++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99875432 23456789999999999999876 456899999999999999988874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=263.85 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=205.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|....++|.|.||.|||+++. .++..|||.++.....+..-..+|+.+++..+|+|||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4567888999999999999999964 789999999998777788888899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+.+|+|++.-+... ++++.+...+.++.+++|+|||+.+ -+|||||=.|||+++.+.+|++|||.+-.+...-
T Consensus 93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999988654 6999999999999999999999999 7999999999999999999999999987654321
Q ss_pred cceeecccccccccCcccc---ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYF---QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.....+.||+.|||||+. +.+.|..++|||++|+...||---++|....- .+.....+.... .++
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTkS~----~qp 234 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTKSG----FQP 234 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhccC----CCC
Confidence 123457799999999986 45678999999999999999988777743111 111111222111 111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..+++ ...-.+.+.++++.+|.++|++||+++.++
T Consensus 235 p~lkD-k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 PTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CcccC-CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11111 223346689999999999999999998754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=227.76 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=188.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeece-EeeCCcceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGC-CLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 453 (708)
.+.|.+.+.||+|.||.+-++.++ +...+++|.+.. ......+|.+|..---.| .|.||+.-|+. |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 477999999999999999999977 456788887654 345567899998765555 59999998865 56677788999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCcEEEeeccCCcccC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD--DKYCAKVSDFGASRSIA 531 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGls~~~~ 531 (708)
||++.|+|.+-+...+ +.+..-.+++.|++.||.|||+++ ++|||||.+||||- +..++||+|||+.+...
T Consensus 102 E~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999887753 778888899999999999999999 99999999999993 44589999999987542
Q ss_pred cCCcceeecccccccccCccccccC-----CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSS-----HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
. ......-+..|.+||..... ...+.+|||.||++++..+||+.||+. ....++....|....-+ ...
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~r--k~~ 247 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKR--KNP 247 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcc--cCc
Confidence 1 11222346679999976432 346789999999999999999999983 33333444443321111 111
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
.+... -....+.+..+.++-|..++++|=-..++.++-..+
T Consensus 248 -----~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 -----ALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred -----cCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 11111 122345577788999999999996666655544433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-27 Score=237.25 Aligned_cols=202 Identities=24% Similarity=0.360 Sum_probs=167.6
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 447 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 447 (708)
+....+.|...++||+|.|++||++.+. ..+.||+|.+.... ......+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567889999999999999999954 36789999887643 345688999999999 5999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGA 526 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGl 526 (708)
...+|+||++.....+++.. ++..++...+..++.||.++|..| ||||||||+|+|.+. .++-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999888888763 667888899999999999999999 999999999999985 46789999999
Q ss_pred CcccCcCC-------------c------------------------------ceeecccccccccCcccccc-CCCCccc
Q 047038 527 SRSIAVDQ-------------T------------------------------HLTTQVQGTFGYLDPEYFQS-SHFTEKS 562 (708)
Q Consensus 527 s~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ks 562 (708)
+....... . .......||+||.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87211000 0 00112469999999999865 5689999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCC
Q 047038 563 DVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 563 Dv~SlGvvl~elltg~~P~~~~~ 585 (708)
||||.|||++-+++++.||....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ceeeccceeehhhccccccccCc
Confidence 99999999999999999996543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=274.52 Aligned_cols=195 Identities=21% Similarity=0.249 Sum_probs=140.2
Q ss_pred hcCC-CceeeeeceE-------eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 047038 430 QINH-RNVVKLLGCC-------LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501 (708)
Q Consensus 430 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i 501 (708)
.++| +||++++++| .+.+.+++++|++ +++|.++|.... ..+++.+++.++.||++||.|||+.+ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888887 3345678889987 559999997542 35899999999999999999999998 9
Q ss_pred EecCCCCCcEEEcC-------------------CCcEEEeeccCCcccCcCC---------------cceeecccccccc
Q 047038 502 YHRDIKSTNILLDD-------------------KYCAKVSDFGASRSIAVDQ---------------THLTTQVQGTFGY 547 (708)
Q Consensus 502 iHrDikp~NIll~~-------------------~~~~kl~DFGls~~~~~~~---------------~~~~~~~~gt~~y 547 (708)
+||||||+||||+. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 3455666666665321100 0001124578899
Q ss_pred cCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHH
Q 047038 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAK 627 (708)
Q Consensus 548 ~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 627 (708)
||||++.+..++.++|||||||+||||++|.+|+.... .... .+.. ..+++.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~----~~~~----~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS----SLRH----RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH----HHHH----hhcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988863111 0000 0000 0111111 111234568
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047038 628 LAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 628 li~~cl~~~p~~RPt~~ev~~ 648 (708)
++.+||+.+|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=231.97 Aligned_cols=262 Identities=24% Similarity=0.260 Sum_probs=200.5
Q ss_pred CCcccceEeeeccEEEEEEEEcCC--cEEEEEEcccCChHHHHHHHHHHHHHHhcCC----CceeeeeceE-eeCCcceE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDG--KIVAVKKSKIIDESKVEEFINEVVILSQINH----RNVVKLLGCC-LETEVPLL 451 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 451 (708)
+|.+.++||+|+||.||++..... +.+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 4788887765433333378889999998873 6899999998 47778899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-----CcEEEeeccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-----YCAKVSDFGA 526 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-----~~~kl~DFGl 526 (708)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 679999886654 457999999999999999999999999 9999999999999855 4699999999
Q ss_pred Cc--ccCcCCcc----e---eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 527 SR--SIAVDQTH----L---TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 527 s~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
++ .+...... . .....||.+|.++..+.+...+.+.|+||++.++.||+.|..||........... +.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HH
Confidence 98 33222111 1 2345699999999999999999999999999999999999999976543322111 11
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
........ .. .....+..+.++...+-..+..++|....+...|..+....
T Consensus 251 ~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111100 00 11222344566666666699999999999999998887754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=215.68 Aligned_cols=265 Identities=18% Similarity=0.245 Sum_probs=212.5
Q ss_pred ccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.-+|.+.++||+|.||+++.|+ +-++++||||.... ..+..++..|.+..+.| ..++|...+-+..++..-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3479999999999999999999 55899999997554 33445677888888888 47899999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEeeccCCcc
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-----KYCAKVSDFGASRS 529 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGls~~ 529 (708)
.+ |.+|+++..-... .++.+++..||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+++.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 6799998876544 6999999999999999999999999 999999999999963 44699999999998
Q ss_pred cCcCCcce------eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 530 IAVDQTHL------TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 530 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+....+.. .....||.+||+-..+.+...+.+.|+-|||-|+++.|.|..||++......+...+.+-..-+.-
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 76544332 234569999999999999999999999999999999999999999887766544443332222221
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
.+.++ ....++++...++-.-.++-.+-|+.+-+...+..+...++
T Consensus 259 ~i~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 259 PIEVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred CHHHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 11111 22345567777787888899999999999888888766544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=210.80 Aligned_cols=169 Identities=21% Similarity=0.239 Sum_probs=127.3
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
|+|.++++... ..+++.+++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 68889997643 25999999999999999999999876 999999999999999 99987654321
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCC
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGG 618 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 618 (708)
..||+.|||||++.+..++.++||||||+++|||++|+.||....... .........+.... +. .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------PR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------cc-ccccH
Confidence 258999999999999999999999999999999999999985432211 11111111111100 00 00011
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 619 KDEFK--MVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 619 ~~~~~--~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..... .+.+++.+||+.+|++||++.|+++.+..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 12222 58999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=193.94 Aligned_cols=106 Identities=44% Similarity=0.788 Sum_probs=85.2
Q ss_pred CCCCCCCCCCeeeecCCCCCCCCCCCCCCeEEeccCCCCCCcceeccccccccccccCCCcceEEEEeeeeeeecccCCC
Q 047038 23 KERCPNQCGGVNIRYPFGIGEGCYFDKSFEVVCDNNSTRSPKALLKSINLELSPYMSNGSGLAYISVNISVIRLNRRKST 102 (708)
Q Consensus 23 ~~~C~~~CG~v~IpYPFgi~~~C~~~~~F~l~C~~~~~~~~~~~l~~~~~~v~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (708)
+++||++||||+|||||||+++|+++|+|+|+| ++++++|++++..++|+|++| ++++ ++++|..++.. .|....
T Consensus 1 ~~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C-~~~~~~~~l~l~~~~~~V~~I-~~~~--~~i~v~~~~~~-~~~~~~ 75 (106)
T PF13947_consen 1 KPGCPSSCGNVSIPYPFGIGPGCGRDPGFELTC-NNNTSPPKLLLSSGNYEVLSI-SYEN--GTIRVSDPISS-NCYSSS 75 (106)
T ss_pred CCCCCCccCCEeecCCCccCCCCCCCCCcEEEC-CCCCCCceeEecCCcEEEEEE-ecCC--CEEEEEecccc-ceecCC
Confidence 589999999999999999999999988999999 554567888888999999999 9998 89998888754 343333
Q ss_pred cccccccccccCCCceEeecCCCEEEEECccc
Q 047038 103 SHNINAKGVNLSGTPFSFSQTDNRFIAIGCNS 134 (708)
Q Consensus 103 ~~~~~~~~~~l~~~pf~~S~~~N~~~~~gC~~ 134 (708)
........+++.+ ||.+|+++|+|+++||++
T Consensus 76 ~~~~~~~~~~~~~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 76 SSNSSNSNLSLNG-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred CCcccccEEeecC-CceEccCCcEEEEECCCC
Confidence 2222122344544 899999999999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=205.89 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=208.9
Q ss_pred ccCCcccceEeeeccEEEEEEE-EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 454 (708)
...|.+.++||.|+||.+|.|. ..+|..||||.-.. .....++..|.++...++| ..|+.+..+..+.+.-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4679999999999999999999 56899999998654 3334578889999999975 678888888999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccCCcccC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGASRSIA 531 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGls~~~~ 531 (708)
.+ |.+|++++.-... .++-++++.+|-|++.-++|+|.++ ++||||||+|+|..- -..+.|+||||++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 6799998876544 5888999999999999999999999 999999999999963 3569999999998775
Q ss_pred cCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 532 VDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 532 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
...+. ..+...||.+|.+-..+.+-..+.+.|+-|+|.+|.++..|..||++.......+..+...+.--.-
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~-- 243 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST-- 243 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC--
Confidence 33221 1344679999999998888888999999999999999999999999877655444333322111110
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.........+.++.-.+.-|-...-++-|+..-+.+.+.-|..
T Consensus 244 -------~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 -------PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred -------CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111233345568888999999999999999988888877765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=223.41 Aligned_cols=166 Identities=20% Similarity=0.161 Sum_probs=130.8
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc--CCcEEEEEEcccC-----ChHHHHHHHHHHHHHHhcCCCceee-eeceEe
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE--DGKIVAVKKSKII-----DESKVEEFINEVVILSQINHRNVVK-LLGCCL 444 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~ 444 (708)
.....++|...++||+|+||+||+|... +++.||||+.... .....+.|.+|+++|++++|+|+++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999865 5778899986432 2334567999999999999999985 443
Q ss_pred eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCcEEEee
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI-KSTNILLDDKYCAKVSD 523 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDi-kp~NIll~~~~~~kl~D 523 (708)
.+..+|||||+++++|... ... . ...++.|+++||.|||+.+ |+|||| ||+|||++.++++||+|
T Consensus 90 -~~~~~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -cCCcEEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 2467999999999999632 111 1 1457889999999999998 999999 99999999999999999
Q ss_pred ccCCcccCcCCcc-------eeecccccccccCcccccc
Q 047038 524 FGASRSIAVDQTH-------LTTQVQGTFGYLDPEYFQS 555 (708)
Q Consensus 524 FGls~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 555 (708)
||+++.+...... ..+...+++.|+|||++..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999876532211 1145678889999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=200.85 Aligned_cols=248 Identities=20% Similarity=0.312 Sum_probs=192.2
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
....+|.+...|+.|+|+++.+. +++|+++..+ .....+|..|.-.|+-+.||||..++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34456888999999999997544 5566665432 33345799999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEe--eccCCcccCcCCcc
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS--DFGASRSIAVDQTH 536 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~--DFGls~~~~~~~~~ 536 (708)
|+|+..|++... ..++..+..+++.++++|++|||+.... |.---|.+..+++|++.+++|+ |--++..
T Consensus 272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeee-------
Confidence 999999998743 4577889999999999999999998742 4444689999999999988874 2111111
Q ss_pred eeecccccccccCccccccCCC---CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHF---TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~---t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....-.+.||+||.++..+- -+++|+|||.++||||.|...||....+-+.. ..+.-..+
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialegl 406 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGL 406 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccc
Confidence 111123678999999987653 35899999999999999999999754443321 12222334
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
....++.....+..|+.-|+..||.+||.+..|+-.||.++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 44556667778999999999999999999999999988764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-21 Score=204.16 Aligned_cols=261 Identities=31% Similarity=0.411 Sum_probs=197.6
Q ss_pred CcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChH---HHHHHHHHHHHHHhcCCC-ceeeeeceEeeCCcceEEEEe
Q 047038 380 FNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES---KVEEFINEVVILSQINHR-NVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 455 (708)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999976 78899987663322 477899999999999988 799999999777778999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~~~~~ 534 (708)
+.+++|.+++........+.......+..|++.++.|+|+.+ ++||||||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966654421125888999999999999999999999 99999999999999988 79999999998554333
Q ss_pred cc-----eeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 535 TH-----LTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 535 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
.. ......||..|++||.+.. .......|+||+|++++++++|..||...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2356679999999999987 57889999999999999999999997654431 0001111111111000
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.................+.+++.+++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223568899999999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=228.28 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=188.7
Q ss_pred cccceEeeeccEEEEEEEEc-CCcEEEEEEcc-----cCChHHH-HHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 381 NTNRILGQGGQGTVYKGMLE-DGKIVAVKKSK-----IIDESKV-EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~-----~~~~~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
...+++|.|++|.|+..... ..+..+.|... .....+. ..+..|+-+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977776633 34444444322 1111121 22667888888899999999888888777766679
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++ +|..++.... .+....+-.++.|++.|+.|||+.+ |.|||||++|++++.++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999998652 4788888899999999999999999 999999999999999999999999998876543
Q ss_pred Cc---ceeecccccccccCccccccCCCCc-cchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 534 QT---HLTTQVQGTFGYLDPEYFQSSHFTE-KSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 534 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.. .......|...|+|||++....|.+ ..||||.|+++..|++|+.||......+... ...........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~-- 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNI-- 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccc--
Confidence 33 4466788999999999999988875 6899999999999999999998665443321 00000000000
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..-........+.+.+.++.++|+.+|.+|.|+++|+
T Consensus 547 -~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 547 -FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred -ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 0001111234456678999999999999999999996
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=223.28 Aligned_cols=250 Identities=20% Similarity=0.233 Sum_probs=184.4
Q ss_pred CCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC-hHHHHHHHHHHHH--HHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID-ESKVEEFINEVVI--LSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++...+.||.+.|=.|.+++.++|. |+||++-..+ .-..+.|.++++- ...++|||.+++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777889999999999999998887 8888764433 3344444444433 4556999999998887777788999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC--cC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA--VD 533 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~--~~ 533 (708)
+.+ +|+|.|.... .+...+.+.|+.|++.||...|..+ |+|+|||.+||||+.-..+.|+||..-+... .+
T Consensus 103 vkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 976 8999887653 5788888999999999999999999 9999999999999999999999998765432 22
Q ss_pred Cc----ceeecccccccccCcccccc----------CC-CCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHH
Q 047038 534 QT----HLTTQVQGTFGYLDPEYFQS----------SH-FTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 534 ~~----~~~~~~~gt~~y~aPE~~~~----------~~-~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 597 (708)
+. ....+......|+|||.+.. .. ++++.||||+||+++||++ |++||. -.++..+-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHhc
Confidence 22 22233334557999998743 12 7889999999999999999 899984 222222211
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
. ..... ..++++.+. ..+++|+..|++.||++|.++++.++.-.+
T Consensus 250 ~---~~~~~----e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 G---NADDP----EQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred c---CccCH----HHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1 00000 111111111 248899999999999999999999877443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=190.27 Aligned_cols=172 Identities=16% Similarity=0.160 Sum_probs=133.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC---hHHHHH------HHHHHHHHHhcCCCceeeeeceEee
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID---ESKVEE------FINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~------~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
-..++|+..++||.|+||.||.... +++.+|||.+.... +...+. |.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999655 57789999886532 222222 6899999999999999999988664
Q ss_pred C--------CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 446 T--------EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 446 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
. ...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++||||||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999987632 222 24569999999999999 99999999999999988
Q ss_pred cEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHH
Q 047038 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ell 575 (708)
++|+|||.......+... ..+.....+..++|+|+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654221111 01334445668999999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-21 Score=184.59 Aligned_cols=139 Identities=19% Similarity=0.140 Sum_probs=108.2
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChH--H-------H-----------------HHHHHHHHHHHhcCCCce
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES--K-------V-----------------EEFINEVVILSQINHRNV 436 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~H~ni 436 (708)
...||+|+||.||+|...+|+.||||+++..... . . ....+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999988653211 1 1 122459999999988877
Q ss_pred eeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEEcC
Q 047038 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL-HSAASIPIYHRDIKSTNILLDD 515 (708)
Q Consensus 437 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yL-H~~~~~~iiHrDikp~NIll~~ 515 (708)
.....+.. ...+|||||+++++|...+... ..+++.....++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 54433322 2348999999988776543222 2588999999999999999999 6878 999999999999984
Q ss_pred CCcEEEeeccCCccc
Q 047038 516 KYCAKVSDFGASRSI 530 (708)
Q Consensus 516 ~~~~kl~DFGls~~~ 530 (708)
+.++|+|||++...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 78999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=177.20 Aligned_cols=139 Identities=22% Similarity=0.192 Sum_probs=110.7
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChH--------------------------HHHHHHHHHHHHHhcCCCce
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES--------------------------KVEEFINEVVILSQINHRNV 436 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~ni 436 (708)
...||+|++|.||+|...+|+.||||.++..... ....+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999987653210 01234679999999999988
Q ss_pred eeeeceEeeCCcceEEEEeccCCCcccc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEc
Q 047038 437 VKLLGCCLETEVPLLVYEFISNGTLSQY-IDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLD 514 (708)
Q Consensus 437 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~ 514 (708)
.....+... ..+|||||++++++... +.. ..++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444332 34899999998865433 322 247788899999999999999999 88 99999999999999
Q ss_pred CCCcEEEeeccCCcccC
Q 047038 515 DKYCAKVSDFGASRSIA 531 (708)
Q Consensus 515 ~~~~~kl~DFGls~~~~ 531 (708)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=172.87 Aligned_cols=185 Identities=14% Similarity=0.023 Sum_probs=138.3
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHH----HHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEe
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESK----VEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~----~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.+...|++|+||+||.+.. .+.+++.+.+.....-. ...|.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3557899999999997765 67778877766543321 235889999999995 5889999886 446999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI-KSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDi-kp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
+.|.+|...+.. ....++.|++++|.++|+.+ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654321 11346789999999999999 999999 7999999999999999999998554322
Q ss_pred cc----e--------eecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCC
Q 047038 535 TH----L--------TTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRL 583 (708)
Q Consensus 535 ~~----~--------~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~ 583 (708)
.. . ......++.|++|+...- ..--.+.+.++-|..+|.++|+..|.-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 001225777888875432 2222567888999999999999888543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-20 Score=197.22 Aligned_cols=218 Identities=24% Similarity=0.459 Sum_probs=165.8
Q ss_pred HHhcCCCceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 047038 428 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507 (708)
Q Consensus 428 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDik 507 (708)
|+++.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ...++|.-...+..+|+.||+|||+.. -.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 45789999999999999999999999999999999999874 346999999999999999999999865 13999999
Q ss_pred CCcEEEcCCCcEEEeeccCCcccCcC-CcceeecccccccccCccccccC-------CCCccchhHhHHHHHHHHHhCCC
Q 047038 508 STNILLDDKYCAKVSDFGASRSIAVD-QTHLTTQVQGTFGYLDPEYFQSS-------HFTEKSDVYSFGVVLVELLTGER 579 (708)
Q Consensus 508 p~NIll~~~~~~kl~DFGls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDv~SlGvvl~elltg~~ 579 (708)
+.|.++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765320 11111122234569999998763 24778999999999999999999
Q ss_pred CCCCCCcchhh-hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 580 PIRLTNSEEDK-SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 580 P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
||......+.. .+..+ ++.+ ....+-+.+... .+..+.+..++.+||..+|++||++++|-..++.+.+.
T Consensus 157 ~~~~~~~~~~~~eii~~----~~~~-~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILR----VKKG-GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHH----HHhc-CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99865443332 22222 1110 011111111111 13344689999999999999999999999999888773
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=181.84 Aligned_cols=233 Identities=21% Similarity=0.302 Sum_probs=150.6
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcC----------CCceeeeeceEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQIN----------HRNVVKLLGCCL 444 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~----------H~niv~l~g~~~ 444 (708)
.+...+.||.|+++.||.+++. +++.+|||..... .....+++.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456688999999999999976 5899999975442 2345677777776555532 222332222222
Q ss_pred ---------eC---C-----cceEEEEeccCCCccccccc---cCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 047038 445 ---------ET---E-----VPLLVYEFISNGTLSQYIDD---QNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503 (708)
Q Consensus 445 ---------~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH 503 (708)
.. . ..+++|+-+. ++|.+++.. ... ...+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 2256777774 588777543 211 223556677788899999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCcccccc--------CCCCccchhHhHHHHHHHHH
Q 047038 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS--------SHFTEKSDVYSFGVVLVELL 575 (708)
Q Consensus 504 rDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDv~SlGvvl~ell 575 (708)
+||||+|++++++|.++|+||+....... . ......+..|.+||.... -.++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT--R--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE--E--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc--e--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654321 1 111335678999997643 24788999999999999999
Q ss_pred hCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCC
Q 047038 576 TGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKR 640 (708)
Q Consensus 576 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 640 (708)
++..||.....+..... ...... +.++.+..||..+|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999976543322111 112223 778889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-20 Score=202.51 Aligned_cols=225 Identities=25% Similarity=0.294 Sum_probs=178.7
Q ss_pred eEeeeccEEEEEEE----EcCCcEEEEEEcccCCh--HHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEecc
Q 047038 385 ILGQGGQGTVYKGM----LEDGKIVAVKKSKIIDE--SKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~----~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|+|.||.|+.+. .+.+..+|+|.++.... ........|-.++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998755 23467788887655221 11225667888888886 9999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|.|...+.... .+.+........+++-|++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998887654 4667777778889999999999999 999999999999999999999999999875433222
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
.||..|||||++. ....++|.||||++++||+||..||.. + ......+. ....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHHHhhh-----------ccCC
Confidence 6899999999998 457799999999999999999999964 1 01111110 1123
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
+.+.......++.+++..+|.+|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 55666778889999999999999655
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=170.91 Aligned_cols=136 Identities=15% Similarity=0.191 Sum_probs=106.4
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-----CCCceeeeeceEeeCC---c-ceE
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-----NHRNVVKLLGCCLETE---V-PLL 451 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 451 (708)
...++||+|+||.||. ..+....+||+.........+.+.+|+.+++++ +||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 333233479987765455667899999999999 5799999999998864 3 337
Q ss_pred EEEe--ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEEcC----CCcEEEeec
Q 047038 452 VYEF--ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI-SYLHSAASIPIYHRDIKSTNILLDD----KYCAKVSDF 524 (708)
Q Consensus 452 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al-~yLH~~~~~~iiHrDikp~NIll~~----~~~~kl~DF 524 (708)
|+|| ..+++|.+++... .+++. ..++.|++.++ +|||+.+ |+||||||+|||++. +.+++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999653 25544 35577888777 9999999 999999999999974 348999995
Q ss_pred cCC
Q 047038 525 GAS 527 (708)
Q Consensus 525 Gls 527 (708)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.8e-19 Score=200.78 Aligned_cols=202 Identities=22% Similarity=0.303 Sum_probs=164.4
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeC
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN---HRNVVKLLGCCLET 446 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 446 (708)
..+.+.-...|.+.+.||+|+||+||+|...+|+.||+|.-+..... +|.--.+++.+|+ -+-|..+..+..-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 44566667789999999999999999999888999999987664432 2333344555555 33455555555667
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-------CCCcE
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-------DKYCA 519 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-------~~~~~ 519 (708)
+.-+||+||.+.|+|.+++... .-++|...+.++.|+++.+++||..+ |||+||||+|+||. +..-+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 7889999999999999999833 36999999999999999999999999 99999999999994 34569
Q ss_pred EEeeccCCcccCc-CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCC
Q 047038 520 KVSDFGASRSIAV-DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580 (708)
Q Consensus 520 kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P 580 (708)
+|+|||-+..+.. ......+..++|-.+--+|...+..++...|.|.|+.+++-||.|+.-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999876642 222345677889999999999999999999999999999999999764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.7e-19 Score=186.60 Aligned_cols=241 Identities=22% Similarity=0.325 Sum_probs=161.3
Q ss_pred ccceEeeeccEEEEEEEEcCC----cEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeec-------eEe-----e
Q 047038 382 TNRILGQGGQGTVYKGMLEDG----KIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLG-------CCL-----E 445 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~----~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g-------~~~-----~ 445 (708)
..+..+..+++.++.....++ .-++.|..+..+........+++..+....|.+..-+.. ... .
T Consensus 248 ~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~ 327 (516)
T KOG1033|consen 248 ISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK 327 (516)
T ss_pred ccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence 334455566666655443222 233444443333223333444555444444433333322 111 1
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
...++|.|+++...+|.++|.........++...+.++.|++.|++| ++ .+|||+||.||++..+..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 33578999999999999999877666678999999999999999999 66 8999999999999999999999999
Q ss_pred CCcccCcCC-----cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHH
Q 047038 526 ASRSIAVDQ-----THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 526 ls~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
+........ ....+...||..||+||.+.+..|+.|+||||||++|+||+. =..++. ......-
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTD 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhh
Confidence 987665443 233456679999999999999999999999999999999997 222221 1111222
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
++.+.+. +....+.+. =..|+.+++.+.|.+||++.++.
T Consensus 472 ~r~g~ip----~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIP----PEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCC----hHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHh
Confidence 2333222 112222222 34689999999999999665543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=163.65 Aligned_cols=134 Identities=22% Similarity=0.308 Sum_probs=113.9
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
+.||+|++|.||+|.. +|..|++|+..... ......+.+|+.++..++|++++....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 67788999754321 11234688999999999999998888888888889999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 78889999999999999998 99999999999999 78899999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=159.84 Aligned_cols=145 Identities=21% Similarity=0.158 Sum_probs=113.2
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCCh----------------------HHHHHHHHHHHHH
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE----------------------SKVEEFINEVVIL 428 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~Ei~~l 428 (708)
+++.+....|...+.||+|+||.||++...+|+.||||+...... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445778899999999999999988899999997553210 0112367889999
Q ss_pred HhcCCCc--eeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 047038 429 SQINHRN--VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI 506 (708)
Q Consensus 429 ~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDi 506 (708)
..+.|++ ++..++ ....++||||+++++|.++... .....++.+++.++.++|+.+ |+||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 3456899999999998776431 234568889999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEeeccCCcccC
Q 047038 507 KSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 507 kp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-17 Score=163.25 Aligned_cols=148 Identities=20% Similarity=0.118 Sum_probs=113.8
Q ss_pred HHhhccCCcccceEeeeccEEEEEEE--EcCCcEEEEEEcccCChH------------------------HHHHHHHHHH
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGM--LEDGKIVAVKKSKIIDES------------------------KVEEFINEVV 426 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~Ei~ 426 (708)
+.+-...|.+.+.||+|+||.||+|. ..+|+.||||.++..... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444458888999999999999998 568999999987643210 1123678999
Q ss_pred HHHhcCCC--ceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 047038 427 ILSQINHR--NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504 (708)
Q Consensus 427 ~l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHr 504 (708)
+++++.+. .+++++++ ...+|||||+++.+|...+.... .+...+...++.|++.+|.+||+.+ .|+||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 99999763 34445543 23589999999988877653221 3556667889999999999999987 39999
Q ss_pred CCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 505 DIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 505 Dikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
||||+||+++ ++.++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999988743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-17 Score=187.55 Aligned_cols=208 Identities=25% Similarity=0.347 Sum_probs=146.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+|+.+++|..|+||.||..+++. .+.+|+|.-+. +. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch-----hhhc--cccccCCccee------------------
Confidence 4689999999999999999998764 56678853221 10 0000 22222333333
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC-
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ- 534 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~- 534 (708)
|+=...++..+ +++.. ++.+++|||+.+ |+|||+||+|.||..-|++|+.|||+++......
T Consensus 136 ---gDc~tllk~~g---~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG---PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccCC---CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33334444322 23332 277899999999 9999999999999999999999999987532110
Q ss_pred -------------cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 535 -------------THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 535 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
......+.||+.|+|||++..+.|+..+|.|++|+|+||.+-|..||.+...++- ...+ +.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg~v---is 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQV---IS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hhhh---hh
Confidence 0113446799999999999999999999999999999999999999988776652 1111 11
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP 641 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 641 (708)
. .....+.....+.+.+++|.+.|+.+|.+|-
T Consensus 273 d--------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 D--------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h--------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 1111222444556789999999999999994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-17 Score=183.58 Aligned_cols=137 Identities=19% Similarity=0.279 Sum_probs=112.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEE-ccc-CC------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKK-SKI-ID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~-~~~-~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
...|...++||+|+||+||+|.+.+.. +++|+ ... .. ....+.+.+|++++++++|++++....++.+.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445567889999999999999876544 33332 211 11 1234578999999999999999998888888788
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998775 34678999999999999998 9999999999999 57789999999987
Q ss_pred c
Q 047038 529 S 529 (708)
Q Consensus 529 ~ 529 (708)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=158.55 Aligned_cols=130 Identities=22% Similarity=0.330 Sum_probs=107.4
Q ss_pred eEeeeccEEEEEEEEcCCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 385 ILGQGGQGTVYKGMLEDGKIVAVKKSKIID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+||+|+||+||+|.. +++.|++|...... ....+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56789999754311 112366889999999999988766666666777789999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875431 1 78899999999999998 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=161.64 Aligned_cols=196 Identities=22% Similarity=0.256 Sum_probs=136.8
Q ss_pred CCCceeeeeceEee---------------------------CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHH
Q 047038 432 NHRNVVKLLGCCLE---------------------------TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI 484 (708)
Q Consensus 432 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 484 (708)
+|||||+++++|.+ ...+|+||.-.+. +|.+++.... .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999888753 2345788887754 8988887653 55556667888
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CC--CcEEEeeccCCcccCcC-----CcceeecccccccccCcccccc
Q 047038 485 DVSGAISYLHSAASIPIYHRDIKSTNILLD--DK--YCAKVSDFGASRSIAVD-----QTHLTTQVQGTFGYLDPEYFQS 555 (708)
Q Consensus 485 ~i~~al~yLH~~~~~~iiHrDikp~NIll~--~~--~~~kl~DFGls~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 555 (708)
|+++|+.|||.++ |.|||+|++||||. ++ -.+.|+|||.+-..... ........-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 33 35899999976432211 1111122336677899999765
Q ss_pred CC------CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHH
Q 047038 556 SH------FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLA 629 (708)
Q Consensus 556 ~~------~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 629 (708)
.+ .-.|+|.|+.|.+.||+++...||....... -+.. ..++.++. ..+...+..+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r-----~Yqe~qLP---------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTR-----TYQESQLP---------ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echh-----hhhhhhCC---------CCcccCChHHHHHH
Confidence 32 2358999999999999999999996522110 0011 12222221 12334456689999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 047038 630 KRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 630 ~~cl~~~p~~RPt~~ev~~~L 650 (708)
...|+.||.+||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999877555444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-15 Score=139.50 Aligned_cols=135 Identities=24% Similarity=0.240 Sum_probs=115.1
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeCCcceEEEEeccCC
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999855 7899998765433 5678999999999976 58999999888888899999999988
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
.+..+ +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||+++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4556677899999999999997545699999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-15 Score=145.90 Aligned_cols=136 Identities=24% Similarity=0.264 Sum_probs=98.7
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCCh--HHHHHH----------------------HHHHHHHHhcCCCc--e
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE--SKVEEF----------------------INEVVILSQINHRN--V 436 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~----------------------~~Ei~~l~~l~H~n--i 436 (708)
.+.||+|+||+||+|...+++.||||....... .....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999998664221 111111 35666666665443 4
Q ss_pred eeeeceEeeCCcceEEEEeccCCCcccc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEc
Q 047038 437 VKLLGCCLETEVPLLVYEFISNGTLSQY-IDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLD 514 (708)
Q Consensus 437 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~ 514 (708)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 346899999999654322 22111 11 5667889999999999999 77 99999999999999
Q ss_pred CCCcEEEeeccCCcccC
Q 047038 515 DKYCAKVSDFGASRSIA 531 (708)
Q Consensus 515 ~~~~~kl~DFGls~~~~ 531 (708)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=146.76 Aligned_cols=135 Identities=20% Similarity=0.251 Sum_probs=105.7
Q ss_pred cceEe-eeccEEEEEEEEcCCcEEEEEEcccCC-------------hHHHHHHHHHHHHHHhcCCCce--eeeeceEeeC
Q 047038 383 NRILG-QGGQGTVYKGMLEDGKIVAVKKSKIID-------------ESKVEEFINEVVILSQINHRNV--VKLLGCCLET 446 (708)
Q Consensus 383 ~~~lG-~G~~g~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 446 (708)
..+|| .||.|+||++... +..++||+..... ......+.+|+.++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999875 6778998764311 1234568899999999998885 6777775443
Q ss_pred Cc----ceEEEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 447 EV----PLLVYEFISN-GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 447 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
.. .++|||++++ .+|.+++... .++.. .+.+|+++|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 3599999997 6898887643 34443 3568999999999999 999999999999999889999
Q ss_pred eeccCCcc
Q 047038 522 SDFGASRS 529 (708)
Q Consensus 522 ~DFGls~~ 529 (708)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-16 Score=175.68 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=188.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc--CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE--DGKIVAVKKSKIID--ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 451 (708)
...|...+.||+|+|+.|-..... ....+|+|...... ....+....|..+-+.+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345677778999999999887753 24456777665533 333445556777777776 9999999999999999999
Q ss_pred EEEeccCCCccccc-cccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDVSGAISYLH-SAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~al~yLH-~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~ 528 (708)
+.||..++++.+.+ +.... ..+.......+.|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||++.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999988 43321 3455556678899999999999 777 99999999999999999 99999999998
Q ss_pred ccCc-C-Ccceeecccc-cccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 529 SIAV-D-QTHLTTQVQG-TFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 529 ~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
.+.. . .........| ++.|+|||...+ ....+..|+||.|+++.-+++|..||......... ...| +....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~----~~~~~ 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSW----KSNKG 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceee----ccccc
Confidence 8765 2 2333445668 999999999887 45577899999999999999999999765443311 0100 11000
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
. ..............+++.+++..+|..|.+.+++.
T Consensus 249 ~-------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 R-------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred c-------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0 00001122234467788999999999999998874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.8e-13 Score=148.46 Aligned_cols=140 Identities=21% Similarity=0.219 Sum_probs=101.4
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHH----------------------------------------HHHH
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV----------------------------------------EEFI 422 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~ 422 (708)
.+.||.|++|.||+|++++|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999998654211110 1355
Q ss_pred HHHHHHHhcC-----CCceeeeeceE-eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 047038 423 NEVVILSQIN-----HRNVVKLLGCC-LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG-AISYLHS 495 (708)
Q Consensus 423 ~Ei~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-al~yLH~ 495 (708)
+|+..+.+++ ++++ .+-..+ ......+|||||++|++|.++....... . .+..++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHh
Confidence 6666666652 3333 322222 2345679999999999999876532211 2 23456666666 4788898
Q ss_pred cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 496 ~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
.+ ++|+|+||.||+++++++++|.|||++..+.
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-13 Score=134.55 Aligned_cols=201 Identities=23% Similarity=0.306 Sum_probs=139.6
Q ss_pred HHHHhcCCCceeeeeceEeeCC-----cceEEEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 047038 426 VILSQINHRNVVKLLGCCLETE-----VPLLVYEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASI 499 (708)
Q Consensus 426 ~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~ 499 (708)
.-|-++-|.|||++..|+.+.. ...++.|||+.|+|..+|++... ...+......+|..||..||.|||+.. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455667999999999986543 46799999999999999987543 446788888899999999999999986 6
Q ss_pred CeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC----CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHH
Q 047038 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD----QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575 (708)
Q Consensus 500 ~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ell 575 (708)
||+|+++.-+-|++..++-+|+.-- ........ .........+-++|.+||+=..-..+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7999999999999999998887421 11111100 000111234678999999987777888999999999999998
Q ss_pred hCCCCCCCCCc-chhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 576 TGERPIRLTNS-EEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 576 tg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
-+..--....+ .+.+....... +..+.. .=+.++.+|++.+|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i---------------~~len~-----lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVI---------------IGLENG-----LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhhe---------------eeccCc-----cccCcCcccccCCCCCCcchhhhhc
Confidence 76543111111 11000000000 000000 1245789999999999999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.1e-13 Score=142.60 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=182.3
Q ss_pred cCCcccceEee--eccEEEEEEEE---cCCcEEEEEEccc--CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcc
Q 047038 378 DNFNTNRILGQ--GGQGTVYKGML---EDGKIVAVKKSKI--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 449 (708)
..|.....+|. |.+|.||++.. +++..+|+|+-+. ........=.+|+...+.+ .|+|.|+.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666778999 99999999987 3688899998544 2233333445566666666 499999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeec
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG----AISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDF 524 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DF 524 (708)
++-.|++. .+|.++.+.... .++....+.+..+..+ ||.++|+.. ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 688888876543 4677777788888888 999999998 9999999999999999 88999999
Q ss_pred cCCcccCcCCcc----eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 525 GASRSIAVDQTH----LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 525 Gls~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
|+...+...... ......|...|++||..+ +.++.++|+|++|.++.+..++..+........ | ...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W--~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W--SQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c--ccc
Confidence 998877643321 122335788899999876 457889999999999999998776643321110 0 000
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
+... +..++......++..++..+++.+|..|++.+.+. .|.-|.
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~ 383 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIH 383 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-cccccc
Confidence 1000 11111222223455689999999999999887654 344433
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.3e-12 Score=118.97 Aligned_cols=130 Identities=20% Similarity=0.105 Sum_probs=97.1
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCcee-eeeceEeeCCcceEEEEeccCCCc
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV-KLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
.+.|+.|.++.||++... ++.+++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999865 77899998754322 233567899999998765544 455443 3346899999999887
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA--SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+.. . ....++.+++++|..||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6530 0 11235678999999999987 23369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.5e-12 Score=109.08 Aligned_cols=95 Identities=22% Similarity=0.448 Sum_probs=68.7
Q ss_pred CCCCCCcCCCcccccCccccccc-cceeeeEEeec----ccccceeeEEEeeeeeeeecccCCcccccccccceeeeecc
Q 047038 152 PTQNSDCCNMLCNIPQSSIIIKV-LDAYSSYVYSQ----NISQVCTSVSVVYLDWFFSNYLRFPNVLENKEYVSAKLEWG 226 (708)
Q Consensus 152 ~c~g~~Cc~~~c~~~~~~~~~~~-~~~~~~~~~~~----~~~~~C~~a~~~~~~~~~~~~~~~~~~~~~~~~~p~~ldW~ 226 (708)
.|+|.+|||+ .|| .+ ++.+.+.+... ....+|++||++++.||.++.+++.. ....+++||+|+|+
T Consensus 3 ~CsG~~CCQt--~iP------~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~-~~~~~y~pv~L~W~ 73 (103)
T PF08488_consen 3 SCSGIGCCQT--SIP------SGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPED-FHAMGYVPVVLDWF 73 (103)
T ss_pred ccCCcceecc--CCC------CCCceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHH-hccCCeeEEEEEEE
Confidence 6899999999 999 64 56777777753 23479999999999999887665543 36778999999999
Q ss_pred ccCCCCcccCCCCCccccCCCceeecCCCceEeecC
Q 047038 227 KTGGSTCSEEYNLDTSCNQDGYCLVQLGSGYFCLCN 262 (708)
Q Consensus 227 i~~~~c~~~~~~~~~~C~~~s~C~~~~~~Gy~C~C~ 262 (708)
|...+.. ....++|........ ..+|.|.
T Consensus 74 i~t~~~~---~~~s~~C~~~~~y~~----~~~C~C~ 102 (103)
T PF08488_consen 74 IDTSDSS---FSNSLACKNNTEYSS----SNRCSCS 102 (103)
T ss_pred EecCCcC---cCcCccCCCceeccC----CCcEeCC
Confidence 9754332 233478887755211 1278885
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.7e-12 Score=139.07 Aligned_cols=144 Identities=17% Similarity=0.160 Sum_probs=93.5
Q ss_pred cCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChH------------------------------H----HH---
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDES------------------------------K----VE--- 419 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~------------------------------~----~~--- 419 (708)
..|+. +.||+|++|.||+|++++ |+.||||+.+..-.. - .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 999999987642110 0 11
Q ss_pred ---HHHHHHHHHHhcC----CCceeeeeceEee-CCcceEEEEeccCCCccccc--cccCC-CCCCCHHHHHHHHHHHHH
Q 047038 420 ---EFINEVVILSQIN----HRNVVKLLGCCLE-TEVPLLVYEFISNGTLSQYI--DDQNK-DFRISWEMRLCIAIDVSG 488 (708)
Q Consensus 420 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~~i~~ 488 (708)
+|.+|+..+.+++ +.+.+.+=.++.+ ....+|||||++|+.+.++- ...+. ...+.......++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~---- 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT---- 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH----
Confidence 2444555454442 3333333333332 45678999999999997742 22210 01122222222333
Q ss_pred HHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEeeccCCcccCc
Q 047038 489 AISYLHSAASIPIYHRDIKSTNILLDDKY----CAKVSDFGASRSIAV 532 (708)
Q Consensus 489 al~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFGls~~~~~ 532 (708)
.++..+ ++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 275 ---Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 ---QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334566 99999999999999888 999999999876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.3e-11 Score=128.17 Aligned_cols=232 Identities=17% Similarity=0.167 Sum_probs=152.8
Q ss_pred EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHH
Q 047038 399 LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM 478 (708)
Q Consensus 399 ~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 478 (708)
..++.+|.|...+..+....+...+-++.|+.++||||++++.....+...|||+|-+. .|..++.+. ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence 34678888887776555555667888899999999999999999999999999999885 566666643 3455
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCC
Q 047038 479 RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF 558 (708)
Q Consensus 479 ~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 558 (708)
....+.||+.||.|||+.+. ++|++|....|+++..|+.||++|.+......... ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66678899999999997663 99999999999999999999999988754332111 011111122466777655433
Q ss_pred CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCC
Q 047038 559 TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGK 638 (708)
Q Consensus 559 t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~ 638 (708)
-..|.|-||++++|++.|..+-. .......... ....+..-..+... ....+. ..+++..|....+-
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~~~--~~~~~~~~ip--------k~~~~~~~k~~~~~-~~~r~n-~~~~~~~~~~~~gf 248 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLLTK--TDLSNTGKIP--------KALIELYCKKLGAT-ELKRPN-KLRFILECRLLGGF 248 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccCcc--hhhhccCccc--------hhHHHHHHHHhccc-cccccc-hhhHHHHHHhcccc
Confidence 35699999999999999933211 0000000000 00000000000000 011111 55677777777777
Q ss_pred CCCCHHHHHHHHHcccc
Q 047038 639 KRPTMREVGIELTGIRG 655 (708)
Q Consensus 639 ~RPt~~ev~~~L~~l~~ 655 (708)
-|=.+-+++..|+.++-
T Consensus 249 f~n~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 249 FRNDFVDTLLFLEELRL 265 (690)
T ss_pred ccchHHHHHHHHHhccc
Confidence 77777777777777754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-10 Score=113.28 Aligned_cols=142 Identities=20% Similarity=0.251 Sum_probs=111.6
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCC--CceeeeeceEeeCC---cceEEEEecc
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE-SKVEEFINEVVILSQINH--RNVVKLLGCCLETE---VPLLVYEFIS 457 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 457 (708)
+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+++ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998765322 235578999999999976 44677777766543 6689999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA---------------------------------------- 497 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~---------------------------------------- 497 (708)
+.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988886642 14677788888889999999998631
Q ss_pred -------------CCCeEecCCCCCcEEEcC--CCcEEEeeccCCcc
Q 047038 498 -------------SIPIYHRDIKSTNILLDD--KYCAKVSDFGASRS 529 (708)
Q Consensus 498 -------------~~~iiHrDikp~NIll~~--~~~~kl~DFGls~~ 529 (708)
...++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244799999999999998 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.6e-10 Score=108.34 Aligned_cols=135 Identities=17% Similarity=0.150 Sum_probs=98.0
Q ss_pred ceEeeeccEEEEEEEEcC-------CcEEEEEEcccC-------------C---------hHHHHHHH----HHHHHHHh
Q 047038 384 RILGQGGQGTVYKGMLED-------GKIVAVKKSKII-------------D---------ESKVEEFI----NEVVILSQ 430 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~-------------~---------~~~~~~~~----~Ei~~l~~ 430 (708)
..||.|--+.||.|...+ +..+|||..+.. + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 478999964321 0 01122333 89999999
Q ss_pred cCC--CceeeeeceEeeCCcceEEEEeccCCCcc-ccccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 047038 431 INH--RNVVKLLGCCLETEVPLLVYEFISNGTLS-QYIDDQNKDFRISWEMRLCIAIDVSGAISYL-HSAASIPIYHRDI 506 (708)
Q Consensus 431 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~i~~al~yL-H~~~~~~iiHrDi 506 (708)
+.. -++++++++ ..-+|||||+.+..+. ..+.+. .++..+...+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 567777764 5678999999875442 222221 344556667889999999999 7888 999999
Q ss_pred CCCcEEEcCCCcEEEeeccCCccc
Q 047038 507 KSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 507 kp~NIll~~~~~~kl~DFGls~~~ 530 (708)
++.|||+++ +.+.|+|||.+...
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeC
Confidence 999999974 57999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.8e-11 Score=129.77 Aligned_cols=260 Identities=20% Similarity=0.214 Sum_probs=183.0
Q ss_pred ccccChHH-HHhhccCCcccceEeeeccEEEEEEEE--cCCcEEEEEEcccCCh--HHHHHHHHHHHHHHhc-CCCceee
Q 047038 365 TKLFTSNE-LEKATDNFNTNRILGQGGQGTVYKGML--EDGKIVAVKKSKIIDE--SKVEEFINEVVILSQI-NHRNVVK 438 (708)
Q Consensus 365 ~~~~~~~e-l~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~ 438 (708)
.++|...+ .-..+.+|..+..||.|.|+.|++... .++..+++|.+...-. .+...-..|+.+...+ .|.++++
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 34454444 344567899999999999999998774 3577899997654222 2222335566666666 5999999
Q ss_pred eeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-C
Q 047038 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-Y 517 (708)
Q Consensus 439 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~ 517 (708)
.+..+...+..++=-||++++++...+.- ...+....++++..|++.++.++|+.. ++|+|+||+||++..+ +
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~ 404 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGF 404 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchh
Confidence 98888888888899999999988766522 224677788889999999999999888 9999999999999886 8
Q ss_pred cEEEeeccCCcccCcCCcceeeccccccccc--CccccccCCCCccchhHhHHHHHHHHHhCCCC-CCCCCcchhhhHHH
Q 047038 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYL--DPEYFQSSHFTEKSDVYSFGVVLVELLTGERP-IRLTNSEEDKSLAA 594 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P-~~~~~~~~~~~~~~ 594 (708)
.-++.|||....+... ......+-+++ +++......+-.+.|++|||.-+.|.+++..- .......
T Consensus 405 ~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~------- 473 (524)
T KOG0601|consen 405 FSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL------- 473 (524)
T ss_pred hhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-------
Confidence 8899999988643211 11112333444 56666677888999999999999999987643 1111110
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.++.+.+. . .......+..+.+.++..++..||.+.++....+.++.
T Consensus 474 ----~i~~~~~p--------~--~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 474 ----TIRSGDTP--------N--LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ----eeeccccc--------C--CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 01111110 0 11122557788999999999999999988766655543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=101.36 Aligned_cols=131 Identities=22% Similarity=0.305 Sum_probs=101.4
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEE-ccc-C------ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKK-SKI-I------DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~-~~~-~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..+++|+-+.+|.+.+.+ ..+++|. ++. . ..-..+.-.+|+.++.+++--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997753 4466663 221 1 112234578899999999766766666667778888899999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++|..|.+++... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888764 2356667777788899999 99999999999998876 99999999863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.5e-09 Score=111.21 Aligned_cols=169 Identities=21% Similarity=0.291 Sum_probs=129.1
Q ss_pred cEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEe----eCCcceEEEEeccC-CCcccc
Q 047038 391 QGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL----ETEVPLLVYEFISN-GTLSQY 464 (708)
Q Consensus 391 ~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 464 (708)
-.+.||+.. .||..|++|+++.........-..-+++++++.|.|||++..++. .+..++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899984 489999999995433333333445678899999999999999887 34567899999985 467665
Q ss_pred ccccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 465 IDDQN------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 465 l~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
..... ....+++...|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43321 1235788999999999999999999999 88899999999999999999999998766544
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCC
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P 580 (708)
+.. |-+.. -.+-|.=-||.+++.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 1367888999999999999654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.2e-11 Score=136.61 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=171.7
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
...+.|.+.+-+-+|.++.++.+.-. .|...++|.....+ ..+.+....+-.++-..+||-++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777778889999999887633 34444444433221 112223333333333345677776666666778889
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
||++|..+++|...|+... ..+..........+.++++|||... +.|||++|.|+|...+++.++.|||+....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999998765 2444444445667889999999987 899999999999999999999999843221
Q ss_pred C-c-----------------------------CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCC
Q 047038 531 A-V-----------------------------DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580 (708)
Q Consensus 531 ~-~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P 580 (708)
. . +.........||+.|.+||...+..-...+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 1 0 000112235689999999999999999999999999999999999999
Q ss_pred CCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047038 581 IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644 (708)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 644 (708)
|........ |...... . + -......+......+++.+.+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~------f~ni~~~-~----~---~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI------FENILNR-D----I---PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh------hhccccC-C----C---CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 965443321 1111110 0 0 01122344456688899999999999997776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.8e-09 Score=96.56 Aligned_cols=143 Identities=22% Similarity=0.245 Sum_probs=106.8
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEc-cc-------CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKS-KI-------IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~-~~-------~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
...+|-+|+-+.|+++.+. |+...||.- .. ...-...+-.+|++.|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5578999999999999874 677777742 11 11223456789999999987556655555667777778999
Q ss_pred EeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEeeccCCcc
Q 047038 454 EFISN-GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRS 529 (708)
Q Consensus 454 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGls~~ 529 (708)
||+++ .++.+++....... ........++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47888887654432 222333678888999999999999 99999999999996543 468999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.1e-08 Score=101.19 Aligned_cols=138 Identities=15% Similarity=0.104 Sum_probs=99.4
Q ss_pred EeeeccEEEEEEEEcCCcEEEEEEcccCChHH-H----------HHHHHHHHHHHhcCCCc--eeeeeceEee-----CC
Q 047038 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESK-V----------EEFINEVVILSQINHRN--VVKLLGCCLE-----TE 447 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-~----------~~~~~Ei~~l~~l~H~n--iv~l~g~~~~-----~~ 447 (708)
+-.-....|++..+ +|+.+.||+.......+ . ..+.+|...+.++...+ .++++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667655 57889999764433211 1 14789999998885444 3455666543 22
Q ss_pred cceEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------CCcE
Q 047038 448 VPLLVYEFISNG-TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-------KYCA 519 (708)
Q Consensus 448 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-------~~~~ 519 (708)
.-+||+|++++. +|.+++..... ...+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 467999999986 79888854321 23556677789999999999999999 999999999999985 5789
Q ss_pred EEeeccCCc
Q 047038 520 KVSDFGASR 528 (708)
Q Consensus 520 kl~DFGls~ 528 (708)
.|+||+.++
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-08 Score=96.71 Aligned_cols=125 Identities=28% Similarity=0.270 Sum_probs=82.5
Q ss_pred EEEEEEEcCCcEEEEEEcccCC--------------------------hHHHHHHHHHHHHHHhcCCC--ceeeeeceEe
Q 047038 393 TVYKGMLEDGKIVAVKKSKIID--------------------------ESKVEEFINEVVILSQINHR--NVVKLLGCCL 444 (708)
Q Consensus 393 ~Vy~~~~~~~~~vAvK~~~~~~--------------------------~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 444 (708)
.||.|...+|..+|||..+... ........+|++.|.++..- ++++++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998899999999643310 01123567899999999765 56777655
Q ss_pred eCCcceEEEEecc--CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 445 ETEVPLLVYEFIS--NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY-LHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 445 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~y-LH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
+.-.|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 34579999999 54454433222 1123345677788886655 57887 9999999999999988 8999
Q ss_pred eeccCCccc
Q 047038 522 SDFGASRSI 530 (708)
Q Consensus 522 ~DFGls~~~ 530 (708)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-07 Score=97.47 Aligned_cols=264 Identities=17% Similarity=0.142 Sum_probs=159.4
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeece----E---eeCCcceEEE
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGC----C---LETEVPLLVY 453 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~----~---~~~~~~~lV~ 453 (708)
..+.||+|+.+.+|-.--- +..| .|+...-......+. +..|... .||-+-.-+.+ . ..+...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4577999999999954311 1223 343332222222222 2233333 45543321111 0 1122355777
Q ss_pred EeccCCC-cccccc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 454 EFISNGT-LSQYID---DQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 454 E~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
..+++.- ...++. +...-....|...++++..++.+.+-||..| .+-+|+.++|+|++++..+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7776542 222222 1222235789999999999999999999999 88999999999999999999998664433
Q ss_pred cCcCCcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhC-CCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTG-ERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
. .........+|...|.+||.-. +..-+...|-|.||+++++|+.| ++||.+.......-.. ....+..+
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p--~E~~Ia~g 242 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP--LETDIAHG 242 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc--chhhhhcc
Confidence 2 2233344567899999999754 34457789999999999999985 9999765321110000 00011111
Q ss_pred hhhhhhhhhh-----hccCC-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHcccccc
Q 047038 604 RLFEILDAQI-----LKEGG-KDEFKMVAKLAKRCLNLN--GKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 604 ~~~~~~d~~~-----~~~~~-~~~~~~l~~li~~cl~~~--p~~RPt~~ev~~~L~~l~~~~ 657 (708)
++...-+.+. ..+.+ ...+..+..|..+|+... +.-|||++.++..|..++..+
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111111110 01111 123456778888888654 568999999999998887653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.7e-07 Score=89.60 Aligned_cols=143 Identities=20% Similarity=0.138 Sum_probs=100.0
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC--------------------C--hHHHHHHHHHHHHH
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII--------------------D--ESKVEEFINEVVIL 428 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--------------------~--~~~~~~~~~Ei~~l 428 (708)
..+.+-..-..+...||-|--+.||.|...+|.++|||.-+.. + .-.+....+|.++|
T Consensus 84 ~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L 163 (304)
T COG0478 84 HALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL 163 (304)
T ss_pred HHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence 3333333334566889999999999999999999999942220 0 01134567899999
Q ss_pred HhcCCC--ceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 047038 429 SQINHR--NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI 506 (708)
Q Consensus 429 ~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDi 506 (708)
.+|.-. .|++.+++ +.-.+||||+++-.|...-- +....-.++..|++-+.-+-..| |+|+|+
T Consensus 164 ~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDl 228 (304)
T COG0478 164 QRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDL 228 (304)
T ss_pred HHhhhcCCCCCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 999655 78887775 55579999999866655431 11222234444444444444666 999999
Q ss_pred CCCcEEEcCCCcEEEeeccCCc
Q 047038 507 KSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 507 kp~NIll~~~~~~kl~DFGls~ 528 (708)
.+-||++++++.+.++||--+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999996544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.2e-07 Score=89.70 Aligned_cols=106 Identities=19% Similarity=0.202 Sum_probs=85.0
Q ss_pred HHHHHHHHHHHHhcC--CCceeeeeceEeeCC----cceEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHH
Q 047038 418 VEEFINEVVILSQIN--HRNVVKLLGCCLETE----VPLLVYEFISNG-TLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490 (708)
Q Consensus 418 ~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al 490 (708)
...+.+|...+.++. .-.+++.+++..... ..+||+|++++. +|.+++..... .+...+..++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 446788888888875 344566777766533 347999999974 79998876432 55667788999999999
Q ss_pred HHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEeeccCCcc
Q 047038 491 SYLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRS 529 (708)
Q Consensus 491 ~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGls~~ 529 (708)
.-||..+ |+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=84.02 Aligned_cols=139 Identities=19% Similarity=0.117 Sum_probs=102.9
Q ss_pred EeeeccEEEEEEEEcCCcEEEEEEccc------CChHHHHHHHHHHHHHHhcCCC--ceeeeeceEeeCC----cceEEE
Q 047038 386 LGQGGQGTVYKGMLEDGKIVAVKKSKI------IDESKVEEFINEVVILSQINHR--NVVKLLGCCLETE----VPLLVY 453 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~~~~~vAvK~~~~------~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~----~~~lV~ 453 (708)
-|+||.+-|++-.+. |+.+-+|+-.. .-+.....|.+|+..|.++... .+++++.+..... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999997764 45788997542 1033567899999999998533 3555552222211 357999
Q ss_pred EeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--EEEeeccCCcc
Q 047038 454 EFISN-GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC--AKVSDFGASRS 529 (708)
Q Consensus 454 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGls~~ 529 (708)
|-+++ -+|.+++.+... .+.+...+..+..++++.+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 478888765432 24677888899999999999999999 999999999999986666 99999976653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4e-08 Score=108.01 Aligned_cols=150 Identities=21% Similarity=0.263 Sum_probs=104.2
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc--------eeecccccccccCcccccc
Q 047038 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH--------LTTQVQGTFGYLDPEYFQS 555 (708)
Q Consensus 484 ~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 555 (708)
.+++.||.|+|... .+||++|.|++|.++.++..||..|+.+........+ ..--.+....|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45669999999876 4999999999999999999999999987544321111 1111234567999999999
Q ss_pred CCCCccchhHhHHHHHHHHHhCCCC-CCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcc
Q 047038 556 SHFTEKSDVYSFGVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLN 634 (708)
Q Consensus 556 ~~~t~ksDv~SlGvvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~ 634 (708)
...+.++|+||+|+++|.+..|..+ +............. ..+..-........+.++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999965444 33222111111110 000001112235566778899999999
Q ss_pred cCCCCCCCHHHHHH
Q 047038 635 LNGKKRPTMREVGI 648 (708)
Q Consensus 635 ~~p~~RPt~~ev~~ 648 (708)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.8e-06 Score=95.47 Aligned_cols=141 Identities=20% Similarity=0.183 Sum_probs=94.1
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCChHH------------------------------H----------HHHHH
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESK------------------------------V----------EEFIN 423 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~------------------------------~----------~~~~~ 423 (708)
+-|+.++-|.||+|++++|+.||||+.+..-... . -+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999755421110 0 12445
Q ss_pred HHHHHHhcC-----CCceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 047038 424 EVVILSQIN-----HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA-ISYLHSAA 497 (708)
Q Consensus 424 Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~a-l~yLH~~~ 497 (708)
|...+.+++ .+++.-..=+..-.....|+|||++|-.+.+...-... .++ +..++..++++ +..+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhcC
Confidence 555555542 34443333333446778999999999989888432221 233 22333333333 22333345
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 498 ~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
++|.|.+|.||+++.++++-+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.5e-06 Score=82.35 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=85.3
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc--eeeeeceEeeCCcceEEEEeccCCC-
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYEFISNGT- 460 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs- 460 (708)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24567788776422 3345688999999986544 4677888777777889999999863
Q ss_pred ccccc---------------------cccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHh-cCCCCeEecCC
Q 047038 461 LSQYI---------------------DDQNKDFRISWEMRLC-IAI----------DVSG-AISYLHS-AASIPIYHRDI 506 (708)
Q Consensus 461 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~i~~-al~yLH~-~~~~~iiHrDi 506 (708)
+...+ |..... ......+.. +.. .+.+ ...+|.. ...+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 110000 011111000 000 0111 1222221 12345789999
Q ss_pred CCCcEEEcCCCcEEEeeccCCc
Q 047038 507 KSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 507 kp~NIll~~~~~~kl~DFGls~ 528 (708)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=9.9e-06 Score=78.83 Aligned_cols=137 Identities=19% Similarity=0.224 Sum_probs=90.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHH---------HHHHHHHHHhcCC---CceeeeeceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEE---------FINEVVILSQINH---RNVVKLLGCC 443 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~---------~~~Ei~~l~~l~H---~niv~l~g~~ 443 (708)
...+|...+++-......|.+-.. +|+.+++|..+.......+. ..+++..+.+++. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346777777777776666666554 57889999776533322222 2334444444432 2333333332
Q ss_pred e-----eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 444 L-----ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 444 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
. .....+|+|||++|..|.++.. ++. .++..+.+++.-||..| ++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2234568999999988877642 222 24567788899999999 99999999999999665
Q ss_pred EEEeeccCCc
Q 047038 519 AKVSDFGASR 528 (708)
Q Consensus 519 ~kl~DFGls~ 528 (708)
+++.||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998655
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=5.8e-06 Score=79.94 Aligned_cols=105 Identities=23% Similarity=0.300 Sum_probs=83.8
Q ss_pred HHHHHHHHhcCC-CceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 047038 422 INEVVILSQINH-RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500 (708)
Q Consensus 422 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ 500 (708)
.+|.-+|+.+++ +++++++|+|-+ ++|.||...+++...-.....-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888998876 699999999943 689999987766532111111124799999999999999999999866556
Q ss_pred eEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 501 iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+.-.|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.8e-07 Score=101.63 Aligned_cols=183 Identities=19% Similarity=0.138 Sum_probs=132.7
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeeCCcceEEEEeccCC-C
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVYEFISNG-T 460 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-s 460 (708)
-+-+++|+++.++|.+....+....+.+... ....-++++|.+++||| .+..++-+..++..++++++...+ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3457889999999987544444445544332 45566889999999999 777777777777889999999876 2
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeec
Q 047038 461 LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540 (708)
Q Consensus 461 L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~ 540 (708)
-...... ....+...+...+...-++++++||+.- =+||| ||+..+ ...|..||+....+.... ..+.
T Consensus 322 ~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 322 SALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred ccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 2222111 1112344445556667788999999864 48999 777766 568999999887664332 3445
Q ss_pred ccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCC
Q 047038 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582 (708)
Q Consensus 541 ~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~ 582 (708)
..+|+.|+|||+...+.+..+.|+|++|+-..+|.-|.+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 678999999999999999999999999988888887877743
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.3e-05 Score=75.21 Aligned_cols=151 Identities=22% Similarity=0.218 Sum_probs=101.9
Q ss_pred cChHHHHhhccCCcccceEee---eccEEEEEEEEcCCcEEEEEEcccCChH--HH----------------------HH
Q 047038 368 FTSNELEKATDNFNTNRILGQ---GGQGTVYKGMLEDGKIVAVKKSKIIDES--KV----------------------EE 420 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~---G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~----------------------~~ 420 (708)
.+.+.+....++..+....|. |--..||+|...++..+|||+.+..... .+ .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345566666667666666654 5556799999888999999976542211 00 11
Q ss_pred HHHHHHHHHhcC--CCceeeeeceEeeCCcceEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-c
Q 047038 421 FINEVVILSQIN--HRNVVKLLGCCLETEVPLLVYEFISNG-TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-A 496 (708)
Q Consensus 421 ~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~ 496 (708)
...|+.-|+++. +-.+++.+++. .-.|||||+... .-.-.|.+- .+...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence 245777777763 45556666553 346999999753 222222222 23333566677888888888877 6
Q ss_pred CCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 497 ~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+ ++|+||..=|||+. ++.+.|+|||-+...
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 6 99999999999999 788999999987644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.7e-05 Score=80.50 Aligned_cols=139 Identities=16% Similarity=0.118 Sum_probs=86.1
Q ss_pred Eeeecc-EEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEeccCCCccc
Q 047038 386 LGQGGQ-GTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGTLSQ 463 (708)
Q Consensus 386 lG~G~~-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 463 (708)
|-.|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+++++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788998764 4678888876543 345678999988884 4456678888777777899999999987764
Q ss_pred ccc-------------------ccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----cC
Q 047038 464 YID-------------------DQNK-DFRIS--WEMRLCIAI--------------------DVSGAISYLHS----AA 497 (708)
Q Consensus 464 ~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~i~~al~yLH~----~~ 497 (708)
... .... ...+. ...++.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 421 1100 00111 001110000 01111222211 12
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 498 ~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3458999999999999998888999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.6e-05 Score=79.88 Aligned_cols=143 Identities=19% Similarity=0.191 Sum_probs=85.4
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC--ceeeeeceEeeC---CcceEEEEecc
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR--NVVKLLGCCLET---EVPLLVYEFIS 457 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~ 457 (708)
++.|+.|..+.||+....+ +.+++|..... .....+.+|+.+++.+... .+++++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999877 68999986543 4566788899999888533 356777654332 34689999999
Q ss_pred CCCccc----------------cc---cccC-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 047038 458 NGTLSQ----------------YI---DDQN-KDFRISWEM---------RLCI------------AIDVSG-AISYLHS 495 (708)
Q Consensus 458 ~gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~i~~-al~yLH~ 495 (708)
+..+.. .+ +... ......+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 11 1110 000111100 0000 112222 3333332
Q ss_pred ----cCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCc
Q 047038 496 ----AASIPIYHRDIKSTNILLD-DKYCAKVSDFGASR 528 (708)
Q Consensus 496 ----~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~ 528 (708)
.....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1334599999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.9e-05 Score=89.49 Aligned_cols=80 Identities=15% Similarity=0.275 Sum_probs=58.5
Q ss_pred cceEeeeccEEEEEEEEcCC---cEEEEEEcccCC-hHHHHHHHHHHHHHHhcC-CCce--eeeeceEeeC---CcceEE
Q 047038 383 NRILGQGGQGTVYKGMLEDG---KIVAVKKSKIID-ESKVEEFINEVVILSQIN-HRNV--VKLLGCCLET---EVPLLV 452 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 452 (708)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ ++++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999876654 367777754322 123457889999999995 6665 7788887664 467999
Q ss_pred EEeccCCCcc
Q 047038 453 YEFISNGTLS 462 (708)
Q Consensus 453 ~E~~~~gsL~ 462 (708)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999986543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00019 Score=69.77 Aligned_cols=132 Identities=20% Similarity=0.280 Sum_probs=90.8
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcccCC----------------hHHHHHHHHHHHHHHhcC------CCceeee
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID----------------ESKVEEFINEVVILSQIN------HRNVVKL 439 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~l 439 (708)
....||+|+.-.||.= .+.....||+..... .....++.+|+.-..++. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999963 334446677665533 223456677777666655 8899999
Q ss_pred eceEeeCCcceEEEEeccCC------CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 047038 440 LGCCLETEVPLLVYEFISNG------TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL 513 (708)
Q Consensus 440 ~g~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll 513 (708)
+|+.+++..+-+|+|.+.+. +|.+++... .++. ... ..+-+-..||-+.. |+.+|++|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEEE
Confidence 99999999999999987642 566666433 3444 222 33334456777777 9999999999999
Q ss_pred cCC---C-cEEEee-ccC
Q 047038 514 DDK---Y-CAKVSD-FGA 526 (708)
Q Consensus 514 ~~~---~-~~kl~D-FGl 526 (708)
... . .+.|+| ||-
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 633 2 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=73.39 Aligned_cols=75 Identities=17% Similarity=0.232 Sum_probs=47.8
Q ss_pred ceEeeeccE-EEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC---ceeeeeceEeeC---CcceEEEEec
Q 047038 384 RILGQGGQG-TVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR---NVVKLLGCCLET---EVPLLVYEFI 456 (708)
Q Consensus 384 ~~lG~G~~g-~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~ 456 (708)
+.|+.||.. .||+. +..+++|..+. ......+.+|+++|..+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48875 23467776543 22345788999999888532 344445443332 2358999999
Q ss_pred cCCCcccc
Q 047038 457 SNGTLSQY 464 (708)
Q Consensus 457 ~~gsL~~~ 464 (708)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99877543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00012 Score=80.87 Aligned_cols=138 Identities=19% Similarity=0.147 Sum_probs=89.3
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCChHH-------------------------------------HHHHHHHHH
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESK-------------------------------------VEEFINEVV 426 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-------------------------------------~~~~~~Ei~ 426 (708)
+-||.-+.|.||+|++++|+.||||.-+..-+.. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999999999999999754311110 013555555
Q ss_pred HHHhc----CCCc------eeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH-HHh
Q 047038 427 ILSQI----NHRN------VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY-LHS 495 (708)
Q Consensus 427 ~l~~l----~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~y-LH~ 495 (708)
-..+. .|-+ |++++- .-.....|+||||+|..+.+.-.-... .++... |+..+.++... |=.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHHH---HHHHHHHHHHHHHHh
Confidence 44433 3555 333332 224567899999999988776322111 244443 33333333222 222
Q ss_pred cCCCCeEecCCCCCcEEEcC----CCcEEEeeccCCcccC
Q 047038 496 AASIPIYHRDIKSTNILLDD----KYCAKVSDFGASRSIA 531 (708)
Q Consensus 496 ~~~~~iiHrDikp~NIll~~----~~~~kl~DFGls~~~~ 531 (708)
.| ++|.|=.|.||++.. +.++.+.|||+...+.
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 34 999999999999983 6789999999987654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=9.3e-05 Score=68.92 Aligned_cols=127 Identities=20% Similarity=0.224 Sum_probs=88.7
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCcee-eeeceEeeCCcceEEEEeccCC
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV-KLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g 459 (708)
+..+.|++|.+|.||+|.+.. ..+|+|.-+. ++....+..|+++|..++-.++- +++.|.. .++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 345789999999999999864 5788887654 45567899999999999866654 4554432 34559999987
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CC-cEEEcCCCcEEEeeccCCc
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK-ST-NILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDik-p~-NIll~~~~~~kl~DFGls~ 528 (708)
.|.+.-... + .+-...++++---|...+ |-|..|. |. ||++.+ ..+.|+||..+.
T Consensus 98 ~L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchh
Confidence 777655422 1 122334555544556666 8999887 44 555554 489999999876
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00033 Score=73.22 Aligned_cols=77 Identities=10% Similarity=0.039 Sum_probs=57.4
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC---CceeeeeceEee---CCcceEEEEe
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH---RNVVKLLGCCLE---TEVPLLVYEF 455 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E~ 455 (708)
..+.||.|..+.||+....+++ +.+|..+. ......|..|...|+.+.- -.++++++++.. .+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3467999999999998766664 56666432 1123578899999998853 468888988764 3568999999
Q ss_pred ccCCCc
Q 047038 456 ISNGTL 461 (708)
Q Consensus 456 ~~~gsL 461 (708)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998766
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00027 Score=68.13 Aligned_cols=125 Identities=26% Similarity=0.416 Sum_probs=90.0
Q ss_pred cCCcccceEeeecc-EEEEEEEEcCCcEEEEEEccc---CCh------------------HHHHHHHHHHHHHHhcC---
Q 047038 378 DNFNTNRILGQGGQ-GTVYKGMLEDGKIVAVKKSKI---IDE------------------SKVEEFINEVVILSQIN--- 432 (708)
Q Consensus 378 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vAvK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 432 (708)
.+++..+.||.|.. |.|||++.. |+.+|+|..+. ... .....|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 999999984 77999998222 000 12235888888877774
Q ss_pred CCce--eeeeceEeeCC------------------cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 047038 433 HRNV--VKLLGCCLETE------------------VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492 (708)
Q Consensus 433 H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~y 492 (708)
+.++ |+.+||..-.. ...||.||++... ....+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 5566 99999974321 1246777765432 1122335577888899
Q ss_pred HHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 493 LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999975 3589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00037 Score=70.26 Aligned_cols=74 Identities=22% Similarity=0.193 Sum_probs=48.6
Q ss_pred ceEeeeccEEEEEEEEcC--CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeeCCcceEEEEeccCCC
Q 047038 384 RILGQGGQGTVYKGMLED--GKIVAVKKSKIIDESKVEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
+.|..|-...+|+....+ ++.|++|........ .-+-.+|+.+++.+...+ .+++++... ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999988664 678889976542221 122347888888885433 444544332 248999999877
Q ss_pred cc
Q 047038 461 LS 462 (708)
Q Consensus 461 L~ 462 (708)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00038 Score=71.23 Aligned_cols=137 Identities=14% Similarity=0.146 Sum_probs=78.2
Q ss_pred EeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEEEeccCCCcccc
Q 047038 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISNGTLSQY 464 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~ 464 (708)
+..|-...+|+.. .+++.+++|........-.-+..+|..+++.+....+ ++++.... .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4557778899887 4567788887543222111235778899988864433 44444432 4799999998776532
Q ss_pred -----------------ccccCC-CCCCCHHHHH-HHH---------HHHHHHHHHHHhc-----CCCCeEecCCCCCcE
Q 047038 465 -----------------IDDQNK-DFRISWEMRL-CIA---------IDVSGAISYLHSA-----ASIPIYHRDIKSTNI 511 (708)
Q Consensus 465 -----------------l~~~~~-~~~l~~~~~~-~i~---------~~i~~al~yLH~~-----~~~~iiHrDikp~NI 511 (708)
||.... ..+++...++ ... .++.+.+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111110 1112222111 111 0111122222211 123489999999999
Q ss_pred EEcCCCcEEEeeccCCc
Q 047038 512 LLDDKYCAKVSDFGASR 528 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~ 528 (708)
++++++ ++|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00049 Score=80.61 Aligned_cols=198 Identities=18% Similarity=0.220 Sum_probs=135.6
Q ss_pred HHHHHHHHHHHHhcCCCceeeeeceEeeCCcc----eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 047038 418 VEEFINEVVILSQINHRNVVKLLGCCLETEVP----LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493 (708)
Q Consensus 418 ~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yL 493 (708)
...-..|...+.++.|+|++.++.|-.+.... .+..|++...++...+.... .++....+.+..++..||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHH
Confidence 34455677788888999999999998764432 34556777777777776543 578888888999999999999
Q ss_pred HhcCCCCeEecCCCCC---cEEEcCCCcEEEe--eccCCcccCcCCcceeecccccccccCccccccCCCC--ccchhHh
Q 047038 494 HSAASIPIYHRDIKST---NILLDDKYCAKVS--DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFT--EKSDVYS 566 (708)
Q Consensus 494 H~~~~~~iiHrDikp~---NIll~~~~~~kl~--DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t--~ksDv~S 566 (708)
|+.. ..|.-+..+ +-..+.++.+.++ ||+.++.......... ..-+..+.+||......+. ...|+|.
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHH
Confidence 9985 555555444 4455667777777 9998876654332221 2235567788877665544 4479999
Q ss_pred HHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047038 567 FGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646 (708)
Q Consensus 567 lGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 646 (708)
+|..+..+..|..+-..... ...+++ .... ..+.+...+|+..++++|++..++
T Consensus 378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~-----~~~~---~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV------------------PVSLLD-----VLST---SELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCcccccccc------------------hhhhhc-----cccc---hhhhhhhhhhcchhhhhccchhhh
Confidence 99999999988765211100 011111 1111 146778899999999999999998
Q ss_pred HHH
Q 047038 647 GIE 649 (708)
Q Consensus 647 ~~~ 649 (708)
+..
T Consensus 432 l~~ 434 (1351)
T KOG1035|consen 432 LTH 434 (1351)
T ss_pred hhc
Confidence 753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0014 Score=68.60 Aligned_cols=142 Identities=15% Similarity=0.152 Sum_probs=85.8
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc--eeeeece------EeeCCcceEEEE
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN--VVKLLGC------CLETEVPLLVYE 454 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 454 (708)
.+.|..|....+|+....+ ..+++|+... ...+....|++++..+.+.+ +++++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999987654 4688888764 22345667888888875433 4555442 123455689999
Q ss_pred eccCCCcccc--------------ccccCCC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 047038 455 FISNGTLSQY--------------IDDQNKD--------FRISWEMRL----------CIAIDVSGAISYLHS----AAS 498 (708)
Q Consensus 455 ~~~~gsL~~~--------------l~~~~~~--------~~l~~~~~~----------~i~~~i~~al~yLH~----~~~ 498 (708)
+++|..+... +|..... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776431 1110000 011222111 011123344555543 122
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 499 ~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0047 Score=65.36 Aligned_cols=155 Identities=13% Similarity=0.169 Sum_probs=82.8
Q ss_pred hHHHHhhccCCcc-----cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC--ceeeeec-
Q 047038 370 SNELEKATDNFNT-----NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR--NVVKLLG- 441 (708)
Q Consensus 370 ~~el~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g- 441 (708)
.+++......|.. .+.|+.|...++|+....+| .+++|+...... +....|+.++..+... .+++.+.
T Consensus 9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 3444443344533 34566777789999886655 588887652222 3333455555555322 2333332
Q ss_pred -----eEeeCCcceEEEEeccCCCcccc--------------ccccCCC--------CCCCH-HHHHH------------
Q 047038 442 -----CCLETEVPLLVYEFISNGTLSQY--------------IDDQNKD--------FRISW-EMRLC------------ 481 (708)
Q Consensus 442 -----~~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~~--------~~l~~-~~~~~------------ 481 (708)
+....+..++++||++|..+... +|..... ..+.| .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 11234567899999998754321 1111110 01112 11111
Q ss_pred HH-HHHHHHHHHHHhc----CCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 482 IA-IDVSGAISYLHSA----ASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 482 i~-~~i~~al~yLH~~----~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.. ..+...++.+... -+..++|+|+.|.|||++++...-|+||+.+.
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 1111222333211 23459999999999999977666899999765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0025 Score=68.76 Aligned_cols=75 Identities=23% Similarity=0.222 Sum_probs=55.2
Q ss_pred ceEeeeccEEEEEEEEcCC-cEEEEEEcccC----C---hHHHHHHHHHHHHHHhcC---CCceeeeeceEeeCCcceEE
Q 047038 384 RILGQGGQGTVYKGMLEDG-KIVAVKKSKII----D---ESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~-~~vAvK~~~~~----~---~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 452 (708)
+.||.|.+..||++...+| +.|+||..... . ....+.+..|.+.|+.+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998877 58999974321 1 124567788888888763 3467778877 44567899
Q ss_pred EEeccCCC
Q 047038 453 YEFISNGT 460 (708)
Q Consensus 453 ~E~~~~gs 460 (708)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0023 Score=67.35 Aligned_cols=143 Identities=17% Similarity=0.213 Sum_probs=82.2
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc--eeeeeceE------eeCCcceEEEE
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN--VVKLLGCC------LETEVPLLVYE 454 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 454 (708)
.+.++.|-...+|+....++ .+++|+..... ..++...|++++..|...+ +++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45567777789999876555 57788764421 1234556677777764222 34444321 12455789999
Q ss_pred eccCCCcccc--------------ccccCCCC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 047038 455 FISNGTLSQY--------------IDDQNKDF---------RISWEMRL------------CIAIDVSGAISYLHS---- 495 (708)
Q Consensus 455 ~~~~gsL~~~--------------l~~~~~~~---------~l~~~~~~------------~i~~~i~~al~yLH~---- 495 (708)
|++|..+... +|...... .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654321 11111110 01111110 011223345555543
Q ss_pred cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 496 ~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.-...++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223559999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0017 Score=68.21 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=83.1
Q ss_pred ceEeeeccEEEEEEEEcC-------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGMLED-------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 455 (708)
+.|..|-...+|+....+ ++.+++|...... ....+..+|+++++.+...++ +++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456666677899988655 5788899865432 223456778888888853333 45555553 2368999
Q ss_pred ccCCCcccc-----------------ccccCCCC------CC--CHHHHHH--------------------------HHH
Q 047038 456 ISNGTLSQY-----------------IDDQNKDF------RI--SWEMRLC--------------------------IAI 484 (708)
Q Consensus 456 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~ 484 (708)
++|.++... +|...... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776531 11111110 00 0111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCcEEEcCC----CcEEEeeccCCc
Q 047038 485 DVSGAISYLHS------AASIPIYHRDIKSTNILLDDK----YCAKVSDFGASR 528 (708)
Q Consensus 485 ~i~~al~yLH~------~~~~~iiHrDikp~NIll~~~----~~~kl~DFGls~ 528 (708)
++...+..|.. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 134568999999999999985 889999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0057 Score=63.20 Aligned_cols=69 Identities=16% Similarity=0.065 Sum_probs=40.5
Q ss_pred eeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-C-Cc-eeeeeceEeeCCcceEEEEeccCCCc
Q 047038 387 GQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-H-RN-VVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 387 G~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H-~n-iv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
++|-...|+.....+|+.+++|..+. ........+|+++|+.+. | +- +.+++. .+...++|++++|..+
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~----~~~~~~~y~~i~G~p~ 91 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRV----HTPELIAYPKLPGVPA 91 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceee----ecCceEEEeccCCCcc
Confidence 33434455655445688899998753 333456789999999885 2 21 122221 1223567777776554
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0034 Score=76.72 Aligned_cols=28 Identities=21% Similarity=0.650 Sum_probs=22.8
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTY 270 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy 270 (708)
.|...++|.. .+.||.|+|++||.|.-.
T Consensus 3910 PC~~GgtCip-~~n~f~CnC~~gyTG~~C 3937 (4289)
T KOG1219|consen 3910 PCLTGGTCIP-FYNGFLCNCPNGYTGKRC 3937 (4289)
T ss_pred CCCCCCEEEe-cCCCeeEeCCCCccCcee
Confidence 5777788987 355899999999999865
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.008 Score=64.27 Aligned_cols=139 Identities=19% Similarity=0.215 Sum_probs=78.8
Q ss_pred eEeeeccEEEEEEEEcC-----CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEEEeccC
Q 047038 385 ILGQGGQGTVYKGMLED-----GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~ 458 (708)
.|-.|-.-.+|+....+ ++.|++|..........+ -.+|..+++.+...++ +++++.+... .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446666788876432 367888876553322222 3678888888864444 3556665332 58999987
Q ss_pred CCcccc-----------------ccccCC---CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-c
Q 047038 459 GTLSQY-----------------IDDQNK---DFRISWEMRLCIAID-----------------VSGAISYL----HS-A 496 (708)
Q Consensus 459 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~-----------------i~~al~yL----H~-~ 496 (708)
.+|... +|.... .....|.+...+..+ +...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776521 121110 001112222222211 11112222 21 2
Q ss_pred CCCCeEecCCCCCcEEEcC-CCcEEEeeccCCc
Q 047038 497 ASIPIYHRDIKSTNILLDD-KYCAKVSDFGASR 528 (708)
Q Consensus 497 ~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~ 528 (708)
....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2345899999999999986 4689999998765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0029 Score=64.64 Aligned_cols=134 Identities=19% Similarity=0.192 Sum_probs=94.6
Q ss_pred CCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC-----------------hH-----HHHHHHHHHHHHHhcCC--C
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID-----------------ES-----KVEEFINEVVILSQINH--R 434 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-----------------~~-----~~~~~~~Ei~~l~~l~H--~ 434 (708)
-+.+.+.||-|--+.||.+-..+|++.++|.-.... .. .+-...+|...|+.+.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 466788999999999999999999999998422100 00 11234678888888853 2
Q ss_pred ceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 047038 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD 514 (708)
Q Consensus 435 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~ 514 (708)
-+++.+++ +.-++|||++.+-.|...-+-.. .. .+...+..-+.-|..+| +||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d------~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVED------PP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCC------hH---HHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34455554 44579999999988876654322 11 23333444455677777 99999999999999
Q ss_pred CCCcEEEeeccCCc
Q 047038 515 DKYCAKVSDFGASR 528 (708)
Q Consensus 515 ~~~~~kl~DFGls~ 528 (708)
++..++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.011 Score=61.29 Aligned_cols=74 Identities=23% Similarity=0.239 Sum_probs=49.3
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeCCcceEEEEeccC
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+++++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34678888899999877 677889999765 333456888888888873 55688999998888888999999987
Q ss_pred C
Q 047038 459 G 459 (708)
Q Consensus 459 g 459 (708)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.00026 Score=84.53 Aligned_cols=160 Identities=13% Similarity=-0.024 Sum_probs=114.0
Q ss_pred HHHHHHHHHhcCCCceeeeeceEe--eCCcceEEEEeccCCCccccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 047038 421 FINEVVILSQINHRNVVKLLGCCL--ETEVPLLVYEFISNGTLSQYIDDQNKD-FRISWEMRLCIAIDVSGAISYLHSAA 497 (708)
Q Consensus 421 ~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~al~yLH~~~ 497 (708)
.+.|..-++...|++++....-.. ++.+.+.+++++..|.+.+.+-+.... ..+........-.+...+..-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 444555555678998876655443 344678999999999999988654432 22333333333333345555545432
Q ss_pred --CCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHH
Q 047038 498 --SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELL 575 (708)
Q Consensus 498 --~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ell 575 (708)
..-.+|+++|+-|.+|..+.++|+.++|+.+.... .........+++.|+.|+....-.++.++|+|..|.-+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23378999999999999999999999999984332 223334456788999999999989999999999999999998
Q ss_pred hCCCCC
Q 047038 576 TGERPI 581 (708)
Q Consensus 576 tg~~P~ 581 (708)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.031 Score=58.31 Aligned_cols=129 Identities=16% Similarity=0.192 Sum_probs=76.9
Q ss_pred CcEEEEEEcc-cCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeCC--cceEEEEeccCCCccccccccCCC-----
Q 047038 402 GKIVAVKKSK-IIDESKVEEFINEVVILSQINH--RNVVKLLGCCLETE--VPLLVYEFISNGTLSQYIDDQNKD----- 471 (708)
Q Consensus 402 ~~~vAvK~~~-~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~----- 471 (708)
++.+++.+.. ...........+|+.+++.+.- .-+...++.|.++. .++.||+|++|..+.+.+......
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 6777777331 2334455667788888888753 33445567777666 779999999985444333221100
Q ss_pred ------------------------------CCCCHHHHHHHH--------HHHHHHHHHHHhcC-----CCCeEecCCCC
Q 047038 472 ------------------------------FRISWEMRLCIA--------IDVSGAISYLHSAA-----SIPIYHRDIKS 508 (708)
Q Consensus 472 ------------------------------~~l~~~~~~~i~--------~~i~~al~yLH~~~-----~~~iiHrDikp 508 (708)
+...|...++.+ -....-..+|+... .+.++|+|+.+
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 000111111100 01122233443322 36699999999
Q ss_pred CcEEEcCCCcEEEeeccCCccc
Q 047038 509 TNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 509 ~NIll~~~~~~kl~DFGls~~~ 530 (708)
.||+++++.-+-|.||+++..-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999988999999998753
|
|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0053 Score=37.16 Aligned_cols=24 Identities=21% Similarity=0.375 Sum_probs=20.3
Q ss_pred ceEeecCCCCCCCCCcCccCcccc
Q 047038 256 GYFCLCNDRRLSGTYPDLCEGYYD 279 (708)
Q Consensus 256 Gy~C~C~~G~~gnpy~~~c~~~~~ 279 (708)
+|.|.|..||.-+|-...|.|++|
T Consensus 1 sy~C~C~~Gy~l~~d~~~C~DIdE 24 (24)
T PF12662_consen 1 SYTCSCPPGYQLSPDGRSCEDIDE 24 (24)
T ss_pred CEEeeCCCCCcCCCCCCccccCCC
Confidence 599999999998876667998865
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.056 Score=56.93 Aligned_cols=30 Identities=13% Similarity=0.253 Sum_probs=27.1
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 499 ~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
..++|+|+.++|||+++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 459999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.042 Score=58.39 Aligned_cols=140 Identities=19% Similarity=0.192 Sum_probs=77.0
Q ss_pred ceEeeeccEEEEEEEEcC----CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLED----GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~ 458 (708)
+.|..|-.-.+|+....+ +..|++|....... ..-+-.+|..+++.+...++ +++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 344446666788876543 23788887654322 12233578888888865555 4566665322 58999987
Q ss_pred CCcccc-----------------ccccCC--CC-CCCHHHHHHHHHH----------------------HHHHHHHHH--
Q 047038 459 GTLSQY-----------------IDDQNK--DF-RISWEMRLCIAID----------------------VSGAISYLH-- 494 (708)
Q Consensus 459 gsL~~~-----------------l~~~~~--~~-~l~~~~~~~i~~~----------------------i~~al~yLH-- 494 (708)
.+|... +|.... .. .-.|....++..+ +.+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 111110 00 1122222222211 111122221
Q ss_pred --hc-CCCCeEecCCCCCcEEEcC-CCcEEEeeccCCc
Q 047038 495 --SA-ASIPIYHRDIKSTNILLDD-KYCAKVSDFGASR 528 (708)
Q Consensus 495 --~~-~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~ 528 (708)
.. .+.-+.|.|+.+.|||+++ ++.++++||..+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11 1233789999999999975 5789999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.019 Score=56.69 Aligned_cols=29 Identities=28% Similarity=0.409 Sum_probs=20.7
Q ss_pred CeEecCCCCCcEEE-cCCCcEEEeeccCCc
Q 047038 500 PIYHRDIKSTNILL-DDKYCAKVSDFGASR 528 (708)
Q Consensus 500 ~iiHrDikp~NIll-~~~~~~kl~DFGls~ 528 (708)
.+.|+|+.+.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38899999999999 888999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.18 Score=54.42 Aligned_cols=73 Identities=16% Similarity=0.167 Sum_probs=50.2
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEccc----CCh---HHHHHHHHHHHHHHhcC---CCceeeeeceEeeCCcceEE
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKI----IDE---SKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~----~~~---~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 452 (708)
.+.||.|-.-.||+.... ++.++||+-.. ... ...++-..|+..|+.+. ..++++++.++. +.-+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998764 55689997542 111 13344455577776653 357888888877 456789
Q ss_pred EEeccC
Q 047038 453 YEFISN 458 (708)
Q Consensus 453 ~E~~~~ 458 (708)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PHA03099 epidermal growth factor-like protein (EGF-like protein); Provisional | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.0092 Score=51.52 Aligned_cols=26 Identities=23% Similarity=0.549 Sum_probs=20.0
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
-|-. |.|.. ..-..+.|+|..||.|.
T Consensus 52 YClH-G~C~yI~dl~~~~CrC~~GYtGe 78 (139)
T PHA03099 52 YCLH-GDCIHARDIDGMYCRCSHGYTGI 78 (139)
T ss_pred EeEC-CEEEeeccCCCceeECCCCcccc
Confidence 4554 37776 55667999999999997
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.19 Score=52.82 Aligned_cols=29 Identities=34% Similarity=0.359 Sum_probs=25.0
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 499 ~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
..++|+|+.+.||++++ +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999998 568999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.023 Score=48.15 Aligned_cols=69 Identities=22% Similarity=0.376 Sum_probs=44.0
Q ss_pred ccceeeEEEee-eeeeeecccCCcccccccccceeeeeccccCCCCcccCCCCCccccCC-Cceee-cCCCceEeecCCC
Q 047038 188 SQVCTSVSVVY-LDWFFSNYLRFPNVLENKEYVSAKLEWGKTGGSTCSEEYNLDTSCNQD-GYCLV-QLGSGYFCLCNDR 264 (708)
Q Consensus 188 ~~~C~~a~~~~-~~~~~~~~~~~~~~~~~~~~~p~~ldW~i~~~~c~~~~~~~~~~C~~~-s~C~~-~~~~Gy~C~C~~G 264 (708)
...|...+.+. ..............+......+++|+|.+....|. +|..+ +.|.+ .+..-+.|.|++|
T Consensus 22 ~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~--------~C~~SgG~Cgy~~~~~~f~C~C~dg 93 (94)
T PF14380_consen 22 AGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCR--------ECEASGGRCGYDSNSEQFTCFCSDG 93 (94)
T ss_pred CCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCc--------ChhcCCCEeCCCCCCceEEEECCCC
Confidence 36787755443 33221110011122344456899999997666786 99888 99998 5567899999987
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.093 Score=55.63 Aligned_cols=72 Identities=19% Similarity=0.214 Sum_probs=47.9
Q ss_pred eEeeeccEEEEEEEEcCC-cEEEEEEccc----C---ChHHHHHHHHHHHHHHhcC--CC-ceeeeeceEeeCCcceEEE
Q 047038 385 ILGQGGQGTVYKGMLEDG-KIVAVKKSKI----I---DESKVEEFINEVVILSQIN--HR-NVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~~~~~-~~vAvK~~~~----~---~~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 453 (708)
.||.|-...||++...+| +.|+||.-.. . -+-..++..-|...|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999998654 6899996332 1 1333455667778887653 23 45555543 455567999
Q ss_pred EeccC
Q 047038 454 EFISN 458 (708)
Q Consensus 454 E~~~~ 458 (708)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.12 Score=54.17 Aligned_cols=138 Identities=22% Similarity=0.212 Sum_probs=93.1
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccC-----Ch--------------------HHH-HHHHHHHHHHHhcCCCce
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKII-----DE--------------------SKV-EEFINEVVILSQINHRNV 436 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~-----~~--------------------~~~-~~~~~Ei~~l~~l~H~ni 436 (708)
.--|..|--..||.+.-.+|..+|||+.+.. +. ..+ --...|++-|++|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3457788889999999999999999975431 11 001 123568888888876555
Q ss_pred eeeeceEeeCCcceEEEEeccCCC-ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 047038 437 VKLLGCCLETEVPLLVYEFISNGT-LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD 515 (708)
Q Consensus 437 v~l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~ 515 (708)
.-.--.... .-.|||+|+.... -.-.|+ ...++...+...-.|++.-|.-|-+.+. +||.||.--|+|+-+
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC
Confidence 433222222 2359999996321 122222 2246666777778888888888877663 999999999998865
Q ss_pred CCcEEEeeccCCcc
Q 047038 516 KYCAKVSDFGASRS 529 (708)
Q Consensus 516 ~~~~kl~DFGls~~ 529 (708)
|.+.|+|-+-+..
T Consensus 301 -G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVE 313 (520)
T ss_pred -CEEEEEEcccccc
Confidence 4699999887653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.23 Score=52.48 Aligned_cols=139 Identities=20% Similarity=0.299 Sum_probs=81.4
Q ss_pred EeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce---ee---eeceEe--eCC--cceEEEEe
Q 047038 386 LGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV---VK---LLGCCL--ETE--VPLLVYEF 455 (708)
Q Consensus 386 lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni---v~---l~g~~~--~~~--~~~lV~E~ 455 (708)
|.+ .-..+|+....+|+. ++|..... ....+...|+..|..+.-.+| ++ +=|-.. -.. ..+-|++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456689988887776 88876654 344566667777777632222 22 111111 123 67789999
Q ss_pred ccCCCccc-cc--------------cccCCC---------CCCCHHH-------------HHHHHHHHHHHHHHHHhcC-
Q 047038 456 ISNGTLSQ-YI--------------DDQNKD---------FRISWEM-------------RLCIAIDVSGAISYLHSAA- 497 (708)
Q Consensus 456 ~~~gsL~~-~l--------------~~~~~~---------~~l~~~~-------------~~~i~~~i~~al~yLH~~~- 497 (708)
++|..+.. .. |....+ ....|.. ......++...+..+.+.-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988873 11 110011 1233330 0112334444555554421
Q ss_pred ---C---CCeEecCCCCCcEEEcCCCc-EEEeeccCCc
Q 047038 498 ---S---IPIYHRDIKSTNILLDDKYC-AKVSDFGASR 528 (708)
Q Consensus 498 ---~---~~iiHrDikp~NIll~~~~~-~kl~DFGls~ 528 (708)
. ..+||+|+.|.||+++++.. +.+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 12899999999999999885 8999999764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.087 Score=51.24 Aligned_cols=152 Identities=15% Similarity=0.135 Sum_probs=90.1
Q ss_pred eccEEEEEEEEcCCcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCCCccccccc
Q 047038 389 GGQGTVYKGMLEDGKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD 467 (708)
Q Consensus 389 G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 467 (708)
++..+.-++.-+- .+..+|++....-. ...-|.++..++.+++ .|++|..= ..-..-++.|.+-...
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------- 140 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence 3444544444332 23566666554333 4456788999998885 46666521 2223457888774310
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccc
Q 047038 468 QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547 (708)
Q Consensus 468 ~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 547 (708)
.. . ..++.-=+.+|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+... . .+.-|
T Consensus 141 ------i~--~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~-----------~~V~~ 197 (308)
T PF07387_consen 141 ------IN--F-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E-----------NQVNM 197 (308)
T ss_pred ------cc--h-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--h-----------heeeE
Confidence 11 0 111221246778889654 349999999999999999999999976422 1 01112
Q ss_pred cCccccccCCCCccchhHhHHHHHHHHHhCC
Q 047038 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578 (708)
Q Consensus 548 ~aPE~~~~~~~t~ksDv~SlGvvl~elltg~ 578 (708)
.--| ....|.++.+=+|=.-++++....
T Consensus 198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred Eeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 2211 133577888888877777777643
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.48 Score=50.24 Aligned_cols=73 Identities=16% Similarity=0.112 Sum_probs=45.5
Q ss_pred eeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC--ceeeee---c--eEeeCCcceEEEEeccCCC
Q 047038 388 QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR--NVVKLL---G--CCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 388 ~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~---g--~~~~~~~~~lV~E~~~~gs 460 (708)
.+.-..||+....+++.+++|..+.. .....+...|++.+..+... .++... | ....++..+.|+++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34557799998888888999976532 22345666777777766321 123222 1 1223456788999998765
Q ss_pred c
Q 047038 461 L 461 (708)
Q Consensus 461 L 461 (708)
+
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 4
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.31 Score=52.46 Aligned_cols=74 Identities=19% Similarity=0.102 Sum_probs=49.0
Q ss_pred cceEeeeccEEEEEEEEcC-CcEEEEEEccc------CChHHHHHHHHHHHHHHhcC--CC-ceeeeeceEeeCCcceEE
Q 047038 383 NRILGQGGQGTVYKGMLED-GKIVAVKKSKI------IDESKVEEFINEVVILSQIN--HR-NVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~------~~~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV 452 (708)
.+.||.|--..||++.+.+ ++.|+||.-.. .-+-..++..-|.+.|+.+. -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3578999999999999753 56899996322 11334566677888887663 23 46666654 44455678
Q ss_pred EEeccC
Q 047038 453 YEFISN 458 (708)
Q Consensus 453 ~E~~~~ 458 (708)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 708 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-45 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-28 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-27 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-25 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-25 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-25 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-25 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-21 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-19 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-19 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-19 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-19 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-19 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-19 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-19 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-117
Identities = 112/301 (37%), Positives = 169/301 (56%), Gaps = 5/301 (1%)
Query: 355 LSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID 414
LSS+ ++ +LE+AT+NF+ ++G G G VYKG+L DG VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 415 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-DDQNKDFR 473
+EEF E+ LS H ++V L+G C E +L+Y+++ NG L +++
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV- 532
+SWE RL I I + + YLH+ I HRD+KS NILLD+ + K++DFG S+
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSL 592
DQTHL+T V+GT GY+DPEYF TEKSDVYSFGVVL E+L I + E +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 593 AAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652
A + + + +L +I+D + + + + A +CL L+ + RP+M +V +L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 653 I 653
Sbjct: 313 A 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-109
Identities = 103/292 (35%), Positives = 169/292 (57%), Gaps = 4/292 (1%)
Query: 359 EGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV 418
E + + K F+ EL+ A+DNF+ ILG+GG G VYKG L DG +VAVK+ K
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 419 E-EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-DDQNKDFRISW 476
E +F EV ++S HRN+++L G C+ LLVY +++NG+++ + + + W
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 477 EMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536
R IA+ + ++YLH I HRD+K+ NILLD+++ A V DFG ++ + TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS--EEDKSLAA 594
+TT V+GT G++ PEY + +EK+DV+ +GV+L+EL+TG+R L ++D L
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ ++E +L ++D + +E + + ++A C + +RP M EV
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-104
Identities = 97/311 (31%), Positives = 158/311 (50%), Gaps = 18/311 (5%)
Query: 354 ELSSNEGGIDKTKLFTSNELEKATDNFN------TNRILGQGGQGTVYKGMLEDGKIVAV 407
E S E + F+ EL+ T+NF+ +G+GG G VYKG + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 408 KKSKIIDESKV----EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQ 463
KK + + ++F E+ ++++ H N+V+LLG + + LVY ++ NG+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 464 YIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523
+ + +SW MR IA + I++LH I HRDIKS NILLD+ + AK+SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISD 176
Query: 524 FGASRSIAV-DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
FG +R+ QT +T+++ GT Y+ PE T KSD+YSFGVVL+E++TG +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642
+ L E++ E + + + + + +A +CL+ KRP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 643 MREVGIELTGI 653
+++V L +
Sbjct: 294 IKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-72
Identities = 70/319 (21%), Positives = 123/319 (38%), Gaps = 33/319 (10%)
Query: 351 LQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKS 410
+ + G+D + L + + +G G V+K L + VAVK
Sbjct: 1 MGHHHHHHSSGVD----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55
Query: 411 KIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP----LLVYEFISNGTLSQYID 466
I D+ + EV L + H N+++ +G L+ F G+LS ++
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113
Query: 467 DQNKDFRISWEMRLCIAIDVSGAISYLHSAASI-------PIYHRDIKSTNILLDDKYCA 519
K +SW IA ++ ++YLH I HRDIKS N+LL + A
Sbjct: 114 ---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 520 KVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSH-----FTEKSDVYSFGVVLVE 573
++DFG + ++ T GT Y+ PE + + + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 574 LLTGERPIRLTNSE-----EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE-FKMVAK 627
L + E E++ L M+E + + + K M+ +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 628 LAKRCLNLNGKKRPTMREV 646
+ C + + + R + V
Sbjct: 291 TIEECWDHDAEARLSAGCV 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 7e-71
Identities = 80/272 (29%), Positives = 129/272 (47%), Gaps = 26/272 (9%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
++G+G G V K K VA+K+ I ES+ + FI E+ LS++NH N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 444 LETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
L P+ LV E+ G+L + + + + S ++YLHS +
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 503 HRDIKSTNILLDDKY-CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
HRD+K N+LL K+ DFG + I QTH+T G+ ++ PE F+ S+++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621
DV+S+G++L E++T +P E R I +
Sbjct: 184 CDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPPLIKNLP--------- 230
Query: 622 FKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
K + L RC + + +RP+M E+ +T +
Sbjct: 231 -KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 9e-70
Identities = 82/272 (30%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLG 441
+G G GTV++ G VAVK +V EF+ EV I+ ++ H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
+ +V E++S G+L + + ++ RL +A DV+ ++YLH+ + PI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEK 561
HR++KS N+L+D KY KV DFG SR A + GT ++ PE + EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEK 219
Query: 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDE 621
SDVYSFGV+L EL T ++P + RL EI ++
Sbjct: 220 SDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRL-EI---------PRNL 264
Query: 622 FKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
VA + + C KRP+ + L +
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 4e-66
Identities = 88/287 (30%), Positives = 141/287 (49%), Gaps = 41/287 (14%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDES-------KVEEFINEVVILSQINHRN 435
+ +G+GG G V+KG ++D +VA+K + D K +EF EV I+S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+VKL G P +V EF+ G L + D+ I W ++L + +D++ I Y+ +
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN 140
Query: 496 AASIPIYHRDIKSTNILLDDK-----YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
+ PI HRD++S NI L CAKV+DFG S+ H + + G F ++ P
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 551 EYF--QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--RLF 606
E + +TEK+D YSF ++L +LTGE P +E F+ +RE+ R
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSYGKIKFINMIREEGLRP- 249
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
I +D + + + C + + KKRP + EL+ +
Sbjct: 250 TI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-66
Identities = 85/282 (30%), Positives = 136/282 (48%), Gaps = 35/282 (12%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES----KVEEFINEVVILSQINHRNVVKL 439
I+G GG G VY+ G VAVK ++ + +E E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
G CL+ LV EF G L++ + + RI ++ + A+ ++ ++YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 500 PIYHRDIKSTNILLDDKY--------CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
PI HRD+KS+NIL+ K K++DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPE 184
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
++S F++ SDV+S+GV+L ELLTGE P LA + AM + L I
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGVAMNKLAL-PIP-- 236
Query: 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+ AKL + C N + RP+ + +LT I
Sbjct: 237 -------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-62
Identities = 57/278 (20%), Positives = 109/278 (39%), Gaps = 31/278 (11%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLG 441
L + G ++KG G + VK K+ K +F E L +H NV+ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 442 CCLETEVPLL--VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
C P + ++ G+L + + +F + + A+D++ +++LH+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ---SS 556
I + S ++++D+ A++S S + ++ PE Q
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616
+D++SF V+L EL+T E P + ++ A+ R +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKVALEGLRP-------TIPP 234
Query: 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
G +KL K C+N + KRP + L ++
Sbjct: 235 GISPHV---SKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-59
Identities = 61/285 (21%), Positives = 111/285 (38%), Gaps = 38/285 (13%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLG 441
++G+G G VY G G+ VA++ I +E +++ F EV+ Q H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
C+ ++ TL + ++ + IA ++ + YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAV----DQTHLTTQVQGTFGYLDPEYFQSS- 556
H+D+KS N+ D+ ++DFG V + G +L PE +
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 557 --------HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
F++ SDV++ G + EL E P + +E + M +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIW---QMGTGMKPNL 263
Query: 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+ KE ++ + C ++RPT ++ L +
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-59
Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 45/291 (15%)
Query: 384 RILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
+LG+G G K E G+++ +K+ DE F+ EV ++ + H NV+K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
+ + + E+I GTL I ++ D + W R+ A D++ ++YLH S+ I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT-------------TQVQGTFGYLD 549
HRD+ S N L+ + V+DFG +R + ++T V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
PE + EK DV+SFG+VL E++ D L +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------------DPDYLPRTM 230
Query: 610 DAQILKEGGKDEF------KMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
D + G D + + RC +L+ +KRP+ ++ L +R
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-59
Identities = 71/278 (25%), Positives = 127/278 (45%), Gaps = 29/278 (10%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLG 441
+ +G G GTVYKG G VAVK + +++ F NEV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 442 CCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
T L +V ++ +L ++ + + + + IA + + YLH+
Sbjct: 88 YS--TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ-THLTTQVQGTFGYLDPE---YFQSS 556
I HRD+KS NI L + K+ DFG + + +H Q+ G+ ++ PE S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIR-LTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615
++ +SDVY+FG+VL EL+TG+ P + N + + R ++ +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIEM-VGRGSLSPDLSKVR--- 251
Query: 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+ K + +L CL +RP+ + E+ +
Sbjct: 252 ---SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 6e-59
Identities = 67/324 (20%), Positives = 124/324 (38%), Gaps = 48/324 (14%)
Query: 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVI 427
++E DN ++G+G G VYKG L D + VAVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 428 --LSQINHRNVVKLLGCCLETEVP-----LLVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
+ + H N+ + + LLV E+ NG+L +Y+ W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114
Query: 481 CIAIDVSGAISYLHSAASI------PIYHRDIKSTNILLDDKYCAKVSDFGASR------ 528
+A V+ ++YLH+ I HRD+ S N+L+ + +SDFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 529 -SIAVDQTHLTTQVQGTFGYLDPEYFQSS-------HFTEKSDVYSFGVVLVELLTGERP 580
++ + GT Y+ PE + + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 581 IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG-----------GKDEFKMVAKLA 629
+ S + +A F + FE + + +E + + +
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 630 KRCLNLNGKKRPTMREVGIELTGI 653
+ C + + + R T + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAEL 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 62/296 (20%), Positives = 107/296 (36%), Gaps = 35/296 (11%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVI--LSQINHRNVVKLLG 441
+G+G G V++G G+ VAVK I + + E + + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 442 CCLETEVP----LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+ + L+ + G+L Y+ + + L I + ++ +++LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 498 SI-----PIYHRDIKSTNILLDDKYCAKVSDFGASR----SIAVDQTHLTTQVQGTFGYL 548
I HRD+KS NIL+ ++D G + S +V GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 549 DPE------YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE----EDKSLAAYFLR 598
PE ++ D+++FG+VL E+ + D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 599 AMREDRLFEILDAQILKEGGKDE-FKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
MR+ + I D +AKL K C N R T + LT I
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-51
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 33/295 (11%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINE--VVILSQINHRNVVKLLG 441
+ +G+G G V+ G G+ VAVK + ++ + E + + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 442 CCLETEVP----LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
++ L+ ++ NG+L Y+ K + + L +A + +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 498 SI-----PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL---TTQVQGTFGYLD 549
I HRD+KS NIL+ ++D G + D + GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 550 PE------YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE----EDKSLAAYFLRA 599
PE +D+YSFG++L E+ + D +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 600 MREDRLFEILDAQILKEGGKDEF-KMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
MRE + L DE + + KL C N R T V L +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 55/299 (18%), Positives = 115/299 (38%), Gaps = 43/299 (14%)
Query: 385 ILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINE--VVILSQINHRNVVKLLGC 442
+G+G G V++G G+ VAVK I + + E + + H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 443 CLETEVP----LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
+ LV ++ +G+L Y+ + ++ E + +A+ + +++LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 499 -----IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT---TQVQGTFGYLDP 550
I HRD+KS NIL+ ++D G + + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 551 E------YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
E + +++D+Y+ G+V E+ R + + + + D
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-----RCSIGGIHEDYQLPYYDLVPSDP 275
Query: 605 LFEILDAQILKEG----------GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
E + + ++ + +++AK+ + C NG R T + L+ +
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 22/274 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK---SKIIDESKVEEFINEVVILSQINH 433
NF + +G+G VY+ L DG VA+KK ++D + I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR-ISWEMRLCIAIDVSGAISY 492
NV+K +E +V E G LS+ I K R I + + A+ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
+HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
+ + KSD++S G +L E+ + P + +L + + + D
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEQCDY------PP 257
Query: 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + +E + +L C+N + +KRP + V
Sbjct: 258 LPSDHYSEELR---QLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHR 434
+++ +G G G K DGKI+ K+ + E++ + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 435 NVVKLLGCCLETEVPLL--VYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAIS 491
N+V+ ++ L V E+ G L+ I K+ + E + + ++ A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 492 YLHS--AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
H + HRD+K N+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
PE + EKSD++S G +L EL P S + F +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIREGK--FRRI 236
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ E + ++ R LNL RP++ E+
Sbjct: 237 PYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 24/286 (8%)
Query: 364 KTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEE 420
L T N ++ + + + +G+G G EDG+ +K+ I + + EE
Sbjct: 10 GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 421 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
EV +L+ + H N+V+ E +V ++ G L + I+ Q + L
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQIL 128
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+ + A+ ++H I HRDIKS NI L ++ DFG +R +
Sbjct: 129 DWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
+ GT YL PE ++ + KSD+++ G VL EL T + E S+ L+ +
Sbjct: 186 I-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF------EAGSMKNLVLKII 238
Query: 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
F + + + L + N + RP++ +
Sbjct: 239 SGS--FPPVSLHYSYD--------LRSLVSQLFKRNPRDRPSVNSI 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 30/271 (11%)
Query: 383 NRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK--VEEFINEVVILSQINHRNVVKL 439
+ +G+G TVYKG+ E VA + + +K + F E +L + H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 440 LGCCLETEVP----LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
T +LV E +++GTL Y+ + K +I C I + G + +LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQI-LKG-LQFLHT 147
Query: 496 AASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
+ PI HRD+K NI + K+ D G + + + V GT ++ PE ++
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE 203
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
+ E DVY+FG+ ++E+ T E P E ++ A + R +
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVK------PASF 251
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
+ E K ++ + C+ N +R ++++
Sbjct: 252 DKVAIPEVK---EIIEGCIRQNKDERYSIKD 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-42
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 35/286 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKI-VAVKKSK-IIDESKVEEFINEVVILSQINHRN 435
++ +G+G G V+ G L VAVK + + +F+ E IL Q +H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+V+L+G C + + +V E + G ++ + + R+ + L + D + + YL S
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYF 553
I HRD+ + N L+ +K K+SDFG SR A D + + PE
Sbjct: 232 KCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEAL 287
Query: 554 QSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSEEDKSLAA-YFLRAMRE--DRLFEI 608
++ +SDV+SFG++L E + G P L+N + + + L D +F +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
M ++C +RP+ + EL IR
Sbjct: 348 ---------------M-----EQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
+F ++G GG G V+K DGK +K+ + + E+ EV L++++H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLDHVNI 66
Query: 437 VKLLGCCLETEVPL----------------LVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
V GC + + EF GTL Q+I+ + + ++ + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLAL 125
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+ ++ + Y+HS + +RD+K +NI L D K+ DFG S+ D T
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRS 181
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
GT Y+ PE S + ++ D+Y+ G++L ELL A
Sbjct: 182 K-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AF 222
Query: 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ F L I+ + + K L ++ L+ + RP E+
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEK---TLLQKLLSKKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 59/294 (20%), Positives = 113/294 (38%), Gaps = 46/294 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRN 435
+F + LG+GG G V++ D A+K+ ++ + E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 436 VVKLLGCCLE---------TEVPLLVY---EFISNGTLSQYIDDQNKDFRISWEMRLCIA 483
+V+ LE + + +Y + L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ- 542
+ ++ A+ +LHS + HRD+K +NI KV DFG ++ D+ T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 543 ----------GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSL 592
GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 593 AAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
F M R + ++ + + L+ + +RP +
Sbjct: 226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 57/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 384 RILGQGGQGTVYKGML----EDGKI-VAVKKSK-IIDESKVEEFINEVVILSQINHRNVV 437
++LG G GTVYKG+ E KI VA+K+ + +E ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+LLG CL + V L+ + + G L Y+ + I + L + ++ ++YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT---FGYLDPEYFQ 554
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 555 SSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+T +SDV+S+GV + EL+T G +P + SE
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 26/294 (8%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID 414
S+ EG + L E D +LG+G G VY G L + +A+K+ D
Sbjct: 4 STEEGDCESDLLEYDYEY----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59
Query: 415 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRI 474
+ E+ + + H+N+V+ LG E + E + G+LS + + +
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAVD 533
+ + + + YLH I HRDIK N+L++ K+SDFG S+ +A
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 534 QTHLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS 591
T GT Y+ PE + + +D++S G ++E+ TG+ P E +
Sbjct: 177 NPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP----FYELGEP 231
Query: 592 LAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
AA F M + EI ++ + K F +C + KR +
Sbjct: 232 QAAMFKVGMFKVH-PEIPES--MSAEAKA-F------ILKCFEPDPDKRACAND 275
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 70/302 (23%), Positives = 127/302 (42%), Gaps = 57/302 (18%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN 435
+F +LGQG G V K D + A+KK + E K+ ++EV++L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 436 VVKLLGCCLETEVPL-------------LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI 482
VV+ LE + + E+ NGTL I +N + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DEYWRL 121
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI------------ 530
+ A+SY+HS I HRD+K NI +D+ K+ DFG ++++
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 531 --AVDQTHLTTQVQGTFGYLDPEYFQ-SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587
+LT+ + GT Y+ E + H+ EK D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---------- 227
Query: 588 EDKSLAAYFLRAMREDRLFEIL---DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644
F M + + L + + ++ K+ K+ + ++ + KRP R
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
Query: 645 EV 646
+
Sbjct: 280 TL 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 65/234 (27%), Positives = 115/234 (49%), Gaps = 18/234 (7%)
Query: 359 EGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKV 418
G + F + + +G+G G V G G VAVK K +++
Sbjct: 2 GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATA 58
Query: 419 EEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWE 477
+ F+ E +++Q+ H N+V+LLG +E + L +V E+++ G+L Y+ + + + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGD 117
Query: 478 MRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537
L ++DV A+ YL + HRD+ + N+L+ + AKVSDFG ++ +
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 168
Query: 538 TTQVQGTFGY--LDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+TQ G PE + F+ KSDV+SFG++L E+ + G P R+ +
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 70/205 (34%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 384 RILGQGGQGTVYKGMLED---GKIVAVK--KSKII-DESKVEEFINEVVILSQINHRNVV 437
LG GG TVY ED VA+K E ++ F EV SQ++H+N+V
Sbjct: 17 DKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
++ E + LV E+I TLS+YI+ +S + + + I + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT--QVQGTFGYLDPEYFQS 555
I HRDIK NIL+D K+ DFG ++ A+ +T LT V GT Y PE +
Sbjct: 132 ---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 556 SHFTEKSDVYSFGVVLVELLTGERP 580
E +D+YS G+VL E+L GE P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-40
Identities = 69/209 (33%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 384 RILGQGGQGTVYKGMLEDGK----IVAVKKSK-IIDESKVEEFINEVVILSQINHRNVVK 438
++G+G G VY G L D AVK I D +V +F+ E +I+ +H NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 439 LLGCCLETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
LLG CL +E L V ++ +G L +I +N+ + + + + V+ + +L A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL-----DPEY 552
S HRD+ + N +LD+K+ KV+DFG +R + + T L E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALES 267
Query: 553 FQSSHFTEKSDVYSFGVVLVELLT-GERP 580
Q+ FT KSDV+SFGV+L EL+T G P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 69/209 (33%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 384 RILGQGGQGTVYKGMLEDGK----IVAVKKSK-IIDESKVEEFINEVVILSQINHRNVVK 438
++G+G G VY G L D AVK I D +V +F+ E +I+ +H NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 439 LLGCCLETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
LLG CL +E L V ++ +G L +I +N+ + + + + V+ + YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL-----DPEY 552
+ HRD+ + N +LD+K+ KV+DFG +R + + T L E
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALES 203
Query: 553 FQSSHFTEKSDVYSFGVVLVELLT-GERP 580
Q+ FT KSDV+SFGV+L EL+T G P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 71/209 (33%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 384 RILGQGGQGTVYKGMLEDGKI-VAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
LG G G VY+G+ + + VAVK K D +VEEF+ E ++ +I H N+V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
C ++ EF++ G L Y+ + N+ +S + L +A +S A+ YL I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI--- 133
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTE 560
HRD+ + N L+ + + KV+DFG SR + D T F PE + F+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 561 KSDVYSFGVVLVELLT-GERP-IRLTNSE 587
KSDV++FGV+L E+ T G P + S+
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+ LG G G V G + VAVK K +EF E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ +V E+ISNG L Y+ ++ + L + DV +++L S I H
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI---H 127
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTEK 561
RD+ + N L+D C KVSDFG +R + DQ + V F PE F ++ K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 562 SDVYSFGVVLVELLT-GERP-IRLTNSE 587
SDV++FG+++ E+ + G+ P TNSE
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 64/214 (29%), Positives = 116/214 (54%), Gaps = 16/214 (7%)
Query: 383 NRILGQGGQGTVYKGMLEDGKI---VAVK--KSKIIDESKVEEFINEVVILSQINHRNVV 437
++ LG G GTV KG + K+ VAVK K++ D + +E + E ++ Q+++ +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+++G C E +LV E G L++Y+ ++ + + + + VS + YL +
Sbjct: 82 RMIGICEA-ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQS 555
+ HRD+ + N+LL ++ AK+SDFG S+++ D+ + Q G + + PE
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 556 SHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
F+ KSDV+SFGV++ E + G++P + SE
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 361 GIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGK----IVAVK--KSKIID 414
GI ++ F R+LG+G G+V + L+ VAVK K+ II
Sbjct: 6 GISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA 65
Query: 415 ESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPLLVYEFISNGTLSQYI--- 465
S +EEF+ E + + +H +V KL+G L + +P+++ F+ +G L ++
Sbjct: 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 466 DDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525
F + + + +D++ + YL +S HRD+ + N +L + V+DFG
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 526 ASRSIAVDQTHLTTQVQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GER 579
SR I + QG L E + +T SDV++FGV + E++T G+
Sbjct: 183 LSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 580 P 580
P
Sbjct: 239 P 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 12/208 (5%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+ +G G G V+ G + VA+K + E+FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
LE LV EF+ +G LS Y+ + + + E L + +DV ++YL A I H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEACVI---H 127
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTEK 561
RD+ + N L+ + KVSDFG +R + DQ T+ F PE F S ++ K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 562 SDVYSFGVVLVELLT-GERP-IRLTNSE 587
SDV+SFGV++ E+ + G+ P +NSE
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 32/289 (11%)
Query: 384 RILGQGGQGTVYKGMLE-----DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVK 438
+ LG+G G+V + G++VAVKK + E + +F E+ IL + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 439 LLGCCLET-EVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
G C L L+ E++ G+L Y+ Q RI L + + YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQ 554
I HRD+ + NIL++++ K+ DFG ++ + D+ + G + PE
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
S F+ SDV+SFGVVL EL T + +E + + M L E +L
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-----LL 245
Query: 615 KEGGKDEFKM---------VAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
K ++ + + C N N +RP+ R++ + + IR
Sbjct: 246 KNN----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGK----IVAVK--KSKIIDESKVEEFINEVVILSQI 431
+ +ILG+G G+V +G L+ VAVK K + ++EEF++E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 432 NHRNVVKLLGCCLETE-----VPLLVYEFISNGTLSQYI---DDQNKDFRISWEMRLCIA 483
+H NV++LLG C+E P+++ F+ G L Y+ + I + L
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG 543
+D++ + YL ++ HRD+ + N +L D V+DFG S+ I + QG
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQG 206
Query: 544 TFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+ E +T KSDV++FGV + E+ T G P
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 384 RILGQGGQGTVYKGML---EDGKI-VAVKKSKI-IDESKVEEFINEVVILSQINHRNVVK 438
+I+G G G V G L + VA+K K E + +F++E I+ Q +H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L G + ++V E++ NG+L ++ + D + + + + V + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL--DPEYFQSS 556
+ HRD+ + N+L+D KVSDFG SR + D T G PE
Sbjct: 173 V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
F+ SDV+SFGVV+ E+L GERP +TN +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+ LG G G V G VA+K K +EFI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503
+ ++ E+++NG L Y+ + R + L + DV A+ YL S + H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQFL---H 143
Query: 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTEK 561
RD+ + N L++D+ KVSDFG SR + D+ T+ V F PE S F+ K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 562 SDVYSFGVVLVELLT-GERP-IRLTNSE 587
SD+++FGV++ E+ + G+ P R TNSE
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 32/289 (11%)
Query: 384 RILGQGGQGTVYKGMLE-----DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVK 438
+ LG+G G+V + G++VAVKK + E + +F E+ IL + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 439 LLGCCLET-EVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
G C L L+ E++ G+L Y+ Q RI L + + YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQ 554
I HRD+ + NIL++++ K+ DFG ++ + D+ + + G + PE
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
S F+ SDV+SFGVVL EL T + +E + + M L E +L
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-----LL 276
Query: 615 KEGGKDEFKM---------VAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
K ++ + + C N N +RP+ R++ + + IR
Sbjct: 277 KNN----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-39
Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 8/207 (3%)
Query: 384 RILGQGGQGTVYKGMLEDGKI-VAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
LG G G VY+G+ + + VAVK K D +VEEF+ E ++ +I H N+V+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
C ++ EF++ G L Y+ + N+ +S + L +A +S A+ YL I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI--- 340
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKS 562
HR++ + N L+ + + KV+DFG SR + D + + PE + F+ KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 563 DVYSFGVVLVELLT-GERPI-RLTNSE 587
DV++FGV+L E+ T G P + S+
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 33/288 (11%)
Query: 384 RILGQGGQGTVYKGML-----EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVK 438
LG+G G+V G +VAVK+ + + +F E+ IL ++ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 439 LLGCCLET-EVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
G L LV E++ +G L ++ Q R+ L + + + YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQ 554
+ HRD+ + NIL++ + K++DFG ++ + +D+ + + G + PE
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 555 SSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
+ F+ +SDV+SFGVVL EL T ++ + S E + RL E +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLE-----L 256
Query: 614 LKEGGK--------DEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
L+EG + E V +L K C + + RP+ +G +L +
Sbjct: 257 LEEGQRLPAPPACPAE---VHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 16/211 (7%)
Query: 386 LGQGGQGTVYKGML--EDGKI-VAVK--KSKIIDESKVEEFINEVVILSQINHRNVVKLL 440
LG G G+V +G+ +I VA+K K EE + E I+ Q+++ +V+L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLI 76
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIP 500
G C + +LV E G L +++ K I + VS + YL +
Sbjct: 77 GVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV- 132
Query: 501 IYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQSSHF 558
HRD+ + N+LL +++ AK+SDFG S+++ D ++ T + G + + PE F
Sbjct: 133 --HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 559 TEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+ +SDV+S+GV + E L+ G++P ++ E
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-39
Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 20/254 (7%)
Query: 341 KFFKRNGGLLLQQ--ELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM 398
+ + + L + + EG + F + + +G+G G V G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 399 LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIS 457
G VAVK K +++ + F+ E +++Q+ H N+V+LLG +E + L +V E+++
Sbjct: 214 YR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270
Query: 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517
G+L Y+ + + + + L ++DV A+ YL + HRD+ + N+L+ +
Sbjct: 271 KGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDN 326
Query: 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTEKSDVYSFGVVLVELL 575
AKVSDFG ++ + +TQ G PE + F+ KSDV+SFG++L E+
Sbjct: 327 VAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 576 T-GERP-IRLTNSE 587
+ G P R+ +
Sbjct: 381 SFGRVPYPRIPLKD 394
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 76/290 (26%), Positives = 116/290 (40%), Gaps = 36/290 (12%)
Query: 384 RILGQGGQGTVYKGMLED-----GKIVAVKKSK-IIDESKVEEFINEVVILSQINHRNVV 437
R LG+G G V + G++VAVK K + E+ IL + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 438 KLLGCCLETEVP--LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
K GCC + LV E++ G+L Y+ I L A + ++YLH+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYF 553
I HRD+ + N+LLD+ K+ DFG ++++ + + G + PE
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 554 QSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
+ F SDV+SFGV L ELLT + + A M RL E
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTE----- 262
Query: 613 ILKEGGK--------DEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
+L+ G + E V L K C RPT + L +
Sbjct: 263 LLERGERLPRPDKCPAE---VYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-39
Identities = 61/250 (24%), Positives = 115/250 (46%), Gaps = 10/250 (4%)
Query: 341 KFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE 400
++ ++ L + + +T+ + E ++ LGQG G V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 401 DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNG 459
VA+K K E F+ E ++ ++ H +V+L +E P+ +V E++S G
Sbjct: 207 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 263
Query: 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519
+L ++ + + + + +A ++ ++Y+ + HRD+++ NIL+ +
Sbjct: 264 SLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 319
Query: 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GE 578
KV+DFG +R I ++ + + PE FT KSDV+SFG++L EL T G
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 579 RP-IRLTNSE 587
P + N E
Sbjct: 380 VPYPGMVNRE 389
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 48/292 (16%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
++ + LG+GG V L DG A+K+ ++ EE E + NH N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 438 KLLGCCLETEVP----LLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAISY 492
+L+ CL L+ F GTL I+ ++K ++ + L + + + +
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR--SIAVDQTHLTTQVQ------GT 544
+H+ HRD+K TNILL D+ + D G+ I V+ + +Q T
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 545 FGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
Y PE F E++DV+S G VL ++ GE P +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP---------------Y----- 246
Query: 602 EDRLFEILDAQILKEGGKDEF-------KMVAKLAKRCLNLNGKKRPTMREV 646
D +F+ D+ L + + +L + ++ +RP + +
Sbjct: 247 -DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 384 RILGQGGQGTVYKGML----EDGKI-VAVKKSK-IIDESKVEEFINEVVILSQINHRNVV 437
++LG G GTVYKG+ E KI VA+K+ + +E ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+LLG CL L+ + + G L Y+ + I + L + ++ ++YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT---FGYLDPEYFQ 554
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 555 SSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+T +SDV+S+GV + EL+T G +P + SE
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 73/290 (25%), Positives = 124/290 (42%), Gaps = 36/290 (12%)
Query: 384 RILGQGGQGTVYKGMLE-----DGKIVAVKKSK-IIDESKVEEFINEVVILSQINHRNVV 437
R LG+G G V + G+ VAVK K + + + E+ IL + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 438 KLLGCCLETEV-PL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
K G C E + L+ EF+ +G+L +Y+ +I+ + +L A+ + + YL S
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYF 553
+ HRD+ + N+L++ ++ K+ DFG +++I D+ + T + + PE
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 554 QSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
S F SDV+SFGV L ELLT + + M RL
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQMTVTRLVN----- 254
Query: 613 ILKEGGKDEFKM---------VAKLAKRCLNLNGKKRPTMREVGIELTGI 653
LKEG ++ V +L ++C R + + + +
Sbjct: 255 TLKEG----KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 17/215 (7%)
Query: 384 RILGQGGQGTVYKGMLEDGKI-----VAVK--KSKIIDESKVEEFINEVVILSQINHRNV 436
+++G G G VYKGML+ VA+K K+ ++ + +F+ E I+ Q +H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNI 108
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
++L G + + +++ E++ NG L +++ + KD S + + ++ + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQ 554
+ HRD+ + NIL++ KVSDFG SR + D T G PE
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 555 SSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
FT SDV+SFG+V+ E++T GERP L+N E
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 384 RILGQGGQGTVYKGML----EDGKI-VAVKKSK-IIDESKVEEFINEVVILSQINHRNVV 437
++LG G GTV+KG+ E KI V +K + + + ++ + ++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+LLG C LV +++ G+L ++ + + ++ L + ++ + YL
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT---FGYLDPEYFQ 554
+ HR++ + N+LL +V+DFG + + D L ++ E
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIH 190
Query: 555 SSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+T +SDV+S+GV + EL+T G P L +E
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
LG G G V+ G VAVK K + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 444 LETEVPLL-VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
T+ P+ + E++ NG+L ++ +++ L +A ++ ++++ I
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYI--- 131
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTE 560
HRD+++ NIL+ D K++DFG +R I ++ T + F PE FT
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 561 KSDVYSFGVVLVELLT-GERP-IRLTNSE 587
KSDV+SFG++L E++T G P +TN E
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 384 RILGQGGQGTVYKGMLEDGK----IVAVKKSK-IIDESKVEEFINEVVILSQINHRNVVK 438
R++G+G G VY G D A+K I + +VE F+ E +++ +NH NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 439 LLGCCLETE-VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
L+G L E +P ++ ++ +G L Q+I ++ + + + + V+ + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL-----DPEY 552
+ HRD+ + N +LD+ + KV+DFG +R I + Q L E
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALES 199
Query: 553 FQSSHFTEKSDVYSFGVVLVELLT-GERP 580
Q+ FT KSDV+SFGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 61/303 (20%), Positives = 104/303 (34%), Gaps = 34/303 (11%)
Query: 351 LQQELSSNEGGIDKTKLFTSN-ELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK 408
L E NEG + KL + E + +G+G G V++ + G AVK
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 409 KSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQ 468
K ++ E+V + ++ +V L G E + E + G+L Q I
Sbjct: 90 KVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 141
Query: 469 NKDFRISWEMRLC-IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGA 526
K E R + YLH+ + H D+K+ N+LL A + DFG
Sbjct: 142 -KQMGCLPEDRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFGH 197
Query: 527 SRSIAVDQTHLTTQ----VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
+ + D + + GT ++ PE K D++S +++ +L G P
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-- 255
Query: 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642
++ A + EI + + L R +
Sbjct: 256 --WTQYF-RGPLCLKIASEPPPIREIPPS--CAPLTAQ-------AIQEGLRKEPVHRAS 303
Query: 643 MRE 645
E
Sbjct: 304 AME 306
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 14/213 (6%)
Query: 384 RILGQGGQGTVYKGML----EDGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVK 438
+++G G G V G L + VA+K K+ E + +F+ E I+ Q +H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAAS 498
L G +++ ++V E++ NG+L ++ + D + + + + ++ + YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL--DPEYFQSS 556
+ HRD+ + NIL++ KVSDFG R + D T G PE
Sbjct: 169 V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 557 HFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
FT SDV+S+G+VL E+++ GERP ++N +
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 384 RILGQGGQGTVYKGML--EDGKI--VAVK--KSKIIDESKV-EEFINEVVILSQINHRNV 436
LG G G V +G GK VAVK K ++ + + ++FI EV + ++HRN+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 437 VKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
++L G L P+ +V E G+L + + A+ V+ + YL S
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYF 553
I HRD+ + N+LL + K+ DFG R++ + H Q + PE
Sbjct: 140 KRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 554 QSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
++ F+ SD + FGV L E+ T G+ P I L S+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-38
Identities = 61/250 (24%), Positives = 115/250 (46%), Gaps = 10/250 (4%)
Query: 341 KFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE 400
++ ++ L + + +T+ + E ++ LGQG G V+ G
Sbjct: 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 289
Query: 401 DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNG 459
VA+K K E F+ E ++ ++ H +V+L +E P+ +V E++S G
Sbjct: 290 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 346
Query: 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519
+L ++ + + + + +A ++ ++Y+ + HRD+++ NIL+ +
Sbjct: 347 SLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 402
Query: 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GE 578
KV+DFG +R I ++ + + PE FT KSDV+SFG++L EL T G
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 579 RP-IRLTNSE 587
P + N E
Sbjct: 463 VPYPGMVNRE 472
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 384 RILGQGGQGTVYKGMLEDGK----IVAVK--KSKIIDESKVEEFINEVVILSQINHRNVV 437
R +G+G G V++G+ + VA+K K+ D + E+F+ E + + Q +H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIV 79
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
KL+G E ++ E + G L ++ Q + + + + A +S A++YL S
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF--GYLDPEYFQS 555
+ HRDI + N+L+ C K+ DFG SR + +G ++ PE
Sbjct: 137 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINF 191
Query: 556 SHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
FT SDV+ FGV + E+L G +P + N++
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKI----VAVK--KSKIIDESKVEEFINEVVILSQI 431
++ NRILG+G G VY+G+ + K VAVK K ++K E+F++E VI+ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNL 70
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+H ++VKL+G E E ++ E G L Y+ + + + ++ + A++
Sbjct: 71 DHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMA 127
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT---FGYL 548
YL S + HRDI NIL+ C K+ DFG SR I + + T ++
Sbjct: 128 YLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWM 181
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
PE FT SDV+ F V + E+L+ G++P L N +
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 384 RILGQGGQGTVYKGMLED---GKIVAVK--KSKII-DESKVEEFINEVVILSQINHRNVV 437
ILG GG V+ D + VAVK ++ + D S F E + +NH +V
Sbjct: 18 EILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 438 KLL--GC--CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+ G +P +V E++ TL + + ++ + + + D A+++
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFS 132
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT--QVQGTFGYLDPE 551
H I HRD+K NI++ KV DFG +R+IA +T V GT YL PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERP 580
+ +SDVYS G VL E+LTGE P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 60/286 (20%), Positives = 119/286 (41%), Gaps = 42/286 (14%)
Query: 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRN 435
++ + +G GG V++ + E +I A+K + D ++ + NE+ L+++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 436 --VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+++L + + +V E N L+ ++ + I R ++ A+ +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 143
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT--HLTTQVQGTFGYLDPE 551
H I H D+K N L+ D K+ DFG + + D T +QV GT Y+ PE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE 198
Query: 552 YFQSSH-----------FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
+ + KSDV+S G +L + G+ P + ++ +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLH-AII 253
Query: 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ E D I ++ +D + K CL + K+R ++ E+
Sbjct: 254 DPNHEIEFPD--IPEKDLQD-------VLKCCLKRDPKQRISIPEL 290
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 24/208 (11%)
Query: 384 RILGQGGQGTVYKGMLED---GKIVAVKKSKII------DESKVEEFINEVVILSQINHR 434
R++G+GG G VY+ ED +IVA+K ++ D E ++
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRERIVALK---LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+VV + + I+ L+ + Q ++ + I + A+ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAH 151
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT--QVQGTFGYLDPEY 552
+A HRD+K NIL+ A + DFG + A LT GT Y+ PE
Sbjct: 152 AAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPER 206
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERP 580
F SH T ++D+Y+ VL E LTG P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 43/302 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+ + ILGQG V++G + G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 434 RNVVKLLGC--CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+N+VKL T +L+ EF G+L +++ + + + L + DV G ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 492 YLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
+L I HR+IK NI+ D + K++DFGA+R + D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEY 181
Query: 548 LDPEYFQSS--------HFTEKSDVYSFGVVLVELLTGERPIR---------------LT 584
L P+ ++ + + D++S GV TG P R +T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 585 NSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644
D ++ + L G + + L + +K
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANILEADQEKCWGFD 298
Query: 645 EV 646
+
Sbjct: 299 QF 300
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 59/274 (21%), Positives = 100/274 (36%), Gaps = 33/274 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVE--EFINEVVILSQI-NH 433
+F LG G G V+K EDG++ AVK+S + + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAISY 492
V+L E + L E +L Q+ + E ++ D A+++
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LHS + H D+K NI L + K+ DFG + +G Y+ PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPEL 227
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
Q S+ +DV+S G+ ++E+ + +R+ L A
Sbjct: 228 LQGSY-GTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAG 276
Query: 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ E + + L + K R T +
Sbjct: 277 L-----SSELR---SVLVMMLEPDPKLRATAEAL 302
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 2e-37
Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 386 LGQGGQGTVYKGML--EDGKI-VAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLG 441
LG G G+V +G+ +I VA+K K +++ EE + E I+ Q+++ +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPI 501
C + +LV E G L +++ K I + VS + YL +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 502 YHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFT 559
HR++ + N+LL +++ AK+SDFG S+++ D ++ T + G + PE F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 560 EKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+SDV+S+GV + E L+ G++P ++ E
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 62/279 (22%), Positives = 116/279 (41%), Gaps = 33/279 (11%)
Query: 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVV 437
+F +LG G +GT+ + D + VAV K I EV +L + + H NV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAV---KRILPECFSFADREVQLLRESDEHPNVI 81
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+ + + + E + TL +Y+ + KDF + + + +++LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 498 SIPIYHRDIKSTNILLDDK-----YCAKVSDFGASRSIAVDQTHLT--TQVQGTFGYLDP 550
I HRD+K NIL+ A +SDFG + +AV + + + V GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 551 EYFQSS---HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
E + T D++S G V +++ + + A L L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILL--GACSLDC 249
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + ++ L ++ + ++ +KRP+ + V
Sbjct: 250 LHPEKHEDVIARE-------LIEKMIAMDPQKRPSAKHV 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 28/231 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGK------IVAVKKSK-IIDESKVEEFINEVVILSQ 430
+ +R LGQG G VY+G+ + VA+K + EF+NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQY-------IDDQNKDFRISWEMRLCIA 483
N +VV+LLG + + L++ E ++ G L Y + + S + +A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG 543
+++ ++YL + HRD+ + N ++ + + K+ DFG +R I + +G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKG 197
Query: 544 TFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR-LTNSE 587
G L PE + FT SDV+SFGVVL E+ T E+P + L+N +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 9e-37
Identities = 46/242 (19%), Positives = 89/242 (36%), Gaps = 41/242 (16%)
Query: 384 RILGQGGQGTVYKG--MLEDGKIVAVKKSKII----DESKVEEFINEVVILSQINHRNVV 437
+ GG G +Y +G+ V +K + D + E L+++ H ++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 438 KLL-----GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
++ V +V E++ +L + ++ + +++ A+SY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSY 197
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LHS + + D+K NI+L ++ K+ D GA ++ + GT G+ PE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEEQ-LKLIDLGAVS--RINSF---GYLYGTPGFQAPE- 247
Query: 553 FQ-SSHFTEKSDVYSFGVVLVELLTGERP----------IRLTNSEEDKSLAAYFLRAMR 601
+ T +D+Y+ G L L + S RA+
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306
Query: 602 ED 603
D
Sbjct: 307 PD 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 61/285 (21%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVK--KSKIIDESKVEEFINEVVILSQINH--R 434
++ + +G GG V++ + E +I A+K + D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+++L + + +V E N L+ ++ + I R ++ A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH 125
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT--HLTTQVQGTFGYLDPEY 552
I H D+K N L+ D K+ DFG + + D T +QV GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 180
Query: 553 FQ-----------SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
+ S + KSDV+S G +L + G+ P + ++ +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLH-AIID 235
Query: 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ E D I ++ +D + K CL + K+R ++ E+
Sbjct: 236 PNHEIEFPD--IPEKDLQD-------VLKCCLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 65/315 (20%), Positives = 129/315 (40%), Gaps = 43/315 (13%)
Query: 352 QQELSSNEGGIDKTKLFTSNELEKATDN---FNTNRILGQGGQGTVYKGMLEDGKIVAVK 408
+Q + S + G D +S+ E + ++ + +G GG V++ + E +I A+K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 409 --KSKIIDESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFISNGTLSQY 464
+ D ++ + NE+ L+++ +++L + + +V E N L+ +
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145
Query: 465 IDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524
+ + I R ++ A+ +H I H D+K N L+ D K+ DF
Sbjct: 146 LKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDF 198
Query: 525 GASRSIAVDQT--HLTTQVQGTFGYLDPEYFQSS-----------HFTEKSDVYSFGVVL 571
G + + D T +QV G Y+ PE + + KSDV+S G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 572 VELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKR 631
+ G+ P + ++ + + E D I ++ +D + K
Sbjct: 258 YYMTYGKTPF----QQIINQISKLH-AIIDPNHEIEFPD--IPEKDLQD-------VLKC 303
Query: 632 CLNLNGKKRPTMREV 646
CL + K+R ++ E+
Sbjct: 304 CLKRDPKQRISIPEL 318
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 384 RILGQGGQGTVYKGMLEDGK------IVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
LG+G G V+ + +VAVK K ES ++F E +L+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQY------------IDDQNKDFRISWEMRLCIAID 485
+ G C E L+V+E++ +G L+++ + + L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
V+ + YL A + HRD+ + N L+ K+ DFG SR I +V G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219
Query: 546 GYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
L PE FT +SDV+SFGVVL E+ T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-36
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+ LG G G V+ VAVK K VE F+ E ++ + H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 444 LETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502
T+ P+ ++ EF++ G+L ++ ++ + + + ++ ++++ I
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 306
Query: 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY--LDPEYFQSSHFTE 560
HRD+++ NIL+ K++DFG +R I ++ T + F PE FT
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTI 364
Query: 561 KSDVYSFGVVLVELLT-GERPI-RLTNSE 587
KSDV+SFG++L+E++T G P ++N E
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPE 393
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 4e-36
Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 37/303 (12%)
Query: 369 TSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEVV 426
+ + + + LG GG G V + + + G+ VA+K+ + + E + E+
Sbjct: 5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ 64
Query: 427 ILSQINHRNVVKLLGCCLETE-------VPLLVYEFISNGTLSQYIDDQNKDFRISWEMR 479
I+ ++NH NVV + +PLL E+ G L +Y++ +
Sbjct: 65 IMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASRSIAVDQTH 536
+ D+S A+ YLH I HRD+K NI+L + K+ D G ++ + DQ
Sbjct: 124 RTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGE 178
Query: 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596
L T+ GT YL PE + +T D +SFG + E +TG RP +
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ------W 232
Query: 597 LRAMREDRLFEILDAQILKEGGKDEFKMVA-------------KLAKRCLNLNGKKRPTM 643
+RE I+ L K + + + L + ++R T
Sbjct: 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292
Query: 644 REV 646
+
Sbjct: 293 PQN 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 38/311 (12%), Positives = 72/311 (23%), Gaps = 52/311 (16%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVI 427
L + L G + V+ +E + A+K S++E
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 428 LSQINHRNVVKLLGCCLETEVP--------------------------LLVYEFISNGTL 461
+++ + + LL+ S L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174
Query: 462 SQYIDDQNK----DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517
+ + + + L S + H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDG 231
Query: 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELL 575
+ D Y E+ +S FT + + G+ + +
Sbjct: 232 RLMLGDVS----ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 576 TGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNL 635
P L S LR D L + + K L R LN
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL-PDFVKT-------LIGRFLNF 339
Query: 636 NGKKRPTMREV 646
+ ++R E
Sbjct: 340 DRRRRLLPLEA 350
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 43/302 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+ + ILGQG V++G + G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 434 RNVVKLLGC--CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+N+VKL T +L+ EF G+L +++ + + + L + DV G ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 492 YLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
+L I HR+IK NI+ D + K++DFGA+R + D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEY 181
Query: 548 LDPEYFQSS--------HFTEKSDVYSFGVVLVELLTGERPIR---------------LT 584
L P+ ++ + + D++S GV TG P R +T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 585 NSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR 644
D ++ + L G + + L + +K
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANILEADQEKCWGFD 298
Query: 645 EV 646
+
Sbjct: 299 QF 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-36
Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 29/282 (10%)
Query: 370 SNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEV 425
+ + + ++F +LG+G VY+ + G VA+K K + V+ NEV
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 426 VILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI 484
I Q+ H ++++L E + LV E NG +++Y+ ++ K F E R +
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARHFMH- 119
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
+ + YLHS I HRD+ +N+LL K++DFG + + + T + GT
Sbjct: 120 QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGT 175
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
Y+ PE S +SDV+S G + LL G P + ++ + + D
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF------DTDTVKNTLNKVVLAD- 228
Query: 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+E+ L KD L + L N R ++ V
Sbjct: 229 -YEM--PSFLSIEAKD-------LIHQLLRRNPADRLSLSSV 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 384 RILGQGGQGTVYKGMLEDGK------IVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
R LG+G G V+ + +VAVK K + ++F E +L+ + H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQY-------------IDDQNKDFRISWEMRLCIAI 484
K G C + + ++V+E++ +G L+++ + + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
++ + YL AS HRD+ + N L+ K+ DFG SR + + G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193
Query: 545 FGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
L PE FT +SDV+SFGV+L E+ T G++P +L+N+E
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 45/237 (18%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKI--------VAVKKSKIIDESKVEEFINEVVILS 429
++ N LGQG ++KG+ + V +K + E F ++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 430 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+++H+++V G C+ + +LV EF+ G+L Y+ + I+ +L +A ++ A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 490 ISYLHSAASIPIYHRDIKSTNILLD--------DKYCAKVSDFGASRSIAVDQTHLTTQV 541
+ +L I H ++ + NILL + K+SD G S ++
Sbjct: 126 MHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 542 QGTFGYLDP---------EYFQSSHFTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
+ E + + +D +SFG L E+ + G++P L +
Sbjct: 176 ----ILQERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-35
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 384 RILGQGGQGTVYKGMLEDGK----IVAVK--KSKIIDESKVEEFINEVVILSQINHRNVV 437
R +G+G G V++G+ + VA+K K+ D + E+F+ E + + Q +H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIV 454
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
KL+G E V ++ E + G L ++ Q + F + + A +S A++YL S
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
+ HRDI + N+L+ C K+ DFG SR + + ++ + ++ PE
Sbjct: 512 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 558 FTEKSDVYSFGVVLVELLT-GERP-IRLTNSE 587
FT SDV+ FGV + E+L G +P + N++
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 42/279 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F R LG+G G VY + I+A+K K+++ + EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
N+++L G + L+ E+ GT+ + + K + + +++ A+SY
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
HS + HRDIK N+LL K++DFG S+ + T GT YL PE
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLC-GTLDYLPPEM 178
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
+ EK D++S GV+ E L G+ P E + + R I +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANTYQETYKR---------ISRVE 223
Query: 613 I-----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ EG +D L R L N +RP +REV
Sbjct: 224 FTFPDFVTEGARD-------LISRLLKHNPSQRPMLREV 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 30/232 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGK------IVAVK--KSKIIDESKVEEFINEVVILS 429
N R LG G G VY+G + VAVK ++ + +F+ E +I+S
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIIS 88
Query: 430 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI----DDQNKDFRISWEMRLCIAID 485
+ NH+N+V+ +G L++ ++ E ++ G L ++ ++ ++ L +A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASRSIAVDQTHLTTQVQ 542
++ YL HRDI + N LL AK+ DFG +R I + +
Sbjct: 149 IACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RK 201
Query: 543 GTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPI-RLTNSE 587
G L PE F FT K+D +SFGV+L E+ + G P +N E
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/275 (21%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+ R LG+GG ++ + ++ A K KS ++ + E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRIS-WEMRLCIAIDVSGAIS 491
++VV G E + +V E +L + + ++ E R +
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQ 155
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLH + HRD+K N+ L++ K+ DFG + + D + GT Y+ PE
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+ + DV+S G ++ LL G+ P E L +LR + + + I
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETYLRIKKNE--YSI--P 261
Query: 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + L ++ L + RPT+ E+
Sbjct: 262 KHINPVAAS-------LIQKMLQTDPTARPTINEL 289
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 41/237 (17%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGK------IVAVKKSK-IIDESKVEEFINEVVILSQ 430
N + LG+G G V K K VAVK K S++ + ++E +L Q
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQY---------------------IDDQN 469
+NH +V+KL G C + LL+ E+ G+L + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 470 KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529
+ ++ + A +S + YL A + + HRD+ + NIL+ + K+SDFG SR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 530 IAVDQTHLTTQVQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+ + ++ V+ + G + E +T +SDV+SFGV+L E++T G P
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-34
Identities = 74/288 (25%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 366 KLFTSNELEKATDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEF 421
+F + +D + R+LG+G G V G+ AVK K ++ ++ E
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 422 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
+ EV +L Q++H N++KL + LV E + G L I + R S
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAAR 130
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHLT 538
I V I+Y+H I HRD+K N+LL+ K ++ DFG S + +
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186
Query: 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598
++ GT Y+ PE ++ EK DV+S GV+L LL+G P + +
Sbjct: 187 DKI-GTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFN------GANEYDILKK 238
Query: 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ FE+ + + E KD L ++ L R + R+
Sbjct: 239 VEKGKYTFELPQWKKVSESAKD-------LIRKMLTYVPSMRISARDA 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 64/295 (21%), Positives = 119/295 (40%), Gaps = 52/295 (17%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEE--FINEVVILSQI-N 432
T F+ +G G G+V+K + DG I A+K+SK V+E + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVSGAIS 491
H +VV+ E + L+ E+ + G+L+ I + + E L + + V +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 492 YLHSAASIPIYHRDIKSTNILLD-------------------DKYCAKVSDFGASRSIAV 532
Y+HS + + H DIK +NI + +K K+ D G I+
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 533 DQTHLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS 591
Q +G +L E Q ++ K+D+++ + +V E R +
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236
Query: 592 LAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+R+ RL I Q+L + + L K ++ + ++RP+ +
Sbjct: 237 -----WHEIRQGRLPRI--PQVLSQEFTE-------LLKVMIHPDPERRPSAMAL 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 60/275 (21%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+ R LG+GG ++ + ++ A K KS ++ + E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRIS-WEMRLCIAIDVSGAIS 491
++VV G E + +V E +L + + ++ E R +
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQ 129
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLH + HRD+K N+ L++ K+ DFG + + D + GT Y+ PE
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 185
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+ + DV+S G ++ LL G+ P E L +LR + + + I
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETYLRIKKNE--YSI--P 235
Query: 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + L ++ L + RPT+ E+
Sbjct: 236 KHINPVAAS-------LIQKMLQTDPTARPTINEL 263
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 384 RILGQGGQGTVYKGMLEDGK------IVAVK--KSKIIDESKVEEFINEVVILSQINHRN 435
R LG G G VY+G + VAVK ++ + +F+ E +I+S+ NH+N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQN 135
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYI----DDQNKDFRISWEMRLCIAIDVSGAIS 491
+V+ +G L++ ++ E ++ G L ++ ++ ++ L +A D++
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 492 YLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
YL HRDI + N LL AK+ DFG +R I + +G L
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAML 248
Query: 549 -----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPI-RLTNSE 587
PE F FT K+D +SFGV+L E+ + G P +N E
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 70/231 (30%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSK-IIDESKVEEFINEVVILSQ 430
D + LG+G G V + + VAVK K S+ ++E+ IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 431 I-NHRNVVKLLGCCLETEVPLLV-YEFISNGTLSQY-------------IDDQNKDFRIS 475
I +H NVV LLG C + PL+V EF G LS Y + ++
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 476 WEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535
E +C + V+ + +L AS HRD+ + NILL +K K+ DFG +R I D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 536 HLTTQVQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+ V+ L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 384 RILGQGGQGTVYKGMLEDGK---IVAVKKSK-IIDESKVEEFINEVVILSQI-NHRNVVK 438
++G+G G V K ++ A+K+ K + +F E+ +L ++ +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 439 LLGCCLETEVPLLVYEFISNGTLSQY-------------IDDQNKDFRISWEMRLCIAID 485
LLG C L E+ +G L + + +S + L A D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
V+ + YL + HRD+ + NIL+ + Y AK++DFG SR V V+ T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 200
Query: 546 GYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
G L E S +T SDV+S+GV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 42/283 (14%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN 435
+ + LG G G VYK E G + A K + E ++E++I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI---DVSGAISY 492
+VKLLG ++ EF G + + + ++ I + + A+++
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE- 551
LHS I HRD+K+ N+L+ + +++DFG S + + GT ++ PE
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 552 ----YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-LRAMREDRLF 606
+ + + K+D++S G+ L+E+ E P + L MR L
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP--------------HHELNPMRV--LL 232
Query: 607 EIL--DAQILKEGGK--DEFKMVAKLAKRCLNLNGKKRPTMRE 645
+I D L K EF+ K L+ N + RP+ +
Sbjct: 233 KIAKSDPPTLLTPSKWSVEFR---DFLKIALDKNPETRPSAAQ 272
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 352 QQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK-- 408
++ L +F +++ ++ + + LG G G V A+K
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 409 -KSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDD 467
K+ + + + EV +L ++H N++KL + LV E G L I
Sbjct: 71 RKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 468 QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDF 524
+ + + I V ++YLH I HRD+K N+LL+ K K+ DF
Sbjct: 130 RM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLT 584
G S + + ++ GT Y+ PE + + EK DV+S GV+L LL G P
Sbjct: 184 GLSAVFENQKK-MKERL-GTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPF--- 237
Query: 585 NSEEDKSLAAYFLRAMREDRLFE-ILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKK 639
+ + + + + E+K V++ AK + L + ++
Sbjct: 238 -------------GGQTDQEILRKVEKGKYTFDS--PEWKNVSEGAKDLIKQMLQFDSQR 282
Query: 640 RPTMREV 646
R + ++
Sbjct: 283 RISAQQA 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-33
Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 50/299 (16%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNV 436
+ + +ILG G GTV G+ VAV K + + + E+ +L++ +H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAV---KRMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 437 VKLLGCCLETEVPL-LVYEFISNGTLSQYI---DDQNKDFRISWEMRLCIAI-DVSGAIS 491
++ C T+ L + E N L + + +++ ++ E + ++ ++
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYC-------------AKVSDFGASRSIAVDQTHLT 538
+LH S+ I HRD+K NIL+ +SDFG + + Q+
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 539 TQVQ---GTFGYLDPEYFQSSHF-------TEKSDVYSFGVVLVELLT-GERPIRLTNSE 587
T + GT G+ PE + S+ T D++S G V +L+ G+ P S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E + F D + + D ++ E D L + ++ + KRPT +V
Sbjct: 247 ESNIIRGIF----SLDEMKCLHDRSLIAE-ATD-------LISQMIDHDPLKRPTAMKV 293
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 384 RILGQGGQGTVYKGMLEDGK------IVAVK--KSKIIDESKVEEFINEVVILSQINHRN 435
LG+ G VYKG L VA+K K K + EEF +E ++ +++ H N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPN 73
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQY-------------IDDQNKDFRISWEMRLCI 482
VV LLG + + +++ + S+G L ++ DD+ + + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542
++ + YL +S + H+D+ + N+L+ DK K+SD G R + +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL---- 186
Query: 543 GTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
L PE F+ SD++S+GVVL E+ + G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 384 RILGQGGQGTVYKGMLEDGK------IVAVKKSK-IIDESKVEEFINEVVILSQINHRNV 436
R +G+G G V++ +VAVK K +F E ++++ ++ N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQY---------------------IDDQNKDFRIS 475
VKLLG C + L++E+++ G L+++ +S
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 476 WEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535
+LCIA V+ ++YL + HRD+ + N L+ + K++DFG SR+I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 536 HLTTQVQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+ + PE + +T +SDV+++GVVL E+ + G +P
Sbjct: 230 Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGML--------EDGKIVAVKKSK-IIDESKVEEFINEVVIL 428
D + LG+G G V ++ VAVK K E + + ++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 429 SQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQY-------------IDDQNKDFRI 474
I H+N++ LLG C + ++ E+ S G L +Y ++ + ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534
+++ + ++ + YL AS HRD+ + N+L+ + K++DFG +R I
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 535 THLTTQVQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+ + T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 212 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 75/278 (26%), Positives = 123/278 (44%), Gaps = 39/278 (14%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN 435
++ +G+G G V G+ VAVK + + + E NEVVI+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
VV++ L E ++ EF+ G L+ D R++ E + V A++YLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRDIKS +ILL K+SDFG I+ D + V GT ++ PE
Sbjct: 160 QGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF----LRAMREDRLFEILDA 611
S + + D++S G++++E++ GE P YF ++A + + D+
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP--------------YFSDSPVQA-----MKRLRDS 256
Query: 612 QI--LKEGGK--DEFKMVAKLAKRCLNLNGKKRPTMRE 645
LK K + +R L + ++R T +E
Sbjct: 257 PPPKLKNSHKVSPVLR---DFLERMLVRDPQERATAQE 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 39/278 (14%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN 435
+ +GQG GTVY M + G+ VA+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+V L L + +V E+++ G+L+ D + + + + A+ +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRDIKS NILL K++DFG I +Q+ +T V GT ++ PE
Sbjct: 135 NQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF----LRAMREDRLFEILDA 611
+ K D++S G++ +E++ GE P Y LRA L+ I
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP--------------YLNENPLRA-----LYLIATN 231
Query: 612 QI--LKEGGK--DEFKMVAKLAKRCLNLNGKKRPTMRE 645
L+ K F+ RCL ++ +KR + +E
Sbjct: 232 GTPELQNPEKLSAIFR---DFLNRCLEMDVEKRGSAKE 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 78/290 (26%), Positives = 129/290 (44%), Gaps = 41/290 (14%)
Query: 366 KLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID-ESKVEEFIN 423
KL + ++ + F+ LG+G G+VYK + E G+IVA+K + ES ++E I
Sbjct: 17 KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK---QVPVESDLQEIIK 73
Query: 424 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIA 483
E+ I+ Q + +VVK G + +V E+ G++S I +NK IA
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IA 128
Query: 484 I---DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+ YLH I HRDIK+ NILL+ + AK++DFG + + T
Sbjct: 129 TILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-LRA 599
+ GT ++ PE Q + +D++S G+ +E+ G+ P Y +
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP--------------YADIHP 230
Query: 600 MREDRLFEI--LDAQILKEGGK--DEFKMVAKLAKRCLNLNGKKRPTMRE 645
MR +F I ++ D F K+CL + ++R T +
Sbjct: 231 MRA--IFMIPTNPPPTFRKPELWSDNFT---DFVKQCLVKSPEQRATATQ 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGML--------EDGKIVAVKKSK-IIDESKVEEFINEVVIL 428
D + LG+G G V ++ VAVK K E + + ++E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 429 SQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQY-------------IDDQNKDFRI 474
I H+N++ LLG C + ++ E+ S G L +Y ++ + ++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534
+++ + ++ + YL AS HRD+ + N+L+ + K++DFG +R I
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 535 THLTTQVQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+ + T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 258 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 67/269 (24%), Positives = 114/269 (42%), Gaps = 32/269 (11%)
Query: 337 KLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYK 396
K K K + +++ ++ ID T+L + + E +N + LG G G V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 397 GML------EDGKIVAVKKSK-IIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV 448
+ VAVK K + E ++E+ I+S + H N+V LLG C
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 449 PLLVYEFISNGTLSQY-----------IDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
L++ E+ G L + + S L + V+ +++L A
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---A 181
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL-----DPEY 552
S HRD+ + N+LL + + AK+ DFG +R I D + + L PE
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNARLPVKWMAPES 237
Query: 553 FQSSHFTEKSDVYSFGVVLVELLT-GERP 580
+T +SDV+S+G++L E+ + G P
Sbjct: 238 IFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D+F+ R LG+G G VY ++ I+A+K KS++ E + E+ I S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRIS-WEMRLCIAIDVSGAIS 491
N++++ + L+ EF G L + + K R + +++ A+
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME-ELADALH 128
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
Y H + HRDIK N+L+ K K++DFG S+ T GT YL PE
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRTMC-GTLDYLPPE 182
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+ EK D++ GV+ E L G P + S R + D F
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPF------DSPSHTETHRRIVNVDLKF----P 232
Query: 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L +G KD L + L + +R ++ V
Sbjct: 233 PFLSDGSKD-------LISKLLRYHPPQRLPLKGV 260
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 67/272 (24%), Positives = 109/272 (40%), Gaps = 36/272 (13%)
Query: 338 LKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKG 397
H + G+ + +L E D + LG+G G V
Sbjct: 29 HHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLA 88
Query: 398 ML--------EDGKIVAVKKSK-IIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 447
VAVK K E + + I+E+ ++ I H+N++ LLG C +
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148
Query: 448 VPLLVYEFISNGTLSQY-------------IDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
++ E+ S G L +Y N + ++S + + A V+ + YL
Sbjct: 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL- 207
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL-----D 549
AS HRD+ + N+L+ + K++DFG +R I + + T G L
Sbjct: 208 --ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMA 261
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
PE +T +SDV+SFGV+L E+ T G P
Sbjct: 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 49/302 (16%)
Query: 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIID-------- 414
++ + K +++ R LG G G V A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 415 --ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF 472
E EE NE+ +L ++H N++KL + + LV EF G L + I +++
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--- 141
Query: 473 RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRS 529
+ I + I YLH I HRDIK NILL++K K+ DFG S
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
+ D L ++ GT Y+ PE + + EK DV+S GV++ LL G P
Sbjct: 199 FSKDYK-LRDRL-GTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPP--------- 246
Query: 590 KSLAAYFLRAMREDRLFE-ILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMR 644
F + + + + + + +++K ++ AK L + KR T
Sbjct: 247 ------F-GGQNDQDIIKKVEKGKYYFDF--NDWKNISDEAKELIKLMLTYDYNKRCTAE 297
Query: 645 EV 646
E
Sbjct: 298 EA 299
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 63/295 (21%), Positives = 119/295 (40%), Gaps = 43/295 (14%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLG 441
R+L +GG VY+ + G+ A+K+ +E K I EV + ++ H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 442 CCLETEVP-------LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
+ L+ + G L +++ +S + L I A+ ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ-----------G 543
PI HRD+K N+LL ++ K+ DFG++ +I+ + + +
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 544 TFGYLDPEYFQS-SHF--TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
T Y PE S+F EK D+++ G +L L + P ED +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF------EDGAKLR------ 260
Query: 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655
I++ + ++ + L + L +N ++R ++ EV +L I
Sbjct: 261 -------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 47/284 (16%), Positives = 93/284 (32%), Gaps = 28/284 (9%)
Query: 351 LQQELSSNEGGIDKT----KLFTSNELEKATDNFNTNRILGQGGQGTVYKGM------LE 400
L + +SS + + E + + + +LG+G VY+ +
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 401 DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 460
+ + +K K + + + L +K L +LV E S GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 461 LSQYIDD--QNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518
L I+ + + + + A+ + I +H I H DIK N +L + +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210
Query: 519 A-----------KVSDFGASRSIAV-DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYS 566
+ D G S + + + + T T G+ E + + + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 567 FGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
+ +L G +++ N + F R D E
Sbjct: 271 VAATVYCMLFGT-YMKVKNEGGECKPEGLFRRLPHLDMWNEFFH 313
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 384 RILGQGGQGTVYKGML------EDGKIVAVKKSK-IIDESKVEEFINEVVILSQI-NHRN 435
+ LG G G V + + VAVK K ++ E ++E+ +LS + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMR---------------L 480
+V LLG C L++ E+ G L ++ + F S L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+ V+ +++L AS HRD+ + NILL K+ DFG +R I D +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---- 201
Query: 541 VQGTFGYL-----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
V L PE + +T +SDV+S+G+ L EL + G P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 38/277 (13%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID----ESKVEEFINEVVILSQI 431
+ F +G+G G V+KG+ K+VA+K IID E ++E+ E+ +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQC 77
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
+ V K G L+ ++ E++ G+ D + + I ++ +
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
YLHS I HRDIK+ N+LL + K++DFG + + Q T V GT ++ PE
Sbjct: 134 YLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL-- 609
+ S + K+D++S G+ +EL GE P +SE M+ LF I
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP----HSELH---------PMKV--LFLIPKN 234
Query: 610 DAQILKEGGKDEFK-MVAKLAKRCLNLNGKKRPTMRE 645
+ L+ K V CLN RPT +E
Sbjct: 235 NPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKE 267
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 41/278 (14%)
Query: 337 KLKHKFFKRNGGLLLQQELSSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYK 396
K + ++ + + + + +D + + E +N ++LG G G V
Sbjct: 4 KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMN 63
Query: 397 GMLEDGK------IVAVKKSK-IIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV 448
VAVK K D S+ E ++E+ +++Q+ +H N+V LLG C +
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 449 PLLVYEFISNGTLSQY--------------------IDDQNKDFRISWEMRLCIAIDVSG 488
L++E+ G L Y ++++ +++E LC A V+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+ +L HRD+ + N+L+ K+ DFG +R I D + V L
Sbjct: 184 GMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARL 236
Query: 549 -----DPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
PE +T KSDV+S+G++L E+ + G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 42/283 (14%)
Query: 377 TDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
+ +N +LG+G G V K + AVK K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLD 79
Query: 433 HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
H N++KL E +V E + G L I + R S I V I+
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGIT 135
Query: 492 YLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
Y+H I HRD+K NILL+ K K+ DFG S + + ++ GT Y+
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYI 190
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE- 607
PE + ++ EK DV+S GV+L LL+G P F E + +
Sbjct: 191 APEVLRGTY-DEKCDVWSAGVILYILLSGTPP---------------F-YGKNEYDILKR 233
Query: 608 ILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ + + +++ ++ AK + L + R T +
Sbjct: 234 VETGKYAFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 73/295 (24%), Positives = 124/295 (42%), Gaps = 52/295 (17%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIID----ESKVEEFINEVVILSQIN 432
D++ ++G G V + VA+K I+ ++ ++E + E+ +SQ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCH 71
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM--RLCIAI---DVS 487
H N+V + + LV + +S G++ I + IA +V
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF-G 546
+ YLH I HRD+K+ NILL + +++DFG S +A +V+ TF G
Sbjct: 132 EGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 547 ---YLDPEYF-QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602
++ PE Q + K+D++SFG+ +EL TG P + M+
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP----YHKYP---------PMKV 235
Query: 603 DRLFEIL--DAQILKEGGKD---------EFK-MVAKLAKRCLNLNGKKRPTMRE 645
L L D L+ G +D F+ M++ CL + +KRPT E
Sbjct: 236 --LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAE 284
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 66/302 (21%), Positives = 119/302 (39%), Gaps = 45/302 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVK-----------------KSKIIDESKVEE 420
+++ R L QG + +D K A+K KI +SK ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 421 FINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYID-----DQNKDFRI 474
F NE+ I++ I + + G + + ++YE++ N ++ ++ + D+N I
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534
++ CI V + SY+H+ +I HRD+K +NIL+D K+SDFG S +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEY--MVD 204
Query: 535 THLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSL 592
+ GT+ ++ PE+F + S+ K D++S G+ L + P SL
Sbjct: 205 KKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-----SLKISL 258
Query: 593 AAYFLRAMRED-------RLFEILDAQILKEGGKDEFKMVAK-LAKRCLNLNGKKRPTMR 644
F ++ F + K L N +R T
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 645 EV 646
+
Sbjct: 319 DA 320
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 34/309 (11%), Positives = 83/309 (26%), Gaps = 76/309 (24%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQI-------- 431
+LGQ + E G+ V ++ + +++ EV+ L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 432 -----------------NHRNVVKLLGCCLETEVPLLVYEF-ISNGTLSQYIDD----QN 469
+ ++++ + V + + L + + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 470 KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529
+ RL + + V ++ LH + H ++ +I+LD + ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 530 IAVDQTHLTTQVQGTFGYLDPEYFQS-----------SHFTEKSDVYSFGVVLVELLTGE 578
+ G+ PE + T D ++ G+V+ + +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 579 RPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEF-KMVAKLAKRCLNLNG 637
P I + + V L + L
Sbjct: 311 LP---------------I-----TKDAALGGSEWIFR--SCKNIPQPVRALLEGFLRYPK 348
Query: 638 KKRPTMREV 646
+ R +
Sbjct: 349 EDRLLPLQA 357
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 61/339 (17%), Positives = 110/339 (32%), Gaps = 91/339 (26%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFI-NEVVILSQINHRN 435
+F + +G+GG G V++ D A+K+ ++ + E + EV L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWE------------------ 477
+V+ LET E + D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 478 --------------MRLC-------------------------IAIDVSGAISYLHSAAS 498
M+LC I I ++ A+ +LHS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 499 IPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ-----------GTFGY 547
+ HRD+K +NI KV DFG ++ D+ T GT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
+ PE ++++ K D++S G++L ELL F M R+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS------------------FSTQMERVRIIT 284
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ ++ + + L+ + +RP ++
Sbjct: 285 DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 74/316 (23%), Positives = 124/316 (39%), Gaps = 58/316 (18%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSK 411
S G L +++ D + ++G+G V + + E G+ AVK +K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 412 IIDESK--VEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQ 468
E+ E I + H ++V+LL ++ L +V+EF+ L I +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 469 NKDFRISWE------MRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA--- 519
+ E MR + A+ Y H I HRD+K +LL K +
Sbjct: 121 ADAGFVYSEAVASHYMR-----QILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPV 172
Query: 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGER 579
K+ FG + + +V GT ++ PE + + + DV+ GV+L LL+G
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
Query: 580 PIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK---- 630
P T +RLFE I+K GK ++ +++ AK
Sbjct: 232 PFYGTK-----------------ERLFE----GIIK--GKYKMNPRQWSHISESAKDLVR 268
Query: 631 RCLNLNGKKRPTMREV 646
R L L+ +R T+ E
Sbjct: 269 RMLMLDPAERITVYEA 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 78/332 (23%), Positives = 136/332 (40%), Gaps = 50/332 (15%)
Query: 350 LLQQELSSNEGGIDKTKLFTSNELEKAT-DNFNTNRILGQGGQGTVYKGML-EDGKIVAV 407
L + EL + + L ++ + D+F LG G G V+K G ++A
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 408 KKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYID 466
K + I + + I E+ +L + N +V G + E + G+L D
Sbjct: 64 KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----D 119
Query: 467 DQNKDFRISWEMRL-CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525
K E L ++I V ++YL I HRD+K +NIL++ + K+ DFG
Sbjct: 120 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFG 177
Query: 526 AS----RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
S S+A + V GT Y+ PE Q +H++ +SD++S G+ LVE+ G PI
Sbjct: 178 VSGQLIDSMA------NSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
Query: 582 RLTNSEEDKSLAAYFLRAMREDR-----------------------LFEILDAQILKEG- 617
+++E + + + + +FE+LD I+ E
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD-YIVNEPP 289
Query: 618 ---GKDEFKMVAK-LAKRCLNLNGKKRPTMRE 645
F + + +CL N +R +++
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 47/283 (16%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK---VEEFINEVVILSQIN 432
F+ R +G G G VY + + ++VA+KK + ++ I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI---DVSGA 489
H N ++ GC L LV E+ G+ S ++ K + E + IA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ---E--VEIAAVTHGALQG 166
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
++YLHS I HRD+K+ NILL + K+ DFG++ +A + GT ++
Sbjct: 167 LAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMA 218
Query: 550 PE---YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-LRAMREDRL 605
PE + K DV+S G+ +EL + P F + AM L
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--------------LFNMNAMSA--L 262
Query: 606 FEI--LDAQILKEGG-KDEFKMVAKLAKRCLNLNGKKRPTMRE 645
+ I ++ L+ G + F+ CL + RPT
Sbjct: 263 YHIAQNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEV 302
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 377 TDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
+ +N +LG+G G V K + AVK K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
H N++KL ++ +V E + G L I + + S I V I+Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITY 136
Query: 493 LHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+H I HRD+K NILL+ K K+ DFG S + + ++ GT Y+
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIA 191
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
PE + ++ EK DV+S GV+L LL+G P F E + +
Sbjct: 192 PEVLRGTY-DEKCDVWSAGVILYILLSGTPP---------------F-YGKNEYDILK-- 232
Query: 610 DAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
++ GK +++ ++ AK + L + R T +
Sbjct: 233 --RVET--GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 32/305 (10%), Positives = 78/305 (25%), Gaps = 69/305 (22%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQ--------- 430
+LGQ + E G+ V ++ + +++ EV+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 431 -------------INHRNVVKLLGCCLETEVPLLVYEFI-------SNGTLSQYIDDQNK 470
+ K++ L+ ++ F + T + + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 471 -DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529
+ RL + + V ++ LH + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 530 IAVDQTHLTTQVQGTFGYLDPE-----YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLT 584
+ + T D ++ G+ + + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 585 NSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKM---VAKLAKRCLNLNGKKRP 641
I + + V L + L + R
Sbjct: 317 -----------NTDDAALGGSEWIF---------RSCKNIPQPVRALLEGFLRYPKEDRL 356
Query: 642 TMREV 646
+
Sbjct: 357 LPLQA 361
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 48/287 (16%)
Query: 377 TDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
D F R LG G G V+ G +K K + + +E+ E+ +L ++
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78
Query: 433 HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYI-DDQNKDFRISWEMRLCIAIDVSGAI 490
H N++K+ E + +V E G L + I Q + +S + + A+
Sbjct: 79 HPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
+Y HS + H+D+K NIL D K+ DFG + D+ T GT Y
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTALY 192
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
+ PE F+ T K D++S GVV+ LLTG P F + + +
Sbjct: 193 MAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLP---------------F-TGTSLEEVQQ 235
Query: 608 ILDAQILKEGGK----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ + E + + A + L + ++RP+ +V
Sbjct: 236 ----KATY--KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 75/291 (25%), Positives = 116/291 (39%), Gaps = 60/291 (20%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
F +LG G V+ GK+ A+K KS +S +E NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 433 HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRLCIAIDVS 487
H N+V L E+ LV + +S G L I ++ KD + V
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVL 116
Query: 488 GAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
A+ YLH I HRD+K N+L ++ ++DFG S+ ++T GT
Sbjct: 117 SAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
GY+ PE +++ D +S GV+ LL G P F E +
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP---------------F-YEETESK 214
Query: 605 LFEILDAQILKEGGKDEF-----KMVAKLAK----RCLNLNGKKRPTMREV 646
LFE +I + G EF +++ AK L + +R T +
Sbjct: 215 LFE----KIKE--GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 41/285 (14%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILS 429
D ++ LG G G V++ + G++ K +D NE+ I++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMN 103
Query: 430 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI-DVS 487
Q++H ++ L E + + L+ EF+S G L I +D+++S E + +
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAA--EDYKMS-EAEVINYMRQAC 159
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTF 545
+ ++H + I H DIK NI+ + K + K+ DFG + + + + T
Sbjct: 160 EGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATA 214
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
+ PE +D+++ GV+ LL+G P F + L
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGEDDLETL 259
Query: 606 FEILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ E +D F V+ AK L +KR T+ +
Sbjct: 260 QNVKRCDW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 52/290 (17%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILS 429
+ +G+G G V A K K + D + + E+ I+
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMK 61
Query: 430 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG 488
++H N+++L E + LV E + G L + + + I DV
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLS 117
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
A++Y H + HRD+K N L K+ DFG + + + T+V GT
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTP 172
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
Y+ P+ + + + D +S GV++ LL G P F A + +
Sbjct: 173 YYVSPQVLEGLY-GPECDEWSAGVMMYVLLCGYPP---------------F-SAPTDSEV 215
Query: 606 FEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+I + G ++ V+ A+ R L + K+R T +
Sbjct: 216 ML----KIRE--GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 45/290 (15%)
Query: 373 LEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEV-VILS 429
+E D+ LG+G G V K + G+I+AVK+ ++ + + + ++ + +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 430 QINHRNVVKLLGCCL-ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLC-IAIDVS 487
++ V G E +V + E + Y +K I E L IA+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIP-EDILGKIAVSIV 119
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS----RSIAVDQTHLTTQVQG 543
A+ +LHS S+ I HRD+K +N+L++ K+ DFG S +A G
Sbjct: 120 KALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-----KDIDA-G 171
Query: 544 TFGYLDPE----YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599
Y+ PE ++ KSD++S G+ ++EL P + +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--------- 222
Query: 600 MREDRLFEIL--DAQILKEGG-KDEFK-MVAKLAKRCLNLNGKKRPTMRE 645
L +++ + L EF ++ CL N K+RPT E
Sbjct: 223 -----LKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 263
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 71/287 (24%), Positives = 114/287 (39%), Gaps = 49/287 (17%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
+DN++ LG+G V + + G A K K+ ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQ 63
Query: 433 HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
H N+V+L + E LV++ ++ G L + I + S + +I+
Sbjct: 64 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIA 119
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
Y HS I HR++K N+LL K K++DFG + + D GT GYL
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTPGYL 174
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
PE + +++ D+++ GV+L LL G P F + RL+
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP---------------F-WDEDQHRLYA- 217
Query: 609 LDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
QI G E+ V AK L +N KKR T +
Sbjct: 218 ---QIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 68/305 (22%), Positives = 125/305 (40%), Gaps = 41/305 (13%)
Query: 356 SSNEGGIDKTKLFTSNELEKAT-DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI- 412
SS G L + +A ++ +G G G V+K + G ++AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 413 IDESKVEEFINEV-VILSQINHRNVVKLLGCCL-ETEVPLLVYEFISNGTLSQYIDDQNK 470
++ + + + ++ V+L + +V+ G + T+V + E + Q
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQG- 119
Query: 471 DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530
I + + + + A+ YL + I HRD+K +NILLD++ K+ DFG S +
Sbjct: 120 --PIPERILGKMTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 531 AVDQTHLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTN 585
VD G Y+ PE + ++DV+S G+ LVEL TG+ P +
Sbjct: 176 -VDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233
Query: 586 SEEDKSLAAYFLRAMREDRLFEIL--DAQILKEGGK--DEFK-MVAKLAKRCLNLNGKKR 640
++ L ++L + +L +F+ V CL + +KR
Sbjct: 234 TD------------FEV--LTKVLQEEPPLLPGHMGFSGDFQSFVKD----CLTKDHRKR 275
Query: 641 PTMRE 645
P +
Sbjct: 276 PKYNK 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 46/287 (16%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK--VEEFINEVVILSQ 430
++ + + LG+G G V++ + K K + E+ IL+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK---FVKVKGTDQVLVKKEISILNI 57
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDV 486
HRN++ L E+ L +++EFIS + + I+ + I + V
Sbjct: 58 ARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QV 111
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGT 544
A+ +LHS I H DI+ NI+ + + K+ +FG +R +
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TA 166
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
Y PE Q + +D++S G ++ LL+G P FL A +
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FL-AETNQQ 210
Query: 605 LFE-ILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ E I++A+ ++ FK ++ A R L K R T E
Sbjct: 211 IIENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 71/282 (25%), Positives = 106/282 (37%), Gaps = 54/282 (19%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN----EVVILSQINHRNVVK 438
+ LG+G G V + + VAVK I+D + + E+ I +NH NVVK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 439 LLGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFR--ISWEMRLCIAIDVS 487
G L E+ S G L I D + F ++
Sbjct: 70 FYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA------------ 116
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT--HLTTQVQGTF 545
+ YLH I HRDIK N+LLD++ K+SDFG + + L GT
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTL 171
Query: 546 GYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
Y+ PE + F E DV+S G+VL +L GE P + S Y ++
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKK-- 225
Query: 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + + L + L N R T+ ++
Sbjct: 226 -TYLNPWKKIDSAPLA-------LLHKILVENPSARITIPDI 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 31/280 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI-IDESKVEEFINEV-VILSQINHR 434
++ +G+G G+V K + G+I+AVK+ + +DE + ++ + ++ V++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 435 NVVKLLGCCL-ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRL-CIAIDVSGAISY 492
+V+ G E + + E +S Y + + E L I + A+++
Sbjct: 82 YIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
L I HRDIK +NILLD K+ DFG S + VD T G Y+ PE
Sbjct: 141 LKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPER 196
Query: 553 FQSSH----FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
S + +SDV+S G+ L EL TG P NS L ++
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---------VFDQ-----LTQV 242
Query: 609 L--DAQILKEGGKDEFKMVAK-LAKRCLNLNGKKRPTMRE 645
+ D L + EF CL + KRP +E
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-27
Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 52/289 (17%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESK-----VEEFINEVVILSQ 430
T+ + LG+G V + + + G+ A II+ K ++ E I
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKLEREARICRL 66
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ H N+V+L E L+++ ++ G L + I + S + A
Sbjct: 67 LKHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEA 122
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCA---KVSDFGASRSIAVDQTHLTTQVQGTFG 546
+ + H + HR++K N+LL K K++DFG + + +Q GT G
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
YL PE + + + D+++ GV+L LL G P F + RL+
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP---------------F-WDEDQHRLY 222
Query: 607 EILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ QI G E+ V AK + L +N KR T E
Sbjct: 223 Q----QIKA--GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 68/294 (23%), Positives = 112/294 (38%), Gaps = 54/294 (18%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKII-----DESKVEEFINEVVI 427
D + ++ LG G G V + K VA++ K K + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 428 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVS 487
L ++NH ++K+ + E +V E + G L + + + +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQML 249
Query: 488 GAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
A+ YLH I HRD+K N+LL ++ K++DFG S+ + + + + T GT
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GT 304
Query: 545 FGYLDPEYFQSSHF---TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
YL PE S D +S GV+L L+G P F
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSEHRT 349
Query: 602 EDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ L + QI GK + + V++ A + L ++ K R T E
Sbjct: 350 QVSLKD----QITS--GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 33/284 (11%)
Query: 369 TSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINE 424
+ + + N+ + +G+G V + G+ VA+K K+++ + + +++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFRE 64
Query: 425 VVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIA 483
V I+ +NH N+VKL +ETE L L+ E+ S G + Y+ R+ +
Sbjct: 65 VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKF 120
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG 543
+ A+ Y H I HRD+K+ N+LLD K++DFG S V L G
Sbjct: 121 RQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-G 175
Query: 544 TFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602
Y PE FQ + + DV+S GV+L L++G P + ++L R +R
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF------DGQNLKELRERVLRG 229
Query: 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ I + ++ L KR L LN KR T+ ++
Sbjct: 230 K--YRI--PFYMSTDCEN-------LLKRFLVLNPIKRGTLEQI 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 47/212 (22%), Positives = 79/212 (37%), Gaps = 25/212 (11%)
Query: 386 LGQGGQ--GTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLL 440
+G+G + TV G+ V V++ + V E+ + NH N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMR-LCIAI---DVSGAISYLHSA 496
+ +V F++ G+ I D M L IA V A+ Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMD-----GMNELAIAYILQGVLKALDYIHHM 147
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ------GTFGYLDP 550
+ HR +K+++IL+ +S ++ S+ +L P
Sbjct: 148 GYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 551 EYFQSSH--FTEKSDVYSFGVVLVELLTGERP 580
E Q + + KSD+YS G+ EL G P
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 47/283 (16%)
Query: 382 TNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKL 439
++ LG+G K + + + AVK II + E+ L H N+VKL
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQN----KDFRISWEMRLCIAIDVSGAISYLHS 495
+ LV E ++ G L + I + + S+ MR + A+S++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE--ASYIMR-----KLVSAVSHMHD 124
Query: 496 AASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
+ HRD+K N+L D+ K+ DFG +R D L T T Y PE
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPEL 180
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
+ + E D++S GV+L +L+G+ P + + + A EI+ +
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV------------EIMK-K 227
Query: 613 ILKEGGKDEF-----KMVAKLAK----RCLNLNGKKRPTMREV 646
I K G F K V++ AK L ++ KR M +
Sbjct: 228 IKK--GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 69/295 (23%), Positives = 111/295 (37%), Gaps = 60/295 (20%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESK---VEEFINEVVILS 429
D++ LG G V K GK A K K ++ + EE EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 430 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRLCIAI 484
+I H N++ L E + + L+ E +S G L ++ ++ + + ++
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDE--ATQFLK----- 115
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA----KVSDFGASRSIAVDQTHLTTQ 540
+ + YLHS I H D+K NI+L DK K+ DFG + I
Sbjct: 116 QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNI 171
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 172 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL-GE 214
Query: 601 REDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ I + F ++LAK R L + K+R T+ +
Sbjct: 215 TKQETLT----NISA--VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 55/287 (19%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHR 434
+ ILG G G V+K G +A K + D EE NE+ +++Q++H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146
Query: 435 NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDVSGAI 490
N+++L E++ + LV E++ G L I D++ + M+ + I
Sbjct: 147 NLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-----QICEGI 200
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
++H I H D+K NIL ++ K+ DFG +R + L GT +L
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFL 255
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
PE + +D++S GV+ LL+G P FL +
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP---------------FL-GDNDAETLN- 298
Query: 609 LDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
IL + +EF+ +++ AK + L R + E
Sbjct: 299 ---NILA--CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 73/351 (20%), Positives = 117/351 (33%), Gaps = 86/351 (24%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSK 411
+ + F L + ++ +GQG G V + + I A+K K+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 412 I--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQN 469
I I+ VE EV ++ +++H N+ +L + + LV E G L ++
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 470 KDFRISWEMRLC-------------------------------------IAIDVSGAISY 492
D M + I + A+ Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAV----DQTHLTTQVQGTFG 546
LH+ I HRDIK N L K+ DFG S+ + +TT+ GT
Sbjct: 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPY 239
Query: 547 YLDPE--YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
++ PE + + K D +S GV+L LL G P F + +
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP---------------F-PGVNDAD 283
Query: 605 LFEILDAQILKEGGKDEFKM--------VAK-LAKRCLNLNGKKRPTMREV 646
Q+L K F+ +A+ L LN N +R
Sbjct: 284 TIS----QVLN--KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 70/294 (23%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESK---VEEFINEVV 426
E D ++T LG G V K G A K K + + E+ EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRLC 481
IL +I H NV+ L E + + L+ E ++ G L ++ ++ ++ + ++
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEE--ATEFLK-- 121
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA----KVSDFGASRSIAVDQTHL 537
+ + YLHS I H D+K NI+L D+ K+ DFG + I D +
Sbjct: 122 ---QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNE 173
Query: 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597
+ GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 218
Query: 598 RAMREDRLFE-ILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ + E + F + LAK R L + KKR T+++
Sbjct: 219 -GDTKQETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 60/298 (20%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESK---VEEFINEVV 426
+K D ++ LG G V K G A K K + + EE EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRLC 481
IL Q+ H NV+ L E + L+ E +S G L ++ + ++ + ++
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEE--ATSFIK-- 122
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA----KVSDFGASRSIAVDQTHL 537
+ ++YLH+ I H D+K NI+L DK K+ DFG + I +
Sbjct: 123 ---QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597
+ GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 598 RAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ I + F ++LAK + L +KR T++E
Sbjct: 220 -GDTKQETLA----NITS--VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 74/308 (24%), Positives = 120/308 (38%), Gaps = 49/308 (15%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSK 411
+ + + F N K +DN++ LG+G V + + G A K K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 412 IIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNK 470
+ ++ E I ++ H N+V+L + E LV++ ++ G L + I +
Sbjct: 67 LSARD-FQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 471 DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA---KVSDFGAS 527
S + +I+Y HS I HR++K N+LL K K++DFG +
Sbjct: 125 ---YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587
+ D GT GYL PE + +++ D+++ GV+L LL G P
Sbjct: 179 IEVN-DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP------- 229
Query: 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGK 638
F + RL+ QI G E+ V AK L +N K
Sbjct: 230 --------F-WDEDQHRLYA----QIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPK 274
Query: 639 KRPTMREV 646
KR T +
Sbjct: 275 KRITADQA 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 52/291 (17%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHR 434
F ++G G G VYKG ++ G++ A+K + + EE E+ +L + +HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 435 NVVKLLGCCLETEVPL------LVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAI--- 484
N+ G ++ P LV EF G+++ I + + + W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
++ +S+LH I HRDIK N+LL + K+ DFG S + T + GT
Sbjct: 137 EILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 192
Query: 545 FGYLDPEYFQSSHFTE-----KSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF-LR 598
++ PE + KSD++S G+ +E+ G P +
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--------------LCDMH 238
Query: 599 AMREDRLFEIL--DAQILKEGG-KDEFKM-VAKLAKRCLNLNGKKRPTMRE 645
MR LF I A LK +F+ + CL N +RP +
Sbjct: 239 PMRA--LFLIPRNPAPRLKSKKWSKKFQSFIES----CLVKNHSQRPATEQ 283
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 59/284 (20%), Positives = 105/284 (36%), Gaps = 39/284 (13%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN 432
+ D+++ + LG G G V++ G A K ES E E+ +S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 433 HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDF---RISWEMRLCIAIDVSG 488
H +V L E + + ++YEF+S G L + + D++ MR V
Sbjct: 213 HPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-----QVCK 266
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTFG 546
+ ++H H D+K NI+ K K+ DFG + + D GT
Sbjct: 267 GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAE 321
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
+ PE + +D++S GV+ LL+G P F ++ L
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---------------FGGENDDETLR 366
Query: 607 EILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ + F +++ K + L + R T+ +
Sbjct: 367 NVKSCDWNMDD--SAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/282 (25%), Positives = 106/282 (37%), Gaps = 54/282 (19%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN----EVVILSQINHRNVVK 438
+ LG+G G V + + VAVK I+D + + E+ I +NH NVVK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 439 LLGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFR--ISWEMRLCIAIDVS 487
G L E+ S G L I D + F ++
Sbjct: 70 FYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA------------ 116
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT--HLTTQVQGTF 545
+ YLH I HRDIK N+LLD++ K+SDFG + + L GT
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTL 171
Query: 546 GYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604
Y+ PE + F E DV+S G+VL +L GE P + S Y ++
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKK-- 225
Query: 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + + L + L N R T+ ++
Sbjct: 226 -TYLNPWKKIDSAPLA-------LLHKILVENPSARITIPDI 259
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 68/298 (22%), Positives = 113/298 (37%), Gaps = 60/298 (20%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESK---VEEFINEVV 426
+K D ++ LG G V K G A K K + + EE EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRLC 481
IL Q+ H N++ L E + L+ E +S G L ++ + ++ + ++
Sbjct: 68 ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEE--ATSFIK-- 122
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA----KVSDFGASRSIAVDQTHL 537
+ ++YLH+ I H D+K NI+L DK K+ DFG + I +
Sbjct: 123 ---QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597
+ GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 598 RAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMREV 646
+ I + F ++LAK + L +KR T++E
Sbjct: 220 -GDTKQETLA----NITA--VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/225 (23%), Positives = 110/225 (48%), Gaps = 15/225 (6%)
Query: 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEF----INEV 425
+ + + + +G+G G VYK G+IVA+K+ ++ +++ E I E+
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL--DAEDEGIPSTAIREI 70
Query: 426 VILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAID 485
+L +++H N+V L+ LV+EF+ L + +D+ + S +++
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIK-IYLYQ 127
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF 545
+ +++ H I HRD+K N+L++ K++DFG +R+ + T +V T
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TL 183
Query: 546 GYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
Y P+ S ++ D++S G + E++TG +P+ +++D
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDD 227
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 58/297 (19%)
Query: 370 SNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFIN-- 423
+ E + +LG+GG GTV+ G L D VA+K +++++ S + + +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 424 -EVVILSQIN----HRNVVKLLGCCLETEVPL-LVYEFISNGT-LSQYIDDQNKDFRISW 476
EV +L ++ H V++LL ET+ LV E L YI ++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG---PLGE 138
Query: 477 EMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-KVSDFGASRSIAVDQT 535
C V AI + HS + HRDIK NIL+D + K+ DFG+ +
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDE 193
Query: 536 HLTTQVQGTFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594
T GT Y PE+ + + V+S G++L +++ G+ P
Sbjct: 194 PYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-------------- 238
Query: 595 YFLRAMREDRLFEILDAQI-----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
F E EIL+A++ + L +RCL RP++ E+
Sbjct: 239 -F-----ERDQ-EILEAELHFPAHVSPDCCA-------LIRRCLAPKPSSRPSLEEI 281
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 69/296 (23%), Positives = 114/296 (38%), Gaps = 57/296 (19%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKII-----------------------DES 416
+G+G G V D A+K K K+I
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 417 KVEEFINEVVILSQINHRNVVKL---LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR 473
+E+ E+ IL +++H NVVKL L E + +V+E ++ G + + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK----P 133
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533
+S + D+ I YLH I HRDIK +N+L+ + K++DFG S
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 534 QTHLTTQVQGTFGYLDPEYFQSSHFT---EKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
L+ V GT ++ PE + + DV++ GV L + G+ P D+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF------MDE 243
Query: 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + + E D + E KD L R L+ N + R + E+
Sbjct: 244 RIMCLHSKIKSQA--LEFPDQPDIAEDLKD-------LITRMLDKNPESRIVVPEI 290
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQIN 432
+ +G+G GTV+K E +IVA+K+ ++ D+ E + E+ +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
H+N+V+L + LV+EF L +Y D N D ++ + + +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE-IVK-SFLFQLLKGLGF 116
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
HS + HRD+K N+L++ K+++FG +R+ + + +V T Y P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 553 -FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
F + ++ D++S G + EL RP+ N +D
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 48/285 (16%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFI-NEVVILSQINHR 434
+D F LG+G VY+ K A+K ++ ++ ++ + E+ +L +++H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRLSHP 108
Query: 435 NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
N++KL ET + LV E ++ G L I ++ S + A++YL
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYL 164
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCA---KVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
H I HRD+K N+L K++DFG S+ + Q + T GT GY P
Sbjct: 165 HENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVC-GTPGYCAP 219
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
E + + + D++S G++ LL G P F + +F
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDERGDQFMFR--- 261
Query: 611 AQILKEGGKDEF-----KMVAKLAK----RCLNLNGKKRPTMREV 646
+IL + F V+ AK + + L+ KKR T +
Sbjct: 262 -RILN--CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 54/301 (17%)
Query: 370 SNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKII-----DESKVEE 420
S + D + ++ LG G G V + K VA+K K K +
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 421 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
E+ IL ++NH ++K+ + E +V E + G L + + + + +L
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR-LKEA-TCKL 118
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHL 537
+ A+ YLH I HRD+K N+LL + K++DFG S+ I + + +
Sbjct: 119 YFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLM 173
Query: 538 TTQVQGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594
T GT YL PE S + D +S GV+L L+G P
Sbjct: 174 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-------------- 218
Query: 595 YFLRAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMRE 645
F + L + QI GK + + V++ A + L ++ K R T E
Sbjct: 219 -FSEHRTQVSLKD----QITS--GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271
Query: 646 V 646
Sbjct: 272 A 272
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 54/285 (18%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFIN-----EVVILS 429
++T LG G G V+ + E K V VK K K++++ +E+ E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 430 QINHRNVVKLLGCCLETEVPL-LVYEFISNGT-LSQYIDDQNKDFRISWEMRLCIAIDVS 487
++ H N++K+L E + LV E +G L +ID R+ + I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLV 140
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
A+ YL I HRDIK NI++ + + K+ DFG++ + + T GT Y
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTIEY 195
Query: 548 LDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
PE + + + +++S GV L L+ E P F L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP---------------F------CELE 234
Query: 607 EILDAQI-----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E ++A I + + L L ++R T+ ++
Sbjct: 235 ETVEAAIHPPYLVSKELMS-------LVSGLLQPVPERRTTLEKL 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 74/309 (23%), Positives = 125/309 (40%), Gaps = 56/309 (18%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSK 411
+ + TKL E E + +LG GG G+VY G+ + D VA+K K +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 412 IIDESKVEEFIN---EVVILSQINHR--NVVKLLGCCLETEVPL-LVYEFISN-GTLSQY 464
I D ++ EVV+L +++ V++LL E L+ E L +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139
Query: 465 IDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSD 523
I ++ + E+ V A+ + H+ + HRDIK NIL+D ++ K+ D
Sbjct: 140 ITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193
Query: 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIR 582
FG+ + T T GT Y PE+ + + + V+S G++L +++ G+ P
Sbjct: 194 FGSGALL--KDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-- 248
Query: 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQI-----LKEGGKDEFKMVAKLAKRCLNLNG 637
F + EI+ Q+ + + L + CL L
Sbjct: 249 -------------F------EHDEEIIRGQVFFRQRVSSECQH-------LIRWCLALRP 282
Query: 638 KKRPTMREV 646
RPT E+
Sbjct: 283 SDRPTFEEI 291
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 15/217 (6%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEF----INEVVILSQINH 433
+ ++ +G+G G VYK G+ A+KK ++ E E I E+ IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
N+VKL + +LV+E + L + +D + + + I+Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESV-TAK-SFLLQLLNGIAYC 116
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY- 552
H + HRD+K N+L++ + K++DFG +R+ + T ++ T Y P+
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
S ++ D++S G + E++ G P+ SE D
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEAD 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 27/201 (13%), Positives = 58/201 (28%), Gaps = 44/201 (21%)
Query: 386 LGQGGQGTVYKGMLED---GKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
G ++ D + VA+ ++ + ++E ++ + LS+I+ V ++
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASI 499
L L+V E+I G+L + D S + ++ A H A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFT 559
+ + + + + +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDA-------N 180
Query: 560 EKSDVYSFGVVLVELLTGERP 580
+ D+ G L LL P
Sbjct: 181 PQDDIRGIGASLYALLVNRWP 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 71/300 (23%), Positives = 119/300 (39%), Gaps = 65/300 (21%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKI-----IDESKVEEFINEVVI 427
++ ++G+G V + + G AVK + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 428 LSQI-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRLC 481
L Q+ H +++ L+ E+ + LV++ + G L Y+ ++ K+ R
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-------S 204
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
I + A+S+LH+ I HRD+K NILLDD ++SDFG S + + L
Sbjct: 205 IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC 260
Query: 542 QGTFGYLDPE------YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595
GT GYL PE + ++ D+++ GV+L LL G P
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP--------------- 304
Query: 596 FLRAMREDRLFEILDAQILKEGGKDEFKM--------VAK-LAKRCLNLNGKKRPTMREV 646
F R+ + I++ G+ +F K L R L ++ + R T +
Sbjct: 305 F-WHRRQILMLR----MIME--GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 73/301 (24%), Positives = 115/301 (38%), Gaps = 66/301 (21%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIID------ESKVEEFINEVV 426
+N+ ILG+G V + + K AVK + + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 427 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQN----KDFRISWEMRL 480
IL +++ H N+++L ET LV++ + G L Y+ ++ K+ R
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------- 127
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
I + I LH I HRD+K NILLDD K++DFG S + + L
Sbjct: 128 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 541 VQGTFGYLDPE------YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594
GT YL PE + ++ D++S GV++ LL G P
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------------- 228
Query: 595 YFLRAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNGKKRPTMRE 645
F ++ + I+ G E+ + K R L + +KR T E
Sbjct: 229 -F-WHRKQMLMLR----MIMS--GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 646 V 646
Sbjct: 281 A 281
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 23/223 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN-----EVVILSQI 431
+ LG+G TVYK +IVA+KK K+ S+ ++ IN E+ +L ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRI----SWEMRLCIAIDVS 487
+H N++ LL LV++F+ L I D + ++ +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTL------ 122
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
+ YLH I HRD+K N+LLD+ K++DFG ++S T QV T Y
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWY 178
Query: 548 LDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
PE F + + D+++ G +L ELL P +S+ D
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLD 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 72/279 (25%), Positives = 111/279 (39%), Gaps = 52/279 (18%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
LG G G V G G VAVK + KI V + E+ L H +++KL
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFR--ISWEMRLCIAIDVSG 488
+ T +V E++S G L YI + + F+ +S
Sbjct: 77 YQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS------------- 122
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
A+ Y H + HRD+K N+LLD AK++DFG S ++ D L T G+ Y
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYA 177
Query: 549 DPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE + + D++S GV+L LL G P +D+ + F + F
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF------DDEHVPTLFKKIRGGV--FY 229
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
I + L L L ++ KR T++++
Sbjct: 230 I--PEYLNRSVAT-------LLMHMLQVDPLKRATIKDI 259
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 53/289 (18%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQ-INHR 434
TD + +G G + + AVK IID+SK + E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQN----KDFRISWEMRLCIAIDVSGAI 490
N++ L + + +V E + G L I Q ++ + ++ +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-------AVLFTITKTV 129
Query: 491 SYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
YLH+ + HRD+K +NIL + ++ DFG ++ + + L T T
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTAN 185
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
++ PE + + D++S GV+L +LTG P F +
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---------------FANGPDDTP-E 229
Query: 607 EILDAQILKEGGKDEF-----KMVAKLAK----RCLNLNGKKRPTMREV 646
EIL +I GK V+ AK + L+++ +R T V
Sbjct: 230 EILA-RIGS--GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 69/309 (22%), Positives = 113/309 (36%), Gaps = 59/309 (19%)
Query: 364 KTKLFTSNELEKATDNFN-----TNRILGQGGQGTVYKGM-LEDGKIVAVK--KSKIIDE 415
L T N ++ +NFN T++ LG+G V + + G+ A K K + +
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 416 SKVEEFINEVVILSQINHR-NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDF- 472
E ++E+ +L V+ L E + L+ E+ + G + + +
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 473 ---RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA---KVSDFGA 526
+ ++ + + YLH I H D+K NILL Y K+ DFG
Sbjct: 129 SENDVIRLIK-----QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
Query: 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586
SR I L + GT YL PE T +D+++ G++ LLT P
Sbjct: 181 SRKIG-HACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP------ 232
Query: 587 EEDKSLAAYFLRAMREDRLFEILDAQILKEGGK-----DEFKMVAKLAK----RCLNLNG 637
F+ + I + + F V++LA L N
Sbjct: 233 ---------FV-GEDNQETYL----NISQ--VNVDYSEETFSSVSQLATDFIQSLLVKNP 276
Query: 638 KKRPTMREV 646
+KRPT
Sbjct: 277 EKRPTAEIC 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQIN 432
+ + LG+G TVYKG +VA+K+ ++ E E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
H N+V L + LV+E++ L QY+DD + ++ + ++Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVK-LFLFQLLRGLAY 115
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
H + HRD+K N+L++++ K++DFG +R+ ++ +V T Y P+
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 553 -FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
S+ ++ + D++ G + E+ TG RP+ ++ E+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEE 208
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 378 DNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F +ILG+G TV L + A+K K II E+KV E ++S+++H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAIS 491
VKL + + L + NG L +YI K E ++ A+
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI---RKIGSFD-ETCTRFYTAEIVSALE 144
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG-ASRSIAVDQTHLTTQVQGTFGYLDP 550
YLH I HRD+K NILL++ +++DFG A + GT Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
E + SD+++ G ++ +L+ G P R N E +F+
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----------------EYLIFQ--- 242
Query: 611 AQILKEGGK--DEFKMVAK-LAKRCLNLNGKKR 640
+I+K ++F A+ L ++ L L+ KR
Sbjct: 243 -KIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 12/216 (5%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN--EVVILSQINHR 434
+ + +G+G G V+K + G+IVA+KK ++ V + I E+ +L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+V LL LV+E+ + T+ +D + + I A+++ H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGV--PEHLVKSITWQTLQAVNFCH 119
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY-F 553
HRD+K NIL+ K+ DFG +R + + +V T Y PE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLV 175
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
+ + DV++ G V ELL+G P+ S+ D
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVD 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 54/295 (18%)
Query: 385 ILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQI-NHRNVVKL 439
+LG+G V + L + AVK K S+V EV +L Q HRNV++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLEL 76
Query: 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQN----KDFRISWEMRLCIAIDVSGAISYLHS 495
+ E + LV+E + G++ +I + + + DV+ A+ +LH+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------VVVQDVASALDFLHN 129
Query: 496 AASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRSI-------AVDQTHLTTQVQGTF 545
I HRD+K NIL + K+ DF I + L T G+
Sbjct: 130 KG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSA 185
Query: 546 GYLDPE-----YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
Y+ PE ++S + ++ D++S GV+L LL+G P D
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-GRCGSDCGWDRGEACPA 244
Query: 601 REDRLFEILDAQILKEGGKDEF-----KMVAKLAK----RCLNLNGKKRPTMREV 646
++ LFE I + GK EF ++ AK + L + K+R + +V
Sbjct: 245 CQNMLFE----SIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 64/293 (21%), Positives = 106/293 (36%), Gaps = 72/293 (24%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFIN-EVVILSQINHRNVVK 438
+LG+G G V + + E AVK K K+ E + E+ +L ++ H+NV++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 439 LLG-CCLETEVPL-LVYEFISNGT--LSQYI-------DDQNKDFR--ISWEMRLCIAID 485
L+ E + + +V E+ G + + + F I
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---------- 120
Query: 486 VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG--ASRSIAVDQTHLTTQVQG 543
+ YLHS I H+DIK N+LL K+S G + T QG
Sbjct: 121 ---GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQG 173
Query: 544 TFGYLDPEYFQSSHFTE--KSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601
+ + PE K D++S GV L + TG P E ++
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF------EGDNIY-------- 219
Query: 602 EDRLFE-ILDAQILKEGGKDEFKM-------VAKLAKRCLNLNGKKRPTMREV 646
+LFE I + + ++ L K L KR ++R++
Sbjct: 220 --KLFENIGKG---------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 12/226 (5%)
Query: 372 ELEKAT-DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVV 426
E + D F R+LG+GG G V+ ++ GK+ A K K ++ + + E
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AI 484
IL++++ R +V L ET+ L LV ++ G + +I + ++D E R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
+ + +LH I +RD+K N+LLDD ++SD G + + QT GT
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590
G++ PE + D ++ GV L E++ P R + +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQIN 432
+ +GQG G V+K + G+ VA+KK + E++ E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALREIKILQLLK 74
Query: 433 HRNVVKLLGCCLETEVPL--------LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAI 484
H NVV L+ C P LV++F + L+ + + F +S E++ +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQ 131
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV----DQTHLTTQ 540
+ + Y+H I HRD+K+ N+L+ K++DFG +R+ ++ T +
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 541 VQGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
V T Y PE + D++ G ++ E+ T PI N+E+
Sbjct: 189 VV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 12/216 (5%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN--EVVILSQINHR 434
+ + ++G+G G V K + G+IVA+KK D+ K+ + I E+ +L Q+ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+V LL C + + LV+EF+ + T+ ++ ++ + I + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ-VVQ-KYLFQIINGIGFCH 141
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY-F 553
S I HRDIK NIL+ K+ DFG +R++A +V T Y PE
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLV 197
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
+ + DV++ G ++ E+ G P+ +S+ D
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDID 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 376 ATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQ 430
++ F LG G TVYKG+ G VA+K+ K+ E E I E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKE 59
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR---ISWEMRLCIAIDVS 487
+ H N+V+L LV+EF+ N L +Y+D + + + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
+++ H I HRD+K N+L++ + K+ DFG +R+ + +++V T Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 548 LDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
P+ S ++ D++S G +L E++TG +P+ ++E+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 372 ELEKAT-DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVV 426
E + T + F R+LG+GG G V + GK+ A K K +I +NE
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AI 484
IL ++N R VV L ET+ L LV ++ G L +I + E R A
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI--YHMGQAGFPEARAVFYAA 293
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
++ + LH I +RD+K NILLDD ++SD G + + QT GT
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGT 348
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
GY+ PE ++ +T D ++ G +L E++ G+ P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 73/286 (25%), Positives = 111/286 (38%), Gaps = 66/286 (23%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
LG G G V G G VAVK + KI V + E+ L H +++KL
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFR--ISWEMRLCIAIDVSG 488
+ T + +V E++S G L YI + + F+ +S
Sbjct: 82 YQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS------------- 127
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+ Y H + HRD+K N+LLD AK++DFG S ++ D L T G+ Y
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYA 182
Query: 549 DPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE + + D++S GV+L LL G P +D + F +
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPF------DDDHVPTLFKK--------- 227
Query: 608 ILDAQILKEGGKDEFKM-------VAKLAKRCLNLNGKKRPTMREV 646
I D F V L K L ++ KR T++++
Sbjct: 228 ICDG---------IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKG-MLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D+F +++G+G V M + G++ A+K K ++ +V F E +L +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEM-RLCIAIDVSGAIS 491
R + +L + E L LV E+ G L + RI EM R +A V AI
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLAEIVM-AID 176
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
+H + HRDIK NILLD +++DFG+ + D T + GT YL PE
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 552 YFQSSHFTEKSDVY-------SFGVVLVELLTGERP 580
Q+ + Y + GV E+ G+ P
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 68/290 (23%), Positives = 108/290 (37%), Gaps = 70/290 (24%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
+ +G G G ++VAVK + IDE V+ E++ + H N+V+
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REIINHRSLRHPNIVRF 81
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFR--ISWEMRLCIAIDVSG 488
+ T L ++ E+ S G L + I D+ F+ +S
Sbjct: 82 KEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS------------- 127
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTFG 546
+SY HS I HRD+K N LLD K+ DFG S +V + + V GT
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTV-GTPA 182
Query: 547 YLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
Y+ PE + + +DV+S GV L +L G P ED R
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF------EDPEEP----------RD 226
Query: 606 FEILDAQILKEGGKDEFKM---------VAKLAKRCLNLNGKKRPTMREV 646
+ +IL ++ + L R + R ++ E+
Sbjct: 227 YRKTIQRILSV----KYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 63/287 (21%), Positives = 107/287 (37%), Gaps = 56/287 (19%)
Query: 382 TNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKL 439
+ ++LG G G V + G+ A+K ++ + EV Q ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALK---LLY--DSPKARQEVDHHWQASGGPHIVCI 87
Query: 440 LGCCLETEVP----LLVYEFISNGTLSQYIDDQNKDF----RISWEMRLCIAIDVSGAIS 491
L L++ E + G L I ++ + MR D+ AI
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-----DIGTAIQ 142
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+LHS I HRD+K N+L K K++DFG ++ Q L T T Y+
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYV 196
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
PE + + D++S GV++ LL G P F + +
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---------------F-YSNTGQAISPG 240
Query: 609 LDAQILKEGGKDEF-----KMVAKLAK----RCLNLNGKKRPTMREV 646
+ +I G+ F V++ AK L + +R T+ +
Sbjct: 241 MKRRIRL--GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 22/229 (9%)
Query: 375 KATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN-----EVVIL 428
AT + +G G GTVYK G VA+K ++ + + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 429 SQIN---HRNVVKLLGCCLETEVPL-----LVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
++ H NVV+L+ C + LV+E + L Y+D + E
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-LPAETIK 123
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+ + +LH+ I HRD+K NIL+ K++DFG +R + LT
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPV 179
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
V T Y PE S + D++S G + E+ +P+ NSE D
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 30/261 (11%)
Query: 369 TSNELEKATDNFN-TNRILGQGGQGTVYKGM---LEDGKIVAVKKSKIIDESKVEEFINE 424
S+E E+ D F +G+G G VYK +D K A+K+ + E
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACRE 68
Query: 425 VVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRL-- 480
+ +L ++ H NV+ L L + + L++++ + L I ++L
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127
Query: 481 ----CIAIDVSGAISYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASRSIAV 532
+ + I YLH+ + HRD+K NIL+ ++ K++D G +R
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 533 ---DQTHLTTQVQGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
L V TF Y PE + H+T+ D+++ G + ELLT PI E+
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED 242
Query: 589 DKSLAAYFLRAMREDRLFEIL 609
K+ Y + DR+F ++
Sbjct: 243 IKTSNPYHHDQL--DRIFNVM 261
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 69/305 (22%), Positives = 123/305 (40%), Gaps = 60/305 (19%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEF----INEVVILSQIN 432
D + LG+G G VYK + + VA+K+ ++ E + E I EV +L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLLKELQ 91
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
HRN+++L L++E+ N L +Y+D +N D + ++ + +++
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD-KNPDVSMR-VIK-SFLYQLINGVNF 147
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCA-----KVSDFGASRSIAVDQTHLTTQVQGTFGY 547
HS HRD+K N+LL + K+ DFG +R+ + T ++ T Y
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 548 LDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED----------------- 589
PE S H++ D++S + E+L P+ +SE D
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 590 ---KSLAAY------FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKR 640
+L + F + L +LD + G D L L ++ KR
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDE-----GLD-------LLTAMLEMDPVKR 310
Query: 641 PTMRE 645
+ +
Sbjct: 311 ISAKN 315
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 17/230 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D+F R +G+G G V D K+ A+K K K ++ ++V E+ I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
+V L + E + +V + + G L ++ QN F+ ++L I ++ A+ Y
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEE-TVKLFIC-ELVMALDY 130
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
L + I HRD+K NILLD+ ++DF + + + T + GT Y+ PE
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 553 FQSSHFTEKS---DVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599
F S S D +S GV ELL G RP + +S K + F
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 66/288 (22%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 382 TNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKL 439
T+++LG G G V + + A+K ++ + EV + + ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPHIVRI 120
Query: 440 LGCCLETEVP-----LLVYEFISNGTLSQYIDDQNKDF----RISWEMRLCIAIDVSGAI 490
+ E L+V E + G L I D+ S M+ + AI
Sbjct: 121 VDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----SIGEAI 174
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
YLHS I I HRD+K N+L K K++DFG ++ + LTT T Y
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
+ PE + + D++S GV++ LL G P + +
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGMKT 277
Query: 608 ILDAQILKEGGKDEF-----KMV---AK-LAKRCLNLNGKKRPTMREV 646
+I G+ EF V K L + L +R T+ E
Sbjct: 278 ----RIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 68/279 (24%), Positives = 111/279 (39%), Gaps = 53/279 (18%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINHRNVVKL 439
LG+G G V + + VA+K + + E+ L + H +++KL
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 440 LGCCLETEVPL-LVYEFISNGTLSQYI--------DDQNKDFR--ISWEMRLCIAIDVSG 488
+ T + +V E+ G L YI D+ + F+ I
Sbjct: 75 YDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC------------- 119
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
AI Y H I HRD+K N+LLDD K++DFG S +I D L T G+ Y
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYA 174
Query: 549 DPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
PE + + DV+S G+VL +L G P +D+ + F + +
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF------DDEFIPNLFKKVNSCV--YV 226
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ L G + L +R + + +R T++E+
Sbjct: 227 M--PDFLSPGAQS-------LIRRMIVADPMQRITIQEI 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 375 KATDNFNTNRILGQGGQGTVYKG--MLEDGKIVAVKKSKIIDESKVEEF----INEVVIL 428
+A + +G+G G V+K + G+ VA+K+ ++ E I EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVL 65
Query: 429 SQIN---HRNVVKLLGCCLETEVPL-----LVYEFISNGTLSQYIDDQNKDFRISWEMRL 480
+ H NVV+L C + LV+E + L+ Y+D + + E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIK 123
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ 540
+ + + +LHS + HRD+K NIL+ K++DFG +R + LT+
Sbjct: 124 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSV 179
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
V T Y PE S + D++S G + E+ +P+ +S+ D
Sbjct: 180 VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVD 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 378 DNFNTNRILGQGGQGTVYK-GMLEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+++ +++G+G G V K+ A+K K ++I S F E I++ N
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISW------EMRLCIAIDV 486
VV+L + + L +V E++ G L + N D W E+ L
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVL------ 179
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
A+ +H S+ HRD+K N+LLD K++DFG + + GT
Sbjct: 180 --ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 547 YLDPEYFQS----SHFTEKSDVYSFGVVLVELLTGERP 580
Y+ PE +S ++ + D +S GV L E+L G+ P
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 53/238 (22%)
Query: 370 SNELEKATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFIN-EVVI 427
++ +++G G G VY+ L + G++VA+KK ++ + + F N E+ I
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKR---FKNRELQI 100
Query: 428 LSQINHRNVVKLLGCCLET-----EVPL-LVYEFISNGTLSQYIDDQNKD---------- 471
+ +++H N+V+L + EV L LV +++ T+ + ++
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 472 ------FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDF 524
FR +++Y+HS I HRDIK N+LLD D K+ DF
Sbjct: 160 LYMYQLFR---------------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 525 GASRSIAVDQTHLTTQVQGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
G+++ + + + + + Y PE F ++ +T DV+S G VL ELL G +PI
Sbjct: 202 GSAKQLVRGEP-NVSYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 58/244 (23%), Positives = 107/244 (43%), Gaps = 15/244 (6%)
Query: 352 QQELSSNEGGIDKTKLFTSNELEKAT-DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK- 408
+ S+ G ++ ++ + + T + F ++LG+G G V + G+ A+K
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 409 --KSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYI 465
K I+ + +V + E +L H + L +T L V E+ + G L ++
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL 239
Query: 466 DDQNKDFRISWEMRLCI-AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524
+ F E R ++ A+ YLHS ++ +Y RD+K N++LD K++DF
Sbjct: 240 SRERV-FS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITDF 293
Query: 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLT 584
G + + GT YL PE + + + D + GVV+ E++ G P
Sbjct: 294 GLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
Query: 585 NSEE 588
+ E+
Sbjct: 353 DHEK 356
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 52/259 (20%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE 415
+ + K E+ + +++G G G V++ L + VA+K K++ +
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQD 75
Query: 416 SKVEEFIN-EVVILSQINHRNVVKLLGCCLET-----EVPL-LVYEFISNGTLSQYIDDQ 468
+ F N E+ I+ + H NVV L EV L LV E++ T+ +
Sbjct: 76 ---KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY 131
Query: 469 NKD----------------FRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512
K R +++Y+HS I HRDIK N+L
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLR---------------SLAYIHSIG---ICHRDIKPQNLL 173
Query: 513 LD-DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVV 570
LD K+ DFG+++ + + + + + Y PE F ++++T D++S G V
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEP-NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTGCV 231
Query: 571 LVELLTGERPIRLTNSEED 589
+ EL+ G +P+ S D
Sbjct: 232 MAELMQG-QPLFPGESGID 249
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQIN- 432
++F+ +RI+G+GG G VY D GK+ A+K K +I + +NE ++LS ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 433 --HRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+V + T L + + ++ G L ++ F + +MR A ++
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEA-DMRFYAA-EIILG 304
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ ++H+ + +RD+K NILLD+ ++SD G + + + H V GT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMA 358
Query: 550 PEYFQSSHFTEKS-DVYSFGVVLVELLTGERPIRLTNSE 587
PE Q + S D +S G +L +LL G P R ++
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
++F +++G+G G V + K+ A+K K +++ ++ F E +L
Sbjct: 74 EDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEM-RLCIAIDVSG 488
+ + + L + + L LV ++ G L + + R+ EM R +A ++
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLA-EMVI 186
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
AI +H + HRDIK NIL+D +++DFG+ + D T ++ GT Y+
Sbjct: 187 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 549 DPEYFQSSHFTEKS-----DVYSFGVVLVELLTGERP 580
PE Q+ + D +S GV + E+L GE P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 20/211 (9%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHR 434
D++ R LG+G V++ + + + + V VK K + + K+ E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91
Query: 435 NVVKLLGCCL--ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
N++ L + P LV+E ++N Q + + A+D Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALD------Y 145
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCA-KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE 551
HS I HRD+K N+++D ++ ++ D+G + Q +V + + PE
Sbjct: 146 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYFKGPE 200
Query: 552 -YFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
+ D++S G +L ++ + P
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 358 NEGGIDKTKLFTSNELEKAT-DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---K 409
+ D K + + A D F+ + LG G G V ML E G A+K K
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDK 76
Query: 410 SKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQ 468
K++ ++E +NE IL +N +VKL + L +V E+++ G + ++
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 469 NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528
+ F R A + YLHS + +RD+K N+L+D + +V+DFG ++
Sbjct: 136 GR-FSEPH-ARFYAA-QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
+ T + GT L PE S + + D ++ GV++ E+ G P
Sbjct: 190 RV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 61/278 (21%), Positives = 94/278 (33%), Gaps = 79/278 (28%)
Query: 378 DNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSK-IIDESKVEEFINEVVILSQ 430
D + LG+G G V + + VAVK K S+ ++E+ IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 431 I-NHRNVVKLLGCCLETEVPLLV-YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVS- 487
I +H NVV LLG C + PL+V EF G LS Y+ + +F
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 488 -----------------------------GAISYLHSAASIPIYHRDIKSTNILL----- 513
++S + + ++D + L+
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 514 -------------------------DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+K K+ DFG +R I D + V+ L
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARL 257
Query: 549 D-----PEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580
PE +T +SDV+SFGV+L E+ + G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 57/309 (18%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQ 430
+ + +G G QG V + VA+KK + E+V++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 80
Query: 431 INHRNVVKLLGCCLETEVPL------LVYEFISNGTLSQYIDDQNKDFRISWEMR--LCI 482
+NH+N++ LL + +V E + L Q I + R+S+ + LC
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC- 138
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542
I +LHSA I HRD+K +NI++ K+ DFG +R+ +T V
Sbjct: 139 ------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYV- 187
Query: 543 GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPI-----------RLTN-----S 586
T Y PE + E D++S G ++ E++ G + ++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 587 EED----KSLAAYFLRAMRE------DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLN 636
E + ++ + ++LF + E K + L + L ++
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 637 GKKRPTMRE 645
KR ++ E
Sbjct: 307 ASKRISVDE 315
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDES--KVEEFINEVVILSQ 430
K D F R+ GQG GTV G G VA+KK +I + + E + + L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRE-LQIMQDLAV 75
Query: 431 INHRNVVKLL------GCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIA 483
++H N+V+L G ++ L +V E++ + TL + + + ++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-------RQVAPP 127
Query: 484 ID--------VSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-KVSDFGASRSIAVDQ 534
+ +I LH S+ + HRDIK N+L+++ K+ DFG+++ ++ +
Sbjct: 128 PILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 535 THLTTQVQGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
++ + Y PE F + H+T D++S G + E++ G PI
Sbjct: 187 PNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 70/242 (28%), Positives = 116/242 (47%), Gaps = 22/242 (9%)
Query: 359 EGGIDKTKL--FTSNELEKAT-DNFNTNRILGQGGQGTVY----KGMLEDGKIVAVK--- 408
EG I + + EKA F ++LGQG G V+ + ++ A+K
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 409 KSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDD 467
K+ + +V E IL ++NH +VKL +TE L L+ +F+ G L +
Sbjct: 62 KATLKVRDRVRT-KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 468 QNKDFRISWEMRLCI-AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526
+ F E + +++ A+ +LHS I +RD+K NILLD++ K++DFG
Sbjct: 120 EVM-FT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586
S+ ++D GT Y+ PE T+ +D +SFGV++ E+LTG P + +
Sbjct: 173 SK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 587 EE 588
+E
Sbjct: 232 KE 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKK--SKIIDESKVEEFIN---------EVVILSQIN 432
R + G G V G+ +G VA+K+ + + D V + E+ +L+ +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 433 HRNVVKLLGCCLETEVPL-----LVYEFISNGT-LSQYIDDQNK---DFRISWEMR--LC 481
H N++ L + E P LV E + T L+Q I DQ I + M L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
+ LH A + HRD+ NILL D + DF +R D + T V
Sbjct: 146 -------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA-NKTHYV 194
Query: 542 QGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
Y PE Q FT+ D++S G V+ E+ + +
Sbjct: 195 T-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 23/221 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
++F+ ++LG+G G V +L G+ A+K K II + +V + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSG 488
H + L +T L V E+ + G L ++ + F E R ++
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV-FT---EERARFYGAEIVS 116
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFGY 547
A+ YLHS + +RDIK N++LD K++DFG + I+ T GT Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
L PE + + + D + GVV+ E++ G P + E
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 59/310 (19%), Positives = 112/310 (36%), Gaps = 59/310 (19%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQ 430
+ + +G G QG V + VA+KK + E+V++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 117
Query: 431 INHRNVVKLL-----GCCLETEVPL-LVYEFIS---NGTLSQYIDDQNKDFRISWEMRLC 481
+NH+N++ LL LE + LV E + + +D + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-- 175
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
I +LHSA I HRD+K +NI++ K+ DFG +R+ +T V
Sbjct: 176 -------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 224
Query: 542 QGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPI-----------RLTN----- 585
T Y PE + E D++S G ++ E++ + + ++
Sbjct: 225 -VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTP 282
Query: 586 SEED----KSLAAYFLRAMRE------DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNL 635
E + ++ + +LF E K + L + L +
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 636 NGKKRPTMRE 645
+ KR ++ +
Sbjct: 343 DPAKRISVDD 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 374 EKAT-DNFNTNRILGQGGQGTVY----KGMLEDGKIVAVK---KSKIIDESK-VEEFINE 424
EK + F R+LG+GG G V+ GKI A+K K+ I+ +K E
Sbjct: 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 425 VVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI- 482
IL ++ H +V L+ +T L L+ E++S G L ++ + F E C
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI-FM---EDTACFY 126
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQ 542
++S A+ +LH I +RD+K NI+L+ + K++DFG + ++ +T
Sbjct: 127 LAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC 182
Query: 543 GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
GT Y+ PE S D +S G ++ ++LTG P N ++
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 66/248 (26%), Positives = 116/248 (46%), Gaps = 32/248 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
+F+ R++G+G V +L + +I A+K K + D+ ++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 431 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVS 487
NH +V L C +TE L V E+++ G L ++ Q K E + ++S
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LP---EEHARFYSAEIS 120
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFG 546
A++YLH I +RD+K N+LLD + K++D+G + + T T+ GT
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 175
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
Y+ PE + + D ++ GV++ E++ G P + S ++ ED LF
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLF 228
Query: 607 E-ILDAQI 613
+ IL+ QI
Sbjct: 229 QVILEKQI 236
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 53/259 (20%), Positives = 106/259 (40%), Gaps = 69/259 (26%)
Query: 373 LEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN-EVVILSQ 430
LE ++ ++ + LG G G V + +E GK A+KK ++ + + + N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56
Query: 431 INHRNVVKLLGC-------------------------------------CLETEVPL-LV 452
++H N++KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAID--------VSGAISYLHSAASIPIYHR 504
E++ + TL + + + I ++ + A+ ++HS I HR
Sbjct: 117 MEYVPD-TLHKVL-------KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHR 165
Query: 505 DIKSTNILLDDKYCA-KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSSHFTEKS 562
DIK N+L++ K K+ DFG+++ + + + + Y PE ++ +T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYI-CSRFYRAPELMLGATEYTPSI 223
Query: 563 DVYSFGVVLVELLTGERPI 581
D++S G V EL+ G +P+
Sbjct: 224 DLWSIGCVFGELILG-KPL 241
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 65/248 (26%), Positives = 116/248 (46%), Gaps = 32/248 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
+F+ R++G+G V +L + +I A++ K + D+ ++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 431 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVS 487
NH +V L C +TE L V E+++ G L ++ Q K E + ++S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LP---EEHARFYSAEIS 163
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFG 546
A++YLH I +RD+K N+LLD + K++D+G + + T T+ GT
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 218
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
Y+ PE + + D ++ GV++ E++ G P + S ++ ED LF
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLF 271
Query: 607 E-ILDAQI 613
+ IL+ QI
Sbjct: 272 QVILEKQI 279
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 74/222 (33%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
DNF R+LG+G G V ML E G + AVK K I+ + VE + E ILS
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 431 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVS 487
NH + +L CC +T L V EF++ G L +I + F E R A ++
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FD---EARARFYAAEII 134
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFG 546
A+ +LH I +RD+K N+LLD + K++DFG + I T T GT
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
Y+ PE Q + D ++ GV+L E+L G P N ++
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 52/233 (22%), Positives = 96/233 (41%), Gaps = 60/233 (25%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK---SKIIDESKVEEFINEVVILSQINHRNVVKL 439
+ LG GG G V+ + + K VA+KK + + E+ I+ +++H N+VK+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLDHDNIVKV 73
Query: 440 L------GCCLETEVPL--------LVYEF--------ISNGTLS----QYIDDQNKDFR 473
G L +V +V E+ + G L + Q
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ----- 128
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-KVSDFGASRSIAV 532
L + Y+HSA + HRD+K N+ ++ + K+ DFG +R +
Sbjct: 129 -----LLR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 533 DQTH---LTTQVQGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
+H L+ + T Y P +++T+ D+++ G + E+LTG + +
Sbjct: 174 HYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 59/286 (20%), Positives = 96/286 (33%), Gaps = 78/286 (27%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLG 441
++LG G G V + + A+K ++ + EV + + ++V+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPHIVRIVD 78
Query: 442 CCLETEVP-----LLVYEFISNGTLSQYIDDQNKDF----RISWEMRLCIAIDVSGAISY 492
E L+V E + G L I D+ S M+ + AI Y
Sbjct: 79 VY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----SIGEAIQY 132
Query: 493 LHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
LHS I HRD+K N+L K K++DFG + G Y
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG-----------FAKETTGE-KY-- 175
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
+ D++S GV++ LL G P + +
Sbjct: 176 ---------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGMKT-- 212
Query: 610 DAQILKEGGKDEF-----KMV---AK-LAKRCLNLNGKKRPTMREV 646
+I G+ EF V K L + L +R T+ E
Sbjct: 213 --RIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 8e-17
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLED-GKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+FN +LG+G G V + ++ AVK K +I + VE + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 434 RNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSGAIS 491
+ L C +T L V E+++ G L +I + F+ E A +++ +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FK---EPHAVFYAAEIAIGLF 456
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFGYLDP 550
+L S I +RD+K N++LD + K++DFG + +I T T GT Y+ P
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAP 511
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
E + + D ++FGV+L E+L G+ P + +E
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 22/247 (8%)
Query: 359 EGGIDKTKLFTSNELEKAT-DNFNTNRILGQGGQGTVY----KGMLEDGKIVAVK---KS 410
+ + EK +NF ++LG G G V+ + GK+ A+K K+
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 411 KIIDESK-VEEFINEVVILSQINHRN-VVKLLGCCLETEVPL-LVYEFISNGTLSQYIDD 467
I+ ++K E E +L I +V L +TE L L+ ++I+ G L ++
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQ 152
Query: 468 QNKDFRISWEMRLCI-AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526
+ + F E + I ++ A+ +LH I +RDIK NILLD ++DFG
Sbjct: 153 RER-FT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLT 584
S+ D+T GT Y+ P+ + + D +S GV++ ELLTG P +
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
Query: 585 NSEEDKS 591
+ ++
Sbjct: 266 GEKNSQA 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
+FN +LG+G G V ML ++ AVK K +I + VE + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 431 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVS 487
+ +L C +T L V E+++ G L +I + F+ E A +++
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FK---EPHAVFYAAEIA 131
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFG 546
+ +L S I +RD+K N++LD + K++DFG + +I T T GT
Sbjct: 132 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPD 186
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
Y+ PE + + D ++FGV+L E+L G+ P + +E
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
+F R LG G G V L +G+ A+K K ++ +VE +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 431 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVSG 488
+ H ++++ G + + ++ ++I G L + + F A +V
Sbjct: 63 VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQR-FP---NPVAKFYAAEVCL 117
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTF-G- 546
A+ YLHS I +RD+K NILLD K++DFG ++ + D T+ T G
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY-------TLCGT 166
Query: 547 --YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
Y+ PE + + + D +SFG+++ E+L G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 25/233 (10%)
Query: 368 FTSNELEKAT-DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVE 419
+ A +F+ +++G+G G V +L + AVK K I+ + + +
Sbjct: 27 LGPSSNPHAKPSDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEK 83
Query: 420 EFINEVVILSQ-INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWE 477
++E +L + + H +V L +T L V ++I+ G L ++ + F E
Sbjct: 84 HIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC-FL---E 138
Query: 478 MRLCI-AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS-RSIAVDQT 535
R A +++ A+ YLHS I +RD+K NILLD + ++DFG +I + T
Sbjct: 139 PRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195
Query: 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
T+ GT YL PE + D + G VL E+L G P N+ E
Sbjct: 196 --TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
++F +++LG+G G V L + + A+K K ++ + VE + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 431 -INHRNVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCI-AIDVS 487
H + + C +T+ L V E+++ G L +I +K F R A ++
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FD---LSRATFYAAEII 128
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR-SIAVDQTHLTTQVQGTFG 546
+ +LHS I +RD+K NILLD K++DFG + ++ D T GT
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPD 183
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE 588
Y+ PE + D +SFGV+L E+L G+ P + EE
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQ 430
+ + +G G G+V + G+ VA+KK I + E+++L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLLKH 79
Query: 431 INHRNVVKLLGCCLETEVPL------LVYEFISNGT-LSQYIDDQNKDFRISWEM--RLC 481
+ H NV+ LL LV F+ T L + + + + +I + + L
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEEKIQYLVYQMLK 137
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV 541
+ Y+HSA + HRD+K N+ +++ K+ DFG +R +T V
Sbjct: 138 -------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYV 184
Query: 542 QGTFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
T Y PE H+ + D++S G ++ E+LTG + +
Sbjct: 185 V-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 35/214 (16%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQINHRNVV 437
+ +G G G V + G VA+KK + + E+ +L + H NV+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELRLLKHMRHENVI 87
Query: 438 KLLGCCLETEVPL------LVYEFISNGTLSQYIDDQN-KDFRISWEM--RLCIAIDVSG 488
LL E LV F+ L + + + + RI + + L
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLK------- 139
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
+ Y+H+A I HRD+K N+ +++ K+ DFG +R + +T V T Y
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVV-TRWYR 192
Query: 549 DPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
PE +T+ D++S G ++ E++TG + +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 58/235 (24%), Positives = 84/235 (35%), Gaps = 66/235 (28%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN---------EVVILSQINH 433
+LG+G G V G+IVA+KK +E F E+ IL H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIKILKHFKH 68
Query: 434 RNVVKLLGCCLETEVPL-----LVYEF--------ISNGTLS----QYIDDQNKDFRISW 476
N++ + ++ E IS LS QY Q
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-------- 120
Query: 477 EMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536
L A+ LH + + HRD+K +N+L++ KV DFG +R I
Sbjct: 121 --TLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 537 LTTQVQGTFG---------YLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
+ G Y PE S+ ++ DV+S G +L EL RPI
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 45/228 (19%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFIN---------EVV 426
+ +G+G G V + VA+KK + F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 427 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFISNGT-LSQYIDDQN-KDFRISWEMR 479
IL + H N++ + + +V + + T L + + Q+ + I + +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLY 135
Query: 480 --LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH- 536
L + Y+HSA + HRD+K +N+LL+ K+ DFG +R D H
Sbjct: 136 QILR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 537 --LTTQVQGTFGYLDPEY-FQSSHFTEKSDVYSFGVVLVELLTGERPI 581
LT V T Y PE S +T+ D++S G +L E+L+ RPI
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVE--EFINEVVILSQINH 433
+ + +G G G+V + G VAVKK +S + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 434 RNVVKLLGCCLETEVPL------LVYEFISNGT-LSQYIDDQN-KDFRISWEMR--LCIA 483
NV+ LL LV + G L+ + Q D + + + L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR-- 143
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG 543
+ Y+HSA I HRD+K +N+ +++ K+ DFG +R A +T V
Sbjct: 144 -----GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVA- 191
Query: 544 TFGYLDPE-YFQSSHFTEKSDVYSFGVVLVELLTGERPI 581
T Y PE H+ + D++S G ++ ELLTG R +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 49/226 (21%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK--KSK------IIDESKVEEFINEVVILSQ--IN 432
R LG G TV+ + + VA+K + DE K+ + +N+ + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 433 HRNVVKLLGC-----------CLETEVPLL---VYEFISNGTLSQYIDDQNKDFRISWEM 478
+++KLL + E +L + I + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIK----------KYEHRGIPLIY 132
Query: 479 RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD------KYCAKVSDFGASRSIAV 532
I+ + + Y+H I I H DIK N+L++ K++D G +
Sbjct: 133 VKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLG---NACW 187
Query: 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
H T +Q Y PE + + +D++S ++ EL+TG+
Sbjct: 188 YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 45/243 (18%), Positives = 85/243 (34%), Gaps = 69/243 (28%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQINHRNVV 437
++G+G G VY K VA+KK +ID ++ + E+ IL+++ ++
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNRLKSDYII 88
Query: 438 KLLGCCLETEVPL-----LVYEFI---------SNGTLS----QYIDDQNKDFRISWEMR 479
+L + ++ +V E + L+ + I
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN----------L 138
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539
L +++H + I HRD+K N LL+ KV DFG +R+I ++
Sbjct: 139 LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 540 QVQGTFGYLDP----------EY------------FQSSHFTEKSDVYSFGVVLVELLTG 577
P + ++T+ D++S G + ELL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 578 ERP 580
+
Sbjct: 249 LQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 51/262 (19%), Positives = 95/262 (36%), Gaps = 74/262 (28%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQ 430
D + ++G G G V + + ++VA+KK +ID ++ + E+ IL++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108
Query: 431 INHRNVVKLLGCCLETEVPL-----LVYEFI---------SNGTLS----QYIDDQNKDF 472
+NH +VVK+L + +V +V E + L+ + +
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN---- 164
Query: 473 RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532
L + Y+HSA I HRD+K N L++ KV DFG +R++
Sbjct: 165 ------LLV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208
Query: 533 DQTHLTTQVQGTFGYLDP---------------EY------------FQSSHFTEKSDVY 565
+ + + ++TE DV+
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
Query: 566 SFGVVLVELLTGERPIRLTNSE 587
S G + ELL + +++
Sbjct: 269 SIGCIFAELLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 72/333 (21%), Positives = 124/333 (37%), Gaps = 93/333 (27%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKK-----SKIIDESKVEEFINEVVILSQIN-HRNV 436
+ LG+G G V+K + G++VAVKK D + E++IL++++ H N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTELSGHENI 71
Query: 437 VKLLGCCLETEVPL--------LVYEFISNGT-LSQYIDDQN-KDFRISWEMR--LCIAI 484
V LL V LV++++ T L I + + + +
Sbjct: 72 VNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIK--- 120
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
I YLHS + HRD+K +NILL+ + KV+DFG SRS +
Sbjct: 121 ----VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 545 FGYLDP---------EY------------FQSSHFTEKSDVYSFGVVLVELLTGERPI-- 581
+ +Y S+ +T+ D++S G +L E+L G +PI
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFP 232
Query: 582 ---------RLTN-----SEED-----KSLAAYFLRAMREDRLFEILDAQILKEGGKDEF 622
R+ S ED A + +++E + + + K+
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 623 KMVAKLA----------KRCLNLNGKKRPTMRE 645
+ A + L N KR + +
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 48/229 (20%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK----KSKIIDESKVEEFINEVVILSQINHR---- 434
+++G+G G V K + + VA+K + + ++ E + IL + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRILEHLRKQDKDN 157
Query: 435 --NVVKLLGC-------CLETEVPLL---VYEFISNGTLSQYIDDQNKDFRISWEMRLCI 482
NV+ +L C+ E LL +YE I +NK S +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFE--LLSMNLYELIK----------KNKFQGFSLPLVRKF 205
Query: 483 AIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQ 540
A + + LH I H D+K NILL + + KV DFG S + + T
Sbjct: 206 AHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTY 259
Query: 541 VQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589
+Q F Y PE + + D++S G +L ELLTG P+ E D
Sbjct: 260 IQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY-PLLPGEDEGD 306
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 70/376 (18%), Positives = 114/376 (30%), Gaps = 128/376 (34%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKII--DESKVEEFINEVVILSQI-- 431
++ R LG G TV+ ++ K VA+K ++ E E ++E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRN 92
Query: 432 ------NHRNVVKLLGC-----------CLETEVPLL--VYEFISNGTLSQYIDDQNKDF 472
N VV+LL C+ E L + ++I ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWI----------IKSNYQ 141
Query: 473 RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL------------------- 513
+ I V + YLH+ I H DIK NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 514 ------------------------------DDKYCAKVSDFGASRSIAVDQTHLTTQVQG 543
+K K++D G + H T +Q
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ- 255
Query: 544 TFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED-------------- 589
T Y E S + +D++S + EL TG+ + EE
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315
Query: 590 -----------KSLAAYF--------LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAK 630
K +F + ++ LFE+L + E ++E
Sbjct: 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLL 373
Query: 631 RCLNLNGKKRPTMREV 646
L L +KR T E
Sbjct: 374 PMLELIPEKRATAAEC 389
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 74/361 (20%), Positives = 127/361 (35%), Gaps = 94/361 (26%)
Query: 356 SSNEGGIDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK----KS 410
N+G D + EK D + + ++G+G G V K + + VA+K K
Sbjct: 32 VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK 91
Query: 411 KIIDESKVEEFINEVVILSQINHR------NVVKLLGC-------CLETEVPLL---VYE 454
++++++E V +L +N +V L CL E +L +Y+
Sbjct: 92 AFLNQAQIE-----VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYD 144
Query: 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL- 513
+ +S + A + A+ +L + + I H D+K NILL
Sbjct: 145 LL----------RNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 514 DDKYCA-KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLV 572
+ K A K+ DFG+S + Q +Q F Y PE + D++S G +LV
Sbjct: 194 NPKRSAIKIVDFGSS--CQLGQRI-YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILV 249
Query: 573 ELLTGERPIRLTNSE-----------------------------EDKSLAAYFLRAMRED 603
E+ TGE P+ +E E + L+ ++
Sbjct: 250 EMHTGE-PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDG 308
Query: 604 R----------LFEILDAQILKEGGKDEFKMVAK---------LAKRCLNLNGKKRPTMR 644
+ L IL + GG+ + L R L+ + K R
Sbjct: 309 KREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368
Query: 645 E 645
Sbjct: 369 Y 369
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 62/331 (18%), Positives = 104/331 (31%), Gaps = 94/331 (28%)
Query: 384 RILGQGGQGTVYKGM--LEDGKIVAVK----KSKIIDESKVEEFINEVVILSQINHR--- 434
LG+G G V + + VA+K K + +++E + +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKKIKEKDKE 79
Query: 435 ---NVVKLLGC-------CLETEVPLL---VYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
V + C+ E LL +EF+ +N
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLK----------ENNFQPYPLPHVRH 127
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-------------------KVS 522
+A + A+ +LH H D+K NIL + +V+
Sbjct: 128 MAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
DFG S D H TT V Y PE + + DV+S G +L E G +
Sbjct: 185 DFG---SATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRGF-TLF 239
Query: 583 LTNSEED------------------KSLAAYFLRAMREDRLFEILDAQILKEGGKD---- 620
T+ + ++ + D + +KE K
Sbjct: 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
Query: 621 ------EFKMVAKLAKRCLNLNGKKRPTMRE 645
E + L +R L + +R T+ E
Sbjct: 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 31/220 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRN 435
+ F R +G G G +Y G ++ + VA+K + ++K + + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+ + +E + +LV + + +L + ++ S + L +A + + ++HS
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHS 121
Query: 496 AASIPIYHRDIKSTNILLDDKYCAK---VSDFGASRSIAVDQTHL------TTQVQGTFG 546
+ + HRDIK N L+ A + DFG ++ TH + GT
Sbjct: 122 KSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 547 Y------LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
Y L E QS + D+ S G VL+ L G P
Sbjct: 179 YASVNTHLGIE--QS----RRDDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRN 435
++ R +G+G G +++G L + + VA+K S + +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+ + E +LV + + +L +D + F S + A + + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHE 124
Query: 496 AASIPIYHRDIKSTNILL---DDKYCAKVS--DFGASRSIAVDQTHL------TTQVQGT 544
+ + +RDIK N L+ + K + DFG + T + GT
Sbjct: 125 KSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 545 FGY------LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
Y L E QS + D+ + G V + L G P
Sbjct: 182 ARYMSINTHLGRE--QS----RRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 31/220 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH-RN 435
+ + R +G G G +Y G + G+ VA+K + ++K + E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+ + C E + ++V E + +L + ++ F S + L +A + I Y+HS
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHS 123
Query: 496 AASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSIAVDQTHL------TTQVQGTFG 546
I HRD+K N L+ + DFG ++ +TH + GT
Sbjct: 124 KNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 547 Y------LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580
Y L E QS + D+ S G VL+ G P
Sbjct: 181 YASINTHLGIE--QS----RRDDLESLGYVLMYFNLGSLP 214
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 60/240 (25%), Positives = 86/240 (35%), Gaps = 69/240 (28%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVK----KSKIIDESKVEEFINEVVILSQINHR---- 434
R +G G G V +++ K AVK K +K+E IL +I +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQNDDINN 95
Query: 435 -NVVKLLGC-------CLETEVPLL---VYEFISNGTLSQYIDDQNKDFRISWEMRLCIA 483
N+VK G CL E L +YE I+ +N E
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIIT----------RNNYNGFHIEDIKLYC 143
Query: 484 IDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA------------------------ 519
I++ A++YL + H D+K NILLDD Y
Sbjct: 144 IEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 520 -KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE 578
K+ DFG + + + Y PE + + SD++SFG VL EL TG
Sbjct: 201 IKLIDFG---CATFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 65/343 (18%), Positives = 115/343 (33%), Gaps = 118/343 (34%)
Query: 384 RILGQGGQGTVYKG--MLEDGKIVAVK----KSKIIDESKVEEFINEVVILSQINHR--- 434
LG+G G V + G+ VAVK + + ++ E + +L +N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNTTDPN 74
Query: 435 ---NVVKLLGC-------CLETEVPLL---VYEFISNGTLSQYIDDQNKDFRISWEMRLC 481
V++L C+ E LL Y+FI +N +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIK----------ENGFLPFRLDHIRK 122
Query: 482 IAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA-------------------KVS 522
+A + ++++LHS H D+K NIL KV
Sbjct: 123 MAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH-----------FTEKSDVYSFGVVL 571
DFG++ D+ H T + H +++ DV+S G +L
Sbjct: 180 DFGSA--TYDDEHHST-------------LVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224
Query: 572 VELLTGERPIRLTNSEEDKSLA----------AYFLRAMREDRLF--EILDAQILKEGGK 619
+E G + T+ ++ LA + ++ R+ + F + LD G+
Sbjct: 225 IEYYLGF-TVFPTHDSKEH-LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282
Query: 620 -----------------DEFKMVAKLAKRCLNLNGKKRPTMRE 645
E + + L ++ L + KR T+RE
Sbjct: 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 5e-09
Identities = 71/497 (14%), Positives = 140/497 (28%), Gaps = 158/497 (31%)
Query: 237 YNLDTSCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYD-FNQELQCQSRTSHSLR 295
+++D + Y Y D+ + D F C+ +
Sbjct: 5 HHMDFETGEHQYQ--------------------YKDILSVFEDAFVDNFDCKD-VQDMPK 43
Query: 296 --FRKKSRDKFIIIGCTIGGLGMLSLLTGTLWLYKFFRRRGEIKLKHKFF----KRNGGL 349
K+ D I+ ++GTL L+ + E ++ KF + N
Sbjct: 44 SILSKEEIDHIIMSK---------DAVSGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKF 93
Query: 350 LLQQELSSNEGGIDKTKLFTSNELEKATDN-----FNTNRI-----LGQG------GQGT 393
L+ + T+++ DN +N +R+ L Q +
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 394 VYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL--- 450
+ G+L GK + + ++ L+ L C E L
Sbjct: 154 LIDGVLGSGKTWVALDV-CLSYKVQCKMDFKIFWLN----------LKNCNSPETVLEML 202
Query: 451 --LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKS 508
L+Y+ N T D + ++R+ + + L + + ++
Sbjct: 203 QKLLYQIDPNWT-------SRSDHSSNIKLRI---HSIQAELRRL-------LKSKPYEN 245
Query: 509 TNILLDDKYCAKVSDFGASRSI-AVD---QTHLTTQVQGTFGYLDPEY-------FQSSH 557
++L + V + +++ A + + LTT+ + +L S
Sbjct: 246 CLLVLLN-----VQN---AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 558 FTEKSDVYSFGVVL--------VELLTG-------------ERPIRLTNSEE-------- 588
T L E+LT + N +
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 589 --DKSLAA--------YF--LRAMRED-----RLFEILDAQILKEGGKDEFKMVAKLAKR 631
+ SL F L L ++ ++K D +V KL K
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---DVMVVVNKLHKY 414
Query: 632 CLNLNGKKRPTMREVGI 648
L +K+P + I
Sbjct: 415 SL---VEKQPKESTISI 428
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 36/253 (14%), Positives = 71/253 (28%), Gaps = 69/253 (27%)
Query: 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE--------SKVEEFINEVVI 427
T+ +G+G G V++ + D VA+K I EE + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 428 LSQI---------NHRNVVKLLGCCL----------------------ETEVPL------ 450
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 451 --LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKS 508
+V EF G + + + S I ++ +++ + S+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 509 TNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQG--------------TFGYLDPEYFQ 554
N+LL K+ +S + L + +D + F
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250
Query: 555 SSHFTEKSDVYSF 567
+ D+Y
Sbjct: 251 GDG-DYQFDIYRL 262
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 15/157 (9%)
Query: 379 NFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNV 436
NF + +G G G + G L + VA+K + +S+ + E Q+ + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
++ + +V E + +L D ++ F S + L IAI + + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTF--SLKTVLMIAIQLISRMEYVHSK 124
Query: 497 ASIPIYHRDIKSTNILL---DDKYCAKV--SDFGASR 528
I +RD+K N L+ +K + DF ++
Sbjct: 125 NLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/182 (18%), Positives = 63/182 (34%), Gaps = 41/182 (22%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKII-----------DESKVEEFINEVVILSQIN 432
+GQGG G +Y + + V ++ E K + + + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGT----------------LSQYIDDQNKDFRISW 476
+K LG VP + L + + K F S
Sbjct: 101 RTRKLKYLG------VPKYWG-SGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF--SR 151
Query: 477 EMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV--SDFGASRSIAVDQ 534
+ L +++ + + Y+H + H DIK++N+LL+ K +V D+G + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 535 TH 536
H
Sbjct: 209 VH 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 35/178 (19%), Positives = 62/178 (34%), Gaps = 36/178 (20%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKI--------IDESKVEEFINEVVILSQINHR 434
+ +G GG G +Y + A K+ E K + + + + + R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQY----ID----------DQNKDFRISWEMRL 480
+ LG +PL ++ Y ++ QN F L
Sbjct: 103 KQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF--KKSTVL 154
Query: 481 CIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV--SDFGASRSIAVDQTH 536
+ I + + Y+H + H DIK+ N+LL K +V +D+G S + H
Sbjct: 155 QLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 23/181 (12%), Positives = 58/181 (32%), Gaps = 39/181 (21%)
Query: 384 RILGQGGQGTVYKGM---------LEDGKIVAVK----KSKIIDESKVEEFINEVVILSQ 430
+ QG +Y+ + ++K ++ +E + + + +++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNG------------TLSQYIDDQN-KDFRISWE 477
LL +P + + +L +D S
Sbjct: 108 WKKLYSTPLLA------IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL--SER 159
Query: 478 MRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV--SDFGASRSIAVDQT 535
L +A + A+ +LH + H ++ + NI +D + ++V + +G +
Sbjct: 160 SVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 536 H 536
H
Sbjct: 217 H 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 708 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.78 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.47 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.81 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.59 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.37 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.9 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 89.49 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 88.75 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 87.76 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 87.54 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 86.8 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 86.64 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 86.63 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.46 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 84.71 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 84.56 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 83.91 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.52 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 83.04 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 82.93 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 82.71 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 82.6 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 82.13 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 82.04 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 81.26 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 80.87 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 80.11 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=461.07 Aligned_cols=260 Identities=26% Similarity=0.447 Sum_probs=212.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.++|.+.++||+|+||+||+|+++ +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999864 47889999998877888889999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 451 LVYEFISNGTLSQYIDDQNK------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
|||||+++|+|.++|+.... ..+++|.+++.|+.||+.||+|||+.+ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976532 236999999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHH
Q 047038 519 AKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 596 (708)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ .
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~ 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------A 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999987654332 23445679999999999999999999999999999999999 999997544322 1
Q ss_pred HHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+..+. ..+.+...++.+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 270 ~~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 IDCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11122211 112233445679999999999999999999999999999876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=458.81 Aligned_cols=259 Identities=25% Similarity=0.444 Sum_probs=218.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 477899999988777888899999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 452 VYEFISNGTLSQYIDDQN----------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
||||+++|+|.++|+... ....++|.+++.|+.||+.||+|||+.+ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 2346999999999999999999999998 999999999999999999999
Q ss_pred eeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHH
Q 047038 522 SDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
+|||+++......... .....||+.|||||++.+..++.++|||||||+||||+| |+.||......+ ....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999998765433322 334569999999999999999999999999999999999 999997544322 1112
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+..+.. .+.+...++.+.+|+.+||+.||++|||++||.+.|+.+.+
T Consensus 243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222211 12233455679999999999999999999999999999876
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-55 Score=454.54 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=214.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.+++..++||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999963 4678999998753 3345678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 451 LVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
|||||+++|+|.++|+.... ...++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965421 235899999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHH
Q 047038 518 CAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 595 (708)
++||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||......+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------- 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999987654332 23445679999999999999999999999999999999999 899997554322
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
+...+..+.. ...+...+..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 256 ~~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 VVEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1122222211 1223445567999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=449.28 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=210.4
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++...+++.+.++||+|+||+||+|++++ .||||.++. .+....++|.+|+.+|++++|||||+++|++.+ +.++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34455678889999999999999998753 599998875 345667889999999999999999999998865 5689
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.++|+.... .++|.+++.|+.||+.||+|||+.+ |+||||||+||||++++++||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999976533 6999999999999999999999998 999999999999999999999999999876
Q ss_pred CcCC-cceeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 531 AVDQ-THLTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 531 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
.... ........||+.|||||++.. ..|+.++|||||||+||||+||+.||........ ....+..+..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~- 255 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYA- 255 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCC-
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCC-
Confidence 5322 233455679999999999864 4689999999999999999999999975443221 1111111110
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.+. ........++.+.+|+.+||+.||++||||.||++.|+.|+..
T Consensus 256 ---~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 256 ---SPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ---CCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ---CCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 010 1122334456799999999999999999999999999998763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=447.02 Aligned_cols=270 Identities=28% Similarity=0.430 Sum_probs=223.7
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCC-Cceeee
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKII-DESKVEEFINEVVILSQINH-RNVVKL 439 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H-~niv~l 439 (708)
+...+++...++|++.+.||+|+||+||+|.+.. ++.||||+++.. .....++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556778888999999999999999999999653 368999998763 34566789999999999965 899999
Q ss_pred eceEeeC-CcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 047038 440 LGCCLET-EVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRD 505 (708)
Q Consensus 440 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrD 505 (708)
+|+|.+. +..+||||||++|+|.++|+.... ...++|.+++.++.|||+||+|||+.+ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 568999999999999999976432 235899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCC
Q 047038 506 IKSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRL 583 (708)
Q Consensus 506 ikp~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~ 583 (708)
|||+||||++++.+||+|||+|+....+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977544433 3445679999999999999999999999999999999998 9999976
Q ss_pred CCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 584 TNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+. +...+..+. ....+...++++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 291 ~~~~~~------~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKIDEE------FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCSHH------HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH------HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 543321 122222221 112233345678999999999999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=443.92 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=205.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.++|++.+.||+|+||+||+|+.. +|+.||||+++. ......+.|.+|+++|++++|||||++++++.+.+..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999965 699999999865 34566788999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.++|.... ...+++.+++.|+.||+.||+|||+.+ |+||||||+||||++++++||+|||+++.....
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999997653 235799999999999999999999999 999999999999999999999999999876432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. ...+...||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+ .+..... +..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-~~~-------- 242 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIIS-GSF-------- 242 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH-TCC--------
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc-CCC--------
Confidence 1 22345679999999999999999999999999999999999999997543222 1111111 111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...+..+.+||.+||+.||++|||++|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112334566899999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=439.68 Aligned_cols=268 Identities=20% Similarity=0.215 Sum_probs=215.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..+.|...++||+|+||+||+|+.. +|+.||||+++... .+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3456888899999999999999975 68999999987532 22479999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCcccCcC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAVD 533 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~~~~ 533 (708)
|+++|+|.++|+... .+++.++..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+..+
T Consensus 131 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999998654 5999999999999999999999998 99999999999999987 6999999999876543
Q ss_pred Ccc----eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 534 QTH----LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 534 ~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
... ......||+.|||||++.+..|+.++|||||||+||||++|++||......+.. . .......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i~~~~~----- 273 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---L---KIASEPP----- 273 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---H---HHHHSCC-----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---H---HHHcCCC-----
Confidence 221 123457999999999999999999999999999999999999999765443311 1 1111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCCCcccCCCCceee
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVHQGCFEEI 671 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~~~~~~~~~~~~ 671 (708)
...+.+...++.+.+|+.+||+.||++|||+.|+++.|........ ...++|..+.
T Consensus 274 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~---~l~hPw~~~~ 329 (336)
T 4g3f_A 274 ---PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG---GLKSPWKGEY 329 (336)
T ss_dssp ---GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT---SSCSCSSSSC
T ss_pred ---CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh---hccCCCcCCC
Confidence 0112234455679999999999999999999999999987766433 2345555544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=434.56 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=210.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.++||+|+||+||+|+.. +++.||||.+... .....+.+.+|+++|++++|||||++++++.+.+..+||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999965 6899999998642 234467899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999998654 5999999999999999999999999 99999999999999999999999999997754
Q ss_pred CCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 533 DQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 533 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
... .......||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+ + + ..+....+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~---~-~~i~~~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---I---F-AKIIKLEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHTCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H---H-HHHHcCCC------
Confidence 332 33456789999999999999999999999999999999999999997543221 1 1 11111111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..+...++++.+||.+||+.||++|||++|++
T Consensus 252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11233445689999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=438.80 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=209.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
..|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56899999999999999999975 69999999987655555677999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999999753 5999999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
..+...||+.|||||++.+..|+.++|||||||+||||++|+.||......+. ...+..+.. +. ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~-----~~--~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLP-----PR--LK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSSC-----CC--CS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCC-----CC--CC
Confidence 34556799999999999999999999999999999999999999975432221 111111100 00 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.....++.+.+|+.+||+.||++|||++|++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 1223456689999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=425.33 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=199.2
Q ss_pred cccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee----CCcceEEE
Q 047038 381 NTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVY 453 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 453 (708)
+..++||+|+||+||+|... +++.||||++.. ......+.|.+|+++|++++|||||++++++.+ .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999975 688999998754 345667889999999999999999999999875 34579999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~~~~~ 532 (708)
||+++|+|.++++... .+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998654 5999999999999999999999986 35999999999999984 78999999999986432
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.......||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .....+..+.....
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~~---- 250 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPAS---- 250 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGG----
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCCC----
Confidence 23445679999999998865 69999999999999999999999996433221 11122222211111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.+...++++.+|+.+||+.||++|||++|++
T Consensus 251 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 251 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1112234589999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=431.04 Aligned_cols=268 Identities=21% Similarity=0.321 Sum_probs=203.5
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC----cceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----VPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 453 (708)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|++.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 589999999865322 2223345666667899999999999998764 468999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-----ASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-----~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
||+++|+|.++|+.. .++|..+++++.|+++||+|||+. ..++|+||||||+|||||+++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999764 589999999999999999999987 23459999999999999999999999999998
Q ss_pred ccCcCCcce---eecccccccccCccccccC------CCCccchhHhHHHHHHHHHhCCCCCCCCCcchh--------hh
Q 047038 529 SIAVDQTHL---TTQVQGTFGYLDPEYFQSS------HFTEKSDVYSFGVVLVELLTGERPIRLTNSEED--------KS 591 (708)
Q Consensus 529 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~--------~~ 591 (708)
......... .....||+.|||||++.+. .++.++|||||||+||||+||++|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433222 2345799999999998764 467899999999999999999888754322110 00
Q ss_pred HHHHHHHHhhhchhhhhhhhhhhcc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 592 LAAYFLRAMREDRLFEILDAQILKE-GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
........+..+.+ ++.+... ...+.++.+.+|+.+||+.||++||||.||++.|++|.+
T Consensus 237 ~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111211111 1111111 123556789999999999999999999999999999876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=440.69 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=210.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999975 6999999999876666667899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999753 4999999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......||+.|||||++.+..|+.++|||||||+||||++|+.||......+. ...+..+.. +. .
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~-----~~--~ 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLP-----PR--L 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCC-----CC--C
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCC-----CC--C
Confidence 34456799999999999999999999999999999999999999965432221 111111110 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
......+..+.+|+.+||+.||++|||+.|++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 11223446689999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=412.43 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=192.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||+|+.. +|+.||||.++.. .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 7999999988642 2344567999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+ +|+|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 679999987653 5999999999999999999999999 999999999999999999999999999865432
Q ss_pred CcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. ......||+.|||||++.+..+ +.++|||||||+||||++|+.||......+ .+ ..+..+..
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~-~~i~~~~~------- 229 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LF-KNISNGVY------- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCC-------
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHcCCC-------
Confidence 2 2345679999999999998876 579999999999999999999996533221 11 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112234466899999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=412.74 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=191.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-------
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV------- 448 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------- 448 (708)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999975 78999999987543 4456789999999999999999999999976543
Q ss_pred -----ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 449 -----PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 449 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.+|||||+++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999987655445677888999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCcCCcc-----------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhH
Q 047038 524 FGASRSIAVDQTH-----------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSL 592 (708)
Q Consensus 524 FGls~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~ 592 (708)
||+|+....+... ..+...||+.|||||++.+..|+.++|||||||+||||++ ||... . ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~-~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----M-ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----H-HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----c-HH
Confidence 9999876533221 1234579999999999999999999999999999999996 76421 1 11
Q ss_pred HHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 593 AAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ....+........ .....+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1111111111111 1122345678999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=420.91 Aligned_cols=242 Identities=26% Similarity=0.311 Sum_probs=195.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|++.+.||+|+||+||+|+.. +++.||||.++.. .......+.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 4789999988642 22334578899999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998754 5999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
... .......||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+. + ..+.....
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~-~~i~~~~~------ 243 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------M-TMILKAKL------ 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHHCCC------
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------H-HHHHcCCC------
Confidence 322 223456799999999999999999999999999999999999999975443221 1 11111111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
..+...++.+.+|+.+||+.||++|||+
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123345668999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=400.09 Aligned_cols=286 Identities=38% Similarity=0.625 Sum_probs=249.3
Q ss_pred ccChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC
Q 047038 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET 446 (708)
Q Consensus 367 ~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 446 (708)
.++..+++.++++|+..+.||+|+||+||+|.+++++.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 45566778899999999999999999999999888999999998877667788999999999999999999999999999
Q ss_pred CcceEEEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976542 236899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcC-CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 526 ASRSIAVD-QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 526 ls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+++..... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865422 22223445689999999999989999999999999999999999999987766666666666655566666
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+...+++........+.+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 666667666666778889999999999999999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=409.66 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=202.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee------CC
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE------TE 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~ 447 (708)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 467999999999999999999975 7999999998653 34556789999999999999999999998764 35
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
.+||||||++ |+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6899999996 68999987643 6999999999999999999999999 999999999999999999999999999
Q ss_pred cccCcCC---cceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 528 RSIAVDQ---THLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 528 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|++||...+..+...............
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764321 2234557899999999998775 56999999999999999999999997654333211111110000000
Q ss_pred h--------hhhhhhhhhhc-------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 604 R--------LFEILDAQILK-------EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 604 ~--------~~~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
. ....+. .+.. .........+.+|+.+||+.||++|||++|++
T Consensus 286 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 286 VIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp GTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred Hhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0 000000 0000 00011235688999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=398.38 Aligned_cols=204 Identities=20% Similarity=0.342 Sum_probs=173.9
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 446 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 446 (708)
.+....++|++.++||+|+||+||+|+.+ .++.||||++... ....++.+|+++|+++ +|||||++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34456788999999999999999999854 4678999987653 3345788999999998 699999999999999
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeecc
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFG 525 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFG 525 (708)
+..+|||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999984 4889999999999999999999999 9999999999999877 799999999
Q ss_pred CCcccCcCCc---------------------------ceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhC
Q 047038 526 ASRSIAVDQT---------------------------HLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTG 577 (708)
Q Consensus 526 ls~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg 577 (708)
+|+....... ...+...||+.|||||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986532211 112345799999999999775 589999999999999999999
Q ss_pred CCCCCCCCc
Q 047038 578 ERPIRLTNS 586 (708)
Q Consensus 578 ~~P~~~~~~ 586 (708)
+.||.....
T Consensus 244 ~~Pf~~~~~ 252 (361)
T 4f9c_A 244 RYPFYKASD 252 (361)
T ss_dssp CSSSSCCSS
T ss_pred CCCCCCCCC
Confidence 999965443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=396.47 Aligned_cols=293 Identities=35% Similarity=0.611 Sum_probs=247.5
Q ss_pred CcccccChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCCh-HHHHHHHHHHHHHHhcCCCceeeeec
Q 047038 363 DKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE-SKVEEFINEVVILSQINHRNVVKLLG 441 (708)
Q Consensus 363 ~~~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g 441 (708)
...+.|+..+++.+.++|+..++||+|+||+||+|...+++.||||++..... .....+.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567889999999999999999999999999999988899999999876332 22336899999999999999999999
Q ss_pred eEeeCCcceEEEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 047038 442 CCLETEVPLLVYEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAK 520 (708)
Q Consensus 442 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~k 520 (708)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+...++|+||||||+|||+++++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987542 34599999999999999999999999222399999999999999999999
Q ss_pred EeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCC--cchhhhHHHHHHH
Q 047038 521 VSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTN--SEEDKSLAAYFLR 598 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~--~~~~~~~~~~~~~ 598 (708)
|+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998776555555566679999999999998889999999999999999999999996321 1223334445555
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
......+....+.........+.+..+.+++.+||+.||++|||++||+++|++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 555566666666666667788889999999999999999999999999999987544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=415.11 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=211.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|++.+.||+|+||+||+++.+ +|+.||||.+........+.+.+|+.+|++++|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 6999999999877777788899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--CcEEEeeccCCcccCcC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK--YCAKVSDFGASRSIAVD 533 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~--~~~kl~DFGls~~~~~~ 533 (708)
+++|+|.++|..... .+++.++..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999875432 5999999999999999999999999 9999999999999854 89999999999977543
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. ......||+.|||||++.+..|+.++|||||||+||||++|+.||......+. + ..+...... ++.
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~-~~i~~~~~~--~~~-- 377 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------L-RNVKSCDWN--MDD-- 377 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H-HHHHTTCCC--CCS--
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------H-HHHHhCCCC--CCc--
Confidence 3 33455799999999999999999999999999999999999999975443221 1 111111100 001
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......++.+.+||.+||+.||++|||+.|+++
T Consensus 378 --~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456889999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=410.95 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=201.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC------ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII------DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.++|++.++||+|+||+||+++.. +|+.||||+++.. ..........++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 6999999987541 112223334456777788999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
||||||++||+|.++|.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998754 5999999999999999999999999 99999999999999999999999999987
Q ss_pred cCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
+.... .....||+.|||||++.. ..|+.++|||||||+||||++|++||......+...+ . ..+....
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~-~~i~~~~---- 410 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---D-RMTLTMA---- 410 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---H-HHHHHCC----
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---H-HhhcCCC----
Confidence 65332 344679999999999975 5799999999999999999999999975433221111 1 1111110
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVG 647 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~ 647 (708)
...+...+..+.+||.+||+.||++|++ ++||+
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 1123334566899999999999999998 57765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=377.44 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=217.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|...++||+|+||+||++... +++.||+|++...+....+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999975 6899999998877788889999999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999987433 5999999999999999999999998 99999999999999999999999999987643222
Q ss_pred ce-------------eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 536 HL-------------TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 536 ~~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------- 233 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------- 233 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence 11 1145699999999999999999999999999999999999999865433221100
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.......+. ..+...+..+.+|+.+||+.||++|||+.|+++.|+.++..
T Consensus 234 ~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 234 LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000111111 11223334588999999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=378.90 Aligned_cols=271 Identities=31% Similarity=0.422 Sum_probs=211.3
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
+...+++...++|++.+.||+|+||+||+|.. +++.||||++... .....++|.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33445555677899999999999999999987 5888999997653 35566789999999999999999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.+..++||||+++|+|.+++........+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999999987543345999999999999999999999986 359999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. . .+..
T Consensus 185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~----~~~~--- 253 (309)
T 3p86_A 185 LSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---A----AVGF--- 253 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---H----HHHH---
T ss_pred CCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHh---
Confidence 997543221 2234456999999999999999999999999999999999999999754332211 0 0000
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.......+...+..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 254 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 -----KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0001122333456689999999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=370.10 Aligned_cols=283 Identities=32% Similarity=0.529 Sum_probs=231.0
Q ss_pred ccccChHHHHhhccCCccc------ceEeeeccEEEEEEEEcCCcEEEEEEcccC----ChHHHHHHHHHHHHHHhcCCC
Q 047038 365 TKLFTSNELEKATDNFNTN------RILGQGGQGTVYKGMLEDGKIVAVKKSKII----DESKVEEFINEVVILSQINHR 434 (708)
Q Consensus 365 ~~~~~~~el~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~----~~~~~~~~~~Ei~~l~~l~H~ 434 (708)
...|+..++++++++|... +.||+|+||+||+|.. +++.||||++... .....+.|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4678999999999999887 8999999999999987 5789999987642 234567899999999999999
Q ss_pred ceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 047038 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD 514 (708)
Q Consensus 435 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~ 514 (708)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999986554557999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHH
Q 047038 515 DKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA 593 (708)
Q Consensus 515 ~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~ 593 (708)
+++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||............
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999986643322 22334569999999998865 5789999999999999999999999765433211111
Q ss_pred HHHHHHhh-hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 594 AYFLRAMR-EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 594 ~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...... ...+.+.++..+ .......+..+.+++.+||+.+|++|||++||++.|++++.
T Consensus 247 --~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 --KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111 112223333222 33456778889999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=382.87 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=216.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc--------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE--------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 445 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 445 (708)
..++|.+.+.||+|+||+||+|... ++..||||.++.. .....+.+.+|+.+|+++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999863 3567999998764 345667899999999999 89999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIl 512 (708)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999986532 235899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhh
Q 047038 513 LDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDK 590 (708)
Q Consensus 513 l~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~ 590 (708)
|+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 99999999999999986643322 12334557889999999999999999999999999999999 9999976543321
Q ss_pred hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
. ..+..+ .....+...+..+.+|+.+||+.||++||++.|+++.|+.+..
T Consensus 315 --~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 315 --F----KLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --H----HHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111111 1112233445679999999999999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=385.96 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=203.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.++|++.++||+|+||+||+|++. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999965 5678999998764 45567789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.++++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999997653 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 532 VDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 532 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i-------- 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAV-------- 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHH--------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH--------
Confidence 432221 222345778999999999999999999999999999998 999996543221 11111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
........+...+..+.+|+.+||+.||++||+++||++.|+.+..
T Consensus 264 -~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111112233445679999999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.85 Aligned_cols=267 Identities=28% Similarity=0.467 Sum_probs=212.9
Q ss_pred ccCCcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 449 (708)
.++|++.+.||+|+||+||++++ .+++.||||++........+.|.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 26889999999887788888999999999999999999999998653 458
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999987543 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc----
Q 047038 530 IAVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---- 603 (708)
Q Consensus 530 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 603 (708)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence 6543221 223345788899999999999999999999999999999999998532111 01111100
Q ss_pred ----hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 604 ----RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 604 ----~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.+.+.+........+...++.+.+|+.+||+.||++|||++||+++|+.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111112222344557799999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=365.89 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=217.3
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
...++|++.+.||+|+||+||++...+++.||||+++.... ..+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 34578999999999999999999998888999999876432 34679999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999976532 5899999999999999999999998 9999999999999999999999999998765544
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
........+|+.|+|||.+.+..++.++||||||++++||++ |+.||......+. ... +..+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~-~~~~~--------- 222 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLK-VSQGH--------- 222 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHH-HHTTC---------
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHH-HHcCC---------
Confidence 444444557788999999998889999999999999999999 9999965443221 111 11110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+...++.+.+++.+||+.+|++|||++|+++.|+.++.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 011122234568999999999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.27 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=213.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
..++|++.++||+|+||+||+|.+. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467899999999999999999974 3556999998764 4556778999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.++++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999976432 5999999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 531 AVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 531 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------ISSVEEG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcC----
Confidence 543222 2233456789999999998899999999999999999999 9999965433221 1111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.....+...+..+.+|+.+||+.||++|||++||++.|+.+...
T Consensus 271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11122334456799999999999999999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=367.17 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=216.1
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..++|+..+.||+|+||+||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3467889999999999999999998899999999875332 346799999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999976533 5899999999999999999999998 99999999999999999999999999986654333
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......+|+.|+|||.+....++.++||||||++++||++ |+.||......+. ...+..+ ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~---------~~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTG---------FR 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTT---------CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcC---------cc
Confidence 33344557889999999999999999999999999999999 9999965433221 1111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11122334668999999999999999999999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=393.85 Aligned_cols=266 Identities=23% Similarity=0.383 Sum_probs=220.3
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
...+++...++|++.+.||+|+||+||+|.+.++..||||+++... ...+.|.+|+.+|++++|||||++++++. .+.
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 3455677788999999999999999999999888999999987643 34678999999999999999999999986 667
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+++|+|.++++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 899999999999999997542 225889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..............+|+.|+|||++....++.++||||||++||||++ |+.||......+. . ..+..+
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~----~~i~~~---- 401 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I----RALERG---- 401 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H----HHHHHT----
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcC----
Confidence 764332222333456889999999999999999999999999999999 9999975433221 1 111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.....+...++.+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 402 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 -----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11112334456799999999999999999999999999999763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=367.01 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=209.1
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999995 47899999998765555677899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++|+|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999764 4899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......... . ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~-~-------~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT-P-------EL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS-C-------CC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC-C-------CC
Confidence 23445699999999999999999999999999999999999999965432221 111111100 0 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112334466899999999999999999999963
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=386.81 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=216.0
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++...++|.+.+.||+|+||+||+|.+. +++.||||.++.. .....++|.+|+++|++++|||||++++++.+.+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445678999999999999999999986 7899999998753 3445568999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 189 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999986532 5899999999999999999999998 999999999999999999999999999865
Q ss_pred CcCCccee-ecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 531 AVDQTHLT-TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 531 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
........ ....+++.|+|||.+....++.++||||||+++|||++ |+.||......+. ...+..+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~----- 331 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKG----- 331 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTT-----
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcC-----
Confidence 43221111 12235778999999998899999999999999999998 9999975433221 1111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...+..+.+|+.+||+.||++|||+++|++.|+.+++
T Consensus 332 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 ----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1111223345678999999999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=378.10 Aligned_cols=269 Identities=24% Similarity=0.334 Sum_probs=211.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc----ceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----PLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~l 451 (708)
..++|++.++||+|+||+||+|+.. ++.||||++... ......+.+|+.++++++|||||++++++.+... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4568999999999999999999875 789999998653 3344566779999999999999999999987554 699
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA----------ASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~----------~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999999764 489999999999999999999998 7 999999999999999999999
Q ss_pred eeccCCcccCcCCcc-eeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH
Q 047038 522 SDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 522 ~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~ 595 (708)
+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 2334579999999999986 3456789999999999999999999976543322111111
Q ss_pred ---------HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 596 ---------FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 596 ---------~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.............+... ......+..+.+|+.+||+.||++|||+.||++.|+.|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01111111000000000 01234566799999999999999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=365.00 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=211.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||++... +++.||+|.+.. ......+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999965 688999998754 3345567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998654 5899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....+... .. .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~-----~ 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VP-----N 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CC-----C
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CC-----C
Confidence 433334456799999999999999999999999999999999999999975443221 11111111 10 1
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHccccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRP-TMREVGIELTGIRGC 656 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~~ 656 (708)
.........+..+.+++.+||+.||++|| +++++.+.|+.+...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11112333456799999999999999998 999999999998763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=379.21 Aligned_cols=271 Identities=28% Similarity=0.424 Sum_probs=221.4
Q ss_pred ccChHHHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceee
Q 047038 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVK 438 (708)
Q Consensus 367 ~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~ 438 (708)
.+...+++...++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+++++++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4556778888899999999999999999999842 4578999998763 345567899999999999 7999999
Q ss_pred eeceEeeCCc-ceEEEEeccCCCccccccccCC-----------------------------------------------
Q 047038 439 LLGCCLETEV-PLLVYEFISNGTLSQYIDDQNK----------------------------------------------- 470 (708)
Q Consensus 439 l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 470 (708)
+++++.+.+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999976532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 471 ----------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 471 ----------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112899999999999999999999998 9999999999999999999999999998664332
Q ss_pred c-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 535 T-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 535 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. +...+..+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~--------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEG--------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHT---------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcC---------
Confidence 2 23345668999999999999999999999999999999998 9999976543321 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...+..+.+++.+||+.||++|||++||++.|+.+..
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111223344568999999999999999999999999999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.87 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=215.6
Q ss_pred cccChHHHHhhccC----------CcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC
Q 047038 366 KLFTSNELEKATDN----------FNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHR 434 (708)
Q Consensus 366 ~~~~~~el~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ 434 (708)
..++.++++.+++. |+..+.||+|+||+||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777888777764 677789999999999999976 7999999998876666678899999999999999
Q ss_pred ceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 047038 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD 514 (708)
Q Consensus 435 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~ 514 (708)
||+++++++...+..++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 9999999999999999999999999999998753 5899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 515 DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 515 ~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~- 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM- 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH-
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-
Confidence 999999999999987654322 2344579999999999999999999999999999999999999996543221 11
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+..... +.. ......+..+.+++.+||+.||++|||++|+++
T Consensus 251 ---~~~~~~~~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 ---KRLRDSPP-----PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHSSC-----CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHhcCCC-----CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111100 000 011223456899999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=377.75 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=219.8
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc--------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeece
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE--------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGC 442 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 442 (708)
++...++|.+.++||+|+||+||+|... ++..||||+++.. .....+++.+|+++++++ +|||||+++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 4555678999999999999999999863 2357999998763 455668899999999999 99999999999
Q ss_pred EeeCCcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 047038 443 CLETEVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKST 509 (708)
Q Consensus 443 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~ 509 (708)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 9999999999999999999999986532 235899999999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcc
Q 047038 510 NILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSE 587 (708)
Q Consensus 510 NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~ 587 (708)
||||++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++++||++ |+.||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986653322 22344567899999999999999999999999999999999 99999654422
Q ss_pred hhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
+ ....+..+. ....+...+..+.+|+.+||+.||++|||++||++.|+.+....
T Consensus 301 ~-------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 E-------LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp H-------HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred H-------HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2 111111111 11122334566999999999999999999999999999998743
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.85 Aligned_cols=267 Identities=16% Similarity=0.184 Sum_probs=217.3
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..++|++.+.||+|+||+||+|.. .+++.||||.+.... ..+.+.+|+.+++++ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356799999999999999999996 578999999876432 334688999999999 8999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-----EEEeeccCCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC-----AKVSDFGASR 528 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kl~DFGls~ 528 (708)
||+ +++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999986532 5999999999999999999999998 999999999999987766 9999999998
Q ss_pred ccCcCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 529 SIAVDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 529 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76543221 234466999999999999999999999999999999999999999876544333222222211111
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCC
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGA 659 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 659 (708)
.... .. ....++.+.+|+.+||+.||++||++++|++.|+.+......
T Consensus 240 ~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 240 TPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp SCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccHH-----HH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1111 11 112345699999999999999999999999999999875543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=368.39 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=219.4
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceE
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCC 443 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 443 (708)
.+++...++|.+.+.||+|+||+||++... +++.||||.++.. .....+.+.+|+.++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 344455678999999999999999999862 3578999998753 456678899999999999999999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNK---------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ii 502 (708)
.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 999999999999999999999986532 134899999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCC
Q 047038 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERP 580 (708)
Q Consensus 503 HrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P 580 (708)
||||||+|||+++++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765433222 233457889999999999889999999999999999999 9999
Q ss_pred CCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 581 IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
|......... ..+..+ .....+...+..+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 253 ~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 253 YPGIPPERLF-------NLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp STTCCGGGHH-------HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHH-------HHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9765443211 111111 1112233445679999999999999999999999999998865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=387.16 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=213.0
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
...++...++|++.+.||+|+||+||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 344556678899999999999999999999888889999987643 335789999999999999999999999876 778
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 99999999999999997542 225899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.............+++.|+|||.+....++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~----- 397 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG----- 397 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT-----
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-----
Confidence 65433333334557889999999999999999999999999999999 999997543322 11111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.....+...++.+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 398 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11112334456799999999999999999999999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.10 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=213.6
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
+...++|+..+.||+|+||+||++...+++.||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 445678999999999999999999999888999999875432 3467999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999976432 5999999999999999999999998 999999999999999999999999999866543
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ..+...
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~---~----~~~~~~--------- 237 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---A----EHIAQG--------- 237 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H----HHHHTT---------
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---H----HHHhcc---------
Confidence 3333334457889999999999999999999999999999998 9999975443221 1 111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...++.+.+|+.+||+.+|++|||++|+++.|+.+..
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1111122234568999999999999999999999999998865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.16 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=209.1
Q ss_pred hhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
...++|++.+.||+|+||+||+|.. .+|+.||||++.. .+....+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999997 5799999998765 345667789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999997654 5899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCcceeecccccccccCccccccCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
... ......||+.|+|||++.+..+. .++||||||+++|||++|+.||......+. ...+..+..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~----- 231 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-------RERVLRGKY----- 231 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC-----
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC-----
Confidence 332 23456799999999999888765 799999999999999999999975442221 111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112233456889999999999999999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.31 Aligned_cols=268 Identities=24% Similarity=0.398 Sum_probs=220.4
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEE------cCCcEEEEEEcccCC-hHHHHHHHHHHHHHHhc-CCCceeeeece
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKIID-ESKVEEFINEVVILSQI-NHRNVVKLLGC 442 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 442 (708)
.+++...++|+..+.||+|+||+||+|.. .+++.||||.++... ....+.+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 34555667899999999999999999985 246789999987543 45567899999999999 99999999999
Q ss_pred EeeCCcceEEEEeccCCCccccccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 047038 443 CLETEVPLLVYEFISNGTLSQYIDDQNK---------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507 (708)
Q Consensus 443 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDik 507 (708)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999986542 124899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCC
Q 047038 508 STNILLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTN 585 (708)
Q Consensus 508 p~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~ 585 (708)
|+|||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999999998765443322 334557889999999999999999999999999999999 999997654
Q ss_pred cchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 586 SEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.... . ...+. .......+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 253 ~~~~--~----~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSK--F----YKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHH--H----HHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhH--H----HHHhc---------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 3321 1 11111 1111111233456799999999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=362.77 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=202.8
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
+...++|++.+.||+|+||+||+|.... +..||+|..+.. .....+.|.+|+.++++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3445789999999999999999999643 457999998763 3455678999999999999999999999984 567
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 899999999999999997653 25899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..............+|+.|+|||.+....++.++||||||+++|||++ |..||......+. .. .+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~----~i~~~~--- 234 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----RIENGE--- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTC---
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH----HHHcCC---
Confidence 765443333344557889999999999999999999999999999997 9999976543321 11 111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011223345678999999999999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.07 Aligned_cols=274 Identities=17% Similarity=0.197 Sum_probs=218.3
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.+.||+|+||+||+|.. .+++.||||.+.... ..+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 578999999876532 234688999999999 99999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-----EEEeeccCCcc
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC-----AKVSDFGASRS 529 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kl~DFGls~~ 529 (708)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 899999998653 26999999999999999999999998 999999999999999887 99999999987
Q ss_pred cCcCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 530 IAVDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 530 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6433221 1245679999999999999999999999999999999999999998765443322222211111000
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCCCcccCCCCc
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVHQGCF 668 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~~~~~~~~~ 668 (708)
. .... ....+ .+.+++.+||+.+|.+||++++|++.|+.+....+........|.
T Consensus 240 ~------~~~~---~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 240 P------IEVL---CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp C------HHHH---TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred C------HHHH---hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 0 0000 11122 699999999999999999999999999999876554433333343
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=394.04 Aligned_cols=263 Identities=29% Similarity=0.451 Sum_probs=219.9
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
+++...++|++.++||+|+||+||+|.+.. ++.||||.++... ...++|.+|+.+|++++|||||++++++.+.+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 344556789999999999999999999874 8899999987643 34678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999986432 36899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
............+++.|+|||++....++.++||||||++||||++ |+.||......+. . . .+
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~----~---------~~ 432 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----E---------LL 432 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----H---------HH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----H---------HH
Confidence 5443333334456789999999999999999999999999999999 9999976543321 1 1 11
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
........+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111112233445679999999999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.26 Aligned_cols=266 Identities=25% Similarity=0.412 Sum_probs=218.1
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCL 444 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 444 (708)
+++...++|++.+.||+|+||+||+|... +++.||||.++.. .....+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44556789999999999999999999975 3478999998764 3455678999999999999999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNK---------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH 503 (708)
+.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999999976431 146899999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCC
Q 047038 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPI 581 (708)
Q Consensus 504 rDikp~NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~ 581 (708)
|||||+|||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543222 22334568999999999999999999999999999999999 99999
Q ss_pred CCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 582 RLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
......+ ....+..+.. ...+...+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 278 ~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAHEE-------VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCChHH-------HHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 6543222 1111222211 111233446699999999999999999999999999998763
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=383.37 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=213.6
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCL 444 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 444 (708)
...+++...++|+..++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566777899999999999999999999976 47899999986422 122334889999999999999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDF 524 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF 524 (708)
+.+..+|||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999998643 25999999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
|+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+. +...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhh
Confidence 999876655544455567999999999987 56789999999999999999999999975443221 1111
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIE 649 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 649 (708)
+...... . .........+.+.+||.+||..+|++ ||+++|+++.
T Consensus 294 ~~~~~~~-----~-~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERF-----Q-FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHC-----C-CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccccc-----c-CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1110000 0 00111224456899999999988888 9999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=366.59 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=203.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 78999999986533 2334678999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997553 5999999999999999999999998 9999999999999999999999999998664322
Q ss_pred c-ceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 535 T-HLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 535 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... .. ........
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~----~~~~~~~~------- 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS----DWKEKKTY------- 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH----HHHTTCTT-------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH----HHhccccc-------
Confidence 2 22345679999999999987765 78999999999999999999999754432211 11 11111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+|+.+||+.||++|||+.|+++
T Consensus 228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0011233456889999999999999999999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=358.34 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=215.1
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
..++|+..+.||+|+||+||++...+++.||+|.++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3467889999999999999999998889999999876433 346899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999976532 5899999999999999999999998 99999999999999999999999999986643322
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+ ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~i~~~---------~~ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTG---------FR 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTT---------CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-------HHHHhcC---------Cc
Confidence 22334557889999999998999999999999999999999 8999965432211 1111111 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122334568999999999999999999999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=369.54 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=205.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.++|+..++||+|+||+||+|.+. +++ .||+|.+... .....++|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357889999999999999999964 444 3688887543 3345678999999999999999999999998754 78
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+|+||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999987543 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 531 AVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 531 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~ 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SI 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----------------HH
Confidence 543322 2334457889999999999999999999999999999999 99999765443311 11
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+........+...+..+.+++.+||+.+|++||+++||++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111112233345668999999999999999999999999998865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.63 Aligned_cols=264 Identities=23% Similarity=0.404 Sum_probs=217.5
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++++...++|++.+.||+|+||+||+|...+++.||||.++... ...+.+.+|++++++++||||+++++++. .+..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 45566678899999999999999999998888899999987533 34578999999999999999999999986 45689
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999999999999997642 225899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
............++..|+|||.+.+..++.++||||||++++||++ |+.||......+ . ...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~------ 226 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V----IQNLERG------ 226 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTT------
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H----HHHHhcc------
Confidence 5443333344557889999999998889999999999999999999 999996543322 1 1111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.....+...+..+.+|+.+||+.||++|||++++++.|+.+...
T Consensus 227 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 ---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 01111233446799999999999999999999999999998763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.66 Aligned_cols=254 Identities=31% Similarity=0.510 Sum_probs=199.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE----SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|+..++||+|+||+||+|... ++.||||.++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999975 88999998865332 2356899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--------CCcEEEeec
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD--------KYCAKVSDF 524 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~--------~~~~kl~DF 524 (708)
|||+++++|.+++... .+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998643 5899999999999999999999998666999999999999986 678999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
|+++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||........ ... ....
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~- 229 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYG-VAMN- 229 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHH-HHTS-
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHh-hhcC-
Confidence 9998654322 2234689999999999999999999999999999999999999975432211 000 1111
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
......+...++.+.+++.+||+.||++|||+.|+++.|+.|
T Consensus 230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111112333456799999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=368.67 Aligned_cols=271 Identities=27% Similarity=0.438 Sum_probs=222.3
Q ss_pred cccChHHHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceee
Q 047038 366 KLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVK 438 (708)
Q Consensus 366 ~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~ 438 (708)
..+..++++...++|++.+.||+|+||+||+|... +++.||||.+... .......|.+|+.++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 44566777888899999999999999999999864 3678999998753 3455668999999999999999999
Q ss_pred eeceEeeCCcceEEEEeccCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 439 LLGCCLETEVPLLVYEFISNGTLSQYIDDQNK-------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 439 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
+++++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 99999999999999999999999999976431 135799999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchh
Q 047038 512 LLDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEED 589 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~ 589 (708)
|++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 248 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-
Confidence 99999999999999998654332211 223457889999999999999999999999999999999 899986543221
Q ss_pred hhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 590 KSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+..+.. ...+...+..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 249 ------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 ------VLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111111 11223345668999999999999999999999999998866
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.51 Aligned_cols=265 Identities=26% Similarity=0.423 Sum_probs=201.6
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEcC-Cc---EEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLED-GK---IVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~---~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
++....++|++.+.||+|+||+||+|.... ++ .||||.++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344556789999999999999999999654 32 7999998753 45567889999999999999999999999987
Q ss_pred CCcc------eEEEEeccCCCccccccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 047038 446 TEVP------LLVYEFISNGTLSQYIDDQNK---DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK 516 (708)
Q Consensus 446 ~~~~------~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~ 516 (708)
.+.. ++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 999999999999999965432 225899999999999999999999998 9999999999999999
Q ss_pred CcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHH
Q 047038 517 YCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 517 ~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 594 (708)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H
Confidence 99999999999866433221 2234457889999999999999999999999999999999 99999765443211 1
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+..+ .....+...+..+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus 251 ----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 ----YLIGG---------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ----HHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHhcC---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111 0111233445679999999999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.22 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=212.6
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-cceE
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE-VPLL 451 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~l 451 (708)
++...++|++.+.||+|+||+||+|.+. ++.||||.++... ..+.|.+|+.+|++++|||||++++++.+.+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3445678999999999999999999885 7899999987643 5578999999999999999999999987765 7899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999987542 24799999999999999999999998 9999999999999999999999999998543
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.. .....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+. . ..+..+
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~----~~i~~~------- 402 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKG------- 402 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H----HHHHTT-------
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcC-------
Confidence 22 122357889999999999999999999999999999998 9999976543321 1 111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...+..+.+|+.+||+.||++|||+.||++.|+.++.
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1112233445679999999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=368.97 Aligned_cols=267 Identities=25% Similarity=0.433 Sum_probs=215.9
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceE
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCC 443 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 443 (708)
+++...++|+..+.||+|+||+||+|... +++.||||.++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45556789999999999999999999962 4568999998753 334557899999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNKD--------------------FRISWEMRLCIAIDVSGAISYLHSAASIPIYH 503 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH 503 (708)
.+.+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999999765421 24799999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCC
Q 047038 504 RDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPI 581 (708)
Q Consensus 504 rDikp~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~ 581 (708)
|||||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876543332 2334557889999999999999999999999999999998 99999
Q ss_pred CCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 582 RLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
........ +...+..+ .....+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 276 ~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHH------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 76543321 11111111 11112233456799999999999999999999999999998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=362.45 Aligned_cols=263 Identities=30% Similarity=0.465 Sum_probs=222.0
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
+++...++|++.+.||+|+||+||+|... +++.||+|.++. +....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 44556788999999999999999999976 488999999875 3445678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999976532 36999999999999999999999999 999999999999999999999999999877
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
............+|+.|+|||.+.+..++.++||||||+++++|++ |..||......... +.+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~----------------~~~ 225 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------ELL 225 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------------HHH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHH
Confidence 6554444455567889999999999999999999999999999999 99999765433211 111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
........+...++.+.+|+.+||+.||++|||++|+++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1111122233445679999999999999999999999999998876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.70 Aligned_cols=274 Identities=24% Similarity=0.372 Sum_probs=217.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC--cceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 452 (708)
.++|.+.++||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999976 58999999987533 334677899999999999999999999998765 67999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEeeccCCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASR 528 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGls~ 528 (708)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655555999999999999999999999998 9999999999999 888899999999998
Q ss_pred ccCcCCcceeecccccccccCccccc--------cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchh-hhHHHHHHHH
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQ--------SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED-KSLAAYFLRA 599 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~ 599 (708)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||........ ..........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 23456999999999986 57789999999999999999999999975443322 1111111111
Q ss_pred hhhchhhhhh-----------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 600 MREDRLFEIL-----------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 600 ~~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+..+. +..............+.+++.+||+.||++|||++|+++......-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111000000 0001123346777889999999999999999999999998876544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=376.41 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=214.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..++|++.+.||+|+||+||+|.+. +++.||||+++.. ......++.+|+.++++++|||||++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3468999999999999999999953 4678999998653 45566789999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEE
Q 047038 449 PLLVYEFISNGTLSQYIDDQNK----DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY---CAKV 521 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl 521 (708)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999986542 235899999999999999999999998 99999999999999554 5999
Q ss_pred eeccCCcccCcCC-cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHH
Q 047038 522 SDFGASRSIAVDQ-THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 522 ~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~ 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEF 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 9999997553221 122334567999999999999999999999999999999998 999996543322 1111
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
+..+. ....+...+..+.+|+.+||+.+|++|||+.||++.|+.+...
T Consensus 299 i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11111 1112333455689999999999999999999999999998763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=361.57 Aligned_cols=265 Identities=20% Similarity=0.331 Sum_probs=205.3
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
+...++|++.++||+|+||+||+|...+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34557899999999999999999999889999999986532 3345789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++ +|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999985 78887765432 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---hhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---RLFE 607 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 607 (708)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .......... .+..
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQ 246 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGG
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhh
Confidence 3222 2334568999999999876 56899999999999999999999999765544322 1111111110 0000
Q ss_pred hhh-------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILD-------------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+ .............++.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00000001122356889999999999999999999973
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=367.36 Aligned_cols=268 Identities=25% Similarity=0.391 Sum_probs=218.4
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeec
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLG 441 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g 441 (708)
.++++...++|+..+.||+|+||+||+|.... .+.||+|.++.. .....+.+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566677899999999999999999999642 247999998764 345667899999999999 8999999999
Q ss_pred eEeeCCcceEEEEeccCCCccccccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 442 CCLETEVPLLVYEFISNGTLSQYIDDQNK-----------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 442 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 99999999999999999999999976421 235799999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcch
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~ 588 (708)
||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999999866433322 2334557889999999999999999999999999999999 999997544332
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
. +...... ......+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 275 ~------~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 K------FYKLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp H------HHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1 1111111 11111122334668999999999999999999999999998765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=358.05 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=203.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeeC----Ccc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQ--INHRNVVKLLGCCLET----EVP 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~ 449 (708)
..++|++.+.||+|+||+||+|.. +++.||||++.. ...+.+..|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356899999999999999999987 689999999864 344566777777776 7999999999997653 457
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH--------SAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH--------~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
++||||+++|+|.++++.. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999643 5999999999999999999999 766 999999999999999999999
Q ss_pred eeccCCcccCcCCcce---eecccccccccCccccccC------CCCccchhHhHHHHHHHHHhC----------CCCCC
Q 047038 522 SDFGASRSIAVDQTHL---TTQVQGTFGYLDPEYFQSS------HFTEKSDVYSFGVVLVELLTG----------ERPIR 582 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDv~SlGvvl~elltg----------~~P~~ 582 (708)
+|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997654333222 2334799999999999876 455799999999999999999 88886
Q ss_pred CCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
........ . ...............+.. .......+..+.+|+.+||+.||++|||+.||++.|+.|
T Consensus 235 ~~~~~~~~-~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS-F-EDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC-H-HHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc-h-hhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 44322211 1 111111111110000000 111234667899999999999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=364.17 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=201.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV------ 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 448 (708)
.++|+..+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+++|++++|||||++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999976 7999999998753 34456789999999999999999999999876542
Q ss_pred ---------------------------------------------------ceEEEEeccCCCccccccccCCCCCCCHH
Q 047038 449 ---------------------------------------------------PLLVYEFISNGTLSQYIDDQNKDFRISWE 477 (708)
Q Consensus 449 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 477 (708)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999887665567888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc-----------ceeeccccccc
Q 047038 478 MRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT-----------HLTTQVQGTFG 546 (708)
Q Consensus 478 ~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~-----------~~~~~~~gt~~ 546 (708)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 99999999999999999999999999987654321 12234569999
Q ss_pred ccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHH
Q 047038 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVA 626 (708)
Q Consensus 547 y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 626 (708)
|+|||.+.+..++.++||||||+++|||++|..|+. +... ............ ........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~----~~~~~~~~~~~~---------~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVR----IITDVRNLKFPL---------LFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHH----HHHHHHTTCCCH---------HHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHH----HHHHhhccCCCc---------ccccCChhHH
Confidence 999999999999999999999999999999877641 1110 111111111110 0123345678
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 047038 627 KLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 627 ~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+|+.+||+.||++|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=363.07 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=207.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|+..+.||+|+||+||+++.. +++.||||.++.. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999975 6899999998652 233466789999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997653 5899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + + ..+....
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~-~~i~~~~-------- 221 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---F-ELILMEE-------- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHCC--------
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---H---H-HHHHcCC--------
Confidence 22 22345679999999999999999999999999999999999999996543221 1 1 1111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGIE 649 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 649 (708)
...+...+..+.+|+.+||+.||++|| +++||++.
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011223446689999999999999999 89998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=369.64 Aligned_cols=273 Identities=17% Similarity=0.231 Sum_probs=212.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEcC------CcEEEEEEcccCChHH-----------HHHHHHHHHHHHhcCCCceee
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLED------GKIVAVKKSKIIDESK-----------VEEFINEVVILSQINHRNVVK 438 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~ 438 (708)
..++|++.++||+|+||+||+|.+.+ ++.||||.+....... ...+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 4789999976644221 123455667778889999999
Q ss_pred eeceEeeC----CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 047038 439 LLGCCLET----EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD 514 (708)
Q Consensus 439 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~ 514 (708)
+++++.+. ...+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 999999998643 36999999999999999999999998 99999999999999
Q ss_pred --CCCcEEEeeccCCcccCcCCcce------eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCc
Q 047038 515 --DKYCAKVSDFGASRSIAVDQTHL------TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586 (708)
Q Consensus 515 --~~~~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~ 586 (708)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||++||||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332211 1334599999999999999999999999999999999999999975332
Q ss_pred chhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCCC
Q 047038 587 EEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGAS 660 (708)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~ 660 (708)
... ......... ...+.++++..+. ....+..+.+++.+||+.+|++||++.+|++.|+.+.......
T Consensus 267 ~~~--~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 267 DPK--YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CHH--HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CHH--HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 221 111111111 1223334433321 1223456899999999999999999999999999998765533
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.52 Aligned_cols=257 Identities=29% Similarity=0.457 Sum_probs=203.1
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|++.+.||+|+||+||++... ++.||||++.. ....+.|.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 57888999999999999999875 78899999864 345678999999999999999999999887 45899999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-EEEeeccCCcccCcCCcc
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC-AKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~-~kl~DFGls~~~~~~~~~ 536 (708)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999987654445889999999999999999999943223999999999999998876 799999998755322
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ... ....+. ...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~-~~~~~~---------~~~ 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMW-AVHNGT---------RPP 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHH-HHHTTC---------CCC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHH-HHhcCC---------CCC
Confidence 22345899999999999999999999999999999999999999754332211 000 011110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
.....+..+.+|+.+||+.||++|||++|+++.|+.+....
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 12233456899999999999999999999999999998743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=390.52 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=218.2
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.+.++...++|++.++||+|+||+||+|.+.++..||||+++... ...++|.+|+++|++++|+|||++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344556678899999999999999999999888889999987643 335789999999999999999999999876 778
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+|||||+++|+|.++|.... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 99999999999999997542 125899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.............++..|+|||.+....++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~----- 480 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG----- 480 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTT-----
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-----
Confidence 65332222333457889999999999999999999999999999999 999996543322 11111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.....+...+..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 481 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11112234456789999999999999999999999999998763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=354.39 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=209.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
..++|.+.+.||+|+||+||+|...+ +..||||.++.. .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998653 346999998764 45567889999999999999999999999765 4678
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999976532 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... +..+.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~----~~~~~----- 231 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGV----LEKGD----- 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHH----HHHTC-----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHH----HhcCC-----
Confidence 5443333344567889999999998999999999999999999998 9999975443321 111 11110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+...++.+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 011122334568999999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=364.11 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=216.4
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc--------CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE--------DGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCC 443 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 443 (708)
+...++|.+.+.||+|+||+||+|... +++.||||+++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445678999999999999999999863 4678999998753 345677899999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999986542 224899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcch
Q 047038 511 ILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588 (708)
Q Consensus 511 Ill~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~ 588 (708)
||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999999876543322 2333457889999999998889999999999999999999 999997543222
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
....+..+. ....+...+..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 268 -------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 -------LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -------HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111 1112233446689999999999999999999999999999774
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=351.56 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=209.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 452 (708)
.++|+..+.||+|+||+||+|..+ ++.||||.++.. .....+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457889999999999999999985 888999998763 355667899999999999999999999999887 778999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||||+|||+++++.+||.|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999998653 235899999999999999999999976 3599999999999999999999999998764322
Q ss_pred CCcceeecccccccccCccccccCCCC---ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFT---EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t---~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
....||+.|+|||.+.+..++ .++||||||+++|||++|+.||......+. .......
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~------- 226 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALE------- 226 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHS-------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhc-------
Confidence 234589999999999875544 489999999999999999999965432221 1111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
......+...+..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 227 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 --GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112233345669999999999999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.54 Aligned_cols=257 Identities=24% Similarity=0.449 Sum_probs=203.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.++|++.++||+|+||+||+|... +++ .||+|.+.. ......+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999964 444 357777654 33455678999999999999999999999998754 78
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+|+||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999987543 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 531 AVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 531 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~------ 234 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEK------ 234 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHT------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHc------
Confidence 433222 2233457889999999999999999999999999999999 99999765443311 11111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
......+...+..+.+|+.+||+.||++||++.|+++.|+.+..
T Consensus 235 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 235 ---GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11112233345568999999999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=355.42 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=213.5
Q ss_pred ccCCcccc-eEeeeccEEEEEEEEc---CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNR-ILGQGGQGTVYKGMLE---DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.++|.+.+ .||+|+||+||+|... +++.||||.++.. .....+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 9999999999999854 5788999998764 455678899999999999999999999999 5667899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999997543 25899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 532 VDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 532 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~---- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGK---- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCC----
Confidence 433322 223456899999999998889999999999999999998 9999975543221 11111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
....+...+..+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 231 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 231 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 112233445679999999999999999999999999999977533
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.86 Aligned_cols=273 Identities=25% Similarity=0.355 Sum_probs=215.7
Q ss_pred cCCcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEe--eCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL--ETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 450 (708)
++|+..+.||+|+||+||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788999999999999999984 368899999998877778888999999999999999999999987 455688
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999986433 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 531 AVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 531 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......... .............+.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHH
Confidence 543322 223355888999999999988999999999999999999999998532211000 00000000000111122
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
+........+...++.+.+|+.+||+.||++|||++||++.|+.+...
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 222222233445567799999999999999999999999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=361.07 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=208.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|++.+.||+|+||+||++... +++.||+|.++.. ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999976 6889999988754 3455678999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCcEEEeeccCCcccCc
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD--KYCAKVSDFGASRSIAV 532 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGls~~~~~ 532 (708)
|+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999997643 35899999999999999999999998 999999999999987 78999999999987653
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+...... .+..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~~i~~~~~~--~~~~ 225 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II----ENIMNAEYT--FDEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHHTCCC--CCHH
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH----HHHHcCCCC--CChh
Confidence 32 2344568999999999998889999999999999999999999997543221 11 111111100 0011
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.. ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1224568999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.18 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=197.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh--------------------------HHHHHHHHHHHHHH
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE--------------------------SKVEEFINEVVILS 429 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--------------------------~~~~~~~~Ei~~l~ 429 (708)
.++|++.+.||+|+||+||+|... +++.||||.+..... ...+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999965 688999998765321 12457899999999
Q ss_pred hcCCCceeeeeceEee--CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 047038 430 QINHRNVVKLLGCCLE--TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIK 507 (708)
Q Consensus 430 ~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDik 507 (708)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999999876532 5999999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCC---CCccchhHhHHHHHHHHHhCCCCCCCC
Q 047038 508 STNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVELLTGERPIRLT 584 (708)
Q Consensus 508 p~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDv~SlGvvl~elltg~~P~~~~ 584 (708)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987653322 234457999999999998765 378899999999999999999999643
Q ss_pred CcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 585 NSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.... ....+..... ........++.+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~-------~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMC-------LHSKIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHH-------HHHHHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHH-------HHHHHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 1111111110 00111233456899999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.94 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=211.4
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
..+++...++|++.++||+|+||+||+++.. +++.||+|+++... ....+.+.+|+.+++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3456667889999999999999999999976 58899999886421 1223458899999999999999999999999
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
.+..+|||||+++|+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999999753 4899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCC----CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH----FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+++..............||+.|+|||++.... ++.++||||||++||||++|+.||......+. +...+.
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~ 287 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMN 287 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHh
Confidence 99876554443445677999999999998765 78999999999999999999999975432221 111111
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKK--RPTMREVGIE 649 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 649 (708)
... .+........+..+.+||.+||+.+|++ ||+++||++.
T Consensus 288 ~~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 100 0000111233466899999999999988 9999999854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.02 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=206.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..++|++.+.||+|+||+||++... +|+.||+|.++.... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999976 689999998865332 135789999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEeec
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY----CAKVSDF 524 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DF 524 (708)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997643 5999999999999999999999998 99999999999998876 7999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. + ..+....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~-~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L-ANITAVS 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H-HHHHTTC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhcC
Confidence 9998764322 23445699999999999999999999999999999999999999975432221 1 1111111
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. .++.... ..+..+.+||.+||+.||++|||+.|+++
T Consensus 235 ~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0111111 22355889999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=363.05 Aligned_cols=269 Identities=27% Similarity=0.382 Sum_probs=212.9
Q ss_pred CcccceEeeeccEEEEEEEEc-----CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--CcceE
Q 047038 380 FNTNRILGQGGQGTVYKGMLE-----DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 451 (708)
Q Consensus 380 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 451 (708)
|+..+.||+|+||+||++.+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988643 6889999998764 345577899999999999999999999999874 56799
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999764 3899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
..... ......+|..|+|||.+.+..++.++||||||++++||++|+.||....... ...............+.+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence 43322 2334557889999999999899999999999999999999999985322110 00000000001111122222
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
........+...+..+.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 22222333445567799999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=359.32 Aligned_cols=245 Identities=22% Similarity=0.262 Sum_probs=196.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|+..++||+|+||+||+|... +++.||||++.. ........+..|+..+.++ +||||+++++++.+.+..+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999976 799999998754 3344555677777777666 899999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+ +++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6699988876543 5999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+..+... +.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~----~~ 272 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLP----PE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCC----HH
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCC----cc
Confidence 22 2344569999999999876 789999999999999999999776532110 1111111111 11
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ...++.+.+|+.+||+.||++|||++|+++
T Consensus 273 ~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 123456899999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.22 Aligned_cols=267 Identities=19% Similarity=0.269 Sum_probs=212.6
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceE-eeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC-LETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 453 (708)
..++|++.+.||+|+||+||+|+. .+++.||||.+..... .+++.+|+.++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999996 5789999998765332 34688999999999988877666655 5667789999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCccc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSI 530 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~~~ 530 (708)
||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 8999999975432 5999999999999999999999998 9999999999999 58889999999999876
Q ss_pred CcCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 531 AVDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 531 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12445799999999999999999999999999999999999999986554333222222211111100
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCC
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGA 659 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 659 (708)
. +.+ ....++.+.+++.+||+.||++|||++||++.|+.+......
T Consensus 239 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 I-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp H-----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred h-----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 011 122345689999999999999999999999999999876553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.89 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=209.6
Q ss_pred cCCcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC--Ccc
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 449 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 449 (708)
++|+..+.||+|+||+||++++ .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4688899999999999999984 36889999998753 334567899999999999999999999999876 668
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999966543 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh-------
Q 047038 530 IAVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM------- 600 (708)
Q Consensus 530 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 600 (708)
....... ......||..|+|||.+.+..++.++||||||+++|||++|..|+..... .+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--------LFLKMIGPTHGQM 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--------HHHHHHCSCCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--------HHhhccCCccccc
Confidence 6544332 23345688899999999999999999999999999999999998642110 000000
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
....+...+........+...++.+.+|+.+||+.||++|||+.|++++|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000111111111122223445567999999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.42 Aligned_cols=267 Identities=19% Similarity=0.273 Sum_probs=209.2
Q ss_pred hhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceE-eeCCcceEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC-LETEVPLLV 452 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV 452 (708)
...++|++.+.||+|+||+||+|+. .+++.||||..... ...+++.+|+.++++++|++++..++.+ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999996 57899999986542 2234688999999999988877776665 566778999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~~ 529 (708)
|||+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 8999999975433 5999999999999999999999998 9999999999999 7889999999999987
Q ss_pred cCcCCc------ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 530 IAVDQT------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 530 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 654322 12234579999999999999999999999999999999999999998755443332322221111110
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
.. +.. ....+..+.+|+.+||+.||++|||++||++.|+.+.....
T Consensus 238 ~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 238 PI-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CH-----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hh-----hhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00 001 11224569999999999999999999999999999988654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.83 Aligned_cols=271 Identities=28% Similarity=0.434 Sum_probs=220.4
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEE------cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeee
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKL 439 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l 439 (708)
+...+++...++|++.+.||+|+||+||+|.. .+++.||||.++.. .....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556677788999999999999999999984 24688999998763 345567899999999999 79999999
Q ss_pred eceEeeCC-cceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 047038 440 LGCCLETE-VPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRD 505 (708)
Q Consensus 440 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrD 505 (708)
++++.+.+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988755 58999999999999999986543 123889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCC
Q 047038 506 IKSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRL 583 (708)
Q Consensus 506 ikp~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~ 583 (708)
|||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 2334567899999999999999999999999999999998 9999976
Q ss_pred CCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 584 TNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
....+. +...+..+. ....+...+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 254 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDEE------FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSHH------HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHH------HHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 543321 111111111 1111223345689999999999999999999999999998763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.89 Aligned_cols=263 Identities=27% Similarity=0.443 Sum_probs=201.5
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
+...++|++.++||+|+||+||+|... ..||||.++.. .....+.|.+|+.++++++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344678999999999999999999864 35999987653 455678899999999999999999999965 5567899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999997543 35899999999999999999999998 9999999999999999999999999997654
Q ss_pred cC-CcceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 532 VD-QTHLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 532 ~~-~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
.. .........||+.|+|||.+. ...++.++||||||++++||++|+.||......+. ....+..+....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCc
Confidence 32 122234456899999999986 56788999999999999999999999975443321 111111111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
. ........++.+.+|+.+||+.+|++|||+.|++++|+.+.+
T Consensus 246 ~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 D-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp C-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred c-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 111123345679999999999999999999999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.77 Aligned_cols=261 Identities=21% Similarity=0.343 Sum_probs=201.3
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCCh--HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|+..+.||+|+||+||+|...+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999998899999999865432 2346789999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++ +|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 89888876432 5899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---hhhhh---
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---RLFEI--- 608 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 608 (708)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. ........... .+...
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcc
Confidence 2234468999999999876 4589999999999999999999999975443221 11111111110 00000
Q ss_pred --hhhhh-------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 --LDAQI-------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 --~d~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.++.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00111223466889999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=374.40 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=211.9
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceE
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCC 443 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 443 (708)
+..++++...++|+..++||+|+||+||+++.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445666777899999999999999999999975 68999999986422 22344588999999999999999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.+.+..+|||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999986532 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccc-------cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-------SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 596 (708)
||+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+. +
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------Y 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------H
Confidence 9999877654443444567999999999987 45689999999999999999999999975443221 1
Q ss_pred HHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 047038 597 LRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKR---PTMREVGI 648 (708)
Q Consensus 597 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~ 648 (708)
...+..... +. ........+..+.+||.+||. +|++| |+++|+++
T Consensus 280 ~~i~~~~~~---~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 GKIVHYKEH---LS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHTHHHH---CC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHhcccC---cC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111110000 00 000112334568999999999 99998 68999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=363.61 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=207.9
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
...++|++.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999975 6899999998653 45566789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGls~ 528 (708)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999887543 5899999999999999999999998 99999999999998654 59999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ...+..+... .
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~----~~~i~~~~~~-~ 249 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YAQIKAGAYD-Y 249 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHTCCC-C
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHhCCCC-C
Confidence 665322 2334679999999999999999999999999999999999999996543221 1 1111111110 0
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
. .......+..+.+|+.+||+.||++||++.|+++.
T Consensus 250 -~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -C----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -C----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00012234568999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.43 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=205.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChH---H----HHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDES---K----VEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~---~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
.++|+..+.||+|+||+||+|... +++.||||++...... . .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467899999999999999999974 7899999988653221 1 168999999999999999999999986544
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-----EEEee
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC-----AKVSD 523 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kl~D 523 (708)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999988876533 6999999999999999999999986 35999999999999988776 99999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccc--cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ--SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........... ....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-----NMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-----HHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-----HHHh
Confidence 999975432 234456999999999984 45678999999999999999999999975544322111 1111
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
.. ......+...+..+.+++.+||+.||++|||++|+++.|++|
T Consensus 244 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EE--------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HS--------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cc--------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 111122334456799999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=365.66 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=201.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 451 (708)
.++|++.++||+|+||+||+++.. +++.||||+++.. .....+.+.+|..+|.++ +|||||++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999976 5789999988652 233445688999999887 89999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998654 5999999999999999999999998 9999999999999999999999999998533
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh--hHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK--SLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 609 (708)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .........+....
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 22 22344567999999999999999999999999999999999999999754322211 11111111111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
...+......+.+|+.+||+.||++||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11233345668999999999999999995
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.87 Aligned_cols=249 Identities=28% Similarity=0.378 Sum_probs=201.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 450 (708)
..++|++.++||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999975 6899999998652 234556788999999998 7999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999998654 5999999999999999999999998 999999999999999999999999999854
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. + ..+..+.
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~-~~i~~~~------ 240 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------F-EAILNDE------ 240 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHHCC------
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------H-HHHHcCC------
Confidence 3222 224456799999999999998999999999999999999999999975443221 1 1111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM------REVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~ 648 (708)
...+......+.+|+.+||+.||++||++ +|+++
T Consensus 241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122344568999999999999999998 66653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=365.07 Aligned_cols=253 Identities=20% Similarity=0.281 Sum_probs=209.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.++|++.+.||+|+||+||+|... +++.||+|.+..........+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999975 6889999998876666777899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCcEEEeeccCCcccCcC
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD--KYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGls~~~~~~ 533 (708)
+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999997643 35899999999999999999999998 999999999999974 578999999999876543
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+..... ..
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~----~~i~~~~~------~~ 269 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL----QNVKRCDW------EF 269 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHHCCC------CC
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCC------CC
Confidence 32 334469999999999999999999999999999999999999997543221 11 11111110 00
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011112334568999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.60 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=206.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..++|+..+.||+|+||+||++... +++.||+|.++.... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467899999999999999999975 689999998765322 136789999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEeec
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY----CAKVSDF 524 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DF 524 (708)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999997543 5899999999999999999999998 99999999999999887 8999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
|+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||......+. .. .+....
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~----~~~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA----NVSAVN 233 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH----HHHHTC
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH----HHHhcC
Confidence 9998764332 23345699999999999999999999999999999999999999965432221 11 111100
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. . ...... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~-~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y-E-FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-C-CCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-C-cCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 001111 122355889999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=364.60 Aligned_cols=256 Identities=22% Similarity=0.387 Sum_probs=205.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcE----EEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKI----VAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
++|+..++||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999964 4443 7888765422 333457889999999999999999999886 567899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999997653 26889999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~----- 234 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGE----- 234 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTC-----
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCC-----
Confidence 43322 2344567889999999999999999999999999999999 99999765433311 1111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+...+..+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 235 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 ----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111122233458889999999999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=365.22 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=206.0
Q ss_pred hccCCcccceEeee--ccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQG--GQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
..++|++.++||+| +||+||+++.. +++.||||+++. ......+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999976 689999999865 33555678899999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999986532 25899999999999999999999998 999999999999999999999999998654
Q ss_pred CcCCc------ceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh-
Q 047038 531 AVDQT------HLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR- 601 (708)
Q Consensus 531 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~- 601 (708)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCc
Confidence 32111 11223468999999999987 67999999999999999999999999765433211 000000000
Q ss_pred --------hc-------------hhhhhhhh---------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 --------ED-------------RLFEILDA---------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 --------~~-------------~~~~~~d~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. .+.+.+.. .............+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 00000000 0000112233466899999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.62 Aligned_cols=267 Identities=16% Similarity=0.206 Sum_probs=203.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccCChH-----------HHHHHHHHHHHHHhcCCCceeeeec
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKIIDES-----------KVEEFINEVVILSQINHRNVVKLLG 441 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g 441 (708)
.++|.+.+.||+|+||+||+|... ++..||||+....... ..+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999975 5778999987654321 1234778899999999999999999
Q ss_pred eEee----CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 047038 442 CCLE----TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 442 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~ 517 (708)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999998654 6999999999999999999999998 99999999999999887
Q ss_pred --cEEEeeccCCcccCcCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchh
Q 047038 518 --CAKVSDFGASRSIAVDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589 (708)
Q Consensus 518 --~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~ 589 (708)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 11345699999999999999999999999999999999999999964322211
Q ss_pred hhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 590 KSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
. .......... .+.+.+... ......+..+.+++.+||+.||++||++++|++.|+.+...
T Consensus 269 ~--~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 269 A--VQTAKTNLLD-ELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp H--HHHHHHHHHH-TTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred H--HHHHHHhhcc-cccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1 1111111111 011111100 00113445699999999999999999999999999987653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=364.25 Aligned_cols=266 Identities=27% Similarity=0.457 Sum_probs=214.4
Q ss_pred ccCCcccceEeeeccEEEEEEEE-----cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC--cc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-----EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~ 449 (708)
.++|++.+.||+|+||.||++.. .+++.||||++........+.|.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788999999999999999984 368899999998877777889999999999999999999999987654 78
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999986532 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc----
Q 047038 530 IAVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---- 603 (708)
Q Consensus 530 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 603 (708)
........ .....++..|+|||.+.+..++.++||||||++++||++|..|+..... .+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--------~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--------HHHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--------HHHHhhccccchh
Confidence 65443221 2234577889999999988899999999999999999999999753210 011111000
Q ss_pred ----hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 604 ----RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 604 ----~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+.+.+........+...+..+.+|+.+||+.||++|||+.||++.|+.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111112233445679999999999999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=364.23 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=201.7
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeCCcce
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPL 450 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~ 450 (708)
...++|++.+.||+|+||+||++...+++.||||++.. ......+.+.+|+.+|++++| +||+++++++.+.+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 34567999999999999999999998899999998765 345566789999999999976 99999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 56789999998653 5899999999999999999999998 99999999999997 578999999999876
Q ss_pred CcCCcc-eeecccccccccCcccccc-----------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH
Q 047038 531 AVDQTH-LTTQVQGTFGYLDPEYFQS-----------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 531 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 598 (708)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~--- 229 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK--- 229 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH---
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HH---
Confidence 543322 2345679999999999865 678999999999999999999999996432211 11
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
+..++++......+......+.+|+.+||+.||++|||+.|+++.-
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 230 ------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1112222222222333345689999999999999999999998653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.76 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=208.1
Q ss_pred CCcccceEeeeccEEEEEEEEcC-C---cEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc-eEE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLED-G---KIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP-LLV 452 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 452 (708)
.|...++||+|+||+||+|...+ + ..||+|.++.. .....+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998542 2 37999988753 345678899999999999999999999999876655 999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 35899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCc---ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCC-CCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 533 DQT---HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP-IRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 533 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
... .......+|+.|+|||.+.+..++.++||||||+++|||++|..| |......+ ... .+...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~----~~~~~----- 244 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH----FLAQG----- 244 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH----HHHTT-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH----HhhcC-----
Confidence 221 123345678999999999999999999999999999999995555 43322221 111 11111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
.....+...+..+.+++.+||+.||++|||++|++++|+.+.....
T Consensus 245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111123344669999999999999999999999999999987544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.41 Aligned_cols=276 Identities=24% Similarity=0.281 Sum_probs=214.0
Q ss_pred CcccccChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-----CCce
Q 047038 363 DKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-----HRNV 436 (708)
Q Consensus 363 ~~~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~ni 436 (708)
+....++..+.....++|++.++||+|+||+||+|+.. +++.||||+++. .....+.+..|+.++++++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34455667777778899999999999999999999974 688999999874 3455667888999999986 9999
Q ss_pred eeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-
Q 047038 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD- 515 (708)
Q Consensus 437 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~- 515 (708)
|++++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 99999999999999999999 8999999986542 25899999999999999999999998 999999999999975
Q ss_pred ------------------------CCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHH
Q 047038 516 ------------------------KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVL 571 (708)
Q Consensus 516 ------------------------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl 571 (708)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 788999999999864322 2345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh--------hhh-hh-----------------ccC---CHHHH
Q 047038 572 VELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL--------DAQ-IL-----------------KEG---GKDEF 622 (708)
Q Consensus 572 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------d~~-~~-----------------~~~---~~~~~ 622 (708)
|||++|+.||......+................+.+.. +.. .. ... .....
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 99999999997654332211111110000000000000 000 00 000 00011
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 623 KMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 623 ~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.+.+|+.+||+.||++|||++|+++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 56889999999999999999999963
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.57 Aligned_cols=259 Identities=29% Similarity=0.479 Sum_probs=206.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEe-eCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~ 450 (708)
..+|+..++||+|+||+||+|...+ ...||+|.++. ......+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999999642 23689998875 34556788999999999999999999999865 456789
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997643 35899999999999999999999998 999999999999999999999999999866
Q ss_pred CcCCc---ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 531 AVDQT---HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 531 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
..... .......+|+.|+|||.+.+..++.++||||||++++||++ |.+||......+. ... +..+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~----~~~~~-- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGR-- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH----HHTTC--
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH----HhcCC--
Confidence 43221 12334567889999999999999999999999999999999 5666654433221 111 11110
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
....+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111222345699999999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.06 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=206.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-----CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-----GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.++|...++||+|+||+||+|.... +..||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4577888999999999999998653 236999998753 4455678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999997643 26899999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 531 AVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 531 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~---- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDG---- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTT----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCC----
Confidence 533221 1223346889999999999999999999999999999999 999996543221 11111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...+..+.+|+.+||+.+|++||++.||++.|+.+..
T Consensus 267 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 267 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111123345668999999999999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.42 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=206.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC-C-------cEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED-G-------KIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
.++|.+.+.||+|+||+||+|.... + +.||+|.+........+.|.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678899999999999999999653 3 4799999877666777899999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--------EE
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC--------AK 520 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~--------~k 520 (708)
.++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999986532 4899999999999999999999998 999999999999998887 99
Q ss_pred EeeccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCC-CCCCCCcchhhhHHHHHHH
Q 047038 521 VSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGER-PIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~-P~~~~~~~~~~~~~~~~~~ 598 (708)
|+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|.. |+........ . .
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~----~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---L----Q 229 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H----H
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---H----H
Confidence 999999875432 123458899999999987 779999999999999999999554 4432221110 0 0
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.... ....+...+..+.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 230 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 230 FYED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred Hhhc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0000 0011112234588999999999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=352.56 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=201.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 6899999988653 34455789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 5555554432 25999999999999999999999998 9999999999999999999999999998764322
Q ss_pred cceeecccccccccCccccccCC-CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRLFEILD 610 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d 610 (708)
. ......||+.|+|||++.+.. ++.++||||||++++||++|..||....... ............ ..+.....
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcc
Confidence 2 234456899999999998765 8999999999999999999888864333221 111111111111 00000000
Q ss_pred ------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 ------------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111234466899999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=370.90 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=206.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
...++|++.+.||+|+||+||++... +|+.+|+|.+.... ....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999964 78999999876533 4456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGls~ 528 (708)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999988653 5999999999999999999999998 99999999999998 56789999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||......+ ....+..+...
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~-- 231 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYD-- 231 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC--
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCC--
Confidence 7654322 2344679999999999999999999999999999999999999996543221 11111111110
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 ----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000111233456899999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.20 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=210.6
Q ss_pred HHhhccCCcccc-eEeeeccEEEEEEEEc---CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC
Q 047038 373 LEKATDNFNTNR-ILGQGGQGTVYKGMLE---DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET 446 (708)
Q Consensus 373 l~~~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 446 (708)
+....++|.+.+ .||+|+||+||+|.+. +++.||||.++... ....+++.+|+.++++++||||+++++++ +.
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 334456788877 9999999999999653 46789999987532 33467899999999999999999999999 66
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 77899999999999999998653 5899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 527 SRSIAVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 527 s~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~ 236 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG 236 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC
Confidence 98765443322 223346789999999998889999999999999999999 999997544322 11111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
. ....+...+..+.+++.+||+.||++||++.||++.|+.+...
T Consensus 237 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 E---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 1112334456799999999999999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=363.92 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=205.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999965 5889999987642 233457889999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999998643 5999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcceeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
. .......||+.|+|||++.. ..++.++||||||+++|||++|+.||..............+ ...
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~------ 235 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETT------ 235 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHC------
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhc------
Confidence 2 22345679999999999874 45899999999999999999999999755443322222111 110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-MREVG 647 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~ 647 (708)
....+...+..+.+|+.+||+.||++||+ +++|+
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 11123334566899999999999999998 66665
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.98 Aligned_cols=267 Identities=25% Similarity=0.430 Sum_probs=205.6
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCL 444 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 444 (708)
+++....++|.+.+.||+|+||+||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556678999999999999999999864 3458999998753 4556678999999999999999999999998
Q ss_pred eCCc-----ceEEEEeccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 047038 445 ETEV-----PLLVYEFISNGTLSQYIDDQN---KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK 516 (708)
Q Consensus 445 ~~~~-----~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~ 516 (708)
+.+. .++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7553 499999999999999985432 2346999999999999999999999998 9999999999999999
Q ss_pred CcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHH
Q 047038 517 YCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 517 ~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 594 (708)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH
Confidence 99999999999866433221 2233457889999999999999999999999999999999 8999876543321 11
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
. +..+. ....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 261 ~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 261 Y----LLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp H----HHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11110 1111233446699999999999999999999999999998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=357.35 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=203.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 451 (708)
.++|+..+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.+++++ +|||||++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357899999999999999999976 5889999988652 445667789999999988 89999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999998653 5899999999999999999999998 9999999999999999999999999998643
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh--hHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK--SLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 609 (708)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........+....
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 222 2234567999999999999999999999999999999999999999753322111 11111111111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
...+...+..+.+|+.+||+.||++||++
T Consensus 236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11223345668999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.26 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=204.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.++|++.+.||+|+||+||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999975 68999999875421 224678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEeeccC
Q 047038 451 LVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC---AKVSDFGA 526 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGl 526 (708)
+||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876542 2345899999999999999999999998 999999999999986654 99999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+ + ..+..+...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~-~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL---F-EGIIKGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH---H-HHHHHTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH---H-HHHHcCCCC
Confidence 987654322 23445699999999999999999999999999999999999999965311 11 1 111111110
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.++... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111 122356899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.46 Aligned_cols=259 Identities=29% Similarity=0.472 Sum_probs=200.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc--CC--cEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEee-CCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE--DG--KIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 451 (708)
..|+..++||+|+||+||+|.+. ++ ..||||.++. .+....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999964 22 3689998865 345667889999999999999999999998764 557899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++..... .+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976433 5889999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCcc---eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 532 VDQTH---LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 532 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+.. .. +..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~----~~~~~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VY----LLQGRR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HH----HHTTCC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HH----HHcCCC--
Confidence 32211 1233457889999999999999999999999999999999 77888654433211 11 111110
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
...+...+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 315 -------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 315 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1112233456899999999999999999999999999998743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=352.19 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=201.0
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|+..+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999976 58999999875533 3446778999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999887543 5899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH--------Hhhhchh
Q 047038 535 THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR--------AMREDRL 605 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--------~~~~~~~ 605 (708)
. ......||+.|+|||.+.+ ..++.++||||||++++||++|+.||......+.......... .......
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2334568999999999876 6789999999999999999999999976554332221111100 0000000
Q ss_pred hhhhh---hhh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILD---AQI---LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d---~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... +.. ........+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 000 00000223456889999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.88 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=209.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee----CCcc
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVP 449 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 449 (708)
...++|++.+.||+|+||+||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999997 5789999999877777788899999999999999999999999973 3467
Q ss_pred eEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 450 LLVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 89999999999999997632 2346999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCcCCcc--------eeecccccccccCccccccCC---CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 529 SIAVDQTH--------LTTQVQGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 529 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||........ .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~------ 255 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S------ 255 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C------
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h------
Confidence 65321110 012345799999999987554 68999999999999999999999842111000 0
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+...+............+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 256 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 256 -------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000000111111122344679999999999999999999999999999876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=360.46 Aligned_cols=261 Identities=25% Similarity=0.301 Sum_probs=204.1
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-----ChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-----DESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
++....++|++.+.||+|+||+||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667789999999999999999999974 6889999987542 34566789999999999999999999999999
Q ss_pred CCcceEEEEeccCCCccccccccC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQN-------------------------------------KDFRISWEMRLCIAIDVSG 488 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~ 488 (708)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999986311 0123467788899999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCcEEEcCCC--cEEEeeccCCcccCcCC---cceeecccccccccCcccccc--CCCCcc
Q 047038 489 AISYLHSAASIPIYHRDIKSTNILLDDKY--CAKVSDFGASRSIAVDQ---THLTTQVQGTFGYLDPEYFQS--SHFTEK 561 (708)
Q Consensus 489 al~yLH~~~~~~iiHrDikp~NIll~~~~--~~kl~DFGls~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~t~k 561 (708)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||.+.. ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 89999999998654321 112345669999999999975 678999
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 047038 562 SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP 641 (708)
Q Consensus 562 sDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 641 (708)
+||||||+++|||++|+.||......+. ............ ..........+.+|+.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999965443221 111111111000 000112345689999999999999999
Q ss_pred CHHHHHH
Q 047038 642 TMREVGI 648 (708)
Q Consensus 642 t~~ev~~ 648 (708)
++.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=386.38 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=207.2
Q ss_pred ccCCcccc-eEeeeccEEEEEEEEc---CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 377 TDNFNTNR-ILGQGGQGTVYKGMLE---DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.+++.+.+ .||+|+||+||+|.+. ++..||||+++.. .....++|.+|+++|++++|||||++++++.+ +..+|
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34444444 7999999999999865 4567999998764 34467889999999999999999999999976 56899
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999997643 36999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 532 VDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 532 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... .....+|+.|+|||++....++.++||||||++||||++ |+.||......+. ...+..+.
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~---- 556 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGK---- 556 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHHHHTTC----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCC----
Confidence 433222 122345689999999999999999999999999999998 9999976544321 11121111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
....+...+..+.+|+.+||+.+|++||++++|++.|+.+...
T Consensus 557 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 557 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1122334556799999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.39 Aligned_cols=261 Identities=27% Similarity=0.363 Sum_probs=201.6
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc--
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP-- 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-- 449 (708)
..++|++.+.||+|+||+||++.. .+++.||||+++.. +....+.|.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346899999999999999999996 57899999998653 344567899999999999999999999999876654
Q ss_pred --eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 450 --LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 450 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
++||||+++++|.++++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999998654 5899999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcc--eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 528 RSIAVDQTH--LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 528 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence 866433221 2334568999999999999999999999999999999999999996543322 11111111111
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHcccc
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE-VGIELTGIRG 655 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-v~~~L~~l~~ 655 (708)
.. ... ....+..+.+|+.+||+.||++||++.+ +.+.|..+..
T Consensus 238 ~~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 PP---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CH---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred Cc---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 10 000 1123456899999999999999996555 5566666544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=364.91 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=200.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcC--CCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQIN--HRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||++...+++.||||++.. .+....+.+.+|+.+|++++ |||||++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999988899999998764 34556788999999999996 59999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56889999998654 5899999999999999999999998 99999999999996 57899999999987654
Q ss_pred CCcc-eeecccccccccCcccccc-----------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 533 DQTH-LTTQVQGTFGYLDPEYFQS-----------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 533 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
.... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||....... ..+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~---- 277 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL---- 277 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHH----
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHH----
Confidence 3322 2345679999999999865 468999999999999999999999996433211 111
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+++.......+......+.+|+.+||+.||++|||+.|+++.
T Consensus 278 -----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11222221112222224568999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.67 Aligned_cols=268 Identities=14% Similarity=0.182 Sum_probs=209.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEcC---------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceee---------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLED---------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVK--------- 438 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 438 (708)
.++|.+.+.||+|+||+||+|+... ++.||||.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 789999998653 46889999999999999998
Q ss_pred ------eeceEee-CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 439 ------LLGCCLE-TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 439 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667766 67889999999 999999998652 236999999999999999999999998 99999999999
Q ss_pred EEcCCC--cEEEeeccCCcccCcCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 047038 512 LLDDKY--CAKVSDFGASRSIAVDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRL 583 (708)
Q Consensus 512 ll~~~~--~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~ 583 (708)
|++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876533221 12345799999999999999999999999999999999999999975
Q ss_pred CCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccCCC
Q 047038 584 TNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGAS 660 (708)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~ 660 (708)
....... ..... ...... ...+.+... .....+..+.+|+.+||+.||++|||++||++.|+.+.......
T Consensus 271 ~~~~~~~-~~~~~-~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 271 CLPNTED-IMKQK-QKFVDK-PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GTTCHHH-HHHHH-HHHHHS-CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcCHHH-HHHHH-HhccCC-hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 4322211 11111 111000 000000000 00122466999999999999999999999999999998765533
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=356.14 Aligned_cols=263 Identities=23% Similarity=0.374 Sum_probs=191.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|+..+.||+|+||+||+|... +++.||||.++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999965 68999999887533 3345678999999999999999999999999999999999
Q ss_pred eccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 455 FISNGTLSQYIDDQN---KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886542 1235899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRLFE 607 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 607 (708)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .......... ..+..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence 3222 2234568999999999976 4689999999999999999999999976543322 1111111110 00000
Q ss_pred hh-----------------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 608 IL-----------------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 608 ~~-----------------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.. ...+...........+.+|+.+||+.||++|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 00 00000111112345689999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.28 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=197.6
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEee----
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLE---- 445 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~---- 445 (708)
.++....+|++.++||+|+||+||++... +++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34455678999999999999999999965 78999999987777777889999999999996 9999999999953
Q ss_pred ----CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 446 ----TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 446 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
....++||||++ |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 334789999996 699999876444446999999999999999999999976 35999999999999999999999
Q ss_pred eeccCCcccCcCCcce-----------eecccccccccCcccc---ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcc
Q 047038 522 SDFGASRSIAVDQTHL-----------TTQVQGTFGYLDPEYF---QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~ 587 (708)
+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765322211 1134589999999998 5677899999999999999999999999643221
Q ss_pred hhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
. ++...............+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 260 ~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 R-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 0000000111112223478999999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=353.28 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=205.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||+++.. +|+.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999975 68999999886521 23456788999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998653 5899999999999999999999998 99999999999999999999999999986542
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+...... .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~-~-------- 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNA-E-------- 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHC-C--------
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-C--------
Confidence 2 234569999999999999999999999999999999999999996543221 11111111 1
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
...+......+.+|+.+||+.||++|| +++|+++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 011223345689999999999999999 8888863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.09 Aligned_cols=272 Identities=21% Similarity=0.323 Sum_probs=206.1
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc--CCCceeeeeceEeeC---
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI--NHRNVVKLLGCCLET--- 446 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~--- 446 (708)
......++|++.++||+|+||+||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33455678999999999999999999875 899999998642 234555666666654 899999999999887
Q ss_pred -CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEEcCCCcEE
Q 047038 447 -EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA-----SIPIYHRDIKSTNILLDDKYCAK 520 (708)
Q Consensus 447 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-----~~~iiHrDikp~NIll~~~~~~k 520 (708)
...++||||+++|+|.++++.. .+++..++.++.|++.||.|||+.. .++|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 6789999999999999999754 5899999999999999999999981 11299999999999999999999
Q ss_pred EeeccCCcccCcCCcce---eecccccccccCccccccCCCCcc------chhHhHHHHHHHHHhC----------CCCC
Q 047038 521 VSDFGASRSIAVDQTHL---TTQVQGTFGYLDPEYFQSSHFTEK------SDVYSFGVVLVELLTG----------ERPI 581 (708)
Q Consensus 521 l~DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDv~SlGvvl~elltg----------~~P~ 581 (708)
|+|||+++......... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997664332221 224569999999999988766665 9999999999999999 6666
Q ss_pred CCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 582 RLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
......... .................... ......+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 263 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 263 HDLVPSDPS--YEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhhcCCCCc--hhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 543222111 11111111111111000000 01235677899999999999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=354.49 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=195.7
Q ss_pred ccCCcccceEeeeccEEEEEEEE----cCCcEEEEEEcccCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML----EDGKIVAVKKSKIID----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
.++|++.++||+|+||+||+++. .+++.||+|+++... ......+.+|+.+|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 478999999987532 3345678899999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997654 5899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... .... ..
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~-~~---- 237 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TID---KILK-CK---- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH-TC----
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHh-CC----
Confidence 543222 22344569999999999999999999999999999999999999997543221 111 1111 10
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
...+......+.+|+.+||+.||++|| ++.|+++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111223446689999999999999999 7777764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.25 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=205.1
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCc
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV 448 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 448 (708)
....++|.+.++||+|+||+||+|+.. +++.||||.++... ....+.+..|..+++++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999976 68999999986521 23456788999999987 99999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999998653 5899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ...+....
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~----~~~i~~~~---- 234 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L----FHSIRMDN---- 234 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCC----
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHhCC----
Confidence 643222 22345679999999999999999999999999999999999999997543221 1 11111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR-EVG 647 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 647 (708)
...+......+.+|+.+||+.||++||++. ||+
T Consensus 235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011223345689999999999999999997 554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=365.39 Aligned_cols=272 Identities=24% Similarity=0.368 Sum_probs=216.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC--cceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 452 (708)
.++|.+.++||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999976 58999999987533 334677889999999999999999999998765 67999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEeeccCCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL----DDKYCAKVSDFGASR 528 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGls~ 528 (708)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987655555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCcCCcceeecccccccccCcccccc--------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQS--------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.......... ......+
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKII 240 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHh
Confidence 764332 2334569999999999865 567889999999999999999999997543322111 1111111
Q ss_pred hhchh---hhh---h--------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 601 REDRL---FEI---L--------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 601 ~~~~~---~~~---~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..... ... . +..............+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11100 000 0 0001122346677889999999999999999999999999998866
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=358.19 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=205.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|+..+.||+|+||+||+++.. +++.||||.++... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357899999999999999999975 68999999886422 23456889999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998654 5899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV------- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 2 234569999999999999999999999999999999999999997543221 1111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
..+...+..+.+|+.+||+.||++||+ ++||++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112234456899999999999999998 777764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.28 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=180.5
Q ss_pred cceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEeccCCC
Q 047038 383 NRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
.++||+|+||+||++... +++.||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 689999999864 34567889999999997 9999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEeeccCCcccCcCCcce
Q 047038 461 LSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY---CAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 461 L~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGls~~~~~~~~~~ 537 (708)
|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 999998653 5999999999999999999999998 99999999999998765 899999999986543322 2
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+.... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~---- 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEA---- 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHH----
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cccc----
Confidence 3445689999999999999999999999999999999999999975443221111112222222221100 0000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
....++.+.+|+.+||+.||++|||++|++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 112346689999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.61 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=203.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-CcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 454 (708)
..++|+..+.||+|+||+||++... ++.||||.++.. ...+.|.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4568999999999999999999874 889999998753 3567899999999999999999999997654 47899999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999976532 24889999999999999999999998 999999999999999999999999998754322
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....+++.|+|||.+.+..++.++||||||++++||++ |+.||......+. . ..+..+ .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----~~~~~~---------~ 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKG---------Y 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H----HHHTTT---------C
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcC---------C
Confidence 123357889999999999999999999999999999998 9999975443221 1 111111 1
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 112233345679999999999999999999999999999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=358.54 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=202.8
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.+.|+..+.||+|+||+||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688999999999999999996 57899999998653 234457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||++ |+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 688888765432 6899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||......+. ........ .
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~-~---- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-S---- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC-C----
Confidence 2 2356999999999984 56789999999999999999999999965432211 11111111 0
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
........+..+.+|+.+||+.||++|||++|+++...
T Consensus 271 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 271 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 00111223456889999999999999999999986543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=362.22 Aligned_cols=248 Identities=25% Similarity=0.294 Sum_probs=199.5
Q ss_pred cccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccCC
Q 047038 381 NTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 459 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 459 (708)
...++||+|+||+||+|... +|+.||+|+++.......+.|.+|+.+|++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33578999999999999965 68999999998877677889999999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCCCcEEEeeccCCcccCcCCcce
Q 047038 460 TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL--DDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 460 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll--~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++...... .
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 9999887543 25899999999999999999999998 9999999999999 577899999999998765332 2
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccC
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 617 (708)
.....||+.|+|||++....++.++||||||+++|||++|+.||......+. ....... ... .....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~-~~~------~~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILAC-RWD------LEDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHT-CCC------SCSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-cCC------CChhh
Confidence 2344699999999999999999999999999999999999999975443211 1111111 000 00000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 618 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....++.+.+|+.+||+.||++|||+.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1223456899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=359.91 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=192.7
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.....++|++.+.||+|+||+||+|... +++.||||.++.. ...+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3455678999999999999999999976 5789999998753 244678899999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGls~ 528 (708)
||||+++++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999997643 5899999999999999999999998 999999999999975 8899999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ . + ..+......
T Consensus 200 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~-~~i~~~~~~-- 269 (349)
T 2w4o_A 200 IVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---F-RRILNCEYY-- 269 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---H-HHHHTTCCC--
T ss_pred ccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---H-HHHHhCCCc--
Confidence 65432 223445699999999999999999999999999999999999999965433221 1 1 111111100
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 270 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 ----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111234456899999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.46 Aligned_cols=259 Identities=21% Similarity=0.255 Sum_probs=202.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||++... +++.||||.+... +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 6889999998653 334457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999998653 5899999999999999999999998 99999999999999999999999999986654
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.... .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~------ 252 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-P------ 252 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-C------
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-C------
Confidence 4333344556899999999999999999999999999999999999999643211 1111111110 0
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRP-TMREVGIELTGIRG 655 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~ 655 (708)
.........+..+.+++.+||+.||++|| +++++++.|+.+..
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00111233345689999999999999999 99999999998876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=358.53 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=203.1
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|.+.+.||+|+||+||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999996 478999999876421 12235789999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 679988887654 5999999999999999999999999 99999999999999999999999999986643
Q ss_pred CCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......+.. ..+..
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~ 222 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS 222 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc
Confidence 32 2344569999999999988776 78999999999999999999999754332210 00000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
. ....+...+..+.+|+.+||+.||.+|||++|+++.
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 011122334568999999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.13 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=194.9
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCC--c
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETE--V 448 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~ 448 (708)
...++|++.+.||+|+||+||+|... +++.||||++.. ......+.+.+|+.+|+++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999965 689999998754 34566778999999999997 999999999998644 6
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999998 5898888753 5899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcC--------------------CcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcc
Q 047038 529 SIAVD--------------------QTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587 (708)
Q Consensus 529 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~ 587 (708)
..... .....+...||+.|+|||++.+ ..++.++||||||++++||++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112344679999999999976 67899999999999999999999999765433
Q ss_pred hhhhHHHHHHHHhhhchhh-----------hhhh---------------------hhh-hccCCHHHHHHHHHHHHHhcc
Q 047038 588 EDKSLAAYFLRAMREDRLF-----------EILD---------------------AQI-LKEGGKDEFKMVAKLAKRCLN 634 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~-----------~~~d---------------------~~~-~~~~~~~~~~~l~~li~~cl~ 634 (708)
+.... ....+...... ..+. ... ...........+.+|+.+||+
T Consensus 238 ~~~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQLER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 22111 11111100000 0000 000 000011224568999999999
Q ss_pred cCCCCCCCHHHHHH
Q 047038 635 LNGKKRPTMREVGI 648 (708)
Q Consensus 635 ~~p~~RPt~~ev~~ 648 (708)
.||++|||++|+++
T Consensus 315 ~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 315 FNPNKRISANDALK 328 (388)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred cCcccCCCHHHHhC
Confidence 99999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.75 Aligned_cols=267 Identities=25% Similarity=0.379 Sum_probs=205.3
Q ss_pred hhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
...++|++.+.||+|+||+||+|.. .+++.||||+++. .+....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3456899999999999999999996 4789999998864 34566778999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 451 LVYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999997532 2336899999999999999999999998 99999999999999999999999999876
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+ ...+......
T Consensus 186 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~~~~--- 256 (310)
T 2wqm_A 186 FSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL----CKKIEQCDYP--- 256 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HH----HHHHHTTCSC---
T ss_pred ecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HH----HHHhhcccCC---
Confidence 543221 22345689999999999999999999999999999999999999964432211 11 1111111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
.......+..+.+|+.+||+.||++|||++||++.|++++....
T Consensus 257 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 -----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 00112334568999999999999999999999999999987433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=356.33 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=197.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|...+.||+|+||+||+|... +++.||||+++..... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999976 7899999988753322 222566899999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
++ |+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 589888876543 5899999999999999999999998 99999999999999999999999999876543222
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+.........
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2334568999999999876 56899999999999999999999999765443322111111111111111111110000
Q ss_pred -------------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 -------------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 -------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0001123456889999999999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.99 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=204.1
Q ss_pred HHHhhccCCccc-ceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeC
Q 047038 372 ELEKATDNFNTN-RILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 446 (708)
Q Consensus 372 el~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 446 (708)
..+...++|.+. +.||+|+||+||++... +++.||||.++.. .......+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556677777 89999999999999976 6899999987652 334467899999999999 569999999999999
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEee
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSD 523 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~D 523 (708)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999986542 236999999999999999999999998 999999999999998 78999999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. . . +...
T Consensus 178 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~---~-i~~~ 248 (327)
T 3lm5_A 178 FGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY---L---N-ISQV 248 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHT
T ss_pred CccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---H---H-HHhc
Confidence 99998664322 233456999999999999999999999999999999999999999654432211 0 0 0000
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
. ..............+.+|+.+||+.||++|||++|++
T Consensus 249 ~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 249 N------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp C------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred c------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 0001111223445689999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=354.23 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=207.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcE--EEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKI--VAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
++|++.+.||+|+||+||+|+.. +++. ||||.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999965 5664 499987653 344566799999999999 899999999999999999999
Q ss_pred EEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 453 YEFISNGTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997653 2236899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHH
Q 047038 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 598 (708)
||+|||+++..... .......+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence 99999998743321 11233457889999999998889999999999999999998 999996544221 111
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.+..+ .....+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 253 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11122333456799999999999999999999999999998773
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=357.06 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=205.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 450 (708)
..++|+..++||+|+||+||+++.. +++.||||.++.. .....+.+.+|..+|+.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999976 4789999988652 223456788999999988 8999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999998654 5899999999999999999999998 999999999999999999999999999864
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + + ..+....
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~---~-~~i~~~~------ 237 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---F-QSIMEHN------ 237 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHCC------
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---H---H-HHHHhCC------
Confidence 3222 22345679999999999999999999999999999999999999997543221 1 1 1111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
...+...+..+.+|+.+||+.||++||+ ++|+++
T Consensus 238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122334566899999999999999995 466654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=360.88 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=195.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|++.+.||+|+||+||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3568999999999999999999976 78999999986533 233578899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--EEEeeccCCcccCc
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC--AKVSDFGASRSIAV 532 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGls~~~~~ 532 (708)
|+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999997654 5999999999999999999999998 999999999999987765 99999999875332
Q ss_pred CCcceeecccccccccCccccccCCCCcc-chhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEK-SDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||......... ......... .
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~---------~ 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILS---------V 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHT---------T
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhc---------C
Confidence 21 2234569999999999988887665 89999999999999999999754432211 111111111 1
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111234568999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.70 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=207.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
..++|++.+.||+|+||+||+|... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999975 588999998754 3455667899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC---AKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGls~~ 529 (708)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998887653 5899999999999999999999998 999999999999986655 99999999976
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
..... ......||+.|+|||.+.+..++.++||||||+++++|++|+.||......+. . ..+..+...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~----~~~~~~~~~--- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---Y----AQIKAGAYD--- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHTCCC---
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---H----HHHHhcccc---
Confidence 54322 23345699999999999999999999999999999999999999965432211 1 111111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000111233456899999999999999999999976
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=343.00 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=205.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|++.+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999976 577899999876555567889999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCcccC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~~~~ 531 (708)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999987654 5899999999999999999999998 9999999999999 788999999999998664
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
... ......||+.|+|||.+.+. ++.++||||||++++||++|+.||......+. ...+..+.... ..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~--~~ 228 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGTFTF--PE 228 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC--CH
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCCC--Cc
Confidence 332 23345699999999998754 89999999999999999999999975432221 11111111100 00
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ...++.+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 122456899999999999999999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.12 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=205.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.+.||+|+||+||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999976 6899999987643 33456789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999997543 5899999999999999999999998 9999999999999999999999999998654322
Q ss_pred c-ceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 535 T-HLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 535 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. .......||+.|+|||.+.+..+ +.++||||||++++||++|+.||......... .. ........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~----~~~~~~~~------- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS----DWKEKKTY------- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HH----HHHTTCTT-------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HH----Hhhhcccc-------
Confidence 2 22344568999999999987665 78999999999999999999999764432211 11 11111000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+..+.+|+.+||+.||++|||++|+++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0001223456889999999999999999999963
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=371.17 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=196.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|++.++||+|+||+||++... +++.||||+++. ........+.+|+.++++++||||+++++++.+.+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999965 689999998864 234455678899999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999997654 58999999999999999999998 77 999999999999999999999999999864
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||........ + ..+....
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~-~~i~~~~------ 365 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------F-ELILMEE------ 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHHCC------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------H-HHHHhCC------
Confidence 3322 223456799999999999999999999999999999999999999965433211 1 1111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
...+......+.+|+.+||+.||++|| +++|+++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011223446689999999999999999 9999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=383.83 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=201.8
Q ss_pred ceEeeeccEEEEEEEEc---CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLE---DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||+|.+. .++.||||+++.. +....++|.+|+++|++++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999754 4678999998753 3445688999999999999999999999986 4568899999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc--
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH-- 536 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~-- 536 (708)
|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997543 5899999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
......+|+.|+|||++....++.++||||||++||||++ |+.||......+ ....+..+ ...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~---------~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG---------ERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT---------CCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------CCC
Confidence 2233457889999999999999999999999999999998 999997554322 11111111 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
..+...+..+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2233445679999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=353.66 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=200.1
Q ss_pred ccCCccc-ceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEE
Q 047038 377 TDNFNTN-RILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 377 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 453 (708)
.+.|.+. ++||+|+||+||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999954 7899999998776556678899999999995 7999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEeeccCCccc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC---AKVSDFGASRSI 530 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGls~~~ 530 (708)
||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998653 5899999999999999999999998 999999999999998776 999999998765
Q ss_pred CcCCc------ceeecccccccccCcccccc-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhh--------
Q 047038 531 AVDQT------HLTTQVQGTFGYLDPEYFQS-----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS-------- 591 (708)
Q Consensus 531 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~-------- 591 (708)
..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223459999999999875 558899999999999999999999997654322100
Q ss_pred HHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 592 LAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
........+..+... . ..... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~~-~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-F-PDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCC-C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcc-c-Cchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 011111111111110 0 00000 112456899999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.95 Aligned_cols=248 Identities=28% Similarity=0.381 Sum_probs=202.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
+.++|++.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4568999999999999999999966 57799999875422 2235678999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999997654 5899999999999999999999998 9999999999999999999999999886543
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ......||+.|+|||.+.+..++.++||||||+++++|++|+.||......+.. ..+...
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~-------- 222 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRV-------- 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHT--------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-------HHHHhC--------
Confidence 22 223456899999999999999999999999999999999999999754322211 111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
....+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111222344568899999999999999999999853
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.76 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=207.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee---------
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--------- 445 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 445 (708)
..++|+..+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999976 78999999987643 356789999999999999999999864
Q ss_pred -------CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 047038 446 -------TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518 (708)
Q Consensus 446 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~ 518 (708)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 445799999999999999997653 236899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH
Q 047038 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 598 (708)
+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.. .. ....
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~----~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TS----KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH----HHHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH----HHHH
Confidence 9999999998765432 22345689999999999999999999999999999999999988631 10 0111
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.+.... .+...+..+.+++.+||+.||++|||+.|+++.|+.+++.
T Consensus 230 ~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111 1122334588999999999999999999999999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=366.12 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=198.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE----- 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 447 (708)
..++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999965 6899999998653 4566778999999999999999999999997654
Q ss_pred -cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 448 -VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 448 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
..+|||||++++ |.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 459999999864 5555542 3889999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--- 603 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 603 (708)
++..... ...+...||+.|+|||++.+..++.++||||||++|+||++|+.||...+..+... .........
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~---~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTPCPE 285 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHH
Confidence 9865432 23445679999999999999999999999999999999999999997654332111 111111000
Q ss_pred ----------------------hhhhhhhhhhhcc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 604 ----------------------RLFEILDAQILKE---GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 604 ----------------------~~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.+.......+... ........+.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 011225678999999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=354.93 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=209.4
Q ss_pred hccCCcccceEeeeccEEEEEEEE------cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..++|++.+.||+|+||+||+|+. .+++.||||.+... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 25778999998653 45566789999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEE
Q 047038 449 PLLVYEFISNGTLSQYIDDQNK----DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKV 521 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl 521 (708)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986542 135899999999999999999999998 999999999999984 456999
Q ss_pred eeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHH
Q 047038 522 SDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 522 ~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHH
Confidence 99999875532222 12334567899999999999999999999999999999998 999996543221 1111
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
+..+. ....+...+..+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 258 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111 111123344568999999999999999999999999998876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.87 Aligned_cols=265 Identities=19% Similarity=0.274 Sum_probs=211.7
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.++||+|+||+||+|.. .+++.||||++..... .+++.+|+++++.++| ++++.+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 4789999998765332 2458899999999987 556666667778888899999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCcccC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~~~~ 531 (708)
|+ +++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 8999999975433 5999999999999999999999998 9999999999999 688999999999998765
Q ss_pred cCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 532 VDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 532 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
..... ......||+.|+|||.+.+..++.++||||||++||||++|+.||.......................+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 123567999999999999999999999999999999999999999876554433322222111111111
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
. .+.. ..+.++.+|+.+||+.+|++||++.+|++.|+.+.....
T Consensus 238 ~-----~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 238 E-----ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp H-----HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-----HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 1 1111 223568999999999999999999999999999976443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=352.46 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=199.4
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC-----hHHHHHHHHHHHHHHhc---CCCceeeeeceEeeC
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID-----ESKVEEFINEVVILSQI---NHRNVVKLLGCCLET 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~ 446 (708)
..++|++.++||+|+||+||+|.. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 478999999876422 11234566777777766 499999999999876
Q ss_pred C-----cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 447 E-----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 447 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
. ..++||||++ ++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 599999986543 24999999999999999999999999 999999999999999999999
Q ss_pred eeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 522 SDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .........
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 9999998654322 23456789999999999999999999999999999999999999975443321 111111111
Q ss_pred h---chhhhhh---hhh-------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 602 E---DRLFEIL---DAQ-------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 602 ~---~~~~~~~---d~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
. ..+.... ... .......+..+.+.+|+.+||+.||++|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 0 0000000 000 00000122346689999999999999999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=372.22 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=208.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|+..++||+|+||.||++... +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 6899999998642 12345678999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999997653 235899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...+...
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~-------- 404 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEV-------- 404 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHC--------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhcc--------
Confidence 332 233457999999999999989999999999999999999999999765432211111 1111111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
....+...+..+.+|+.+||+.||++|| +++||++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1112233456789999999999999999 7888874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=349.29 Aligned_cols=269 Identities=22% Similarity=0.343 Sum_probs=212.0
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeeCC--
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQ--INHRNVVKLLGCCLETE-- 447 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~-- 447 (708)
......++|.+.+.||+|+||+||+|.. +++.||||.+.. ...+.+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3455567899999999999999999998 589999999864 344678889999988 78999999999998876
Q ss_pred --cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEcCCC
Q 047038 448 --VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH--------SAASIPIYHRDIKSTNILLDDKY 517 (708)
Q Consensus 448 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH--------~~~~~~iiHrDikp~NIll~~~~ 517 (708)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 789999999999999999754 5899999999999999999999 666 99999999999999999
Q ss_pred cEEEeeccCCcccCcCCcc---eeecccccccccCccccccCC------CCccchhHhHHHHHHHHHhC----------C
Q 047038 518 CAKVSDFGASRSIAVDQTH---LTTQVQGTFGYLDPEYFQSSH------FTEKSDVYSFGVVLVELLTG----------E 578 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDv~SlGvvl~elltg----------~ 578 (708)
++||+|||+++........ ......||+.|+|||.+.+.. ++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999866543322 123456999999999987652 34789999999999999999 7
Q ss_pred CCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 579 RPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 579 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.||........ .. ......+....+...+... ....+.+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 265 ~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDP-SV-EEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSC-CH-HHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcc-cH-HHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 78765432211 11 1111111111111111100 01235667899999999999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=347.57 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=206.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..++|++.+.||+|+||+||++... +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999976 689999998765322 136789999999999999999999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEeec
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY----CAKVSDF 524 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DF 524 (708)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999997643 5899999999999999999999998 99999999999999887 7999999
Q ss_pred cCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 525 GASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 525 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
|+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. . ..+....
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~----~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L----ANITSVS 234 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H----HHHHTTC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHhcc
Confidence 9998664322 23345699999999999999999999999999999999999999965432211 1 1111110
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. ..++.... ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00111111 22355899999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.17 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=202.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+.|....+||+|+||+||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999964 68899999988766667788999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeeccCCcccCcCCc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGls~~~~~~~~ 535 (708)
++++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999987655556789999999999999999999998 999999999999997 89999999999986543221
Q ss_pred ceeecccccccccCccccccCC--CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
......||+.|+|||.+.... ++.++||||||+++|||++|+.||......... ...... ...
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~----------~~~ 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA----MFKVGM----------FKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----HHHHHH----------HCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----HHhhcc----------ccc
Confidence 233456899999999997643 889999999999999999999999643222110 000000 001
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+...+..+.+|+.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11223334566899999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.00 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=207.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999976 6899999998764 45566789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998654 589999999999999999999996 7 999999999999999999999999998754321
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH----------------
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL---------------- 597 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~---------------- 597 (708)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.........
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2234568999999999999999999999999999999999999997654333211110000
Q ss_pred -------HHhhhchhhhhhhhhhh----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 -------RAMREDRLFEILDAQIL----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 -------~~~~~~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+.++.... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000001111111110 0111223456999999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=354.18 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=194.0
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
....++|++.++||+|+||+||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999965 78999999987543 233567889999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-----cCCCcEEEeecc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL-----DDKYCAKVSDFG 525 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll-----~~~~~~kl~DFG 525 (708)
+||||+++ +|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 9999987654 5899999999999999999999998 9999999999999 455669999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh--
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE-- 602 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 602 (708)
+++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. +...+ .....
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~-~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIF-EVLGLPD 258 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCC
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHH-HHhCCCc
Confidence 9986543222 23345689999999999874 489999999999999999999999975443221 11111 11100
Q ss_pred -chhhhhhh-------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 603 -DRLFEILD-------------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 603 -~~~~~~~d-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
........ ..+...........+.+|+.+||+.||++|||++|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 00000000 0000000111335688999999999999999999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.23 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=185.0
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|++.+.||+|+||+||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999997 478999999886422 1224679999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999998643 36899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+.. ......
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~-------- 227 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLA-------- 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS--------
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhc--------
Confidence 3222 123356899999999999989999999999999999999999999754432210 000000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. ...+...+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 0112223456899999999999999999999963
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.71 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=206.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcceE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLL 451 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 451 (708)
.++|++.+.||+|+||+||++... +++.||+|.+.. ......+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 689999999865 345567789999999999999999999998864 567899
Q ss_pred EEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAA--SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997643 2335899999999999999999999976 2349999999999999999999999999987
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF--- 233 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC---
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhccc---
Confidence 6543221 2233568999999999999999999999999999999999999997543221 1111111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTG 652 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 652 (708)
...+...+..+.+++.+||+.||++||++.||++.+..
T Consensus 234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11222344669999999999999999999999865543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=358.11 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=205.9
Q ss_pred ccCCcccceEeeeccEEEEEEEE----cCCcEEEEEEcccCC----hHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML----EDGKIVAVKKSKIID----ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 447 (708)
.++|++.++||+|+||+||+++. .+++.||||+++... ....+.+.+|+.+|+++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999997 378999999876422 23345678899999999 6999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..+|||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999998654 5899999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
+..............||+.|+|||++.+ ..++.++||||||++||||++|+.||......... ..........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc---
Confidence 8765444444455679999999999985 45789999999999999999999999754433221 1111111100
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGIE 649 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 649 (708)
....+...+..+.+|+.+||+.||++|| +++|+++.
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1112333446689999999999999999 99998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.70 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=200.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc--CCc--EEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE--DGK--IVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.++|++.+.||+|+||+||+|.+. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999864 333 6899987653 3455678999999999999999999999998755 8
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999998653 25899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 530 IAVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 530 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
........ .....+|+.|+|||.+.+..++.++||||||++++||++ |+.||......+. ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~--- 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEG--- 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccC---
Confidence 65433221 233457889999999998889999999999999999999 9999975442211 11111111
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.........+..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 242 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0111123345679999999999999999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.41 Aligned_cols=268 Identities=23% Similarity=0.366 Sum_probs=199.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHH--HHhcCCCceeeeeceEee-----CCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVI--LSQINHRNVVKLLGCCLE-----TEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~ 448 (708)
..++|++.++||+|+||+||+|+. +++.||||++... ..+.+..|.++ +..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 346899999999999999999976 6899999998643 23444455555 445899999999986543 235
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCcEEEcCCCcE
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA---------ASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~---------~~~~iiHrDikp~NIll~~~~~~ 519 (708)
.++||||+++|+|.+++... ..++..++.++.||+.||.|||+. + |+||||||+||||+.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 68999999999999999765 368999999999999999999998 6 9999999999999999999
Q ss_pred EEeeccCCcccCcCCc-------ceeecccccccccCcccccc-------CCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 047038 520 KVSDFGASRSIAVDQT-------HLTTQVQGTFGYLDPEYFQS-------SHFTEKSDVYSFGVVLVELLTGERPIRLTN 585 (708)
Q Consensus 520 kl~DFGls~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~SlGvvl~elltg~~P~~~~~ 585 (708)
||+|||+++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987643221 11234569999999999986 456779999999999999999977764332
Q ss_pred cchhh-hHH----------HHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 586 SEEDK-SLA----------AYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 586 ~~~~~-~~~----------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
..... ... ...............+.. ........+..+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 21110 000 000000110000000000 00112345678999999999999999999999999999998
Q ss_pred cc
Q 047038 655 GC 656 (708)
Q Consensus 655 ~~ 656 (708)
..
T Consensus 318 ~~ 319 (336)
T 3g2f_A 318 MI 319 (336)
T ss_dssp HC
T ss_pred HH
Confidence 63
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.97 Aligned_cols=252 Identities=26% Similarity=0.337 Sum_probs=198.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|.+.+.||+|+||+||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357899999999999999999975 6889999987653 23456789999999999999999999999999999999999
Q ss_pred eccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCccc
Q 047038 455 FISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSI 530 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~~~ 530 (708)
|+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986532 2236999999999999999999999998 9999999999999 45678999999999865
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... ......||+.|+|||.+. ..++.++||||||++++||++|+.||......+... .......
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~------ 242 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATYKEP------ 242 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC------
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhccCCc------
Confidence 4322 234456899999999986 568999999999999999999999997544322110 0000000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ........+.+.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 -NY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0001113456889999999999999999999973
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.02 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=210.9
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEE------EcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC---CCceeeee
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGM------LEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN---HRNVVKLL 440 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~ 440 (708)
..+++...++|.+.++||+|+||+||+|. ..+++.||||+++... ..++..|+.++++++ |+||++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34556677889999999999999999994 4468899999987543 446777888887776 99999999
Q ss_pred ceEeeCCcceEEEEeccCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---
Q 047038 441 GCCLETEVPLLVYEFISNGTLSQYIDDQN--KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD--- 515 (708)
Q Consensus 441 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~--- 515 (708)
+++...+..+|||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence 99999999999999999999999997532 2346999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEeeccCCcccCc-CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCc
Q 047038 516 --------KYCAKVSDFGASRSIAV-DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586 (708)
Q Consensus 516 --------~~~~kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~ 586 (708)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976542 223334556799999999999999999999999999999999999999853322
Q ss_pred chhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHccccc
Q 047038 587 EEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKR-PTMREVGIELTGIRGC 656 (708)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~ev~~~L~~l~~~ 656 (708)
... .+... . ... ...+.+.+++.+||+.+|.+| |+++++.+.|+.+...
T Consensus 291 ~~~--------------~~~~~----~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 291 GEC--------------KPEGL----F-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TEE--------------EECSC----C-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Cce--------------eechh----c-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 110 00000 0 011 124557889999999999999 7889999999887663
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.83 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=195.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHH-HHhcCCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVI-LSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
..++|+..++||+|+||+||+++.. +++.||||+++.. .....+.+.+|..+ ++.++|||||++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999976 5889999988652 23345567778777 57789999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999998654 5889999999999999999999998 999999999999999999999999999864
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+..... ..
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~-~~------ 255 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILN-KP------ 255 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHH-SC------
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHh-cc------
Confidence 322 223445679999999999999999999999999999999999999996543221 1111111 11
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
...+......+.+|+.+||+.||++||++.+.+++
T Consensus 256 ----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 256 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 01122344568999999999999999998644433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=342.08 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=201.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 451 (708)
..++|++.+.||+|+||+||+|... +++.||||.++. .......++.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999976 789999998875 3345567899999999999 99999999999999999999
Q ss_pred EEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---------------
Q 047038 452 VYEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD--------------- 515 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~--------------- 515 (708)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976432 135899999999999999999999998 999999999999984
Q ss_pred ----CCcEEEeeccCCcccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh
Q 047038 516 ----KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK 590 (708)
Q Consensus 516 ----~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~ 590 (708)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998664322 23489999999999875 567899999999999999999887632110
Q ss_pred hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+..+.. ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ------WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 011111111 1122234466899999999999999999999963
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=353.62 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=198.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----- 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 447 (708)
..++|+..+.||+|+||+||+|... +|+.||||++.. ......+.+.+|+++|++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999974 689999999854 34455678999999999999999999999998764
Q ss_pred -cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 448 -VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 448 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
..++||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 359999999 78999998753 5899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH--------H
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF--------L 597 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~ 597 (708)
++..... .+...+|+.|+|||++.+ ..++.++||||||++++||++|+.||......+........ .
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9865422 334568999999999877 67999999999999999999999999765432211111000 0
Q ss_pred HHhhhchhhhhhhh------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMREDRLFEILDA------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+........+.. .............+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000000 0001111233466899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.57 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=208.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
.+.|+..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456889999999999999999965 68899999986533 4456789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998653 5899999999999999999999998 9999999999999999999999999998664332
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
. ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ . ..+.... .
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~~---------~ 236 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---L----FLIPKNN---------P 236 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H----HHHHHSC---------C
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---H----HHhhcCC---------C
Confidence 2 23345689999999999999999999999999999999999999964432211 0 1111110 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.......+..+.+|+.+||+.||++|||+.|+++...
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1112233456899999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.63 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=207.4
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|...+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3467899999999999999999976 5789999987542 34567789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999887653 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+. ... +....
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~------- 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNE------- 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTTC-------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-Hhhcc-------
Confidence 3222 23345689999999999998999999999999999999999999965432211 111 11111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+++.+||+.||++|||++|+++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0112233456889999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.47 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=200.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee----CCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 450 (708)
..|.+.+.||+|+||+||+|... ++..||+|.+.. ......+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45778889999999999999975 678899998764 345667889999999999999999999999875 34589
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCcc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRS 529 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~~ 529 (708)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999998653 5899999999999999999999986 3599999999999998 789999999999975
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.... ......||+.|+|||.+. ..++.++||||||+++++|++|+.||........ ....+..+....
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~-- 249 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA-- 249 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG--
T ss_pred cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCcc--
Confidence 4332 233456899999999887 4589999999999999999999999965433221 111111111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111122346899999999999999999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=364.17 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=205.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999976 79999999986422 22356799999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 5999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... + + ..+..+..
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~---~-~~i~~~~~------ 233 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L---F-KKICDGIF------ 233 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H---H-HHHHTTCC------
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H---H-HHHhcCCc------
Confidence 32 2344569999999999988765 689999999999999999999997543321 1 1 11111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+......+.+|+.+||+.||++|||++|+++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 112223456899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=359.54 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=192.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
...++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+.+|++++|||||++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 44678999999999999999999965 68999999876421 122335889999999999999999999975
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEe
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVS 522 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~ 522 (708)
.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 455799999999999999987643 5999999999999999999999998 9999999999999754 459999
Q ss_pred eccCCcccCcCCcceeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH
Q 047038 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599 (708)
Q Consensus 523 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 599 (708)
|||+++..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ +. ..
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~~ 356 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQ 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----HH
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----HH
Confidence 99999876432 23345679999999999853 6788999999999999999999999975433221 11 11
Q ss_pred hhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 600 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+..+.... .+... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 357 i~~~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCC--Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111100 01111 122456899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=378.83 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=211.7
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
.+.+...++|++.+.||+|+||+||+|.+.. +..||||+++.. .....+.|.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 4455566789999999999999999999742 467999998763 4455678999999999999999999999985
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 467899999999999999997643 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+++..............+|+.|+|||.+....++.++||||||+++|||++ |..||......+. . ..+..+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~----~~i~~~~ 609 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I----GRIENGE 609 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----HHHHHTC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---H----HHHHcCC
Confidence 998765443333344557889999999999999999999999999999997 9999975443221 1 1111111
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111223345678999999999999999999999999998865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.88 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=204.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|.+.+.||+|+||+||++... +++.||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999975 789999999887555566789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCcccC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~~~~ 531 (708)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999987653 5899999999999999999999998 9999999999999 788999999999987543
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+...
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~----- 225 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE----- 225 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC-----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 22 2233458999999999999999999999999999999999999996543221 11111111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111233466899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=348.48 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=207.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|.+.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4568999999999999999999976 5789999987542 34567789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999987653 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ... +....
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-~~~~~------- 257 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNE------- 257 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHHTC-------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH-HhcCC-------
Confidence 3322 23345689999999999999999999999999999999999999965432211 111 11110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+......+.+|+.+||+.||++|||++|+++
T Consensus 258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112223456889999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=356.65 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=193.6
Q ss_pred ccCCccc-ceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHh-cCCCceeeeeceEee----CCcc
Q 047038 377 TDNFNTN-RILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQ-INHRNVVKLLGCCLE----TEVP 449 (708)
Q Consensus 377 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~ 449 (708)
.++|... ++||+|+||+||++... +++.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 78999999999999975 6889999998632 456788888754 589999999999876 5678
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccC
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGA 526 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl 526 (708)
+|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999998653 235999999999999999999999998 999999999999997 78999999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh-hHHHHHHHHhhhchh
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK-SLAAYFLRAMREDRL 605 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~ 605 (708)
++...... ......||+.|+|||++.+..++.++||||||++||||++|+.||......... .... .+..+..
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcc
Confidence 98654322 234556899999999999999999999999999999999999999765432211 0111 1111110
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 650 (708)
. .........+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 00000123345689999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.58 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=202.4
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..++|++.+.||+|+||+||++... +++.||||.++.... .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999976 688999999865332 345688889888 7999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CcEEEeeccCCcc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK----YCAKVSDFGASRS 529 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~----~~~kl~DFGls~~ 529 (708)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997653 5899999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+. ..+..+...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc---
Confidence 653322 234456899999999998888899999999999999999999999754322221111 112211110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.........+..+.+|+.+||+.||++||++.|+++.
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111122345668999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.85 Aligned_cols=244 Identities=16% Similarity=0.176 Sum_probs=193.0
Q ss_pred hhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEccc---CChHHHHHHHHHH---HHHHhcCCCceeeee-------
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKI---IDESKVEEFINEV---VILSQINHRNVVKLL------- 440 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~---~~~~~~~~~~~Ei---~~l~~l~H~niv~l~------- 440 (708)
...++|++.+.||+|+||+||+|+. .+|+.||||++.. ......+.|.+|+ ++|++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 4467899999999999999999996 5699999999863 3445678899999 455566899999998
Q ss_pred ceEeeCC-----------------cceEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 047038 441 GCCLETE-----------------VPLLVYEFISNGTLSQYIDDQNK----DFRISWEMRLCIAIDVSGAISYLHSAASI 499 (708)
Q Consensus 441 g~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~ 499 (708)
+++.+.+ ..+|||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5554443 278999999 6899999986431 123456888999999999999999998
Q ss_pred CeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccC-----------CCCccchhHhHH
Q 047038 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-----------HFTEKSDVYSFG 568 (708)
Q Consensus 500 ~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDv~SlG 568 (708)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999985322 2344567 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 569 VVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 569 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
++||||++|+.||........ ...+.. .....++.+.+|+.+||+.||++|||+.|+++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999964332211 011110 01223456899999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=352.45 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=201.4
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET------- 446 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 446 (708)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999997 478999999875532 23356788999999999999999999999874
Q ss_pred -CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 447 -EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 447 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
+..++||||+++ +|.+.+..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999985 77777765432 5899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCC---cceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 526 ASRSIAVDQ---THLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 526 ls~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+++...... ........||+.|+|||++.+ ..++.++||||||++++||++|+.||......+.............
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998764222 122344568999999999876 4589999999999999999999999976543332222111111111
Q ss_pred hchhhhhhhhhhhcc--------CC-HH------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 EDRLFEILDAQILKE--------GG-KD------EFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~--------~~-~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......-....... .. .+ ..+.+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111100000000000 00 00 1345889999999999999999999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.78 Aligned_cols=266 Identities=23% Similarity=0.295 Sum_probs=198.2
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChH-----HHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDES-----KVEEFINEVVILSQINHRNVVKLLGCCLETE 447 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 447 (708)
....++|+..+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999975 6899999998753221 1346889999999999999999999999999
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999986 8888887643 35888899999999999999999999 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---c
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---D 603 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~ 603 (708)
+...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|.+||......+ .+. ........ .
T Consensus 160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~-~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLT-RIFETLGTPTEE 235 (346)
T ss_dssp STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-HHHHHHCCCCTT
T ss_pred eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHH-HHHHHcCCCChh
Confidence 8764322 22344568999999999876 458999999999999999999999987544322 111 11111110 0
Q ss_pred hhhhhh---hh---hhh-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 604 RLFEIL---DA---QIL-----KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 604 ~~~~~~---d~---~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.+.+.. +. ... .+........+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00 000 00012234679999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.61 Aligned_cols=258 Identities=25% Similarity=0.341 Sum_probs=206.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.++|++.+.||+|+||+||++... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999976 689999998765321 2367899999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEeecc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY----CAKVSDFG 525 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG 525 (708)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 5899999999999999999999998 99999999999998877 89999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
++....... ......||+.|+|||.+....++.++||||||+++++|++|+.||......+. . ..+.....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---L----TNISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H----HHHHTTCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---H----HHhHhccc
Confidence 998654322 22345689999999999999999999999999999999999999975432211 1 11111100
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHcccc
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI--ELTGIRG 655 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~--~L~~l~~ 655 (708)
..+.... ...+..+.+++.+||+.||++|||+.|+++ .++.++.
T Consensus 229 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 229 --DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0011111 122356899999999999999999999986 4555544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=364.06 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=187.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----C
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET-----E 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 447 (708)
..++|++.++||+|+||+||+|... +++.||||++.. .+....+.+.+|+++|++++|||||++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3578999999999999999999965 689999998865 3455677899999999999999999999999543 4
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 6899999985 68998887543 5999999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCc--------------------------ceeecccccccccCcccc-ccCCCCccchhHhHHHHHHHHHh----
Q 047038 528 RSIAVDQT--------------------------HLTTQVQGTFGYLDPEYF-QSSHFTEKSDVYSFGVVLVELLT---- 576 (708)
Q Consensus 528 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDv~SlGvvl~ellt---- 576 (708)
+....... ...+...||+.|+|||++ ....++.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87642211 123445789999999986 55679999999999999999999
Q ss_pred -------CCCCCCCCCcch-----------------hhhHHHHHHHHhhhchhh-----------hhhh---h---hhhc
Q 047038 577 -------GERPIRLTNSEE-----------------DKSLAAYFLRAMREDRLF-----------EILD---A---QILK 615 (708)
Q Consensus 577 -------g~~P~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~-----------~~~d---~---~~~~ 615 (708)
|+++|.+..... ...........+...... ..+. . ....
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 666665432100 001111111111000000 0000 0 0000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+........+.+|+.+||+.||++|||++|+++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011222466889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=351.36 Aligned_cols=269 Identities=22% Similarity=0.291 Sum_probs=202.0
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC-----------ChHHHHHHHHHHHHHHhcCCCcee
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII-----------DESKVEEFINEVVILSQINHRNVV 437 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~-----------~~~~~~~~~~Ei~~l~~l~H~niv 437 (708)
...++....++|.+.+.||+|+||+||+|...+++.||||++... +....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356788889999999999999999999999888999999987542 223347899999999999999999
Q ss_pred eeeceEeeCC-----cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 047038 438 KLLGCCLETE-----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512 (708)
Q Consensus 438 ~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIl 512 (708)
++++++...+ ..++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999986533 5699999998 58888887543 36899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhh
Q 047038 513 LDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS 591 (708)
Q Consensus 513 l~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~ 591 (708)
++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-- 242 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999999999997543322 2334568999999999877 6789999999999999999999999976543321
Q ss_pred HHHHHHHHhhhchhhh-----------hhhhhh-------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 592 LAAYFLRAMREDRLFE-----------ILDAQI-------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~-----------~~d~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..............+ .+.... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111111110 000000 00001122456899999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.75 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=202.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLET 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 446 (708)
..++|++.+.||+|+||+||+|... +++.||||.++... ....+.+.+|+.+|++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999964 68899999876532 12345688899999999999999999999999
Q ss_pred CcceEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 447 EVPLLVYEFISNG-TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 447 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999987653 5999999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------ 235 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------ 235 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence 998765432 2334569999999999988776 8899999999999999999999953111
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... ...+...+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ---~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 236 ---TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ---GTTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0112223456899999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.38 Aligned_cols=266 Identities=26% Similarity=0.393 Sum_probs=201.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
..++|+..++||+|+||+||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3568999999999999999999976 5899999987543 344456789999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988866443 5899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH--------HHhhhc
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL--------RAMRED 603 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--------~~~~~~ 603 (708)
... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+......... ......
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 222 23345689999999999875 78999999999999999999999997654332211111000 000000
Q ss_pred hhhh-hhhhhhhc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 RLFE-ILDAQILK-----EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ~~~~-~~d~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.... ...+.... ......++.+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 001123567999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.54 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=204.7
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLET----- 446 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 446 (708)
....++|++.++||+|+||+||++... +++.||||++... .....+.+.+|+++|++++||||+++++++...
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 344578999999999999999999965 6889999998753 344567899999999999999999999999765
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcc
Confidence 36799999997 4899988653 4899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcce--eecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 527 SRSIAVDQTHL--TTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 527 s~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
++......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...............
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 98765332221 244579999999998755 458999999999999999999999997655443221111110000000
Q ss_pred hhhhhhh---hh----hh-------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 RLFEILD---AQ----IL-------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ~~~~~~d---~~----~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+....+ .. .. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00 00 0001123456899999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.87 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=205.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|...++||+|+||+||+++.. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999975 68999999986422 23356789999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 453 YEFISNGTLSQYIDDQNK-DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876432 336999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .... ..+....
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~-~~i~~~~------- 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELK-QRVLEQA------- 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHH-HHHHHCC-------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHH-HHHhhcc-------
Confidence 3322 233457999999999999999999999999999999999999999765332111 1111 1111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM 643 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 643 (708)
...+...+..+.+|+.+||+.||++||++
T Consensus 410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11233345668999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.39 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=204.7
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357899999999999999999976 57889999875422 22346789999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999998654 5899999999999999999999998 99999999999999999999999999875542
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. .....|++.|+|||.+.+..++.++||||||++++||++|+.||......+. . ..+....
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~-~~~~~~~-------- 228 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------H-RRIVNVD-------- 228 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H-HHHHTTC--------
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------H-HHHhccc--------
Confidence 21 2345689999999999999999999999999999999999999965432211 1 1111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...+..+.+++.+||+.||++||+++|+++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1112233456899999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.08 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=201.9
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEee--CCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLE--TEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV 452 (708)
.++|++.+.||+|+||+||+|.. .+++.||||.++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999996 47899999998743 3467899999999997 9999999999987 6678999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCcccC
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIA 531 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~~ 531 (708)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999885 3888999999999999999999998 99999999999999776 89999999998664
Q ss_pred cCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||........ .+ ...........+.+.++
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l-~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QL-VRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HH-HHHHHHHCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HH-HHHHHhcCCchhhhHHH
Confidence 3322 334568999999999877 6789999999999999999999999964433221 11 11111111111111111
Q ss_pred hhh-----------------------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQI-----------------------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~-----------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ...........+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 100 00111124567999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.05 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=206.1
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhc-CCCceeeeec
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--------ESKVEEFINEVVILSQI-NHRNVVKLLG 441 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~l~g 441 (708)
......++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34555678999999999999999999986 79999999876532 12245788999999999 8999999999
Q ss_pred eEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 442 CCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 442 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999997653 5999999999999999999999998 999999999999999999999
Q ss_pred eeccCCcccCcCCcceeecccccccccCcccccc------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHH
Q 047038 522 SDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~ 595 (708)
+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~--- 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---M--- 313 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---H---
Confidence 9999998765332 2344679999999999863 358899999999999999999999996533211 1
Q ss_pred HHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 596 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+..+... . ...... ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 314 -~~~i~~~~~~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 -LRMIMEGQYQ-F-SSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHHHTCCC-C-CHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHhCCCC-C-CCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111110 0 000001 12355899999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.27 Aligned_cols=199 Identities=25% Similarity=0.389 Sum_probs=168.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----C
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET-----E 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 447 (708)
..++|.+.++||+|+||+||+|... +++.||||+++. ......+.+.+|+++|++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999965 688999999865 3455667899999999999999999999999876 5
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||++ ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999987 59999987543 5999999999999999999999999 999999999999999999999999999
Q ss_pred cccCcCCc---------------------ceeecccccccccCcccc-ccCCCCccchhHhHHHHHHHHHhCCCCC
Q 047038 528 RSIAVDQT---------------------HLTTQVQGTFGYLDPEYF-QSSHFTEKSDVYSFGVVLVELLTGERPI 581 (708)
Q Consensus 528 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDv~SlGvvl~elltg~~P~ 581 (708)
+....... ...+...||+.|+|||++ ....++.++|||||||+||||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87643221 123556799999999986 5567999999999999999999854444
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=350.63 Aligned_cols=260 Identities=25% Similarity=0.253 Sum_probs=203.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC--------CCceeeeeceEe---
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN--------HRNVVKLLGCCL--- 444 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 444 (708)
.++|++.++||+|+||+||+|+.. +++.||||+++. .....+.+.+|+.+|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999964 688999999874 3455678999999999985 888999999998
Q ss_pred -eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCC-----
Q 047038 445 -ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKY----- 517 (708)
Q Consensus 445 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~----- 517 (708)
+....+|||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 556666655432 23599999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------cEEEeeccCCcccCcCCcceeecccccccccCcccc
Q 047038 518 --------------------------------------------CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553 (708)
Q Consensus 518 --------------------------------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~ 553 (708)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999865432 2344689999999999
Q ss_pred ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh---hHHHHHHHHhhhchhh------------------------
Q 047038 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK---SLAAYFLRAMREDRLF------------------------ 606 (708)
Q Consensus 554 ~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~------------------------ 606 (708)
.+..++.++||||||++||||++|+.||......+.. ................
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999765543321 1111111111110000
Q ss_pred ------hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 607 ------EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 607 ------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.+.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 346 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000 11235667788999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=346.42 Aligned_cols=260 Identities=24% Similarity=0.399 Sum_probs=201.8
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 445 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 445 (708)
+...++....++|++.+.||+|+||+||+|... +++.||||.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 445566677889999999999999999999974 78999999986533 3456889999999999 89999999999987
Q ss_pred ------CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 446 ------TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 446 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 467899999999999999998653 236899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
||+|||++....... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||........
T Consensus 169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 242 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 242 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----
Confidence 999999987654221 1223456899999999987 56789999999999999999999999964332211
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... +..... ........+..+.+|+.+||+.||++||++.|+++
T Consensus 243 -~~~-~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 -LFL-IPRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHH-HHHSCC--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHH-hhcCcc--------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 111100 00111223456899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.82 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=206.4
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLET 446 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 446 (708)
...+++...++|++.+.||+|+||+||+|...+ .||+|.++.. .....+.|.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345556667889999999999999999998754 4999987653 233446788999999999999999999999999
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999997653 35899999999999999999999998 99999999999998 67999999999
Q ss_pred CcccCcCC----cceeecccccccccCcccccc---------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHH
Q 047038 527 SRSIAVDQ----THLTTQVQGTFGYLDPEYFQS---------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA 593 (708)
Q Consensus 527 s~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~ 593 (708)
++...... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---- 251 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---- 251 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 87653211 112233458999999999864 4578999999999999999999999975443221
Q ss_pred HHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 594 AYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 594 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
...+..+.... ......+..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 252 ---~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 252 ---IWQMGTGMKPN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ---HHHHHTTCCCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ---HHHhccCCCCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111100 001123345889999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=351.70 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=186.1
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET----- 446 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 446 (708)
...++|+..+.||+|+||+||+|... +|+.||||++.. ......+.+.+|+.+|++++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 34578999999999999999999964 689999999865 3455677899999999999999999999998754
Q ss_pred -CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 447 -EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 447 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
...++|+|++ +++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5579999999 68999988752 5999999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh--
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE-- 602 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 602 (708)
+++..... .+...||+.|+|||++.+ ..++.++||||||++++||++|+.||......+.. .........
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~ 250 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCC
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCC
Confidence 99865322 334578999999999887 67899999999999999999999999765433221 111111110
Q ss_pred ---------chhhhhhhhhhhc--c-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 ---------DRLFEILDAQILK--E-----GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 ---------~~~~~~~d~~~~~--~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......+. .+.. . ........+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 0000 0 00112356899999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=340.33 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=189.2
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHH-HHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
...++|+..+.||+|+||+||++... +++.||||+++.. .... .+.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34578999999999999999999974 7899999998753 2233 3345555566888999999999999999999999
Q ss_pred EEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 452 VYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
||||+++ +|.+++... .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999974 888877642 1234699999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCcCCcceeecccccccccCcccc----ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYF----QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
..... ......||+.|+|||.+ ....++.++||||||++++||++|+.||........ .........
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-- 230 (290)
T 3fme_A 160 LVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEP-- 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHHHSC--
T ss_pred ccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHhccC--
Confidence 54322 22334689999999996 556789999999999999999999999964332211 111111111
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111233456899999999999999999999965
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.81 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=202.9
Q ss_pred cChHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcC--CCceeeeeceE
Q 047038 368 FTSNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQIN--HRNVVKLLGCC 443 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~ 443 (708)
+....+....++|++.+.||+|+||+||++...+++.||||.+.. ......+.+.+|+.++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 334445566788999999999999999999988899999998864 34556788999999999997 59999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.+.+..++||| +.+++|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 56889999998653 5899999999999999999999998 999999999999975 7899999
Q ss_pred ccCCcccCcCCcc-eeecccccccccCcccccc-----------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhh
Q 047038 524 FGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQS-----------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS 591 (708)
Q Consensus 524 FGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~ 591 (708)
||+++........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--- 246 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--- 246 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence 9999876433222 1234568999999999875 468899999999999999999999996433221
Q ss_pred HHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 592 LAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
... ..+++.......+......+.+++.+||+.||++||++.|+++.
T Consensus 247 --~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 --SKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --HHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 11111111112222234568999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=354.66 Aligned_cols=201 Identities=24% Similarity=0.296 Sum_probs=175.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhc------CCCceeeeeceEeeCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQI------NHRNVVKLLGCCLETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~ 448 (708)
...+|++.++||+|+||+||+|... +++.||||+++. .....+++.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567999999999999999999865 588999999875 344556788899998887 57799999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--EEEeeccC
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC--AKVSDFGA 526 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGl 526 (708)
.++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 589998876542 25899999999999999999999998 999999999999999887 99999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCc
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~ 586 (708)
++..... .....||+.|+|||++.+..++.++||||||++||||++|++||.....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9754322 2345689999999999999999999999999999999999999976543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.24 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=197.8
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|.+.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999976 78999999876522 2235678999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999997654 5899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
... ......||+.|+|||.+.+..+ +.++||||||+++++|++|+.||....... ....+..+..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----- 228 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVF----- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCcc-----
Confidence 322 2234568999999999988765 689999999999999999999996433211 1111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122234568999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.15 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=188.0
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
....++|++.+.||+|+||+||+|... +++.||||.+.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999954 68899999886533 3446678999999999999999999999999999999
Q ss_pred EEEeccCCCcccccccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 452 VYEFISNGTLSQYIDDQ-----NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998742 12335899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCc----ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 527 SRSIAVDQT----HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 527 s~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhc
Confidence 876543211 11234568999999999876 56899999999999999999999999765433211 01111
Q ss_pred hchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 EDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ..........+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 110 0000000001111223456899999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=362.38 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=203.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
..++|++.++||+|+||+||++... +++.||||++... .....+.+.+|+.+|++++|||||++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 7899999987542 233467899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGls~~ 529 (708)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887653 5899999999999999999999998 99999999999995 456799999999986
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+..+.....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~- 242 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFD- 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSC-
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC-
Confidence 54332 2344569999999999875 59999999999999999999999997543322 1111111111100
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00012234568999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=344.46 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=196.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEe-----------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCL----------- 444 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 444 (708)
.++|+..+.||+|+||+||+|... +++.||||++...+....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 48999999988777778889999999999999999999999874
Q ss_pred ---eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEE
Q 047038 445 ---ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAK 520 (708)
Q Consensus 445 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~k 520 (708)
+....++||||++ |+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467799999998 5999998643 5899999999999999999999998 99999999999997 567999
Q ss_pred EeeccCCcccCcCCc--ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 521 VSDFGASRSIAVDQT--HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 521 l~DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
|+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||......+.. ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 999999987643221 12234457999999998865 67899999999999999999999999765432211 1111
Q ss_pred HHhhh---chhhhh-------hhhhhh------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMRE---DRLFEI-------LDAQIL------KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~---~~~~~~-------~d~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... ....++ +..... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11100 000000 000000 0001223567999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.34 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=200.4
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|++.+.||+|+||+||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999976 588999999877666677899999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999876433 5899999999999999999999998 999999999999999999999999987543211
Q ss_pred cceeecccccccccCcccc-----ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYF-----QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
........||+.|+|||.+ ....++.++||||||+++|||++|+.||....... .......... ..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~-- 241 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP-PT-- 241 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-CC--
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC-cc--
Confidence 1112334689999999998 46778999999999999999999999996543221 1111111110 00
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0012223456899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.69 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=193.2
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 448 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 448 (708)
..+.....++|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|++.++.++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456677789999999999999999999975 6899999987543 2334567788899999999999999999976443
Q ss_pred -------ceEEEEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEEcC-CC
Q 047038 449 -------PLLVYEFISNGTLSQYIDD-QNKDFRISWEMRLCIAIDVSGAISYLH--SAASIPIYHRDIKSTNILLDD-KY 517 (708)
Q Consensus 449 -------~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~al~yLH--~~~~~~iiHrDikp~NIll~~-~~ 517 (708)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 7899999987 44443332 223346899999999999999999999 777 999999999999997 89
Q ss_pred cEEEeeccCCcccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH
Q 047038 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 596 (708)
.+||+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ...
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL---HEI 244 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH---HHH
Confidence 99999999998765332 23345689999999998664 4899999999999999999999999765433221 111
Q ss_pred HHHhhhc--hhhhhhh----------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 597 LRAMRED--RLFEILD----------------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 597 ~~~~~~~--~~~~~~d----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....... .....++ ..............+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111100 0000000 01111222234677999999999999999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=340.20 Aligned_cols=262 Identities=22% Similarity=0.320 Sum_probs=205.2
Q ss_pred ccCCcccceEeeeccEEEEEEEE-c-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeeCCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-E-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN------VVKLLGCCLETEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 448 (708)
.++|++.+.||+|+||+||++.. . +++.||||+++.. ....+.+.+|+.++++++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 6889999998753 445678899999999987664 9999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------------
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD------------- 515 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~------------- 515 (708)
.++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8899999976532 36899999999999999999999998 999999999999987
Q ss_pred ------CCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchh
Q 047038 516 ------KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589 (708)
Q Consensus 516 ------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~ 589 (708)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999864322 2345689999999999999999999999999999999999999976544332
Q ss_pred hhHHHHHHHHhhhchhh----------------------hhhhh-----hhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 047038 590 KSLAAYFLRAMREDRLF----------------------EILDA-----QILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~----------------------~~~d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 642 (708)
...............+. ..+.. ...........+.+.+|+.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 21111111000000000 00000 0001123345678999999999999999999
Q ss_pred HHHHHH
Q 047038 643 MREVGI 648 (708)
Q Consensus 643 ~~ev~~ 648 (708)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999963
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=361.59 Aligned_cols=252 Identities=29% Similarity=0.377 Sum_probs=202.9
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh-------------HHHHHHHHHHHHHHhcCCCceeeee
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE-------------SKVEEFINEVVILSQINHRNVVKLL 440 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~ 440 (708)
...++|.+.++||+|+||+||+|... +++.||||.++.... ...+.+.+|+.+|++++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999975 578999998765321 2356799999999999999999999
Q ss_pred ceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---
Q 047038 441 GCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY--- 517 (708)
Q Consensus 441 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~--- 517 (708)
+++.+....++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999987653 5999999999999999999999998 99999999999998775
Q ss_pred cEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 518 CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 518 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+ ..
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------II 256 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HH
Confidence 69999999998765332 234456999999999987 468999999999999999999999997544322 11
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+..+.... +.... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 257 ~~i~~~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1122221110 00001 122356899999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.29 Aligned_cols=254 Identities=13% Similarity=0.089 Sum_probs=184.4
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhc--CCCceeeee-------ce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQI--NHRNVVKLL-------GC 442 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~ 442 (708)
...+|...+.||+|+||+||+|... +++.||||+++... ....+.+.+|+.+++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3556899999999999999999965 78999999987643 34456788886555554 699988755 44
Q ss_pred EeeC-----------------CcceEEEEeccCCCccccccccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 047038 443 CLET-----------------EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMR------LCIAIDVSGAISYLHSAASI 499 (708)
Q Consensus 443 ~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~al~yLH~~~~~ 499 (708)
+... ...+|||||++ |+|.+++..... .+++..+ +.++.||+.||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 4333 23799999999 899999987532 3455555 788899999999999998
Q ss_pred CeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhC
Q 047038 500 PIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTG 577 (708)
Q Consensus 500 ~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg 577 (708)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||++||||++|
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986532 1224557799999999987 7799999999999999999999
Q ss_pred CCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 578 ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 578 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
+.||.......... ......................+..+.+|+.+||+.||++|||+.|++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99997654322110 000000000001111111123456799999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.19 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=203.6
Q ss_pred HhhccCCcccceEeeeccEEEEEEEE--cCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhc---CCCceeeeeceEe--
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGML--EDGKIVAVKKSKIID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCL-- 444 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~-- 444 (708)
..+.++|++.+.||+|+||+||+|.. .+++.||||+++... ......+.+|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34567899999999999999999997 368899999876422 22234567788777766 8999999999987
Q ss_pred ---eCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 445 ---ETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 445 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
.....++||||++ |+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence 4567899999998 699999976532 25899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 522 SDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 236 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcC
Confidence 9999998654322 2334568999999999999999999999999999999999999997544322 1111111111
Q ss_pred h---chhhhhh----------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 E---DRLFEIL----------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 ~---~~~~~~~----------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. ..+.... ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000 000011112334566899999999999999999999973
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.73 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=199.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc------c
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV------P 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~ 449 (708)
...+|...++||+|+||+||+|+..++..||+|++..... ...+|+++|++++||||+++++++...+. .
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3457999999999999999999988777799998754221 22369999999999999999999975443 7
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASR 528 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~ 528 (708)
++||||++++.+............+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 899999987554444332223346999999999999999999999998 99999999999999 79999999999998
Q ss_pred ccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. +.. ............
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~-i~~~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVE-IIKVLGTPSREQ 265 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHHH
Confidence 7643322 3345689999999998764 589999999999999999999999976543321 111 111111000000
Q ss_pred --hhhhh-------------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcccc
Q 047038 608 --ILDAQ-------------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIRG 655 (708)
Q Consensus 608 --~~d~~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~ 655 (708)
..++. .........+..+.+|+.+||+.||++|||+.|+++. ++.++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00000 0011122244679999999999999999999999864 444443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.40 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=204.8
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---------hHHHHHHHHHHHHHHhcC-CCceeeeeceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---------ESKVEEFINEVVILSQIN-HRNVVKLLGCC 443 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~ 443 (708)
...++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 68999999986532 233567899999999995 99999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999998653 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccc------cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ------SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
||++....... ......||+.|+|||.+. ...++.++||||||++++||++|+.||......+ . .
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~----~ 238 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M----L 238 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----H
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---H----H
Confidence 99998764332 233456899999999985 4568899999999999999999999996543221 1 1
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+..+... .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111110 000111234466999999999999999999999963
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=344.98 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=193.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 447 (708)
.++|++.+.||+|+||+||+|... +++.||||++.. ......+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 688999999865 34556678999999999999999999999998665
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+++ +|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 78777752 4889999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh------
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR------ 601 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------ 601 (708)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .........
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CCCCCHHH
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 865422 223445689999999999999999999999999999999999999976543221 111100000
Q ss_pred -------------hc------hhhhhhhhhhhcc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 -------------ED------RLFEILDAQILKE---GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 -------------~~------~~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. .+........... ........+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 0000000000000 01223567999999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.98 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=200.6
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
...++|++.+.||+|+||+||+|... +|+.||||.+... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 44578999999999999999999976 5899999998753 23567899999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999997433 26899999999999999999999998 999999999999999999999999999765432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ........
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~------ 244 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFM-IPTNPPPT------ 244 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHSCCCC------
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HhcCCCcc------
Confidence 22 23345689999999999999999999999999999999999999964432211 000 11100000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111223456899999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.62 Aligned_cols=251 Identities=27% Similarity=0.360 Sum_probs=205.7
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
..++|+..++||+|+||+||++... +++.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999976 7899999987542 23456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL---DDKYCAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGls~ 528 (708)
||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999987653 5899999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|++||......+ ....+..+.....
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFE 247 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 664332 2334569999999999876 68999999999999999999999997544322 1111222111100
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......++.+.+|+.+||+.+|++|||+.|+++
T Consensus 248 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 ------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0001233456899999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=375.40 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=206.5
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcce
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 450 (708)
..++|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+..|..+|..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999975 6889999998642 233456788999999987 7999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.++++... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998754 5999999999999999999999998 999999999999999999999999999864
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+ .+...+. ..
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~-~~------ 558 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIME-HN------ 558 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHS-SC------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHHHHh-CC------
Confidence 3322 23445679999999999999999999999999999999999999997543321 1111111 11
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTM-----REVG 647 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~ 647 (708)
...+......+.+||.+||+.||++||++ +||+
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 11233445678999999999999999997 6665
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.60 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=204.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChH-----------------HHHHHHHHHHHHHhcCCCceeee
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDES-----------------KVEEFINEVVILSQINHRNVVKL 439 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~H~niv~l 439 (708)
.++|.+.+.||+|+||+||+|.. +++.||||.+...... ..+.|.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999987642211 12789999999999999999999
Q ss_pred eceEeeCCcceEEEEeccCCCcccc------ccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEE
Q 047038 440 LGCCLETEVPLLVYEFISNGTLSQY------IDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNIL 512 (708)
Q Consensus 440 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIl 512 (708)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 5542 13469999999999999999999999 88 999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccC-CCCc-cchhHhHHHHHHHHHhCCCCCCCCCcchhh
Q 047038 513 LDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTE-KSDVYSFGVVLVELLTGERPIRLTNSEEDK 590 (708)
Q Consensus 513 l~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDv~SlGvvl~elltg~~P~~~~~~~~~~ 590 (708)
++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||++++||++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE- 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 999999999999999865432 33456689999999999887 6666 99999999999999999999975543211
Q ss_pred hHHHHHHHHhhhchhhhhhh---------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 591 SLAAYFLRAMREDRLFEILD---------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
....+.........+ ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 261 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 -----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111122111100000 00000001234567899999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.28 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=197.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeC
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLET 446 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 446 (708)
..++|.+.+.||+|+||+||+|... +++.||||.+.... ......+.+|+.+|++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999975 58899999876422 12334688999999999999999999998765
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEee
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC---AKVSD 523 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~D 523 (708)
+ .++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999887543 5899999999999999999999998 999999999999987654 99999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +... +
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~----~ 232 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----I 232 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH----H
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH----H
Confidence 9999865432 1223456899999999974 56789999999999999999999999975443221 1111 1
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+.... .+... ...+..+.+|+.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~--~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCcccc--Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111100 01111 122456899999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.43 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=196.9
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLET----- 446 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 446 (708)
++...++|++.+.||+|+||+||+|.. .+++.||||++..... ...+|+.+|++++|||||++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678899999999999999999996 4789999998765322 234799999999999999999998543
Q ss_pred ---------------------------------CcceEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 047038 447 ---------------------------------EVPLLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISY 492 (708)
Q Consensus 447 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~y 492 (708)
...++||||++ ++|.+.+... .....+++..+..++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23789999998 4887777642 123469999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCcccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHH
Q 047038 493 LHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVV 570 (708)
Q Consensus 493 LH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvv 570 (708)
||+.+ |+||||||+|||++ +++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99998 99999999999998 68899999999998664332 23345689999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh---------------hhhhhccCCHHHHHHHHHHHHHhccc
Q 047038 571 LVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL---------------DAQILKEGGKDEFKMVAKLAKRCLNL 635 (708)
Q Consensus 571 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------d~~~~~~~~~~~~~~l~~li~~cl~~ 635 (708)
+|||++|+.||......+. ...............+. ........+...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999976443321 11111111111000000 00001111223456689999999999
Q ss_pred CCCCCCCHHHHHH
Q 047038 636 NGKKRPTMREVGI 648 (708)
Q Consensus 636 ~p~~RPt~~ev~~ 648 (708)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=361.10 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=200.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
..++|+..++||+|+||+||+|... +++.||||.+.... ....+.+.+|+.+|++++|||||++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999976 68899999886532 33457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGls~~ 529 (708)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887653 5899999999999999999999998 9999999999999764 4599999999987
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+ ....+..+... .
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~--~ 256 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT--F 256 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--C
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--C
Confidence 65332 234456999999999986 568999999999999999999999997544322 11111111110 0
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 1123456899999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.36 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=201.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----Cc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 448 (708)
..++|++.+.||+|+||+||+|... +|+.||||+++.. .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999976 6899999998653 345567889999999999999999999988764 67
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||++ ++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 5899888753 5899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCCcc---------eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHH
Q 047038 529 SIAVDQTH---------LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 529 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 598 (708)
........ ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHH
Confidence 76432211 1223568999999998764 77899999999999999999999999765432211 11111
Q ss_pred Hhhhc------------hhhhhhhhh------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 599 AMRED------------RLFEILDAQ------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 599 ~~~~~------------~~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... ...+.+... .........+..+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11000 000000000 000001233466899999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.33 Aligned_cols=267 Identities=23% Similarity=0.327 Sum_probs=184.9
Q ss_pred ccCCcc-cceEeeeccEEEEEEEEc---CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcce
Q 047038 377 TDNFNT-NRILGQGGQGTVYKGMLE---DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPL 450 (708)
Q Consensus 377 ~~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 450 (708)
.+.|.+ .++||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.+|++++|||||++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345655 458999999999999965 57889999987532 23468899999999999999999999964 66789
Q ss_pred EEEEeccCCCccccccccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEE
Q 047038 451 LVYEFISNGTLSQYIDDQN------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL----DDKYCAK 520 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll----~~~~~~k 520 (708)
|||||+++ +|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 7877775322 1224899999999999999999999998 9999999999999 7788999
Q ss_pred EeeccCCcccCcCCc--ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcch------hhh
Q 047038 521 VSDFGASRSIAVDQT--HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE------DKS 591 (708)
Q Consensus 521 l~DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~------~~~ 591 (708)
|+|||+++....... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||....... ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643221 22344678999999999987 458999999999999999999999997554321 011
Q ss_pred HHHHHHHHhhh---chhhhh---------hh---h---------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 592 LAAYFLRAMRE---DRLFEI---------LD---A---------QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 592 ~~~~~~~~~~~---~~~~~~---------~d---~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
........+.. ..+..+ .. . .............+.+|+.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111111110 000000 00 0 000000111134688999999999999999999998
Q ss_pred HH
Q 047038 648 IE 649 (708)
Q Consensus 648 ~~ 649 (708)
+.
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.26 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=199.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEe--eCCc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID----ESKVEEFINEVVILSQINHRNVVKLLGCCL--ETEV 448 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~ 448 (708)
..++|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999974 68899999886532 234678999999999999999999999984 4557
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||++++ |.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 777776543 336999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCC-cceeecccccccccCccccccCC--CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 529 SIAVDQ-THLTTQVQGTFGYLDPEYFQSSH--FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 529 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
...... ........||+.|+|||.+.+.. .+.++||||||+++|||++|+.||......+ ....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGS- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCC-
Confidence 764322 22234556999999999987644 3789999999999999999999997543221 111111111
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
...+......+.+++.+||+.||++|||++|+++.
T Consensus 230 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01122334568899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.43 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=198.2
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc---
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP--- 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~--- 449 (708)
..++|...+.||+|+||+||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999965 6899999998653 345567899999999999999999999999887765
Q ss_pred ---eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 450 ---LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 450 ---~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
++||||++ ++|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 588877742 4899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc--
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED-- 603 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 603 (708)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......+.. ..........
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGT 263 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCcH
Confidence 9855322 334568999999999987 78999999999999999999999999754432211 1111111000
Q ss_pred ---------hhhhhhhhhhhc-------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 604 ---------RLFEILDAQILK-------EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 604 ---------~~~~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...... ..+.. .........+.+|+.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYI-QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHH-HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhh-hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000 00000 001123467899999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.15 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=197.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------cc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~ 449 (708)
..+|+..++||+|+||+||+|++. +++.||||++.... ..+.+|+++|++++|||||++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999975 68999999876432 22347999999999999999999986432 35
Q ss_pred eEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEeeccCC
Q 047038 450 LLVYEFISNGTLSQYIDDQ-NKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-YCAKVSDFGAS 527 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGls 527 (708)
++||||+++ +|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 566555431 12346999999999999999999999998 9999999999999955 67899999999
Q ss_pred cccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--- 603 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 603 (708)
+...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+ .+...+ ..+...
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~-~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEII-KVLGTPTRE 279 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCSCCHH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCCHH
Confidence 8764332 23345689999999998764 79999999999999999999999997644322 111111 111100
Q ss_pred hhhhhhhhh-------------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHcccc
Q 047038 604 RLFEILDAQ-------------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI--ELTGIRG 655 (708)
Q Consensus 604 ~~~~~~d~~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~--~L~~l~~ 655 (708)
.+.+. .+. .........+..+.+|+.+||+.||++|||+.|+++ .++.++.
T Consensus 280 ~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 280 QIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 00000 000 000011233467899999999999999999999985 3444443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.50 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=194.9
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee---------
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--------- 445 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 445 (708)
..++|+..+.||+|+||+||+|... +++.||||.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999975 789999999864 34556789999999999999999999999865
Q ss_pred ----CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 047038 446 ----TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKV 521 (708)
Q Consensus 446 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl 521 (708)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 356789999999999999998643 35788999999999999999999998 999999999999999999999
Q ss_pred eeccCCcccCcCC-------------cceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcc
Q 047038 522 SDFGASRSIAVDQ-------------THLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSE 587 (708)
Q Consensus 522 ~DFGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~ 587 (708)
+|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998654221 1122345689999999999764 78999999999999999998 543111
Q ss_pred hhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 588 EDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+. .. ....+... ............+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~---~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ER---VN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH---HH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hH---HH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11 11111111 011112223444566899999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.67 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=198.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-----
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----- 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 448 (708)
.++|...+.||+|+||+||+|... +|+.||||++.. ......+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467899999999999999999975 689999999865 334556789999999999999999999999987654
Q ss_pred -ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 449 -PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 449 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
.++||||++ ++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588887743 4899999999999999999999998 999999999999999999999999999
Q ss_pred cccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh----
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---- 602 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 602 (708)
+..... .....||+.|+|||.+.+ ..++.++||||||++++||++|+.||......+. ..........
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 864322 234568999999999877 6789999999999999999999999976543221 1111111100
Q ss_pred -------chhhhhhh---hh---hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 -------DRLFEILD---AQ---ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 -------~~~~~~~d---~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
......+. .. ............+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 00 001112234567999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.92 Aligned_cols=208 Identities=27% Similarity=0.355 Sum_probs=175.8
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CC-----ceeeeeceE
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HR-----NVVKLLGCC 443 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~ 443 (708)
.+.+...++|++.++||+|+||+||+|... +++.||||+++. .....+++..|+.+++.++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 334556789999999999999999999965 688999999874 3445677888999998885 44 499999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCcEEE
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD--DKYCAKV 521 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl 521 (708)
...+..+|||||++ ++|.+++..... ..+++..+..++.|++.||.|||++. .+|+||||||+||||+ .++.+||
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999996 599999986542 25899999999999999999999531 2399999999999994 5788999
Q ss_pred eeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCc
Q 047038 522 SDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586 (708)
Q Consensus 522 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~ 586 (708)
+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999866422 2345689999999999999999999999999999999999999976543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.24 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=203.7
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
...++|++.+.||+|+||+||++... +++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999976 6899999987542 23456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEeeccCCc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK---YCAKVSDFGASR 528 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGls~ 528 (708)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999887653 5899999999999999999999998 9999999999999754 479999999988
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
...... ......||+.|+|||.+.+ .++.++||||||+++++|++|+.||......+ ....+..+.....
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 242 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFD 242 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 654322 1233458999999999875 48999999999999999999999997543221 1111111111000
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. .. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~--~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L--PQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S--GG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c--hh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00 1123456899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=340.37 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=201.7
Q ss_pred ccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-----------CCceeeeeceEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-----------HRNVVKLLGCCL 444 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 444 (708)
.++|.+.+.||+|+||+||+|.. .+++.||||.+.. +....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999996 4789999999874 3445678899999999886 899999999998
Q ss_pred eCC----cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEc-----
Q 047038 445 ETE----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLD----- 514 (708)
Q Consensus 445 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~----- 514 (708)
..+ ..++|||++ +++|.+++..... ..+++..++.++.||+.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 8899999986532 2589999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhh---
Q 047038 515 -DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDK--- 590 (708)
Q Consensus 515 -~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~--- 590 (708)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999865432 23346899999999999999999999999999999999999999755432211
Q ss_pred hHHHHHHHHhhhch------------------------------hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCC
Q 047038 591 SLAAYFLRAMREDR------------------------------LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKR 640 (708)
Q Consensus 591 ~~~~~~~~~~~~~~------------------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 640 (708)
............-. +.+.+. .....+......+.+|+.+||+.||++|
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111111111000 000000 0112346678889999999999999999
Q ss_pred CCHHHHHH
Q 047038 641 PTMREVGI 648 (708)
Q Consensus 641 Pt~~ev~~ 648 (708)
||++|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=336.02 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=201.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CC-cEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeeCCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DG-KIVAVKKSKIIDESKVEEFINEVVILSQINHRN------VVKLLGCCLETEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 448 (708)
.++|++.+.||+|+||+||++... ++ +.||||.++. .....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999975 34 6899999874 3455678899999999997766 9999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---------------
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILL--------------- 513 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll--------------- 513 (708)
.++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5677777665432 35899999999999999999999998 9999999999999
Q ss_pred ----cCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchh
Q 047038 514 ----DDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED 589 (708)
Q Consensus 514 ----~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~ 589 (708)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67889999999999864322 2345689999999999999999999999999999999999999975543322
Q ss_pred hhHHHHHHHHhhhchhh----------------------hhhhh-----hhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 047038 590 KSLAAYFLRAMREDRLF----------------------EILDA-----QILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~----------------------~~~d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 642 (708)
...............+. ..+.. .............+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 11111110000000000 00000 0000112344567999999999999999999
Q ss_pred HHHHH
Q 047038 643 MREVG 647 (708)
Q Consensus 643 ~~ev~ 647 (708)
+.|++
T Consensus 328 ~~e~l 332 (355)
T 2eu9_A 328 LAEAL 332 (355)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 99985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.83 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=181.3
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeCCcceEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
..++|+..+.||+|+||+||+|... +++.||||+++.. ......++..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578899999999999999999975 6899999998764 3445556777776 67778999999999999999999999
Q ss_pred EEeccCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQN--KDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
|||+++ +|.+++.... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 8877776311 133689999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCcCCcceeecccccccccCcccc----ccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYF----QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
..... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .... ...+.
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~- 246 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGD- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSC-
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCC-
Confidence 54322 22334689999999998 456789999999999999999999999964322110 0000 00000
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+.+........+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 ----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 011111111234566999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.53 Aligned_cols=245 Identities=29% Similarity=0.424 Sum_probs=192.2
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh------HHHHHHHHHHHHHHhc----CCCceeeee
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE------SKVEEFINEVVILSQI----NHRNVVKLL 440 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l----~H~niv~l~ 440 (708)
+.+...++|++.+.||+|+||+||+|... +++.||||.+..... .....+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556788999999999999999999864 688999999865332 2334567899999998 899999999
Q ss_pred ceEeeCCcceEEEEe-ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCc
Q 047038 441 GCCLETEVPLLVYEF-ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYC 518 (708)
Q Consensus 441 g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~ 518 (708)
+++.+.+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 78999999998654 5899999999999999999999998 99999999999999 8899
Q ss_pred EEEeeccCCcccCcCCcceeecccccccccCccccccCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH
Q 047038 519 AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFT-EKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL 597 (708)
Q Consensus 519 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 597 (708)
+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||.... .
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------ 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------ 244 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H------
Confidence 9999999998765332 2345689999999999876664 58999999999999999999985311 0
Q ss_pred HHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 598 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+... ....+......+.+++.+||+.||++|||++|+++
T Consensus 245 ----------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ----------ILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----------HHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------Hhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01112234456899999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.47 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=188.4
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|+++ +|||||++++++.+.+..+|||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998776678999999987642 345678999999987 8999999999999999999999999
Q ss_pred cCCCccccccccCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-------------CcE
Q 047038 457 SNGTLSQYIDDQNKDF----RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDK-------------YCA 519 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~-------------~~~ 519 (708)
+ |+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999997654211 1133355789999999999999998 9999999999999754 489
Q ss_pred EEeeccCCcccCcCCcc---eeecccccccccCcccccc-------CCCCccchhHhHHHHHHHHHh-CCCCCCCCCcch
Q 047038 520 KVSDFGASRSIAVDQTH---LTTQVQGTFGYLDPEYFQS-------SHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~ 588 (708)
||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543322 1234579999999999975 678999999999999999999 999996443221
Q ss_pred hhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. . ..... . .. +..........+..+.+|+.+||+.||++|||+.||++
T Consensus 248 ~----~----i~~~~-~-~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S----N----IIRGI-F-SL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----H----HHHTC-C-CC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----H----HhcCC-C-Cc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 0 01100 0 00 00011123456678999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=334.27 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=173.7
Q ss_pred hccCCccc-ceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee----CCcc
Q 047038 376 ATDNFNTN-RILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVP 449 (708)
Q Consensus 376 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 449 (708)
..++|.+. ++||+|+||+||+|... +++.||||++... .... .+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45678885 46999999999999976 6899999998652 2211 222234566799999999999976 4458
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccC
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGA 526 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl 526 (708)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999986532 36999999999999999999999998 999999999999986 45599999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
++..... ......||+.|+|||++....++.++||||||+++|+|++|+.||......... ......+.....
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc-
Confidence 9865422 223456899999999998888999999999999999999999999654332210 000000110000
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........+..+.+|+.+||+.||++|||++|+++
T Consensus 251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 -----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001111234566899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.73 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=200.1
Q ss_pred ccChHHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh------HHHHHHHHHHHHHHhcC--CCcee
Q 047038 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE------SKVEEFINEVVILSQIN--HRNVV 437 (708)
Q Consensus 367 ~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~niv 437 (708)
..+..+.+...++|++.++||+|+||+||+|... +++.||||.++.... ...+.+.+|+.++++++ |+||+
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 3344556667789999999999999999999964 689999998765321 12346778999999996 59999
Q ss_pred eeeceEeeCCcceEEEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-C
Q 047038 438 KLLGCCLETEVPLLVYEFISN-GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-D 515 (708)
Q Consensus 438 ~l~g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~ 515 (708)
++++++.+.+..++|||++.+ ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ +
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 999999999999999999986 89999998653 5899999999999999999999998 99999999999999 7
Q ss_pred CCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHH
Q 047038 516 KYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594 (708)
Q Consensus 516 ~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~ 594 (708)
++.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence 899999999999876432 2234568999999999987665 6889999999999999999999953110
Q ss_pred HHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 595 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... .. .......+..+.+|+.+||+.||++|||++||++
T Consensus 255 ----~~~-~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----IIR-GQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----HHH-CC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hhc-cc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 0112223456899999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.16 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=189.1
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 453 (708)
....+|...++||+|+||+|+.....+++.||||++..... +.+.+|+.+|+++ +|||||++++++.+.+..+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34567999999999999997655566789999999864322 2456899999999 7999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEeeccCCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-----KYCAKVSDFGASR 528 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGls~ 528 (708)
||++ |+|.+++..... .+.+..++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 599999976542 3445566789999999999999998 999999999999943 3468899999998
Q ss_pred ccCcCCc--ceeecccccccccCccccc---cCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhh
Q 047038 529 SIAVDQT--HLTTQVQGTFGYLDPEYFQ---SSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRE 602 (708)
Q Consensus 529 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 602 (708)
....... .......||+.|+|||++. ...++.++||||||+++|||++ |..||........ ......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhcc
Confidence 7653322 2234467999999999997 4667889999999999999999 9999854322211 001111
Q ss_pred chhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... .. ..........+.+|+.+||+.||++|||++||++
T Consensus 245 ~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 00 0112334556889999999999999999999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.44 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=181.9
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHH-HHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
....++|+..+.||+|+||+||+|... +++.||||.+.... ... .+.+.++..+++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 344578999999999999999999975 78999999987533 223 334455556788889999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+||||+ ++.+..++.... ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 101 lv~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999 445555544322 3689999999999999999999995 8 99999999999999999999999999976
Q ss_pred cCcCCcceeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
..... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ . .........
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~~~~~ 247 (318)
T 2dyl_A 175 LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V---LTKVLQEEP 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H---HHHHHHSCC
T ss_pred ccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H---HHHHhccCC
Confidence 54322 223456899999999984 45688999999999999999999999975332211 1 111111110
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+. .......+..+.+|+.+||+.||.+||+++|+++
T Consensus 248 ------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ------PL--LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CC--CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CC--CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 0001123456899999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=356.14 Aligned_cols=274 Identities=24% Similarity=0.338 Sum_probs=207.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEee------CCc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE------TEV 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 448 (708)
.++|++.++||+|+||+||+|... +|+.||||+++. ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999964 689999998865 345667789999999999999999999998765 677
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEeecc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC---AKVSDFG 525 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFG 525 (708)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999987655556899999999999999999999998 999999999999997664 9999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhh--HHHHH-HHHhhh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKS--LAAYF-LRAMRE 602 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~--~~~~~-~~~~~~ 602 (708)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..... ......
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998764332 2344679999999999999999999999999999999999999996532111000 00000 000000
Q ss_pred chhhhhh--h--hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHcccc
Q 047038 603 DRLFEIL--D--AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE-----VGIELTGIRG 655 (708)
Q Consensus 603 ~~~~~~~--d--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----v~~~L~~l~~ 655 (708)
......+ . ...........+..+.+++.+||+.||++|||+.| +.+.++.+..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000 0 00112234456788999999999999999999988 5566666655
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=317.95 Aligned_cols=233 Identities=14% Similarity=0.094 Sum_probs=186.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.+.||+|+||+||+|... +++.||||.+... +....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999976 4899999998753 245567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++... ....++.+++.|++.||+|||+.+ |+||||||+||||++++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999542 355578889999999999999998 9999999999999999999997543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
|++| ++.++||||||+++|||++|+.||......+..... ...+.... .
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~--~ 223 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQP--I 223 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCB--C
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCC--C
Confidence 3333 688999999999999999999999765433210000 00000000 0
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
.........+..+.+|+.+||+.||++| |+.|+++.|+.+...
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0001122334568999999999999999 999999999998773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=356.49 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=196.1
Q ss_pred ccCCcccceEeeeccEEEEEEEEc--CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc-----
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE--DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----- 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 448 (708)
.++|++.+.||+|+||+||++.+. +++.||||++... .....+.|.+|+.++++++|||||++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 6899999988653 44566789999999999999999999999988766
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||+.+ |+||||||+|||++++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987754 5899999999999999999999998 9999999999999986 89999999998
Q ss_pred ccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
..... ....||+.|+|||++.+.. +.++||||||++|+||++|.+||........ .+
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~~- 286 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------PE- 286 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------CT-
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------cc-
Confidence 65432 3456999999999987654 8999999999999999999998753211100 00
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-TMREVGIELTGIR 654 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~ 654 (708)
..........+.+|+.+||+.||++|| +++++.+.|..+.
T Consensus 287 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 ------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000111235688999999999999999 5677777777664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.61 Aligned_cols=241 Identities=17% Similarity=0.179 Sum_probs=182.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcC---------CCceee-
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--------ESKVEEFINEVVILSQIN---------HRNVVK- 438 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~- 438 (708)
.++|++.++||+|+||+||+|+. +|+.||||+++... ....+.+.+|+.+|++++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 68999999987532 233478999999999886 555554
Q ss_pred ----------------eeceEee-------------CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHH
Q 047038 439 ----------------LLGCCLE-------------TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489 (708)
Q Consensus 439 ----------------l~g~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~a 489 (708)
+++++.+ .+..+|||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 4444443 6789999999999987776643 258999999999999999
Q ss_pred HHHHH-hcCCCCeEecCCCCCcEEEcCCC--------------------cEEEeeccCCcccCcCCcceeeccccccccc
Q 047038 490 ISYLH-SAASIPIYHRDIKSTNILLDDKY--------------------CAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548 (708)
Q Consensus 490 l~yLH-~~~~~~iiHrDikp~NIll~~~~--------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~ 548 (708)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 888 99999999999999887 8999999999865422 236999999
Q ss_pred CccccccCCCCccchhHhHHHH-HHHHHhCCCCCCCCCcchhhhHHHHHHHHhh-hchhhhhhhhhhhccCCHHHHHHHH
Q 047038 549 DPEYFQSSHFTEKSDVYSFGVV-LVELLTGERPIRLTNSEEDKSLAAYFLRAMR-EDRLFEILDAQILKEGGKDEFKMVA 626 (708)
Q Consensus 549 aPE~~~~~~~t~ksDv~SlGvv-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~ 626 (708)
|||++.+.. +.++|||||+.+ .+++++|..||.. ..........+. ..... ...........++.+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccC----cccchhhhhhcCHHHH
Confidence 999998766 899999998777 7778889999731 100011111110 00000 0000111234667899
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q 047038 627 KLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 627 ~li~~cl~~~p~~RPt~~ev~ 647 (708)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 888887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.43 Aligned_cols=230 Identities=23% Similarity=0.311 Sum_probs=177.7
Q ss_pred cCCccc-ceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHH-HhcCCCceeeeeceEee----CCcce
Q 047038 378 DNFNTN-RILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVIL-SQINHRNVVKLLGCCLE----TEVPL 450 (708)
Q Consensus 378 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~ 450 (708)
++|.+. ++||+|+||+||++... +++.||||.++. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 78999999999999974 689999999864 24577889888 55699999999999987 67789
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccCC
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGAS 527 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGls 527 (708)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999987532 36999999999999999999999998 999999999999998 788999999998
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
.... +..++.++||||||+++|||++|+.||.......... .....+..... .
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~-~ 220 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY-E 220 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---CSCCSSCTTCC-S
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---HHHHHHhhccc-c
Confidence 6432 1346789999999999999999999996443221000 00000000000 0
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 221 -~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 -FPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -SCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCchh----cccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 0123456899999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=328.77 Aligned_cols=246 Identities=15% Similarity=0.178 Sum_probs=184.1
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh---HHHHHHHHHHHHHHhcCC-Cceeeee-------
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE---SKVEEFINEVVILSQINH-RNVVKLL------- 440 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~niv~l~------- 440 (708)
+...+.+|...++||+|+||+||+|.+. +|+.||||+++.... ...+.|.+|+.+++.++| +|.....
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 4445567888899999999999999954 799999998874332 336789999999999987 3221111
Q ss_pred --------------ceEee-----CCcceEEEEeccCCCcccccccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 047038 441 --------------GCCLE-----TEVPLLVYEFISNGTLSQYIDDQ----NKDFRISWEMRLCIAIDVSGAISYLHSAA 497 (708)
Q Consensus 441 --------------g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~al~yLH~~~ 497 (708)
.++.. ....+++|+++ +++|.+++... .....+++..++.++.||+.||+|||+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11111 11345666654 67999888521 12335889999999999999999999998
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecccccccccCcccc----------ccCCCCccchhHhH
Q 047038 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF----------QSSHFTEKSDVYSF 567 (708)
Q Consensus 498 ~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDv~Sl 567 (708)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 232 ---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 232 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp ---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ---cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999999999999999999998765322 344567 999999999 55668899999999
Q ss_pred HHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 568 GVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 568 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
|++||||++|+.||......+. ...++. .....++.+.+|+.+||+.||++||++.|++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHCCCCCCCcchhhh---------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999999965432211 011111 0112346699999999999999999988875
Q ss_pred H
Q 047038 648 I 648 (708)
Q Consensus 648 ~ 648 (708)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-30 Score=289.10 Aligned_cols=185 Identities=18% Similarity=0.123 Sum_probs=130.8
Q ss_pred eEeeeccEEEEEEE-EcCCcEEEEEEcccC----------ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 385 ILGQGGQGTVYKGM-LEDGKIVAVKKSKII----------DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 385 ~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~----------~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
.++.|+.|.+..++ ..-|+.+|+|.+... .+...++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666655 335888999987542 123456799999999999 799999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||++|++|.++|.... +++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999998654 46654 48899999999999999 99999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCC
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP 580 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P 580 (708)
+.. ......||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2345679999999999875 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-27 Score=262.88 Aligned_cols=184 Identities=15% Similarity=0.209 Sum_probs=146.7
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
...++||+|+||+||++.. .++.+|+|+..... ....+.|.+|+++|++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 57788998743311 11245689999999999999999777777788889999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++++|.+++.. ++.++.|+++||+|||+.+ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 4578999999999999998 999999999999999 999999999997754
Q ss_pred CCcce------eecccccccccCcccccc--CCCCccchhHhHHHHHHHHHhCCCCC
Q 047038 533 DQTHL------TTQVQGTFGYLDPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPI 581 (708)
Q Consensus 533 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDv~SlGvvl~elltg~~P~ 581 (708)
..... .....||+.|||||++.. ..|+...|+|+..+-.++.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 235679999999999987 56888999999999999888877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=215.77 Aligned_cols=154 Identities=16% Similarity=0.118 Sum_probs=125.1
Q ss_pred hHHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCCh------------------HHHHHHHHHHHHHHhc
Q 047038 370 SNELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDE------------------SKVEEFINEVVILSQI 431 (708)
Q Consensus 370 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~Ei~~l~~l 431 (708)
...+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.+|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555667778899999999999999997799999999864221 2456799999999999
Q ss_pred CCCceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 432 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
+ | +++.+++. .+..++||||+++++|.+ +... ....++.|++.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~~---------~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRVE---------NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCCS---------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cchh---------hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 5 77777554 466799999999999998 5321 23468999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCCcceeecccccccccCcccccc
Q 047038 512 LLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 555 (708)
|++ ++.+||+|||+++. +..++|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 999 99999999999863 445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=183.25 Aligned_cols=138 Identities=22% Similarity=0.168 Sum_probs=106.8
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcE--EEEEEcccCCh------------------------HHHHHHHHHHHHHHh
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKI--VAVKKSKIIDE------------------------SKVEEFINEVVILSQ 430 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vAvK~~~~~~~------------------------~~~~~~~~Ei~~l~~ 430 (708)
.-|.+.+.||+|+||.||+|.. .+|+. ||||..+.... .....+.+|+.+|++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999997 68999 99998654211 112368899999999
Q ss_pred cCCCce--eeeeceEeeCCcceEEEEeccC-C----CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 047038 431 INHRNV--VKLLGCCLETEVPLLVYEFISN-G----TLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH-SAASIPIY 502 (708)
Q Consensus 431 l~H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH-~~~~~~ii 502 (708)
++|+++ +.+++. +..+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988864 344432 467899999952 5 44443321 234456789999999999999 888 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 503 HRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 503 HrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
||||||+|||+++ .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=7e-17 Score=171.11 Aligned_cols=143 Identities=15% Similarity=0.163 Sum_probs=100.9
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--------------hHHHHHH--------HHHHHHHHh
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--------------ESKVEEF--------INEVVILSQ 430 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--------------~~~~~~~--------~~Ei~~l~~ 430 (708)
+.+...-|.+.+.||+|+||.||+|...+|+.||||.++... ....... ..|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 333334489999999999999999999899999999764310 0011122 235555555
Q ss_pred cCCCceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 047038 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTN 510 (708)
Q Consensus 431 l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~N 510 (708)
+.+.++....-+ .....+|||||+++++|.++.... ....++.|++.+|.|||+.+ ||||||||.|
T Consensus 170 L~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 170 LYEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp HHHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred HHhcCCCCCeee--eccCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 544333211111 112347999999998887765321 23467889999999999998 9999999999
Q ss_pred EEEcCCC----------cEEEeeccCCcc
Q 047038 511 ILLDDKY----------CAKVSDFGASRS 529 (708)
Q Consensus 511 Ill~~~~----------~~kl~DFGls~~ 529 (708)
|||++++ .+.|+||+-+..
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEEeCCCCcccccccccceEEEEeCCccc
Confidence 9998776 489999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=5.6e-12 Score=128.20 Aligned_cols=146 Identities=17% Similarity=0.128 Sum_probs=114.0
Q ss_pred HhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEE
Q 047038 374 EKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 374 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 452 (708)
......|.....++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..++++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344457888888898999999999754 6889999876422122346889999999984 67888999999988899999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA----------------------------------- 497 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~----------------------------------- 497 (708)
|||++|.+|.+.+... .....++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999987764211 123467889999999999821
Q ss_pred ---------------------CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 498 ---------------------SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 498 ---------------------~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999887667899998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.4e-11 Score=121.91 Aligned_cols=138 Identities=14% Similarity=0.133 Sum_probs=102.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc--eeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E 454 (708)
...+....+.+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +++++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445443333455569999998777888999986543 2346788999999986544 5668888888888899999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA------------------------------------- 497 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~------------------------------------- 497 (708)
|++|.+|. ... .. ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 221 11 1256778888888888753
Q ss_pred ------------------CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 498 ------------------SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 498 ------------------~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
...++|+|++|.|||++++..++|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999988777899999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=7.1e-10 Score=118.16 Aligned_cols=142 Identities=15% Similarity=0.181 Sum_probs=107.2
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcc--cCC-hHHHHHHHHHHHHHHhcC--CCceeeeeceEeeC---CcceEEE
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSK--IID-ESKVEEFINEVVILSQIN--HRNVVKLLGCCLET---EVPLLVY 453 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 453 (708)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 578888765 321 123457888999999997 45688899988776 3489999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA------------------------------------ 497 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~------------------------------------ 497 (708)
||++|..+.+... ..++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988854221 13678888899999999999999831
Q ss_pred -------------------CCCeEecCCCCCcEEEcCCCc--EEEeeccCCcc
Q 047038 498 -------------------SIPIYHRDIKSTNILLDDKYC--AKVSDFGASRS 529 (708)
Q Consensus 498 -------------------~~~iiHrDikp~NIll~~~~~--~kl~DFGls~~ 529 (708)
.+.++|+|+++.|||+++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=3.5e-10 Score=117.55 Aligned_cols=186 Identities=20% Similarity=0.243 Sum_probs=123.8
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCc--eeeeeceEeeCC---cceEEEEec
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRN--VVKLLGCCLETE---VPLLVYEFI 456 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~ 456 (708)
.+.++.|....||+.. +.+++|.... ......+.+|+++|+.+. +.. +++++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 4588887543 344578999999999883 333 445555443333 458999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA--------------------------------------- 497 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~--------------------------------------- 497 (708)
+|.+|.+.... .++..++..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888753321 3677788888999999999998621
Q ss_pred ----------------CCCeEecCCCCCcEEEcC--CCcEEEeeccCCcccCcCCc--ceee-----------ccccccc
Q 047038 498 ----------------SIPIYHRDIKSTNILLDD--KYCAKVSDFGASRSIAVDQT--HLTT-----------QVQGTFG 546 (708)
Q Consensus 498 ----------------~~~iiHrDikp~NIll~~--~~~~kl~DFGls~~~~~~~~--~~~~-----------~~~gt~~ 546 (708)
.+.++|+|++|.||++++ ...+.|+||+.+..-..... .... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134899999999999998 56689999998764321000 0000 0000111
Q ss_pred ccC-ccccccCCCCccchhHhHHHHHHHHHhCCCCC
Q 047038 547 YLD-PEYFQSSHFTEKSDVYSFGVVLVELLTGERPI 581 (708)
Q Consensus 547 y~a-PE~~~~~~~t~ksDv~SlGvvl~elltg~~P~ 581 (708)
... |+..... ....+.|+++.+++.+.+|..+|
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 122 2222111 12368999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.1e-06 Score=91.09 Aligned_cols=135 Identities=14% Similarity=0.148 Sum_probs=95.6
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC---ceeeeeceEe-eCCcceEEEEeccC
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR---NVVKLLGCCL-ETEVPLLVYEFISN 458 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~ 458 (708)
.+.++.|....||+. ++.+++|+.. .......+.+|+++|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888999987 5668888753 234557899999999999753 3567777764 44567899999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA------------------------------------------ 496 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~------------------------------------------ 496 (708)
.+|.+.... .++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 234455555556666666666543
Q ss_pred ---------------CCCCeEecCCCCCcEEEcC---CCc-EEEeeccCCc
Q 047038 497 ---------------ASIPIYHRDIKSTNILLDD---KYC-AKVSDFGASR 528 (708)
Q Consensus 497 ---------------~~~~iiHrDikp~NIll~~---~~~-~kl~DFGls~ 528 (708)
..+.++|+|++|.|||+++ ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2234799999999999997 355 5899999765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.9e-06 Score=87.46 Aligned_cols=134 Identities=18% Similarity=0.173 Sum_probs=96.6
Q ss_pred eEeeeccE-EEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEEeccCCCc
Q 047038 385 ILGQGGQG-TVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 385 ~lG~G~~g-~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 461 (708)
.+..|..| .||+.... ++..+++|+... ....++.+|..+|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44555555 68988755 456788997553 34567888999999884 44477889999999999999999999887
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 047038 462 SQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA-------------------------------------------- 497 (708)
Q Consensus 462 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-------------------------------------------- 497 (708)
.+...... .....+..++++.|..||...
T Consensus 108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 66543211 122345566666666666421
Q ss_pred -----------CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 498 -----------SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 498 -----------~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999988877899998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.6e-06 Score=91.85 Aligned_cols=81 Identities=4% Similarity=-0.006 Sum_probs=57.0
Q ss_pred ceE-eeeccEEEEEEEEc-------CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcC-C--CceeeeeceEeeC---
Q 047038 384 RIL-GQGGQGTVYKGMLE-------DGKIVAVKKSKIID---ESKVEEFINEVVILSQIN-H--RNVVKLLGCCLET--- 446 (708)
Q Consensus 384 ~~l-G~G~~g~Vy~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--- 446 (708)
+.| +.|....+|+.... +++.+++|...... ......+.+|+.+|+.+. + -.+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999988764 26778898764321 001245778888888884 2 3577888887665
Q ss_pred CcceEEEEeccCCCcccc
Q 047038 447 EVPLLVYEFISNGTLSQY 464 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~ 464 (708)
+..++|||+++|.++.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 357899999999887653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.3e-05 Score=80.94 Aligned_cols=140 Identities=16% Similarity=0.195 Sum_probs=80.5
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC--Cceeeeec------eEeeCCcceEEEEe
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH--RNVVKLLG------CCLETEVPLLVYEF 455 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g------~~~~~~~~~lV~E~ 455 (708)
+.|+.|..+.||+....+| .+++|+... .. +++..|+.+++.+.. -.+++++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999887655 488998765 22 233445555555531 13444443 12345677899999
Q ss_pred ccCCCccc--------------cccccCCCC-----------CCCHHHHH------------------------------
Q 047038 456 ISNGTLSQ--------------YIDDQNKDF-----------RISWEMRL------------------------------ 480 (708)
Q Consensus 456 ~~~gsL~~--------------~l~~~~~~~-----------~l~~~~~~------------------------------ 480 (708)
++|.++.. .+|...... ...|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 112111000 11232110
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 481 -CIAIDVSGAISYLHS----------AASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 481 -~i~~~i~~al~yLH~----------~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+..++.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446667763 123459999999999999888889999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.4e-05 Score=84.10 Aligned_cols=75 Identities=16% Similarity=0.167 Sum_probs=50.3
Q ss_pred cceEeeeccEEEEEEEEc-CCcEEEEEEcccCCh-------HHHHHHHHHHHHHHhcCC--C-ceeeeeceEeeCCcceE
Q 047038 383 NRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDE-------SKVEEFINEVVILSQINH--R-NVVKLLGCCLETEVPLL 451 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~-niv~l~g~~~~~~~~~l 451 (708)
.+.||.|..+.||++... +++.++||....... ...+.+..|+++|+.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899997543211 123456789999988742 3 34456644 4556789
Q ss_pred EEEeccCC
Q 047038 452 VYEFISNG 459 (708)
Q Consensus 452 V~E~~~~g 459 (708)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00013 Score=75.47 Aligned_cols=139 Identities=18% Similarity=0.143 Sum_probs=93.4
Q ss_pred ccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeCCcceEEEEeccC
Q 047038 382 TNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
..+.|+.|....+|+... +++.+++|+... .....|..|+..|+.+. ...+++++++....+..++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999876 467788897653 23567889999999884 36788899988888889999999998
Q ss_pred CCccc-----------cccccCC-------------------CCCCCHHHHH---HHHH----------------HHHHH
Q 047038 459 GTLSQ-----------YIDDQNK-------------------DFRISWEMRL---CIAI----------------DVSGA 489 (708)
Q Consensus 459 gsL~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~~----------------~i~~a 489 (708)
..+.. .||.... ...-+|.... ++.. ++++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86632 1222111 0112454321 1111 11111
Q ss_pred H-HHHHh-cCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 490 I-SYLHS-AASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 490 l-~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23422 2346799999999999999887 8898974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0001 Score=75.29 Aligned_cols=80 Identities=18% Similarity=0.148 Sum_probs=58.8
Q ss_pred CCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC---CceeeeeceEeeCCcceEEEEe
Q 047038 379 NFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH---RNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.....+.+|.|..+.||+..+.||+.|.+|+...........|..|+..|+.+.- --+++++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 4455678999999999999999999999998654433334567889999998842 234555554 345899999
Q ss_pred ccCCCcc
Q 047038 456 ISNGTLS 462 (708)
Q Consensus 456 ~~~gsL~ 462 (708)
++++...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9876543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00038 Score=72.14 Aligned_cols=158 Identities=11% Similarity=0.142 Sum_probs=88.8
Q ss_pred cChHHHHhhccCCcc-----cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc--eeeee
Q 047038 368 FTSNELEKATDNFNT-----NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN--VVKLL 440 (708)
Q Consensus 368 ~~~~el~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~ 440 (708)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... ...+++..|+.+++.+...+ +++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555555544 34566788889999987666 5788876642 12234566777777764222 34444
Q ss_pred ce------EeeCCcceEEEEeccCCCcccc--------------ccccCCCC---------CCCHHHHHH----------
Q 047038 441 GC------CLETEVPLLVYEFISNGTLSQY--------------IDDQNKDF---------RISWEMRLC---------- 481 (708)
Q Consensus 441 g~------~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~~~---------~l~~~~~~~---------- 481 (708)
.. ....+..+++|+|++|..+... +|...... ...|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 22 1223567899999998765321 12111000 012322111
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 482 --IAIDVSGAISYLHSA----ASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 482 --i~~~i~~al~yLH~~----~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
+...+.+.++.|+.. ....++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244556666532 13459999999999999987666899998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00025 Score=76.76 Aligned_cols=78 Identities=9% Similarity=0.054 Sum_probs=47.1
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcceeecc-cccccccCccccccCC---CCccchhHhHHHHHHH
Q 047038 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQV-QGTFGYLDPEYFQSSH---FTEKSDVYSFGVVLVE 573 (708)
Q Consensus 498 ~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~t~ksDv~SlGvvl~e 573 (708)
.+.++|+|++|.|||+++++ ++|+||+.+..-.... ...... .-...|++|+...... -....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999999876 9999999886432110 000000 0123466766554211 1123455677777777
Q ss_pred HHhC
Q 047038 574 LLTG 577 (708)
Q Consensus 574 lltg 577 (708)
.+.+
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00046 Score=74.79 Aligned_cols=74 Identities=19% Similarity=0.213 Sum_probs=51.0
Q ss_pred cceEeeeccEEEEEEEEcC--------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEE
Q 047038 383 NRILGQGGQGTVYKGMLED--------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVY 453 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 453 (708)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+.+|+.+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 4788899874311 12456689999988853333 667776542 3899
Q ss_pred EeccCCCcc
Q 047038 454 EFISNGTLS 462 (708)
Q Consensus 454 E~~~~gsL~ 462 (708)
||+++.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00099 Score=70.62 Aligned_cols=140 Identities=17% Similarity=0.195 Sum_probs=82.0
Q ss_pred ceEeeeccEEEEEEEEc--------CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEE
Q 047038 384 RILGQGGQGTVYKGMLE--------DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 454 (708)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777788988764 2478899985331 223456678999998884 3233667766643 29999
Q ss_pred eccCCCcccc-c----------------cccCC--CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 047038 455 FISNGTLSQY-I----------------DDQNK--DFRIS--WEMRLCIAIDVSG-------------------AISYLH 494 (708)
Q Consensus 455 ~~~~gsL~~~-l----------------~~~~~--~~~l~--~~~~~~i~~~i~~-------------------al~yLH 494 (708)
|++|.+|..- + |.... ..... |.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 1 11100 11122 3444444433321 233332
Q ss_pred ----hc-CCCCeEecCCCCCcEEEcCC----CcEEEeeccCCc
Q 047038 495 ----SA-ASIPIYHRDIKSTNILLDDK----YCAKVSDFGASR 528 (708)
Q Consensus 495 ----~~-~~~~iiHrDikp~NIll~~~----~~~kl~DFGls~ 528 (708)
.. ....++|+|+.+.|||++++ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 23458999999999999876 789999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00093 Score=68.57 Aligned_cols=72 Identities=17% Similarity=0.138 Sum_probs=45.1
Q ss_pred cceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEEEec-cCCC
Q 047038 383 NRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFI-SNGT 460 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 460 (708)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .++++. +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577999999999998 45888876542111 1123467877777643233 456554 344457999999 6655
Q ss_pred cc
Q 047038 461 LS 462 (708)
Q Consensus 461 L~ 462 (708)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0016 Score=67.82 Aligned_cols=141 Identities=12% Similarity=0.094 Sum_probs=72.2
Q ss_pred ceEeeeccEE-EEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeCCcceEEEEeccCCC
Q 047038 384 RILGQGGQGT-VYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 384 ~~lG~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
+.|+.|+... +|+....+++.+++|....... +++..|+.+++.+.. -.+++++.+..+. -+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 3455554444 6676654467777776543211 234456777766632 3356677663332 378999997766
Q ss_pred ccccccccC---------------------C-CC-CCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 047038 461 LSQYIDDQN---------------------K-DF-RISWEMRL-------C-------------IAIDVSGAISYLH--- 494 (708)
Q Consensus 461 L~~~l~~~~---------------------~-~~-~l~~~~~~-------~-------------i~~~i~~al~yLH--- 494 (708)
+.+.+.... . .. .++..... . ....+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 544332110 0 00 01111000 0 0011122223331
Q ss_pred hcCCCCeEecCCCCCcEEEcCC----CcEEEeeccCCcc
Q 047038 495 SAASIPIYHRDIKSTNILLDDK----YCAKVSDFGASRS 529 (708)
Q Consensus 495 ~~~~~~iiHrDikp~NIll~~~----~~~kl~DFGls~~ 529 (708)
......++|+|+.+.|||++++ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0017 Score=70.69 Aligned_cols=75 Identities=15% Similarity=0.053 Sum_probs=48.3
Q ss_pred cceEeeeccEEEEEEEEcC-CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeCCcceEEEEeccCCC
Q 047038 383 NRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISNGT 460 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 460 (708)
.+.|+.|-...+|+....+ ++.+++|+....... .-+-.+|..+++.+...++ +++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998765 477888875432111 1112478899998865554 56777663 2 36999999866
Q ss_pred cc
Q 047038 461 LS 462 (708)
Q Consensus 461 L~ 462 (708)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0038 Score=64.65 Aligned_cols=141 Identities=14% Similarity=0.108 Sum_probs=81.6
Q ss_pred ceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCC--ceeeeece-----EeeCCcceEEEEec
Q 047038 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHR--NVVKLLGC-----CLETEVPLLVYEFI 456 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~E~~ 456 (708)
+.|+ |....||+....+|+.+++|...... ...+.+..|..+++.+... .+++++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 78889999887778789999875321 1234666788888877422 24555543 12234557899999
Q ss_pred cCCCccc----c----------ccccCC------CCCCCHHHH----HH---------------HHHHHHHHHHHHHhc-
Q 047038 457 SNGTLSQ----Y----------IDDQNK------DFRISWEMR----LC---------------IAIDVSGAISYLHSA- 496 (708)
Q Consensus 457 ~~gsL~~----~----------l~~~~~------~~~l~~~~~----~~---------------i~~~i~~al~yLH~~- 496 (708)
+|..+.. . +|.... ....++... .. +...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 0 111100 011222111 00 011111223333321
Q ss_pred ---CCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 497 ---ASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 497 ---~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234488999999999999 4 89999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0021 Score=68.03 Aligned_cols=73 Identities=12% Similarity=0.105 Sum_probs=44.1
Q ss_pred ceEeeeccEEEEEEEEcC---------CcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeeCCcceEEE
Q 047038 384 RILGQGGQGTVYKGMLED---------GKIVAVKKSKIIDESKVEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 453 (708)
+.|+.|..-.+|+....+ ++.+++|+..... ....+...|..+++.+...+ .+++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 456777788899988654 2678888765421 11122357888888775333 44666544 247899
Q ss_pred EeccCCCc
Q 047038 454 EFISNGTL 461 (708)
Q Consensus 454 E~~~~gsL 461 (708)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0036 Score=59.88 Aligned_cols=99 Identities=15% Similarity=0.126 Sum_probs=65.7
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCccee
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 538 (708)
-+|.+.|...+. ++++.++|.++.|.+.+|.-+-....+ ..+=+-|..|+|..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence 478888887654 799999999999999998776221111 1223446899999999888764 1111
Q ss_pred ecccccccccCccccccCCCCccchhHhHHHHHHHHHh
Q 047038 539 TQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT 576 (708)
Q Consensus 539 ~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt 576 (708)
.....+.+||... ...+.+.=|||||++||.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123456888764 345789999999999999986
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0093 Score=62.21 Aligned_cols=64 Identities=11% Similarity=0.111 Sum_probs=42.0
Q ss_pred cEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC---CCceeeeece------EeeCCcceEEEEeccCCCc
Q 047038 391 QGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN---HRNVVKLLGC------CLETEVPLLVYEFISNGTL 461 (708)
Q Consensus 391 ~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~------~~~~~~~~lV~E~~~~gsL 461 (708)
...||+....+| .+++|+...... ..|+.+++.+. -+++++++.. ....+..++||||++|..+
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 678999987777 899997655331 34566666553 2225555532 2335667899999998766
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.0029 Score=43.56 Aligned_cols=28 Identities=21% Similarity=0.196 Sum_probs=14.9
Q ss_pred EEEeccchhhhHHHHHHHHHHHhhhhhh
Q 047038 305 IIIGCTIGGLGMLSLLTGTLWLYKFFRR 332 (708)
Q Consensus 305 ~ii~~~~~~~~~l~l~~~~~~~~~~~~~ 332 (708)
.|++++++++++++++++++|+++++|+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 4555666655555555555555544333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0028 Score=43.48 Aligned_cols=30 Identities=27% Similarity=0.266 Sum_probs=15.8
Q ss_pred eEEEeccchhhhHHHHHHHHHHHhhhhhhc
Q 047038 304 FIIIGCTIGGLGMLSLLTGTLWLYKFFRRR 333 (708)
Q Consensus 304 ~~ii~~~~~~~~~l~l~~~~~~~~~~~~~~ 333 (708)
..|++++++++++++++++.+|+++++|++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 345556666565555555555555444433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.021 Score=61.29 Aligned_cols=75 Identities=9% Similarity=0.019 Sum_probs=48.1
Q ss_pred cceEeeeccEEEEEEEEcC--------CcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEE
Q 047038 383 NRILGQGGQGTVYKGMLED--------GKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 453 (708)
.+.|..|-...+|+....+ ++.+++|+...... ..-+-.+|..+++.+. +.-.+++++.+ .-++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567777788899988753 57889988644221 1112346888888774 32245566533 237899
Q ss_pred EeccCCCcc
Q 047038 454 EFISNGTLS 462 (708)
Q Consensus 454 E~~~~gsL~ 462 (708)
||++|.+|.
T Consensus 150 efI~G~~l~ 158 (424)
T 3mes_A 150 EFIDGEPLT 158 (424)
T ss_dssp ECCCSEECC
T ss_pred EEeCCccCC
Confidence 999987653
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.93 E-value=0.025 Score=38.70 Aligned_cols=8 Identities=38% Similarity=0.700 Sum_probs=4.2
Q ss_pred EEEeccch
Q 047038 305 IIIGCTIG 312 (708)
Q Consensus 305 ~ii~~~~~ 312 (708)
.|+++++|
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 45545555
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.90 E-value=0.41 Score=50.84 Aligned_cols=28 Identities=36% Similarity=0.439 Sum_probs=24.0
Q ss_pred eEecCCCCCcEEE------cCCCcEEEeeccCCc
Q 047038 501 IYHRDIKSTNILL------DDKYCAKVSDFGASR 528 (708)
Q Consensus 501 iiHrDikp~NIll------~~~~~~kl~DFGls~ 528 (708)
++|+|+.+.|||+ +++..++++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999998875
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=89.49 E-value=0.095 Score=42.30 Aligned_cols=38 Identities=24% Similarity=0.540 Sum_probs=29.9
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCC-cCccCccccCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTY-PDLCEGYYDFN 281 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy-~~~c~~~~~c~ 281 (708)
.|. ++.|.+..+ +|.|.|..||.++++ ...|.++++|.
T Consensus 12 ~C~-~g~C~n~~g-~y~C~C~~Gy~~~~~~g~~C~dideC~ 50 (86)
T 1lmj_A 12 LCG-RGQCVNTPG-DFECKCDEGYESGFMMMKNCMDIDECQ 50 (86)
T ss_dssp TTT-TSCEEEETT-EEEECCCSSEEECTTTSSSEEECCHHH
T ss_pred CCC-CCEEECCCC-CEEeeCCCCcCccCCCCCccCCccccc
Confidence 473 458888544 899999999998877 56799988884
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.75 E-value=0.075 Score=43.04 Aligned_cols=38 Identities=16% Similarity=0.336 Sum_probs=29.9
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCCcCccCccccCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFN 281 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c~ 281 (708)
.| .++.|.+.. .+|.|.|..||.+++....|.++++|.
T Consensus 12 ~C-~~~~C~n~~-g~y~C~C~~G~~~~~~g~~C~dideC~ 49 (87)
T 1z6c_A 12 IC-GTAVCKNIP-GDFECECPEGYRYNLKSKSCEDIDECS 49 (87)
T ss_dssp SB-TTSSCCCBT-TBCCCSSSTTCEEETTTTEEECCCHHH
T ss_pred CC-CCCEeECCC-CCEEEECCCCceECCCCCcCCCcCeeC
Confidence 37 557888743 379999999999888766788888873
|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
Probab=87.76 E-value=0.34 Score=33.83 Aligned_cols=26 Identities=23% Similarity=0.432 Sum_probs=21.5
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
.|.. +.|.+ ....+|.|.|..||.|.
T Consensus 13 pC~n-G~C~~~~~~~~~~C~C~~GytG~ 39 (46)
T 1k36_A 13 YCLH-GQCIYLVDMSQNYCRCEVGYTGV 39 (46)
T ss_dssp SCSS-EEEEEETTTTEEEEEECTTCSST
T ss_pred CCCC-CEeeccCCCCCEEEECCCCCccC
Confidence 6877 89987 44468999999999996
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=87.54 E-value=0.19 Score=40.11 Aligned_cols=42 Identities=19% Similarity=0.433 Sum_probs=28.6
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCCcCccCccccCCCccccc
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFNQELQCQ 287 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c~~~~~C~ 287 (708)
.|. ++.|.+.. .+|.|.|..||.++. ..|.++++|.....|.
T Consensus 13 ~C~-~g~C~n~~-g~y~C~C~~Gy~~~g--~~C~dideC~~~~~C~ 54 (82)
T 1emn_A 13 VCK-HGQCINTD-GSYRCECPFGYILAG--NECVDTDECSVGNPCG 54 (82)
T ss_dssp SCS-SSEECCCS-SCCCEECCTTEEEET--TEEEECCGGGTCCTTS
T ss_pred CcC-CCEEEecC-CCEEEECCCCeECCC--CccCCcccccCCCCCC
Confidence 464 37888743 479999999998421 2688888886444454
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=86.80 E-value=0.45 Score=31.64 Aligned_cols=26 Identities=23% Similarity=0.408 Sum_probs=21.3
Q ss_pred cccCCCceeecCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.+. ..+|.|.|+.||.|.
T Consensus 10 pC~ngg~C~~~-~~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 10 PCLNGGSCKDD-INSYECWCPFGFEGK 35 (39)
T ss_dssp CCCTTCEEEEE-TTEEEEECCTTCCST
T ss_pred CCCCCCEeEcC-CCceEeECCCCCcCC
Confidence 67777899874 347999999999985
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=86.64 E-value=0.13 Score=54.45 Aligned_cols=49 Identities=12% Similarity=0.215 Sum_probs=5.6
Q ss_pred ceeecCCCceEeecCCCCCCCCCcCccCccccCCCccccccC-----Cccccccc
Q 047038 248 YCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFNQELQCQSR-----TSHSLRFR 297 (708)
Q Consensus 248 ~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c~~~~~C~~~-----~~~~c~~~ 297 (708)
.|.+. ..+|.|.|..||..++....|.++++|.....|..+ ..|.|.|.
T Consensus 16 ~C~~~-~g~~~C~C~~G~~l~~~~~~C~d~~eC~~~~~C~~~C~~~~g~~~C~C~ 69 (386)
T 3v65_B 16 KCQMI-RGAVQCTCHTGYRLTEDGRTCQDVNECAEEGYCSQGCTNSEGAFQCWCE 69 (386)
T ss_dssp -------------------------------------CCTTEEC-----CCEECC
T ss_pred CCcCC-CCCcEeECCCCceECCCCCccCccceeCCcCcccCcCCCCCCCCeEEEC
Confidence 55332 335999999999987776789999999644444321 23677663
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=86.63 E-value=0.21 Score=49.59 Aligned_cols=36 Identities=17% Similarity=0.353 Sum_probs=28.7
Q ss_pred ccccCCCceeecCCCceEeecCCCCCCCCCcCccCcccc
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYD 279 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~ 279 (708)
..|..+..|.|+.| +|.|.|+.||.||.. .|.++++
T Consensus 13 ~~C~~~a~C~Nt~G-sy~C~C~~Gy~GnG~--~C~d~d~ 48 (285)
T 1gl4_A 13 HQCSVHAECRDYAT-GFCCRCVANYTGNGR--QCVAEGS 48 (285)
T ss_dssp GGSCTTEEEEECSS-CEEEEECTTEEECSS--SEEETTC
T ss_pred CCCCCCCEeEcCCC-CeEEEcCCCCCCCCC--cCCCCCC
Confidence 47988899999544 799999999999865 5776654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.46 E-value=1.5 Score=41.66 Aligned_cols=116 Identities=6% Similarity=0.078 Sum_probs=76.9
Q ss_pred CCCceeeeeceEeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 432 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
.||+++.. .+-.+++...+.|+.-+ +...+-.- ..++...+++++.+|+....+++. -+|-=|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888766 45555565555555443 23332221 147888999999999988866654 36888999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCC
Q 047038 512 LLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~ 582 (708)
+++.++.+++.-.|+-..+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999876653322 222 11222223457788999999988873
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=84.71 E-value=0.68 Score=33.30 Aligned_cols=27 Identities=22% Similarity=0.452 Sum_probs=22.0
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.. ....+|.|.|..||.|.
T Consensus 13 pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 40 (53)
T 1egf_A 13 YCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp SSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred cCCCCcEEEeeCCCCCEEEECCCCCcCC
Confidence 5887799984 34568999999999985
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=84.56 E-value=0.5 Score=32.69 Aligned_cols=27 Identities=19% Similarity=0.308 Sum_probs=21.9
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.. ....+|.|.|..||.|.
T Consensus 10 pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 37 (45)
T 1a3p_A 10 YCLNGGVXMHIESLDSYTCNCVIGYSGD 37 (45)
T ss_dssp CCSSSCEEEECTTTSSEEEECCTTEETT
T ss_pred CCCCCCEEEeecCCCCEEEEcCCCCcCC
Confidence 5887889984 34568999999999985
|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
Probab=83.91 E-value=0.36 Score=36.00 Aligned_cols=26 Identities=38% Similarity=0.768 Sum_probs=20.6
Q ss_pred cccCC--CceeecCCCceEeecCCCCC-CC
Q 047038 242 SCNQD--GYCLVQLGSGYFCLCNDRRL-SG 268 (708)
Q Consensus 242 ~C~~~--s~C~~~~~~Gy~C~C~~G~~-gn 268 (708)
.|... +.|.+.. .+|.|.|+.||. |.
T Consensus 18 PC~nga~gtC~~~~-g~y~C~C~~Gy~~G~ 46 (61)
T 2k2s_B 18 PCGPEAAGTCKETN-SGYICRCNQGYRISL 46 (61)
T ss_dssp SSCSSSCCEEEECS-SEEEEECCTTEEEEE
T ss_pred CCcCCCccccccCC-CceEeECCCCCccCC
Confidence 47666 7898743 479999999998 85
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.52 E-value=0.12 Score=56.05 Aligned_cols=60 Identities=8% Similarity=0.062 Sum_probs=17.5
Q ss_pred cceEeeeccEEEEEEEEcC-CcEEEE------EEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 047038 383 NRILGQGGQGTVYKGMLED-GKIVAV------KKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE 445 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~-~~~vAv------K~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 445 (708)
.+.|| ||+||+|.+.. ..+||| |..+. ........|.+|..++++++|+|+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 34565 99999999864 357888 76554 223445678999999999999999999888653
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
Probab=83.04 E-value=0.48 Score=34.45 Aligned_cols=36 Identities=14% Similarity=0.395 Sum_probs=25.5
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCCcCccCccccC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDF 280 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c 280 (708)
.|. ..|.++.| +|.|.|..||.-.+-...|.++++|
T Consensus 10 ~C~--~~C~nt~G-sy~C~C~~Gy~L~~d~~~C~didec 45 (55)
T 2jkh_L 10 DCD--QFCHEEQN-SVVCSCARGYTLADNGKACIPTGPY 45 (55)
T ss_dssp GCS--SEEEEETT-EEEEECCTTEEECTTSSCEEESSSS
T ss_pred CcC--cEeEcCCC-CeEEeCCCCCEECCCCCeeccCccc
Confidence 454 36877544 8999999999755444468887766
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=82.93 E-value=0.54 Score=33.91 Aligned_cols=28 Identities=25% Similarity=0.543 Sum_probs=22.8
Q ss_pred ccccCCCceee-cCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
..|...++|.. ....+|.|.|..||.|.
T Consensus 12 ~pC~nGG~C~~~~~~~~~~C~C~~GytG~ 40 (53)
T 1nql_B 12 GYCLHDGVCMYIEALDKYACNCVVGYIGE 40 (53)
T ss_dssp CEECTTCEEEEETTTTEEEEEECTTEEST
T ss_pred CCCCCCeEEeeecCCCCEEEecCCCCcCC
Confidence 46888899985 44568999999999996
|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
Probab=82.71 E-value=0.53 Score=33.93 Aligned_cols=33 Identities=18% Similarity=0.362 Sum_probs=23.8
Q ss_pred ceeecCCCceEeecCCCCCCCCCcCccCccccC
Q 047038 248 YCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDF 280 (708)
Q Consensus 248 ~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c 280 (708)
.|.++.+.+|.|.|..||.-.+-...|.++++|
T Consensus 12 ~C~n~~ggs~~C~C~~Gy~L~~Dg~tC~d~dec 44 (53)
T 2bz6_L 12 YCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEY 44 (53)
T ss_dssp EEEEETTTEEEEECCTTEEECTTSSCEEECSSS
T ss_pred EeEcCCCCCEEeeCCCCCEECCCCCcccCCccc
Confidence 577655546999999999754444468888776
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.60 E-value=0.6 Score=47.71 Aligned_cols=36 Identities=25% Similarity=0.602 Sum_probs=28.5
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCCcCccC-ccccCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCE-GYYDFNQ 282 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~-~~~~c~~ 282 (708)
.|...+.|.+.. .+|.|.|..||.|+ .|. ++++|..
T Consensus 12 pC~~~g~C~~~~-~~~~C~C~~g~~g~----~C~~~~~eC~~ 48 (317)
T 3h5c_B 12 PCLHNGSCQDSI-WGYTCTCSPGYEGS----NCELAKNECHP 48 (317)
T ss_dssp CCTTTCCCCCCS-SSCCCCCSSSCCSS----SSCCCSSSCCT
T ss_pred CCCCCCEeECCC-CCeEEECCCCCcCC----ccccCcccCCC
Confidence 587778898743 47999999999986 677 7778754
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
Probab=82.13 E-value=0.62 Score=49.39 Aligned_cols=49 Identities=20% Similarity=0.291 Sum_probs=33.4
Q ss_pred CceeecCCCceEeecCCCCCCCCCcCccCccccCCCcccccc-----CCccccccc
Q 047038 247 GYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFNQELQCQS-----RTSHSLRFR 297 (708)
Q Consensus 247 s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c~~~~~C~~-----~~~~~c~~~ 297 (708)
..|.+.. .+|.|.|+.||.+. -...|.+++||..+..|.. ...|.|.|.
T Consensus 12 ~~C~~~~-~~y~C~C~~G~~~~-~~~~C~dideC~~~~~C~~~C~n~~g~~~C~C~ 65 (400)
T 3p5b_L 12 HVCNDLK-IGYECLCPDGFQLV-AQRRCEDIDECQDPDTCSQLCVNLEGGYKCQCE 65 (400)
T ss_dssp SEEEECS-SSEEEECCTTEEEC-SSSCEEECCCCSTTSSCSSCCBCCSSSCBCCCC
T ss_pred CEeECCC-CCeEEECCCCCCcC-CCCcccCchhhhccCCCCCccCCCccceeeecc
Confidence 5787743 47999999999861 1347999999975444432 123777773
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.04 E-value=0.7 Score=33.57 Aligned_cols=28 Identities=29% Similarity=0.643 Sum_probs=21.9
Q ss_pred ccccCCCceee----cCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLV----QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~----~~~~Gy~C~C~~G~~gn 268 (708)
..|...++|.. ....+|.|.|..||.|.
T Consensus 14 ~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~ 45 (55)
T 3u7u_G 14 TFCVNGGECFMVKDLSNPSRYLCKCPNEFTGD 45 (55)
T ss_dssp TTSCTTCEEEEECCC--CCCEEEEECTTEEST
T ss_pred CCCCCCCCcCCCCccCCCCCEeEeCCCCCcCC
Confidence 46888899964 23468999999999996
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
Probab=81.26 E-value=0.64 Score=42.21 Aligned_cols=35 Identities=31% Similarity=0.549 Sum_probs=26.1
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCCcCccCccccCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFN 281 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c~ 281 (708)
.|...+.|.+. ..+|.|.|..||.|. .|....+|.
T Consensus 126 ~C~~~g~C~~~-~~~~~c~C~~g~~G~----~Ce~~~~c~ 160 (162)
T 1g1s_A 126 SCSKQGECLET-IGNYTCSCYPGFYGP----ECEYVRDDD 160 (162)
T ss_dssp GGGGSEEEEEC-SSSEEEEECTTEEST----TSCEECC--
T ss_pred CCCCCCEEecC-CCCceEeCCCCCcCc----ccccCcccC
Confidence 68777889873 347999999999996 677666653
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=80.87 E-value=0.38 Score=40.57 Aligned_cols=37 Identities=27% Similarity=0.453 Sum_probs=19.9
Q ss_pred ceeecCCCceEeecCCCCCCCCCcCccCccccCCCcccc
Q 047038 248 YCLVQLGSGYFCLCNDRRLSGTYPDLCEGYYDFNQELQC 286 (708)
Q Consensus 248 ~C~~~~~~Gy~C~C~~G~~gnpy~~~c~~~~~c~~~~~C 286 (708)
.|.+. ..+|.|.|+.||.|++ ...|+++++|.....|
T Consensus 42 ~C~n~-~g~y~C~C~~Gy~g~~-g~~C~dideC~~~~~C 78 (107)
T 2w2n_E 42 VCNDL-KIGYECLCPDGFQLVA-QRRCEDIDECQDPDTC 78 (107)
T ss_dssp EEECC-SBSCEEECCTTCEEET-TTEEEC----------
T ss_pred EeEeC-CCCeEEECCCCccccC-CCccccccccCCCCCc
Confidence 56663 3479999999999852 2368888888643344
|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
Probab=80.11 E-value=0.86 Score=34.09 Aligned_cols=27 Identities=26% Similarity=0.608 Sum_probs=22.0
Q ss_pred cccCCCceee----cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV----QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~----~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.+ ....+|.|.|..||.|.
T Consensus 13 pC~ngG~C~~~~~~~~~~~y~C~C~~Gf~G~ 43 (63)
T 1hae_A 13 FCVNGGECFMVKDLSNPSRYLCKCQPGFTGA 43 (63)
T ss_dssp TSCTTCEEEEEESSSSSCCEEEECCTTEEST
T ss_pred cCCCCcEEecCCccCCCCCEEEECCCCCcCC
Confidence 5777789986 24568999999999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 708 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 5e-69
Identities = 64/287 (22%), Positives = 119/287 (41%), Gaps = 21/287 (7%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQI 431
+ E + +G G GTVYKG V + +++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 432 NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAIS 491
H N++ +G +V ++ +L ++ + + IA + +
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMD 118
Query: 492 YLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ-THLTTQVQGTFGYLDP 550
YLH+ I HRD+KS NI L + K+ DFG + + +H Q+ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 551 EYFQ---SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
E + + ++ +SDVY+FG+VL EL+TG+ P + + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSP 229
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
L + + K + +L CL +RP ++ + +
Sbjct: 230 DLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 6e-68
Identities = 71/303 (23%), Positives = 130/303 (42%), Gaps = 37/303 (12%)
Query: 373 LEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEVVILSQ 430
+E D+F LG G G V+K G ++A K I + + I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
N +V G + E + G+L Q + RI ++ ++I V +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
+YL I HRD+K +NIL++ + K+ DFG S + + GT Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED--------------------- 589
E Q +H++ +SD++S G+ LVE+ G PI +++E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 590 --KSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTM 643
+ L++Y + + +FE+LD + + K + + + +CL N +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 644 REV 646
+++
Sbjct: 293 KQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-64
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 21/269 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
+ LG G G V+ G VAVK K + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+L + + ++ E++ NG+L ++ + +++ L +A ++ ++++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
HRD+++ NIL+ D K++DFG +R I ++ + + PE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
FT KSDV+SFG++L E++T R M + + L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVR 231
Query: 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + + +L + C + RPT +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYL 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (540), Expect = 5e-64
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 21/283 (7%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGMLED-GKIVAVKKSKIIDESKVEEFINEVVILSQ 430
+ E + LG G G VY+G+ + VAVK K D +VEEF+ E ++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
I H N+V+LLG C ++ EF++ G L Y+ + N+ +S + L +A +S A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 128
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
YL HRD+ + N L+ + + KV+DFG SR + D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 551 EYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
E + F+ KSDV++FGV+L E+ T + +++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
E + + V +L + C N RP+ E+ +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-63
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 21/277 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
+ +G G G V+ G + VA+K + E+FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+L G CLE LV+EF+ +G LS Y + + + E L + +DV ++YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
+ HRD+ + N L+ + KVSDFG +R + DQ +T + + PE F S
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
++ KSDV+SFGV++ E+ + + + E +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223
Query: 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
+ V ++ C + RP + +L I
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-63
Identities = 69/278 (24%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
+ +G+G G V G G VAVK I +++ + F+ E +++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 438 KLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
+LLG +E + L +V E+++ G+L Y+ + + + + L ++DV A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSS 556
HRD+ + N+L+ + AKVSDFG ++ + Q + + PE +
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREK 175
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616
F+ KSDV+SFG++L E+ + R +D + + + + D
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD------ 223
Query: 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
V ++ K C +L+ RP+ ++ +L I+
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-62
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHR 434
+++ +G G G K DGKI+ K+ + E++ + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 435 NVVKLLGCCLETE--VPLLVYEFISNGTLSQYIDDQNKDF-RISWEMRLCIAIDVSGAIS 491
N+V+ ++ +V E+ G L+ I K+ + E L + ++ A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 492 YLH--SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
H S + HRD+K N+ LD K K+ DFG +R + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
PE + EKSD++S G +L EL P + +E +RE + I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRI- 234
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
DE ++ R LNL RP++ E+
Sbjct: 235 -----PYRYSDELN---EIITRMLNLKDYHRPSVEEI 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 60/269 (22%), Positives = 112/269 (41%), Gaps = 21/269 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
++ LGQG G V+ G VA+K K E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+L E + +V E++S G+L ++ + + + +A ++ ++Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM- 132
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
HRD+++ NIL+ + KV+DFG +R I ++ + + PE
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
FT KSDV+SFG++L EL T R M + + ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + + L +C ++RPT +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-61
Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN 435
+ +GQG GTVY M + G+ VA+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+V L L + +V E+++ G+L+ + + + + + A+ +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS 134
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
+ HRDIKS NILL K++DFG I +Q+ +T V GT ++ PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615
+ K D++S G++ +E++ GE P N L + + E+ + + L
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPELQNPEKLS 243
Query: 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+D RCL+++ +KR + +E+
Sbjct: 244 AIFRD-------FLNRCLDMDVEKRGSAKEL 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-61
Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 21/269 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV 437
+ + LG G G V G VA+K K +EFI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+L G C + ++ E+++NG L Y+ + R + L + DV A+ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSH 557
HRD+ + N L++D+ KVSDFG SR + D+ + + + PE S
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 558 FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEG 617
F+ KSD+++FGV++ E+ + + E + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222
Query: 618 GKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ V + C + +RPT + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 7e-61
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 40/305 (13%)
Query: 368 FTSNELEKATDNFNTN---------RILGQGGQGTVYKGML----EDGKIVAVKK-SKII 413
FT + +A F +++G G G V G L + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 414 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR 473
E + +F++E I+ Q +H NV+ L G ++ +++ EF+ NG+L ++ + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 474 ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533
+ + + ++ + YL HRD+ + NIL++ KVSDFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 534 QTHLTT----QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEE 588
+ T + + PE Q FT SDV+S+G+V+ E+++ GERP
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 233
Query: 589 DKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648
M + ++ D + +L C + RP ++
Sbjct: 234 --------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 649 ELTGI 653
L +
Sbjct: 286 TLDKM 290
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 8e-61
Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 30/273 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F R LG+G G VY + I+A+K K+++ + EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
N+++L G + L+ E+ GT+ + + + + + +++ A+SY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS + HRDIK N+LL K++DFG S + + GT YL PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
+ EK D++S GV+ E L G+ P E + + R R + F
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANTYQETYKRISRVEFTFP----DF 226
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ EG +D L R L N +RP +REV
Sbjct: 227 VTEGARD-------LISRLLKHNPSQRPMLREV 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 1e-60
Identities = 65/311 (20%), Positives = 127/311 (40%), Gaps = 47/311 (15%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKK-SKIIDESKVEEFINE 424
LE +N R +G+G G V++ E +VAVK + +F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 425 VVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF------------ 472
++++ ++ N+VKLLG C + L++E+++ G L++++ +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 473 ---------RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523
+S +LCIA V+ ++YL HRD+ + N L+ + K++D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 183
Query: 524 FGASRSIA-VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIR 582
FG SR+I D ++ PE + +T +SDV+++GVVL E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT 642
+ E+ + +R+ + + + + L + C + RP+
Sbjct: 244 YGMAHEE------VIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPS 288
Query: 643 MREVGIELTGI 653
+ L +
Sbjct: 289 FCSIHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 29/293 (9%)
Query: 381 NTNRILGQGGQGTVYKGMLEDGK----IVAVKK-SKIIDESKVEEFINEVVILSQINHRN 435
+ N ++G+G G VY G L D AVK ++I D +V +F+ E +I+ +H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 436 VVKLLGCCLETE-VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
V+ LLG CL +E PL+V ++ +G L +I ++ + + + + + +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV-----AKGMK 144
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA---VDQTHLTTQVQGTFGYLDPE 551
AS HRD+ + N +LD+K+ KV+DFG +R + D H T + ++ E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 552 YFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
Q+ FT KSDV+SFGV+L EL+T P D + + ++ RL +
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLLQ---- 255
Query: 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNGASNIVH 664
+ + ++ +C + + RP+ E+ ++ I + VH
Sbjct: 256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-60
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 383 NRILGQGGQGTVYKGMLED---GKIVAVK--KSKIIDESKVEEFINEVVILSQINHRNVV 437
++ LG G GTV KG + K VAVK K++ D + +E + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
+++G C E E +LV E G L++Y+ + + + + VS + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQ--VQGTFGYLDPEYFQS 555
HRD+ + N+LL ++ AK+SDFG S+++ D+ + Q + + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 556 SHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
F+ KSDV+SFGV++ E + G++P R M+ + +L+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGER 228
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
+ + L C + + RP V + L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 9e-60
Identities = 62/272 (22%), Positives = 119/272 (43%), Gaps = 30/272 (11%)
Query: 383 NRILGQGGQGTVYKGML-EDGKIVAVKK--SKIIDESKVEEFINEVVILSQINHRNVVKL 439
+ +G+G TVYKG+ E VA + + + +S+ + F E +L + H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 440 LGCCLET----EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
T + +LV E +++GTL Y+ + ++ + + +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130
Query: 496 AASIPIYHRDIKSTNILLDDKYC-AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
+ PI HRD+K NI + K+ D G + + + V GT ++ PE ++
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
+ E DVY+FG+ ++E+ T E P + AA R + D +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E V ++ + C+ N +R +++++
Sbjct: 240 PE--------VKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 3e-59
Identities = 64/291 (21%), Positives = 107/291 (36%), Gaps = 36/291 (12%)
Query: 363 DKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKV 418
D +LF ++ EK F+ R +G G G VY + + ++VA+K S K
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 419 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEM 478
++ I EV L ++ H N ++ GC L LV E+ + +
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 479 RLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT 538
+ ++YLHS + HRD+K+ NILL + K+ DFG++ +
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APA 168
Query: 539 TQVQGTFGYLDPEYFQSS---HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAY 595
GT ++ PE + + K DV+S G+ +EL + P
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--------------- 213
Query: 596 FLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L+ I + + CL + RPT +
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-59
Identities = 66/330 (20%), Positives = 132/330 (40%), Gaps = 49/330 (14%)
Query: 349 LLLQQELSSNEGG---IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGMLED---- 401
L + Q S++ +D + + E +N ++LG G G V
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 402 --GKIVAVKK-SKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIS 457
VAVK + D S+ E ++E+ +++Q+ +H N+V LLG C + L++E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 458 NGTLSQYIDDQNKDF--------------------RISWEMRLCIAIDVSGAISYLHSAA 497
G L Y+ + + F +++E LC A V+ + +L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT-TQVQGTFGYLDPEYFQSS 556
HRD+ + N+L+ K+ DFG +R I D ++ + ++ PE
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616
+T KSDV+S+G++L E+ + + + ++++ +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNP--------------YPGIPVDANFYKLIQNGFKMD 287
Query: 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + + + C + +KRP+ +
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-59
Identities = 58/294 (19%), Positives = 114/294 (38%), Gaps = 29/294 (9%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCC 443
+G+G G V++G G+ VAVK E + E+ + H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 444 LETE----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA-- 497
+ LV ++ +G+L Y+ + ++ E + +A+ + +++LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 498 ---SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL---TTQVQGTFGYLDPE 551
I HRD+KS NIL+ ++D G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 552 YFQSS------HFTEKSDVYSFGVVLVELLTGERPIRLTNSEE----DKSLAAYFLRAMR 601
S +++D+Y+ G+V E+ + + D + + MR
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 602 EDRLFEILDAQILKEG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
+ + L I + +++AK+ + C NG R T + L+ +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-59
Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 28/288 (9%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGMLEDG-----KIVAVKK-SKIIDESKVEEFINEVVI 427
E +++G G G VYKGML+ VA+K E + +F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 428 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVS 487
+ Q +H N+++L G + + +++ E++ NG L +++ +++ +F S + + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIA 120
Query: 488 GAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ--THLTTQVQGTF 545
+ YL + HRD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
+ PE FT SDV+SFG+V+ E++T + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+ ++ D + +L +C +RP ++ L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-58
Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 26/276 (9%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRN 435
D + LG G G VYK E + A K E ++E+++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+VKLL ++ EF + G + + + + ++ + A++YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
I HRD+K+ NIL K++DFG S + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 556 -----SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610
+ K+DV+S G+ L+E+ E P + + L+ + +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIAKSEPPTLAQP 238
Query: 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
++ K+CL N R T ++
Sbjct: 239 SRWSSN--------FKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-58
Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 30/287 (10%)
Query: 372 ELEKATDNFN-TNRILGQGGQGTVYKGML---EDGKIVAVKK-SKIIDESKVEEFINEVV 426
+L DN + LG G G+V +G+ + VA+K + +++ EE + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 427 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDV 486
I+ Q+++ +V+L+G C + E +LV E G L +++ + + I + V
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQV 118
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT--TQVQGT 544
S + YL HRD+ + N+LL +++ AK+SDFG S+++ D ++ T + +
Sbjct: 119 SMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMRED 603
+ PE F+ +SDV+S+GV + E L+ G++P + E + + +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228
Query: 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIEL 650
+ E + + L C + RP V +
Sbjct: 229 KRMECPP---------ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 41/309 (13%)
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKK-SKIID 414
ID T+L ++ E + + + LG G G V + + VAVK
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 415 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF- 472
++ E ++E+ +LS + NH N+V LLG C L++ E+ G L ++ + F
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 473 --------------RISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYC 518
+ E L + V+ +++L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 519 AKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG 577
K+ DFG +R I D + + + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 578 ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNG 637
+ K ++++ + + + K C + +
Sbjct: 244 GSSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 638 KKRPTMREV 646
KRPT +++
Sbjct: 290 LKRPTFKQI 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 195 bits (497), Expect = 5e-57
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 23/272 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
D+++ + LG G G V++ G A K ES E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
V L + +++YEF+S G L + + D++ ++S + + V + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 497 ASIPIYHRDIKSTNILLDDKYC--AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
H D+K NI+ K K+ DFG + + Q+ T GT + PE +
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAE 198
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
+D++S GV+ LL+G P N +E D + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMDDSAFSGI 252
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E GKD ++ L + R T+ +
Sbjct: 253 SEDGKD-------FIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 5e-57
Identities = 71/273 (26%), Positives = 110/273 (40%), Gaps = 24/273 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEVVILSQINHRN 435
++++ + LG+G G V + + VAVK E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
VVK G E + L E+ S G L I D + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD-QTHLTTQVQGTFGYLDPEYFQ 554
I HRDIK N+LLD++ K+SDFG + + + L ++ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 555 SSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
F E DV+S G+VL +L GE P + S + +E + + +I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
L + L N R T+ ++
Sbjct: 233 DSA--------PLALLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 26/287 (9%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGML----EDGKIVAVKK-SKIIDESKVEEFINEVV 426
+ E + R +G+G G V++G+ VA+K +S E+F+ E +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 427 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDV 486
+ Q +H ++VKL+G E V ++ E + G L + Q + + + + A +
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQL 117
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
S A++YL S HRDI + N+L+ C K+ DFG SR + + ++ +
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
++ PE FT SDV+ FGV + E+L D + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERL 228
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+ + + L +C + +RP E+ +L+ I
Sbjct: 229 PMPP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-56
Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 28/278 (10%)
Query: 374 EKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILS 429
+K ++F +ILG+G TV L + A+K K II E+KV E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 430 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+++H VKL + E + NG L +YI ++ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD-QTHLTTQVQGTFGYL 548
+ YLH I HRD+K NILL++ +++DFG ++ ++ + + GT Y+
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
PE + SD+++ G ++ +L+ G P R + F + ++ + F
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYDFP- 230
Query: 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ F L ++ L L+ KR E+
Sbjct: 231 ----------EKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 65/295 (22%), Positives = 118/295 (40%), Gaps = 38/295 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDG---KIVAVKK-SKIIDESKVEEFINEVVILSQI-N 432
++ ++G+G G V K ++ A+K+ + + +F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDF-------------RISWEMR 479
H N++ LLG C L E+ +G L ++ +S +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539
L A DV+ + YL HRD+ + NIL+ + Y AK++DFG SR V T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 540 QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA 599
+ ++ E S +T SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 600 MREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654
M L+E L E + V L ++C +RP+ ++ + L +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 29/278 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLE----DGKIVAVK---KSKIIDESKVEEFINEVVILSQ 430
+ LG G G V +G + VAVK + +++FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
++HRN+++L G L + +V E G+L + A+ V+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGM 124
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH--LTTQVQGTFGYL 548
YL S HRD+ + N+LL + K+ DFG R++ + H + + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 549 DPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608
PE ++ F+ SD + FGV L E+ T + + + + +E
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPR 236
Query: 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ D + + + +C + RPT +
Sbjct: 237 PE---------DCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-55
Identities = 62/286 (21%), Positives = 128/286 (44%), Gaps = 29/286 (10%)
Query: 375 KATDNFNTNRILGQGGQGTVYKGM-LEDGK----IVAVKK-SKIIDESKVEEFINEVVIL 428
K T+ F ++LG G GTVYKG+ + +G+ VA+K+ + +E ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 429 SQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG 488
+ +++ +V +LLG CL + V L+ + + G L Y+ + + + L + ++
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAK 122
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGY 547
++YL + HRD+ + N+L+ K++DFG ++ + ++ + + +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
+ E +T +SDV+S+GV + EL+T + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
IL+ V + +C ++ RP RE+ IE + +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 186 bits (473), Expect = 1e-54
Identities = 77/293 (26%), Positives = 119/293 (40%), Gaps = 32/293 (10%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQIN 432
+D + ILG GG V+ L + VAVK D S F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 433 HRNVVKLLGCCLETE----VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG 488
H +V + +P +V E++ TL + + ++ + + + D
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL--TTQVQGTFG 546
A+++ H I HRD+K NI++ KV DFG +R+IA + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
YL PE + +SDVYS G VL E+LTGE P S + + +RED +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-TMREVGIELTGIRGCNG 658
+ L + + L N + R T E+ +L + NG
Sbjct: 234 PSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADLVRVH--NG 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-53
Identities = 76/307 (24%), Positives = 132/307 (42%), Gaps = 33/307 (10%)
Query: 362 IDKTKLFTSNELEKATDNFNTNRILGQGGQGTVYKGML------EDGKIVAVKK-SKIID 414
++ +E E A + +R LGQG G VY+G+ E VA+K ++
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 415 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFR- 473
+ EF+NE ++ + N +VV+LLG + + L++ E ++ G L Y+
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 474 ------ISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527
S + +A +++ ++YL++ HRD+ + N ++ + + K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 528 RSI-AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNS 586
R I D + ++ PE + FT SDV+SFGVVL E+ T S
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 587 EEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E LR + E L + D + M+ +L + C N K RP+ E+
Sbjct: 241 NEQ------VLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 647 GIELTGI 653
+
Sbjct: 286 ISSIKEE 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 183 bits (466), Expect = 1e-52
Identities = 56/272 (20%), Positives = 103/272 (37%), Gaps = 23/272 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
D ++ LG G G V++ + G++ K NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
+ L + +L+ EF+S G L I +D+++S + + ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 497 ASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
I H DIK NI+ + K + K+ DFG + + + + T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVD 201
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
+D+++ GV+ LL+G P + R D F+ +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPF------AGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
KD K L +KR T+ +
Sbjct: 256 SPEAKD-------FIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 1e-52
Identities = 62/277 (22%), Positives = 108/277 (38%), Gaps = 20/277 (7%)
Query: 372 ELEKATDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEVVILS 429
+ E D ++ +LG G V K+VA+K +K E K NE+ +L
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 430 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+I H N+V L L+ + +S G L I ++ + + V A
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDA 119
Query: 490 ISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+ YLH + + LD+ +SDFG S+ D + + GT GY+
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVA 177
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
PE +++ D +S GV+ LL G P D++ A F + ++ + F+
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKAEYEFDSP 231
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + KD + + + +KR T +
Sbjct: 232 YWDDISDSAKD-------FIRHLMEKDPEKRFTCEQA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-51
Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 378 DNFNTNRILGQGGQGTVYKGM------LEDGKIVAVKK-SKIIDESKVEEFINEVVILSQ 430
D + LG+G G V + + VAVK + S+ ++E+ IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 431 INHR-NVVKLLGCCLETEVPL-LVYEFISNGTLSQYIDDQNKDF-------------RIS 475
I H NVV LLG C + PL ++ EF G LS Y+ + +F ++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 476 WEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535
E +C + V+ + +L S HRD+ + NILL +K K+ DFG +R I D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 536 HL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAA 594
++ + ++ PE +T +SDV+SFGV+L E+ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244
Query: 595 YFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
F R ++E D + + C + +RPT E+ L +
Sbjct: 245 EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 24/272 (8%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
+ + LG+G G V++ + K K K + + E+ IL+ HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
+ L E ++++EFIS + + I F ++ + V A+ +LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 497 ASIPIYHRDIKSTNILLDDKYCA--KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
I H DI+ NI+ + + K+ +FG +R + + Y PE Q
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQ 176
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614
+ +D++S G ++ LL+G P ++ M + F+ + +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPF------LAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
D R L K R T E
Sbjct: 231 SIEAMD-------FVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (446), Expect = 1e-50
Identities = 73/286 (25%), Positives = 114/286 (39%), Gaps = 38/286 (13%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK---------SKIIDESKVEEFINEVVI 427
+N+ ILG+G V + + K AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 428 LSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDV 486
L +++ H N+++L LV++ + G L Y+ ++ +S + I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
I LH I HRD+K NILLDD K++DFG S + D +V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174
Query: 547 YLDPEYFQSSH------FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600
YL PE + S + ++ D++S GV++ LL G P + M
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIM 228
Query: 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ F + + KD L R L + +KR T E
Sbjct: 229 SGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAEEA 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 66/300 (22%), Positives = 121/300 (40%), Gaps = 42/300 (14%)
Query: 378 DNFNTNRILGQGGQGTVYKGML--------EDGKIVAVKK-SKIIDESKVEEFINEVVIL 428
D + LG+G G V VAVK E + + I+E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 429 SQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYI-------------DDQNKDFRI 474
I H+N++ LLG C + ++ E+ S G L +Y+ N + ++
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 475 SWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534
S + + A V+ + YL S HRD+ + N+L+ + K++DFG +R I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 535 THLTTQVQ-GTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLA 593
+ T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 594 AYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653
+ + LF++L + + + + + C + +RPT +++ +L I
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 5e-48
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 29/273 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILS-QIN 432
++F +++LG+G G V+ + + A+K K ++ + VE + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 433 HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISY 492
H + + E V E+++ G L +I + + A ++ + +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 493 LHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
LHS I +RD+K NILLD K++DFG + + T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
+ D +SFGV+L E+L G+ P + EE ++R D F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF------ 221
Query: 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645
+ E K L + +KR +R
Sbjct: 222 -YPRWLEKEAK---DLLVKLFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 168 bits (425), Expect = 1e-47
Identities = 53/283 (18%), Positives = 109/283 (38%), Gaps = 20/283 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRN 435
+ ++ +G+G G VYK G+ A+KK ++ DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 436 VVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+VKL + +LV+E + + + + + I+Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 496 AASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQS 555
+ HRD+K N+L++ + K++DFG +R+ + T ++ + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 556 SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE------------DKSLAAYFLRAMRED 603
++ D++S G + E++ G + + + + D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
F + + + K + L + L L+ +R T ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 3e-47
Identities = 59/280 (21%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVV---ILSQ 430
++F+ +RI+G+GG G VY + GK+ A+K K +I + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
+ +V + + + + ++ G L ++ A ++ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120
Query: 491 SYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDP 550
++H+ + +RD+K NILLD+ ++SD G + + + H GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 551 EYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609
E Q + +D +S G +L +LL G P R +++ + L E
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649
L + E + L + L + +R G +
Sbjct: 228 ----LPDSFSPELR---SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (423), Expect = 5e-47
Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
+F R LG G G V+ +G+ A+K K ++ +VE +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
++++ G + + ++ ++I G L K R + A +V A+ YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS I +RD+K NILLD K++DFG ++ + +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
+ + + D +SFG+++ E+L G P D + + + + + F
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPF------YDSNTMKTYEKILNAELRFP----PF 223
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649
E KD L R + + +R + G E
Sbjct: 224 FNEDVKD-------LLSRLITRDLSQRLGNLQNGTE 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-47
Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 20/284 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK--KSKIIDESKVEEFINEVVILSQINHR 434
+NF +G+G G VYK G++VA+K + E I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+VKLL LV+EF+ D + I + + +++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
S + HRD+K N+L++ + K++DFG +R+ V T +V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERP------------IRLTNSEEDKSLAAYFLRAMRE 602
+++ D++S G + E++T I T D+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 603 DRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
F Q + + L + L+ + KR + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 55/289 (19%), Positives = 109/289 (37%), Gaps = 22/289 (7%)
Query: 377 TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK-SKIIDESKVEEFINEVVILSQINHR 434
+ +G+G G V + VA+KK S ++ + + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N++ + + + ++ + + K +S + + + Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLT--TQVQGTFGYLDPEY 552
SA + HRD+K +N+LL+ K+ DFG +R D H T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 553 FQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+S +T+ D++S G +L E+L+ + + + L + ++ L I++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 612 QI--------------LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ + L + L N KR + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 62/292 (21%), Positives = 112/292 (38%), Gaps = 25/292 (8%)
Query: 375 KATDNFNTNRILGQGGQGTVYKG--MLEDGKIVAVK--KSKIIDESKVEEFINEVVILSQ 430
+A + +G+G G V+K + G+ VA+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 431 I---NHRNVVKLLGCCLETEVPLLVYEFISNGTLSQ---YIDDQNKDFRISWEMRLCIAI 484
+ H NVV+L C + + + Q D+ + + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 485 DVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGT 544
+ + +LHS + HRD+K NIL+ K++DFG +R + T V T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 545 FGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED- 603
Y PE S + D++S G + E+ + R ++ + + E+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 604 ---------RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ F AQ +++ D ++ L +CL N KR +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-45
Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 25/281 (8%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKI-----IDESKVEEFINEVVILSQINHRNVV 437
LG+G TVYK +IVA+KK K+ + + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 438 KLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA 497
LL LV++F+ D ++ + + YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 498 SIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPE-YFQSS 556
I HRD+K N+LLD+ K++DFG ++S T QV T Y PE F +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 557 HFTEKSDVYSFGVVLVELLTGERPIRLTNSEE-----------DKSLAAYFLRAMREDRL 605
+ D+++ G +L ELL + + + + ++ +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
F+ L + L + N R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 59/289 (20%), Positives = 106/289 (36%), Gaps = 28/289 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
++ +++G G G VY+ L + G++VA+KK E+ I+ +++H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 437 VKLLGCCLETEVP------LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
V+L + LV +++ + + ++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 491 SYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLD 549
+Y+HS I HRDIK N+LLD D K+ DFG+++ + + +++ + +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 550 PEYFQSSHFTEKSDVYSFGVVLVELLTGERP------------IRLTNSEEDKSLAAYFL 597
F ++ +T DV+S G VL ELL G+ I +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 598 RAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E + +I K L R L R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 59/274 (21%), Positives = 100/274 (36%), Gaps = 29/274 (10%)
Query: 382 TNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKL 439
T+++LG G G V + + A+K + + EV + + ++V++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 70
Query: 440 LGCC----LETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS 495
+ + L+V E + G L I D+ + I + AI YLHS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129
Query: 496 AASIPIYHRDIKSTNILLDDKYC---AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
I HRD+K N+L K K++DFG ++ + T T Y+ PE
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEV 184
Query: 553 FQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612
+ + D++S GV++ LL G P + R F +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQYEFPNPEWS 242
Query: 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
+ E K L + L +R T+ E
Sbjct: 243 EVSEEVKM-------LIRNLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 68/280 (24%), Positives = 108/280 (38%), Gaps = 32/280 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESK---VEEFINEVVILSQ 430
D ++T LG G V K G A K K + + E+ EV IL +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 431 INHRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAI 490
I H NV+ L +L+ E ++ G L ++ ++ ++ E + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126
Query: 491 SYLHSAASIPIYHRDIKSTNILLDD----KYCAKVSDFGASRSIAVDQTHLTTQVQGTFG 546
YLHS I H D+K NI+L D K K+ DFG + I D + + GT
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPE 181
Query: 547 YLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
++ PE ++D++S GV+ LL+G P +E + F
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVNYEF 235
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E KD +R L + KKR T+++
Sbjct: 236 EDEYFSNTSALAKD-------FIRRLLVKDPKKRMTIQDS 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-44
Identities = 52/285 (18%), Positives = 108/285 (37%), Gaps = 22/285 (7%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHR 434
+ +G+G GTV+K E +IVA+K+ ++ DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N+V+L + LV+EF + E+ + + + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
S + HRD+K N+L++ K+++FG +R+ + + +V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEED---------KSLAAYFLRAMREDRL 605
+ ++ D++S G + EL RP+ N +D + +M +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 606 FEILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
++ + + + L N +R + E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 28/276 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
++F+ ++LG+G G V G+ A+K K II + +V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+ L + V E+ + G L ++ +++ + E ++ A+ YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS + +RDIK N++LD K++DFG + D + T GT YL PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
+ + + D + GVV+ E++ G P ++ F + E+ F +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDHERLFELILMEEIRFP----RT 227
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649
L K L L + K+R +
Sbjct: 228 LSPEAKS-------LLAGLLKKDPKQRLGGGPSDAK 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 7e-43
Identities = 51/279 (18%), Positives = 96/279 (34%), Gaps = 26/279 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
+ + R +G G G +Y G + G+ VA+K ++K + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVG 64
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
+ + C ++ + +L + ++ + S + L +A + I Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK 122
Query: 497 ASIPIYHRDIKSTNILLDDKYCAKV---SDFGASRSIAVDQTH------LTTQVQGTFGY 547
HRD+K N L+ + DFG ++ +TH + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607
+ + D+ S G VL+ G P + + + R
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------RQKYERISEKKM 233
Query: 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
++L +G EF C +L +P +
Sbjct: 234 STPIEVLCKGYPSEFA---TYLNFCRSLRFDDKPDYSYL 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-42
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 44/281 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVE---EFINEVVILSQ 430
+ +LG GG G+VY G+ + D VA+K K +I D ++ EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 431 IN--HRNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG 488
++ V++LL + +L+ E + + E+ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLE 121
Query: 489 AISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGY 547
A+ + H+ + HRDIK NIL+D ++ K+ DFG+ + + + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175
Query: 548 LDPEYFQ-SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
PE+ + + + V+S G++L +++ G+ P
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------------- 214
Query: 607 EILDAQI-LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
EI+ Q+ ++ E + L + CL L RPT E+
Sbjct: 215 EIIRGQVFFRQRVSSECQ---HLIRWCLALRPSDRPTFEEI 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-41
Identities = 56/301 (18%), Positives = 114/301 (37%), Gaps = 28/301 (9%)
Query: 368 FTSNELEKAT----DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK--KSKIIDESKVEE 420
F E+ K + + +G G G V + G VA+K E +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 421 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL-SQYIDDQNKDFRISWEMR 479
E+ +L + H NV+ LL E +F + K ++ +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539
+ + + Y+H+A I HRD+K N+ +++ K+ DFG +R + +T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 540 QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--------DKS 591
V + +T+ D++S G ++ E++TG+ + ++ + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 592 LAAYFLRAMREDRLFEILDA--QILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMRE 645
A F++ ++ D + ++ K+ + LA + L L+ ++R T E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 646 V 646
Sbjct: 298 A 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 2e-40
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK---KSKIIDESKVEEFINEVVILSQINH 433
D F+ + LG G G V E G A+K K K++ ++E +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
+VKL + +V E+++ G + ++ R S A + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYF 553
HS + +RD+K N+L+D + +V+DFG A T + GT L PE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEALAPEII 210
Query: 554 QSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613
S + + D ++ GV++ E+ G P + Y + R + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIVSGKVRFPSHFSSDL 265
Query: 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649
L + L ++ KR + G+
Sbjct: 266 ------------KDLLRNLLQVDLTKRFGNLKNGVN 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 60/299 (20%), Positives = 118/299 (39%), Gaps = 36/299 (12%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHR 434
+ +GQG G V+K + G+ VA+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 435 NVVKLLGCCLETEVP--------LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDV 486
NVV L+ C P LV++F + + K F +S R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML-- 126
Query: 487 SGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT---HLTTQVQG 543
++ L+ I HRD+K+ N+L+ K++DFG +R+ ++ + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 544 TFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE 602
T Y PE + D++ G ++ E+ T ++ + +L + ++
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 603 DRLFEILDAQILKE-----GGKDEFKMVAK----------LAKRCLNLNGKKRPTMREV 646
+ + + ++ ++ G K + K K L + L L+ +R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 1e-39
Identities = 45/281 (16%), Positives = 93/281 (33%), Gaps = 28/281 (9%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV 436
++ R +G+G G +++G L + + VA+K S + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 437 VKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA 496
+ + + + ++ + +L +D + F S + A + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHEK 120
Query: 497 ASIPIYHRDIKSTNILLDDKYC-----AKVSDFGASRSIAVDQT------HLTTQVQGTF 545
+ +RDIK N L+ V DFG + T + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 546 GYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605
Y+ + + D+ + G V + L G P + + + + +R+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---------KQKYERI 228
Query: 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREV 646
E + L+E + K NL P +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (360), Expect = 3e-38
Identities = 53/298 (17%), Positives = 112/298 (37%), Gaps = 45/298 (15%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRN 435
D++ R LG+G V++ + + + + V VK I+ K ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPN 91
Query: 436 VVKLLGCCLE--TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
++ L + + P LV+E ++N Q ++ ++ A+ Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 494 HSAASIPIYHRDIKSTNILLDDKYC-AKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEY 552
HS I HRD+K N+++D ++ ++ D+G + Q + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 553 FQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611
+ D++S G +L ++ + P + D + + + L++ +D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK 258
Query: 612 ----------QILKEGGKDEFKMVAK-------------LAKRCLNLNGKKRPTMREV 646
IL + ++ + L + + R T RE
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-37
Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 30/283 (10%)
Query: 378 DNFNTNRILGQGGQGTVYKGML----EDGKIVAVK---KSKIIDESK-VEEFINEVVILS 429
+NF ++LG G G V+ + GK+ A+K K+ I+ ++K E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 430 QINHR-NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSG 488
I +V L L+ ++I+ G L ++ ++ R + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVL 140
Query: 489 AISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYL 548
A+ +LH I +RDIK NILLD ++DFG S+ D+T GT Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 549 DPEYFQS--SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606
P+ + S + D +S GV++ ELLTG P + + R
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS------QAEISRRILKS 251
Query: 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649
E Q + KD L +R L + KKR +
Sbjct: 252 EPPYPQEMSALAKD-------LIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-36
Identities = 60/301 (19%), Positives = 114/301 (37%), Gaps = 28/301 (9%)
Query: 368 FTSNELEKA----TDNFNTNRILGQGGQGTVYKGM-LEDGKIVAVK--KSKIIDESKVEE 420
F EL K + + +G G G+V + G VAVK +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 421 FINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEFISNGTLSQYIDDQNKDFRISWEMR 479
E+ +L + H NV+ LL + ++ + +++ K +++ +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 480 LCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTT 539
+ + + Y+HSA I HRD+K +N+ +++ K+ DFG +R +T
Sbjct: 124 QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTG 177
Query: 540 QVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEE--------DKS 591
V + H+ + D++S G ++ ELLTG T+ + +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 592 LAAYFLRAMREDRLFEILDA--QILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMRE 645
A L+ + + + + Q+ K + F LA + L L+ KR T +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 646 V 646
Sbjct: 298 A 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 33/297 (11%)
Query: 378 DNFNTNRILGQGGQGTVYKGM-LEDGKIVAVKK--SKIIDESKVEEFINEVVILSQINHR 434
+ + +G G QG V + VA+KK +++ + E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 435 NVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLH 494
N++ LL + + L Q + E + + I +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 495 SAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQ 554
S I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVIL 191
Query: 555 SSHFTEKSDVYSFGVVLVELLTGERP---------------IRLTNSEEDKSLAAYFLRA 599
+ E D++S G ++ E++ + T E +R
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 600 MREDRL------FEILDAQILKEGGKDEFKMVAKLAK----RCLNLNGKKRPTMREV 646
E+R F L L + K+ A A+ + L ++ KR ++ +
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 9e-30
Identities = 56/310 (18%), Positives = 103/310 (33%), Gaps = 50/310 (16%)
Query: 384 RILGQGGQGTVYKGM-LEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGC 442
R LG G TV+ + + VA+K + D+ E +E+ +L ++N + K
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 443 CLETEVPLLVY-------------EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGA 489
+ LL + F G + + + I I+ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 490 ISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFG-ASRSIAVDQTHLTTQVQGTFGY 547
+ Y+H I H DIK N+L++ + A A T T Y
Sbjct: 138 LDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 548 LDPEYFQSSHFTEKSDVYSFGVVLVELLTGERP--------------------------- 580
PE + + +D++S ++ EL+TG+
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 581 ---IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK-EGGKDEFKMVAKLAKRCLNLN 636
+R + LR + + + + + D K + KDE K ++ L L+
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 637 GKKRPTMREV 646
+KR +
Sbjct: 316 PRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 5e-19
Identities = 32/202 (15%), Positives = 66/202 (32%), Gaps = 28/202 (13%)
Query: 384 RILGQGGQGTVYKGMLEDGKIVAVK----------KSKIIDESKVEEFINEVVILSQINH 433
+++G+G + V+ E VK K K + F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 434 RNVVKLLGCCLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYL 493
R + KL G + Y + N L + ID + + + ++
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 494 HSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA--VDQTHLTTQVQGTFGYLDPE 551
+ I H D+ N+L+ + + DF S + + L V+
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI-----IT 170
Query: 552 YFQSSHFTEKSDVYSFGVVLVE 573
YF + + D+ S +++
Sbjct: 171 YFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 708 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.56 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.18 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 95.54 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 93.22 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 93.04 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 92.51 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 91.5 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 90.98 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.78 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.62 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 90.16 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 89.87 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 89.72 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 89.55 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.48 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 89.23 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 88.96 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 88.42 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.27 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.27 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.23 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 88.11 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 87.49 | |
| d1dx5i1 | 43 | Thrombomodulin, different EGF-like domains {Human | 85.81 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 83.85 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 83.56 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.23 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 82.22 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 80.54 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=431.35 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=203.5
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688899999999999999999889999999987633 345789999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999876543 6899999999999999999999998 9999999999999999999999999998776544444
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHhC-CCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG-ERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....||+.|+|||++.+..++.++||||||++||||+|+ ++|+......+ .. ..+..+ ....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~----~~i~~~---------~~~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV----EDISTG---------FRLY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HH----HHHHHT---------CCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHhc---------CCCC
Confidence 4556799999999999999999999999999999999995 55554322211 11 111111 1111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+...++++.+|+.+||+.||++||||+||++.|++|++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 223334678999999999999999999999999999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=430.18 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=210.2
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++...++|++.++||+|+||+||+|+++ ..||||+++. .+....+.|.+|+.+|++++|||||++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 3445678999999999999999999864 3599999865 345667899999999999999999999998754 5689
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.++++.... .+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999999999999976533 5999999999999999999999998 999999999999999999999999999876
Q ss_pred CcCC-cceeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 531 AVDQ-THLTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 531 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
.... ........||+.|||||++.. ..++.++|||||||+||||+||+.||........ . ...+..+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~----~~~~~~~~~~ 228 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IFMVGRGYLS 228 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHHHTSCC
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--H----HHHHhcCCCC
Confidence 5332 223455679999999999864 4589999999999999999999999975443321 1 1111111110
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
+ .........++.+.+|+.+||+.||++|||++||++.|+.|++.
T Consensus 229 ----p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 ----P-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ----C-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----C-cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0 01122334456799999999999999999999999999999873
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=428.22 Aligned_cols=263 Identities=23% Similarity=0.382 Sum_probs=215.1
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++++...++|++.+.||+|+||+||+|.+++++.||||+++.. ....++|.+|+++|++++|||||+++|++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 3455556789999999999999999999988899999998753 3345689999999999999999999998754 5679
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.+++..... ..++|..++.|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence 99999999999998865532 35899999999999999999999998 999999999999999999999999999987
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
............||+.|||||++.+..++.++||||||++||||+||..|+....... . ....+..+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~----~~~~i~~~------- 226 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--E----VIQNLERG------- 226 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTT-------
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHhc-------
Confidence 6554444556679999999999999999999999999999999999655543222211 1 11111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccc
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIR 654 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 654 (708)
.....+...++.+.+|+.+||+.||++||||+||++.|+.+-
T Consensus 227 --~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 227 --YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111122334566899999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-52 Score=431.69 Aligned_cols=265 Identities=28% Similarity=0.414 Sum_probs=221.5
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
+++|...++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+.+..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 345555678999999999999999999976 5889999998753 34467899999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+|||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999976532 36999999999999999999999998 99999999999999999999999999998
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...+.........||+.|+|||++.+..++.++||||||+++|||++|..|+........ ....+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~-------- 230 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLE-------- 230 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH--------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHh--------
Confidence 765555555556789999999999999999999999999999999997766543222111 111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+.+...++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 231 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 -KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111222233445679999999999999999999999999998865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-52 Score=430.33 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=202.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CC---cEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DG---KIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
++|++.++||+|+||+||+|.++ ++ ..||||++.. ......++|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677789999999999999975 23 3689998765 4556677899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++..... .++|.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998876533 5999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcce----eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 533 DQTHL----TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 533 ~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
..... .....||+.|||||.+.+..++.++|||||||+||||+| |+.||......+ ....+..+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~---- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQD---- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTT----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC----
Confidence 32221 223457999999999999999999999999999999998 899996543322 11111111
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...++.+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1112233455679999999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=415.78 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=216.4
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEecc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 457 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 457 (708)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998889999999876433 45689999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce
Q 047038 458 NGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL 537 (708)
Q Consensus 458 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~ 537 (708)
+|+|.+++..... .+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999776543 5899999999999999999999998 9999999999999999999999999998766555444
Q ss_pred eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 538 TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 538 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+. ...+..+. ...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~---------~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGL---------RLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTC---------CCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCC---------CCC
Confidence 555679999999999999999999999999999999998 8999976543321 11122111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
.+...++.+.+|+.+||+.||++|||++||++.|.+|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2233446799999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=418.77 Aligned_cols=250 Identities=28% Similarity=0.389 Sum_probs=203.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 68999999986533 23456799999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++.......
T Consensus 85 ~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999997543 6999999999999999999999998 99999999999999999999999999987654332
Q ss_pred -ceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 536 -HLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 536 -~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
...+...||+.|||||++.+..+ +.++|||||||+||||++|+.||......... . .. ......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~---~~-~~~~~~-------- 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y---SD-WKEKKT-------- 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--H---HH-HHTTCT--------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--H---HH-HhcCCC--------
Confidence 23455679999999999988776 67899999999999999999999754432211 0 01 111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
........++.+.+|+.+||+.||++|||++|++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 0011122345688999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=419.21 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=211.1
Q ss_pred cCCcccce-EeeeccEEEEEEEEc---CCcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRI-LGQGGQGTVYKGMLE---DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
++|...+. ||+|+||+||+|.++ ++..||||.++. ......++|.+|+++|++++|||||+++|++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 355799999875 345667889999999999999999999999864 568999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999865433 6999999999999999999999998 99999999999999999999999999987754
Q ss_pred CCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 533 DQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 533 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
..... .....||+.|||||++....++.++|||||||++|||+| |+.||......+ +...+..+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~---- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR---- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCC----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 33322 234568999999999999999999999999999999998 999997544322 1122222211
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+.+...++.+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 231 -----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12233445679999999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=418.67 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=205.9
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCC-----cEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDG-----KIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
.+.|+..++||+|+||+||+|.+++. ..||||+++. ......++|.+|+.+|++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999997642 3799999865 34555678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+.+++|.+++..... .++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998876543 6999999999999999999999998 999999999999999999999999999876
Q ss_pred CcCCc--ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 531 AVDQT--HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 531 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
..... .......||+.|||||++.+..++.++||||||++||||++|..|+....... . ....+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~----~~~~i~~------ 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E----VMKAIND------ 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H----HHHHHHT------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--H----HHHHHhc------
Confidence 54322 22334568999999999999999999999999999999999666654332221 1 1111211
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
......+...+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 229 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 ---GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11222334455679999999999999999999999999998876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=416.89 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=209.0
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
++...++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 333456899999999999999999999988899999987543 345789999999999999999999999854 568999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++..... ..++|.+++.++.||++||+|||+.+ |+||||||+|||||+++++||+|||+++....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999999876532 25999999999999999999999998 99999999999999999999999999987755
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
..........||+.|+|||++....++.++||||||++||||++|..|+....... .. ...+..+
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~----~~~i~~~--------- 230 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV----LDQVERG--------- 230 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTT---------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HH----HHHHHhc---------
Confidence 44444455679999999999999999999999999999999999766654333221 11 1111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
...+.+...++++.+||.+||+.||++||+|++|+++|+.....
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11122334456799999999999999999999999999987763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=411.06 Aligned_cols=245 Identities=28% Similarity=0.394 Sum_probs=207.1
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||+|+.+ +++.||||++... +....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999975 6889999987642 2234567999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998654 5999999999999999999999998 999999999999999999999999999865432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||......+. ...+....
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~--------- 220 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVE--------- 220 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTC---------
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC---------
Confidence 2 3446799999999999999999999999999999999999999965432221 11111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...++.+.+|+.+||+.||++|||++|+++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112334566899999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=416.54 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=208.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
++|+..+.||+|+||+||+|... +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 69999999987655556778999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999987653 5899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhcc
Q 047038 537 LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKE 616 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 616 (708)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .......+.. . ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~-~-------~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-E-------LQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-C-------CS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCC-C-------CC
Confidence 23455799999999999999999999999999999999999999965432211 1111111110 0 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 617 GGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 617 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.+...++.+.+|+.+||+.||++|||++|++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1233456689999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=416.27 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=197.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee--CCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 452 (708)
++|++.+.||+|+||+||+|+.. +|+.||||.+... ++...+.|.+|+++|++++|||||++++++.+ .+..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 6899999987653 45667789999999999999999999999865 4567999
Q ss_pred EEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 453 YEFISNGTLSQYIDDQN-KDFRISWEMRLCIAIDVSGAISYLHSAA--SIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999987532 2346999999999999999999999865 23599999999999999999999999999987
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...+. .......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+..+..
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~---- 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC----
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 65432 23445679999999999999999999999999999999999999996543221 1111222211
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122334567999999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=413.73 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=201.9
Q ss_pred ceEeeeccEEEEEEEEcC---CcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEeccC
Q 047038 384 RILGQGGQGTVYKGMLED---GKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 458 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~---~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 458 (708)
++||+|+||+||+|.+++ ++.||||+++. .+....++|.+|+++|++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 46899999865 334456789999999999999999999999864 567899999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcce-
Q 047038 459 GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTHL- 537 (708)
Q Consensus 459 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~~- 537 (708)
|+|.++++... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998654 5999999999999999999999998 9999999999999999999999999998765443322
Q ss_pred -eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhc
Q 047038 538 -TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILK 615 (708)
Q Consensus 538 -~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 615 (708)
.....||+.|||||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+. ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~---------~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------RM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 334568999999999999999999999999999999998 899997543322 111222221 11
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 616 EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 616 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
+.+...++.+.+|+.+||+.||++|||++||++.|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 22334456799999999999999999999999988765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=422.23 Aligned_cols=261 Identities=25% Similarity=0.453 Sum_probs=211.5
Q ss_pred HHhhccCCcccceEeeeccEEEEEEEEcC-C-----cEEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeeceEe
Q 047038 373 LEKATDNFNTNRILGQGGQGTVYKGMLED-G-----KIVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCL 444 (708)
Q Consensus 373 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 444 (708)
++...++|++.++||+|+||+||+|+... + ..||||.+.. .+....+.|.+|+.+|+++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34455789999999999999999999653 2 3699998765 3344566899999999998 8999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNK--------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHR 504 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHr 504 (708)
+.+..+|||||+++|+|.++|+.... ...+++..++.++.||++||+|||+.+ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999976532 135899999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCC
Q 047038 505 DIKSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIR 582 (708)
Q Consensus 505 Dikp~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~ 582 (708)
||||+|||++.++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 2345668999999999999999999999999999999998 899997
Q ss_pred CCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047038 583 LTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELT 651 (708)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 651 (708)
.....+. +...+..+ ...+.+...++.+.+||.+||+.||++|||++||++.|.
T Consensus 269 ~~~~~~~------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH------HHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 6543321 11112211 111223344567999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=414.78 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=207.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......+.|.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999975 68999999988777777789999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.+++..... .+++.++..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999999876432 5999999999999999999999998 9999999999999999999999999997653221 1
Q ss_pred eeecccccccccCccccc-----cCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhh
Q 047038 537 LTTQVQGTFGYLDPEYFQ-----SSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDA 611 (708)
Q Consensus 537 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 611 (708)
......||+.|||||++. ...++.++|||||||+||||++|+.||......+. +....... ..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~-~~----- 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSE-PP----- 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSC-CC-----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCC-CC-----
Confidence 233467999999999984 45689999999999999999999999976543321 11111111 00
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 612 QILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 612 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
....+...++.+.+|+.+||+.||++|||++|++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0011233456789999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-50 Score=415.64 Aligned_cols=266 Identities=25% Similarity=0.405 Sum_probs=217.9
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceE
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCC 443 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 443 (708)
.++|...++|++.+.||+|+||+||+|+.+ +++.||||+++... ....++|.+|+++|++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 456667889999999999999999999964 35789999987643 44567899999999999999999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQNK---------------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIY 502 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ii 502 (708)
.+.+..++||||+++|+|.++++.... ...+++..++.|+.|++.||+|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 999999999999999999999965321 224899999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCC-CC
Q 047038 503 HRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE-RP 580 (708)
Q Consensus 503 HrDikp~NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~-~P 580 (708)
||||||+|||||.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||++||||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999986643322 2334567899999999999999999999999999999999985 56
Q ss_pred CCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 581 IRLTNSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
|......+ ....+..+... ..+...++.+.+|+.+||+.+|++||||.||+++|++|.+
T Consensus 243 ~~~~~~~e-------~~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 243 YYGMAHEE-------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTSCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCHHH-------HHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 75443322 11222222221 1233445679999999999999999999999999998853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=422.83 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=209.0
Q ss_pred hhccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
...++|++.++||+|+||+||+|+.. +|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+.+..+||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999965 6899999998653 344567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
|||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+||||++++++||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999998654 599999999999999999999974 7 9999999999999999999999999998654
Q ss_pred cCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHH------------
Q 047038 532 VDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRA------------ 599 (708)
Q Consensus 532 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~------------ 599 (708)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+...........
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 234467999999999999999999999999999999999999999765543321110000000
Q ss_pred -----------hhhchhhhhhhhhhhc---cC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 600 -----------MREDRLFEILDAQILK---EG-GKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 600 -----------~~~~~~~~~~d~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+..+..... .. ....+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000001111110000 00 0112356899999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=404.29 Aligned_cols=246 Identities=23% Similarity=0.392 Sum_probs=198.9
Q ss_pred cccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEee----CCcceEEE
Q 047038 381 NTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVY 453 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 453 (708)
+..++||+|+||+||+|+.. +++.||+|++.. ......+.|.+|+++|++++|||||++++++.+ ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999975 688999998765 345667789999999999999999999999875 34579999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD-DKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGls~~~~~ 532 (708)
||+++|+|.+++.... .+++..++.++.||++||+|||+.+ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998654 5899999999999999999999976 4599999999999996 578999999999986433
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
. ......||+.|||||++.+ .++.++|||||||+||||++|+.||........ ....+..+.... .
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~----~ 233 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA----S 233 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG----G
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCc----c
Confidence 2 2345679999999999865 699999999999999999999999964432221 111222211111 1
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.+...++++.+|+.+||+.||++|||++|+++
T Consensus 234 ----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11122345889999999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=414.91 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=205.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999987642 2334578999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999988654 5999999999999999999999999 999999999999999999999999999877543
Q ss_pred Cc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 534 QT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 534 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. .......||+.|||||++.+..++.++|||||||+||||++|+.||...+..+. + ..+.....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~-~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------F-QKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHTTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH------H-HHHHcCCC-------
Confidence 32 234456799999999999999999999999999999999999999975432211 1 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+...++.+.+||.+||+.||++|||++|++.
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112334566899999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=409.09 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=203.3
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcC----CcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLED----GKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
...++|++.+.||+|+||+||+|++.. +..||||.++. ......+.|.+|+.+|++++|||||+++|++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345689999999999999999998642 35789998865 34555678999999999999999999999986 4678
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
++||||+++|+|.+++..... .+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999998876433 6899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhh
Q 047038 530 IAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEI 608 (708)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (708)
.............||+.|+|||++.+..++.++||||||+++|||++ |.+||......+. . ..+..+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~----~~i~~~~~--- 227 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I----GRIENGER--- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCC---
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCCC---
Confidence 76554445556678999999999999999999999999999999998 8999976554331 1 11111111
Q ss_pred hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 609 LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 609 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+...++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233445679999999999999999999999999998865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-49 Score=410.56 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=202.2
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
+.|+..+.||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+.+..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999964 78899999876532 345578999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|..++.... .+++.+++.++.||+.||.|||+.+ |+||||||+||||++++++||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977665443 6999999999999999999999998 99999999999999999999999999986542
Q ss_pred CcceeecccccccccCcccccc---CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQS---SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+ .+....... ..
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~~-~~---- 232 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SP---- 232 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CC----
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC-CC----
Confidence 234569999999999864 468999999999999999999999996443221 111111111 10
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......++.+.+|+.+||+.||++|||++|+++
T Consensus 233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112233456899999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-48 Score=412.44 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=210.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 68999999998777777888999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCcEEEeeccCCcccCcCC
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD--DKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGls~~~~~~~ 534 (708)
++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999865432 5999999999999999999999999 99999999999995 46789999999998765433
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......||+.|||||++.+..++.++|||||||++|||++|+.||......+. + ..+...... .+
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~-~~i~~~~~~--~~---- 245 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------L-RNVKSCDWN--MD---- 245 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHHTCCC--SC----
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------H-HHHHhCCCC--CC----
Confidence 33456799999999999999999999999999999999999999975432221 1 111111100 00
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.......++.+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112234568999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=402.61 Aligned_cols=252 Identities=26% Similarity=0.458 Sum_probs=202.5
Q ss_pred ccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEee-CCcceEEEEe
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYEF 455 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~ 455 (708)
.++|+..+.||+|+||+||+|.++ |+.||||+++. ....+.|.+|++++++++|||||+++|++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 456888899999999999999984 78899999875 3445789999999999999999999999865 4568999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+++|+|.++|.... ...++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999997643 225899999999999999999999998 999999999999999999999999999865422
Q ss_pred ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
.....+|+.|+|||++.+..++.++||||||+++|||+| |++||......+ .. ..+..+ ..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~~i~~~---------~~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKG---------YK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTT---------CC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcC---------CC
Confidence 233457899999999999999999999999999999998 788876544332 11 112211 11
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+.+...++++.+|+.+||+.||++|||+.||+++|++++.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 22233445678999999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=407.13 Aligned_cols=269 Identities=28% Similarity=0.417 Sum_probs=209.1
Q ss_pred ChHHHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeee
Q 047038 369 TSNELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLL 440 (708)
Q Consensus 369 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~ 440 (708)
...+++...++|++.++||+|+||+||+|... +++.||||+++. ......+.+.+|+.++.++ +|+|||+++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556666688999999999999999999964 346899999875 3455667889999988887 689999999
Q ss_pred ceEeeC-CcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 047038 441 GCCLET-EVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDI 506 (708)
Q Consensus 441 g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDi 506 (708)
+++.+. ...++||||+++|+|.++|+.... ...+++.+++.++.||++||.|||+.+ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 998765 468999999999999999975431 235899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhC-CCCCCCC
Q 047038 507 KSTNILLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTG-ERPIRLT 584 (708)
Q Consensus 507 kp~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg-~~P~~~~ 584 (708)
||+||||++++++||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||++| .+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543332 23456799999999999999999999999999999999996 5677654
Q ss_pred CcchhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 585 NSEEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
...+. +...+..+. ....+...++.+.+|+.+||+.||++|||++||+++|+.+.+
T Consensus 241 ~~~~~------~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 241 KIDEE------FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSHH------HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH------HHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 43221 112222221 112223345668999999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=409.06 Aligned_cols=256 Identities=24% Similarity=0.451 Sum_probs=205.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc----EEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK----IVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 451 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 451 (708)
.+|++.++||+|+||+||+|.+. +|+ .||||+++. .+....++|.+|+.+|++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999965 444 589998765 3344567899999999999999999999999864 5678
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccC
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIA 531 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~ 531 (708)
++||+.+|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998876543 6999999999999999999999998 9999999999999999999999999998775
Q ss_pred cCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 532 VDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 532 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
...... .....||+.|||||++.++.++.++||||||++||||+| |++||......+. . ..+..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~----~~i~~~------ 229 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKG------ 229 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---H----HHHHHT------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcC------
Confidence 443332 344568999999999999999999999999999999999 8899875543331 1 111111
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.....+...++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 230 ---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112233445678999999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-49 Score=409.15 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=192.1
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
..+.|++.++||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999975 68999999986533 334467889999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEeeccCCccc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASRSI 530 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGls~~~ 530 (708)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997643 6999999999999999999999998 99999999999994 5789999999999865
Q ss_pred CcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD 610 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 610 (708)
.... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+ . ........ .
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~---~~~i~~~~-~----- 226 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L---FEQILKAE-Y----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHTTC-C-----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H---HHHHhccC-C-----
Confidence 4322 2344679999999999999999999999999999999999999996543222 1 11111111 0
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..........++.+.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011112234466899999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-48 Score=410.23 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=210.7
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEec
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 456 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 456 (708)
++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 79999999988766667788999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCcEEEeeccCCcccCcCC
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD--DKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGls~~~~~~~ 534 (708)
++|+|.+++.... ..+++.+++.|+.||+.||.|||+.+ |+||||||+||||+ +++.+||+|||+++....+.
T Consensus 109 ~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999998876543 25999999999999999999999998 99999999999998 67899999999998775433
Q ss_pred cceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhhh
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQIL 614 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 614 (708)
......||+.|||||++.+..++.++|||||||+||||++|+.||......+. + ..+..... ...
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~-~~i~~~~~------~~~ 248 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------L-QNVKRCDW------EFD 248 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H-HHHHHCCC------CCC
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhCCC------CCC
Confidence 23445699999999999999999999999999999999999999975433221 1 11111110 011
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 615 KEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 615 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112334566899999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=400.54 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=206.3
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcc
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 449 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 449 (708)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 78999999875421 22467899999999999999999999999999999
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEeecc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY----CAKVSDFG 525 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG 525 (708)
+|||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999998654 5999999999999999999999999 99999999999998776 59999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......+. . ..+.....
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~-~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L-ANVSAVNY 233 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHTTCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------H-HHHHhcCC
Confidence 998764332 23445689999999999999999999999999999999999999975443221 1 11111110
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. ..... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00011 1122356889999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=399.37 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=199.7
Q ss_pred cCCcccceEeeeccEEEEEEEEcC--C--cEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLED--G--KIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++|++.+.||+|+||+||+|++.. + ..||||+++.. +....++|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 2 36899987652 34456789999999999999999999999965 5678
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998876543 5999999999999999999999998 999999999999999999999999999987
Q ss_pred CcCCcce--eecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchhhhHHHHHHHHhhhchhhh
Q 047038 531 AVDQTHL--TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEEDKSLAAYFLRAMREDRLFE 607 (708)
Q Consensus 531 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (708)
....... .....||..|+|||.+.+..++.++||||||+++|||+| |+.||......+. .....+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~--- 232 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGE--- 232 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCC---
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCC---
Confidence 5443322 334567889999999999999999999999999999998 8999975433321 111112211
Q ss_pred hhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcc
Q 047038 608 ILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGI 653 (708)
Q Consensus 608 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 653 (708)
..+.+...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112233446799999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=402.33 Aligned_cols=266 Identities=25% Similarity=0.405 Sum_probs=218.1
Q ss_pred HHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeeceE
Q 047038 372 ELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLGCC 443 (708)
Q Consensus 372 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 443 (708)
+++...++|++.++||+|+||.||+|++. +++.||||+++. .......+|.+|+.+++++ +|||||+++|++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34555678999999999999999999863 467899999876 3455667899999999999 799999999999
Q ss_pred eeCCcceEEEEeccCCCccccccccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 047038 444 LETEVPLLVYEFISNGTLSQYIDDQN---------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKS 508 (708)
Q Consensus 444 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp 508 (708)
.+.+..+|||||+++|+|.++++... ....+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997643 1235899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEeeccCCcccCcCCc-ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCc
Q 047038 509 TNILLDDKYCAKVSDFGASRSIAVDQT-HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNS 586 (708)
Q Consensus 509 ~NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~ 586 (708)
+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987754333 33445679999999999999999999999999999999999 5555544333
Q ss_pred chhhhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 587 EEDKSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+. +. +++........+...+..+.+||.+||+.||++||||.||+++|+++..
T Consensus 254 ~~~------~~---------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 DSK------FY---------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SHH------HH---------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH------HH---------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 221 11 1111222222233345679999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-47 Score=395.06 Aligned_cols=260 Identities=28% Similarity=0.368 Sum_probs=207.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCc----
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV---- 448 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 448 (708)
.++|++.+.||+|+||+||+|+.. +|+.||||.++. .+....+.|.+|+++|++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999964 799999999864 234556789999999999999999999999987543
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+|||||+++++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887654 5999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCcCCc--ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 529 SIAVDQT--HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 529 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
....... .......||+.|||||++.+..++.++|||||||+||||+||+.||......+ .+...+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCC
Confidence 6543222 23445679999999999999999999999999999999999999997543221 122222222111
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcccc
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRP-TMREVGIELTGIRG 655 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~ 655 (708)
........++.+.+++.+||+.||++|| |++++++.|.+++.
T Consensus 234 -------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1111223446699999999999999999 89999999988763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=401.09 Aligned_cols=270 Identities=27% Similarity=0.423 Sum_probs=219.7
Q ss_pred ccChHHHHhhccCCcccceEeeeccEEEEEEEEc------CCcEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeee
Q 047038 367 LFTSNELEKATDNFNTNRILGQGGQGTVYKGMLE------DGKIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKL 439 (708)
Q Consensus 367 ~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l 439 (708)
.+-.++++...++|++.+.||+|+||+||+|.+. +++.||||+++. ........|.+|+.++++++|||||++
T Consensus 9 ~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred CcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 3444556666789999999999999999999864 357899999875 345556679999999999999999999
Q ss_pred eceEeeCCcceEEEEeccCCCccccccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 047038 440 LGCCLETEVPLLVYEFISNGTLSQYIDDQN-------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNIL 512 (708)
Q Consensus 440 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIl 512 (708)
+|++...+..++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+.+ |+||||||+|||
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiL 165 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 165 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCcee
Confidence 999999999999999999999999987542 1235799999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCCcce-eecccccccccCccccccCCCCccchhHhHHHHHHHHHhCC-CCCCCCCcchhh
Q 047038 513 LDDKYCAKVSDFGASRSIAVDQTHL-TTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE-RPIRLTNSEEDK 590 (708)
Q Consensus 513 l~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~-~P~~~~~~~~~~ 590 (708)
|++++++||+|||+++......... .....||+.|+|||.+.+..++.++||||||++||||+||. +||......+
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-- 243 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 243 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998765433322 33456899999999999999999999999999999999974 6775433222
Q ss_pred hHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 591 SLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+ ..+..+.. ...+...+..+.+|+.+||+.+|++||||+||+++|+....
T Consensus 244 ----~~-~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 ----VL-RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----HH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----HH-HHHHhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 11111111 11123344679999999999999999999999999988755
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=398.64 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=206.1
Q ss_pred cceEeeeccEEEEEEEEcCC----cEEEEEEccc-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-CcceEEEEec
Q 047038 383 NRILGQGGQGTVYKGMLEDG----KIVAVKKSKI-IDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPLLVYEFI 456 (708)
Q Consensus 383 ~~~lG~G~~g~Vy~~~~~~~----~~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 456 (708)
.++||+|+||+||+|.+.++ ..||||+++. .+....++|.+|+++|++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997532 2689999874 4566778999999999999999999999998764 5789999999
Q ss_pred cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCcc
Q 047038 457 SNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQTH 536 (708)
Q Consensus 457 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~~ 536 (708)
++|+|.++++.... .+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999886543 5788999999999999999999998 999999999999999999999999999876543322
Q ss_pred ---eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 537 ---LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 537 ---~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
......||+.|+|||.+.+..++.++||||||++||||++|..||....... ... ..+..+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~----~~i~~g~~-------- 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT----VYLLQGRR-------- 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCC--------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH----HHHHcCCC--------
Confidence 2334568999999999999999999999999999999999888875432211 111 11111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccc
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGC 656 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 656 (708)
...+...++.+.+|+.+||+.||++||+|+||++.|+.++..
T Consensus 253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111223345689999999999999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=401.99 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=206.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCc--EEEEEEccc-CChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGK--IVAVKKSKI-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 452 (708)
++|++.++||+|+||+||+|+++ ++. .||||+++. ......++|.+|+++|+++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999975 444 578888754 3445667899999999998 799999999999999999999
Q ss_pred EEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 047038 453 YEFISNGTLSQYIDDQN-------------KDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCA 519 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~ 519 (708)
|||+++|+|.++|+... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997542 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCC-CCCCCCCcchhhhHHHHHHH
Q 047038 520 KVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGE-RPIRLTNSEEDKSLAAYFLR 598 (708)
Q Consensus 520 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~ 598 (708)
||+|||+++...... ......||..|+|||.+....++.++||||||+++|||++|. +||......+ +..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence 999999998654322 223445899999999999999999999999999999999965 5665433221 111
Q ss_pred HhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 599 AMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 599 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+..+ ...+.+...++.+.+||.+||+.||++||||+||++.|+++..
T Consensus 238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22211 1112233445679999999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=400.87 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=208.8
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 452 (708)
.++|++.++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999974 7999999998642 234567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999998764 5899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. .......||+.|||||++.+..++.++|||||||+||||++|++||...+..+ + ...+..+.+
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~----~~~i~~~~~------- 222 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L----FELILMEEI------- 222 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCC-------
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H----HHHHhcCCC-------
Confidence 32 23445679999999999999999999999999999999999999997654322 1 111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
..+...+..+.+||.+||+.||++||+ ++|+++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 122334566899999999999999995 777765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=398.08 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=211.6
Q ss_pred hhccCCcccceEeeeccEEEEEEEEcC--------CcEEEEEEcccC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEe
Q 047038 375 KATDNFNTNRILGQGGQGTVYKGMLED--------GKIVAVKKSKII-DESKVEEFINEVVILSQI-NHRNVVKLLGCCL 444 (708)
Q Consensus 375 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 444 (708)
...++|++.+.||+|+||+||+|+... +..||||+++.. ......++.+|+..+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345688899999999999999998542 247999998763 345568899999999998 8999999999999
Q ss_pred eCCcceEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 047038 445 ETEVPLLVYEFISNGTLSQYIDDQNK-------------DFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNI 511 (708)
Q Consensus 445 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NI 511 (708)
+++..++||||+++|+|.++|..... ...+++.+++.++.||+.||+|||+.+ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999975531 246899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCCcc-eeecccccccccCccccccCCCCccchhHhHHHHHHHHHh-CCCCCCCCCcchh
Q 047038 512 LLDDKYCAKVSDFGASRSIAVDQTH-LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLT-GERPIRLTNSEED 589 (708)
Q Consensus 512 ll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~ellt-g~~P~~~~~~~~~ 589 (708)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||++ |++||......+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 9999999999999999877543332 2344668999999999999999999999999999999998 788886444321
Q ss_pred hhHHHHHHHHhhhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 590 KSLAAYFLRAMREDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
....+..+. ....+...++.+.+|+.+||+.||++|||+.||++.|++|..
T Consensus 246 ------~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ------LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ------HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 112222221 112233345679999999999999999999999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-47 Score=395.02 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=205.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6899999998642 2334678999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999888654 5888999999999999999999998 999999999999999999999999999876432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+..+. ... +..+.
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~-i~~~~--------- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEK-ILNAE--------- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHHCC---------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHH-HHcCC---------
Confidence 2346799999999999999999999999999999999999999975432221 111 11111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
...+...++.+.+++.+||+.||.+|| |++|+++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111233445689999999999999996 8888865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=395.04 Aligned_cols=270 Identities=20% Similarity=0.303 Sum_probs=202.7
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC----cceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----VPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 453 (708)
.+|.+.++||+|+||+||+|++ +|+.||||+++... .....+..|+..+++++|||||++++++.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677788999999999999986 58899999886432 22222334555556789999999999998754 578999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA-----SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-----~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
||+++|+|.++|++. .++|..++.++.|++.||+|||+.. .++|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999864 4899999999999999999999741 2349999999999999999999999999998
Q ss_pred ccCcCCcc---eeecccccccccCccccccCC------CCccchhHhHHHHHHHHHhCCCCCCCCCcchh--------hh
Q 047038 529 SIAVDQTH---LTTQVQGTFGYLDPEYFQSSH------FTEKSDVYSFGVVLVELLTGERPIRLTNSEED--------KS 591 (708)
Q Consensus 529 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~--------~~ 591 (708)
........ ......||+.|+|||++.... ++.++||||||++||||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543322 234567999999999987642 57799999999999999999988754332211 00
Q ss_pred HHHHHHHHhhhchhhhhhhhhhhcc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccccc
Q 047038 592 LAAYFLRAMREDRLFEILDAQILKE-GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCN 657 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 657 (708)
...........+.+ ++.+... ...+....+.+|+.+||+.||++|||+.||++.|+++....
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 11111111111111 1111111 12345567999999999999999999999999999998743
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-46 Score=384.26 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=204.4
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---------hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeC
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---------ESKVEEFINEVVILSQIN-HRNVVKLLGCCLET 446 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 446 (708)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999964 78999999876532 122356899999999997 99999999999999
Q ss_pred CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 447 EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 447 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
+..+|||||+++|+|.++|+... .+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999998654 5999999999999999999999998 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCcccccc------CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHh
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQS------SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAM 600 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 600 (708)
++...... ..+...||+.|+|||.+.+ ..++.++||||+|++||||++|+.||......+. ...+
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-------~~~i 227 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMI 227 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-------HHHH
Confidence 98765432 2345679999999999853 3578899999999999999999999975443221 1111
Q ss_pred hhchhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 601 REDRLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 601 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..+... .........++++.+|+.+||+.||++|||++||+
T Consensus 228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 111110 00111223446799999999999999999999984
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=391.70 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=207.0
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
..++|++.+.||+|+||+||+|... +++.||||.++... .+...+.+|+++|++++|||||++++++.+.+..+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3468999999999999999999975 68899999987643 344678899999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCcEEEeeccCCcccCc
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD--KYCAKVSDFGASRSIAV 532 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGls~~~~~ 532 (708)
|+++|+|.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999997653 25899999999999999999999998 999999999999985 45899999999987643
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..... .... ++..
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~-~~~~--~~~~ 225 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMN-AEYT--FDEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-TCCC--CCHH
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCCC--CChh
Confidence 32 2344568999999999999999999999999999999999999997544322 1111111 1110 0111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
... ..++.+.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 12355889999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-46 Score=397.51 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=200.3
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---hHHHHHH---HHHHHHHHhcCCCceeeeeceEeeCCcce
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---ESKVEEF---INEVVILSQINHRNVVKLLGCCLETEVPL 450 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~---~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 450 (708)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+ .+|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 69999999875311 1122233 44567777888999999999999999999
Q ss_pred EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCccc
Q 047038 451 LVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSI 530 (708)
Q Consensus 451 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~ 530 (708)
|||||+++|+|.++|.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998654 5899999999999999999999999 999999999999999999999999999876
Q ss_pred CcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEIL 609 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (708)
.... .....||+.|||||++.. ..++.++|||||||+||||++|+.||......+...+ .......
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~------ 224 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------ 224 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSC------
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccC------
Confidence 5432 334569999999999975 5689999999999999999999999976544332111 1111110
Q ss_pred hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047038 610 DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVGI 648 (708)
Q Consensus 610 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 648 (708)
....+...++.+.+||.+||+.||++||| ++|+++
T Consensus 225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01112234566899999999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-46 Score=395.62 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=205.9
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 453 (708)
++|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 7999999987642 2344578999999999999999999999999999999999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcC
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVD 533 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~ 533 (708)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997664 5999999999999999999999999 999999999999999999999999999876432
Q ss_pred CcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhhh
Q 047038 534 QTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQI 613 (708)
Q Consensus 534 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 613 (708)
.....||+.|||||++.+..++.++|||||||+||||++|+.||....... .. ..+..+..
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~-~~i~~~~~-------- 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IY-EKIVSGKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC--------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HH-HHHhcCCC--------
Confidence 234579999999999999999999999999999999999999996543221 11 11111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047038 614 LKEGGKDEFKMVAKLAKRCLNLNGKKRP-----TMREVGI 648 (708)
Q Consensus 614 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 648 (708)
..+...++.+.+|+.+||+.||.+|+ |++|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11233446689999999999999994 8888864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=388.84 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=195.5
Q ss_pred ccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHH-----HHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 382 TNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESK-----VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 382 ~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
.+++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999965 68999999986533221 34689999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
++++++..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998877666543 25888999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chhhhhhhh
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRLFEILDA 611 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~ 611 (708)
......||+.|+|||++.. ..++.++|||||||++|||++|++||......+. .......... ..+......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence 2334569999999999865 4579999999999999999999999975543321 1111111110 000000000
Q ss_pred ---h---h-----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 612 ---Q---I-----LKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 612 ---~---~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
. . .........+.+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 0 00001122456899999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=392.49 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=204.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC---ChHHHHHHHHHHHHHH-hcCCCceeeeeceEeeCCcceEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII---DESKVEEFINEVVILS-QINHRNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 452 (708)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|+.++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 6899999998642 2334567778888776 68999999999999999999999
Q ss_pred EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCc
Q 047038 453 YEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAV 532 (708)
Q Consensus 453 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~ 532 (708)
|||+++|+|.++++... .+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998654 5899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhhhh
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILDAQ 612 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 612 (708)
.. ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~-------- 219 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN-------- 219 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC--------
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC--------
Confidence 32 23344679999999999999999999999999999999999999997544322 111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047038 613 ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMR-EVG 647 (708)
Q Consensus 613 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 647 (708)
...+...++.+.+|+.+||+.||++||++. |++
T Consensus 220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111223446689999999999999999996 665
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=385.34 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=199.4
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 478999999986533 2335789999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
|+.++.+ +++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976544 4443322 236999999999999999999999999 9999999999999999999999999998764332
Q ss_pred cceeecccccccccCccccccCC-CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc--hhhhhhh-
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED--RLFEILD- 610 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d- 610 (708)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+ .+...+....... .......
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccc
Confidence 2234456999999999877655 5889999999999999999999997543222 1111111111000 0000000
Q ss_pred hhhhc-----------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 AQILK-----------EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
+.... .......+.+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 001122356889999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=388.56 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=198.8
Q ss_pred ccCCcccc-eEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee----CCcc
Q 047038 377 TDNFNTNR-ILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE----TEVP 449 (708)
Q Consensus 377 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 449 (708)
.++|.+.. +||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788764 699999999999996 4789999999864 24577899987665 89999999999875 4568
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEeeccC
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD---KYCAKVSDFGA 526 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl 526 (708)
+|||||+++|+|.++|.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999997643 236999999999999999999999999 999999999999985 56799999999
Q ss_pred CcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
++...... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ......+......
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYE 235 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCCC
Confidence 98765433 234467999999999999999999999999999999999999999754432211 0111111111100
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.........++.+.+|+.+||+.||++|||+.|+++
T Consensus 236 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000001233466899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-45 Score=379.95 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=201.5
Q ss_pred cCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEEe
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 455 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 455 (708)
++|++.++||+|+||+||+|+.++|+.||||+++... ....+.|.+|+.+|++++|||||++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999986543 33367899999999999999999999999999999999999
Q ss_pred ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCCc
Q 047038 456 ISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQT 535 (708)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~~ 535 (708)
+.++.+..+.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9987777766544 36999999999999999999999998 99999999999999999999999999987643322
Q ss_pred ceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---hhhhhhh-
Q 047038 536 HLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---RLFEILD- 610 (708)
Q Consensus 536 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d- 610 (708)
......+++.|+|||.+.+ ..++.++||||||++++||++|+.||......+ .+...+ ...... .......
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~-~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIF-RILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCTTTSTTGGGS
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHH-HhhCCCChhhccchhhh
Confidence 2334468999999999875 457999999999999999999999997543222 111111 111110 0000000
Q ss_pred ----hh-------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 611 ----AQ-------ILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 611 ----~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
.. ..........+.+.+|+.+||+.||++|||++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00 00111122345688999999999999999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=383.34 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=198.6
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-C-CcEEEEEEcccC--ChHHHHHHHHHHHHHHhc---CCCceeeeeceEee---
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-D-GKIVAVKKSKII--DESKVEEFINEVVILSQI---NHRNVVKLLGCCLE--- 445 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~--- 445 (708)
..++|++.++||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+|+.+ +|||||++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999974 4 678999987642 222334566777777665 79999999999864
Q ss_pred --CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEee
Q 047038 446 --TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSD 523 (708)
Q Consensus 446 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D 523 (708)
....+++|||++++++........ ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346789999999887765544332 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh-
Q 047038 524 FGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE- 602 (708)
Q Consensus 524 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~- 602 (708)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +. ........
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~-~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LG-KILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHhhCCC
Confidence 9998865432 234456799999999999999999999999999999999999999976543321 11 11111110
Q ss_pred --chhhhh----------hhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 603 --DRLFEI----------LDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 603 --~~~~~~----------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
..+... ..............+.+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000011112233456889999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=377.27 Aligned_cols=240 Identities=25% Similarity=0.400 Sum_probs=196.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCC---h---HHHHHHHHHHHHHHhcC--CCceeeeeceEeeCC
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIID---E---SKVEEFINEVVILSQIN--HRNVVKLLGCCLETE 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~---~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~ 447 (708)
.++|++.++||+|+||+||+|+.. +|+.||||+++... . ....++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999965 78999999876421 1 12245778999999996 899999999999999
Q ss_pred cceEEEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEeecc
Q 047038 448 VPLLVYEFISN-GTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-KYCAKVSDFG 525 (708)
Q Consensus 448 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFG 525 (708)
..++||||+.+ +++.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777776543 5999999999999999999999998 999999999999985 4799999999
Q ss_pred CCcccCcCCcceeecccccccccCccccccCCC-CccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch
Q 047038 526 ASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHF-TEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR 604 (708)
Q Consensus 526 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 604 (708)
+++..... ..+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... ...+ ..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~-~~ 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR-GQ 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH-CC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhh-cc
Confidence 99865432 2345679999999999987765 577999999999999999999995311 0011 10
Q ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 221 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0112233456899999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.7e-44 Score=368.74 Aligned_cols=265 Identities=16% Similarity=0.185 Sum_probs=211.6
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 454 (708)
.++|++.++||+|+||+||+|+.. +|+.||||.+.... ..+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 68999999875432 23457789999999965 899999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEeeccCCcc
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDD-----KYCAKVSDFGASRS 529 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGls~~ 529 (708)
|+ +++|.+++..... .+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6799998876543 5899999999999999999999999 999999999999974 57899999999987
Q ss_pred cCcCCc------ceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc
Q 047038 530 IAVDQT------HLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED 603 (708)
Q Consensus 530 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 603 (708)
...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643221 12334679999999999999999999999999999999999999998665544332222211111111
Q ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHccccccC
Q 047038 604 RLFEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRGCNG 658 (708)
Q Consensus 604 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 658 (708)
.. ..+ ....++++.+++..|++.+|++||+++.+.+.|+.+.....
T Consensus 236 ~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred Ch-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 11 111 12234568999999999999999999999999988765443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-44 Score=370.81 Aligned_cols=262 Identities=19% Similarity=0.247 Sum_probs=200.4
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceee-eeceEeeCCcceEEEE
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVK-LLGCCLETEVPLLVYE 454 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~E 454 (708)
.++|++.+.||+|+||+||+|+.. +|+.||||.+.... ..+++..|++++++++|+|++. +.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999964 68999999876532 2346889999999998776555 4555677788899999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEeeccCCcccC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLD---DKYCAKVSDFGASRSIA 531 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGls~~~~ 531 (708)
|+. ++|.+.+.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+.
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 995 56666655433 26899999999999999999999999 99999999999986 45579999999998765
Q ss_pred cCCcc------eeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchh
Q 047038 532 VDQTH------LTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRL 605 (708)
Q Consensus 532 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (708)
..... ......||+.|||||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 33221 23456799999999999999999999999999999999999999976554433222211111000000
Q ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcccc
Q 047038 606 FEILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIELTGIRG 655 (708)
Q Consensus 606 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 655 (708)
.+.. ....++++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 237 ----~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 ----IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0111 12234568999999999999999999999999988755
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=376.20 Aligned_cols=267 Identities=20% Similarity=0.286 Sum_probs=200.0
Q ss_pred hccCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC----cc
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKII-DESKVEEFINEVVILSQINHRNVVKLLGCCLETE----VP 449 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~ 449 (708)
.+++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++|||||++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999996 47999999998653 3455678999999999999999999999997654 23
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcc
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRS 529 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~ 529 (708)
+++++++.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5666777899999999754 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCcCCcc--eeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 530 IAVDQTH--LTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 530 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
....... ......||+.|+|||++.. ..++.++||||+|++++||++|+.||......+..................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 6543222 2345669999999999854 567899999999999999999999997654332221111110000000000
Q ss_pred -----hhhh--hhhhc--c-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047038 607 -----EILD--AQILK--E-----GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE 649 (708)
Q Consensus 607 -----~~~d--~~~~~--~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 649 (708)
.... ..... . ........+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000 0 011123468899999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=372.67 Aligned_cols=266 Identities=20% Similarity=0.276 Sum_probs=197.0
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEee--------
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLE-------- 445 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 445 (708)
.++|++.+.||+|+||+||+|+.. +|+.||||++... .+...+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999974 7999999987543 33445678999999999999999999999865
Q ss_pred CCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeecc
Q 047038 446 TEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFG 525 (708)
Q Consensus 446 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG 525 (708)
....++||||++++++..+..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999999877765554332 5889999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCcCCcc---eeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhh
Q 047038 526 ASRSIAVDQTH---LTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMR 601 (708)
Q Consensus 526 ls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 601 (708)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876533221 22335699999999998765 689999999999999999999999975443332222211111100
Q ss_pred hchhhh--------hhhhhhhccCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 602 EDRLFE--------ILDAQILKEGG-------KDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 602 ~~~~~~--------~~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
...... ........... ......+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000000 00000000000 011245678999999999999999999973
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=376.52 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=197.8
Q ss_pred CCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC------cceE
Q 047038 379 NFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPLL 451 (708)
Q Consensus 379 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 451 (708)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|||||++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 689999999865322 2347999999999999999999986432 4689
Q ss_pred EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCccc
Q 047038 452 VYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSI 530 (708)
Q Consensus 452 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~ 530 (708)
||||++++.+..+.+.......+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655554443333447999999999999999999999998 99999999999999775 8999999999876
Q ss_pred CcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhh---chhh
Q 047038 531 AVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRE---DRLF 606 (708)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~ 606 (708)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +...+ ..... ..+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~-~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII-KVLGTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHH-HHhCCChHHhhh
Confidence 54332 334569999999998765 5789999999999999999999999975543221 11111 11100 0000
Q ss_pred hhh------------hhhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcccc
Q 047038 607 EIL------------DAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIRG 655 (708)
Q Consensus 607 ~~~------------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~ 655 (708)
... .............+.+.+|+.+||+.||++|||+.|+++. |+.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000 0000011122334568999999999999999999999853 444443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=373.29 Aligned_cols=267 Identities=21% Similarity=0.313 Sum_probs=198.1
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----- 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 447 (708)
..++|++.++||+|+||+||+|... +|+.||||+++. .+....+.+.+|+++|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999965 699999999865 34455678999999999999999999999998665
Q ss_pred -cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccC
Q 047038 448 -VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGA 526 (708)
Q Consensus 448 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl 526 (708)
..+|||||+ +.+|..+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 55777766543 5999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCcCCcceeecccccccccCcccccc-CCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH--------
Q 047038 527 SRSIAVDQTHLTTQVQGTFGYLDPEYFQS-SHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL-------- 597 (708)
Q Consensus 527 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-------- 597 (708)
++..... .+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 9865432 344679999999999876 457899999999999999999999997654322111111100
Q ss_pred HHhhhchhhhhhh------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHccc
Q 047038 598 RAMREDRLFEILD------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGIE--LTGIR 654 (708)
Q Consensus 598 ~~~~~~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~ 654 (708)
............. ............+.+.+|+.+||+.||++|||++|+++. |+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000000 000001112234568899999999999999999999863 44443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=361.41 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=204.8
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeCCcceEEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKII--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 454 (708)
++|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 7899999997653 34557889999999999999999999999999999999999
Q ss_pred eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCcccCcCC
Q 047038 455 FISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASRSIAVDQ 534 (708)
Q Consensus 455 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~~~~~~~ 534 (708)
++.+++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988876543 5899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cceeecccccccccCccccccCC-CCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhc---hhh---h
Q 047038 535 THLTTQVQGTFGYLDPEYFQSSH-FTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMRED---RLF---E 607 (708)
Q Consensus 535 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~---~ 607 (708)
. ......+++.|+|||.+.... ++.++|||||||+++||++|+.||.......+ ....+....... ... .
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence 2 233345788999999987655 68999999999999999999999754333221 111111111110 000 0
Q ss_pred hhh---------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 608 ILD---------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 608 ~~d---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
..+ ............+.+.+|+.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 0000111123345688999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=368.53 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=204.5
Q ss_pred cCCcccceEeeeccEEEEEEEEc----CCcEEEEEEcccC----ChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeCCc
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE----DGKIVAVKKSKII----DESKVEEFINEVVILSQINH-RNVVKLLGCCLETEV 448 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 448 (708)
++|++.+.||+|+||+||+|+.. +|+.||||.++.. +....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 4789999987542 22345678999999999976 899999999999999
Q ss_pred ceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 449 PLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 449 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.++||||+.+|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999998765 4788899999999999999999998 9999999999999999999999999998
Q ss_pred ccCcCCcceeecccccccccCccccccC--CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhh
Q 047038 529 SIAVDQTHLTTQVQGTFGYLDPEYFQSS--HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLF 606 (708)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (708)
.+............|++.|++||.+... .++.++|||||||+||||++|+.||......+...... ......
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~---~~~~~~--- 251 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKS--- 251 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHC---
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcccC---
Confidence 7755444445566799999999999764 47889999999999999999999997665443211111 100000
Q ss_pred hhhhhhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 047038 607 EILDAQILKEGGKDEFKMVAKLAKRCLNLNGKKRPT-----MREVG 647 (708)
Q Consensus 607 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~ 647 (708)
....+...++++.+|+.+||+.||++||| ++|++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 11123345567999999999999999994 78875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-42 Score=361.06 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=197.5
Q ss_pred cCCcccceEeeeccEEEEEEEE-cCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEee--CCcceEEE
Q 047038 378 DNFNTNRILGQGGQGTVYKGML-EDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLE--TEVPLLVY 453 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 453 (708)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 47899999998753 3467889999999995 9999999999974 35689999
Q ss_pred EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEeeccCCcccCc
Q 047038 454 EFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKY-CAKVSDFGASRSIAV 532 (708)
Q Consensus 454 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGls~~~~~ 532 (708)
||+++++|..+.+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999987643 4899999999999999999999999 99999999999998654 699999999987653
Q ss_pred CCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhchhhhhhh-
Q 047038 533 DQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDRLFEILD- 610 (708)
Q Consensus 533 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 610 (708)
.. ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||........... ............+...
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~--~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV--RIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH--HHHHHHCHHHHHHHHHH
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH--HHHHHHCCchhhhhhhh
Confidence 32 23445689999999998765 479999999999999999999999976544322111 1111111000000000
Q ss_pred ----------------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 611 ----------------------AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 611 ----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
............+++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111223456899999999999999999999963
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=364.48 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=191.2
Q ss_pred ccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC------C
Q 047038 377 TDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET------E 447 (708)
Q Consensus 377 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 447 (708)
.++|++.++||+|+||+||+|.+. +|+.||||+++. .+....+++.+|+.+|++++|||||++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999976 699999999864 3456667899999999999999999999999643 5
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++||||+.++.+.. +.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~-~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-IQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHH-HTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHh-hhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 7799999997765543 321 4899999999999999999999999 999999999999999999999999998
Q ss_pred cccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHH----------
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFL---------- 597 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~---------- 597 (708)
+..... ...+...+|+.|+|||++.+..++.++||||+||+++||++|+.||................
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 865432 23345568999999999999999999999999999999999999997554222111110000
Q ss_pred ------HHhhhc------hhhhhhhhhhhc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047038 598 ------RAMRED------RLFEILDAQILK---EGGKDEFKMVAKLAKRCLNLNGKKRPTMREVG 647 (708)
Q Consensus 598 ------~~~~~~------~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 647 (708)
...... ............ .........+.+|+.+||+.||++|||++|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 000000 000000000000 01123456789999999999999999999997
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=364.24 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=197.4
Q ss_pred hccCCcccceEeeeccEEEEEEEEc-CCcEEEEEEccc--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeC-----C
Q 047038 376 ATDNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKI--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET-----E 447 (708)
Q Consensus 376 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 447 (708)
..++|++.++||+|+||+||+|+.. +|+.||||+++. .+....+.+.+|+.+|++++|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4678999999999999999999964 799999999865 3445667899999999999999999999998643 3
Q ss_pred cceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEeeccCC
Q 047038 448 VPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVSDFGAS 527 (708)
Q Consensus 448 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGls 527 (708)
..++++|++.+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 457788888999999999653 5999999999999999999999999 999999999999999999999999998
Q ss_pred cccCcCCcceeecccccccccCccccccC-CCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHHHHHhhhch--
Q 047038 528 RSIAVDQTHLTTQVQGTFGYLDPEYFQSS-HFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYFLRAMREDR-- 604 (708)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 604 (708)
..... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||...+........ ........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAE 241 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChH
Confidence 75432 23445689999999987665 5689999999999999999999999765433221111 11110000
Q ss_pred hh--------hhhhhhhhc--c-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047038 605 LF--------EILDAQILK--E-----GGKDEFKMVAKLAKRCLNLNGKKRPTMREVGI 648 (708)
Q Consensus 605 ~~--------~~~d~~~~~--~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 648 (708)
.. ......... . ......+.+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 000000000 0 00122356889999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-37 Score=329.31 Aligned_cols=263 Identities=20% Similarity=0.198 Sum_probs=192.6
Q ss_pred cCCcccceEeeeccEEEEEEEEc-CCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-----------CCceeeeeceEee
Q 047038 378 DNFNTNRILGQGGQGTVYKGMLE-DGKIVAVKKSKIIDESKVEEFINEVVILSQIN-----------HRNVVKLLGCCLE 445 (708)
Q Consensus 378 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 445 (708)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 7999999998753 344567889999998875 5789999998865
Q ss_pred C--CcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCC-----
Q 047038 446 T--EVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHS-AASIPIYHRDIKSTNILLDDKY----- 517 (708)
Q Consensus 446 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiHrDikp~NIll~~~~----- 517 (708)
. ...+++|++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4556777776655544444444444578999999999999999999998 66 99999999999998654
Q ss_pred -cEEEeeccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHHHHHHhCCCCCCCCCcchhhhHHHHH
Q 047038 518 -CAKVSDFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVLVELLTGERPIRLTNSEEDKSLAAYF 596 (708)
Q Consensus 518 -~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 596 (708)
.+|++|||.+..... ......||+.|+|||++....++.++||||+|++++||++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999875532 223456999999999999999999999999999999999999999754332111111111
Q ss_pred ---HHHhhhc--------hh-hhhh-----------------h--hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047038 597 ---LRAMRED--------RL-FEIL-----------------D--AQILKEGGKDEFKMVAKLAKRCLNLNGKKRPTMRE 645 (708)
Q Consensus 597 ---~~~~~~~--------~~-~~~~-----------------d--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 645 (708)
...+... .. .... . ............+.+.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1111000 00 0000 0 00112234567788999999999999999999999
Q ss_pred HHH
Q 047038 646 VGI 648 (708)
Q Consensus 646 v~~ 648 (708)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.2e-23 Score=200.15 Aligned_cols=169 Identities=17% Similarity=0.152 Sum_probs=120.6
Q ss_pred cccceEeeeccEEEEEEEEcCCcEEEEEEcccCC------------------hHHHHHHHHHHHHHHhcCCCceeeeece
Q 047038 381 NTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIID------------------ESKVEEFINEVVILSQINHRNVVKLLGC 442 (708)
Q Consensus 381 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~------------------~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 442 (708)
.+.++||+|+||+||+|...+|+.||||.++... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4568999999999999999899999999754311 0112345678899999999999998865
Q ss_pred EeeCCcceEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEe
Q 047038 443 CLETEVPLLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAASIPIYHRDIKSTNILLDDKYCAKVS 522 (708)
Q Consensus 443 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~ 522 (708)
. ..+++|||+++..+.+ +++.....++.|++++|.|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 3479999998865543 223335678999999999999998 99999999999999765 8999
Q ss_pred eccCCcccCcCCcceeecccccccccCccccccCCCCccchhHhHHHHH
Q 047038 523 DFGASRSIAVDQTHLTTQVQGTFGYLDPEYFQSSHFTEKSDVYSFGVVL 571 (708)
Q Consensus 523 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~SlGvvl 571 (708)
|||++........... ...+... -.|. ....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHH--HHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9999876542221100 0000000 0111 135678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=5e-07 Score=88.77 Aligned_cols=149 Identities=17% Similarity=0.137 Sum_probs=102.9
Q ss_pred HHHHhhccCCcccceEeeeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcc
Q 047038 371 NELEKATDNFNTNRILGQGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVP 449 (708)
Q Consensus 371 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 449 (708)
.|+++....|+..+..+.++...||+... +++.+++|+...........+.+|+..+..+. +--+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666666777666555455578998865 45567788766544444446778888888774 44467888888888899
Q ss_pred eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 047038 450 LLVYEFISNGTLSQYIDDQNKDFRISWEMRLCIAIDVSGAISYLHSAA-------------------------------- 497 (708)
Q Consensus 450 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-------------------------------- 497 (708)
++||+++++.++.+...... ....++.++++.|..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988765443211 12234455566666666421
Q ss_pred ------------------------CCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 498 ------------------------SIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 498 ------------------------~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227899999999999988777799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=9.3e-06 Score=78.91 Aligned_cols=129 Identities=16% Similarity=0.121 Sum_probs=85.7
Q ss_pred Eeeec-cEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeeCCcceEEEEeccCCCcc
Q 047038 386 LGQGG-QGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQIN--HRNVVKLLGCCLETEVPLLVYEFISNGTLS 462 (708)
Q Consensus 386 lG~G~-~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 462 (708)
+..|. -..||+...+++..+++|...... ...+..|+..|+.+. .-.+++++.+..+.+..++|||++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 367999988888888999765433 234667888887764 334677888888888899999999987765
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 047038 463 QYIDDQNKDFRISWEMRLCIAIDVSGAISYLH------------------------------------------------ 494 (708)
Q Consensus 463 ~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH------------------------------------------------ 494 (708)
+.... . ..++.++.+.|.-||
T Consensus 95 ~~~~~--------~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSHLA--------P---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSCCC--------H---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc--------H---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 42110 0 011122233333333
Q ss_pred ---hc----CCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 495 ---SA----ASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 495 ---~~----~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
.. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 11237999999999999988778899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00027 Score=73.06 Aligned_cols=76 Identities=17% Similarity=0.238 Sum_probs=48.7
Q ss_pred ceEeeeccEEEEEEEEcC-CcEEEEEEccc----CC---hHHHHHHHHHHHHHHhcC-C--CceeeeeceEeeCCcceEE
Q 047038 384 RILGQGGQGTVYKGMLED-GKIVAVKKSKI----ID---ESKVEEFINEVVILSQIN-H--RNVVKLLGCCLETEVPLLV 452 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~----~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 452 (708)
+.||.|....||+....+ ++.++||.... .. ....++...|++.|+.+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 67899996332 11 112334556888887663 3 345666654 55677899
Q ss_pred EEeccCCCc
Q 047038 453 YEFISNGTL 461 (708)
Q Consensus 453 ~E~~~~gsL 461 (708)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.61 E-value=0.0024 Score=63.82 Aligned_cols=134 Identities=16% Similarity=0.144 Sum_probs=76.6
Q ss_pred EEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCcee--eee-----ceEeeCCcceEEEEeccCCCcccc
Q 047038 392 GTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNVV--KLL-----GCCLETEVPLLVYEFISNGTLSQY 464 (708)
Q Consensus 392 g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv--~l~-----g~~~~~~~~~lV~E~~~~gsL~~~ 464 (708)
-.||++..++|+.+++|..... ....+++..|...+..|...++. ..+ ......+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999986542 22346677888888877533221 111 122345567889999987544311
Q ss_pred --------------ccc----cC--CCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----cCCCCe
Q 047038 465 --------------IDD----QN--KDFRISW-------------------EMRLCIAIDVSGAISYLHS----AASIPI 501 (708)
Q Consensus 465 --------------l~~----~~--~~~~l~~-------------------~~~~~i~~~i~~al~yLH~----~~~~~i 501 (708)
+|. .. ....+++ ..+..+...+.+.++.+.. .....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 010 00 0011111 1111122222333333332 223458
Q ss_pred EecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 502 YHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 502 iHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
+|+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999854 4589998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.56 E-value=0.0031 Score=64.87 Aligned_cols=73 Identities=19% Similarity=0.174 Sum_probs=49.0
Q ss_pred ceEeeeccEEEEEEEEcCC--------cEEEEEEcccCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeCCcceEEEE
Q 047038 384 RILGQGGQGTVYKGMLEDG--------KIVAVKKSKIIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 454 (708)
Q Consensus 384 ~~lG~G~~g~Vy~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 454 (708)
+.|+.|-.=.+|+....++ +.|.++.... .. ......+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688788889999987543 4566665442 22 2234567888988885 4334577887643 68999
Q ss_pred eccCCCcc
Q 047038 455 FISNGTLS 462 (708)
Q Consensus 455 ~~~~gsL~ 462 (708)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.18 E-value=0.007 Score=59.84 Aligned_cols=158 Identities=8% Similarity=0.011 Sum_probs=83.5
Q ss_pred cChHHHHhhccCCcccceEe-----eeccEEEEEEEEcCCcEEEEEEcccCChHHHHHHHHHHHHHHhcCCCce--eeee
Q 047038 368 FTSNELEKATDNFNTNRILG-----QGGQGTVYKGMLEDGKIVAVKKSKIIDESKVEEFINEVVILSQINHRNV--VKLL 440 (708)
Q Consensus 368 ~~~~el~~~~~~~~~~~~lG-----~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~ 440 (708)
.+.+|++....+|.+.++.. .|---+.|+....+|+ +++|+.... ...+++..|++++..+.+.++ +..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 46678888888887755443 4555778998877665 888987542 122344556666766643222 1111
Q ss_pred c------eEeeCCcceEEEEeccCCCccccccc--------------cCC------C-CCC-----------------CH
Q 047038 441 G------CCLETEVPLLVYEFISNGTLSQYIDD--------------QNK------D-FRI-----------------SW 476 (708)
Q Consensus 441 g------~~~~~~~~~lV~E~~~~gsL~~~l~~--------------~~~------~-~~l-----------------~~ 476 (708)
. +.........++.++.+......-.. ... . ... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 11223445667777665433321100 000 0 000 00
Q ss_pred HHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCcEEEeeccCCc
Q 047038 477 EMRLCIAIDVSGAISYLHSA-ASIPIYHRDIKSTNILLDDKYCAKVSDFGASR 528 (708)
Q Consensus 477 ~~~~~i~~~i~~al~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGls~ 528 (708)
......+..+...+.-.+.. -+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11111222222222222221 12349999999999999998878899999764
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.54 E-value=0.0022 Score=41.84 Aligned_cols=28 Identities=18% Similarity=0.430 Sum_probs=24.0
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTY 270 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy 270 (708)
.|..++.|.++.| +|.|.|+.||.||.+
T Consensus 8 ~C~~~A~C~Nt~G-sy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 8 QCSVHAECRDYAT-GFCCRCVANYTGNGR 35 (40)
T ss_dssp GSCTTEEEEECSS-CEEEEECTTEEECSS
T ss_pred CCCCCCEeecCCC-CeEeECCCCCcCCCC
Confidence 6888899999655 699999999999854
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.22 E-value=0.027 Score=36.71 Aligned_cols=27 Identities=22% Similarity=0.493 Sum_probs=23.5
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.. ....+|.|.|..||.|.
T Consensus 5 PC~ngG~C~~~~~~~~y~C~C~~g~~G~ 32 (41)
T d1tpga1 5 RCFNGGTCQQALYFSDFVCQCPEGFAGK 32 (41)
T ss_dssp CSCTTCEEEEESSSSCEEEECCTTCBSS
T ss_pred CCCCCCEEecCCCCCCeEECCCCCCCCC
Confidence 6888899998 56779999999999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.04 E-value=0.044 Score=35.25 Aligned_cols=27 Identities=22% Similarity=0.399 Sum_probs=22.6
Q ss_pred ccccCCCceeecCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
..|...+.|.+. ..+|.|.|..||.|.
T Consensus 9 ~PC~ngg~C~~~-~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 9 NPCLNGGSCKDD-INSYECWCPFGFEGK 35 (39)
T ss_dssp CCCCTTCEEEEE-TTEEEEECCTTCCST
T ss_pred CCCCCCcEEEcC-CCCEEEECCCCCCCC
Confidence 468888999873 458999999999995
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.51 E-value=0.034 Score=36.47 Aligned_cols=27 Identities=26% Similarity=0.704 Sum_probs=22.5
Q ss_pred ccccCCCceeecCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
..|..++.|.+..+ +|.|.|+.||.|.
T Consensus 11 ~pC~n~g~C~n~~g-~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 11 NPCEHAGKCINTLG-SFECQCLQGYTGP 37 (42)
T ss_dssp CSSSTTCEEEECSS-SEEEECCTTEEST
T ss_pred CCCCCCcEeECCCC-CEEeECCCCCcCC
Confidence 46888899998433 6999999999986
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.50 E-value=0.052 Score=34.87 Aligned_cols=27 Identities=26% Similarity=0.549 Sum_probs=22.3
Q ss_pred ccccCCCceeecCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
..|...+.|.+. ..+|.|.|..||.|.
T Consensus 7 ~PC~n~g~C~~~-~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 7 NPCQNDATCLDQ-IGEFQCICMPGYEGV 33 (39)
T ss_dssp CCCCSSCEEEEC-SSCEEEECCTTEESS
T ss_pred CCCCCCCEEECC-CCCEEEeCCCCCccC
Confidence 368888999973 458999999999995
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.98 E-value=0.076 Score=36.66 Aligned_cols=27 Identities=22% Similarity=0.452 Sum_probs=23.7
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
-|...++|.+ ....+|.|.|..||.|.
T Consensus 13 ~C~NgG~C~~~~~~~~~~C~C~~gy~G~ 40 (53)
T d3egfa_ 13 YCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp CSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred CCCCCcEeeccCCCCCeEeECCCCCcCC
Confidence 5888899987 56679999999999996
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.78 E-value=0.051 Score=35.80 Aligned_cols=29 Identities=24% Similarity=0.453 Sum_probs=21.5
Q ss_pred CCceeecCCCceEeecCCCCCCCCCcCccC
Q 047038 246 DGYCLVQLGSGYFCLCNDRRLSGTYPDLCE 275 (708)
Q Consensus 246 ~s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~ 275 (708)
++.|.++.| +|.|.|..||..++-...|.
T Consensus 14 ~~~C~Nt~G-~y~C~C~~Gy~l~~d~~~C~ 42 (43)
T d1uzka1 14 SGNCVNTPG-SYICDCPPDFELNPTRVGCV 42 (43)
T ss_dssp TSEEEEETT-EEEEECCTTCEECTTSSBEE
T ss_pred CCEeECCCC-CEEEecCCCCEECCCCCccc
Confidence 468888554 89999999998775544443
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.62 E-value=0.072 Score=33.26 Aligned_cols=27 Identities=22% Similarity=0.539 Sum_probs=22.2
Q ss_pred ccccCCCceeecCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
..|...+.|.+. ..+|.|.|..||.|.
T Consensus 6 ~PC~ngg~C~~~-~~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 6 SPCLHNGRCLDK-INEFQCECPTGFTGH 32 (35)
T ss_dssp CCSTTTCEEEEC-SSCEEEECCTTEESS
T ss_pred CCCCCCcEEECC-CCCeEEECCCCCCCC
Confidence 368888999873 348999999999985
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.16 E-value=0.055 Score=34.74 Aligned_cols=27 Identities=22% Similarity=0.497 Sum_probs=22.2
Q ss_pred ccccCCCceeecCCCceEeecCCCCCCC
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
..|...+.|.+. ..+|.|.|..||.|.
T Consensus 6 ~PC~ngg~C~~~-~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 6 SPCQNQGKCKDG-LGEYTCTCLEGFEGK 32 (39)
T ss_dssp CCCCSSCEECCC-SSSCCEECCTTEETT
T ss_pred CCCCCCcEEECC-CCCEEEECCCCCCcC
Confidence 368888999873 457999999999995
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=89.87 E-value=0.06 Score=34.09 Aligned_cols=26 Identities=27% Similarity=0.595 Sum_probs=21.7
Q ss_pred cccCCCceeecCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.+. ..+|.|.|..||.|.
T Consensus 9 PC~ngg~C~~~-~~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 9 PCQNGGSCKDQ-LQSYICFCLPAFEGR 34 (37)
T ss_dssp CCCTTCEEEEE-TTEEEEECCTTEEST
T ss_pred CCCCCCEEECC-CCCeEEECCCCCcCC
Confidence 68888999873 458999999999985
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=89.72 E-value=0.07 Score=34.86 Aligned_cols=28 Identities=21% Similarity=0.434 Sum_probs=22.7
Q ss_pred ccccCCCceeecCCCceEeecCC-CCCCC
Q 047038 241 TSCNQDGYCLVQLGSGYFCLCND-RRLSG 268 (708)
Q Consensus 241 ~~C~~~s~C~~~~~~Gy~C~C~~-G~~gn 268 (708)
..|...+.|.+....+|.|.|.. ||.|.
T Consensus 8 nPC~ngG~C~~~~~~~y~C~C~~~G~~G~ 36 (42)
T d1q4ga2 8 YPCQHQGICVRFGLDRYQCDCTRTGYSGP 36 (42)
T ss_dssp CCCCTTCEEEEETTTEEEEECTTSSEETT
T ss_pred CCCCCCCEeeeCCCCCEEEECCCCCcCCc
Confidence 36888899987555689999985 89885
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.55 E-value=0.064 Score=34.43 Aligned_cols=26 Identities=27% Similarity=0.562 Sum_probs=21.9
Q ss_pred cccCCCceeecCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.+. ..+|.|.|..||.|.
T Consensus 8 pC~ngg~C~~~-~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 8 SCSGHGECVET-INNYTCKCDPGFSGL 33 (39)
T ss_dssp GGGGSEEEEEE-TTEEEEEECTTEEST
T ss_pred cCCCCcEEECC-CCCEEEeCCCCCcCc
Confidence 68888999873 458999999999996
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.48 E-value=0.062 Score=35.47 Aligned_cols=26 Identities=31% Similarity=0.742 Sum_probs=20.5
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGT 269 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnp 269 (708)
.|. .+.|.|+.| +|.|.|+.||.++.
T Consensus 12 ~C~-~~~C~Nt~G-sy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 12 LCG-RGQCVNTPG-DFECKCDEGYESGF 37 (44)
T ss_dssp TTT-TSCEEEETT-EEEECCCSSEEECT
T ss_pred CCC-CCEeEcCCC-CeEEeCCCCCccCC
Confidence 453 578999655 79999999999863
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.23 E-value=0.097 Score=33.75 Aligned_cols=26 Identities=31% Similarity=0.639 Sum_probs=21.7
Q ss_pred cccCCCceeecCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
.|...+.|.+. ..+|.|.|..||.|.
T Consensus 8 pC~ngg~C~~~-~~~y~C~C~~g~~G~ 33 (40)
T d1g1sa2 8 SCSKQGECLET-IGNYTCSCYPGFYGP 33 (40)
T ss_dssp GGGGSEEEEEC-SSSEEEEECTTEEST
T ss_pred cCCCCcEEECC-CCCeEEeCCCCccCC
Confidence 67788999873 348999999999995
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.96 E-value=0.088 Score=35.49 Aligned_cols=27 Identities=26% Similarity=0.577 Sum_probs=23.4
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
.|...++|.. ....+|.|.|..||.|.
T Consensus 11 ~C~ngG~C~~~~~~~~~~C~C~~gy~G~ 38 (48)
T d1nqlb_ 11 YCLHDGVCMYIEALDKYACNCVVGYIGE 38 (48)
T ss_dssp EECTTCEEEEETTTTEEEEEECTTEEST
T ss_pred CCCCCcEEeeeCCCCCeEEeCCCCcccC
Confidence 5888899987 55679999999999996
|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.42 E-value=0.1 Score=33.86 Aligned_cols=27 Identities=22% Similarity=0.488 Sum_probs=21.7
Q ss_pred cccCCCceeecCCCceEeecC-CCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCN-DRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~-~G~~gn 268 (708)
.|...+.|.+....+|.|.|+ .||.|.
T Consensus 8 PC~ngG~C~~~~~~~y~C~C~~~gy~G~ 35 (41)
T d1cvua2 8 PCQNRGECMSTGFDQYKCDCTRTGFYGE 35 (41)
T ss_dssp CCCTTCEEEEEETTEEEEECTTSSEETT
T ss_pred CCCCCCEEEECCCCCEEEeCcCCCcCCc
Confidence 688889998744458999997 499885
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.27 E-value=0.18 Score=32.80 Aligned_cols=27 Identities=26% Similarity=0.557 Sum_probs=20.7
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTY 270 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy 270 (708)
.|. ++.|.|+.| +|+|.|..||..++-
T Consensus 11 ~C~-~~~C~Nt~G-sy~C~C~~Gy~l~~d 37 (42)
T d1lmja2 11 LCR-GGVCHNTEG-SYRCECPPGHQLSPN 37 (42)
T ss_dssp TTT-TSEEEEETT-EEEEESCTTSCCCSS
T ss_pred CCC-CCEeECCCC-CeEEeCCCCCeECcC
Confidence 453 578998655 899999999997643
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.27 E-value=0.18 Score=30.68 Aligned_cols=24 Identities=25% Similarity=0.678 Sum_probs=18.9
Q ss_pred CCceeecCCCceEeecCCCCCCCCC
Q 047038 246 DGYCLVQLGSGYFCLCNDRRLSGTY 270 (708)
Q Consensus 246 ~s~C~~~~~~Gy~C~C~~G~~gnpy 270 (708)
+++|.+.. .|+.|.|.+||+..|-
T Consensus 12 nGTCtNvi-GgFec~C~~GFepgpm 35 (39)
T d1emoa2 12 NGTCKNVI-GGFECTCEEGFEPGPM 35 (39)
T ss_dssp SSCEEECS-SSEEECCSSSSCCCSS
T ss_pred Cceeeecc-cceEEeecCCcCCCcc
Confidence 46777733 3899999999998875
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.23 E-value=0.19 Score=32.89 Aligned_cols=27 Identities=22% Similarity=0.628 Sum_probs=20.4
Q ss_pred cccCCCceeecCCCceEeecCCCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSGTY 270 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gnpy 270 (708)
.|. ++.|.++.| +|+|.|..||..++-
T Consensus 12 ~c~-~~~C~Nt~G-sy~C~C~~Gy~l~~~ 38 (43)
T d1uzka2 12 LCQ-GGKCINTFG-SFQCRCPTGYYLNED 38 (43)
T ss_dssp GGB-TSEEEECSS-CEEEECCTTCCBCTT
T ss_pred CcC-CCEEECCCC-CeEeECCCCCeECcC
Confidence 453 468888554 799999999987743
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.11 E-value=0.24 Score=34.05 Aligned_cols=23 Identities=30% Similarity=0.677 Sum_probs=17.8
Q ss_pred CCceeecCCCceEeecCCCCCCCC
Q 047038 246 DGYCLVQLGSGYFCLCNDRRLSGT 269 (708)
Q Consensus 246 ~s~C~~~~~~Gy~C~C~~G~~gnp 269 (708)
+..|.|+.| +|.|.|..||..++
T Consensus 23 ~~~C~Nt~G-sY~C~C~~Gy~l~~ 45 (53)
T d1apqa_ 23 QHLCHNYVG-GYFCSCRPGYELQE 45 (53)
T ss_dssp SSEEEEETT-EEEEECSTTCEECT
T ss_pred cCEeEcCCC-CeEeECCCCCeECC
Confidence 357888654 89999999998553
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.49 E-value=0.12 Score=33.26 Aligned_cols=23 Identities=22% Similarity=0.509 Sum_probs=17.8
Q ss_pred CceeecCCCceEeecCCCCCCCCC
Q 047038 247 GYCLVQLGSGYFCLCNDRRLSGTY 270 (708)
Q Consensus 247 s~C~~~~~~Gy~C~C~~G~~gnpy 270 (708)
..|.++.| +|+|.|..||..++.
T Consensus 13 ~~C~N~~G-sy~C~C~~Gy~l~g~ 35 (40)
T d1dx5i3 13 GVCHNLPG-TFECICGPDSALAGQ 35 (40)
T ss_dssp SEEEECSS-SEEEEECSSSSCEEE
T ss_pred CEeeCCCC-CeEeECCCCCeeCCC
Confidence 56777444 899999999998643
|
| >d1dx5i1 g.3.11.1 (I:345-387) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.81 E-value=0.084 Score=33.28 Aligned_cols=28 Identities=21% Similarity=0.482 Sum_probs=21.1
Q ss_pred CceeecCCCceEeecCCCCCCCCC-cCcc
Q 047038 247 GYCLVQLGSGYFCLCNDRRLSGTY-PDLC 274 (708)
Q Consensus 247 s~C~~~~~~Gy~C~C~~G~~gnpy-~~~c 274 (708)
-.|...+..+|+|.|..||..-|- |..|
T Consensus 14 ~qCqP~~~~~Y~CiCaeGFaP~p~~PhrC 42 (43)
T d1dx5i1 14 YQCQPLDQTSYLCVCAEGFAPIPHEPHRC 42 (43)
T ss_dssp SEEEECSSSCEEEECCTTEEEETTEEEEE
T ss_pred eeeeeCCCCcceEEeccccccCCCCcccC
Confidence 345555677999999999988776 6555
|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epiregulin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.85 E-value=0.31 Score=32.27 Aligned_cols=26 Identities=23% Similarity=0.432 Sum_probs=21.2
Q ss_pred cccCCCceee-cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV-QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~-~~~~Gy~C~C~~G~~gn 268 (708)
-|.. |.|.. ....+|.|+|..||.|.
T Consensus 13 yC~n-G~C~~~~~~~~~~C~C~~gY~G~ 39 (46)
T d1k36a_ 13 YCLH-GQCIYLVDMSQNYCRCEVGYTGV 39 (46)
T ss_dssp SCSS-EEEEEETTTTEEEEEECTTCSST
T ss_pred cCcC-CEEEEeCCCCccEeECCCCceec
Confidence 5765 77876 56678999999999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.56 E-value=0.18 Score=32.57 Aligned_cols=28 Identities=21% Similarity=0.529 Sum_probs=19.5
Q ss_pred CceeecCCCceEeecCCCCCCCCCcCccC
Q 047038 247 GYCLVQLGSGYFCLCNDRRLSGTYPDLCE 275 (708)
Q Consensus 247 s~C~~~~~~Gy~C~C~~G~~gnpy~~~c~ 275 (708)
..|.++. .+|+|.|..||.-++-...|+
T Consensus 12 ~~C~n~~-Gsy~C~C~~Gy~L~~d~~~C~ 39 (41)
T d1i0ua2 12 QLCVNLE-GGYKCQCEEGFQLDPHTKACK 39 (41)
T ss_dssp SCEECSS-SCCEECCCTTEEECTTTCCEE
T ss_pred CEeECCC-CCEEeECCCCCeECCCCCccc
Confidence 4677744 489999999998765433454
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.23 E-value=0.19 Score=32.86 Aligned_cols=23 Identities=26% Similarity=0.576 Sum_probs=18.0
Q ss_pred CCCceeecCCCceEeecCCCCCCC
Q 047038 245 QDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 245 ~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
.++.|.|+.| +|.|.|+.||.++
T Consensus 15 ~~~~C~Nt~G-sy~C~C~~Gy~~~ 37 (43)
T d1emoa1 15 KHGQCINTDG-SYRCECPFGYILA 37 (43)
T ss_dssp SSSCCCCCSS-CCCCCCCTTEEES
T ss_pred CCCEeECCCC-CeEeECCCCcccC
Confidence 3567888544 7999999999865
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.22 E-value=0.3 Score=34.92 Aligned_cols=27 Identities=26% Similarity=0.608 Sum_probs=22.1
Q ss_pred cccCCCceee----cCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLV----QLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~----~~~~Gy~C~C~~G~~gn 268 (708)
-|...+.|.. ....+|.|.|..||.|.
T Consensus 13 ~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G~ 43 (63)
T d1haea_ 13 FCVNGGECFMVKDLSNPSRYLCKCQPGFTGA 43 (63)
T ss_dssp TSCTTCEEEEEESSSSSCCEEEECCTTEEST
T ss_pred cCCCCCEEeecccccCCCCEEeECCCCCCCC
Confidence 6888899974 23468999999999996
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.54 E-value=0.27 Score=32.88 Aligned_cols=25 Identities=20% Similarity=0.543 Sum_probs=19.6
Q ss_pred cccCCCceeecCCCceEeecCCCCCCC
Q 047038 242 SCNQDGYCLVQLGSGYFCLCNDRRLSG 268 (708)
Q Consensus 242 ~C~~~s~C~~~~~~Gy~C~C~~G~~gn 268 (708)
.|.. ++|.+. ..+|.|.|+.||.|.
T Consensus 15 PC~n-G~C~~~-~~~y~C~C~~G~~G~ 39 (48)
T d1autl1 15 CCGH-GTCIDG-IGSFSCDCRSGWEGR 39 (48)
T ss_dssp TTTS-EEECCC-SSCCCEEECTTEEST
T ss_pred CCCC-CEEECC-CCCCeEeCCCCCcCC
Confidence 5653 888873 347999999999985
|